question_id,model_name,avg_score,question
0,llama4,0.797,HISTOLOGIC GRADE
1,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2,llama4,0.89,TUMOR SITE
3,llama4,0.681,LYMPHOVASCULAR INVASION
4,llama4,0.811,TUMOR FOCALITY
5,llama4,0.697,SPECIMEN LATERALITY
6,llama4,0.742,MARGIN STATUS FOR INVASIVE CARCINOMA
7,llama4,0.827,PROCEDURE
8,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
9,llama4,0.925,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
10,llama4,0.718,SPREAD THROUGH AIR SPACES (STAS)
11,llama4,0.78,VISCERAL PLEURA INVASION
12,llama4,0.938,ADDITIONAL FINDINGS
13,llama4,0.721,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
14,llama4,0.821,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
15,llama4,0.778,HISTOLOGIC GRADE
16,llama4,0.855,MARGIN STATUS FOR INVASIVE CARCINOMA
17,llama4,0.698,NUMBER OF LYMPH NODES WITH TUMOR
18,llama4,0.811,TUMOR FOCALITY
19,llama4,0.772,PROCEDURE
20,llama4,0.83,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
21,llama4,0.739,NUMBER OF LYMPH NODES EXAMINED
22,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
23,llama4,0.786,NODAL SITE(S) EXAMINED
24,llama4,0.681,LYMPHOVASCULAR INVASION
25,llama4,0.761,REGIONAL LYMPH NODE STATUS
26,llama4,0.78,VISCERAL PLEURA INVASION
27,llama4,0.672,MARGIN STATUS FOR NON-INVASIVE TUMOR
28,llama4,0.718,SPREAD THROUGH AIR SPACES (STAS)
29,llama4,0.698,SPECIMEN LATERALITY
30,llama4,0.782,ADDITIONAL FINDINGS
31,llama4,0.689,NODAL SITE(S) WITH TUMOR
32,llama4,0.89,TUMOR SITE
33,llama4,0.702,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
34,llama4,0.759,MARGIN STATUS FOR INVASIVE CARCINOMA
35,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
36,llama4,0.698,SPECIMEN LATERALITY
37,llama4,0.811,TUMOR FOCALITY
38,llama4,0.729,NUMBER OF LYMPH NODES EXAMINED
39,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
40,llama4,0.759,NODAL SITE(S) EXAMINED
41,llama4,0.77,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
42,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
43,llama4,0.686,NODAL SITE(S) WITH TUMOR
44,llama4,0.788,PROCEDURE
45,llama4,0.703,NUMBER OF LYMPH NODES WITH TUMOR
46,llama4,0.856,REGIONAL LYMPH NODE STATUS
47,llama4,0.698,VISCERAL PLEURA INVASION
48,llama4,0.89,TUMOR SITE
49,llama4,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
50,llama4,0.788,PROCEDURE
51,llama4,0.877,REGIONAL LYMPH NODE STATUS
52,llama4,0.811,TUMOR FOCALITY
53,llama4,0.697,SPECIMEN LATERALITY
54,llama4,0.797,HISTOLOGIC GRADE
55,llama4,0.841,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
56,llama4,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
57,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
58,llama4,0.819,NODAL SITE(S) EXAMINED
59,llama4,0.838,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
60,llama4,0.89,TUMOR SITE
61,llama4,0.716,LYMPHOVASCULAR INVASION
62,llama4,0.778,VISCERAL PLEURA INVASION
63,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
64,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
65,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
66,llama4,0.917,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
67,llama4,0.751,ADDITIONAL FINDINGS
68,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
69,llama4,0.778,VISCERAL PLEURA INVASION
70,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
71,llama4,0.877,REGIONAL LYMPH NODE STATUS
72,llama4,0.719,NODAL SITE(S) EXAMINED
73,llama4,0.89,TUMOR SITE
74,llama4,0.714,NUMBER OF LYMPH NODES EXAMINED
75,llama4,0.881,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
76,llama4,0.827,PROCEDURE
77,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
78,llama4,0.759,MARGIN STATUS FOR INVASIVE CARCINOMA
79,llama4,0.687,TUMOR FOCALITY
80,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
81,llama4,0.8,HISTOLOGIC GRADE
82,llama4,0.697,SPECIMEN LATERALITY
83,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
84,llama4,0.827,NODAL SITE(S) EXAMINED
85,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
86,llama4,0.8,HISTOLOGIC GRADE
87,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
88,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
89,llama4,0.826,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
90,llama4,0.841,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
91,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
92,llama4,0.89,TUMOR SITE
93,llama4,0.778,VISCERAL PLEURA INVASION
94,llama4,0.877,REGIONAL LYMPH NODE STATUS
95,llama4,0.697,SPECIMEN LATERALITY
96,llama4,0.707,PROCEDURE
97,llama4,0.736,TUMOR FOCALITY
98,llama4,0.744,NODAL SITE(S) EXAMINED
99,llama4,0.89,TUMOR SITE
100,llama4,0.698,SPECIMEN LATERALITY
101,llama4,0.742,MARGIN STATUS FOR INVASIVE CARCINOMA
102,llama4,0.778,VISCERAL PLEURA INVASION
103,llama4,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
104,llama4,0.732,ADDITIONAL FINDINGS
105,llama4,0.819,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
106,llama4,0.757,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
107,llama4,0.759,PROCEDURE
108,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
109,llama4,0.811,TUMOR FOCALITY
110,llama4,0.874,REGIONAL LYMPH NODE STATUS
111,llama4,0.778,HISTOLOGIC GRADE
112,llama4,0.793,NUMBER OF LYMPH NODES EXAMINED
113,llama4,0.673,TNM DESCRIPTORS
114,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
115,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
116,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
117,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
118,llama4,0.711,NODAL SITE(S) EXAMINED
119,llama4,0.914,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
120,llama4,0.778,VISCERAL PLEURA INVASION
121,llama4,0.772,MARGIN STATUS FOR INVASIVE CARCINOMA
122,llama4,0.811,TUMOR FOCALITY
123,llama4,0.865,TUMOR SITE
124,llama4,0.72,HISTOLOGIC GRADE
125,llama4,0.698,SPECIMEN LATERALITY
126,llama4,0.746,PROCEDURE
127,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
128,llama4,0.661,TNM DESCRIPTORS
129,llama4,0.877,REGIONAL LYMPH NODE STATUS
130,llama4,0.782,ADDITIONAL FINDINGS
131,llama4,0.823,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
132,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
133,llama4,0.8,HISTOLOGIC GRADE
134,llama4,0.782,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
135,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
136,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
137,llama4,0.811,TUMOR FOCALITY
138,llama4,0.788,PROCEDURE
139,llama4,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
140,llama4,0.829,ADDITIONAL FINDINGS
141,llama4,0.697,SPECIMEN LATERALITY
142,llama4,0.838,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
143,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
144,llama4,0.877,REGIONAL LYMPH NODE STATUS
145,llama4,0.81,NODAL SITE(S) EXAMINED
146,llama4,0.787,TUMOR SITE
147,llama4,0.778,VISCERAL PLEURA INVASION
148,llama4,0.706,HISTOLOGIC GRADE
149,llama4,0.697,SPECIMEN LATERALITY
150,llama4,0.741,NODAL SITE(S) EXAMINED
151,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
152,llama4,0.733,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
153,llama4,0.865,TUMOR SITE
154,llama4,0.863,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
155,llama4,0.811,TUMOR FOCALITY
156,llama4,0.729,ADDITIONAL FINDINGS
157,llama4,0.877,REGIONAL LYMPH NODE STATUS
158,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
159,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
160,llama4,0.83,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
161,llama4,0.694,NUMBER OF LYMPH NODES EXAMINED
162,llama4,0.778,VISCERAL PLEURA INVASION
163,llama4,0.788,PROCEDURE
164,llama4,0.781,TUMOR SITE
165,llama4,0.716,LYMPHOVASCULAR INVASION
166,llama4,0.698,SPECIMEN LATERALITY
167,llama4,0.829,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
168,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
169,llama4,0.856,REGIONAL LYMPH NODE STATUS
170,llama4,0.817,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
171,llama4,0.695,TNM DESCRIPTORS
172,llama4,0.715,NUMBER OF LYMPH NODES WITH TUMOR
173,llama4,0.716,ADDITIONAL FINDINGS
174,llama4,0.797,HISTOLOGIC GRADE
175,llama4,0.757,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
176,llama4,0.778,VISCERAL PLEURA INVASION
177,llama4,0.799,NODAL SITE(S) WITH TUMOR
178,llama4,0.757,NODAL SITE(S) EXAMINED
179,llama4,0.718,SPREAD THROUGH AIR SPACES (STAS)
180,llama4,0.761,MARGIN STATUS FOR INVASIVE CARCINOMA
181,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
182,llama4,0.788,PROCEDURE
183,llama4,0.811,TUMOR FOCALITY
184,llama4,0.738,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
185,llama4,0.827,PROCEDURE
186,llama4,0.648,TNM DESCRIPTORS
187,llama4,0.778,VISCERAL PLEURA INVASION
188,llama4,0.697,SPECIMEN LATERALITY
189,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
190,llama4,0.756,MARGIN STATUS FOR INVASIVE CARCINOMA
191,llama4,0.773,TUMOR SITE
192,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
193,llama4,0.693,HISTOLOGIC GRADE
194,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
195,llama4,0.832,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
196,llama4,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
197,llama4,0.8,HISTOLOGIC GRADE
198,llama4,0.697,SPECIMEN LATERALITY
199,llama4,0.826,MARGIN STATUS FOR NON-INVASIVE TUMOR
200,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
201,llama4,0.89,TUMOR SITE
202,llama4,0.775,NODAL SITE(S) EXAMINED
203,llama4,0.811,TUMOR FOCALITY
204,llama4,0.877,REGIONAL LYMPH NODE STATUS
205,llama4,0.713,NUMBER OF LYMPH NODES EXAMINED
206,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
207,llama4,0.827,PROCEDURE
208,llama4,0.837,ADDITIONAL FINDINGS
209,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
210,llama4,0.778,VISCERAL PLEURA INVASION
211,llama4,0.797,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
212,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
213,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
214,llama4,0.811,TUMOR FOCALITY
215,llama4,0.803,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
216,llama4,0.697,NUMBER OF LYMPH NODES EXAMINED
217,llama4,0.826,NODAL SITE(S) EXAMINED
218,llama4,0.8,HISTOLOGIC GRADE
219,llama4,0.697,SPECIMEN LATERALITY
220,llama4,0.819,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
221,llama4,0.778,VISCERAL PLEURA INVASION
222,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
223,llama4,0.827,PROCEDURE
224,llama4,0.77,MARGIN STATUS FOR INVASIVE CARCINOMA
225,llama4,0.877,REGIONAL LYMPH NODE STATUS
226,llama4,0.887,TUMOR SITE
227,llama4,0.788,PROCEDURE
228,llama4,0.713,NUMBER OF LYMPH NODES EXAMINED
229,llama4,0.739,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
230,llama4,0.778,VISCERAL PLEURA INVASION
231,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
232,llama4,0.802,TUMOR SITE
233,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
234,llama4,0.757,LYMPH NODE(S) FROM PRIOR PROCEDURES
235,llama4,0.811,TUMOR FOCALITY
236,llama4,0.8,HISTOLOGIC GRADE
237,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
238,llama4,0.805,NODAL SITE(S) EXAMINED
239,llama4,0.697,SPECIMEN LATERALITY
240,llama4,0.695,ADDITIONAL FINDINGS
241,llama4,0.802,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
242,llama4,0.877,REGIONAL LYMPH NODE STATUS
243,llama4,0.738,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
244,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
245,llama4,0.811,TUMOR FOCALITY
246,llama4,0.859,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
247,llama4,0.778,VISCERAL PLEURA INVASION
248,llama4,0.725,NODAL SITE(S) EXAMINED
249,llama4,0.877,REGIONAL LYMPH NODE STATUS
250,llama4,0.89,TUMOR SITE
251,llama4,0.761,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
252,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
253,llama4,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
254,llama4,0.778,HISTOLOGIC GRADE
255,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
256,llama4,0.697,SPECIMEN LATERALITY
257,llama4,0.788,PROCEDURE
258,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
259,llama4,0.697,NUMBER OF LYMPH NODES EXAMINED
260,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
261,llama4,0.691,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
262,llama4,0.811,TUMOR FOCALITY
263,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
264,llama4,0.697,SPECIMEN LATERALITY
265,llama4,0.78,VISCERAL PLEURA INVASION
266,llama4,0.819,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
267,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
268,llama4,0.718,SPREAD THROUGH AIR SPACES (STAS)
269,llama4,0.749,PROCEDURE
270,llama4,0.687,LYMPHOVASCULAR INVASION
271,llama4,0.89,TUMOR SITE
272,llama4,0.785,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
273,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
274,llama4,0.72,NUMBER OF LYMPH NODES WITH TUMOR
275,llama4,0.797,HISTOLOGIC GRADE
276,llama4,0.73,REGIONAL LYMPH NODE STATUS
277,llama4,0.698,VISCERAL PLEURA INVASION
278,llama4,0.686,NODAL SITE(S) EXAMINED
279,llama4,0.796,REGIONAL LYMPH NODE STATUS
280,llama4,0.741,NODAL SITE(S) WITH TUMOR
281,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
282,llama4,0.877,REGIONAL LYMPH NODE STATUS
283,llama4,0.73,NUMBER OF LYMPH NODES EXAMINED
284,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
285,llama4,0.722,NUMBER OF LYMPH NODES EXAMINED
286,llama4,0.837,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
287,llama4,0.817,PROCEDURE
288,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
289,llama4,0.731,LYMPHOVASCULAR INVASION
290,llama4,0.711,NODAL SITE(S) EXAMINED
291,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
292,llama4,0.746,TUMOR SITE
293,llama4,0.698,VISCERAL PLEURA INVASION
294,llama4,0.86,PROCEDURE
295,llama4,0.718,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
296,llama4,0.822,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
297,llama4,0.697,SPECIMEN LATERALITY
298,llama4,0.811,TUMOR FOCALITY
299,llama4,0.752,MARGIN STATUS FOR INVASIVE CARCINOMA
300,llama4,0.78,VISCERAL PLEURA INVASION
301,llama4,0.734,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
302,llama4,0.827,PROCEDURE
303,llama4,0.697,SPECIMEN LATERALITY
304,llama4,0.715,ADDITIONAL FINDINGS
305,llama4,0.874,REGIONAL LYMPH NODE STATUS
306,llama4,0.811,TUMOR FOCALITY
307,llama4,0.778,HISTOLOGIC GRADE
308,llama4,0.717,NODAL SITE(S) EXAMINED
309,llama4,0.819,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
310,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
311,llama4,0.826,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
312,llama4,0.89,TUMOR SITE
313,llama4,0.811,TUMOR FOCALITY
314,llama4,0.877,REGIONAL LYMPH NODE STATUS
315,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
316,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
317,llama4,0.826,NODAL SITE(S) EXAMINED
318,llama4,0.89,TUMOR SITE
319,llama4,0.896,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
320,llama4,0.756,PROCEDURE
321,llama4,0.697,SPECIMEN LATERALITY
322,llama4,0.802,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
323,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
324,llama4,0.797,HISTOLOGIC GRADE
325,llama4,0.778,VISCERAL PLEURA INVASION
326,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
327,llama4,0.797,HISTOLOGIC GRADE
328,llama4,0.721,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
329,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
330,llama4,0.712,PROCEDURE
331,llama4,0.811,TUMOR FOCALITY
332,llama4,0.697,SPECIMEN LATERALITY
333,llama4,0.877,REGIONAL LYMPH NODE STATUS
334,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
335,llama4,0.778,VISCERAL PLEURA INVASION
336,llama4,0.805,NODAL SITE(S) EXAMINED
337,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
338,llama4,0.829,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
339,llama4,0.872,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
340,llama4,0.89,TUMOR SITE
341,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
342,llama4,0.697,SPECIMEN LATERALITY
343,llama4,0.89,TUMOR SITE
344,llama4,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
345,llama4,0.778,VISCERAL PLEURA INVASION
346,llama4,0.837,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
347,llama4,0.721,ADDITIONAL FINDINGS
348,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
349,llama4,0.874,REGIONAL LYMPH NODE STATUS
350,llama4,0.811,TUMOR FOCALITY
351,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
352,llama4,0.827,PROCEDURE
353,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
354,llama4,0.741,NODAL SITE(S) EXAMINED
355,llama4,0.797,HISTOLOGIC GRADE
356,llama4,0.699,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
357,llama4,0.811,TUMOR FOCALITY
358,llama4,0.838,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
359,llama4,0.698,SPECIMEN LATERALITY
360,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
361,llama4,0.877,REGIONAL LYMPH NODE STATUS
362,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
363,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
364,llama4,0.704,NUMBER OF LYMPH NODES EXAMINED
365,llama4,0.77,PROCEDURE
366,llama4,0.756,NODAL SITE(S) EXAMINED
367,llama4,0.833,TUMOR SITE
368,llama4,0.778,VISCERAL PLEURA INVASION
369,llama4,0.824,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
370,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
371,llama4,0.796,PROCEDURE
372,llama4,0.877,REGIONAL LYMPH NODE STATUS
373,llama4,0.698,SPECIMEN LATERALITY
374,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
375,llama4,0.83,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
376,llama4,0.763,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
377,llama4,0.697,NUMBER OF LYMPH NODES EXAMINED
378,llama4,0.811,TUMOR FOCALITY
379,llama4,0.742,MARGIN STATUS FOR INVASIVE CARCINOMA
380,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
381,llama4,0.778,VISCERAL PLEURA INVASION
382,llama4,0.797,HISTOLOGIC GRADE
383,llama4,0.881,TUMOR SITE
384,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
385,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
386,llama4,0.697,SPECIMEN LATERALITY
387,llama4,0.771,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
388,llama4,0.778,VISCERAL PLEURA INVASION
389,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
390,llama4,0.877,REGIONAL LYMPH NODE STATUS
391,llama4,0.715,ADDITIONAL FINDINGS
392,llama4,0.888,MARGIN STATUS FOR NON-INVASIVE TUMOR
393,llama4,0.86,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
394,llama4,0.801,TUMOR SITE
395,llama4,0.822,NODAL SITE(S) EXAMINED
396,llama4,0.798,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
397,llama4,0.648,TNM DESCRIPTORS
398,llama4,0.735,TUMOR FOCALITY
399,llama4,0.728,HISTOLOGIC GRADE
400,llama4,0.815,PROCEDURE
401,llama4,0.78,VISCERAL PLEURA INVASION
402,llama4,0.913,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
403,llama4,0.789,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
404,llama4,0.715,NUMBER OF LYMPH NODES EXAMINED
405,llama4,0.811,TUMOR FOCALITY
406,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
407,llama4,0.8,HISTOLOGIC GRADE
408,llama4,0.874,REGIONAL LYMPH NODE STATUS
409,llama4,0.697,SPECIMEN LATERALITY
410,llama4,0.802,TUMOR SITE
411,llama4,0.8,NODAL SITE(S) EXAMINED
412,llama4,0.788,PROCEDURE
413,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
414,llama4,0.742,MARGIN STATUS FOR INVASIVE CARCINOMA
415,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
416,llama4,0.754,NODAL SITE(S) EXAMINED
417,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
418,llama4,0.871,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
419,llama4,0.698,SPECIMEN LATERALITY
420,llama4,0.697,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
421,llama4,0.788,PROCEDURE
422,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
423,llama4,0.811,TUMOR FOCALITY
424,llama4,0.874,REGIONAL LYMPH NODE STATUS
425,llama4,0.755,MARGIN STATUS FOR INVASIVE CARCINOMA
426,llama4,0.904,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
427,llama4,0.778,VISCERAL PLEURA INVASION
428,llama4,0.89,TUMOR SITE
429,llama4,0.713,NUMBER OF LYMPH NODES EXAMINED
430,llama4,0.783,HISTOLOGIC GRADE
431,llama4,0.716,LYMPHOVASCULAR INVASION
432,llama4,0.867,NODAL SITE(S) WITH TUMOR
433,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
434,llama4,0.7,NUMBER OF LYMPH NODES WITH TUMOR
435,llama4,0.797,HISTOLOGIC GRADE
436,llama4,0.803,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
437,llama4,0.754,ADDITIONAL FINDINGS
438,llama4,0.781,REGIONAL LYMPH NODE STATUS
439,llama4,0.778,VISCERAL PLEURA INVASION
440,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
441,llama4,0.896,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
442,llama4,0.838,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
443,llama4,0.801,TUMOR SITE
444,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
445,llama4,0.697,SPECIMEN LATERALITY
446,llama4,0.708,TUMOR FOCALITY
447,llama4,0.74,NODAL SITE(S) EXAMINED
448,llama4,0.733,PROCEDURE
449,llama4,0.698,VISCERAL PLEURA INVASION
450,llama4,0.835,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
451,llama4,0.774,ADDITIONAL FINDINGS
452,llama4,0.802,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
453,llama4,0.811,TUMOR FOCALITY
454,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
455,llama4,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
456,llama4,0.765,NODAL SITE(S) EXAMINED
457,llama4,0.788,PROCEDURE
458,llama4,0.89,TUMOR SITE
459,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
460,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
461,llama4,0.697,SPECIMEN LATERALITY
462,llama4,0.8,HISTOLOGIC GRADE
463,llama4,0.762,NUMBER OF LYMPH NODES EXAMINED
464,llama4,0.733,HISTOLOGIC GRADE
465,llama4,0.698,SPECIMEN LATERALITY
466,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
467,llama4,0.798,PROCEDURE
468,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
469,llama4,0.698,VISCERAL PLEURA INVASION
470,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
471,llama4,0.733,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
472,llama4,0.78,NODAL SITE(S) EXAMINED
473,llama4,0.704,NODAL SITE(S) WITH TUMOR
474,llama4,0.798,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
475,llama4,0.763,REGIONAL LYMPH NODE STATUS
476,llama4,0.873,TUMOR FOCALITY
477,llama4,0.745,LYMPHOVASCULAR INVASION
478,llama4,0.726,NUMBER OF LYMPH NODES WITH TUMOR
479,llama4,0.824,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
480,llama4,0.806,TUMOR SITE
481,llama4,0.646,TNM DESCRIPTORS
482,llama4,0.743,MARGIN STATUS FOR NON-INVASIVE TUMOR
483,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
484,llama4,0.694,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
485,llama4,0.827,PROCEDURE
486,llama4,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
487,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
488,llama4,0.697,SPECIMEN LATERALITY
489,llama4,0.797,HISTOLOGIC GRADE
490,llama4,0.787,TUMOR SITE
491,llama4,0.718,ADDITIONAL FINDINGS
492,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
493,llama4,0.778,VISCERAL PLEURA INVASION
494,llama4,0.811,TUMOR FOCALITY
495,llama4,0.745,MARGIN STATUS FOR INVASIVE CARCINOMA
496,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
497,llama4,0.775,REGIONAL LYMPH NODE STATUS
498,llama4,0.788,PROCEDURE
499,llama4,0.642,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
500,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
501,llama4,0.702,LYMPHOVASCULAR INVASION
502,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
503,llama4,0.762,ADDITIONAL FINDINGS
504,llama4,0.789,HISTOLOGIC GRADE
505,llama4,0.811,TUMOR FOCALITY
506,llama4,0.883,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
507,llama4,0.72,NUMBER OF LYMPH NODES WITH TUMOR
508,llama4,0.697,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
509,llama4,0.834,NODAL SITE(S) EXAMINED
510,llama4,0.657,NODAL SITE(S) WITH TUMOR
511,llama4,0.697,SPECIMEN LATERALITY
512,llama4,0.778,VISCERAL PLEURA INVASION
513,llama4,0.802,TUMOR SITE
514,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
515,llama4,0.778,VISCERAL PLEURA INVASION
516,llama4,0.761,PROCEDURE
517,llama4,0.697,SPECIMEN LATERALITY
518,llama4,0.877,REGIONAL LYMPH NODE STATUS
519,llama4,0.81,TUMOR SITE
520,llama4,0.811,TUMOR FOCALITY
521,llama4,0.716,ADDITIONAL FINDINGS
522,llama4,0.764,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
523,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
524,llama4,0.703,NUMBER OF LYMPH NODES EXAMINED
525,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
526,llama4,0.726,NODAL SITE(S) EXAMINED
527,llama4,0.8,HISTOLOGIC GRADE
528,llama4,0.757,MARGIN STATUS FOR INVASIVE CARCINOMA
529,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
530,llama4,0.699,NUMBER OF LYMPH NODES EXAMINED
531,llama4,0.877,REGIONAL LYMPH NODE STATUS
532,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
533,llama4,0.8,HISTOLOGIC GRADE
534,llama4,0.811,TUMOR FOCALITY
535,llama4,0.698,SPECIMEN LATERALITY
536,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
537,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
538,llama4,0.698,VISCERAL PLEURA INVASION
539,llama4,0.721,TUMOR SITE
540,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
541,llama4,0.739,PROCEDURE
542,llama4,0.763,MARGIN STATUS FOR INVASIVE CARCINOMA
543,llama4,0.924,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
544,llama4,0.908,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
545,llama4,0.802,NODAL SITE(S) EXAMINED
546,llama4,0.811,TUMOR FOCALITY
547,llama4,0.89,TUMOR SITE
548,llama4,0.761,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
549,llama4,0.691,NODAL SITE(S) EXAMINED
550,llama4,0.731,MARGIN STATUS FOR INVASIVE CARCINOMA
551,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
552,llama4,0.698,SPECIMEN LATERALITY
553,llama4,0.877,REGIONAL LYMPH NODE STATUS
554,llama4,0.845,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
555,llama4,0.698,VISCERAL PLEURA INVASION
556,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
557,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
558,llama4,0.788,PROCEDURE
559,llama4,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
560,llama4,0.714,ADDITIONAL FINDINGS
561,llama4,0.811,TUMOR FOCALITY
562,llama4,0.698,SPECIMEN LATERALITY
563,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
564,llama4,0.792,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
565,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
566,llama4,0.877,REGIONAL LYMPH NODE STATUS
567,llama4,0.706,TUMOR SITE
568,llama4,0.693,NODAL SITE(S) EXAMINED
569,llama4,0.778,VISCERAL PLEURA INVASION
570,llama4,0.704,NUMBER OF LYMPH NODES EXAMINED
571,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
572,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
573,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
574,llama4,0.904,HISTOLOGIC GRADE
575,llama4,0.715,PROCEDURE
576,llama4,0.913,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
577,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
578,llama4,0.725,NODAL SITE(S) EXAMINED
579,llama4,0.8,HISTOLOGIC GRADE
580,llama4,0.782,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
581,llama4,0.742,MARGIN STATUS FOR INVASIVE CARCINOMA
582,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
583,llama4,0.877,REGIONAL LYMPH NODE STATUS
584,llama4,0.827,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
585,llama4,0.778,VISCERAL PLEURA INVASION
586,llama4,0.801,PROCEDURE
587,llama4,0.811,TUMOR FOCALITY
588,llama4,0.697,SPECIMEN LATERALITY
589,llama4,0.817,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
590,llama4,0.798,TUMOR SITE
591,llama4,0.811,TUMOR FOCALITY
592,llama4,0.8,HISTOLOGIC GRADE
593,llama4,0.746,NODAL SITE(S) EXAMINED
594,llama4,0.697,SPECIMEN LATERALITY
595,llama4,0.829,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
596,llama4,0.78,VISCERAL PLEURA INVASION
597,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
598,llama4,0.874,REGIONAL LYMPH NODE STATUS
599,llama4,0.796,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
600,llama4,0.89,TUMOR SITE
601,llama4,0.788,PROCEDURE
602,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
603,llama4,0.741,MARGIN STATUS FOR INVASIVE CARCINOMA
604,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
605,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
606,llama4,0.751,PROCEDURE
607,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
608,llama4,0.874,NODAL SITE(S) WITH TUMOR
609,llama4,0.778,VISCERAL PLEURA INVASION
610,llama4,0.657,TUMOR FOCALITY
611,llama4,0.72,NUMBER OF LYMPH NODES WITH TUMOR
612,llama4,0.742,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
613,llama4,0.698,SPECIMEN LATERALITY
614,llama4,0.707,ADDITIONAL FINDINGS
615,llama4,0.782,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
616,llama4,0.706,HISTOLOGIC GRADE
617,llama4,0.776,NODAL SITE(S) EXAMINED
618,llama4,0.715,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
619,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
620,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
621,llama4,0.68,TNM DESCRIPTORS
622,llama4,0.89,TUMOR SITE
623,llama4,0.742,REGIONAL LYMPH NODE STATUS
624,llama4,0.748,NODAL SITE(S) EXAMINED
625,llama4,0.908,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
626,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
627,llama4,0.776,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
628,llama4,0.8,HISTOLOGIC GRADE
629,llama4,0.697,SPECIMEN LATERALITY
630,llama4,0.877,REGIONAL LYMPH NODE STATUS
631,llama4,0.791,PROCEDURE
632,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
633,llama4,0.811,TUMOR FOCALITY
634,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
635,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
636,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
637,llama4,0.798,TUMOR SITE
638,llama4,0.778,VISCERAL PLEURA INVASION
639,llama4,0.778,HISTOLOGIC GRADE
640,llama4,0.702,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
641,llama4,0.698,VISCERAL PLEURA INVASION
642,llama4,0.742,MARGIN STATUS FOR INVASIVE CARCINOMA
643,llama4,0.788,PROCEDURE
644,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
645,llama4,0.856,REGIONAL LYMPH NODE STATUS
646,llama4,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
647,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
648,llama4,0.897,NODAL SITE(S) WITH TUMOR
649,llama4,0.89,TUMOR SITE
650,llama4,0.716,LYMPHOVASCULAR INVASION
651,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
652,llama4,0.825,NODAL SITE(S) EXAMINED
653,llama4,0.697,SPECIMEN LATERALITY
654,llama4,0.811,TUMOR FOCALITY
655,llama4,0.797,HISTOLOGIC GRADE
656,llama4,0.745,LYMPHOVASCULAR INVASION
657,llama4,0.782,REGIONAL LYMPH NODE STATUS
658,llama4,0.778,VISCERAL PLEURA INVASION
659,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
660,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
661,llama4,0.696,NODAL SITE(S) EXAMINED
662,llama4,0.786,TUMOR SITE
663,llama4,0.788,PROCEDURE
664,llama4,0.698,SPECIMEN LATERALITY
665,llama4,0.722,NODAL SITE(S) WITH TUMOR
666,llama4,0.713,NUMBER OF LYMPH NODES WITH TUMOR
667,llama4,0.698,NUMBER OF LYMPH NODES EXAMINED
668,llama4,0.648,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
669,llama4,0.811,TUMOR FOCALITY
670,llama4,0.708,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
671,llama4,0.655,TNM DESCRIPTORS
672,llama4,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
673,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
674,llama4,0.778,VISCERAL PLEURA INVASION
675,llama4,0.697,SPECIMEN LATERALITY
676,llama4,0.908,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
677,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
678,llama4,0.684,LYMPHOVASCULAR INVASION
679,llama4,0.769,NODAL SITE(S) WITH TUMOR
680,llama4,0.738,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
681,llama4,0.778,HISTOLOGIC GRADE
682,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
683,llama4,0.718,SPREAD THROUGH AIR SPACES (STAS)
684,llama4,0.705,NUMBER OF LYMPH NODES WITH TUMOR
685,llama4,0.777,REGIONAL LYMPH NODE STATUS
686,llama4,0.841,PROCEDURE
687,llama4,0.898,NODAL SITE(S) EXAMINED
688,llama4,0.811,TUMOR FOCALITY
689,llama4,0.692,LYMPH NODE(S) FROM PRIOR PROCEDURES
690,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
691,llama4,0.791,TUMOR SITE
692,llama4,0.696,NUMBER OF LYMPH NODES EXAMINED
693,llama4,0.908,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
694,llama4,0.761,PROCEDURE
695,llama4,0.823,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
696,llama4,0.706,HISTOLOGIC GRADE
697,llama4,0.877,REGIONAL LYMPH NODE STATUS
698,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
699,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
700,llama4,0.698,SPECIMEN LATERALITY
701,llama4,0.782,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
702,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
703,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
704,llama4,0.811,TUMOR FOCALITY
705,llama4,0.758,NODAL SITE(S) EXAMINED
706,llama4,0.865,TUMOR SITE
707,llama4,0.778,VISCERAL PLEURA INVASION
708,llama4,0.778,VISCERAL PLEURA INVASION
709,llama4,0.771,PROCEDURE
710,llama4,0.741,MARGIN STATUS FOR INVASIVE CARCINOMA
711,llama4,0.811,TUMOR FOCALITY
712,llama4,0.877,REGIONAL LYMPH NODE STATUS
713,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
714,llama4,0.905,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
715,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
716,llama4,0.698,SPECIMEN LATERALITY
717,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
718,llama4,0.847,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
719,llama4,0.753,NODAL SITE(S) EXAMINED
720,llama4,0.89,TUMOR SITE
721,llama4,0.783,HISTOLOGIC GRADE
722,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
723,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
724,llama4,0.767,PROCEDURE
725,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
726,llama4,0.819,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
727,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
728,llama4,0.736,TUMOR SITE
729,llama4,0.836,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
730,llama4,0.79,NODAL SITE(S) EXAMINED
731,llama4,0.697,NUMBER OF LYMPH NODES EXAMINED
732,llama4,0.783,HISTOLOGIC GRADE
733,llama4,0.877,REGIONAL LYMPH NODE STATUS
734,llama4,0.811,TUMOR FOCALITY
735,llama4,0.778,VISCERAL PLEURA INVASION
736,llama4,0.698,SPECIMEN LATERALITY
737,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
738,llama4,0.784,PROCEDURE
739,llama4,0.68,TUMOR SITE
740,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
741,llama4,0.715,ADDITIONAL FINDINGS
742,llama4,0.748,HISTOLOGIC GRADE
743,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
744,llama4,0.877,REGIONAL LYMPH NODE STATUS
745,llama4,0.798,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
746,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
747,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
748,llama4,0.778,VISCERAL PLEURA INVASION
749,llama4,0.735,NODAL SITE(S) EXAMINED
750,llama4,0.697,SPECIMEN LATERALITY
751,llama4,0.703,NUMBER OF LYMPH NODES EXAMINED
752,llama4,0.811,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
753,llama4,0.811,TUMOR FOCALITY
754,llama4,0.841,MARGIN STATUS FOR INVASIVE CARCINOMA
755,llama4,0.783,HISTOLOGIC GRADE
756,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
757,llama4,0.707,NUMBER OF LYMPH NODES EXAMINED
758,llama4,0.877,REGIONAL LYMPH NODE STATUS
759,llama4,0.788,PROCEDURE
760,llama4,0.811,TUMOR FOCALITY
761,llama4,0.702,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
762,llama4,0.84,NODAL SITE(S) EXAMINED
763,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
764,llama4,0.697,SPECIMEN LATERALITY
765,llama4,0.73,ADDITIONAL FINDINGS
766,llama4,0.907,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
767,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
768,llama4,0.778,VISCERAL PLEURA INVASION
769,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
770,llama4,0.89,TUMOR SITE
771,llama4,0.79,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
772,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
773,llama4,0.698,VISCERAL PLEURA INVASION
774,llama4,0.828,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
775,llama4,0.7,NUMBER OF LYMPH NODES WITH TUMOR
776,llama4,0.811,TUMOR FOCALITY
777,llama4,0.715,NUMBER OF LYMPH NODES WITH TUMOR
778,llama4,0.807,NODAL SITE(S) EXAMINED
779,llama4,0.89,TUMOR SITE
780,llama4,0.86,NODAL SITE(S) WITH TUMOR
781,llama4,0.797,HISTOLOGIC GRADE
782,llama4,0.788,PROCEDURE
783,llama4,0.697,SPECIMEN LATERALITY
784,llama4,0.856,REGIONAL LYMPH NODE STATUS
785,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
786,llama4,0.645,NODAL SITE(S) EXAMINED
787,llama4,0.82,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
788,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
789,llama4,0.722,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
790,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
791,llama4,0.701,NUMBER OF LYMPH NODES EXAMINED
792,llama4,0.797,HISTOLOGIC GRADE
793,llama4,0.791,MARGIN STATUS FOR INVASIVE CARCINOMA
794,llama4,0.81,TUMOR SITE
795,llama4,0.805,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
796,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
797,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
798,llama4,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
799,llama4,0.811,TUMOR FOCALITY
800,llama4,0.696,NUMBER OF LYMPH NODES EXAMINED
801,llama4,0.795,REGIONAL LYMPH NODE STATUS
802,llama4,0.719,NODAL SITE(S) EXAMINED
803,llama4,0.7,NUMBER OF LYMPH NODES WITH TUMOR
804,llama4,0.778,VISCERAL PLEURA INVASION
805,llama4,0.705,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
806,llama4,0.697,SPECIMEN LATERALITY
807,llama4,0.788,PROCEDURE
808,llama4,0.69,LYMPHOVASCULAR INVASION
809,llama4,0.89,TUMOR SITE
810,llama4,0.721,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
811,llama4,0.706,LYMPHOVASCULAR INVASION
812,llama4,0.79,NODAL SITE(S) EXAMINED
813,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
814,llama4,0.692,SPREAD THROUGH AIR SPACES (STAS)
815,llama4,0.797,HISTOLOGIC GRADE
816,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
817,llama4,0.728,PROCEDURE
818,llama4,0.697,SPECIMEN LATERALITY
819,llama4,0.701,NUMBER OF LYMPH NODES EXAMINED
820,llama4,0.877,REGIONAL LYMPH NODE STATUS
821,llama4,0.698,VISCERAL PLEURA INVASION
822,llama4,0.811,TUMOR FOCALITY
823,llama4,0.914,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
824,llama4,0.824,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
825,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
826,llama4,0.775,REGIONAL LYMPH NODE STATUS
827,llama4,0.698,SPECIMEN LATERALITY
828,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
829,llama4,0.778,VISCERAL PLEURA INVASION
830,llama4,0.811,TUMOR FOCALITY
831,llama4,0.72,NUMBER OF LYMPH NODES WITH TUMOR
832,llama4,0.83,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
833,llama4,0.705,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
834,llama4,0.847,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
835,llama4,0.705,NUMBER OF LYMPH NODES EXAMINED
836,llama4,0.788,PROCEDURE
837,llama4,0.708,NODAL SITE(S) EXAMINED
838,llama4,0.89,TUMOR SITE
839,llama4,0.761,MARGIN STATUS FOR INVASIVE CARCINOMA
840,llama4,0.835,NODAL SITE(S) WITH TUMOR
841,llama4,0.701,NODAL SITE(S) EXAMINED
842,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
843,llama4,0.716,ADDITIONAL FINDINGS
844,llama4,0.877,REGIONAL LYMPH NODE STATUS
845,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
846,llama4,0.641,TUMOR SITE
847,llama4,0.797,HISTOLOGIC GRADE
848,llama4,0.778,VISCERAL PLEURA INVASION
849,llama4,0.806,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
850,llama4,0.67,TUMOR FOCALITY
851,llama4,0.737,PROCEDURE
852,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
853,llama4,0.835,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
854,llama4,0.7,NUMBER OF LYMPH NODES EXAMINED
855,llama4,0.698,SPECIMEN LATERALITY
856,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
857,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
858,llama4,0.718,SPREAD THROUGH AIR SPACES (STAS)
859,llama4,0.797,HISTOLOGIC GRADE
860,llama4,0.672,LYMPHOVASCULAR INVASION
861,llama4,0.755,NODAL SITE(S) WITH TUMOR
862,llama4,0.704,VISCERAL PLEURA INVASION
863,llama4,0.77,LYMPH NODE(S) FROM PRIOR PROCEDURES
864,llama4,0.711,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
865,llama4,0.741,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
866,llama4,0.788,PROCEDURE
867,llama4,0.741,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
868,llama4,0.698,SPECIMEN LATERALITY
869,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
870,llama4,0.715,NUMBER OF LYMPH NODES EXAMINED
871,llama4,0.819,NODAL SITE(S) EXAMINED
872,llama4,0.781,REGIONAL LYMPH NODE STATUS
873,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
874,llama4,0.698,NUMBER OF LYMPH NODES WITH TUMOR
875,llama4,0.811,TUMOR FOCALITY
876,llama4,0.755,MARGIN STATUS FOR INVASIVE CARCINOMA
877,llama4,0.778,VISCERAL PLEURA INVASION
878,llama4,0.751,NODAL SITE(S) EXAMINED
879,llama4,0.698,SPECIMEN LATERALITY
880,llama4,0.827,PROCEDURE
881,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
882,llama4,0.806,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
883,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
884,llama4,0.797,HISTOLOGIC GRADE
885,llama4,0.877,REGIONAL LYMPH NODE STATUS
886,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
887,llama4,0.805,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
888,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
889,llama4,0.89,TUMOR SITE
890,llama4,0.811,TUMOR FOCALITY
891,llama4,0.707,NUMBER OF LYMPH NODES EXAMINED
892,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
893,llama4,0.788,PROCEDURE
894,llama4,0.811,TUMOR FOCALITY
895,llama4,0.697,SPECIMEN LATERALITY
896,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
897,llama4,0.715,NUMBER OF LYMPH NODES WITH TUMOR
898,llama4,0.78,VISCERAL PLEURA INVASION
899,llama4,0.745,LYMPHOVASCULAR INVASION
900,llama4,0.764,NODAL SITE(S) EXAMINED
901,llama4,0.778,HISTOLOGIC GRADE
902,llama4,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
903,llama4,0.718,SPREAD THROUGH AIR SPACES (STAS)
904,llama4,0.712,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
905,llama4,0.709,MARGIN STATUS FOR INVASIVE CARCINOMA
906,llama4,0.821,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
907,llama4,0.885,NODAL SITE(S) WITH TUMOR
908,llama4,0.761,REGIONAL LYMPH NODE STATUS
909,llama4,0.881,TUMOR SITE
910,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
911,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
912,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
913,llama4,0.797,HISTOLOGIC GRADE
914,llama4,0.877,REGIONAL LYMPH NODE STATUS
915,llama4,0.817,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
916,llama4,0.764,PROCEDURE
917,llama4,0.688,NUMBER OF LYMPH NODES EXAMINED
918,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
919,llama4,0.698,SPECIMEN LATERALITY
920,llama4,0.811,TUMOR FOCALITY
921,llama4,0.773,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
922,llama4,0.784,NODAL SITE(S) EXAMINED
923,llama4,0.742,MARGIN STATUS FOR INVASIVE CARCINOMA
924,llama4,0.778,VISCERAL PLEURA INVASION
925,llama4,0.676,TUMOR SITE
926,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
927,llama4,0.803,NODAL SITE(S) WITH TUMOR
928,llama4,0.838,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
929,llama4,0.89,TUMOR SITE
930,llama4,0.702,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
931,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
932,llama4,0.718,SPREAD THROUGH AIR SPACES (STAS)
933,llama4,0.778,HISTOLOGIC GRADE
934,llama4,0.856,REGIONAL LYMPH NODE STATUS
935,llama4,0.78,VISCERAL PLEURA INVASION
936,llama4,0.716,LYMPHOVASCULAR INVASION
937,llama4,0.702,NUMBER OF LYMPH NODES EXAMINED
938,llama4,0.698,SPECIMEN LATERALITY
939,llama4,0.756,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
940,llama4,0.695,NODAL SITE(S) EXAMINED
941,llama4,0.788,PROCEDURE
942,llama4,0.767,MARGIN STATUS FOR INVASIVE CARCINOMA
943,llama4,0.689,NUMBER OF LYMPH NODES WITH TUMOR
944,llama4,0.811,TUMOR FOCALITY
945,llama4,0.72,NUMBER OF LYMPH NODES WITH TUMOR
946,llama4,0.798,TUMOR SITE
947,llama4,0.718,NODAL SITE(S) EXAMINED
948,llama4,0.739,MARGIN STATUS FOR INVASIVE CARCINOMA
949,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
950,llama4,0.778,VISCERAL PLEURA INVASION
951,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
952,llama4,0.797,HISTOLOGIC GRADE
953,llama4,0.715,NUMBER OF LYMPH NODES EXAMINED
954,llama4,0.787,REGIONAL LYMPH NODE STATUS
955,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
956,llama4,0.701,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
957,llama4,0.788,PROCEDURE
958,llama4,0.886,NODAL SITE(S) WITH TUMOR
959,llama4,0.822,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
960,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
961,llama4,0.697,SPECIMEN LATERALITY
962,llama4,0.811,TUMOR FOCALITY
963,llama4,0.847,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
964,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
965,llama4,0.72,NUMBER OF LYMPH NODES WITH TUMOR
966,llama4,0.788,PROCEDURE
967,llama4,0.778,HISTOLOGIC GRADE
968,llama4,0.769,REGIONAL LYMPH NODE STATUS
969,llama4,0.704,NUMBER OF LYMPH NODES EXAMINED
970,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
971,llama4,0.754,NODAL SITE(S) EXAMINED
972,llama4,0.778,VISCERAL PLEURA INVASION
973,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
974,llama4,0.671,NODAL SITE(S) WITH TUMOR
975,llama4,0.892,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
976,llama4,0.811,TUMOR FOCALITY
977,llama4,0.819,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
978,llama4,0.712,TUMOR SITE
979,llama4,0.698,SPECIMEN LATERALITY
980,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
981,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
982,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
983,llama4,0.698,SPECIMEN LATERALITY
984,llama4,0.817,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
985,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
986,llama4,0.686,NUMBER OF LYMPH NODES EXAMINED
987,llama4,0.778,VISCERAL PLEURA INVASION
988,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
989,llama4,0.89,TUMOR SITE
990,llama4,0.877,REGIONAL LYMPH NODE STATUS
991,llama4,0.797,HISTOLOGIC GRADE
992,llama4,0.811,TUMOR FOCALITY
993,llama4,0.709,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
994,llama4,0.767,NODAL SITE(S) EXAMINED
995,llama4,0.746,MARGIN STATUS FOR INVASIVE CARCINOMA
996,llama4,0.806,PROCEDURE
997,llama4,0.811,TUMOR FOCALITY
998,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
999,llama4,0.717,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1000,llama4,0.81,TUMOR SITE
1001,llama4,0.805,NODAL SITE(S) EXAMINED
1002,llama4,0.827,PROCEDURE
1003,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1004,llama4,0.778,HISTOLOGIC GRADE
1005,llama4,0.739,MARGIN STATUS FOR INVASIVE CARCINOMA
1006,llama4,0.697,SPECIMEN LATERALITY
1007,llama4,0.877,REGIONAL LYMPH NODE STATUS
1008,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
1009,llama4,0.778,VISCERAL PLEURA INVASION
1010,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1011,llama4,0.826,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1012,llama4,0.702,LYMPHOVASCULAR INVASION
1013,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1014,llama4,0.788,PROCEDURE
1015,llama4,0.698,SPECIMEN LATERALITY
1016,llama4,0.797,HISTOLOGIC GRADE
1017,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1018,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1019,llama4,0.696,NUMBER OF LYMPH NODES EXAMINED
1020,llama4,0.842,TUMOR SITE
1021,llama4,0.747,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1022,llama4,0.778,VISCERAL PLEURA INVASION
1023,llama4,0.715,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1024,llama4,0.738,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1025,llama4,0.877,REGIONAL LYMPH NODE STATUS
1026,llama4,0.896,ADDITIONAL FINDINGS
1027,llama4,0.638,NODAL SITE(S) EXAMINED
1028,llama4,0.811,TUMOR FOCALITY
1029,llama4,0.798,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1030,llama4,0.8,HISTOLOGIC GRADE
1031,llama4,0.82,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1032,llama4,0.89,TUMOR SITE
1033,llama4,0.778,VISCERAL PLEURA INVASION
1034,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1035,llama4,0.877,REGIONAL LYMPH NODE STATUS
1036,llama4,0.72,NUMBER OF LYMPH NODES EXAMINED
1037,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1038,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
1039,llama4,0.811,TUMOR FOCALITY
1040,llama4,0.926,NODAL SITE(S) EXAMINED
1041,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1042,llama4,0.697,SPECIMEN LATERALITY
1043,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1044,llama4,0.827,PROCEDURE
1045,llama4,0.698,ADDITIONAL FINDINGS
1046,llama4,0.868,ADDITIONAL FINDINGS
1047,llama4,0.732,PROCEDURE
1048,llama4,0.778,VISCERAL PLEURA INVASION
1049,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1050,llama4,0.797,HISTOLOGIC GRADE
1051,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1052,llama4,0.877,REGIONAL LYMPH NODE STATUS
1053,llama4,0.835,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1054,llama4,0.697,SPECIMEN LATERALITY
1055,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1056,llama4,0.902,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1057,llama4,0.798,TUMOR SITE
1058,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1059,llama4,0.718,SPREAD THROUGH AIR SPACES (STAS)
1060,llama4,0.704,NODAL SITE(S) EXAMINED
1061,llama4,0.811,TUMOR FOCALITY
1062,llama4,0.788,PROCEDURE
1063,llama4,0.89,TUMOR SITE
1064,llama4,0.78,NODAL SITE(S) EXAMINED
1065,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
1066,llama4,0.734,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1067,llama4,0.698,SPECIMEN LATERALITY
1068,llama4,0.78,VISCERAL PLEURA INVASION
1069,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1070,llama4,0.655,TNM DESCRIPTORS
1071,llama4,0.811,TUMOR FOCALITY
1072,llama4,0.726,ADDITIONAL FINDINGS
1073,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1074,llama4,0.704,HISTOLOGIC GRADE
1075,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1076,llama4,0.699,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1077,llama4,0.745,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1078,llama4,0.877,REGIONAL LYMPH NODE STATUS
1079,llama4,0.681,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1080,llama4,0.778,VISCERAL PLEURA INVASION
1081,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
1082,llama4,0.702,ADDITIONAL FINDINGS
1083,llama4,0.827,PROCEDURE
1084,llama4,0.698,SPECIMEN LATERALITY
1085,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1086,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1087,llama4,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1088,llama4,0.672,TUMOR FOCALITY
1089,llama4,0.726,TUMOR SITE
1090,llama4,0.738,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1091,llama4,0.778,HISTOLOGIC GRADE
1092,llama4,0.702,LYMPHOVASCULAR INVASION
1093,llama4,0.811,TUMOR FOCALITY
1094,llama4,0.78,VISCERAL PLEURA INVASION
1095,llama4,0.858,NODAL SITE(S) WITH TUMOR
1096,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
1097,llama4,0.697,SPECIMEN LATERALITY
1098,llama4,0.761,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1099,llama4,0.892,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1100,llama4,0.72,NUMBER OF LYMPH NODES WITH TUMOR
1101,llama4,0.789,MARGIN STATUS FOR INVASIVE CARCINOMA
1102,llama4,0.777,REGIONAL LYMPH NODE STATUS
1103,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1104,llama4,0.89,TUMOR SITE
1105,llama4,0.788,PROCEDURE
1106,llama4,0.727,NODAL SITE(S) EXAMINED
1107,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1108,llama4,0.817,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1109,llama4,0.877,REGIONAL LYMPH NODE STATUS
1110,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1111,llama4,0.778,VISCERAL PLEURA INVASION
1112,llama4,0.699,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1113,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1114,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1115,llama4,0.89,TUMOR SITE
1116,llama4,0.906,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1117,llama4,0.698,SPECIMEN LATERALITY
1118,llama4,0.825,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1119,llama4,0.797,HISTOLOGIC GRADE
1120,llama4,0.784,NODAL SITE(S) EXAMINED
1121,llama4,0.803,PROCEDURE
1122,llama4,0.811,TUMOR FOCALITY
1123,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
1124,llama4,0.877,REGIONAL LYMPH NODE STATUS
1125,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1126,llama4,0.781,NODAL SITE(S) EXAMINED
1127,llama4,0.819,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1128,llama4,0.878,ADDITIONAL FINDINGS
1129,llama4,0.758,MARGIN STATUS FOR INVASIVE CARCINOMA
1130,llama4,0.705,SPECIMEN LATERALITY
1131,llama4,0.89,TUMOR SITE
1132,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
1133,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1134,llama4,0.713,NUMBER OF LYMPH NODES EXAMINED
1135,llama4,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1136,llama4,0.778,VISCERAL PLEURA INVASION
1137,llama4,0.797,HISTOLOGIC GRADE
1138,llama4,0.827,PROCEDURE
1139,llama4,0.697,SPECIMEN LATERALITY
1140,llama4,0.811,TUMOR FOCALITY
1141,llama4,0.797,HISTOLOGIC GRADE
1142,llama4,0.827,PROCEDURE
1143,llama4,0.905,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1144,llama4,0.89,TUMOR SITE
1145,llama4,0.741,MARGIN STATUS FOR INVASIVE CARCINOMA
1146,llama4,0.847,NODAL SITE(S) EXAMINED
1147,llama4,0.811,TUMOR FOCALITY
1148,llama4,0.697,SPECIMEN LATERALITY
1149,llama4,0.739,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1150,llama4,0.707,ADDITIONAL FINDINGS
1151,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1152,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1153,llama4,0.877,REGIONAL LYMPH NODE STATUS
1154,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1155,llama4,0.78,VISCERAL PLEURA INVASION
1156,llama4,0.877,REGIONAL LYMPH NODE STATUS
1157,llama4,0.797,HISTOLOGIC GRADE
1158,llama4,0.724,NODAL SITE(S) EXAMINED
1159,llama4,0.761,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1160,llama4,0.814,PROCEDURE
1161,llama4,0.697,NUMBER OF LYMPH NODES EXAMINED
1162,llama4,0.787,ADDITIONAL FINDINGS
1163,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1164,llama4,0.747,TUMOR SITE
1165,llama4,0.73,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1166,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1167,llama4,0.78,VISCERAL PLEURA INVASION
1168,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1169,llama4,0.736,SPREAD THROUGH AIR SPACES (STAS)
1170,llama4,0.68,TUMOR FOCALITY
1171,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1172,llama4,0.697,SPECIMEN LATERALITY
1173,llama4,0.723,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1174,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1175,llama4,0.715,NUMBER OF LYMPH NODES WITH TUMOR
1176,llama4,0.778,HISTOLOGIC GRADE
1177,llama4,0.669,NODAL SITE(S) WITH TUMOR
1178,llama4,0.698,MARGIN STATUS FOR INVASIVE CARCINOMA
1179,llama4,0.73,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1180,llama4,0.697,SPECIMEN LATERALITY
1181,llama4,0.705,MARGIN STATUS FOR NON-INVASIVE TUMOR
1182,llama4,0.708,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1183,llama4,0.802,TUMOR SITE
1184,llama4,0.78,SPREAD THROUGH AIR SPACES (STAS)
1185,llama4,0.638,NODAL SITE(S) EXAMINED
1186,llama4,0.738,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1187,llama4,0.811,TUMOR FOCALITY
1188,llama4,0.788,PROCEDURE
1189,llama4,0.686,LYMPHOVASCULAR INVASION
1190,llama4,0.676,REGIONAL LYMPH NODE STATUS
1191,llama4,0.707,NUMBER OF LYMPH NODES EXAMINED
1192,llama4,0.747,NODAL SITE(S) EXAMINED
1193,llama4,0.89,TUMOR SITE
1194,llama4,0.701,NUMBER OF LYMPH NODES EXAMINED
1195,llama4,0.884,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1196,llama4,0.778,HISTOLOGIC GRADE
1197,llama4,0.745,LYMPHOVASCULAR INVASION
1198,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
1199,llama4,0.78,VISCERAL PLEURA INVASION
1200,llama4,0.751,ADDITIONAL FINDINGS
1201,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1202,llama4,0.698,SPECIMEN LATERALITY
1203,llama4,0.811,TUMOR FOCALITY
1204,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1205,llama4,0.877,REGIONAL LYMPH NODE STATUS
1206,llama4,0.706,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1207,llama4,0.788,PROCEDURE
1208,llama4,0.782,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1209,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1210,llama4,0.904,HISTOLOGIC GRADE
1211,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1212,llama4,0.905,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1213,llama4,0.697,SPECIMEN LATERALITY
1214,llama4,0.893,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1215,llama4,0.76,MARGIN STATUS FOR INVASIVE CARCINOMA
1216,llama4,0.89,TUMOR SITE
1217,llama4,0.778,VISCERAL PLEURA INVASION
1218,llama4,0.713,NUMBER OF LYMPH NODES EXAMINED
1219,llama4,0.732,ADDITIONAL FINDINGS
1220,llama4,0.827,PROCEDURE
1221,llama4,0.811,TUMOR FOCALITY
1222,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1223,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
1224,llama4,0.777,NODAL SITE(S) EXAMINED
1225,llama4,0.877,REGIONAL LYMPH NODE STATUS
1226,llama4,0.682,ADDITIONAL FINDINGS
1227,llama4,0.778,HISTOLOGIC GRADE
1228,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
1229,llama4,0.855,MARGIN STATUS FOR INVASIVE CARCINOMA
1230,llama4,0.786,NODAL SITE(S) EXAMINED
1231,llama4,0.704,NUMBER OF LYMPH NODES EXAMINED
1232,llama4,0.752,VISCERAL PLEURA INVASION
1233,llama4,0.817,TUMOR SITE
1234,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1235,llama4,0.811,TUMOR FOCALITY
1236,llama4,0.877,REGIONAL LYMPH NODE STATUS
1237,llama4,0.698,SPECIMEN LATERALITY
1238,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1239,llama4,0.838,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1240,llama4,0.764,PROCEDURE
1241,llama4,0.699,ADDITIONAL FINDINGS
1242,llama4,0.703,NUMBER OF LYMPH NODES EXAMINED
1243,llama4,0.877,REGIONAL LYMPH NODE STATUS
1244,llama4,0.697,SPECIMEN LATERALITY
1245,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1246,llama4,0.827,PROCEDURE
1247,llama4,0.781,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1248,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1249,llama4,0.778,VISCERAL PLEURA INVASION
1250,llama4,0.797,HISTOLOGIC GRADE
1251,llama4,0.804,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1252,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1253,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
1254,llama4,0.89,TUMOR SITE
1255,llama4,0.816,NODAL SITE(S) EXAMINED
1256,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1257,llama4,0.811,TUMOR FOCALITY
1258,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
1259,llama4,0.745,MARGIN STATUS FOR INVASIVE CARCINOMA
1260,llama4,0.838,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1261,llama4,0.797,HISTOLOGIC GRADE
1262,llama4,0.844,ADDITIONAL FINDINGS
1263,llama4,0.718,SPREAD THROUGH AIR SPACES (STAS)
1264,llama4,0.805,NODAL SITE(S) EXAMINED
1265,llama4,0.877,REGIONAL LYMPH NODE STATUS
1266,llama4,0.788,PROCEDURE
1267,llama4,0.803,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1268,llama4,0.697,SPECIMEN LATERALITY
1269,llama4,0.89,TUMOR SITE
1270,llama4,0.698,VISCERAL PLEURA INVASION
1271,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1272,llama4,0.715,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1273,llama4,0.708,TUMOR FOCALITY
1274,llama4,0.866,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1275,llama4,0.653,TNM DESCRIPTORS
1276,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1277,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1278,llama4,0.688,NODAL SITE(S) EXAMINED
1279,llama4,0.672,TUMOR FOCALITY
1280,llama4,0.827,PROCEDURE
1281,llama4,0.89,TUMOR SITE
1282,llama4,0.693,MARGIN STATUS FOR INVASIVE CARCINOMA
1283,llama4,0.877,REGIONAL LYMPH NODE STATUS
1284,llama4,0.8,HISTOLOGIC GRADE
1285,llama4,0.778,VISCERAL PLEURA INVASION
1286,llama4,0.713,NUMBER OF LYMPH NODES EXAMINED
1287,llama4,0.697,SPECIMEN LATERALITY
1288,llama4,0.736,SPREAD THROUGH AIR SPACES (STAS)
1289,llama4,0.753,NODAL SITE(S) EXAMINED
1290,llama4,0.778,VISCERAL PLEURA INVASION
1291,llama4,0.797,HISTOLOGIC GRADE
1292,llama4,0.692,NUMBER OF LYMPH NODES EXAMINED
1293,llama4,0.823,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1294,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
1295,llama4,0.758,REGIONAL LYMPH NODE STATUS
1296,llama4,0.849,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1297,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
1298,llama4,0.742,MARGIN STATUS FOR INVASIVE CARCINOMA
1299,llama4,0.713,NUMBER OF LYMPH NODES WITH TUMOR
1300,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1301,llama4,0.811,TUMOR FOCALITY
1302,llama4,0.753,PROCEDURE
1303,llama4,0.697,SPECIMEN LATERALITY
1304,llama4,0.887,TUMOR SITE
1305,llama4,0.761,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1306,llama4,0.811,NODAL SITE(S) EXAMINED
1307,llama4,0.801,TUMOR SITE
1308,llama4,0.716,ADDITIONAL FINDINGS
1309,llama4,0.918,TUMOR FOCALITY
1310,llama4,0.827,PROCEDURE
1311,llama4,0.78,SPREAD THROUGH AIR SPACES (STAS)
1312,llama4,0.778,VISCERAL PLEURA INVASION
1313,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
1314,llama4,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1315,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1316,llama4,0.69,HISTOLOGIC GRADE
1317,llama4,0.855,MARGIN STATUS FOR INVASIVE CARCINOMA
1318,llama4,0.877,REGIONAL LYMPH NODE STATUS
1319,llama4,0.713,NUMBER OF LYMPH NODES EXAMINED
1320,llama4,0.698,SPECIMEN LATERALITY
1321,llama4,0.78,VISCERAL PLEURA INVASION
1322,llama4,0.89,TUMOR SITE
1323,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1324,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
1325,llama4,0.827,PROCEDURE
1326,llama4,0.697,SPECIMEN LATERALITY
1327,llama4,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1328,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1329,llama4,0.797,HISTOLOGIC GRADE
1330,llama4,0.811,TUMOR FOCALITY
1331,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1332,llama4,0.725,NODAL SITE(S) EXAMINED
1333,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
1334,llama4,0.877,REGIONAL LYMPH NODE STATUS
1335,llama4,0.904,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1336,llama4,0.716,ADDITIONAL FINDINGS
1337,llama4,0.862,NODAL SITE(S) EXAMINED
1338,llama4,0.755,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1339,llama4,0.874,REGIONAL LYMPH NODE STATUS
1340,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1341,llama4,0.78,VISCERAL PLEURA INVASION
1342,llama4,0.713,NUMBER OF LYMPH NODES EXAMINED
1343,llama4,0.827,PROCEDURE
1344,llama4,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1345,llama4,0.798,TUMOR SITE
1346,llama4,0.697,SPECIMEN LATERALITY
1347,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
1348,llama4,0.797,HISTOLOGIC GRADE
1349,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1350,llama4,0.811,TUMOR FOCALITY
1351,llama4,0.76,MARGIN STATUS FOR INVASIVE CARCINOMA
1352,llama4,0.66,TNM DESCRIPTORS
1353,llama4,0.877,REGIONAL LYMPH NODE STATUS
1354,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1355,llama4,0.855,MARGIN STATUS FOR INVASIVE CARCINOMA
1356,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
1357,llama4,0.823,NODAL SITE(S) EXAMINED
1358,llama4,0.814,PROCEDURE
1359,llama4,0.699,NUMBER OF LYMPH NODES EXAMINED
1360,llama4,0.736,TUMOR FOCALITY
1361,llama4,0.78,VISCERAL PLEURA INVASION
1362,llama4,0.697,SPECIMEN LATERALITY
1363,llama4,0.797,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1364,llama4,0.671,TUMOR SITE
1365,llama4,0.797,HISTOLOGIC GRADE
1366,llama4,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1367,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
1368,llama4,0.821,NODAL SITE(S) EXAMINED
1369,llama4,0.811,TUMOR FOCALITY
1370,llama4,0.703,NUMBER OF LYMPH NODES EXAMINED
1371,llama4,0.893,TUMOR SITE
1372,llama4,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1373,llama4,0.778,VISCERAL PLEURA INVASION
1374,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1375,llama4,0.76,MARGIN STATUS FOR INVASIVE CARCINOMA
1376,llama4,0.765,PROCEDURE
1377,llama4,0.877,REGIONAL LYMPH NODE STATUS
1378,llama4,0.697,SPECIMEN LATERALITY
1379,llama4,0.697,SPECIMEN LATERALITY
1380,llama4,0.686,TUMOR SITE
1381,llama4,0.668,TNM DESCRIPTORS
1382,llama4,0.838,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1383,llama4,0.737,PROCEDURE
1384,llama4,0.745,LYMPHOVASCULAR INVASION
1385,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
1386,llama4,0.867,TUMOR FOCALITY
1387,llama4,0.778,VISCERAL PLEURA INVASION
1388,llama4,0.855,MARGIN STATUS FOR INVASIVE CARCINOMA
1389,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
1390,llama4,0.778,HISTOLOGIC GRADE
1391,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1392,llama4,0.856,REGIONAL LYMPH NODE STATUS
1393,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
1394,llama4,0.689,NODAL SITE(S) EXAMINED
1395,llama4,0.699,NUMBER OF LYMPH NODES WITH TUMOR
1396,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1397,llama4,0.801,PROCEDURE
1398,llama4,0.759,NUMBER OF LYMPH NODES EXAMINED
1399,llama4,0.824,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1400,llama4,0.811,TUMOR FOCALITY
1401,llama4,0.732,ADDITIONAL FINDINGS
1402,llama4,0.777,MARGIN STATUS FOR INVASIVE CARCINOMA
1403,llama4,0.759,NODAL SITE(S) WITH TUMOR
1404,llama4,0.766,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1405,llama4,0.698,VISCERAL PLEURA INVASION
1406,llama4,0.698,SPECIMEN LATERALITY
1407,llama4,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1408,llama4,0.842,TUMOR SITE
1409,llama4,0.8,PROCEDURE
1410,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1411,llama4,0.89,TUMOR SITE
1412,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
1413,llama4,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1414,llama4,0.751,MARGIN STATUS FOR INVASIVE CARCINOMA
1415,llama4,0.693,NUMBER OF LYMPH NODES EXAMINED
1416,llama4,0.716,ADDITIONAL FINDINGS
1417,llama4,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1418,llama4,0.778,HISTOLOGIC GRADE
1419,llama4,0.835,NODAL SITE(S) EXAMINED
1420,llama4,0.877,REGIONAL LYMPH NODE STATUS
1421,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
1422,llama4,0.697,SPECIMEN LATERALITY
1423,llama4,0.778,VISCERAL PLEURA INVASION
1424,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1425,llama4,0.811,TUMOR FOCALITY
1426,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1427,llama4,0.848,MARGIN STATUS FOR NON-INVASIVE TUMOR
1428,llama4,0.731,NODAL SITE(S) EXAMINED
1429,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
1430,llama4,0.721,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1431,llama4,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1432,llama4,0.653,TNM DESCRIPTORS
1433,llama4,0.801,ADDITIONAL FINDINGS
1434,llama4,0.829,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1435,llama4,0.788,PROCEDURE
1436,llama4,0.877,REGIONAL LYMPH NODE STATUS
1437,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1438,llama4,0.8,HISTOLOGIC GRADE
1439,llama4,0.697,SPECIMEN LATERALITY
1440,llama4,0.89,TUMOR SITE
1441,llama4,0.778,VISCERAL PLEURA INVASION
1442,llama4,0.705,TUMOR FOCALITY
1443,llama4,0.775,REGIONAL LYMPH NODE STATUS
1444,llama4,0.805,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1445,llama4,0.78,VISCERAL PLEURA INVASION
1446,llama4,0.879,ADDITIONAL FINDINGS
1447,llama4,0.698,SPECIMEN LATERALITY
1448,llama4,0.716,LYMPHOVASCULAR INVASION
1449,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1450,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1451,llama4,0.831,NODAL SITE(S) WITH TUMOR
1452,llama4,0.757,PROCEDURE
1453,llama4,0.89,TUMOR SITE
1454,llama4,0.722,NODAL SITE(S) EXAMINED
1455,llama4,0.715,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1456,llama4,0.729,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1457,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
1458,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1459,llama4,0.697,NUMBER OF LYMPH NODES EXAMINED
1460,llama4,0.713,NUMBER OF LYMPH NODES WITH TUMOR
1461,llama4,0.811,TUMOR FOCALITY
1462,llama4,0.833,TUMOR SITE
1463,llama4,0.851,NODAL SITE(S) EXAMINED
1464,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1465,llama4,0.755,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1466,llama4,0.695,HISTOLOGIC GRADE
1467,llama4,0.692,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1468,llama4,0.877,REGIONAL LYMPH NODE STATUS
1469,llama4,0.698,SPECIMEN LATERALITY
1470,llama4,0.811,TUMOR FOCALITY
1471,llama4,0.78,VISCERAL PLEURA INVASION
1472,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1473,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1474,llama4,0.774,ADDITIONAL FINDINGS
1475,llama4,0.776,PROCEDURE
1476,llama4,0.826,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1477,llama4,0.731,LYMPHOVASCULAR INVASION
1478,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
1479,llama4,0.877,REGIONAL LYMPH NODE STATUS
1480,llama4,0.811,TUMOR FOCALITY
1481,llama4,0.683,ADDITIONAL FINDINGS
1482,llama4,0.778,VISCERAL PLEURA INVASION
1483,llama4,0.841,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1484,llama4,0.72,PROCEDURE
1485,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1486,llama4,0.697,SPECIMEN LATERALITY
1487,llama4,0.902,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1488,llama4,0.881,TUMOR SITE
1489,llama4,0.749,NODAL SITE(S) EXAMINED
1490,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1491,llama4,0.715,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1492,llama4,0.697,NUMBER OF LYMPH NODES EXAMINED
1493,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1494,llama4,0.745,LYMPHOVASCULAR INVASION
1495,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1496,llama4,0.72,NUMBER OF LYMPH NODES WITH TUMOR
1497,llama4,0.785,REGIONAL LYMPH NODE STATUS
1498,llama4,0.679,HISTOLOGIC GRADE
1499,llama4,0.801,NODAL SITE(S) WITH TUMOR
1500,llama4,0.813,ADDITIONAL FINDINGS
1501,llama4,0.748,NODAL SITE(S) EXAMINED
1502,llama4,0.778,VISCERAL PLEURA INVASION
1503,llama4,0.697,SPECIMEN LATERALITY
1504,llama4,0.682,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1505,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
1506,llama4,0.808,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1507,llama4,0.73,PROCEDURE
1508,llama4,0.84,TUMOR SITE
1509,llama4,0.672,TUMOR FOCALITY
1510,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1511,llama4,0.823,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1512,llama4,0.647,TNM DESCRIPTORS
1513,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1514,llama4,0.797,HISTOLOGIC GRADE
1515,llama4,0.841,NODAL SITE(S) EXAMINED
1516,llama4,0.811,TUMOR FOCALITY
1517,llama4,0.716,LYMPHOVASCULAR INVASION
1518,llama4,0.804,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1519,llama4,0.778,VISCERAL PLEURA INVASION
1520,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1521,llama4,0.827,PROCEDURE
1522,llama4,0.754,MARGIN STATUS FOR INVASIVE CARCINOMA
1523,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1524,llama4,0.697,SPECIMEN LATERALITY
1525,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
1526,llama4,0.89,TUMOR SITE
1527,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1528,llama4,0.735,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1529,llama4,0.877,REGIONAL LYMPH NODE STATUS
1530,llama4,0.697,SPECIMEN LATERALITY
1531,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1532,llama4,0.753,MARGIN STATUS FOR INVASIVE CARCINOMA
1533,llama4,0.825,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1534,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1535,llama4,0.789,ADDITIONAL FINDINGS
1536,llama4,0.812,NODAL SITE(S) EXAMINED
1537,llama4,0.811,TUMOR FOCALITY
1538,llama4,0.73,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1539,llama4,0.877,REGIONAL LYMPH NODE STATUS
1540,llama4,0.78,VISCERAL PLEURA INVASION
1541,llama4,0.797,HISTOLOGIC GRADE
1542,llama4,0.762,PROCEDURE
1543,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
1544,llama4,0.824,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1545,llama4,0.89,TUMOR SITE
1546,llama4,0.736,SPREAD THROUGH AIR SPACES (STAS)
1547,llama4,0.811,TUMOR FOCALITY
1548,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1549,llama4,0.729,TNM DESCRIPTORS
1550,llama4,0.736,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1551,llama4,0.787,TUMOR SITE
1552,llama4,0.738,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1553,llama4,0.795,ADDITIONAL FINDINGS
1554,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1555,llama4,0.697,NUMBER OF LYMPH NODES EXAMINED
1556,llama4,0.778,VISCERAL PLEURA INVASION
1557,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1558,llama4,0.877,REGIONAL LYMPH NODE STATUS
1559,llama4,0.692,HISTOLOGIC GRADE
1560,llama4,0.844,NODAL SITE(S) EXAMINED
1561,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1562,llama4,0.697,SPECIMEN LATERALITY
1563,llama4,0.736,PROCEDURE
1564,llama4,0.798,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1565,llama4,0.751,NODAL SITE(S) EXAMINED
1566,llama4,0.877,REGIONAL LYMPH NODE STATUS
1567,llama4,0.698,SPECIMEN LATERALITY
1568,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
1569,llama4,0.811,TUMOR FOCALITY
1570,llama4,0.789,HISTOLOGIC GRADE
1571,llama4,0.765,PROCEDURE
1572,llama4,0.763,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1573,llama4,0.739,MARGIN STATUS FOR INVASIVE CARCINOMA
1574,llama4,0.716,ADDITIONAL FINDINGS
1575,llama4,0.89,TUMOR SITE
1576,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
1577,llama4,0.78,VISCERAL PLEURA INVASION
1578,llama4,0.835,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1579,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1580,llama4,0.705,NUMBER OF LYMPH NODES EXAMINED
1581,llama4,0.698,SPECIMEN LATERALITY
1582,llama4,0.735,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1583,llama4,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1584,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1585,llama4,0.89,TUMOR SITE
1586,llama4,0.775,NODAL SITE(S) EXAMINED
1587,llama4,0.778,VISCERAL PLEURA INVASION
1588,llama4,0.877,REGIONAL LYMPH NODE STATUS
1589,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1590,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1591,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
1592,llama4,0.811,TUMOR FOCALITY
1593,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1594,llama4,0.797,HISTOLOGIC GRADE
1595,llama4,0.773,PROCEDURE
1596,llama4,0.877,REGIONAL LYMPH NODE STATUS
1597,llama4,0.816,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1598,llama4,0.78,VISCERAL PLEURA INVASION
1599,llama4,0.745,LYMPHOVASCULAR INVASION
1600,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1601,llama4,0.788,PROCEDURE
1602,llama4,0.783,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1603,llama4,0.797,HISTOLOGIC GRADE
1604,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1605,llama4,0.66,TNM DESCRIPTORS
1606,llama4,0.698,SPECIMEN LATERALITY
1607,llama4,0.754,NODAL SITE(S) EXAMINED
1608,llama4,0.708,TUMOR FOCALITY
1609,llama4,0.737,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1610,llama4,0.89,TUMOR SITE
1611,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
1612,llama4,0.685,ADDITIONAL FINDINGS
1613,llama4,0.731,LYMPHOVASCULAR INVASION
1614,llama4,0.779,PROCEDURE
1615,llama4,0.888,TUMOR SITE
1616,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1617,llama4,0.782,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1618,llama4,0.646,TNM DESCRIPTORS
1619,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1620,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1621,llama4,0.765,NODAL SITE(S) WITH TUMOR
1622,llama4,0.698,SPECIMEN LATERALITY
1623,llama4,0.698,VISCERAL PLEURA INVASION
1624,llama4,0.761,NODAL SITE(S) EXAMINED
1625,llama4,0.715,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1626,llama4,0.778,HISTOLOGIC GRADE
1627,llama4,0.747,REGIONAL LYMPH NODE STATUS
1628,llama4,0.72,NUMBER OF LYMPH NODES WITH TUMOR
1629,llama4,0.688,NUMBER OF LYMPH NODES EXAMINED
1630,llama4,0.798,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1631,llama4,0.811,TUMOR FOCALITY
1632,llama4,0.89,TUMOR SITE
1633,llama4,0.713,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1634,llama4,0.765,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1635,llama4,0.742,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1636,llama4,0.805,NODAL SITE(S) EXAMINED
1637,llama4,0.778,VISCERAL PLEURA INVASION
1638,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1639,llama4,0.771,ADDITIONAL FINDINGS
1640,llama4,0.766,PROCEDURE
1641,llama4,0.697,SPECIMEN LATERALITY
1642,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
1643,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1644,llama4,0.877,REGIONAL LYMPH NODE STATUS
1645,llama4,0.811,TUMOR FOCALITY
1646,llama4,0.712,NUMBER OF LYMPH NODES EXAMINED
1647,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
1648,llama4,0.8,HISTOLOGIC GRADE
1649,llama4,0.877,REGIONAL LYMPH NODE STATUS
1650,llama4,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1651,llama4,0.89,TUMOR SITE
1652,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1653,llama4,0.778,VISCERAL PLEURA INVASION
1654,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1655,llama4,0.693,NUMBER OF LYMPH NODES EXAMINED
1656,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1657,llama4,0.754,PROCEDURE
1658,llama4,0.698,SPECIMEN LATERALITY
1659,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1660,llama4,0.798,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1661,llama4,0.811,TUMOR FOCALITY
1662,llama4,0.744,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1663,llama4,0.777,PROCEDURE
1664,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1665,llama4,0.856,REGIONAL LYMPH NODE STATUS
1666,llama4,0.89,TUMOR SITE
1667,llama4,0.817,NODAL SITE(S) WITH TUMOR
1668,llama4,0.703,NUMBER OF LYMPH NODES WITH TUMOR
1669,llama4,0.778,HISTOLOGIC GRADE
1670,llama4,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1671,llama4,0.78,VISCERAL PLEURA INVASION
1672,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1673,llama4,0.721,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1674,llama4,0.745,LYMPHOVASCULAR INVASION
1675,llama4,0.744,NODAL SITE(S) EXAMINED
1676,llama4,0.715,ADDITIONAL FINDINGS
1677,llama4,0.697,SPECIMEN LATERALITY
1678,llama4,0.698,NUMBER OF LYMPH NODES EXAMINED
1679,llama4,0.811,TUMOR FOCALITY
1680,llama4,0.752,MARGIN STATUS FOR INVASIVE CARCINOMA
1681,llama4,0.76,MARGIN STATUS FOR INVASIVE CARCINOMA
1682,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1683,llama4,0.697,SPECIMEN LATERALITY
1684,llama4,0.753,NODAL SITE(S) EXAMINED
1685,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1686,llama4,0.89,TUMOR SITE
1687,llama4,0.686,ADDITIONAL FINDINGS
1688,llama4,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1689,llama4,0.903,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1690,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1691,llama4,0.877,REGIONAL LYMPH NODE STATUS
1692,llama4,0.778,HISTOLOGIC GRADE
1693,llama4,0.811,TUMOR FOCALITY
1694,llama4,0.718,SPREAD THROUGH AIR SPACES (STAS)
1695,llama4,0.788,PROCEDURE
1696,llama4,0.78,VISCERAL PLEURA INVASION
1697,llama4,0.701,NUMBER OF LYMPH NODES EXAMINED
1698,llama4,0.877,REGIONAL LYMPH NODE STATUS
1699,llama4,0.783,HISTOLOGIC GRADE
1700,llama4,0.816,NODAL SITE(S) EXAMINED
1701,llama4,0.738,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1702,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1703,llama4,0.811,TUMOR FOCALITY
1704,llama4,0.738,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1705,llama4,0.798,TUMOR SITE
1706,llama4,0.78,VISCERAL PLEURA INVASION
1707,llama4,0.761,PROCEDURE
1708,llama4,0.69,LYMPHOVASCULAR INVASION
1709,llama4,0.697,SPECIMEN LATERALITY
1710,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1711,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1712,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1713,llama4,0.77,MARGIN STATUS FOR INVASIVE CARCINOMA
1714,llama4,0.808,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1715,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1716,llama4,0.811,TUMOR FOCALITY
1717,llama4,0.747,NODAL SITE(S) EXAMINED
1718,llama4,0.89,TUMOR SITE
1719,llama4,0.892,HISTOLOGIC GRADE
1720,llama4,0.715,ADDITIONAL FINDINGS
1721,llama4,0.788,PROCEDURE
1722,llama4,0.877,REGIONAL LYMPH NODE STATUS
1723,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
1724,llama4,0.697,SPECIMEN LATERALITY
1725,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1726,llama4,0.698,VISCERAL PLEURA INVASION
1727,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1728,llama4,0.761,NODAL SITE(S) EXAMINED
1729,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1730,llama4,0.903,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1731,llama4,0.75,PROCEDURE
1732,llama4,0.778,VISCERAL PLEURA INVASION
1733,llama4,0.797,HISTOLOGIC GRADE
1734,llama4,0.762,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1735,llama4,0.811,TUMOR FOCALITY
1736,llama4,0.698,SPECIMEN LATERALITY
1737,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
1738,llama4,0.877,REGIONAL LYMPH NODE STATUS
1739,llama4,0.89,TUMOR SITE
1740,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1741,llama4,0.782,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1742,llama4,0.797,HISTOLOGIC GRADE
1743,llama4,0.782,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1744,llama4,0.697,NUMBER OF LYMPH NODES EXAMINED
1745,llama4,0.697,SPECIMEN LATERALITY
1746,llama4,0.861,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1747,llama4,0.788,PROCEDURE
1748,llama4,0.91,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1749,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1750,llama4,0.787,TUMOR SITE
1751,llama4,0.841,NODAL SITE(S) EXAMINED
1752,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1753,llama4,0.811,TUMOR FOCALITY
1754,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1755,llama4,0.778,VISCERAL PLEURA INVASION
1756,llama4,0.877,REGIONAL LYMPH NODE STATUS
1757,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
1758,llama4,0.778,VISCERAL PLEURA INVASION
1759,llama4,0.697,SPECIMEN LATERALITY
1760,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1761,llama4,0.688,NUMBER OF LYMPH NODES EXAMINED
1762,llama4,0.89,TUMOR SITE
1763,llama4,0.877,REGIONAL LYMPH NODE STATUS
1764,llama4,0.812,PROCEDURE
1765,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1766,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1767,llama4,0.805,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1768,llama4,0.811,TUMOR FOCALITY
1769,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1770,llama4,0.797,HISTOLOGIC GRADE
1771,llama4,0.812,NODAL SITE(S) EXAMINED
1772,llama4,0.752,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1773,llama4,0.705,LYMPH NODE(S) FROM PRIOR PROCEDURES
1774,llama4,0.731,LYMPHOVASCULAR INVASION
1775,llama4,0.729,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1776,llama4,0.727,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1777,llama4,0.877,REGIONAL LYMPH NODE STATUS
1778,llama4,0.778,HISTOLOGIC GRADE
1779,llama4,0.911,NODAL SITE(S) EXAMINED
1780,llama4,0.778,VISCERAL PLEURA INVASION
1781,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1782,llama4,0.697,SPECIMEN LATERALITY
1783,llama4,0.735,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1784,llama4,0.811,TUMOR FOCALITY
1785,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
1786,llama4,0.819,PROCEDURE
1787,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
1788,llama4,0.787,TUMOR SITE
1789,llama4,0.811,TUMOR FOCALITY
1790,llama4,0.89,TUMOR SITE
1791,llama4,0.697,SPECIMEN LATERALITY
1792,llama4,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1793,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1794,llama4,0.877,REGIONAL LYMPH NODE STATUS
1795,llama4,0.742,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1796,llama4,0.778,PROCEDURE
1797,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1798,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
1799,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1800,llama4,0.778,VISCERAL PLEURA INVASION
1801,llama4,0.744,NODAL SITE(S) EXAMINED
1802,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1803,llama4,0.77,HISTOLOGIC GRADE
1804,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1805,llama4,0.698,VISCERAL PLEURA INVASION
1806,llama4,0.811,TUMOR FOCALITY
1807,llama4,0.797,HISTOLOGIC GRADE
1808,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1809,llama4,0.827,PROCEDURE
1810,llama4,0.698,SPECIMEN LATERALITY
1811,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1812,llama4,0.748,MARGIN STATUS FOR INVASIVE CARCINOMA
1813,llama4,0.703,NUMBER OF LYMPH NODES EXAMINED
1814,llama4,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1815,llama4,0.89,TUMOR SITE
1816,llama4,0.877,REGIONAL LYMPH NODE STATUS
1817,llama4,0.813,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1818,llama4,0.772,NODAL SITE(S) EXAMINED
1819,llama4,0.825,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1820,llama4,0.697,SPECIMEN LATERALITY
1821,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
1822,llama4,0.877,REGIONAL LYMPH NODE STATUS
1823,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1824,llama4,0.693,NUMBER OF LYMPH NODES EXAMINED
1825,llama4,0.778,VISCERAL PLEURA INVASION
1826,llama4,0.735,NODAL SITE(S) EXAMINED
1827,llama4,0.798,TUMOR SITE
1828,llama4,0.811,TUMOR FOCALITY
1829,llama4,0.788,PROCEDURE
1830,llama4,0.802,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1831,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1832,llama4,0.797,HISTOLOGIC GRADE
1833,llama4,0.805,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1834,llama4,0.7,NUMBER OF LYMPH NODES EXAMINED
1835,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
1836,llama4,0.78,VISCERAL PLEURA INVASION
1837,llama4,0.772,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1838,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1839,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1840,llama4,0.742,MARGIN STATUS FOR INVASIVE CARCINOMA
1841,llama4,0.827,PROCEDURE
1842,llama4,0.877,REGIONAL LYMPH NODE STATUS
1843,llama4,0.797,HISTOLOGIC GRADE
1844,llama4,0.716,ADDITIONAL FINDINGS
1845,llama4,0.697,SPECIMEN LATERALITY
1846,llama4,0.732,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1847,llama4,0.686,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1848,llama4,0.811,TUMOR FOCALITY
1849,llama4,0.743,NODAL SITE(S) EXAMINED
1850,llama4,0.787,TUMOR SITE
1851,llama4,0.745,LYMPHOVASCULAR INVASION
1852,llama4,0.811,TUMOR FOCALITY
1853,llama4,0.758,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1854,llama4,0.742,NODAL SITE(S) EXAMINED
1855,llama4,0.7,ADDITIONAL FINDINGS
1856,llama4,0.772,PROCEDURE
1857,llama4,0.858,TUMOR SITE
1858,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1859,llama4,0.877,REGIONAL LYMPH NODE STATUS
1860,llama4,0.782,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1861,llama4,0.855,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1862,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1863,llama4,0.697,SPECIMEN LATERALITY
1864,llama4,0.778,VISCERAL PLEURA INVASION
1865,llama4,0.729,NUMBER OF LYMPH NODES EXAMINED
1866,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1867,llama4,0.877,REGIONAL LYMPH NODE STATUS
1868,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1869,llama4,0.776,PROCEDURE
1870,llama4,0.811,TUMOR FOCALITY
1871,llama4,0.712,ADDITIONAL FINDINGS
1872,llama4,0.797,HISTOLOGIC GRADE
1873,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1874,llama4,0.698,SPECIMEN LATERALITY
1875,llama4,0.778,VISCERAL PLEURA INVASION
1876,llama4,0.89,TUMOR SITE
1877,llama4,0.775,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1878,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1879,llama4,0.817,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1880,llama4,0.8,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1881,llama4,0.747,NODAL SITE(S) EXAMINED
1882,llama4,0.698,SPECIMEN LATERALITY
1883,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1884,llama4,0.8,HISTOLOGIC GRADE
1885,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
1886,llama4,0.744,MARGIN STATUS FOR INVASIVE CARCINOMA
1887,llama4,0.718,NODAL SITE(S) EXAMINED
1888,llama4,0.72,NUMBER OF LYMPH NODES WITH TUMOR
1889,llama4,0.814,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1890,llama4,0.886,NODAL SITE(S) WITH TUMOR
1891,llama4,0.751,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1892,llama4,0.783,REGIONAL LYMPH NODE STATUS
1893,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
1894,llama4,0.782,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1895,llama4,0.694,NUMBER OF LYMPH NODES EXAMINED
1896,llama4,0.736,TUMOR FOCALITY
1897,llama4,0.687,TUMOR SITE
1898,llama4,0.778,VISCERAL PLEURA INVASION
1899,llama4,0.768,PROCEDURE
1900,llama4,0.693,MARGIN STATUS FOR INVASIVE CARCINOMA
1901,llama4,0.877,REGIONAL LYMPH NODE STATUS
1902,llama4,0.698,SPECIMEN LATERALITY
1903,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1904,llama4,0.76,PROCEDURE
1905,llama4,0.77,TUMOR SITE
1906,llama4,0.811,TUMOR FOCALITY
1907,llama4,0.713,NUMBER OF LYMPH NODES EXAMINED
1908,llama4,0.749,NODAL SITE(S) EXAMINED
1909,llama4,0.792,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1910,llama4,0.778,VISCERAL PLEURA INVASION
1911,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
1912,llama4,0.778,HISTOLOGIC GRADE
1913,llama4,0.697,SPECIMEN LATERALITY
1914,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1915,llama4,0.816,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1916,llama4,0.877,REGIONAL LYMPH NODE STATUS
1917,llama4,0.814,NODAL SITE(S) EXAMINED
1918,llama4,0.78,VISCERAL PLEURA INVASION
1919,llama4,0.893,TUMOR SITE
1920,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1921,llama4,0.829,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1922,llama4,0.718,SPREAD THROUGH AIR SPACES (STAS)
1923,llama4,0.755,PROCEDURE
1924,llama4,0.741,MARGIN STATUS FOR INVASIVE CARCINOMA
1925,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
1926,llama4,0.811,TUMOR FOCALITY
1927,llama4,0.783,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1928,llama4,0.8,HISTOLOGIC GRADE
1929,llama4,0.877,REGIONAL LYMPH NODE STATUS
1930,llama4,0.698,SPECIMEN LATERALITY
1931,llama4,0.778,PROCEDURE
1932,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
1933,llama4,0.808,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1934,llama4,0.841,TUMOR FOCALITY
1935,llama4,0.76,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1936,llama4,0.75,NODAL SITE(S) EXAMINED
1937,llama4,0.797,ADDITIONAL FINDINGS
1938,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1939,llama4,0.778,VISCERAL PLEURA INVASION
1940,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1941,llama4,0.89,TUMOR SITE
1942,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
1943,llama4,0.793,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1944,llama4,0.89,TUMOR SITE
1945,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1946,llama4,0.697,SPECIMEN LATERALITY
1947,llama4,0.893,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1948,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
1949,llama4,0.797,HISTOLOGIC GRADE
1950,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1951,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1952,llama4,0.778,VISCERAL PLEURA INVASION
1953,llama4,0.72,NUMBER OF LYMPH NODES EXAMINED
1954,llama4,0.811,TUMOR FOCALITY
1955,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1956,llama4,0.926,NODAL SITE(S) EXAMINED
1957,llama4,0.877,REGIONAL LYMPH NODE STATUS
1958,llama4,0.827,PROCEDURE
1959,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1960,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1961,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1962,llama4,0.797,HISTOLOGIC GRADE
1963,llama4,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1964,llama4,0.695,NUMBER OF LYMPH NODES EXAMINED
1965,llama4,0.697,SPECIMEN LATERALITY
1966,llama4,0.718,SPREAD THROUGH AIR SPACES (STAS)
1967,llama4,0.89,TUMOR SITE
1968,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1969,llama4,0.877,REGIONAL LYMPH NODE STATUS
1970,llama4,0.811,TUMOR FOCALITY
1971,llama4,0.907,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1972,llama4,0.768,PROCEDURE
1973,llama4,0.854,NODAL SITE(S) EXAMINED
1974,llama4,0.778,VISCERAL PLEURA INVASION
1975,llama4,0.798,TUMOR SITE
1976,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1977,llama4,0.697,SPECIMEN LATERALITY
1978,llama4,0.726,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1979,llama4,0.788,PROCEDURE
1980,llama4,0.759,NODAL SITE(S) EXAMINED
1981,llama4,0.757,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1982,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
1983,llama4,0.811,TUMOR FOCALITY
1984,llama4,0.716,NUMBER OF LYMPH NODES EXAMINED
1985,llama4,0.822,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1986,llama4,0.778,VISCERAL PLEURA INVASION
1987,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1988,llama4,0.745,LYMPHOVASCULAR INVASION
1989,llama4,0.72,NUMBER OF LYMPH NODES WITH TUMOR
1990,llama4,0.772,REGIONAL LYMPH NODE STATUS
1991,llama4,0.657,NODAL SITE(S) WITH TUMOR
1992,llama4,0.811,TUMOR FOCALITY
1993,llama4,0.778,VISCERAL PLEURA INVASION
1994,llama4,0.826,NODAL SITE(S) EXAMINED
1995,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
1996,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1997,llama4,0.797,HISTOLOGIC GRADE
1998,llama4,0.827,PROCEDURE
1999,llama4,0.697,SPECIMEN LATERALITY
2000,llama4,0.787,TUMOR SITE
2001,llama4,0.877,REGIONAL LYMPH NODE STATUS
2002,llama4,0.904,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2003,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2004,llama4,0.695,ADDITIONAL FINDINGS
2005,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
2006,llama4,0.697,NUMBER OF LYMPH NODES EXAMINED
2007,llama4,0.82,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2008,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
2009,llama4,0.746,TUMOR SITE
2010,llama4,0.811,TUMOR FOCALITY
2011,llama4,0.658,TNM DESCRIPTORS
2012,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
2013,llama4,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2014,llama4,0.8,HISTOLOGIC GRADE
2015,llama4,0.698,SPECIMEN LATERALITY
2016,llama4,0.782,NUMBER OF LYMPH NODES EXAMINED
2017,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2018,llama4,0.778,VISCERAL PLEURA INVASION
2019,llama4,0.877,REGIONAL LYMPH NODE STATUS
2020,llama4,0.689,ADDITIONAL FINDINGS
2021,llama4,0.8,NODAL SITE(S) EXAMINED
2022,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2023,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
2024,llama4,0.781,PROCEDURE
2025,llama4,0.774,PROCEDURE
2026,llama4,0.811,TUMOR FOCALITY
2027,llama4,0.839,NODAL SITE(S) EXAMINED
2028,llama4,0.774,ADDITIONAL FINDINGS
2029,llama4,0.778,VISCERAL PLEURA INVASION
2030,llama4,0.697,SPECIMEN LATERALITY
2031,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2032,llama4,0.823,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2033,llama4,0.773,TUMOR SITE
2034,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2035,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
2036,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2037,llama4,0.877,REGIONAL LYMPH NODE STATUS
2038,llama4,0.901,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2039,llama4,0.826,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2040,llama4,0.797,HISTOLOGIC GRADE
2041,llama4,0.89,TUMOR SITE
2042,llama4,0.778,VISCERAL PLEURA INVASION
2043,llama4,0.762,ADDITIONAL FINDINGS
2044,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2045,llama4,0.8,HISTOLOGIC GRADE
2046,llama4,0.842,NODAL SITE(S) EXAMINED
2047,llama4,0.698,SPECIMEN LATERALITY
2048,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2049,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
2050,llama4,0.702,NUMBER OF LYMPH NODES EXAMINED
2051,llama4,0.821,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2052,llama4,0.877,REGIONAL LYMPH NODE STATUS
2053,llama4,0.788,PROCEDURE
2054,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2055,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2056,llama4,0.837,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2057,llama4,0.811,TUMOR FOCALITY
2058,llama4,0.824,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2059,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2060,llama4,0.811,TUMOR FOCALITY
2061,llama4,0.89,TUMOR SITE
2062,llama4,0.698,SPECIMEN LATERALITY
2063,llama4,0.687,LYMPHOVASCULAR INVASION
2064,llama4,0.771,MARGIN STATUS FOR INVASIVE CARCINOMA
2065,llama4,0.703,NUMBER OF LYMPH NODES EXAMINED
2066,llama4,0.75,HISTOLOGIC GRADE
2067,llama4,0.814,NODAL SITE(S) EXAMINED
2068,llama4,0.698,VISCERAL PLEURA INVASION
2069,llama4,0.769,PROCEDURE
2070,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
2071,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
2072,llama4,0.728,TNM DESCRIPTORS
2073,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2074,llama4,0.897,NODAL SITE(S) EXAMINED
2075,llama4,0.72,NUMBER OF LYMPH NODES WITH TUMOR
2076,llama4,0.778,VISCERAL PLEURA INVASION
2077,llama4,0.787,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2078,llama4,0.863,TUMOR SITE
2079,llama4,0.679,HISTOLOGIC GRADE
2080,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2081,llama4,0.762,REGIONAL LYMPH NODE STATUS
2082,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2083,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
2084,llama4,0.708,TUMOR FOCALITY
2085,llama4,0.655,TNM DESCRIPTORS
2086,llama4,0.697,SPECIMEN LATERALITY
2087,llama4,0.772,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2088,llama4,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2089,llama4,0.664,NODAL SITE(S) WITH TUMOR
2090,llama4,0.738,PROCEDURE
2091,llama4,0.89,TUMOR SITE
2092,llama4,0.811,TUMOR FOCALITY
2093,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2094,llama4,0.778,VISCERAL PLEURA INVASION
2095,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
2096,llama4,0.838,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2097,llama4,0.84,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2098,llama4,0.757,NODAL SITE(S) EXAMINED
2099,llama4,0.763,PROCEDURE
2100,llama4,0.877,REGIONAL LYMPH NODE STATUS
2101,llama4,0.698,SPECIMEN LATERALITY
2102,llama4,0.797,HISTOLOGIC GRADE
2103,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2104,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2105,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2106,llama4,0.732,NODAL SITE(S) EXAMINED
2107,llama4,0.698,VISCERAL PLEURA INVASION
2108,llama4,0.817,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2109,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
2110,llama4,0.69,PROCEDURE
2111,llama4,0.808,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2112,llama4,0.811,TUMOR FOCALITY
2113,llama4,0.698,LYMPHOVASCULAR INVASION
2114,llama4,0.698,SPECIMEN LATERALITY
2115,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2116,llama4,0.734,NUMBER OF LYMPH NODES EXAMINED
2117,llama4,0.685,TUMOR SITE
2118,llama4,0.797,HISTOLOGIC GRADE
2119,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2120,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2121,llama4,0.877,REGIONAL LYMPH NODE STATUS
2122,llama4,0.715,ADDITIONAL FINDINGS
2123,llama4,0.811,TUMOR FOCALITY
2124,llama4,0.725,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2125,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
2126,llama4,0.759,NODAL SITE(S) EXAMINED
2127,llama4,0.746,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2128,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2129,llama4,0.822,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2130,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
2131,llama4,0.788,PROCEDURE
2132,llama4,0.78,VISCERAL PLEURA INVASION
2133,llama4,0.698,SPECIMEN LATERALITY
2134,llama4,0.786,NUMBER OF LYMPH NODES EXAMINED
2135,llama4,0.778,HISTOLOGIC GRADE
2136,llama4,0.877,REGIONAL LYMPH NODE STATUS
2137,llama4,0.865,TUMOR SITE
2138,llama4,0.778,VISCERAL PLEURA INVASION
2139,llama4,0.788,PROCEDURE
2140,llama4,0.797,HISTOLOGIC GRADE
2141,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2142,llama4,0.907,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2143,llama4,0.89,TUMOR SITE
2144,llama4,0.785,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2145,llama4,0.699,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2146,llama4,0.697,SPECIMEN LATERALITY
2147,llama4,0.877,REGIONAL LYMPH NODE STATUS
2148,llama4,0.811,TUMOR FOCALITY
2149,llama4,0.725,NODAL SITE(S) EXAMINED
2150,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2151,llama4,0.706,ADDITIONAL FINDINGS
2152,llama4,0.699,NUMBER OF LYMPH NODES EXAMINED
2153,llama4,0.749,MARGIN STATUS FOR INVASIVE CARCINOMA
2154,llama4,0.811,TUMOR FOCALITY
2155,llama4,0.827,PROCEDURE
2156,llama4,0.802,TUMOR SITE
2157,llama4,0.797,HISTOLOGIC GRADE
2158,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2159,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2160,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2161,llama4,0.745,NODAL SITE(S) EXAMINED
2162,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2163,llama4,0.829,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2164,llama4,0.877,REGIONAL LYMPH NODE STATUS
2165,llama4,0.697,SPECIMEN LATERALITY
2166,llama4,0.758,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2167,llama4,0.778,VISCERAL PLEURA INVASION
2168,llama4,0.821,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2169,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
2170,llama4,0.778,VISCERAL PLEURA INVASION
2171,llama4,0.788,PROCEDURE
2172,llama4,0.739,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2173,llama4,0.698,NUMBER OF LYMPH NODES EXAMINED
2174,llama4,0.811,TUMOR FOCALITY
2175,llama4,0.821,TUMOR SITE
2176,llama4,0.839,ADDITIONAL FINDINGS
2177,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2178,llama4,0.698,SPECIMEN LATERALITY
2179,llama4,0.877,REGIONAL LYMPH NODE STATUS
2180,llama4,0.785,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2181,llama4,0.771,NODAL SITE(S) EXAMINED
2182,llama4,0.797,HISTOLOGIC GRADE
2183,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2184,llama4,0.733,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2185,llama4,0.692,LYMPHOVASCULAR INVASION
2186,llama4,0.698,SPECIMEN LATERALITY
2187,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2188,llama4,0.732,ADDITIONAL FINDINGS
2189,llama4,0.827,PROCEDURE
2190,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
2191,llama4,0.85,NODAL SITE(S) EXAMINED
2192,llama4,0.654,TNM DESCRIPTORS
2193,llama4,0.78,VISCERAL PLEURA INVASION
2194,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2195,llama4,0.771,NODAL SITE(S) WITH TUMOR
2196,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
2197,llama4,0.678,TUMOR FOCALITY
2198,llama4,0.89,TUMOR SITE
2199,llama4,0.856,REGIONAL LYMPH NODE STATUS
2200,llama4,0.742,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2201,llama4,0.715,ADDITIONAL FINDINGS
2202,llama4,0.738,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2203,llama4,0.835,NODAL SITE(S) EXAMINED
2204,llama4,0.778,VISCERAL PLEURA INVASION
2205,llama4,0.735,PROCEDURE
2206,llama4,0.877,REGIONAL LYMPH NODE STATUS
2207,llama4,0.653,TNM DESCRIPTORS
2208,llama4,0.78,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2209,llama4,0.8,HISTOLOGIC GRADE
2210,llama4,0.888,MARGIN STATUS FOR NON-INVASIVE TUMOR
2211,llama4,0.766,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2212,llama4,0.811,TUMOR FOCALITY
2213,llama4,0.697,SPECIMEN LATERALITY
2214,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2215,llama4,0.89,TUMOR SITE
2216,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2217,llama4,0.887,TUMOR SITE
2218,llama4,0.742,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2219,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2220,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2221,llama4,0.711,PROCEDURE
2222,llama4,0.877,REGIONAL LYMPH NODE STATUS
2223,llama4,0.905,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2224,llama4,0.772,MARGIN STATUS FOR INVASIVE CARCINOMA
2225,llama4,0.797,HISTOLOGIC GRADE
2226,llama4,0.778,VISCERAL PLEURA INVASION
2227,llama4,0.811,TUMOR FOCALITY
2228,llama4,0.807,NODAL SITE(S) EXAMINED
2229,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2230,llama4,0.7,NUMBER OF LYMPH NODES EXAMINED
2231,llama4,0.697,SPECIMEN LATERALITY
2232,llama4,0.874,REGIONAL LYMPH NODE STATUS
2233,llama4,0.804,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2234,llama4,0.778,HISTOLOGIC GRADE
2235,llama4,0.791,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2236,llama4,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
2237,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2238,llama4,0.811,TUMOR FOCALITY
2239,llama4,0.838,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2240,llama4,0.749,PROCEDURE
2241,llama4,0.705,NUMBER OF LYMPH NODES EXAMINED
2242,llama4,0.697,SPECIMEN LATERALITY
2243,llama4,0.887,TUMOR SITE
2244,llama4,0.824,NODAL SITE(S) EXAMINED
2245,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2246,llama4,0.698,VISCERAL PLEURA INVASION
2247,llama4,0.745,LYMPHOVASCULAR INVASION
2248,llama4,0.744,PROCEDURE
2249,llama4,0.698,NUMBER OF LYMPH NODES WITH TUMOR
2250,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
2251,llama4,0.802,TUMOR SITE
2252,llama4,0.733,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2253,llama4,0.778,HISTOLOGIC GRADE
2254,llama4,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2255,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2256,llama4,0.856,REGIONAL LYMPH NODE STATUS
2257,llama4,0.72,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2258,llama4,0.812,NODAL SITE(S) EXAMINED
2259,llama4,0.698,SPECIMEN LATERALITY
2260,llama4,0.712,TUMOR FOCALITY
2261,llama4,0.806,ADDITIONAL FINDINGS
2262,llama4,0.698,SPREAD THROUGH AIR SPACES (STAS)
2263,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2264,llama4,0.682,NUMBER OF LYMPH NODES EXAMINED
2265,llama4,0.778,VISCERAL PLEURA INVASION
2266,llama4,0.647,TNM DESCRIPTORS
2267,llama4,0.798,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2268,llama4,0.787,TUMOR SITE
2269,llama4,0.742,MARGIN STATUS FOR INVASIVE CARCINOMA
2270,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2271,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2272,llama4,0.681,ADDITIONAL FINDINGS
2273,llama4,0.719,NODAL SITE(S) EXAMINED
2274,llama4,0.827,PROCEDURE
2275,llama4,0.663,HISTOLOGIC GRADE
2276,llama4,0.718,SPREAD THROUGH AIR SPACES (STAS)
2277,llama4,0.762,TUMOR SITE
2278,llama4,0.811,TUMOR FOCALITY
2279,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2280,llama4,0.817,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2281,llama4,0.697,SPECIMEN LATERALITY
2282,llama4,0.78,VISCERAL PLEURA INVASION
2283,llama4,0.877,REGIONAL LYMPH NODE STATUS
2284,llama4,0.672,MARGIN STATUS FOR INVASIVE CARCINOMA
2285,llama4,0.697,SPECIMEN LATERALITY
2286,llama4,0.76,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2287,llama4,0.778,VISCERAL PLEURA INVASION
2288,llama4,0.704,HISTOLOGIC GRADE
2289,llama4,0.697,TUMOR SITE
2290,llama4,0.77,NODAL SITE(S) EXAMINED
2291,llama4,0.663,MARGIN STATUS FOR NON-INVASIVE TUMOR
2292,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
2293,llama4,0.877,REGIONAL LYMPH NODE STATUS
2294,llama4,0.691,LYMPH NODE(S) FROM PRIOR PROCEDURES
2295,llama4,0.731,PROCEDURE
2296,llama4,0.811,TUMOR FOCALITY
2297,llama4,0.847,NODAL SITE(S) WITH TUMOR
2298,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2299,llama4,0.907,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2300,llama4,0.816,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2301,llama4,0.745,LYMPHOVASCULAR INVASION
2302,llama4,0.698,SPECIMEN LATERALITY
2303,llama4,0.714,TUMOR SITE
2304,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2305,llama4,0.778,VISCERAL PLEURA INVASION
2306,llama4,0.811,TUMOR FOCALITY
2307,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2308,llama4,0.698,NUMBER OF LYMPH NODES EXAMINED
2309,llama4,0.785,REGIONAL LYMPH NODE STATUS
2310,llama4,0.778,HISTOLOGIC GRADE
2311,llama4,0.701,NODAL SITE(S) EXAMINED
2312,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2313,llama4,0.713,NUMBER OF LYMPH NODES WITH TUMOR
2314,llama4,0.793,PROCEDURE
2315,llama4,0.778,VISCERAL PLEURA INVASION
2316,llama4,0.877,REGIONAL LYMPH NODE STATUS
2317,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2318,llama4,0.795,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2319,llama4,0.74,NODAL SITE(S) EXAMINED
2320,llama4,0.8,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2321,llama4,0.626,TUMOR SITE
2322,llama4,0.827,PROCEDURE
2323,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
2324,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2325,llama4,0.685,ADDITIONAL FINDINGS
2326,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2327,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
2328,llama4,0.693,HISTOLOGIC GRADE
2329,llama4,0.697,SPECIMEN LATERALITY
2330,llama4,0.704,NUMBER OF LYMPH NODES EXAMINED
2331,llama4,0.867,TUMOR FOCALITY
2332,llama4,0.774,NODAL SITE(S) EXAMINED
2333,llama4,0.683,TNM DESCRIPTORS
2334,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2335,llama4,0.796,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2336,llama4,0.793,TUMOR SITE
2337,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
2338,llama4,0.695,NUMBER OF LYMPH NODES EXAMINED
2339,llama4,0.69,PROCEDURE
2340,llama4,0.698,SPECIMEN LATERALITY
2341,llama4,0.694,HISTOLOGIC GRADE
2342,llama4,0.877,REGIONAL LYMPH NODE STATUS
2343,llama4,0.804,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2344,llama4,0.751,ADDITIONAL FINDINGS
2345,llama4,0.778,VISCERAL PLEURA INVASION
2346,llama4,0.735,TUMOR FOCALITY
2347,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2348,llama4,0.784,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2349,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
2350,llama4,0.697,NODAL SITE(S) WITH TUMOR
2351,llama4,0.856,REGIONAL LYMPH NODE STATUS
2352,llama4,0.699,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2353,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2354,llama4,0.89,TUMOR SITE
2355,llama4,0.788,PROCEDURE
2356,llama4,0.697,SPECIMEN LATERALITY
2357,llama4,0.778,VISCERAL PLEURA INVASION
2358,llama4,0.754,NUMBER OF LYMPH NODES EXAMINED
2359,llama4,0.808,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2360,llama4,0.698,LYMPHOVASCULAR INVASION
2361,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
2362,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2363,llama4,0.757,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2364,llama4,0.796,NODAL SITE(S) EXAMINED
2365,llama4,0.739,TUMOR FOCALITY
2366,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2367,llama4,0.778,HISTOLOGIC GRADE
2368,llama4,0.742,PROCEDURE
2369,llama4,0.78,VISCERAL PLEURA INVASION
2370,llama4,0.697,SPECIMEN LATERALITY
2371,llama4,0.761,MARGIN STATUS FOR INVASIVE CARCINOMA
2372,llama4,0.787,TUMOR SITE
2373,llama4,0.735,MARGIN STATUS FOR NON-INVASIVE TUMOR
2374,llama4,0.894,NODAL SITE(S) EXAMINED
2375,llama4,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2376,llama4,0.811,TUMOR FOCALITY
2377,llama4,0.814,REGIONAL LYMPH NODE STATUS
2378,llama4,0.681,LYMPHOVASCULAR INVASION
2379,llama4,0.713,NUMBER OF LYMPH NODES EXAMINED
2380,llama4,0.694,ADDITIONAL FINDINGS
2381,llama4,0.797,HISTOLOGIC GRADE
2382,llama4,0.877,REGIONAL LYMPH NODE STATUS
2383,llama4,0.787,TUMOR SITE
2384,llama4,0.855,MARGIN STATUS FOR INVASIVE CARCINOMA
2385,llama4,0.713,NUMBER OF LYMPH NODES EXAMINED
2386,llama4,0.708,NODAL SITE(S) EXAMINED
2387,llama4,0.811,TUMOR FOCALITY
2388,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
2389,llama4,0.778,VISCERAL PLEURA INVASION
2390,llama4,0.794,PROCEDURE
2391,llama4,0.792,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2392,llama4,0.697,SPECIMEN LATERALITY
2393,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
2394,llama4,0.797,HISTOLOGIC GRADE
2395,llama4,0.828,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2396,llama4,0.723,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2397,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2398,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
2399,llama4,0.89,TUMOR SITE
2400,llama4,0.778,VISCERAL PLEURA INVASION
2401,llama4,0.705,NUMBER OF LYMPH NODES EXAMINED
2402,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2403,llama4,0.811,TUMOR FOCALITY
2404,llama4,0.821,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2405,llama4,0.698,SPECIMEN LATERALITY
2406,llama4,0.687,NODAL SITE(S) EXAMINED
2407,llama4,0.755,PROCEDURE
2408,llama4,0.877,REGIONAL LYMPH NODE STATUS
2409,llama4,0.903,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2410,llama4,0.798,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2411,llama4,0.797,HISTOLOGIC GRADE
2412,llama4,0.877,REGIONAL LYMPH NODE STATUS
2413,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2414,llama4,0.811,TUMOR FOCALITY
2415,llama4,0.697,SPECIMEN LATERALITY
2416,llama4,0.716,ADDITIONAL FINDINGS
2417,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2418,llama4,0.836,NODAL SITE(S) EXAMINED
2419,llama4,0.778,VISCERAL PLEURA INVASION
2420,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2421,llama4,0.712,NUMBER OF LYMPH NODES EXAMINED
2422,llama4,0.719,PROCEDURE
2423,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
2424,llama4,0.89,TUMOR SITE
2425,llama4,0.697,SPECIMEN LATERALITY
2426,llama4,0.811,TUMOR FOCALITY
2427,llama4,0.746,REGIONAL LYMPH NODE STATUS
2428,llama4,0.778,VISCERAL PLEURA INVASION
2429,llama4,0.705,NUMBER OF LYMPH NODES WITH TUMOR
2430,llama4,0.735,PROCEDURE
2431,llama4,0.727,NODAL SITE(S) WITH TUMOR
2432,llama4,0.666,TNM DESCRIPTORS
2433,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2434,llama4,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
2435,llama4,0.752,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2436,llama4,0.798,TUMOR SITE
2437,llama4,0.698,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2438,llama4,0.663,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2439,llama4,0.697,NODAL SITE(S) EXAMINED
2440,llama4,0.717,MARGIN STATUS FOR NON-INVASIVE TUMOR
2441,llama4,0.827,PROCEDURE
2442,llama4,0.698,SPECIMEN LATERALITY
2443,llama4,0.698,MARGIN STATUS FOR INVASIVE CARCINOMA
2444,llama4,0.738,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2445,llama4,0.811,TUMOR FOCALITY
2446,llama4,0.8,HISTOLOGIC GRADE
2447,llama4,0.738,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2448,llama4,0.7,VISCERAL PLEURA INVASION
2449,llama4,0.786,TUMOR SITE
2450,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2451,llama4,0.696,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2452,llama4,0.73,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2453,llama4,0.8,NODAL SITE(S) EXAMINED
2454,llama4,0.826,MARGIN STATUS FOR NON-INVASIVE TUMOR
2455,llama4,0.698,SPECIMEN LATERALITY
2456,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2457,llama4,0.706,ADDITIONAL FINDINGS
2458,llama4,0.698,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2459,llama4,0.788,PROCEDURE
2460,llama4,0.835,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2461,llama4,0.797,HISTOLOGIC GRADE
2462,llama4,0.877,REGIONAL LYMPH NODE STATUS
2463,llama4,0.811,TUMOR FOCALITY
2464,llama4,0.778,VISCERAL PLEURA INVASION
2465,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2466,llama4,0.89,TUMOR SITE
2467,llama4,0.704,NUMBER OF LYMPH NODES EXAMINED
2468,llama4,0.826,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2469,llama4,0.748,MARGIN STATUS FOR INVASIVE CARCINOMA
2470,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
2471,llama4,0.697,SPECIMEN LATERALITY
2472,llama4,0.785,ADDITIONAL FINDINGS
2473,llama4,0.865,TUMOR SITE
2474,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2475,llama4,0.797,HISTOLOGIC GRADE
2476,llama4,0.811,TUMOR FOCALITY
2477,llama4,0.827,PROCEDURE
2478,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2479,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2480,llama4,0.698,VISCERAL PLEURA INVASION
2481,llama4,0.903,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2482,llama4,0.81,TUMOR SITE
2483,llama4,0.695,NODAL SITE(S) WITH TUMOR
2484,llama4,0.747,MARGIN STATUS FOR INVASIVE CARCINOMA
2485,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
2486,llama4,0.811,TUMOR FOCALITY
2487,llama4,0.778,HISTOLOGIC GRADE
2488,llama4,0.78,VISCERAL PLEURA INVASION
2489,llama4,0.811,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2490,llama4,0.856,PROCEDURE
2491,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2492,llama4,0.742,REGIONAL LYMPH NODE STATUS
2493,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
2494,llama4,0.809,NODAL SITE(S) EXAMINED
2495,llama4,0.697,SPECIMEN LATERALITY
2496,llama4,0.817,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2497,llama4,0.759,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2498,llama4,0.817,NODAL SITE(S) EXAMINED
2499,llama4,0.73,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2500,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2501,llama4,0.698,VISCERAL PLEURA INVASION
2502,llama4,0.877,REGIONAL LYMPH NODE STATUS
2503,llama4,0.811,TUMOR FOCALITY
2504,llama4,0.89,TUMOR SITE
2505,llama4,0.797,HISTOLOGIC GRADE
2506,llama4,0.859,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2507,llama4,0.824,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2508,llama4,0.692,SPREAD THROUGH AIR SPACES (STAS)
2509,llama4,0.704,ADDITIONAL FINDINGS
2510,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2511,llama4,0.777,PROCEDURE
2512,llama4,0.794,MARGIN STATUS FOR INVASIVE CARCINOMA
2513,llama4,0.697,SPECIMEN LATERALITY
2514,llama4,0.811,TUMOR FOCALITY
2515,llama4,0.817,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2516,llama4,0.789,HISTOLOGIC GRADE
2517,llama4,0.893,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2518,llama4,0.746,NODAL SITE(S) EXAMINED
2519,llama4,0.697,SPECIMEN LATERALITY
2520,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
2521,llama4,0.789,TUMOR SITE
2522,llama4,0.877,REGIONAL LYMPH NODE STATUS
2523,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
2524,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2525,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2526,llama4,0.793,PROCEDURE
2527,llama4,0.778,VISCERAL PLEURA INVASION
2528,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2529,llama4,0.899,NUMBER OF LYMPH NODES EXAMINED
2530,llama4,0.733,ADDITIONAL FINDINGS
2531,llama4,0.797,HISTOLOGIC GRADE
2532,llama4,0.688,NODAL SITE(S) EXAMINED
2533,llama4,0.819,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2534,llama4,0.778,VISCERAL PLEURA INVASION
2535,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
2536,llama4,0.827,PROCEDURE
2537,llama4,0.877,REGIONAL LYMPH NODE STATUS
2538,llama4,0.893,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2539,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2540,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2541,llama4,0.811,TUMOR FOCALITY
2542,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2543,llama4,0.89,TUMOR SITE
2544,llama4,0.72,NUMBER OF LYMPH NODES EXAMINED
2545,llama4,0.698,SPECIMEN LATERALITY
2546,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2547,llama4,0.729,NODAL SITE(S) EXAMINED
2548,llama4,0.877,REGIONAL LYMPH NODE STATUS
2549,llama4,0.778,HISTOLOGIC GRADE
2550,llama4,0.811,TUMOR FOCALITY
2551,llama4,0.749,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2552,llama4,0.698,SPECIMEN LATERALITY
2553,llama4,0.788,PROCEDURE
2554,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
2555,llama4,0.715,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2556,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2557,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2558,llama4,0.71,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2559,llama4,0.89,TUMOR SITE
2560,llama4,0.7,LYMPH NODE(S) FROM PRIOR PROCEDURES
2561,llama4,0.778,VISCERAL PLEURA INVASION
2562,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2563,llama4,0.816,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2564,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2565,llama4,0.698,SPECIMEN LATERALITY
2566,llama4,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2567,llama4,0.89,TUMOR SITE
2568,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
2569,llama4,0.827,PROCEDURE
2570,llama4,0.811,TUMOR FOCALITY
2571,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2572,llama4,0.77,MARGIN STATUS FOR INVASIVE CARCINOMA
2573,llama4,0.778,VISCERAL PLEURA INVASION
2574,llama4,0.797,HISTOLOGIC GRADE
2575,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2576,llama4,0.798,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2577,llama4,0.827,PROCEDURE
2578,llama4,0.699,NUMBER OF LYMPH NODES EXAMINED
2579,llama4,0.698,SPECIMEN LATERALITY
2580,llama4,0.847,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2581,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2582,llama4,0.778,VISCERAL PLEURA INVASION
2583,llama4,0.877,REGIONAL LYMPH NODE STATUS
2584,llama4,0.811,TUMOR FOCALITY
2585,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2586,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2587,llama4,0.89,TUMOR SITE
2588,llama4,0.748,NODAL SITE(S) EXAMINED
2589,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
2590,llama4,0.72,NODAL SITE(S) EXAMINED
2591,llama4,0.797,HISTOLOGIC GRADE
2592,llama4,0.811,TUMOR FOCALITY
2593,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2594,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2595,llama4,0.696,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2596,llama4,0.778,VISCERAL PLEURA INVASION
2597,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2598,llama4,0.827,PROCEDURE
2599,llama4,0.697,SPECIMEN LATERALITY
2600,llama4,0.877,REGIONAL LYMPH NODE STATUS
2601,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2602,llama4,0.803,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2603,llama4,0.713,NUMBER OF LYMPH NODES EXAMINED
2604,llama4,0.893,TUMOR SITE
2605,llama4,0.697,SPECIMEN LATERALITY
2606,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2607,llama4,0.798,TUMOR SITE
2608,llama4,0.759,MARGIN STATUS FOR INVASIVE CARCINOMA
2609,llama4,0.797,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2610,llama4,0.827,PROCEDURE
2611,llama4,0.811,TUMOR FOCALITY
2612,llama4,0.69,NODAL SITE(S) EXAMINED
2613,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2614,llama4,0.75,HISTOLOGIC GRADE
2615,llama4,0.877,REGIONAL LYMPH NODE STATUS
2616,llama4,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2617,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
2618,llama4,0.778,VISCERAL PLEURA INVASION
2619,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
2620,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2621,llama4,0.7,NUMBER OF LYMPH NODES WITH TUMOR
2622,llama4,0.757,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2623,llama4,0.696,PROCEDURE
2624,llama4,0.876,TUMOR SITE
2625,llama4,0.811,TUMOR FOCALITY
2626,llama4,0.654,TNM DESCRIPTORS
2627,llama4,0.697,SPECIMEN LATERALITY
2628,llama4,0.698,LYMPHOVASCULAR INVASION
2629,llama4,0.735,NODAL SITE(S) EXAMINED
2630,llama4,0.778,HISTOLOGIC GRADE
2631,llama4,0.811,NODAL SITE(S) WITH TUMOR
2632,llama4,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2633,llama4,0.816,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2634,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2635,llama4,0.778,VISCERAL PLEURA INVASION
2636,llama4,0.777,REGIONAL LYMPH NODE STATUS
2637,llama4,0.725,NODAL SITE(S) EXAMINED
2638,llama4,0.744,PROCEDURE
2639,llama4,0.778,VISCERAL PLEURA INVASION
2640,llama4,0.755,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2641,llama4,0.698,SPECIMEN LATERALITY
2642,llama4,0.729,ADDITIONAL FINDINGS
2643,llama4,0.808,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2644,llama4,0.78,SPREAD THROUGH AIR SPACES (STAS)
2645,llama4,0.688,NUMBER OF LYMPH NODES EXAMINED
2646,llama4,0.89,TUMOR SITE
2647,llama4,0.721,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2648,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2649,llama4,0.811,TUMOR FOCALITY
2650,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2651,llama4,0.877,REGIONAL LYMPH NODE STATUS
2652,llama4,0.797,HISTOLOGIC GRADE
2653,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2654,llama4,0.715,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2655,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2656,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
2657,llama4,0.813,NODAL SITE(S) EXAMINED
2658,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2659,llama4,0.788,PROCEDURE
2660,llama4,0.797,HISTOLOGIC GRADE
2661,llama4,0.811,TUMOR FOCALITY
2662,llama4,0.877,REGIONAL LYMPH NODE STATUS
2663,llama4,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2664,llama4,0.778,VISCERAL PLEURA INVASION
2665,llama4,0.698,NUMBER OF LYMPH NODES EXAMINED
2666,llama4,0.811,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2667,llama4,0.802,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2668,llama4,0.89,TUMOR SITE
2669,llama4,0.697,SPECIMEN LATERALITY
2670,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2671,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2672,llama4,0.716,ADDITIONAL FINDINGS
2673,llama4,0.756,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2674,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2675,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
2676,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
2677,llama4,0.89,TUMOR SITE
2678,llama4,0.749,NODAL SITE(S) EXAMINED
2679,llama4,0.778,HISTOLOGIC GRADE
2680,llama4,0.714,LYMPHOVASCULAR INVASION
2681,llama4,0.698,SPECIMEN LATERALITY
2682,llama4,0.713,NUMBER OF LYMPH NODES EXAMINED
2683,llama4,0.778,VISCERAL PLEURA INVASION
2684,llama4,0.793,PROCEDURE
2685,llama4,0.877,REGIONAL LYMPH NODE STATUS
2686,llama4,0.821,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2687,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2688,llama4,0.811,TUMOR FOCALITY
2689,llama4,0.778,VISCERAL PLEURA INVASION
2690,llama4,0.726,NUMBER OF LYMPH NODES WITH TUMOR
2691,llama4,0.8,HISTOLOGIC GRADE
2692,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2693,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
2694,llama4,0.828,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2695,llama4,0.811,TUMOR FOCALITY
2696,llama4,0.779,TUMOR SITE
2697,llama4,0.678,MARGIN STATUS FOR INVASIVE CARCINOMA
2698,llama4,0.697,NUMBER OF LYMPH NODES EXAMINED
2699,llama4,0.697,SPECIMEN LATERALITY
2700,llama4,0.728,REGIONAL LYMPH NODE STATUS
2701,llama4,0.72,NODAL SITE(S) EXAMINED
2702,llama4,0.788,PROCEDURE
2703,llama4,0.725,MARGIN STATUS FOR NON-INVASIVE TUMOR
2704,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
2705,llama4,0.75,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2706,llama4,0.78,NODAL SITE(S) EXAMINED
2707,llama4,0.855,MARGIN STATUS FOR INVASIVE CARCINOMA
2708,llama4,0.778,VISCERAL PLEURA INVASION
2709,llama4,0.701,ADDITIONAL FINDINGS
2710,llama4,0.798,PROCEDURE
2711,llama4,0.698,LYMPHOVASCULAR INVASION
2712,llama4,0.776,REGIONAL LYMPH NODE STATUS
2713,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2714,llama4,0.7,NUMBER OF LYMPH NODES WITH TUMOR
2715,llama4,0.697,SPECIMEN LATERALITY
2716,llama4,0.681,TUMOR SITE
2717,llama4,0.691,NUMBER OF LYMPH NODES EXAMINED
2718,llama4,0.706,NODAL SITE(S) WITH TUMOR
2719,llama4,0.811,TUMOR FOCALITY
2720,llama4,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
2721,llama4,0.89,TUMOR SITE
2722,llama4,0.698,LYMPHOVASCULAR INVASION
2723,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2724,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2725,llama4,0.803,NODAL SITE(S) EXAMINED
2726,llama4,0.697,SPECIMEN LATERALITY
2727,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2728,llama4,0.778,VISCERAL PLEURA INVASION
2729,llama4,0.787,ADDITIONAL FINDINGS
2730,llama4,0.801,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2731,llama4,0.75,PROCEDURE
2732,llama4,0.708,TUMOR FOCALITY
2733,llama4,0.797,HISTOLOGIC GRADE
2734,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2735,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
2736,llama4,0.804,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2737,llama4,0.877,REGIONAL LYMPH NODE STATUS
2738,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2739,llama4,0.745,LYMPHOVASCULAR INVASION
2740,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
2741,llama4,0.811,TUMOR FOCALITY
2742,llama4,0.788,PROCEDURE
2743,llama4,0.886,NODAL SITE(S) WITH TUMOR
2744,llama4,0.78,VISCERAL PLEURA INVASION
2745,llama4,0.72,NUMBER OF LYMPH NODES WITH TUMOR
2746,llama4,0.777,REGIONAL LYMPH NODE STATUS
2747,llama4,0.698,NUMBER OF LYMPH NODES EXAMINED
2748,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
2749,llama4,0.738,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2750,llama4,0.697,SPECIMEN LATERALITY
2751,llama4,0.67,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2752,llama4,0.778,HISTOLOGIC GRADE
2753,llama4,0.727,NODAL SITE(S) EXAMINED
2754,llama4,0.733,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2755,llama4,0.89,TUMOR SITE
2756,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2757,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2758,llama4,0.877,REGIONAL LYMPH NODE STATUS
2759,llama4,0.811,TUMOR FOCALITY
2760,llama4,0.739,LYMPHOVASCULAR INVASION
2761,llama4,0.849,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2762,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2763,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2764,llama4,0.89,TUMOR SITE
2765,llama4,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2766,llama4,0.658,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2767,llama4,0.778,VISCERAL PLEURA INVASION
2768,llama4,0.788,PROCEDURE
2769,llama4,0.693,NODAL SITE(S) EXAMINED
2770,llama4,0.697,SPECIMEN LATERALITY
2771,llama4,0.797,HISTOLOGIC GRADE
2772,llama4,0.856,REGIONAL LYMPH NODE STATUS
2773,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2774,llama4,0.89,TUMOR SITE
2775,llama4,0.692,NUMBER OF LYMPH NODES EXAMINED
2776,llama4,0.667,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2777,llama4,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2778,llama4,0.705,PROCEDURE
2779,llama4,0.78,VISCERAL PLEURA INVASION
2780,llama4,0.811,TUMOR FOCALITY
2781,llama4,0.718,SPREAD THROUGH AIR SPACES (STAS)
2782,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2783,llama4,0.829,NODAL SITE(S) EXAMINED
2784,llama4,0.713,NUMBER OF LYMPH NODES WITH TUMOR
2785,llama4,0.697,SPECIMEN LATERALITY
2786,llama4,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2787,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2788,llama4,0.718,NODAL SITE(S) WITH TUMOR
2789,llama4,0.778,NODAL SITE(S) EXAMINED
2790,llama4,0.778,VISCERAL PLEURA INVASION
2791,llama4,0.698,SPECIMEN LATERALITY
2792,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2793,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2794,llama4,0.727,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2795,llama4,0.89,TUMOR SITE
2796,llama4,0.811,TUMOR FOCALITY
2797,llama4,0.736,ADDITIONAL FINDINGS
2798,llama4,0.756,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2799,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2800,llama4,0.877,REGIONAL LYMPH NODE STATUS
2801,llama4,0.756,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2802,llama4,0.797,HISTOLOGIC GRADE
2803,llama4,0.756,PROCEDURE
2804,llama4,0.697,NUMBER OF LYMPH NODES EXAMINED
2805,llama4,0.877,REGIONAL LYMPH NODE STATUS
2806,llama4,0.89,TUMOR SITE
2807,llama4,0.797,HISTOLOGIC GRADE
2808,llama4,0.788,PROCEDURE
2809,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2810,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2811,llama4,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2812,llama4,0.704,ADDITIONAL FINDINGS
2813,llama4,0.747,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2814,llama4,0.698,SPECIMEN LATERALITY
2815,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
2816,llama4,0.78,VISCERAL PLEURA INVASION
2817,llama4,0.742,MARGIN STATUS FOR INVASIVE CARCINOMA
2818,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2819,llama4,0.811,TUMOR FOCALITY
2820,llama4,0.746,NODAL SITE(S) EXAMINED
2821,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2822,llama4,0.89,TUMOR SITE
2823,llama4,0.797,HISTOLOGIC GRADE
2824,llama4,0.775,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2825,llama4,0.778,VISCERAL PLEURA INVASION
2826,llama4,0.811,TUMOR FOCALITY
2827,llama4,0.749,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2828,llama4,0.725,NUMBER OF LYMPH NODES EXAMINED
2829,llama4,0.698,SPECIMEN LATERALITY
2830,llama4,0.755,PROCEDURE
2831,llama4,0.893,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2832,llama4,0.697,ADDITIONAL FINDINGS
2833,llama4,0.747,NODAL SITE(S) EXAMINED
2834,llama4,0.877,REGIONAL LYMPH NODE STATUS
2835,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
2836,llama4,0.745,LYMPHOVASCULAR INVASION
2837,llama4,0.778,VISCERAL PLEURA INVASION
2838,llama4,0.788,PROCEDURE
2839,llama4,0.715,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2840,llama4,0.811,TUMOR FOCALITY
2841,llama4,0.697,SPECIMEN LATERALITY
2842,llama4,0.794,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2843,llama4,0.877,REGIONAL LYMPH NODE STATUS
2844,llama4,0.89,TUMOR SITE
2845,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2846,llama4,0.695,NUMBER OF LYMPH NODES EXAMINED
2847,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2848,llama4,0.74,NODAL SITE(S) EXAMINED
2849,llama4,0.778,HISTOLOGIC GRADE
2850,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
2851,llama4,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2852,llama4,0.727,ADDITIONAL FINDINGS
2853,llama4,0.697,SPECIMEN LATERALITY
2854,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2855,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2856,llama4,0.781,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2857,llama4,0.877,REGIONAL LYMPH NODE STATUS
2858,llama4,0.698,VISCERAL PLEURA INVASION
2859,llama4,0.818,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2860,llama4,0.698,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2861,llama4,0.692,LYMPHOVASCULAR INVASION
2862,llama4,0.788,PROCEDURE
2863,llama4,0.725,NODAL SITE(S) EXAMINED
2864,llama4,0.72,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2865,llama4,0.778,HISTOLOGIC GRADE
2866,llama4,0.811,TUMOR FOCALITY
2867,llama4,0.893,TUMOR SITE
2868,llama4,0.81,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2869,llama4,0.786,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2870,llama4,0.89,TUMOR SITE
2871,llama4,0.877,REGIONAL LYMPH NODE STATUS
2872,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
2873,llama4,0.778,VISCERAL PLEURA INVASION
2874,llama4,0.797,HISTOLOGIC GRADE
2875,llama4,0.745,MARGIN STATUS FOR INVASIVE CARCINOMA
2876,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2877,llama4,0.697,SPECIMEN LATERALITY
2878,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2879,llama4,0.918,TUMOR FOCALITY
2880,llama4,0.803,NODAL SITE(S) EXAMINED
2881,llama4,0.744,ADDITIONAL FINDINGS
2882,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2883,llama4,0.788,PROCEDURE
2884,llama4,0.792,REGIONAL LYMPH NODE STATUS
2885,llama4,0.745,LYMPHOVASCULAR INVASION
2886,llama4,0.811,TUMOR FOCALITY
2887,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
2888,llama4,0.851,NODAL SITE(S) EXAMINED
2889,llama4,0.893,TUMOR SITE
2890,llama4,0.763,NODAL SITE(S) WITH TUMOR
2891,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2892,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2893,llama4,0.778,VISCERAL PLEURA INVASION
2894,llama4,0.778,HISTOLOGIC GRADE
2895,llama4,0.829,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2896,llama4,0.697,SPECIMEN LATERALITY
2897,llama4,0.803,NUMBER OF LYMPH NODES EXAMINED
2898,llama4,0.72,NUMBER OF LYMPH NODES WITH TUMOR
2899,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2900,llama4,0.788,PROCEDURE
2901,llama4,0.837,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2902,llama4,0.893,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2903,llama4,0.89,TUMOR SITE
2904,llama4,0.697,SPECIMEN LATERALITY
2905,llama4,0.797,HISTOLOGIC GRADE
2906,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2907,llama4,0.738,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2908,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2909,llama4,0.788,PROCEDURE
2910,llama4,0.778,VISCERAL PLEURA INVASION
2911,llama4,0.844,ADDITIONAL FINDINGS
2912,llama4,0.811,TUMOR FOCALITY
2913,llama4,0.877,REGIONAL LYMPH NODE STATUS
2914,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2915,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2916,llama4,0.764,NODAL SITE(S) EXAMINED
2917,llama4,0.698,SPECIMEN LATERALITY
2918,llama4,0.798,PROCEDURE
2919,llama4,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2920,llama4,0.811,TUMOR FOCALITY
2921,llama4,0.758,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2922,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
2923,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
2924,llama4,0.76,NUMBER OF LYMPH NODES EXAMINED
2925,llama4,0.778,VISCERAL PLEURA INVASION
2926,llama4,0.836,REGIONAL LYMPH NODE STATUS
2927,llama4,0.843,TUMOR SITE
2928,llama4,0.651,NODAL SITE(S) EXAMINED
2929,llama4,0.865,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2930,llama4,0.742,MARGIN STATUS FOR INVASIVE CARCINOMA
2931,llama4,0.877,REGIONAL LYMPH NODE STATUS
2932,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2933,llama4,0.89,TUMOR SITE
2934,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2935,llama4,0.697,SPECIMEN LATERALITY
2936,llama4,0.908,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2937,llama4,0.829,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2938,llama4,0.827,PROCEDURE
2939,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2940,llama4,0.713,NODAL SITE(S) EXAMINED
2941,llama4,0.811,TUMOR FOCALITY
2942,llama4,0.778,VISCERAL PLEURA INVASION
2943,llama4,0.78,SPREAD THROUGH AIR SPACES (STAS)
2944,llama4,0.778,HISTOLOGIC GRADE
2945,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
2946,llama4,0.755,HISTOLOGIC GRADE
2947,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
2948,llama4,0.739,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2949,llama4,0.698,VISCERAL PLEURA INVASION
2950,llama4,0.691,TNM DESCRIPTORS
2951,llama4,0.802,NODAL SITE(S) EXAMINED
2952,llama4,0.736,SPREAD THROUGH AIR SPACES (STAS)
2953,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2954,llama4,0.698,SPECIMEN LATERALITY
2955,llama4,0.865,TUMOR SITE
2956,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
2957,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2958,llama4,0.704,NUMBER OF LYMPH NODES EXAMINED
2959,llama4,0.877,REGIONAL LYMPH NODE STATUS
2960,llama4,0.709,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2961,llama4,0.811,TUMOR FOCALITY
2962,llama4,0.697,SPECIMEN LATERALITY
2963,llama4,0.692,SPREAD THROUGH AIR SPACES (STAS)
2964,llama4,0.877,REGIONAL LYMPH NODE STATUS
2965,llama4,0.89,TUMOR SITE
2966,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
2967,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2968,llama4,0.811,TUMOR FOCALITY
2969,llama4,0.778,VISCERAL PLEURA INVASION
2970,llama4,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2971,llama4,0.746,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2972,llama4,0.737,NODAL SITE(S) EXAMINED
2973,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
2974,llama4,0.727,PROCEDURE
2975,llama4,0.751,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2976,llama4,0.811,TUMOR FOCALITY
2977,llama4,0.823,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2978,llama4,0.78,NODAL SITE(S) EXAMINED
2979,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
2980,llama4,0.747,ADDITIONAL FINDINGS
2981,llama4,0.698,SPECIMEN LATERALITY
2982,llama4,0.725,NUMBER OF LYMPH NODES EXAMINED
2983,llama4,0.77,PROCEDURE
2984,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2985,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2986,llama4,0.759,REGIONAL LYMPH NODE STATUS
2987,llama4,0.747,HISTOLOGIC GRADE
2988,llama4,0.698,VISCERAL PLEURA INVASION
2989,llama4,0.793,NODAL SITE(S) WITH TUMOR
2990,llama4,0.801,TUMOR SITE
2991,llama4,0.906,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2992,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2993,llama4,0.745,LYMPHOVASCULAR INVASION
2994,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2995,llama4,0.681,NODAL SITE(S) EXAMINED
2996,llama4,0.823,ADDITIONAL FINDINGS
2997,llama4,0.798,TUMOR SITE
2998,llama4,0.713,NUMBER OF LYMPH NODES WITH TUMOR
2999,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3000,llama4,0.718,SPREAD THROUGH AIR SPACES (STAS)
3001,llama4,0.837,NODAL SITE(S) WITH TUMOR
3002,llama4,0.75,REGIONAL LYMPH NODE STATUS
3003,llama4,0.697,SPECIMEN LATERALITY
3004,llama4,0.78,VISCERAL PLEURA INVASION
3005,llama4,0.75,HISTOLOGIC GRADE
3006,llama4,0.732,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3007,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3008,llama4,0.7,NUMBER OF LYMPH NODES EXAMINED
3009,llama4,0.816,PROCEDURE
3010,llama4,0.876,TUMOR FOCALITY
3011,llama4,0.692,LYMPHOVASCULAR INVASION
3012,llama4,0.742,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3013,llama4,0.72,NUMBER OF LYMPH NODES EXAMINED
3014,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3015,llama4,0.736,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3016,llama4,0.698,SPECIMEN LATERALITY
3017,llama4,0.78,VISCERAL PLEURA INVASION
3018,llama4,0.679,TUMOR SITE
3019,llama4,0.789,HISTOLOGIC GRADE
3020,llama4,0.793,PROCEDURE
3021,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3022,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3023,llama4,0.703,TUMOR FOCALITY
3024,llama4,0.85,REGIONAL LYMPH NODE STATUS
3025,llama4,0.745,LYMPHOVASCULAR INVASION
3026,llama4,0.718,SPREAD THROUGH AIR SPACES (STAS)
3027,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
3028,llama4,0.86,NODAL SITE(S) EXAMINED
3029,llama4,0.805,NODAL SITE(S) EXAMINED
3030,llama4,0.851,TUMOR SITE
3031,llama4,0.807,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3032,llama4,0.759,MARGIN STATUS FOR INVASIVE CARCINOMA
3033,llama4,0.877,REGIONAL LYMPH NODE STATUS
3034,llama4,0.718,SPREAD THROUGH AIR SPACES (STAS)
3035,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3036,llama4,0.788,PROCEDURE
3037,llama4,0.697,SPECIMEN LATERALITY
3038,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3039,llama4,0.768,ADDITIONAL FINDINGS
3040,llama4,0.797,HISTOLOGIC GRADE
3041,llama4,0.824,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3042,llama4,0.811,TUMOR FOCALITY
3043,llama4,0.698,VISCERAL PLEURA INVASION
3044,llama4,0.73,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3045,llama4,0.797,HISTOLOGIC GRADE
3046,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
3047,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3048,llama4,0.768,PROCEDURE
3049,llama4,0.893,TUMOR SITE
3050,llama4,0.793,NUMBER OF LYMPH NODES EXAMINED
3051,llama4,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3052,llama4,0.778,VISCERAL PLEURA INVASION
3053,llama4,0.902,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3054,llama4,0.811,TUMOR FOCALITY
3055,llama4,0.877,REGIONAL LYMPH NODE STATUS
3056,llama4,0.783,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3057,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
3058,llama4,0.697,SPECIMEN LATERALITY
3059,llama4,0.752,MARGIN STATUS FOR INVASIVE CARCINOMA
3060,llama4,0.852,NODAL SITE(S) EXAMINED
3061,llama4,0.679,LYMPH NODE(S) FROM PRIOR PROCEDURES
3062,llama4,0.778,HISTOLOGIC GRADE
3063,llama4,0.692,LYMPHOVASCULAR INVASION
3064,llama4,0.789,TUMOR SITE
3065,llama4,0.813,NODAL SITE(S) EXAMINED
3066,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3067,llama4,0.697,SPECIMEN LATERALITY
3068,llama4,0.78,VISCERAL PLEURA INVASION
3069,llama4,0.877,REGIONAL LYMPH NODE STATUS
3070,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3071,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3072,llama4,0.739,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3073,llama4,0.827,PROCEDURE
3074,llama4,0.918,TUMOR FOCALITY
3075,llama4,0.731,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3076,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3077,llama4,0.887,TUMOR SITE
3078,llama4,0.798,PROCEDURE
3079,llama4,0.72,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3080,llama4,0.725,NODAL SITE(S) EXAMINED
3081,llama4,0.847,REGIONAL LYMPH NODE STATUS
3082,llama4,0.778,HISTOLOGIC GRADE
3083,llama4,0.695,NUMBER OF LYMPH NODES EXAMINED
3084,llama4,0.811,TUMOR FOCALITY
3085,llama4,0.825,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3086,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
3087,llama4,0.697,SPECIMEN LATERALITY
3088,llama4,0.698,VISCERAL PLEURA INVASION
3089,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
3090,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3091,llama4,0.706,REGIONAL LYMPH NODE STATUS
3092,llama4,0.786,TUMOR SITE
3093,llama4,0.797,HISTOLOGIC GRADE
3094,llama4,0.903,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3095,llama4,0.811,TUMOR FOCALITY
3096,llama4,0.698,SPECIMEN LATERALITY
3097,llama4,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3098,llama4,0.787,PROCEDURE
3099,llama4,0.702,NUMBER OF LYMPH NODES EXAMINED
3100,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3101,llama4,0.7,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3102,llama4,0.713,NUMBER OF LYMPH NODES WITH TUMOR
3103,llama4,0.85,NODAL SITE(S) EXAMINED
3104,llama4,0.778,VISCERAL PLEURA INVASION
3105,llama4,0.879,NODAL SITE(S) WITH TUMOR
3106,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
3107,llama4,0.694,ADDITIONAL FINDINGS
3108,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3109,llama4,0.718,SPREAD THROUGH AIR SPACES (STAS)
3110,llama4,0.727,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3111,llama4,0.838,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3112,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3113,llama4,0.89,TUMOR SITE
3114,llama4,0.778,HISTOLOGIC GRADE
3115,llama4,0.663,NODAL SITE(S) WITH TUMOR
3116,llama4,0.811,TUMOR FOCALITY
3117,llama4,0.833,NODAL SITE(S) EXAMINED
3118,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
3119,llama4,0.736,REGIONAL LYMPH NODE STATUS
3120,llama4,0.698,VISCERAL PLEURA INVASION
3121,llama4,0.699,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3122,llama4,0.788,PROCEDURE
3123,llama4,0.72,NUMBER OF LYMPH NODES WITH TUMOR
3124,llama4,0.697,SPECIMEN LATERALITY
3125,llama4,0.788,PROCEDURE
3126,llama4,0.693,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3127,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3128,llama4,0.697,SPECIMEN LATERALITY
3129,llama4,0.735,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3130,llama4,0.938,NODAL SITE(S) EXAMINED
3131,llama4,0.669,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3132,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3133,llama4,0.811,TUMOR FOCALITY
3134,llama4,0.798,TUMOR SITE
3135,llama4,0.797,HISTOLOGIC GRADE
3136,llama4,0.693,NUMBER OF LYMPH NODES EXAMINED
3137,llama4,0.874,REGIONAL LYMPH NODE STATUS
3138,llama4,0.778,VISCERAL PLEURA INVASION
3139,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3140,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3141,llama4,0.711,REGIONAL LYMPH NODE STATUS
3142,llama4,0.818,NODAL SITE(S) EXAMINED
3143,llama4,0.717,PROCEDURE
3144,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3145,llama4,0.78,VISCERAL PLEURA INVASION
3146,llama4,0.72,NUMBER OF LYMPH NODES WITH TUMOR
3147,llama4,0.778,HISTOLOGIC GRADE
3148,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3149,llama4,0.89,TUMOR SITE
3150,llama4,0.697,SPECIMEN LATERALITY
3151,llama4,0.726,NODAL SITE(S) WITH TUMOR
3152,llama4,0.757,MARGIN STATUS FOR INVASIVE CARCINOMA
3153,llama4,0.82,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3154,llama4,0.838,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3155,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
3156,llama4,0.811,TUMOR FOCALITY
3157,llama4,0.788,PROCEDURE
3158,llama4,0.819,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3159,llama4,0.811,TUMOR FOCALITY
3160,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3161,llama4,0.692,NUMBER OF LYMPH NODES EXAMINED
3162,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
3163,llama4,0.676,TUMOR SITE
3164,llama4,0.771,REGIONAL LYMPH NODE STATUS
3165,llama4,0.737,NODAL SITE(S) WITH TUMOR
3166,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3167,llama4,0.745,LYMPHOVASCULAR INVASION
3168,llama4,0.72,NUMBER OF LYMPH NODES WITH TUMOR
3169,llama4,0.797,HISTOLOGIC GRADE
3170,llama4,0.703,MARGIN STATUS FOR INVASIVE CARCINOMA
3171,llama4,0.778,VISCERAL PLEURA INVASION
3172,llama4,0.784,NODAL SITE(S) EXAMINED
3173,llama4,0.698,SPECIMEN LATERALITY
3174,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3175,llama4,0.811,TUMOR FOCALITY
3176,llama4,0.788,PROCEDURE
3177,llama4,0.825,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3178,llama4,0.757,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3179,llama4,0.78,VISCERAL PLEURA INVASION
3180,llama4,0.734,NODAL SITE(S) EXAMINED
3181,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3182,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
3183,llama4,0.841,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3184,llama4,0.877,REGIONAL LYMPH NODE STATUS
3185,llama4,0.828,TUMOR SITE
3186,llama4,0.697,SPECIMEN LATERALITY
3187,llama4,0.797,HISTOLOGIC GRADE
3188,llama4,0.697,NUMBER OF LYMPH NODES EXAMINED
3189,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3190,llama4,0.837,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3191,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
3192,llama4,0.816,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3193,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3194,llama4,0.827,PROCEDURE
3195,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3196,llama4,0.811,TUMOR FOCALITY
3197,llama4,0.759,NODAL SITE(S) EXAMINED
3198,llama4,0.8,HISTOLOGIC GRADE
3199,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3200,llama4,0.713,NUMBER OF LYMPH NODES EXAMINED
3201,llama4,0.877,REGIONAL LYMPH NODE STATUS
3202,llama4,0.89,TUMOR SITE
3203,llama4,0.778,VISCERAL PLEURA INVASION
3204,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3205,llama4,0.698,SPECIMEN LATERALITY
3206,llama4,0.855,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3207,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
3208,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3209,llama4,0.778,VISCERAL PLEURA INVASION
3210,llama4,0.877,REGIONAL LYMPH NODE STATUS
3211,llama4,0.824,NODAL SITE(S) EXAMINED
3212,llama4,0.761,MARGIN STATUS FOR INVASIVE CARCINOMA
3213,llama4,0.797,HISTOLOGIC GRADE
3214,llama4,0.811,TUMOR FOCALITY
3215,llama4,0.849,ADDITIONAL FINDINGS
3216,llama4,0.8,PROCEDURE
3217,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3218,llama4,0.697,SPECIMEN LATERALITY
3219,llama4,0.791,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3220,llama4,0.698,NUMBER OF LYMPH NODES EXAMINED
3221,llama4,0.89,TUMOR SITE
3222,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3223,llama4,0.648,TNM DESCRIPTORS
3224,llama4,0.752,HISTOLOGIC GRADE
3225,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3226,llama4,0.76,ADDITIONAL FINDINGS
3227,llama4,0.811,TUMOR FOCALITY
3228,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3229,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
3230,llama4,0.747,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3231,llama4,0.801,TUMOR SITE
3232,llama4,0.874,REGIONAL LYMPH NODE STATUS
3233,llama4,0.768,PROCEDURE
3234,llama4,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3235,llama4,0.698,SPECIMEN LATERALITY
3236,llama4,0.71,NODAL SITE(S) EXAMINED
3237,llama4,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3238,llama4,0.711,NUMBER OF LYMPH NODES EXAMINED
3239,llama4,0.778,VISCERAL PLEURA INVASION
3240,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3241,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3242,llama4,0.874,REGIONAL LYMPH NODE STATUS
3243,llama4,0.698,NUMBER OF LYMPH NODES EXAMINED
3244,llama4,0.697,SPECIMEN LATERALITY
3245,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3246,llama4,0.835,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3247,llama4,0.823,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3248,llama4,0.704,ADDITIONAL FINDINGS
3249,llama4,0.762,NODAL SITE(S) EXAMINED
3250,llama4,0.786,PROCEDURE
3251,llama4,0.745,MARGIN STATUS FOR INVASIVE CARCINOMA
3252,llama4,0.718,SPREAD THROUGH AIR SPACES (STAS)
3253,llama4,0.811,TUMOR FOCALITY
3254,llama4,0.802,TUMOR SITE
3255,llama4,0.778,VISCERAL PLEURA INVASION
3256,llama4,0.699,HISTOLOGIC GRADE
3257,llama4,0.736,SPREAD THROUGH AIR SPACES (STAS)
3258,llama4,0.762,ADDITIONAL FINDINGS
3259,llama4,0.811,TUMOR FOCALITY
3260,llama4,0.693,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3261,llama4,0.746,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3262,llama4,0.691,NUMBER OF LYMPH NODES EXAMINED
3263,llama4,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
3264,llama4,0.751,NODAL SITE(S) EXAMINED
3265,llama4,0.698,SPECIMEN LATERALITY
3266,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3267,llama4,0.89,TUMOR SITE
3268,llama4,0.64,TNM DESCRIPTORS
3269,llama4,0.693,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3270,llama4,0.778,VISCERAL PLEURA INVASION
3271,llama4,0.768,REGIONAL LYMPH NODE STATUS
3272,llama4,0.741,PROCEDURE
3273,llama4,0.697,NUMBER OF LYMPH NODES EXAMINED
3274,llama4,0.792,REGIONAL LYMPH NODE STATUS
3275,llama4,0.706,ADDITIONAL FINDINGS
3276,llama4,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3277,llama4,0.72,NUMBER OF LYMPH NODES WITH TUMOR
3278,llama4,0.792,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3279,llama4,0.788,PROCEDURE
3280,llama4,0.721,NODAL SITE(S) EXAMINED
3281,llama4,0.811,TUMOR FOCALITY
3282,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3283,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3284,llama4,0.78,VISCERAL PLEURA INVASION
3285,llama4,0.893,TUMOR SITE
3286,llama4,0.758,NODAL SITE(S) WITH TUMOR
3287,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
3288,llama4,0.697,SPECIMEN LATERALITY
3289,llama4,0.736,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3290,llama4,0.71,ADDITIONAL FINDINGS
3291,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3292,llama4,0.842,TUMOR SITE
3293,llama4,0.68,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3294,llama4,0.745,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3295,llama4,0.736,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3296,llama4,0.877,REGIONAL LYMPH NODE STATUS
3297,llama4,0.757,PROCEDURE
3298,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3299,llama4,0.755,NODAL SITE(S) EXAMINED
3300,llama4,0.811,TUMOR FOCALITY
3301,llama4,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
3302,llama4,0.778,VISCERAL PLEURA INVASION
3303,llama4,0.658,TNM DESCRIPTORS
3304,llama4,0.698,SPECIMEN LATERALITY
3305,llama4,0.837,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3306,llama4,0.698,SPECIMEN LATERALITY
3307,llama4,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3308,llama4,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3309,llama4,0.712,PROCEDURE
3310,llama4,0.811,TUMOR FOCALITY
3311,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3312,llama4,0.76,NODAL SITE(S) EXAMINED
3313,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3314,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3315,llama4,0.89,TUMOR SITE
3316,llama4,0.778,VISCERAL PLEURA INVASION
3317,llama4,0.877,REGIONAL LYMPH NODE STATUS
3318,llama4,0.761,PROCEDURE
3319,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3320,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3321,llama4,0.725,NODAL SITE(S) EXAMINED
3322,llama4,0.829,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3323,llama4,0.877,REGIONAL LYMPH NODE STATUS
3324,llama4,0.697,SPECIMEN LATERALITY
3325,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
3326,llama4,0.774,ADDITIONAL FINDINGS
3327,llama4,0.893,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3328,llama4,0.698,VISCERAL PLEURA INVASION
3329,llama4,0.757,MARGIN STATUS FOR INVASIVE CARCINOMA
3330,llama4,0.703,NUMBER OF LYMPH NODES EXAMINED
3331,llama4,0.89,TUMOR SITE
3332,llama4,0.811,TUMOR FOCALITY
3333,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
3334,llama4,0.657,TUMOR FOCALITY
3335,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3336,llama4,0.694,NUMBER OF LYMPH NODES EXAMINED
3337,llama4,0.693,HISTOLOGIC GRADE
3338,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3339,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
3340,llama4,0.777,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3341,llama4,0.788,PROCEDURE
3342,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3343,llama4,0.751,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3344,llama4,0.698,SPECIMEN LATERALITY
3345,llama4,0.877,REGIONAL LYMPH NODE STATUS
3346,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3347,llama4,0.846,TUMOR SITE
3348,llama4,0.778,VISCERAL PLEURA INVASION
3349,llama4,0.649,TNM DESCRIPTORS
3350,llama4,0.772,NODAL SITE(S) EXAMINED
3351,llama4,0.698,LYMPHOVASCULAR INVASION
3352,llama4,0.777,NODAL SITE(S) WITH TUMOR
3353,llama4,0.822,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3354,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
3355,llama4,0.795,REGIONAL LYMPH NODE STATUS
3356,llama4,0.7,NUMBER OF LYMPH NODES WITH TUMOR
3357,llama4,0.798,TUMOR SITE
3358,llama4,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
3359,llama4,0.739,MARGIN STATUS FOR INVASIVE CARCINOMA
3360,llama4,0.778,HISTOLOGIC GRADE
3361,llama4,0.788,PROCEDURE
3362,llama4,0.778,VISCERAL PLEURA INVASION
3363,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3364,llama4,0.851,NODAL SITE(S) EXAMINED
3365,llama4,0.697,SPECIMEN LATERALITY
3366,llama4,0.811,TUMOR FOCALITY
3367,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3368,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3369,llama4,0.751,MARGIN STATUS FOR INVASIVE CARCINOMA
3370,llama4,0.811,TUMOR FOCALITY
3371,llama4,0.908,ADDITIONAL FINDINGS
3372,llama4,0.77,NODAL SITE(S) EXAMINED
3373,llama4,0.904,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3374,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3375,llama4,0.73,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3376,llama4,0.797,HISTOLOGIC GRADE
3377,llama4,0.827,PROCEDURE
3378,llama4,0.697,SPECIMEN LATERALITY
3379,llama4,0.713,NUMBER OF LYMPH NODES EXAMINED
3380,llama4,0.778,VISCERAL PLEURA INVASION
3381,llama4,0.89,TUMOR SITE
3382,llama4,0.877,REGIONAL LYMPH NODE STATUS
3383,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
3384,llama4,0.701,NUMBER OF LYMPH NODES EXAMINED
3385,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3386,llama4,0.758,NODAL SITE(S) EXAMINED
3387,llama4,0.874,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3388,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3389,llama4,0.706,NODAL SITE(S) WITH TUMOR
3390,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3391,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3392,llama4,0.778,VISCERAL PLEURA INVASION
3393,llama4,0.89,TUMOR SITE
3394,llama4,0.778,HISTOLOGIC GRADE
3395,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
3396,llama4,0.713,NUMBER OF LYMPH NODES WITH TUMOR
3397,llama4,0.766,REGIONAL LYMPH NODE STATUS
3398,llama4,0.698,SPECIMEN LATERALITY
3399,llama4,0.788,PROCEDURE
3400,llama4,0.811,TUMOR FOCALITY
3401,llama4,0.838,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3402,llama4,0.788,PROCEDURE
3403,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
3404,llama4,0.811,TUMOR FOCALITY
3405,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
3406,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3407,llama4,0.784,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3408,llama4,0.828,NODAL SITE(S) WITH TUMOR
3409,llama4,0.856,REGIONAL LYMPH NODE STATUS
3410,llama4,0.778,VISCERAL PLEURA INVASION
3411,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3412,llama4,0.741,NODAL SITE(S) EXAMINED
3413,llama4,0.656,TNM DESCRIPTORS
3414,llama4,0.75,HISTOLOGIC GRADE
3415,llama4,0.697,SPECIMEN LATERALITY
3416,llama4,0.919,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3417,llama4,0.887,TUMOR SITE
3418,llama4,0.777,MARGIN STATUS FOR INVASIVE CARCINOMA
3419,llama4,0.913,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3420,llama4,0.698,NODAL SITE(S) EXAMINED
3421,llama4,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3422,llama4,0.734,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3423,llama4,0.778,VISCERAL PLEURA INVASION
3424,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
3425,llama4,0.874,REGIONAL LYMPH NODE STATUS
3426,llama4,0.787,TUMOR SITE
3427,llama4,0.697,SPECIMEN LATERALITY
3428,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3429,llama4,0.827,PROCEDURE
3430,llama4,0.713,NUMBER OF LYMPH NODES EXAMINED
3431,llama4,0.76,MARGIN STATUS FOR INVASIVE CARCINOMA
3432,llama4,0.811,TUMOR FOCALITY
3433,llama4,0.797,HISTOLOGIC GRADE
3434,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3435,llama4,0.798,TUMOR SITE
3436,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
3437,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3438,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3439,llama4,0.698,SPECIMEN LATERALITY
3440,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3441,llama4,0.89,TUMOR SITE
3442,llama4,0.797,HISTOLOGIC GRADE
3443,llama4,0.75,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3444,llama4,0.709,NODAL SITE(S) EXAMINED
3445,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
3446,llama4,0.817,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3447,llama4,0.811,TUMOR FOCALITY
3448,llama4,0.793,PROCEDURE
3449,llama4,0.778,VISCERAL PLEURA INVASION
3450,llama4,0.877,REGIONAL LYMPH NODE STATUS
3451,llama4,0.89,TUMOR SITE
3452,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3453,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3454,llama4,0.781,PROCEDURE
3455,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3456,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
3457,llama4,0.82,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3458,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3459,llama4,0.877,REGIONAL LYMPH NODE STATUS
3460,llama4,0.697,SPECIMEN LATERALITY
3461,llama4,0.731,NODAL SITE(S) EXAMINED
3462,llama4,0.78,VISCERAL PLEURA INVASION
3463,llama4,0.797,HISTOLOGIC GRADE
3464,llama4,0.918,TUMOR FOCALITY
3465,llama4,0.873,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3466,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3467,llama4,0.757,NODAL SITE(S) EXAMINED
3468,llama4,0.699,NUMBER OF LYMPH NODES EXAMINED
3469,llama4,0.88,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3470,llama4,0.689,TUMOR SITE
3471,llama4,0.805,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3472,llama4,0.811,TUMOR FOCALITY
3473,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3474,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3475,llama4,0.877,REGIONAL LYMPH NODE STATUS
3476,llama4,0.72,PROCEDURE
3477,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
3478,llama4,0.78,VISCERAL PLEURA INVASION
3479,llama4,0.698,SPECIMEN LATERALITY
3480,llama4,0.774,ADDITIONAL FINDINGS
3481,llama4,0.797,HISTOLOGIC GRADE
3482,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3483,llama4,0.853,PROCEDURE
3484,llama4,0.761,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3485,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3486,llama4,0.674,NODAL SITE(S) EXAMINED
3487,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3488,llama4,0.888,TUMOR SITE
3489,llama4,0.811,TUMOR FOCALITY
3490,llama4,0.778,VISCERAL PLEURA INVASION
3491,llama4,0.923,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3492,llama4,0.877,REGIONAL LYMPH NODE STATUS
3493,llama4,0.908,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3494,llama4,0.797,HISTOLOGIC GRADE
3495,llama4,0.698,SPECIMEN LATERALITY
3496,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3497,llama4,0.686,NUMBER OF LYMPH NODES EXAMINED
3498,llama4,0.78,VISCERAL PLEURA INVASION
3499,llama4,0.835,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3500,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3501,llama4,0.838,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3502,llama4,0.811,TUMOR FOCALITY
3503,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3504,llama4,0.761,PROCEDURE
3505,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3506,llama4,0.726,ADDITIONAL FINDINGS
3507,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
3508,llama4,0.691,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3509,llama4,0.877,REGIONAL LYMPH NODE STATUS
3510,llama4,0.89,TUMOR SITE
3511,llama4,0.697,SPECIMEN LATERALITY
3512,llama4,0.797,HISTOLOGIC GRADE
3513,llama4,0.818,NODAL SITE(S) EXAMINED
3514,llama4,0.778,VISCERAL PLEURA INVASION
3515,llama4,0.877,REGIONAL LYMPH NODE STATUS
3516,llama4,0.709,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3517,llama4,0.698,SPECIMEN LATERALITY
3518,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3519,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3520,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3521,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
3522,llama4,0.734,PROCEDURE
3523,llama4,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3524,llama4,0.89,TUMOR SITE
3525,llama4,0.756,NODAL SITE(S) EXAMINED
3526,llama4,0.811,TUMOR FOCALITY
3527,llama4,0.7,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3528,llama4,0.764,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3529,llama4,0.841,MARGIN STATUS FOR INVASIVE CARCINOMA
3530,llama4,0.672,TUMOR FOCALITY
3531,llama4,0.742,VISCERAL PLEURA INVASION
3532,llama4,0.858,ADDITIONAL FINDINGS
3533,llama4,0.697,SPECIMEN LATERALITY
3534,llama4,0.84,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3535,llama4,0.877,REGIONAL LYMPH NODE STATUS
3536,llama4,0.693,HISTOLOGIC GRADE
3537,llama4,0.897,LYMPH NODE(S) FROM PRIOR PROCEDURES
3538,llama4,0.79,TUMOR SITE
3539,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3540,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3541,llama4,0.701,NUMBER OF LYMPH NODES EXAMINED
3542,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
3543,llama4,0.836,NODAL SITE(S) EXAMINED
3544,llama4,0.815,PROCEDURE
3545,llama4,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3546,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3547,llama4,0.82,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3548,llama4,0.697,SPECIMEN LATERALITY
3549,llama4,0.778,VISCERAL PLEURA INVASION
3550,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3551,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3552,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
3553,llama4,0.779,NODAL SITE(S) EXAMINED
3554,llama4,0.89,TUMOR SITE
3555,llama4,0.827,PROCEDURE
3556,llama4,0.811,TUMOR FOCALITY
3557,llama4,0.877,REGIONAL LYMPH NODE STATUS
3558,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3559,llama4,0.8,HISTOLOGIC GRADE
3560,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3561,llama4,0.713,NUMBER OF LYMPH NODES EXAMINED
3562,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
3563,llama4,0.711,TUMOR FOCALITY
3564,llama4,0.697,SPECIMEN LATERALITY
3565,llama4,0.72,NUMBER OF LYMPH NODES WITH TUMOR
3566,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3567,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3568,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3569,llama4,0.66,NODAL SITE(S) EXAMINED
3570,llama4,0.689,TUMOR SITE
3571,llama4,0.827,PROCEDURE
3572,llama4,0.776,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3573,llama4,0.883,NODAL SITE(S) WITH TUMOR
3574,llama4,0.742,REGIONAL LYMPH NODE STATUS
3575,llama4,0.913,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3576,llama4,0.778,VISCERAL PLEURA INVASION
3577,llama4,0.71,ADDITIONAL FINDINGS
3578,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3579,llama4,0.703,NUMBER OF LYMPH NODES EXAMINED
3580,llama4,0.687,LYMPH NODE(S) FROM PRIOR PROCEDURES
3581,llama4,0.736,SPREAD THROUGH AIR SPACES (STAS)
3582,llama4,0.701,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3583,llama4,0.811,NODAL SITE(S) EXAMINED
3584,llama4,0.698,SPECIMEN LATERALITY
3585,llama4,0.788,PROCEDURE
3586,llama4,0.739,TNM DESCRIPTORS
3587,llama4,0.801,TUMOR SITE
3588,llama4,0.701,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3589,llama4,0.701,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3590,llama4,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
3591,llama4,0.811,TUMOR FOCALITY
3592,llama4,0.701,HISTOLOGIC GRADE
3593,llama4,0.778,VISCERAL PLEURA INVASION
3594,llama4,0.877,REGIONAL LYMPH NODE STATUS
3595,llama4,0.703,NUMBER OF LYMPH NODES EXAMINED
3596,llama4,0.838,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3597,llama4,0.808,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3598,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3599,llama4,0.759,PROCEDURE
3600,llama4,0.877,REGIONAL LYMPH NODE STATUS
3601,llama4,0.89,TUMOR SITE
3602,llama4,0.778,VISCERAL PLEURA INVASION
3603,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3604,llama4,0.8,HISTOLOGIC GRADE
3605,llama4,0.811,TUMOR FOCALITY
3606,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3607,llama4,0.739,NODAL SITE(S) EXAMINED
3608,llama4,0.697,SPECIMEN LATERALITY
3609,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
3610,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3611,llama4,0.798,TUMOR SITE
3612,llama4,0.861,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3613,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3614,llama4,0.7,NUMBER OF LYMPH NODES EXAMINED
3615,llama4,0.697,SPECIMEN LATERALITY
3616,llama4,0.736,SPREAD THROUGH AIR SPACES (STAS)
3617,llama4,0.811,TUMOR FOCALITY
3618,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3619,llama4,0.817,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3620,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3621,llama4,0.827,PROCEDURE
3622,llama4,0.8,NODAL SITE(S) EXAMINED
3623,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3624,llama4,0.877,REGIONAL LYMPH NODE STATUS
3625,llama4,0.778,VISCERAL PLEURA INVASION
3626,llama4,0.783,HISTOLOGIC GRADE
3627,llama4,0.818,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3628,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
3629,llama4,0.667,TNM DESCRIPTORS
3630,llama4,0.877,REGIONAL LYMPH NODE STATUS
3631,llama4,0.778,VISCERAL PLEURA INVASION
3632,llama4,0.8,HISTOLOGIC GRADE
3633,llama4,0.829,NODAL SITE(S) EXAMINED
3634,llama4,0.89,TUMOR SITE
3635,llama4,0.757,NUMBER OF LYMPH NODES EXAMINED
3636,llama4,0.722,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3637,llama4,0.705,TUMOR FOCALITY
3638,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3639,llama4,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3640,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3641,llama4,0.697,SPECIMEN LATERALITY
3642,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3643,llama4,0.788,PROCEDURE
3644,llama4,0.877,REGIONAL LYMPH NODE STATUS
3645,llama4,0.865,TUMOR SITE
3646,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3647,llama4,0.74,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3648,llama4,0.918,TUMOR FOCALITY
3649,llama4,0.774,ADDITIONAL FINDINGS
3650,llama4,0.77,NODAL SITE(S) EXAMINED
3651,llama4,0.747,MARGIN STATUS FOR INVASIVE CARCINOMA
3652,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3653,llama4,0.697,SPECIMEN LATERALITY
3654,llama4,0.787,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3655,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3656,llama4,0.778,VISCERAL PLEURA INVASION
3657,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
3658,llama4,0.788,PROCEDURE
3659,llama4,0.778,VISCERAL PLEURA INVASION
3660,llama4,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3661,llama4,0.788,PROCEDURE
3662,llama4,0.72,NUMBER OF LYMPH NODES WITH TUMOR
3663,llama4,0.723,ADDITIONAL FINDINGS
3664,llama4,0.811,TUMOR FOCALITY
3665,llama4,0.825,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3666,llama4,0.828,TUMOR SITE
3667,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3668,llama4,0.793,REGIONAL LYMPH NODE STATUS
3669,llama4,0.733,NODAL SITE(S) EXAMINED
3670,llama4,0.733,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3671,llama4,0.698,NODAL SITE(S) WITH TUMOR
3672,llama4,0.716,LYMPHOVASCULAR INVASION
3673,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3674,llama4,0.697,SPECIMEN LATERALITY
3675,llama4,0.692,NUMBER OF LYMPH NODES EXAMINED
3676,llama4,0.8,HISTOLOGIC GRADE
3677,llama4,0.745,MARGIN STATUS FOR INVASIVE CARCINOMA
3678,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
3679,llama4,0.739,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3680,llama4,0.767,REGIONAL LYMPH NODE STATUS
3681,llama4,0.716,PROCEDURE
3682,llama4,0.697,SPECIMEN LATERALITY
3683,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3684,llama4,0.778,VISCERAL PLEURA INVASION
3685,llama4,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3686,llama4,0.74,NODAL SITE(S) EXAMINED
3687,llama4,0.716,LYMPHOVASCULAR INVASION
3688,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3689,llama4,0.811,TUMOR FOCALITY
3690,llama4,0.847,NODAL SITE(S) WITH TUMOR
3691,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3692,llama4,0.89,TUMOR SITE
3693,llama4,0.79,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3694,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
3695,llama4,0.8,HISTOLOGIC GRADE
3696,llama4,0.702,ADDITIONAL FINDINGS
3697,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3698,llama4,0.749,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3699,llama4,0.877,REGIONAL LYMPH NODE STATUS
3700,llama4,0.865,TUMOR SITE
3701,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
3702,llama4,0.778,HISTOLOGIC GRADE
3703,llama4,0.697,SPECIMEN LATERALITY
3704,llama4,0.714,LYMPHOVASCULAR INVASION
3705,llama4,0.78,SPREAD THROUGH AIR SPACES (STAS)
3706,llama4,0.918,TUMOR FOCALITY
3707,llama4,0.91,NODAL SITE(S) EXAMINED
3708,llama4,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3709,llama4,0.703,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3710,llama4,0.788,PROCEDURE
3711,llama4,0.66,TNM DESCRIPTORS
3712,llama4,0.78,VISCERAL PLEURA INVASION
3713,llama4,0.832,NUMBER OF LYMPH NODES EXAMINED
3714,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3715,llama4,0.706,ADDITIONAL FINDINGS
3716,llama4,0.838,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3717,llama4,0.78,VISCERAL PLEURA INVASION
3718,llama4,0.907,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3719,llama4,0.698,SPECIMEN LATERALITY
3720,llama4,0.89,TUMOR SITE
3721,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3722,llama4,0.877,REGIONAL LYMPH NODE STATUS
3723,llama4,0.723,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3724,llama4,0.797,HISTOLOGIC GRADE
3725,llama4,0.725,NODAL SITE(S) EXAMINED
3726,llama4,0.811,TUMOR FOCALITY
3727,llama4,0.788,PROCEDURE
3728,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
3729,llama4,0.792,PROCEDURE
3730,llama4,0.787,TUMOR SITE
3731,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
3732,llama4,0.78,VISCERAL PLEURA INVASION
3733,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3734,llama4,0.781,NODAL SITE(S) EXAMINED
3735,llama4,0.877,REGIONAL LYMPH NODE STATUS
3736,llama4,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3737,llama4,0.811,TUMOR FOCALITY
3738,llama4,0.659,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3739,llama4,0.797,HISTOLOGIC GRADE
3740,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
3741,llama4,0.745,MARGIN STATUS FOR INVASIVE CARCINOMA
3742,llama4,0.697,SPECIMEN LATERALITY
3743,llama4,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3744,llama4,0.651,ADDITIONAL FINDINGS
3745,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
3746,llama4,0.734,NODAL SITE(S) EXAMINED
3747,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
3748,llama4,0.903,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3749,llama4,0.832,NUMBER OF LYMPH NODES EXAMINED
3750,llama4,0.789,HISTOLOGIC GRADE
3751,llama4,0.89,TUMOR SITE
3752,llama4,0.826,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3753,llama4,0.697,SPECIMEN LATERALITY
3754,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3755,llama4,0.733,MARGIN STATUS FOR INVASIVE CARCINOMA
3756,llama4,0.788,PROCEDURE
3757,llama4,0.778,VISCERAL PLEURA INVASION
3758,llama4,0.811,TUMOR FOCALITY
3759,llama4,0.877,REGIONAL LYMPH NODE STATUS
3760,llama4,0.676,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3761,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3762,llama4,0.718,SPREAD THROUGH AIR SPACES (STAS)
3763,llama4,0.722,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3764,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3765,llama4,0.706,ADDITIONAL FINDINGS
3766,llama4,0.686,NUMBER OF LYMPH NODES EXAMINED
3767,llama4,0.78,VISCERAL PLEURA INVASION
3768,llama4,0.811,TUMOR FOCALITY
3769,llama4,0.819,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3770,llama4,0.78,REGIONAL LYMPH NODE STATUS
3771,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
3772,llama4,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3773,llama4,0.703,NODAL SITE(S) EXAMINED
3774,llama4,0.835,NODAL SITE(S) WITH TUMOR
3775,llama4,0.698,SPECIMEN LATERALITY
3776,llama4,0.72,NUMBER OF LYMPH NODES WITH TUMOR
3777,llama4,0.865,TUMOR SITE
3778,llama4,0.788,PROCEDURE
3779,llama4,0.745,LYMPHOVASCULAR INVASION
3780,llama4,0.778,HISTOLOGIC GRADE
3781,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
3782,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3783,llama4,0.81,NUMBER OF LYMPH NODES EXAMINED
3784,llama4,0.728,NODAL SITE(S) EXAMINED
3785,llama4,0.841,MARGIN STATUS FOR INVASIVE CARCINOMA
3786,llama4,0.809,ADDITIONAL FINDINGS
3787,llama4,0.778,VISCERAL PLEURA INVASION
3788,llama4,0.897,LYMPH NODE(S) FROM PRIOR PROCEDURES
3789,llama4,0.78,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3790,llama4,0.762,PROCEDURE
3791,llama4,0.782,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3792,llama4,0.877,REGIONAL LYMPH NODE STATUS
3793,llama4,0.697,SPECIMEN LATERALITY
3794,llama4,0.89,TUMOR SITE
3795,llama4,0.749,HISTOLOGIC GRADE
3796,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3797,llama4,0.72,TNM DESCRIPTORS
3798,llama4,0.642,TUMOR FOCALITY
3799,llama4,0.8,HISTOLOGIC GRADE
3800,llama4,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3801,llama4,0.697,SPECIMEN LATERALITY
3802,llama4,0.823,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3803,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
3804,llama4,0.877,REGIONAL LYMPH NODE STATUS
3805,llama4,0.778,VISCERAL PLEURA INVASION
3806,llama4,0.688,NODAL SITE(S) EXAMINED
3807,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3808,llama4,0.827,PROCEDURE
3809,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3810,llama4,0.798,TUMOR SITE
3811,llama4,0.811,TUMOR FOCALITY
3812,llama4,0.721,ADDITIONAL FINDINGS
3813,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3814,llama4,0.72,NUMBER OF LYMPH NODES EXAMINED
3815,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3816,llama4,0.695,NODAL SITE(S) EXAMINED
3817,llama4,0.788,PROCEDURE
3818,llama4,0.798,TUMOR SITE
3819,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3820,llama4,0.743,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3821,llama4,0.797,HISTOLOGIC GRADE
3822,llama4,0.753,NODAL SITE(S) WITH TUMOR
3823,llama4,0.778,VISCERAL PLEURA INVASION
3824,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3825,llama4,0.69,LYMPH NODE(S) FROM PRIOR PROCEDURES
3826,llama4,0.856,REGIONAL LYMPH NODE STATUS
3827,llama4,0.918,TUMOR FOCALITY
3828,llama4,0.703,NUMBER OF LYMPH NODES EXAMINED
3829,llama4,0.697,SPECIMEN LATERALITY
3830,llama4,0.694,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3831,llama4,0.676,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3832,llama4,0.716,NUMBER OF LYMPH NODES WITH TUMOR
3833,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
3834,llama4,0.811,TUMOR FOCALITY
3835,llama4,0.89,TUMOR SITE
3836,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3837,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3838,llama4,0.778,VISCERAL PLEURA INVASION
3839,llama4,0.798,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3840,llama4,0.782,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3841,llama4,0.8,HISTOLOGIC GRADE
3842,llama4,0.823,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3843,llama4,0.676,NODAL SITE(S) EXAMINED
3844,llama4,0.72,NUMBER OF LYMPH NODES WITH TUMOR
3845,llama4,0.801,PROCEDURE
3846,llama4,0.787,REGIONAL LYMPH NODE STATUS
3847,llama4,0.748,NODAL SITE(S) WITH TUMOR
3848,llama4,0.698,SPECIMEN LATERALITY
3849,llama4,0.737,ADDITIONAL FINDINGS
3850,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3851,llama4,0.89,TUMOR SITE
3852,llama4,0.78,VISCERAL PLEURA INVASION
3853,llama4,0.874,REGIONAL LYMPH NODE STATUS
3854,llama4,0.797,HISTOLOGIC GRADE
3855,llama4,0.824,NODAL SITE(S) EXAMINED
3856,llama4,0.83,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3857,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3858,llama4,0.788,PROCEDURE
3859,llama4,0.697,SPECIMEN LATERALITY
3860,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3861,llama4,0.789,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3862,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3863,llama4,0.811,TUMOR FOCALITY
3864,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
3865,llama4,0.816,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3866,llama4,0.761,MARGIN STATUS FOR INVASIVE CARCINOMA
3867,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3868,llama4,0.748,PROCEDURE
3869,llama4,0.78,VISCERAL PLEURA INVASION
3870,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3871,llama4,0.89,TUMOR SITE
3872,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3873,llama4,0.874,REGIONAL LYMPH NODE STATUS
3874,llama4,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3875,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
3876,llama4,0.717,ADDITIONAL FINDINGS
3877,llama4,0.811,TUMOR FOCALITY
3878,llama4,0.697,SPECIMEN LATERALITY
3879,llama4,0.797,HISTOLOGIC GRADE
3880,llama4,0.748,NODAL SITE(S) EXAMINED
3881,llama4,0.716,ADDITIONAL FINDINGS
3882,llama4,0.795,NODAL SITE(S) EXAMINED
3883,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3884,llama4,0.788,PROCEDURE
3885,llama4,0.704,NUMBER OF LYMPH NODES EXAMINED
3886,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3887,llama4,0.877,REGIONAL LYMPH NODE STATUS
3888,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3889,llama4,0.697,SPECIMEN LATERALITY
3890,llama4,0.731,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3891,llama4,0.778,HISTOLOGIC GRADE
3892,llama4,0.906,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3893,llama4,0.811,TUMOR FOCALITY
3894,llama4,0.718,VISCERAL PLEURA INVASION
3895,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
3896,llama4,0.798,TUMOR SITE
3897,llama4,0.697,SPECIMEN LATERALITY
3898,llama4,0.715,NUMBER OF LYMPH NODES WITH TUMOR
3899,llama4,0.65,TNM DESCRIPTORS
3900,llama4,0.672,MARGIN STATUS FOR NON-INVASIVE TUMOR
3901,llama4,0.856,REGIONAL LYMPH NODE STATUS
3902,llama4,0.858,NODAL SITE(S) EXAMINED
3903,llama4,0.904,HISTOLOGIC GRADE
3904,llama4,0.723,TUMOR SITE
3905,llama4,0.692,LYMPHOVASCULAR INVASION
3906,llama4,0.778,VISCERAL PLEURA INVASION
3907,llama4,0.736,SPREAD THROUGH AIR SPACES (STAS)
3908,llama4,0.743,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3909,llama4,0.734,NODAL SITE(S) WITH TUMOR
3910,llama4,0.855,MARGIN STATUS FOR INVASIVE CARCINOMA
3911,llama4,0.787,PROCEDURE
3912,llama4,0.811,TUMOR FOCALITY
3913,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3914,llama4,0.726,MARGIN STATUS FOR INVASIVE CARCINOMA
3915,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3916,llama4,0.877,REGIONAL LYMPH NODE STATUS
3917,llama4,0.788,PROCEDURE
3918,llama4,0.89,TUMOR SITE
3919,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3920,llama4,0.849,NODAL SITE(S) EXAMINED
3921,llama4,0.724,TUMOR FOCALITY
3922,llama4,0.75,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3923,llama4,0.697,SPECIMEN LATERALITY
3924,llama4,0.774,ADDITIONAL FINDINGS
3925,llama4,0.703,VISCERAL PLEURA INVASION
3926,llama4,0.785,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3927,llama4,0.683,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3928,llama4,0.646,TNM DESCRIPTORS
3929,llama4,0.797,HISTOLOGIC GRADE
3930,llama4,0.742,SPREAD THROUGH AIR SPACES (STAS)
3931,llama4,0.78,VISCERAL PLEURA INVASION
3932,llama4,0.75,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3933,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3934,llama4,0.731,PROCEDURE
3935,llama4,0.817,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3936,llama4,0.807,NODAL SITE(S) EXAMINED
3937,llama4,0.697,SPECIMEN LATERALITY
3938,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3939,llama4,0.778,HISTOLOGIC GRADE
3940,llama4,0.89,TUMOR SITE
3941,llama4,0.692,LYMPHOVASCULAR INVASION
3942,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3943,llama4,0.659,ADDITIONAL FINDINGS
3944,llama4,0.811,TUMOR FOCALITY
3945,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3946,llama4,0.797,HISTOLOGIC GRADE
3947,llama4,0.811,TUMOR FOCALITY
3948,llama4,0.65,TNM DESCRIPTORS
3949,llama4,0.89,TUMOR SITE
3950,llama4,0.768,NODAL SITE(S) EXAMINED
3951,llama4,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3952,llama4,0.78,VISCERAL PLEURA INVASION
3953,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3954,llama4,0.819,NODAL SITE(S) WITH TUMOR
3955,llama4,0.855,MARGIN STATUS FOR INVASIVE CARCINOMA
3956,llama4,0.698,NUMBER OF LYMPH NODES EXAMINED
3957,llama4,0.856,REGIONAL LYMPH NODE STATUS
3958,llama4,0.698,NUMBER OF LYMPH NODES WITH TUMOR
3959,llama4,0.779,PROCEDURE
3960,llama4,0.698,SPECIMEN LATERALITY
3961,llama4,0.745,LYMPHOVASCULAR INVASION
3962,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3963,llama4,0.854,NODAL SITE(S) EXAMINED
3964,llama4,0.774,ADDITIONAL FINDINGS
3965,llama4,0.811,TUMOR FOCALITY
3966,llama4,0.877,REGIONAL LYMPH NODE STATUS
3967,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3968,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3969,llama4,0.697,SPECIMEN LATERALITY
3970,llama4,0.802,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3971,llama4,0.788,PROCEDURE
3972,llama4,0.703,NUMBER OF LYMPH NODES EXAMINED
3973,llama4,0.797,HISTOLOGIC GRADE
3974,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
3975,llama4,0.837,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3976,llama4,0.89,TUMOR SITE
3977,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
3978,llama4,0.778,VISCERAL PLEURA INVASION
3979,llama4,0.715,PROCEDURE
3980,llama4,0.692,SPREAD THROUGH AIR SPACES (STAS)
3981,llama4,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3982,llama4,0.694,NUMBER OF LYMPH NODES EXAMINED
3983,llama4,0.698,SPECIMEN LATERALITY
3984,llama4,0.778,VISCERAL PLEURA INVASION
3985,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3986,llama4,0.775,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3987,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3988,llama4,0.811,TUMOR FOCALITY
3989,llama4,0.914,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3990,llama4,0.759,NODAL SITE(S) EXAMINED
3991,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3992,llama4,0.778,HISTOLOGIC GRADE
3993,llama4,0.801,TUMOR SITE
3994,llama4,0.877,REGIONAL LYMPH NODE STATUS
3995,llama4,0.774,ADDITIONAL FINDINGS
3996,llama4,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3997,llama4,0.829,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3998,llama4,0.89,TUMOR SITE
3999,llama4,0.689,ADDITIONAL FINDINGS
4000,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4001,llama4,0.748,NODAL SITE(S) EXAMINED
4002,llama4,0.797,HISTOLOGIC GRADE
4003,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4004,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
4005,llama4,0.763,MARGIN STATUS FOR INVASIVE CARCINOMA
4006,llama4,0.707,NUMBER OF LYMPH NODES EXAMINED
4007,llama4,0.697,SPECIMEN LATERALITY
4008,llama4,0.698,VISCERAL PLEURA INVASION
4009,llama4,0.877,REGIONAL LYMPH NODE STATUS
4010,llama4,0.811,TUMOR FOCALITY
4011,llama4,0.713,PROCEDURE
4012,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4013,llama4,0.709,PROCEDURE
4014,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4015,llama4,0.8,HISTOLOGIC GRADE
4016,llama4,0.811,TUMOR FOCALITY
4017,llama4,0.784,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4018,llama4,0.697,SPECIMEN LATERALITY
4019,llama4,0.893,TUMOR SITE
4020,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
4021,llama4,0.721,NODAL SITE(S) EXAMINED
4022,llama4,0.877,REGIONAL LYMPH NODE STATUS
4023,llama4,0.778,VISCERAL PLEURA INVASION
4024,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4025,llama4,0.826,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4026,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4027,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4028,llama4,0.778,VISCERAL PLEURA INVASION
4029,llama4,0.903,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4030,llama4,0.811,TUMOR FOCALITY
4031,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4032,llama4,0.697,SPECIMEN LATERALITY
4033,llama4,0.71,ADDITIONAL FINDINGS
4034,llama4,0.807,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4035,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4036,llama4,0.89,TUMOR SITE
4037,llama4,0.797,HISTOLOGIC GRADE
4038,llama4,0.764,MARGIN STATUS FOR INVASIVE CARCINOMA
4039,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4040,llama4,0.785,PROCEDURE
4041,llama4,0.877,REGIONAL LYMPH NODE STATUS
4042,llama4,0.878,ADDITIONAL FINDINGS
4043,llama4,0.697,SPECIMEN LATERALITY
4044,llama4,0.663,TNM DESCRIPTORS
4045,llama4,0.716,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4046,llama4,0.77,PROCEDURE
4047,llama4,0.778,VISCERAL PLEURA INVASION
4048,llama4,0.835,NODAL SITE(S) EXAMINED
4049,llama4,0.797,HISTOLOGIC GRADE
4050,llama4,0.677,TUMOR SITE
4051,llama4,0.793,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4052,llama4,0.692,LYMPHOVASCULAR INVASION
4053,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4054,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4055,llama4,0.742,MARGIN STATUS FOR INVASIVE CARCINOMA
4056,llama4,0.67,TUMOR FOCALITY
4057,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4058,llama4,0.669,HISTOLOGIC GRADE
4059,llama4,0.642,VISCERAL PLEURA INVASION
4060,llama4,0.735,TUMOR FOCALITY
4061,llama4,0.758,TUMOR SITE
4062,llama4,0.732,PROCEDURE
4063,llama4,0.877,REGIONAL LYMPH NODE STATUS
4064,llama4,0.788,SPECIMEN LATERALITY
4065,llama4,0.823,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4066,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4067,llama4,0.703,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4068,llama4,0.791,NODAL SITE(S) EXAMINED
4069,llama4,0.767,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4070,llama4,0.704,NUMBER OF LYMPH NODES EXAMINED
4071,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4072,llama4,0.665,TNM DESCRIPTORS
4073,llama4,0.897,LYMPH NODE(S) FROM PRIOR PROCEDURES
4074,llama4,0.811,TUMOR FOCALITY
4075,llama4,0.697,SPECIMEN LATERALITY
4076,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4077,llama4,0.756,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4078,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4079,llama4,0.703,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4080,llama4,0.8,HISTOLOGIC GRADE
4081,llama4,0.877,REGIONAL LYMPH NODE STATUS
4082,llama4,0.812,NODAL SITE(S) EXAMINED
4083,llama4,0.624,TUMOR SITE
4084,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4085,llama4,0.778,VISCERAL PLEURA INVASION
4086,llama4,0.809,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4087,llama4,0.729,PROCEDURE
4088,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
4089,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4090,llama4,0.664,NODAL SITE(S) EXAMINED
4091,llama4,0.732,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4092,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4093,llama4,0.89,TUMOR SITE
4094,llama4,0.778,VISCERAL PLEURA INVASION
4095,llama4,0.698,SPECIMEN LATERALITY
4096,llama4,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4097,llama4,0.713,NUMBER OF LYMPH NODES EXAMINED
4098,llama4,0.877,REGIONAL LYMPH NODE STATUS
4099,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4100,llama4,0.811,TUMOR FOCALITY
4101,llama4,0.827,PROCEDURE
4102,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4103,llama4,0.683,LYMPH NODE(S) FROM PRIOR PROCEDURES
4104,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4105,llama4,0.739,TUMOR FOCALITY
4106,llama4,0.778,VISCERAL PLEURA INVASION
4107,llama4,0.819,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4108,llama4,0.782,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4109,llama4,0.644,TNM DESCRIPTORS
4110,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4111,llama4,0.697,SPECIMEN LATERALITY
4112,llama4,0.802,TUMOR SITE
4113,llama4,0.858,NODAL SITE(S) EXAMINED
4114,llama4,0.7,NUMBER OF LYMPH NODES WITH TUMOR
4115,llama4,0.788,PROCEDURE
4116,llama4,0.755,REGIONAL LYMPH NODE STATUS
4117,llama4,0.706,NUMBER OF LYMPH NODES EXAMINED
4118,llama4,0.742,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4119,llama4,0.853,NODAL SITE(S) WITH TUMOR
4120,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4121,llama4,0.697,SPECIMEN LATERALITY
4122,llama4,0.832,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4123,llama4,0.865,TUMOR SITE
4124,llama4,0.725,NODAL SITE(S) EXAMINED
4125,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4126,llama4,0.811,TUMOR FOCALITY
4127,llama4,0.862,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4128,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4129,llama4,0.788,PROCEDURE
4130,llama4,0.782,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4131,llama4,0.877,REGIONAL LYMPH NODE STATUS
4132,llama4,0.811,TUMOR FOCALITY
4133,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4134,llama4,0.817,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4135,llama4,0.742,NODAL SITE(S) EXAMINED
4136,llama4,0.703,NUMBER OF LYMPH NODES EXAMINED
4137,llama4,0.709,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4138,llama4,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4139,llama4,0.778,VISCERAL PLEURA INVASION
4140,llama4,0.89,TUMOR SITE
4141,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4142,llama4,0.877,REGIONAL LYMPH NODE STATUS
4143,llama4,0.73,MARGIN STATUS FOR INVASIVE CARCINOMA
4144,llama4,0.797,HISTOLOGIC GRADE
4145,llama4,0.698,SPECIMEN LATERALITY
4146,llama4,0.793,PROCEDURE
4147,llama4,0.797,HISTOLOGIC GRADE
4148,llama4,0.877,REGIONAL LYMPH NODE STATUS
4149,llama4,0.788,PROCEDURE
4150,llama4,0.735,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4151,llama4,0.68,NODAL SITE(S) EXAMINED
4152,llama4,0.811,TUMOR FOCALITY
4153,llama4,0.808,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4154,llama4,0.89,TUMOR SITE
4155,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4156,llama4,0.778,VISCERAL PLEURA INVASION
4157,llama4,0.698,SPECIMEN LATERALITY
4158,llama4,0.701,NUMBER OF LYMPH NODES EXAMINED
4159,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4160,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
4161,llama4,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4162,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4163,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4164,llama4,0.73,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4165,llama4,0.819,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4166,llama4,0.698,VISCERAL PLEURA INVASION
4167,llama4,0.811,TUMOR FOCALITY
4168,llama4,0.89,TUMOR SITE
4169,llama4,0.697,SPECIMEN LATERALITY
4170,llama4,0.877,REGIONAL LYMPH NODE STATUS
4171,llama4,0.724,NODAL SITE(S) EXAMINED
4172,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4173,llama4,0.716,LYMPHOVASCULAR INVASION
4174,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4175,llama4,0.796,PROCEDURE
4176,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4177,llama4,0.697,SPECIMEN LATERALITY
4178,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
4179,llama4,0.715,ADDITIONAL FINDINGS
4180,llama4,0.914,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4181,llama4,0.778,VISCERAL PLEURA INVASION
4182,llama4,0.835,NODAL SITE(S) EXAMINED
4183,llama4,0.89,TUMOR SITE
4184,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4185,llama4,0.702,NUMBER OF LYMPH NODES EXAMINED
4186,llama4,0.746,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4187,llama4,0.752,PROCEDURE
4188,llama4,0.877,REGIONAL LYMPH NODE STATUS
4189,llama4,0.811,TUMOR FOCALITY
4190,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4191,llama4,0.787,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4192,llama4,0.7,TUMOR SITE
4193,llama4,0.877,REGIONAL LYMPH NODE STATUS
4194,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4195,llama4,0.752,NODAL SITE(S) EXAMINED
4196,llama4,0.662,TNM DESCRIPTORS
4197,llama4,0.778,VISCERAL PLEURA INVASION
4198,llama4,0.794,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4199,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4200,llama4,0.698,SPECIMEN LATERALITY
4201,llama4,0.721,ADDITIONAL FINDINGS
4202,llama4,0.808,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4203,llama4,0.788,PROCEDURE
4204,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
4205,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4206,llama4,0.732,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4207,llama4,0.67,TUMOR FOCALITY
4208,llama4,0.693,HISTOLOGIC GRADE
4209,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4210,llama4,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4211,llama4,0.734,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4212,llama4,0.811,TUMOR FOCALITY
4213,llama4,0.698,SPECIMEN LATERALITY
4214,llama4,0.778,VISCERAL PLEURA INVASION
4215,llama4,0.789,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4216,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4217,llama4,0.661,NODAL SITE(S) EXAMINED
4218,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
4219,llama4,0.904,HISTOLOGIC GRADE
4220,llama4,0.877,REGIONAL LYMPH NODE STATUS
4221,llama4,0.865,TUMOR SITE
4222,llama4,0.788,NODAL SITE(S) EXAMINED
4223,llama4,0.788,PROCEDURE
4224,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4225,llama4,0.788,PROCEDURE
4226,llama4,0.778,VISCERAL PLEURA INVASION
4227,llama4,0.877,REGIONAL LYMPH NODE STATUS
4228,llama4,0.838,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4229,llama4,0.811,TUMOR FOCALITY
4230,llama4,0.798,TUMOR SITE
4231,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4232,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4233,llama4,0.799,NODAL SITE(S) EXAMINED
4234,llama4,0.689,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4235,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
4236,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4237,llama4,0.738,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4238,llama4,0.697,SPECIMEN LATERALITY
4239,llama4,0.711,HISTOLOGIC GRADE
4240,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4241,llama4,0.733,REGIONAL LYMPH NODE STATUS
4242,llama4,0.697,SPECIMEN LATERALITY
4243,llama4,0.778,VISCERAL PLEURA INVASION
4244,llama4,0.782,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4245,llama4,0.886,NODAL SITE(S) WITH TUMOR
4246,llama4,0.811,TUMOR FOCALITY
4247,llama4,0.838,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4248,llama4,0.651,NUMBER OF LYMPH NODES WITH TUMOR
4249,llama4,0.866,PROCEDURE
4250,llama4,0.678,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4251,llama4,0.653,TNM DESCRIPTORS
4252,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
4253,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4254,llama4,0.729,ADDITIONAL FINDINGS
4255,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4256,llama4,0.684,TUMOR SITE
4257,llama4,0.742,NODAL SITE(S) EXAMINED
4258,llama4,0.794,NODAL SITE(S) EXAMINED
4259,llama4,0.789,HISTOLOGIC GRADE
4260,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4261,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4262,llama4,0.819,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4263,llama4,0.698,SPECIMEN LATERALITY
4264,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4265,llama4,0.778,VISCERAL PLEURA INVASION
4266,llama4,0.874,REGIONAL LYMPH NODE STATUS
4267,llama4,0.893,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4268,llama4,0.757,MARGIN STATUS FOR INVASIVE CARCINOMA
4269,llama4,0.788,PROCEDURE
4270,llama4,0.718,SPREAD THROUGH AIR SPACES (STAS)
4271,llama4,0.811,TUMOR FOCALITY
4272,llama4,0.697,NUMBER OF LYMPH NODES EXAMINED
4273,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4274,llama4,0.697,SPECIMEN LATERALITY
4275,llama4,0.8,HISTOLOGIC GRADE
4276,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
4277,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4278,llama4,0.695,NUMBER OF LYMPH NODES EXAMINED
4279,llama4,0.903,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4280,llama4,0.701,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4281,llama4,0.877,REGIONAL LYMPH NODE STATUS
4282,llama4,0.801,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4283,llama4,0.793,PROCEDURE
4284,llama4,0.816,NODAL SITE(S) EXAMINED
4285,llama4,0.811,TUMOR FOCALITY
4286,llama4,0.724,TUMOR SITE
4287,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4288,llama4,0.778,VISCERAL PLEURA INVASION
4289,llama4,0.813,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4290,llama4,0.782,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4291,llama4,0.877,REGIONAL LYMPH NODE STATUS
4292,llama4,0.798,TUMOR SITE
4293,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4294,llama4,0.716,ADDITIONAL FINDINGS
4295,llama4,0.763,MARGIN STATUS FOR INVASIVE CARCINOMA
4296,llama4,0.749,NUMBER OF LYMPH NODES EXAMINED
4297,llama4,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4298,llama4,0.697,SPECIMEN LATERALITY
4299,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
4300,llama4,0.811,TUMOR FOCALITY
4301,llama4,0.797,HISTOLOGIC GRADE
4302,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4303,llama4,0.788,PROCEDURE
4304,llama4,0.747,NODAL SITE(S) EXAMINED
4305,llama4,0.778,VISCERAL PLEURA INVASION
4306,llama4,0.65,NODAL SITE(S) WITH TUMOR
4307,llama4,0.811,TUMOR FOCALITY
4308,llama4,0.739,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4309,llama4,0.771,NODAL SITE(S) EXAMINED
4310,llama4,0.78,VISCERAL PLEURA INVASION
4311,llama4,0.798,TUMOR SITE
4312,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4313,llama4,0.672,LYMPHOVASCULAR INVASION
4314,llama4,0.789,REGIONAL LYMPH NODE STATUS
4315,llama4,0.72,PROCEDURE
4316,llama4,0.75,HISTOLOGIC GRADE
4317,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4318,llama4,0.72,NUMBER OF LYMPH NODES WITH TUMOR
4319,llama4,0.78,SPREAD THROUGH AIR SPACES (STAS)
4320,llama4,0.674,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4321,llama4,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4322,llama4,0.713,NUMBER OF LYMPH NODES EXAMINED
4323,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4324,llama4,0.697,SPECIMEN LATERALITY
4325,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4326,llama4,0.697,SPECIMEN LATERALITY
4327,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
4328,llama4,0.827,PROCEDURE
4329,llama4,0.787,TUMOR SITE
4330,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4331,llama4,0.858,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4332,llama4,0.787,TUMOR FOCALITY
4333,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4334,llama4,0.712,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4335,llama4,0.797,HISTOLOGIC GRADE
4336,llama4,0.745,MARGIN STATUS FOR INVASIVE CARCINOMA
4337,llama4,0.78,VISCERAL PLEURA INVASION
4338,llama4,0.877,REGIONAL LYMPH NODE STATUS
4339,llama4,0.797,HISTOLOGIC GRADE
4340,llama4,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4341,llama4,0.827,PROCEDURE
4342,llama4,0.698,SPECIMEN LATERALITY
4343,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4344,llama4,0.704,NODAL SITE(S) EXAMINED
4345,llama4,0.89,TUMOR SITE
4346,llama4,0.893,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4347,llama4,0.713,NUMBER OF LYMPH NODES EXAMINED
4348,llama4,0.78,VISCERAL PLEURA INVASION
4349,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4350,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
4351,llama4,0.811,TUMOR FOCALITY
4352,llama4,0.717,ADDITIONAL FINDINGS
4353,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4354,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4355,llama4,0.718,SPREAD THROUGH AIR SPACES (STAS)
4356,llama4,0.778,HISTOLOGIC GRADE
4357,llama4,0.71,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4358,llama4,0.721,MARGIN STATUS FOR INVASIVE CARCINOMA
4359,llama4,0.718,VISCERAL PLEURA INVASION
4360,llama4,0.702,ADDITIONAL FINDINGS
4361,llama4,0.795,NODAL SITE(S) EXAMINED
4362,llama4,0.89,TUMOR SITE
4363,llama4,0.745,LYMPHOVASCULAR INVASION
4364,llama4,0.811,TUMOR FOCALITY
4365,llama4,0.789,NUMBER OF LYMPH NODES EXAMINED
4366,llama4,0.692,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4367,llama4,0.781,PROCEDURE
4368,llama4,0.698,SPECIMEN LATERALITY
4369,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4370,llama4,0.835,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4371,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4372,llama4,0.653,TNM DESCRIPTORS
4373,llama4,0.778,HISTOLOGIC GRADE
4374,llama4,0.698,SPECIMEN LATERALITY
4375,llama4,0.811,TUMOR FOCALITY
4376,llama4,0.89,TUMOR SITE
4377,llama4,0.856,REGIONAL LYMPH NODE STATUS
4378,llama4,0.727,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4379,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4380,llama4,0.769,PROCEDURE
4381,llama4,0.883,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4382,llama4,0.681,LYMPHOVASCULAR INVASION
4383,llama4,0.655,TNM DESCRIPTORS
4384,llama4,0.773,NODAL SITE(S) EXAMINED
4385,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
4386,llama4,0.742,MARGIN STATUS FOR INVASIVE CARCINOMA
4387,llama4,0.807,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4388,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4389,llama4,0.707,NODAL SITE(S) WITH TUMOR
4390,llama4,0.78,VISCERAL PLEURA INVASION
4391,llama4,0.815,NODAL SITE(S) WITH TUMOR
4392,llama4,0.802,NODAL SITE(S) EXAMINED
4393,llama4,0.72,NUMBER OF LYMPH NODES WITH TUMOR
4394,llama4,0.697,SPECIMEN LATERALITY
4395,llama4,0.892,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4396,llama4,0.811,TUMOR FOCALITY
4397,llama4,0.788,REGIONAL LYMPH NODE STATUS
4398,llama4,0.698,NUMBER OF LYMPH NODES EXAMINED
4399,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4400,llama4,0.938,ADDITIONAL FINDINGS
4401,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4402,llama4,0.681,TUMOR SITE
4403,llama4,0.765,PROCEDURE
4404,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
4405,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4406,llama4,0.735,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4407,llama4,0.778,HISTOLOGIC GRADE
4408,llama4,0.739,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4409,llama4,0.778,VISCERAL PLEURA INVASION
4410,llama4,0.877,REGIONAL LYMPH NODE STATUS
4411,llama4,0.667,NODAL SITE(S) EXAMINED
4412,llama4,0.714,HISTOLOGIC GRADE
4413,llama4,0.669,LYMPH NODE(S) FROM PRIOR PROCEDURES
4414,llama4,0.787,PROCEDURE
4415,llama4,0.736,SPREAD THROUGH AIR SPACES (STAS)
4416,llama4,0.706,MARGIN STATUS FOR INVASIVE CARCINOMA
4417,llama4,0.716,ADDITIONAL FINDINGS
4418,llama4,0.811,TUMOR FOCALITY
4419,llama4,0.657,MARGIN STATUS FOR NON-INVASIVE TUMOR
4420,llama4,0.697,SPECIMEN LATERALITY
4421,llama4,0.671,TNM DESCRIPTORS
4422,llama4,0.778,VISCERAL PLEURA INVASION
4423,llama4,0.738,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4424,llama4,0.759,TUMOR SITE
4425,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4426,llama4,0.735,TUMOR FOCALITY
4427,llama4,0.772,PROCEDURE
4428,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4429,llama4,0.681,TUMOR SITE
4430,llama4,0.713,NUMBER OF LYMPH NODES WITH TUMOR
4431,llama4,0.777,REGIONAL LYMPH NODE STATUS
4432,llama4,0.745,LYMPHOVASCULAR INVASION
4433,llama4,0.697,SPECIMEN LATERALITY
4434,llama4,0.729,NODAL SITE(S) WITH TUMOR
4435,llama4,0.73,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4436,llama4,0.693,HISTOLOGIC GRADE
4437,llama4,0.78,VISCERAL PLEURA INVASION
4438,llama4,0.788,NODAL SITE(S) EXAMINED
4439,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
4440,llama4,0.772,NUMBER OF LYMPH NODES EXAMINED
4441,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4442,llama4,0.791,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4443,llama4,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4444,llama4,0.798,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4445,llama4,0.811,TUMOR FOCALITY
4446,llama4,0.706,ADDITIONAL FINDINGS
4447,llama4,0.788,PROCEDURE
4448,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4449,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4450,llama4,0.797,HISTOLOGIC GRADE
4451,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4452,llama4,0.877,REGIONAL LYMPH NODE STATUS
4453,llama4,0.835,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4454,llama4,0.697,SPECIMEN LATERALITY
4455,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
4456,llama4,0.89,TUMOR SITE
4457,llama4,0.74,NODAL SITE(S) EXAMINED
4458,llama4,0.761,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4459,llama4,0.778,VISCERAL PLEURA INVASION
4460,llama4,0.704,NUMBER OF LYMPH NODES EXAMINED
4461,llama4,0.702,NODAL SITE(S) EXAMINED
4462,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
4463,llama4,0.877,REGIONAL LYMPH NODE STATUS
4464,llama4,0.811,TUMOR FOCALITY
4465,llama4,0.698,VISCERAL PLEURA INVASION
4466,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4467,llama4,0.778,PROCEDURE
4468,llama4,0.718,TUMOR SITE
4469,llama4,0.814,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4470,llama4,0.797,HISTOLOGIC GRADE
4471,llama4,0.731,LYMPHOVASCULAR INVASION
4472,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4473,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4474,llama4,0.755,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4475,llama4,0.749,SPECIMEN LATERALITY
4476,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4477,llama4,0.714,LYMPHOVASCULAR INVASION
4478,llama4,0.702,NUMBER OF LYMPH NODES EXAMINED
4479,llama4,0.908,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4480,llama4,0.723,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4481,llama4,0.778,VISCERAL PLEURA INVASION
4482,llama4,0.772,PROCEDURE
4483,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4484,llama4,0.808,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4485,llama4,0.698,SPECIMEN LATERALITY
4486,llama4,0.778,HISTOLOGIC GRADE
4487,llama4,0.811,TUMOR FOCALITY
4488,llama4,0.759,NODAL SITE(S) EXAMINED
4489,llama4,0.89,TUMOR SITE
4490,llama4,0.877,REGIONAL LYMPH NODE STATUS
4491,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4492,llama4,0.849,ADDITIONAL FINDINGS
4493,llama4,0.707,NUMBER OF LYMPH NODES EXAMINED
4494,llama4,0.91,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4495,llama4,0.697,SPECIMEN LATERALITY
4496,llama4,0.811,TUMOR FOCALITY
4497,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4498,llama4,0.877,REGIONAL LYMPH NODE STATUS
4499,llama4,0.824,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4500,llama4,0.827,PROCEDURE
4501,llama4,0.745,LYMPHOVASCULAR INVASION
4502,llama4,0.698,NODAL SITE(S) EXAMINED
4503,llama4,0.698,VISCERAL PLEURA INVASION
4504,llama4,0.89,TUMOR SITE
4505,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4506,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
4507,llama4,0.698,VISCERAL PLEURA INVASION
4508,llama4,0.709,NODAL SITE(S) EXAMINED
4509,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4510,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4511,llama4,0.64,NODAL SITE(S) WITH TUMOR
4512,llama4,0.718,SPREAD THROUGH AIR SPACES (STAS)
4513,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4514,llama4,0.705,NUMBER OF LYMPH NODES EXAMINED
4515,llama4,0.817,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4516,llama4,0.695,LYMPHOVASCULAR INVASION
4517,llama4,0.72,NUMBER OF LYMPH NODES WITH TUMOR
4518,llama4,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4519,llama4,0.892,HISTOLOGIC GRADE
4520,llama4,0.787,REGIONAL LYMPH NODE STATUS
4521,llama4,0.698,SPECIMEN LATERALITY
4522,llama4,0.811,TUMOR FOCALITY
4523,llama4,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4524,llama4,0.833,TUMOR SITE
4525,llama4,0.728,PROCEDURE
4526,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
4527,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4528,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4529,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4530,llama4,0.877,REGIONAL LYMPH NODE STATUS
4531,llama4,0.697,SPECIMEN LATERALITY
4532,llama4,0.778,HISTOLOGIC GRADE
4533,llama4,0.811,TUMOR FOCALITY
4534,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4535,llama4,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4536,llama4,0.827,PROCEDURE
4537,llama4,0.72,NUMBER OF LYMPH NODES EXAMINED
4538,llama4,0.763,NODAL SITE(S) EXAMINED
4539,llama4,0.778,VISCERAL PLEURA INVASION
4540,llama4,0.798,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4541,llama4,0.865,TUMOR SITE
4542,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4543,llama4,0.753,NODAL SITE(S) EXAMINED
4544,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4545,llama4,0.698,SPECIMEN LATERALITY
4546,llama4,0.721,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4547,llama4,0.811,TUMOR FOCALITY
4548,llama4,0.698,VISCERAL PLEURA INVASION
4549,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4550,llama4,0.89,TUMOR SITE
4551,llama4,0.813,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4552,llama4,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4553,llama4,0.877,REGIONAL LYMPH NODE STATUS
4554,llama4,0.774,ADDITIONAL FINDINGS
4555,llama4,0.757,PROCEDURE
4556,llama4,0.782,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4557,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4558,llama4,0.811,TUMOR FOCALITY
4559,llama4,0.778,VISCERAL PLEURA INVASION
4560,llama4,0.877,REGIONAL LYMPH NODE STATUS
4561,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4562,llama4,0.709,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4563,llama4,0.714,NUMBER OF LYMPH NODES EXAMINED
4564,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4565,llama4,0.733,PROCEDURE
4566,llama4,0.797,HISTOLOGIC GRADE
4567,llama4,0.809,NODAL SITE(S) EXAMINED
4568,llama4,0.914,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4569,llama4,0.697,SPECIMEN LATERALITY
4570,llama4,0.828,TUMOR SITE
4571,llama4,0.778,VISCERAL PLEURA INVASION
4572,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4573,llama4,0.692,LYMPHOVASCULAR INVASION
4574,llama4,0.714,ADDITIONAL FINDINGS
4575,llama4,0.89,TUMOR SITE
4576,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4577,llama4,0.811,TUMOR FOCALITY
4578,llama4,0.712,NUMBER OF LYMPH NODES EXAMINED
4579,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4580,llama4,0.697,SPECIMEN LATERALITY
4581,llama4,0.75,NODAL SITE(S) EXAMINED
4582,llama4,0.877,REGIONAL LYMPH NODE STATUS
4583,llama4,0.854,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4584,llama4,0.718,SPREAD THROUGH AIR SPACES (STAS)
4585,llama4,0.847,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4586,llama4,0.768,PROCEDURE
4587,llama4,0.778,HISTOLOGIC GRADE
4588,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4589,llama4,0.78,VISCERAL PLEURA INVASION
4590,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4591,llama4,0.811,TUMOR FOCALITY
4592,llama4,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4593,llama4,0.686,ADDITIONAL FINDINGS
4594,llama4,0.78,MARGIN STATUS FOR INVASIVE CARCINOMA
4595,llama4,0.788,PROCEDURE
4596,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4597,llama4,0.698,SPECIMEN LATERALITY
4598,llama4,0.715,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4599,llama4,0.676,TUMOR SITE
4600,llama4,0.829,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4601,llama4,0.778,HISTOLOGIC GRADE
4602,llama4,0.755,NODAL SITE(S) EXAMINED
4603,llama4,0.877,REGIONAL LYMPH NODE STATUS
4604,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4605,llama4,0.697,SPECIMEN LATERALITY
4606,llama4,0.827,PROCEDURE
4607,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4608,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
4609,llama4,0.797,HISTOLOGIC GRADE
4610,llama4,0.697,NUMBER OF LYMPH NODES EXAMINED
4611,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4612,llama4,0.877,REGIONAL LYMPH NODE STATUS
4613,llama4,0.89,TUMOR SITE
4614,llama4,0.811,TUMOR FOCALITY
4615,llama4,0.778,VISCERAL PLEURA INVASION
4616,llama4,0.829,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4617,llama4,0.825,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4618,llama4,0.723,NODAL SITE(S) EXAMINED
4619,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4620,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4621,llama4,0.877,REGIONAL LYMPH NODE STATUS
4622,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4623,llama4,0.798,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4624,llama4,0.786,PROCEDURE
4625,llama4,0.697,SPECIMEN LATERALITY
4626,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4627,llama4,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4628,llama4,0.797,HISTOLOGIC GRADE
4629,llama4,0.778,VISCERAL PLEURA INVASION
4630,llama4,0.89,TUMOR SITE
4631,llama4,0.713,NUMBER OF LYMPH NODES EXAMINED
4632,llama4,0.811,TUMOR FOCALITY
4633,llama4,0.75,NODAL SITE(S) EXAMINED
4634,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
4635,llama4,0.715,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4636,llama4,0.788,PROCEDURE
4637,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
4638,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4639,llama4,0.698,SPECIMEN LATERALITY
4640,llama4,0.787,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4641,llama4,0.753,NODAL SITE(S) EXAMINED
4642,llama4,0.738,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4643,llama4,0.877,REGIONAL LYMPH NODE STATUS
4644,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4645,llama4,0.811,TUMOR FOCALITY
4646,llama4,0.709,ADDITIONAL FINDINGS
4647,llama4,0.797,HISTOLOGIC GRADE
4648,llama4,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4649,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4650,llama4,0.778,VISCERAL PLEURA INVASION
4651,llama4,0.715,NUMBER OF LYMPH NODES EXAMINED
4652,llama4,0.89,TUMOR SITE
4653,llama4,0.827,PROCEDURE
4654,llama4,0.703,NUMBER OF LYMPH NODES EXAMINED
4655,llama4,0.681,TUMOR SITE
4656,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4657,llama4,0.877,REGIONAL LYMPH NODE STATUS
4658,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4659,llama4,0.697,SPECIMEN LATERALITY
4660,llama4,0.797,HISTOLOGIC GRADE
4661,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4662,llama4,0.813,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4663,llama4,0.811,TUMOR FOCALITY
4664,llama4,0.78,VISCERAL PLEURA INVASION
4665,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4666,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
4667,llama4,0.913,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4668,llama4,0.73,NODAL SITE(S) EXAMINED
4669,llama4,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4670,llama4,0.702,ADDITIONAL FINDINGS
4671,llama4,0.797,HISTOLOGIC GRADE
4672,llama4,0.711,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4673,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4674,llama4,0.736,SPREAD THROUGH AIR SPACES (STAS)
4675,llama4,0.778,VISCERAL PLEURA INVASION
4676,llama4,0.704,PROCEDURE
4677,llama4,0.703,NUMBER OF LYMPH NODES EXAMINED
4678,llama4,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4679,llama4,0.862,NODAL SITE(S) EXAMINED
4680,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4681,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4682,llama4,0.676,TUMOR SITE
4683,llama4,0.811,TUMOR FOCALITY
4684,llama4,0.877,REGIONAL LYMPH NODE STATUS
4685,llama4,0.698,SPECIMEN LATERALITY
4686,llama4,0.877,REGIONAL LYMPH NODE STATUS
4687,llama4,0.697,SPECIMEN LATERALITY
4688,llama4,0.763,NODAL SITE(S) EXAMINED
4689,llama4,0.797,HISTOLOGIC GRADE
4690,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
4691,llama4,0.798,TUMOR SITE
4692,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4693,llama4,0.72,NUMBER OF LYMPH NODES EXAMINED
4694,llama4,0.811,TUMOR FOCALITY
4695,llama4,0.78,VISCERAL PLEURA INVASION
4696,llama4,0.827,PROCEDURE
4697,llama4,0.813,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4698,llama4,0.732,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4699,llama4,0.811,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4700,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4701,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4702,llama4,0.811,TUMOR FOCALITY
4703,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
4704,llama4,0.827,PROCEDURE
4705,llama4,0.8,HISTOLOGIC GRADE
4706,llama4,0.781,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4707,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4708,llama4,0.71,ADDITIONAL FINDINGS
4709,llama4,0.804,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4710,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4711,llama4,0.77,NODAL SITE(S) EXAMINED
4712,llama4,0.865,TUMOR SITE
4713,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4714,llama4,0.698,VISCERAL PLEURA INVASION
4715,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4716,llama4,0.877,REGIONAL LYMPH NODE STATUS
4717,llama4,0.713,NUMBER OF LYMPH NODES EXAMINED
4718,llama4,0.698,SPECIMEN LATERALITY
4719,llama4,0.697,SPECIMEN LATERALITY
4720,llama4,0.778,VISCERAL PLEURA INVASION
4721,llama4,0.8,HISTOLOGIC GRADE
4722,llama4,0.663,MARGIN STATUS FOR NON-INVASIVE TUMOR
4723,llama4,0.65,MARGIN STATUS FOR INVASIVE CARCINOMA
4724,llama4,0.747,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4725,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4726,llama4,0.815,PROCEDURE
4727,llama4,0.668,TNM DESCRIPTORS
4728,llama4,0.673,TUMOR FOCALITY
4729,llama4,0.751,ADDITIONAL FINDINGS
4730,llama4,0.754,NODAL SITE(S) EXAMINED
4731,llama4,0.877,REGIONAL LYMPH NODE STATUS
4732,llama4,0.758,MARGIN STATUS FOR INVASIVE CARCINOMA
4733,llama4,0.698,SPECIMEN LATERALITY
4734,llama4,0.783,NODAL SITE(S) EXAMINED
4735,llama4,0.778,HISTOLOGIC GRADE
4736,llama4,0.682,ADDITIONAL FINDINGS
4737,llama4,0.718,SPREAD THROUGH AIR SPACES (STAS)
4738,llama4,0.78,VISCERAL PLEURA INVASION
4739,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4740,llama4,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4741,llama4,0.89,TUMOR SITE
4742,llama4,0.877,REGIONAL LYMPH NODE STATUS
4743,llama4,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4744,llama4,0.802,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4745,llama4,0.793,PROCEDURE
4746,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4747,llama4,0.745,LYMPHOVASCULAR INVASION
4748,llama4,0.811,TUMOR FOCALITY
4749,llama4,0.7,NUMBER OF LYMPH NODES EXAMINED
4750,llama4,0.777,NODAL SITE(S) EXAMINED
4751,llama4,0.89,TUMOR SITE
4752,llama4,0.713,NUMBER OF LYMPH NODES EXAMINED
4753,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4754,llama4,0.778,VISCERAL PLEURA INVASION
4755,llama4,0.797,HISTOLOGIC GRADE
4756,llama4,0.697,SPECIMEN LATERALITY
4757,llama4,0.903,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4758,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4759,llama4,0.827,PROCEDURE
4760,llama4,0.718,SPREAD THROUGH AIR SPACES (STAS)
4761,llama4,0.877,REGIONAL LYMPH NODE STATUS
4762,llama4,0.716,ADDITIONAL FINDINGS
4763,llama4,0.811,TUMOR FOCALITY
4764,llama4,0.75,MARGIN STATUS FOR INVASIVE CARCINOMA
4765,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4766,llama4,0.799,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4767,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4768,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4769,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4770,llama4,0.892,HISTOLOGIC GRADE
4771,llama4,0.811,TUMOR FOCALITY
4772,llama4,0.704,NODAL SITE(S) EXAMINED
4773,llama4,0.697,SPECIMEN LATERALITY
4774,llama4,0.906,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4775,llama4,0.713,NUMBER OF LYMPH NODES EXAMINED
4776,llama4,0.877,REGIONAL LYMPH NODE STATUS
4777,llama4,0.778,VISCERAL PLEURA INVASION
4778,llama4,0.826,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4779,llama4,0.89,TUMOR SITE
4780,llama4,0.827,PROCEDURE
4781,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4782,llama4,0.629,NODAL SITE(S) EXAMINED
4783,llama4,0.798,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4784,llama4,0.698,SPECIMEN LATERALITY
4785,llama4,0.877,REGIONAL LYMPH NODE STATUS
4786,llama4,0.811,TUMOR FOCALITY
4787,llama4,0.801,TUMOR SITE
4788,llama4,0.772,MARGIN STATUS FOR INVASIVE CARCINOMA
4789,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4790,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4791,llama4,0.698,VISCERAL PLEURA INVASION
4792,llama4,0.72,NUMBER OF LYMPH NODES EXAMINED
4793,llama4,0.847,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4794,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4795,llama4,0.827,PROCEDURE
4796,llama4,0.709,ADDITIONAL FINDINGS
4797,llama4,0.724,NODAL SITE(S) EXAMINED
4798,llama4,0.823,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4799,llama4,0.764,PROCEDURE
4800,llama4,0.89,TUMOR SITE
4801,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4802,llama4,0.706,HISTOLOGIC GRADE
4803,llama4,0.913,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4804,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4805,llama4,0.877,REGIONAL LYMPH NODE STATUS
4806,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4807,llama4,0.697,SPECIMEN LATERALITY
4808,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4809,llama4,0.778,VISCERAL PLEURA INVASION
4810,llama4,0.811,TUMOR FOCALITY
4811,llama4,0.877,REGIONAL LYMPH NODE STATUS
4812,llama4,0.697,SPECIMEN LATERALITY
4813,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4814,llama4,0.778,VISCERAL PLEURA INVASION
4815,llama4,0.742,NODAL SITE(S) EXAMINED
4816,llama4,0.79,PROCEDURE
4817,llama4,0.849,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4818,llama4,0.885,TUMOR SITE
4819,llama4,0.758,NUMBER OF LYMPH NODES EXAMINED
4820,llama4,0.855,MARGIN STATUS FOR INVASIVE CARCINOMA
4821,llama4,0.718,SPREAD THROUGH AIR SPACES (STAS)
4822,llama4,0.778,HISTOLOGIC GRADE
4823,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4824,llama4,0.873,TUMOR FOCALITY
4825,llama4,0.78,VISCERAL PLEURA INVASION
4826,llama4,0.698,SPECIMEN LATERALITY
4827,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4828,llama4,0.833,TUMOR SITE
4829,llama4,0.718,SPREAD THROUGH AIR SPACES (STAS)
4830,llama4,0.757,PROCEDURE
4831,llama4,0.698,LYMPHOVASCULAR INVASION
4832,llama4,0.769,NODAL SITE(S) WITH TUMOR
4833,llama4,0.856,REGIONAL LYMPH NODE STATUS
4834,llama4,0.699,NUMBER OF LYMPH NODES WITH TUMOR
4835,llama4,0.758,NODAL SITE(S) EXAMINED
4836,llama4,0.778,HISTOLOGIC GRADE
4837,llama4,0.838,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4838,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4839,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4840,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4841,llama4,0.811,TUMOR FOCALITY
4842,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
4843,llama4,0.78,VISCERAL PLEURA INVASION
4844,llama4,0.698,SPECIMEN LATERALITY
4845,llama4,0.721,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4846,llama4,0.793,REGIONAL LYMPH NODE STATUS
4847,llama4,0.879,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4848,llama4,0.811,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4849,llama4,0.811,TUMOR FOCALITY
4850,llama4,0.716,LYMPHOVASCULAR INVASION
4851,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4852,llama4,0.865,TUMOR SITE
4853,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4854,llama4,0.835,NODAL SITE(S) WITH TUMOR
4855,llama4,0.713,NUMBER OF LYMPH NODES WITH TUMOR
4856,llama4,0.788,NODAL SITE(S) EXAMINED
4857,llama4,0.704,NUMBER OF LYMPH NODES EXAMINED
4858,llama4,0.774,ADDITIONAL FINDINGS
4859,llama4,0.788,PROCEDURE
4860,llama4,0.778,HISTOLOGIC GRADE
4861,llama4,0.697,SPECIMEN LATERALITY
4862,llama4,0.811,TUMOR FOCALITY
4863,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4864,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4865,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4866,llama4,0.877,REGIONAL LYMPH NODE STATUS
4867,llama4,0.718,SPREAD THROUGH AIR SPACES (STAS)
4868,llama4,0.708,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4869,llama4,0.778,HISTOLOGIC GRADE
4870,llama4,0.865,TUMOR SITE
4871,llama4,0.793,NODAL SITE(S) EXAMINED
4872,llama4,0.793,PROCEDURE
4873,llama4,0.722,ADDITIONAL FINDINGS
4874,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4875,llama4,0.681,NODAL SITE(S) EXAMINED
4876,llama4,0.778,VISCERAL PLEURA INVASION
4877,llama4,0.755,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4878,llama4,0.692,LYMPHOVASCULAR INVASION
4879,llama4,0.838,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4880,llama4,0.693,NODAL SITE(S) EXAMINED
4881,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
4882,llama4,0.852,ADDITIONAL FINDINGS
4883,llama4,0.697,SPECIMEN LATERALITY
4884,llama4,0.745,MARGIN STATUS FOR INVASIVE CARCINOMA
4885,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4886,llama4,0.887,TUMOR SITE
4887,llama4,0.877,REGIONAL LYMPH NODE STATUS
4888,llama4,0.811,TUMOR FOCALITY
4889,llama4,0.642,MARGIN STATUS FOR NON-INVASIVE TUMOR
4890,llama4,0.78,VISCERAL PLEURA INVASION
4891,llama4,0.797,HISTOLOGIC GRADE
4892,llama4,0.788,PROCEDURE
4893,llama4,0.877,REGIONAL LYMPH NODE STATUS
4894,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4895,llama4,0.697,SPECIMEN LATERALITY
4896,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4897,llama4,0.797,HISTOLOGIC GRADE
4898,llama4,0.72,NODAL SITE(S) EXAMINED
4899,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4900,llama4,0.763,MARGIN STATUS FOR INVASIVE CARCINOMA
4901,llama4,0.811,TUMOR FOCALITY
4902,llama4,0.681,TUMOR SITE
4903,llama4,0.827,PROCEDURE
4904,llama4,0.898,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4905,llama4,0.778,VISCERAL PLEURA INVASION
4906,llama4,0.805,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4907,llama4,0.697,NUMBER OF LYMPH NODES EXAMINED
4908,llama4,0.721,ADDITIONAL FINDINGS
4909,llama4,0.718,SPREAD THROUGH AIR SPACES (STAS)
4910,llama4,0.832,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4911,llama4,0.778,VISCERAL PLEURA INVASION
4912,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4913,llama4,0.742,ADDITIONAL FINDINGS
4914,llama4,0.877,REGIONAL LYMPH NODE STATUS
4915,llama4,0.904,HISTOLOGIC GRADE
4916,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4917,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
4918,llama4,0.723,TUMOR SITE
4919,llama4,0.866,PROCEDURE
4920,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4921,llama4,0.697,SPECIMEN LATERALITY
4922,llama4,0.729,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4923,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4924,llama4,0.727,NODAL SITE(S) EXAMINED
4925,llama4,0.811,TUMOR FOCALITY
4926,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4927,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
4928,llama4,0.698,VISCERAL PLEURA INVASION
4929,llama4,0.717,ADDITIONAL FINDINGS
4930,llama4,0.698,SPECIMEN LATERALITY
4931,llama4,0.817,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4932,llama4,0.797,HISTOLOGIC GRADE
4933,llama4,0.877,REGIONAL LYMPH NODE STATUS
4934,llama4,0.867,NODAL SITE(S) EXAMINED
4935,llama4,0.893,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4936,llama4,0.713,NUMBER OF LYMPH NODES EXAMINED
4937,llama4,0.827,PROCEDURE
4938,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4939,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4940,llama4,0.811,TUMOR FOCALITY
4941,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4942,llama4,0.89,TUMOR SITE
4943,llama4,0.89,TUMOR SITE
4944,llama4,0.877,REGIONAL LYMPH NODE STATUS
4945,llama4,0.811,TUMOR FOCALITY
4946,llama4,0.779,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4947,llama4,0.698,SPECIMEN LATERALITY
4948,llama4,0.741,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4949,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4950,llama4,0.788,PROCEDURE
4951,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
4952,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4953,llama4,0.73,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4954,llama4,0.778,HISTOLOGIC GRADE
4955,llama4,0.785,NODAL SITE(S) EXAMINED
4956,llama4,0.7,VISCERAL PLEURA INVASION
4957,llama4,0.774,ADDITIONAL FINDINGS
4958,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4959,llama4,0.725,MARGIN STATUS FOR INVASIVE CARCINOMA
4960,llama4,0.733,NODAL SITE(S) EXAMINED
4961,llama4,0.634,ADDITIONAL FINDINGS
4962,llama4,0.697,SPECIMEN LATERALITY
4963,llama4,0.778,VISCERAL PLEURA INVASION
4964,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4965,llama4,0.877,REGIONAL LYMPH NODE STATUS
4966,llama4,0.699,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4967,llama4,0.788,PROCEDURE
4968,llama4,0.797,HISTOLOGIC GRADE
4969,llama4,0.798,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4970,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
4971,llama4,0.67,TUMOR FOCALITY
4972,llama4,0.792,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4973,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4974,llama4,0.89,TUMOR SITE
4975,llama4,0.827,PROCEDURE
4976,llama4,0.778,VISCERAL PLEURA INVASION
4977,llama4,0.89,TUMOR SITE
4978,llama4,0.785,NODAL SITE(S) EXAMINED
4979,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4980,llama4,0.797,HISTOLOGIC GRADE
4981,llama4,0.78,SPREAD THROUGH AIR SPACES (STAS)
4982,llama4,0.78,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4983,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4984,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4985,llama4,0.877,REGIONAL LYMPH NODE STATUS
4986,llama4,0.811,TUMOR FOCALITY
4987,llama4,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4988,llama4,0.713,NUMBER OF LYMPH NODES EXAMINED
4989,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4990,llama4,0.698,SPECIMEN LATERALITY
4991,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4992,llama4,0.697,SPECIMEN LATERALITY
4993,llama4,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4994,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4995,llama4,0.877,REGIONAL LYMPH NODE STATUS
4996,llama4,0.89,TUMOR SITE
4997,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4998,llama4,0.739,PROCEDURE
4999,llama4,0.698,VISCERAL PLEURA INVASION
5000,llama4,0.811,TUMOR FOCALITY
5001,llama4,0.837,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5002,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5003,llama4,0.698,NUMBER OF LYMPH NODES EXAMINED
5004,llama4,0.808,NODAL SITE(S) EXAMINED
5005,llama4,0.797,HISTOLOGIC GRADE
5006,llama4,0.671,ADDITIONAL FINDINGS
5007,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
5008,llama4,0.778,HISTOLOGIC GRADE
5009,llama4,0.692,LYMPHOVASCULAR INVASION
5010,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5011,llama4,0.786,REGIONAL LYMPH NODE STATUS
5012,llama4,0.726,NUMBER OF LYMPH NODES WITH TUMOR
5013,llama4,0.81,NODAL SITE(S) EXAMINED
5014,llama4,0.811,TUMOR FOCALITY
5015,llama4,0.72,NUMBER OF LYMPH NODES WITH TUMOR
5016,llama4,0.697,SPECIMEN LATERALITY
5017,llama4,0.926,NODAL SITE(S) WITH TUMOR
5018,llama4,0.89,TUMOR SITE
5019,llama4,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5020,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5021,llama4,0.768,NODAL SITE(S) WITH TUMOR
5022,llama4,0.778,VISCERAL PLEURA INVASION
5023,llama4,0.772,MARGIN STATUS FOR INVASIVE CARCINOMA
5024,llama4,0.762,PROCEDURE
5025,llama4,0.698,NUMBER OF LYMPH NODES EXAMINED
5026,llama4,0.847,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5027,llama4,0.743,MARGIN STATUS FOR NON-INVASIVE TUMOR
5028,llama4,0.835,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5029,llama4,0.693,NUMBER OF LYMPH NODES EXAMINED
5030,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5031,llama4,0.735,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5032,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5033,llama4,0.778,VISCERAL PLEURA INVASION
5034,llama4,0.824,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5035,llama4,0.703,ADDITIONAL FINDINGS
5036,llama4,0.811,TUMOR FOCALITY
5037,llama4,0.708,PROCEDURE
5038,llama4,0.827,NODAL SITE(S) EXAMINED
5039,llama4,0.877,REGIONAL LYMPH NODE STATUS
5040,llama4,0.865,TUMOR SITE
5041,llama4,0.797,HISTOLOGIC GRADE
5042,llama4,0.697,SPECIMEN LATERALITY
5043,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5044,llama4,0.758,MARGIN STATUS FOR INVASIVE CARCINOMA
5045,llama4,0.776,PROCEDURE
5046,llama4,0.904,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5047,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5048,llama4,0.874,REGIONAL LYMPH NODE STATUS
5049,llama4,0.869,TUMOR SITE
5050,llama4,0.706,ADDITIONAL FINDINGS
5051,llama4,0.692,SPREAD THROUGH AIR SPACES (STAS)
5052,llama4,0.811,TUMOR FOCALITY
5053,llama4,0.778,VISCERAL PLEURA INVASION
5054,llama4,0.778,HISTOLOGIC GRADE
5055,llama4,0.734,NODAL SITE(S) EXAMINED
5056,llama4,0.83,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5057,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5058,llama4,0.798,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5059,llama4,0.697,SPECIMEN LATERALITY
5060,llama4,0.697,SPECIMEN LATERALITY
5061,llama4,0.826,NODAL SITE(S) EXAMINED
5062,llama4,0.778,VISCERAL PLEURA INVASION
5063,llama4,0.793,NUMBER OF LYMPH NODES EXAMINED
5064,llama4,0.774,PROCEDURE
5065,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5066,llama4,0.838,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5067,llama4,0.67,TUMOR FOCALITY
5068,llama4,0.893,TUMOR SITE
5069,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5070,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5071,llama4,0.706,HISTOLOGIC GRADE
5072,llama4,0.877,REGIONAL LYMPH NODE STATUS
5073,llama4,0.735,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5074,llama4,0.757,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5075,llama4,0.704,ADDITIONAL FINDINGS
5076,llama4,0.877,REGIONAL LYMPH NODE STATUS
5077,llama4,0.825,NODAL SITE(S) EXAMINED
5078,llama4,0.797,HISTOLOGIC GRADE
5079,llama4,0.811,TUMOR FOCALITY
5080,llama4,0.737,MARGIN STATUS FOR INVASIVE CARCINOMA
5081,llama4,0.833,TUMOR SITE
5082,llama4,0.743,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5083,llama4,0.705,ADDITIONAL FINDINGS
5084,llama4,0.739,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5085,llama4,0.76,PROCEDURE
5086,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5087,llama4,0.78,SPREAD THROUGH AIR SPACES (STAS)
5088,llama4,0.778,VISCERAL PLEURA INVASION
5089,llama4,0.698,SPECIMEN LATERALITY
5090,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5091,llama4,0.821,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5092,llama4,0.776,REGIONAL LYMPH NODE STATUS
5093,llama4,0.811,TUMOR FOCALITY
5094,llama4,0.754,MARGIN STATUS FOR INVASIVE CARCINOMA
5095,llama4,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5096,llama4,0.703,ADDITIONAL FINDINGS
5097,llama4,0.668,NODAL SITE(S) WITH TUMOR
5098,llama4,0.718,SPREAD THROUGH AIR SPACES (STAS)
5099,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5100,llama4,0.698,SPECIMEN LATERALITY
5101,llama4,0.698,VISCERAL PLEURA INVASION
5102,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5103,llama4,0.692,LYMPHOVASCULAR INVASION
5104,llama4,0.754,NODAL SITE(S) EXAMINED
5105,llama4,0.713,NUMBER OF LYMPH NODES WITH TUMOR
5106,llama4,0.89,TUMOR SITE
5107,llama4,0.755,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5108,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5109,llama4,0.778,HISTOLOGIC GRADE
5110,llama4,0.766,NUMBER OF LYMPH NODES EXAMINED
5111,llama4,0.752,PROCEDURE
5112,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5113,llama4,0.838,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5114,llama4,0.778,VISCERAL PLEURA INVASION
5115,llama4,0.697,NUMBER OF LYMPH NODES EXAMINED
5116,llama4,0.847,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5117,llama4,0.811,TUMOR FOCALITY
5118,llama4,0.779,PROCEDURE
5119,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
5120,llama4,0.706,HISTOLOGIC GRADE
5121,llama4,0.743,NODAL SITE(S) EXAMINED
5122,llama4,0.692,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5123,llama4,0.877,REGIONAL LYMPH NODE STATUS
5124,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5125,llama4,0.698,SPECIMEN LATERALITY
5126,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5127,llama4,0.89,TUMOR SITE
5128,llama4,0.777,NODAL SITE(S) EXAMINED
5129,llama4,0.786,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5130,llama4,0.877,REGIONAL LYMPH NODE STATUS
5131,llama4,0.819,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5132,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5133,llama4,0.89,TUMOR SITE
5134,llama4,0.826,MARGIN STATUS FOR NON-INVASIVE TUMOR
5135,llama4,0.811,TUMOR FOCALITY
5136,llama4,0.788,PROCEDURE
5137,llama4,0.707,NUMBER OF LYMPH NODES EXAMINED
5138,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5139,llama4,0.697,SPECIMEN LATERALITY
5140,llama4,0.797,HISTOLOGIC GRADE
5141,llama4,0.778,VISCERAL PLEURA INVASION
5142,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5143,llama4,0.902,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5144,llama4,0.877,REGIONAL LYMPH NODE STATUS
5145,llama4,0.724,NODAL SITE(S) EXAMINED
5146,llama4,0.811,TUMOR FOCALITY
5147,llama4,0.777,PROCEDURE
5148,llama4,0.693,NUMBER OF LYMPH NODES EXAMINED
5149,llama4,0.734,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5150,llama4,0.697,SPECIMEN LATERALITY
5151,llama4,0.701,TUMOR SITE
5152,llama4,0.797,HISTOLOGIC GRADE
5153,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5154,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5155,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5156,llama4,0.778,VISCERAL PLEURA INVASION
5157,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5158,llama4,0.797,HISTOLOGIC GRADE
5159,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5160,llama4,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
5161,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5162,llama4,0.7,NUMBER OF LYMPH NODES EXAMINED
5163,llama4,0.829,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5164,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5165,llama4,0.716,NODAL SITE(S) EXAMINED
5166,llama4,0.697,SPECIMEN LATERALITY
5167,llama4,0.877,REGIONAL LYMPH NODE STATUS
5168,llama4,0.89,TUMOR SITE
5169,llama4,0.827,PROCEDURE
5170,llama4,0.811,TUMOR FOCALITY
5171,llama4,0.825,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5172,llama4,0.778,VISCERAL PLEURA INVASION
5173,llama4,0.671,VISCERAL PLEURA INVASION
5174,llama4,0.772,TUMOR SITE
5175,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5176,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5177,llama4,0.804,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5178,llama4,0.739,PROCEDURE
5179,llama4,0.792,REGIONAL LYMPH NODE STATUS
5180,llama4,0.886,NODAL SITE(S) WITH TUMOR
5181,llama4,0.797,HISTOLOGIC GRADE
5182,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5183,llama4,0.697,SPECIMEN LATERALITY
5184,llama4,0.817,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5185,llama4,0.645,TNM DESCRIPTORS
5186,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5187,llama4,0.733,NODAL SITE(S) EXAMINED
5188,llama4,0.703,NUMBER OF LYMPH NODES EXAMINED
5189,llama4,0.72,NUMBER OF LYMPH NODES WITH TUMOR
5190,llama4,0.735,TUMOR FOCALITY
5191,llama4,0.691,NUMBER OF LYMPH NODES EXAMINED
5192,llama4,0.835,NODAL SITE(S) EXAMINED
5193,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5194,llama4,0.898,TUMOR FOCALITY
5195,llama4,0.877,REGIONAL LYMPH NODE STATUS
5196,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5197,llama4,0.772,PROCEDURE
5198,llama4,0.791,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5199,llama4,0.669,HISTOLOGIC GRADE
5200,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5201,llama4,0.778,VISCERAL PLEURA INVASION
5202,llama4,0.89,TUMOR SITE
5203,llama4,0.697,SPECIMEN LATERALITY
5204,llama4,0.798,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5205,llama4,0.717,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5206,llama4,0.801,TUMOR SITE
5207,llama4,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5208,llama4,0.738,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5209,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5210,llama4,0.797,HISTOLOGIC GRADE
5211,llama4,0.699,NUMBER OF LYMPH NODES EXAMINED
5212,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5213,llama4,0.786,REGIONAL LYMPH NODE STATUS
5214,llama4,0.768,NODAL SITE(S) WITH TUMOR
5215,llama4,0.698,SPECIMEN LATERALITY
5216,llama4,0.705,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5217,llama4,0.713,NUMBER OF LYMPH NODES WITH TUMOR
5218,llama4,0.745,LYMPHOVASCULAR INVASION
5219,llama4,0.788,PROCEDURE
5220,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5221,llama4,0.811,TUMOR FOCALITY
5222,llama4,0.778,VISCERAL PLEURA INVASION
5223,llama4,0.675,NODAL SITE(S) EXAMINED
5224,llama4,0.774,ADDITIONAL FINDINGS
5225,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5226,llama4,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5227,llama4,0.811,TUMOR FOCALITY
5228,llama4,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5229,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5230,llama4,0.89,TUMOR SITE
5231,llama4,0.778,VISCERAL PLEURA INVASION
5232,llama4,0.877,REGIONAL LYMPH NODE STATUS
5233,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
5234,llama4,0.76,PROCEDURE
5235,llama4,0.69,NUMBER OF LYMPH NODES EXAMINED
5236,llama4,0.825,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5237,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5238,llama4,0.815,NODAL SITE(S) EXAMINED
5239,llama4,0.697,SPECIMEN LATERALITY
5240,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5241,llama4,0.835,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5242,llama4,0.775,PROCEDURE
5243,llama4,0.67,TUMOR FOCALITY
5244,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5245,llama4,0.686,NODAL SITE(S) EXAMINED
5246,llama4,0.702,NUMBER OF LYMPH NODES EXAMINED
5247,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
5248,llama4,0.8,HISTOLOGIC GRADE
5249,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5250,llama4,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5251,llama4,0.698,SPECIMEN LATERALITY
5252,llama4,0.877,REGIONAL LYMPH NODE STATUS
5253,llama4,0.89,TUMOR SITE
5254,llama4,0.778,VISCERAL PLEURA INVASION
5255,llama4,0.813,ADDITIONAL FINDINGS
5256,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5257,llama4,0.698,SPECIMEN LATERALITY
5258,llama4,0.713,NUMBER OF LYMPH NODES EXAMINED
5259,llama4,0.716,ADDITIONAL FINDINGS
5260,llama4,0.819,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5261,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5262,llama4,0.673,TUMOR SITE
5263,llama4,0.827,PROCEDURE
5264,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5265,llama4,0.691,NODAL SITE(S) EXAMINED
5266,llama4,0.811,TUMOR FOCALITY
5267,llama4,0.78,VISCERAL PLEURA INVASION
5268,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5269,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
5270,llama4,0.836,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5271,llama4,0.877,REGIONAL LYMPH NODE STATUS
5272,llama4,0.75,HISTOLOGIC GRADE
5273,llama4,0.736,PROCEDURE
5274,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5275,llama4,0.697,SPECIMEN LATERALITY
5276,llama4,0.699,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5277,llama4,0.758,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5278,llama4,0.89,TUMOR SITE
5279,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5280,llama4,0.681,LYMPHOVASCULAR INVASION
5281,llama4,0.824,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5282,llama4,0.811,TUMOR FOCALITY
5283,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5284,llama4,0.812,NODAL SITE(S) EXAMINED
5285,llama4,0.797,HISTOLOGIC GRADE
5286,llama4,0.877,REGIONAL LYMPH NODE STATUS
5287,llama4,0.65,ADDITIONAL FINDINGS
5288,llama4,0.78,VISCERAL PLEURA INVASION
5289,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
5290,llama4,0.797,HISTOLOGIC GRADE
5291,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5292,llama4,0.855,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5293,llama4,0.727,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5294,llama4,0.737,NODAL SITE(S) EXAMINED
5295,llama4,0.701,NUMBER OF LYMPH NODES EXAMINED
5296,llama4,0.877,REGIONAL LYMPH NODE STATUS
5297,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5298,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5299,llama4,0.721,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5300,llama4,0.747,PROCEDURE
5301,llama4,0.681,TUMOR SITE
5302,llama4,0.697,SPECIMEN LATERALITY
5303,llama4,0.78,VISCERAL PLEURA INVASION
5304,llama4,0.811,TUMOR FOCALITY
5305,llama4,0.797,HISTOLOGIC GRADE
5306,llama4,0.699,NUMBER OF LYMPH NODES EXAMINED
5307,llama4,0.699,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5308,llama4,0.86,NODAL SITE(S) WITH TUMOR
5309,llama4,0.805,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5310,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5311,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5312,llama4,0.793,REGIONAL LYMPH NODE STATUS
5313,llama4,0.749,PROCEDURE
5314,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5315,llama4,0.811,TUMOR FOCALITY
5316,llama4,0.833,TUMOR SITE
5317,llama4,0.715,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5318,llama4,0.698,SPECIMEN LATERALITY
5319,llama4,0.756,NODAL SITE(S) EXAMINED
5320,llama4,0.72,NUMBER OF LYMPH NODES WITH TUMOR
5321,llama4,0.698,VISCERAL PLEURA INVASION
5322,llama4,0.811,TUMOR FOCALITY
5323,llama4,0.877,REGIONAL LYMPH NODE STATUS
5324,llama4,0.697,SPECIMEN LATERALITY
5325,llama4,0.788,PROCEDURE
5326,llama4,0.696,NUMBER OF LYMPH NODES EXAMINED
5327,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5328,llama4,0.797,HISTOLOGIC GRADE
5329,llama4,0.738,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5330,llama4,0.778,VISCERAL PLEURA INVASION
5331,llama4,0.747,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5332,llama4,0.897,NODAL SITE(S) EXAMINED
5333,llama4,0.787,TUMOR SITE
5334,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5335,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5336,llama4,0.735,NODAL SITE(S) EXAMINED
5337,llama4,0.89,TUMOR SITE
5338,llama4,0.802,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5339,llama4,0.807,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5340,llama4,0.697,SPECIMEN LATERALITY
5341,llama4,0.683,TUMOR FOCALITY
5342,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
5343,llama4,0.693,HISTOLOGIC GRADE
5344,llama4,0.798,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5345,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5346,llama4,0.888,MARGIN STATUS FOR NON-INVASIVE TUMOR
5347,llama4,0.751,PROCEDURE
5348,llama4,0.778,VISCERAL PLEURA INVASION
5349,llama4,0.877,REGIONAL LYMPH NODE STATUS
5350,llama4,0.715,ADDITIONAL FINDINGS
5351,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5352,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5353,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5354,llama4,0.811,TUMOR FOCALITY
5355,llama4,0.798,TUMOR SITE
5356,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5357,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5358,llama4,0.774,ADDITIONAL FINDINGS
5359,llama4,0.778,VISCERAL PLEURA INVASION
5360,llama4,0.697,SPECIMEN LATERALITY
5361,llama4,0.835,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5362,llama4,0.827,PROCEDURE
5363,llama4,0.735,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5364,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
5365,llama4,0.81,TUMOR SITE
5366,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5367,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5368,llama4,0.798,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5369,llama4,0.797,HISTOLOGIC GRADE
5370,llama4,0.877,REGIONAL LYMPH NODE STATUS
5371,llama4,0.788,PROCEDURE
5372,llama4,0.719,NODAL SITE(S) EXAMINED
5373,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5374,llama4,0.811,TUMOR FOCALITY
5375,llama4,0.745,MARGIN STATUS FOR INVASIVE CARCINOMA
5376,llama4,0.718,VISCERAL PLEURA INVASION
5377,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
5378,llama4,0.697,SPECIMEN LATERALITY
5379,llama4,0.83,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5380,llama4,0.8,HISTOLOGIC GRADE
5381,llama4,0.77,ADDITIONAL FINDINGS
5382,llama4,0.874,REGIONAL LYMPH NODE STATUS
5383,llama4,0.88,LYMPH NODE(S) FROM PRIOR PROCEDURES
5384,llama4,0.772,MARGIN STATUS FOR INVASIVE CARCINOMA
5385,llama4,0.673,TUMOR FOCALITY
5386,llama4,0.847,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5387,llama4,0.703,NUMBER OF LYMPH NODES EXAMINED
5388,llama4,0.849,NODAL SITE(S) EXAMINED
5389,llama4,0.778,VISCERAL PLEURA INVASION
5390,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
5391,llama4,0.743,PROCEDURE
5392,llama4,0.698,SPECIMEN LATERALITY
5393,llama4,0.801,TUMOR SITE
5394,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5395,llama4,0.648,TNM DESCRIPTORS
5396,llama4,0.763,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5397,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5398,llama4,0.874,REGIONAL LYMPH NODE STATUS
5399,llama4,0.778,VISCERAL PLEURA INVASION
5400,llama4,0.697,SPECIMEN LATERALITY
5401,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5402,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5403,llama4,0.778,HISTOLOGIC GRADE
5404,llama4,0.767,LYMPHOVASCULAR INVASION
5405,llama4,0.724,NODAL SITE(S) EXAMINED
5406,llama4,0.732,ADDITIONAL FINDINGS
5407,llama4,0.828,TUMOR SITE
5408,llama4,0.788,PROCEDURE
5409,llama4,0.718,SPREAD THROUGH AIR SPACES (STAS)
5410,llama4,0.755,MARGIN STATUS FOR INVASIVE CARCINOMA
5411,llama4,0.811,TUMOR FOCALITY
5412,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5413,llama4,0.717,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5414,llama4,0.899,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5415,llama4,0.87,MARGIN STATUS FOR NON-INVASIVE TUMOR
5416,llama4,0.839,PROCEDURE
5417,llama4,0.708,TUMOR FOCALITY
5418,llama4,0.713,NUMBER OF LYMPH NODES WITH TUMOR
5419,llama4,0.648,TNM DESCRIPTORS
5420,llama4,0.72,NODAL SITE(S) WITH TUMOR
5421,llama4,0.698,LYMPHOVASCULAR INVASION
5422,llama4,0.729,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5423,llama4,0.679,TUMOR SITE
5424,llama4,0.697,SPECIMEN LATERALITY
5425,llama4,0.839,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5426,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5427,llama4,0.778,VISCERAL PLEURA INVASION
5428,llama4,0.753,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5429,llama4,0.778,HISTOLOGIC GRADE
5430,llama4,0.637,ADDITIONAL FINDINGS
5431,llama4,0.856,NODAL SITE(S) EXAMINED
5432,llama4,0.787,REGIONAL LYMPH NODE STATUS
5433,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5434,llama4,0.798,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5435,llama4,0.697,SPECIMEN LATERALITY
5436,llama4,0.692,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5437,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5438,llama4,0.841,PROCEDURE
5439,llama4,0.811,TUMOR FOCALITY
5440,llama4,0.778,VISCERAL PLEURA INVASION
5441,llama4,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
5442,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5443,llama4,0.8,NUMBER OF LYMPH NODES EXAMINED
5444,llama4,0.877,REGIONAL LYMPH NODE STATUS
5445,llama4,0.748,NODAL SITE(S) EXAMINED
5446,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
5447,llama4,0.798,TUMOR SITE
5448,llama4,0.729,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5449,llama4,0.704,HISTOLOGIC GRADE
5450,llama4,0.778,HISTOLOGIC GRADE
5451,llama4,0.721,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5452,llama4,0.745,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5453,llama4,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5454,llama4,0.877,REGIONAL LYMPH NODE STATUS
5455,llama4,0.78,VISCERAL PLEURA INVASION
5456,llama4,0.688,NUMBER OF LYMPH NODES EXAMINED
5457,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5458,llama4,0.811,TUMOR FOCALITY
5459,llama4,0.74,NODAL SITE(S) EXAMINED
5460,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5461,llama4,0.763,PROCEDURE
5462,llama4,0.89,TUMOR SITE
5463,llama4,0.697,SPECIMEN LATERALITY
5464,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5465,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5466,llama4,0.756,PROCEDURE
5467,llama4,0.73,NODAL SITE(S) WITH TUMOR
5468,llama4,0.811,TUMOR FOCALITY
5469,llama4,0.853,NODAL SITE(S) EXAMINED
5470,llama4,0.793,REGIONAL LYMPH NODE STATUS
5471,llama4,0.893,TUMOR SITE
5472,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5473,llama4,0.697,SPECIMEN LATERALITY
5474,llama4,0.838,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5475,llama4,0.778,VISCERAL PLEURA INVASION
5476,llama4,0.705,NUMBER OF LYMPH NODES WITH TUMOR
5477,llama4,0.797,HISTOLOGIC GRADE
5478,llama4,0.855,MARGIN STATUS FOR INVASIVE CARCINOMA
5479,llama4,0.675,TNM DESCRIPTORS
5480,llama4,0.811,TUMOR FOCALITY
5481,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5482,llama4,0.892,NODAL SITE(S) WITH TUMOR
5483,llama4,0.824,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5484,llama4,0.745,LYMPHOVASCULAR INVASION
5485,llama4,0.776,NODAL SITE(S) EXAMINED
5486,llama4,0.705,NUMBER OF LYMPH NODES EXAMINED
5487,llama4,0.89,TUMOR SITE
5488,llama4,0.856,REGIONAL LYMPH NODE STATUS
5489,llama4,0.654,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5490,llama4,0.767,MARGIN STATUS FOR INVASIVE CARCINOMA
5491,llama4,0.778,HISTOLOGIC GRADE
5492,llama4,0.778,VISCERAL PLEURA INVASION
5493,llama4,0.784,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5494,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5495,llama4,0.801,PROCEDURE
5496,llama4,0.65,TNM DESCRIPTORS
5497,llama4,0.713,NUMBER OF LYMPH NODES WITH TUMOR
5498,llama4,0.827,PROCEDURE
5499,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5500,llama4,0.697,SPECIMEN LATERALITY
5501,llama4,0.811,TUMOR FOCALITY
5502,llama4,0.877,REGIONAL LYMPH NODE STATUS
5503,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5504,llama4,0.681,TUMOR SITE
5505,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5506,llama4,0.847,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5507,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5508,llama4,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5509,llama4,0.797,HISTOLOGIC GRADE
5510,llama4,0.694,NODAL SITE(S) EXAMINED
5511,llama4,0.778,VISCERAL PLEURA INVASION
5512,llama4,0.877,REGIONAL LYMPH NODE STATUS
5513,llama4,0.74,TNM DESCRIPTORS
5514,llama4,0.705,TUMOR FOCALITY
5515,llama4,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
5516,llama4,0.736,SPREAD THROUGH AIR SPACES (STAS)
5517,llama4,0.832,TUMOR SITE
5518,llama4,0.745,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5519,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5520,llama4,0.716,NODAL SITE(S) EXAMINED
5521,llama4,0.705,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5522,llama4,0.778,VISCERAL PLEURA INVASION
5523,llama4,0.675,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5524,llama4,0.664,LYMPH NODE(S) FROM PRIOR PROCEDURES
5525,llama4,0.698,SPECIMEN LATERALITY
5526,llama4,0.78,PROCEDURE
5527,llama4,0.856,REGIONAL LYMPH NODE STATUS
5528,llama4,0.697,SPECIMEN LATERALITY
5529,llama4,0.745,PROCEDURE
5530,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5531,llama4,0.854,NODAL SITE(S) WITH TUMOR
5532,llama4,0.802,NODAL SITE(S) EXAMINED
5533,llama4,0.855,MARGIN STATUS FOR INVASIVE CARCINOMA
5534,llama4,0.856,TUMOR SITE
5535,llama4,0.911,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5536,llama4,0.811,TUMOR FOCALITY
5537,llama4,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
5538,llama4,0.778,VISCERAL PLEURA INVASION
5539,llama4,0.89,TUMOR SITE
5540,llama4,0.792,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5541,llama4,0.797,HISTOLOGIC GRADE
5542,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5543,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5544,llama4,0.877,REGIONAL LYMPH NODE STATUS
5545,llama4,0.826,MARGIN STATUS FOR NON-INVASIVE TUMOR
5546,llama4,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5547,llama4,0.764,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5548,llama4,0.697,SPECIMEN LATERALITY
5549,llama4,0.729,NODAL SITE(S) EXAMINED
5550,llama4,0.778,VISCERAL PLEURA INVASION
5551,llama4,0.744,PROCEDURE
5552,llama4,0.9,TUMOR FOCALITY
5553,llama4,0.668,TNM DESCRIPTORS
5554,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5555,llama4,0.695,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5556,llama4,0.778,HISTOLOGIC GRADE
5557,llama4,0.811,TUMOR FOCALITY
5558,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5559,llama4,0.72,PROCEDURE
5560,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5561,llama4,0.697,SPECIMEN LATERALITY
5562,llama4,0.908,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5563,llama4,0.778,VISCERAL PLEURA INVASION
5564,llama4,0.713,NUMBER OF LYMPH NODES EXAMINED
5565,llama4,0.827,NODAL SITE(S) EXAMINED
5566,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5567,llama4,0.877,REGIONAL LYMPH NODE STATUS
5568,llama4,0.798,TUMOR SITE
5569,llama4,0.797,HISTOLOGIC GRADE
5570,llama4,0.738,PROCEDURE
5571,llama4,0.811,TUMOR FOCALITY
5572,llama4,0.763,NODAL SITE(S) EXAMINED
5573,llama4,0.778,VISCERAL PLEURA INVASION
5574,llama4,0.89,TUMOR SITE
5575,llama4,0.907,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5576,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5577,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5578,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5579,llama4,0.713,NUMBER OF LYMPH NODES EXAMINED
5580,llama4,0.755,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5581,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5582,llama4,0.877,REGIONAL LYMPH NODE STATUS
5583,llama4,0.698,SPECIMEN LATERALITY
5584,llama4,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5585,llama4,0.697,SPECIMEN LATERALITY
5586,llama4,0.877,REGIONAL LYMPH NODE STATUS
5587,llama4,0.698,VISCERAL PLEURA INVASION
5588,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5589,llama4,0.718,LYMPH NODE(S) FROM PRIOR PROCEDURES
5590,llama4,0.811,TUMOR FOCALITY
5591,llama4,0.675,TUMOR SITE
5592,llama4,0.703,NUMBER OF LYMPH NODES EXAMINED
5593,llama4,0.771,MARGIN STATUS FOR INVASIVE CARCINOMA
5594,llama4,0.746,PROCEDURE
5595,llama4,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5596,llama4,0.827,NODAL SITE(S) EXAMINED
5597,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5598,llama4,0.72,PROCEDURE
5599,llama4,0.697,SPECIMEN LATERALITY
5600,llama4,0.787,TUMOR SITE
5601,llama4,0.855,MARGIN STATUS FOR INVASIVE CARCINOMA
5602,llama4,0.877,REGIONAL LYMPH NODE STATUS
5603,llama4,0.811,TUMOR FOCALITY
5604,llama4,0.656,NUMBER OF LYMPH NODES EXAMINED
5605,llama4,0.778,HISTOLOGIC GRADE
5606,llama4,0.718,SPREAD THROUGH AIR SPACES (STAS)
5607,llama4,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5608,llama4,0.698,NODAL SITE(S) EXAMINED
5609,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5610,llama4,0.778,VISCERAL PLEURA INVASION
5611,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5612,llama4,0.692,NUMBER OF LYMPH NODES EXAMINED
5613,llama4,0.697,SPECIMEN LATERALITY
5614,llama4,0.743,PROCEDURE
5615,llama4,0.728,TNM DESCRIPTORS
5616,llama4,0.697,NODAL SITE(S) EXAMINED
5617,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5618,llama4,0.699,MARGIN STATUS FOR INVASIVE CARCINOMA
5619,llama4,0.778,HISTOLOGIC GRADE
5620,llama4,0.877,REGIONAL LYMPH NODE STATUS
5621,llama4,0.78,VISCERAL PLEURA INVASION
5622,llama4,0.707,MARGIN STATUS FOR NON-INVASIVE TUMOR
5623,llama4,0.825,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5624,llama4,0.811,TUMOR FOCALITY
5625,llama4,0.89,TUMOR SITE
5626,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5627,llama4,0.778,VISCERAL PLEURA INVASION
5628,llama4,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5629,llama4,0.649,NODAL SITE(S) EXAMINED
5630,llama4,0.801,TUMOR SITE
5631,llama4,0.741,PROCEDURE
5632,llama4,0.877,REGIONAL LYMPH NODE STATUS
5633,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5634,llama4,0.7,NUMBER OF LYMPH NODES EXAMINED
5635,llama4,0.778,HISTOLOGIC GRADE
5636,llama4,0.698,SPECIMEN LATERALITY
5637,llama4,0.811,TUMOR FOCALITY
5638,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5639,llama4,0.826,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5640,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5641,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5642,llama4,0.89,TUMOR SITE
5643,llama4,0.77,HISTOLOGIC GRADE
5644,llama4,0.877,REGIONAL LYMPH NODE STATUS
5645,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5646,llama4,0.806,PROCEDURE
5647,llama4,0.796,NODAL SITE(S) EXAMINED
5648,llama4,0.697,SPECIMEN LATERALITY
5649,llama4,0.817,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5650,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5651,llama4,0.811,TUMOR FOCALITY
5652,llama4,0.778,VISCERAL PLEURA INVASION
5653,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5654,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
5655,llama4,0.698,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5656,llama4,0.805,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5657,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5658,llama4,0.77,HISTOLOGIC GRADE
5659,llama4,0.877,REGIONAL LYMPH NODE STATUS
5660,llama4,0.778,VISCERAL PLEURA INVASION
5661,llama4,0.811,TUMOR FOCALITY
5662,llama4,0.699,NUMBER OF LYMPH NODES EXAMINED
5663,llama4,0.765,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5664,llama4,0.758,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5665,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5666,llama4,0.697,SPECIMEN LATERALITY
5667,llama4,0.775,PROCEDURE
5668,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5669,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
5670,llama4,0.893,TUMOR SITE
5671,llama4,0.776,NODAL SITE(S) EXAMINED
5672,llama4,0.797,HISTOLOGIC GRADE
5673,llama4,0.89,TUMOR SITE
5674,llama4,0.778,VISCERAL PLEURA INVASION
5675,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5676,llama4,0.698,SPECIMEN LATERALITY
5677,llama4,0.822,NODAL SITE(S) EXAMINED
5678,llama4,0.705,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5679,llama4,0.877,REGIONAL LYMPH NODE STATUS
5680,llama4,0.797,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5681,llama4,0.907,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5682,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5683,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5684,llama4,0.776,PROCEDURE
5685,llama4,0.747,ADDITIONAL FINDINGS
5686,llama4,0.698,SPREAD THROUGH AIR SPACES (STAS)
5687,llama4,0.811,TUMOR FOCALITY
5688,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5689,llama4,0.778,VISCERAL PLEURA INVASION
5690,llama4,0.745,LYMPHOVASCULAR INVASION
5691,llama4,0.89,TUMOR SITE
5692,llama4,0.74,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5693,llama4,0.7,NUMBER OF LYMPH NODES EXAMINED
5694,llama4,0.698,SPECIMEN LATERALITY
5695,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5696,llama4,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
5697,llama4,0.714,HISTOLOGIC GRADE
5698,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5699,llama4,0.746,NODAL SITE(S) EXAMINED
5700,llama4,0.811,TUMOR FOCALITY
5701,llama4,0.827,HISTOLOGIC GRADE
5702,llama4,0.827,PROCEDURE
5703,llama4,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5704,llama4,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
5705,llama4,0.877,REGIONAL LYMPH NODE STATUS
5706,llama4,0.735,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5707,llama4,0.714,HISTOLOGIC GRADE
5708,llama4,0.778,VISCERAL PLEURA INVASION
5709,llama4,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
5710,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5711,llama4,0.703,NODAL SITE(S) WITH TUMOR
5712,llama4,0.788,PROCEDURE
5713,llama4,0.83,NODAL SITE(S) EXAMINED
5714,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5715,llama4,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5716,llama4,0.698,LYMPHOVASCULAR INVASION
5717,llama4,0.698,SPECIMEN LATERALITY
5718,llama4,0.89,TUMOR SITE
5719,llama4,0.703,NUMBER OF LYMPH NODES WITH TUMOR
5720,llama4,0.757,REGIONAL LYMPH NODE STATUS
5721,llama4,0.782,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5722,llama4,0.811,TUMOR FOCALITY
5723,llama4,0.892,HISTOLOGIC GRADE
5724,llama4,0.707,NODAL SITE(S) EXAMINED
5725,llama4,0.716,LYMPHOVASCULAR INVASION
5726,llama4,0.721,TUMOR SITE
5727,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5728,llama4,0.697,SPECIMEN LATERALITY
5729,llama4,0.883,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5730,llama4,0.721,PROCEDURE
5731,llama4,0.811,TUMOR FOCALITY
5732,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5733,llama4,0.697,NUMBER OF LYMPH NODES EXAMINED
5734,llama4,0.778,VISCERAL PLEURA INVASION
5735,llama4,0.91,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5736,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
5737,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5738,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5739,llama4,0.863,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5740,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5741,llama4,0.693,NODAL SITE(S) EXAMINED
5742,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
5743,llama4,0.89,TUMOR SITE
5744,llama4,0.778,VISCERAL PLEURA INVASION
5745,llama4,0.811,TUMOR FOCALITY
5746,llama4,0.797,HISTOLOGIC GRADE
5747,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5748,llama4,0.735,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5749,llama4,0.877,REGIONAL LYMPH NODE STATUS
5750,llama4,0.698,SPECIMEN LATERALITY
5751,llama4,0.699,NUMBER OF LYMPH NODES EXAMINED
5752,llama4,0.689,ADDITIONAL FINDINGS
5753,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5754,llama4,0.827,PROCEDURE
5755,llama4,0.877,REGIONAL LYMPH NODE STATUS
5756,llama4,0.755,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5757,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5758,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5759,llama4,0.697,SPECIMEN LATERALITY
5760,llama4,0.91,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5761,llama4,0.778,HISTOLOGIC GRADE
5762,llama4,0.893,TUMOR SITE
5763,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5764,llama4,0.756,PROCEDURE
5765,llama4,0.778,VISCERAL PLEURA INVASION
5766,llama4,0.843,NODAL SITE(S) EXAMINED
5767,llama4,0.811,TUMOR FOCALITY
5768,llama4,0.695,NUMBER OF LYMPH NODES EXAMINED
5769,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5770,llama4,0.716,ADDITIONAL FINDINGS
5771,llama4,0.865,TUMOR SITE
5772,llama4,0.811,TUMOR FOCALITY
5773,llama4,0.698,VISCERAL PLEURA INVASION
5774,llama4,0.733,NODAL SITE(S) EXAMINED
5775,llama4,0.673,TNM DESCRIPTORS
5776,llama4,0.7,NUMBER OF LYMPH NODES EXAMINED
5777,llama4,0.816,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5778,llama4,0.877,REGIONAL LYMPH NODE STATUS
5779,llama4,0.741,PROCEDURE
5780,llama4,0.775,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5781,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5782,llama4,0.697,SPECIMEN LATERALITY
5783,llama4,0.778,HISTOLOGIC GRADE
5784,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5785,llama4,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5786,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5787,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5788,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5789,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5790,llama4,0.865,TUMOR SITE
5791,llama4,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5792,llama4,0.814,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5793,llama4,0.877,REGIONAL LYMPH NODE STATUS
5794,llama4,0.718,PROCEDURE
5795,llama4,0.811,TUMOR FOCALITY
5796,llama4,0.772,NODAL SITE(S) EXAMINED
5797,llama4,0.797,HISTOLOGIC GRADE
5798,llama4,0.741,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5799,llama4,0.78,VISCERAL PLEURA INVASION
5800,llama4,0.695,NUMBER OF LYMPH NODES EXAMINED
5801,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
5802,llama4,0.698,SPECIMEN LATERALITY
5803,llama4,0.759,NODAL SITE(S) EXAMINED
5804,llama4,0.797,HISTOLOGIC GRADE
5805,llama4,0.714,ADDITIONAL FINDINGS
5806,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5807,llama4,0.73,PROCEDURE
5808,llama4,0.837,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5809,llama4,0.89,TUMOR SITE
5810,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5811,llama4,0.877,REGIONAL LYMPH NODE STATUS
5812,llama4,0.811,TUMOR FOCALITY
5813,llama4,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5814,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5815,llama4,0.695,NUMBER OF LYMPH NODES EXAMINED
5816,llama4,0.914,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5817,llama4,0.778,VISCERAL PLEURA INVASION
5818,llama4,0.698,SPECIMEN LATERALITY
5819,llama4,0.877,REGIONAL LYMPH NODE STATUS
5820,llama4,0.811,TUMOR FOCALITY
5821,llama4,0.778,VISCERAL PLEURA INVASION
5822,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5823,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5824,llama4,0.893,TUMOR SITE
5825,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5826,llama4,0.826,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5827,llama4,0.697,SPECIMEN LATERALITY
5828,llama4,0.765,PROCEDURE
5829,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5830,llama4,0.699,NUMBER OF LYMPH NODES EXAMINED
5831,llama4,0.797,HISTOLOGIC GRADE
5832,llama4,0.709,NODAL SITE(S) EXAMINED
5833,llama4,0.903,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5834,llama4,0.811,TUMOR FOCALITY
5835,llama4,0.7,NUMBER OF LYMPH NODES EXAMINED
5836,llama4,0.78,VISCERAL PLEURA INVASION
5837,llama4,0.823,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5838,llama4,0.77,NODAL SITE(S) EXAMINED
5839,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5840,llama4,0.877,REGIONAL LYMPH NODE STATUS
5841,llama4,0.698,SPECIMEN LATERALITY
5842,llama4,0.833,TUMOR SITE
5843,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5844,llama4,0.827,PROCEDURE
5845,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5846,llama4,0.797,HISTOLOGIC GRADE
5847,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5848,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5849,llama4,0.89,TUMOR SITE
5850,llama4,0.835,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5851,llama4,0.745,PROCEDURE
5852,llama4,0.706,ADDITIONAL FINDINGS
5853,llama4,0.698,SPECIMEN LATERALITY
5854,llama4,0.8,HISTOLOGIC GRADE
5855,llama4,0.829,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5856,llama4,0.714,NODAL SITE(S) EXAMINED
5857,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5858,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5859,llama4,0.778,VISCERAL PLEURA INVASION
5860,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
5861,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5862,llama4,0.723,NUMBER OF LYMPH NODES EXAMINED
5863,llama4,0.877,REGIONAL LYMPH NODE STATUS
5864,llama4,0.811,TUMOR FOCALITY
5865,llama4,0.811,TUMOR FOCALITY
5866,llama4,0.7,NODAL SITE(S) EXAMINED
5867,llama4,0.778,VISCERAL PLEURA INVASION
5868,llama4,0.733,PROCEDURE
5869,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
5870,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5871,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5872,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5873,llama4,0.698,SPECIMEN LATERALITY
5874,llama4,0.797,HISTOLOGIC GRADE
5875,llama4,0.877,REGIONAL LYMPH NODE STATUS
5876,llama4,0.716,ADDITIONAL FINDINGS
5877,llama4,0.847,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5878,llama4,0.89,TUMOR SITE
5879,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5880,llama4,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5881,llama4,0.828,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5882,llama4,0.778,HISTOLOGIC GRADE
5883,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5884,llama4,0.758,MARGIN STATUS FOR INVASIVE CARCINOMA
5885,llama4,0.89,TUMOR SITE
5886,llama4,0.686,LYMPHOVASCULAR INVASION
5887,llama4,0.798,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5888,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5889,llama4,0.739,PROCEDURE
5890,llama4,0.811,TUMOR FOCALITY
5891,llama4,0.877,REGIONAL LYMPH NODE STATUS
5892,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5893,llama4,0.712,NODAL SITE(S) EXAMINED
5894,llama4,0.698,SPECIMEN LATERALITY
5895,llama4,0.713,NUMBER OF LYMPH NODES EXAMINED
5896,llama4,0.718,SPREAD THROUGH AIR SPACES (STAS)
5897,llama4,0.778,VISCERAL PLEURA INVASION
5898,llama4,0.877,REGIONAL LYMPH NODE STATUS
5899,llama4,0.89,TUMOR SITE
5900,llama4,0.778,VISCERAL PLEURA INVASION
5901,llama4,0.811,TUMOR FOCALITY
5902,llama4,0.691,HISTOLOGIC GRADE
5903,llama4,0.663,TNM DESCRIPTORS
5904,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5905,llama4,0.717,ADDITIONAL FINDINGS
5906,llama4,0.677,MARGIN STATUS FOR NON-INVASIVE TUMOR
5907,llama4,0.697,SPECIMEN LATERALITY
5908,llama4,0.724,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5909,llama4,0.708,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5910,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
5911,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5912,llama4,0.782,PROCEDURE
5913,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5914,llama4,0.691,NUMBER OF LYMPH NODES EXAMINED
5915,llama4,0.728,NODAL SITE(S) EXAMINED
5916,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5917,llama4,0.918,TUMOR FOCALITY
5918,llama4,0.832,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5919,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5920,llama4,0.778,VISCERAL PLEURA INVASION
5921,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5922,llama4,0.81,TUMOR SITE
5923,llama4,0.697,SPECIMEN LATERALITY
5924,llama4,0.708,PROCEDURE
5925,llama4,0.877,REGIONAL LYMPH NODE STATUS
5926,llama4,0.834,NODAL SITE(S) EXAMINED
5927,llama4,0.821,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5928,llama4,0.718,SPREAD THROUGH AIR SPACES (STAS)
5929,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5930,llama4,0.778,VISCERAL PLEURA INVASION
5931,llama4,0.811,TUMOR FOCALITY
5932,llama4,0.877,REGIONAL LYMPH NODE STATUS
5933,llama4,0.74,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5934,llama4,0.721,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5935,llama4,0.735,MARGIN STATUS FOR INVASIVE CARCINOMA
5936,llama4,0.797,PROCEDURE
5937,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5938,llama4,0.698,SPECIMEN LATERALITY
5939,llama4,0.698,NUMBER OF LYMPH NODES EXAMINED
5940,llama4,0.89,TUMOR SITE
5941,llama4,0.822,NODAL SITE(S) EXAMINED
5942,llama4,0.797,HISTOLOGIC GRADE
5943,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
5944,llama4,0.697,SPECIMEN LATERALITY
5945,llama4,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5946,llama4,0.73,NODAL SITE(S) EXAMINED
5947,llama4,0.797,HISTOLOGIC GRADE
5948,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5949,llama4,0.817,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5950,llama4,0.89,TUMOR SITE
5951,llama4,0.757,MARGIN STATUS FOR INVASIVE CARCINOMA
5952,llama4,0.885,ADDITIONAL FINDINGS
5953,llama4,0.778,VISCERAL PLEURA INVASION
5954,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5955,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5956,llama4,0.709,NUMBER OF LYMPH NODES EXAMINED
5957,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
5958,llama4,0.811,TUMOR FOCALITY
5959,llama4,0.734,PROCEDURE
5960,llama4,0.877,REGIONAL LYMPH NODE STATUS
5961,llama4,0.74,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5962,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
5963,llama4,0.698,SPECIMEN LATERALITY
5964,llama4,0.703,NUMBER OF LYMPH NODES EXAMINED
5965,llama4,0.778,VISCERAL PLEURA INVASION
5966,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5967,llama4,0.892,NODAL SITE(S) EXAMINED
5968,llama4,0.793,PROCEDURE
5969,llama4,0.778,HISTOLOGIC GRADE
5970,llama4,0.689,ADDITIONAL FINDINGS
5971,llama4,0.811,TUMOR FOCALITY
5972,llama4,0.742,TUMOR SITE
5973,llama4,0.874,REGIONAL LYMPH NODE STATUS
5974,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5975,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5976,llama4,0.835,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5977,llama4,0.698,SPECIMEN LATERALITY
5978,llama4,0.811,TUMOR FOCALITY
5979,llama4,0.877,REGIONAL LYMPH NODE STATUS
5980,llama4,0.837,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5981,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5982,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
5983,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5984,llama4,0.865,TUMOR SITE
5985,llama4,0.908,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5986,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5987,llama4,0.778,VISCERAL PLEURA INVASION
5988,llama4,0.778,HISTOLOGIC GRADE
5989,llama4,0.704,NUMBER OF LYMPH NODES EXAMINED
5990,llama4,0.788,PROCEDURE
5991,llama4,0.791,NODAL SITE(S) EXAMINED
5992,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5993,llama4,0.8,HISTOLOGIC GRADE
5994,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5995,llama4,0.811,TUMOR FOCALITY
5996,llama4,0.714,ADDITIONAL FINDINGS
5997,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5998,llama4,0.783,PROCEDURE
5999,llama4,0.813,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6000,llama4,0.904,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6001,llama4,0.877,REGIONAL LYMPH NODE STATUS
6002,llama4,0.697,SPECIMEN LATERALITY
6003,llama4,0.778,VISCERAL PLEURA INVASION
6004,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
6005,llama4,0.735,NODAL SITE(S) EXAMINED
6006,llama4,0.683,TUMOR SITE
6007,llama4,0.782,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6008,llama4,0.877,REGIONAL LYMPH NODE STATUS
6009,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
6010,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
6011,llama4,0.89,TUMOR SITE
6012,llama4,0.829,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6013,llama4,0.751,NODAL SITE(S) EXAMINED
6014,llama4,0.778,VISCERAL PLEURA INVASION
6015,llama4,0.797,HISTOLOGIC GRADE
6016,llama4,0.83,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6017,llama4,0.788,PROCEDURE
6018,llama4,0.698,SPECIMEN LATERALITY
6019,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
6020,llama4,0.721,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6021,llama4,0.811,TUMOR FOCALITY
6022,llama4,0.697,SPECIMEN LATERALITY
6023,llama4,0.712,MARGIN STATUS FOR INVASIVE CARCINOMA
6024,llama4,0.665,LYMPHOVASCULAR INVASION
6025,llama4,0.817,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6026,llama4,0.865,TUMOR SITE
6027,llama4,0.809,NODAL SITE(S) EXAMINED
6028,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
6029,llama4,0.778,HISTOLOGIC GRADE
6030,llama4,0.698,SPREAD THROUGH AIR SPACES (STAS)
6031,llama4,0.811,TUMOR FOCALITY
6032,llama4,0.72,PROCEDURE
6033,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
6034,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6035,llama4,0.71,VISCERAL PLEURA INVASION
6036,llama4,0.877,REGIONAL LYMPH NODE STATUS
6037,llama4,0.818,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6038,llama4,0.78,VISCERAL PLEURA INVASION
6039,llama4,0.82,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6040,llama4,0.778,HISTOLOGIC GRADE
6041,llama4,0.76,MARGIN STATUS FOR INVASIVE CARCINOMA
6042,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
6043,llama4,0.865,TUMOR SITE
6044,llama4,0.697,SPECIMEN LATERALITY
6045,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
6046,llama4,0.698,NUMBER OF LYMPH NODES EXAMINED
6047,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
6048,llama4,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6049,llama4,0.877,REGIONAL LYMPH NODE STATUS
6050,llama4,0.811,TUMOR FOCALITY
6051,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6052,llama4,0.748,NODAL SITE(S) EXAMINED
6053,llama4,0.788,PROCEDURE
6054,llama4,0.803,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6055,llama4,0.877,REGIONAL LYMPH NODE STATUS
6056,llama4,0.811,TUMOR FOCALITY
6057,llama4,0.698,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6058,llama4,0.778,HISTOLOGIC GRADE
6059,llama4,0.693,NUMBER OF LYMPH NODES EXAMINED
6060,llama4,0.825,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6061,llama4,0.803,PROCEDURE
6062,llama4,0.741,MARGIN STATUS FOR INVASIVE CARCINOMA
6063,llama4,0.698,SPECIMEN LATERALITY
6064,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
6065,llama4,0.737,TUMOR SITE
6066,llama4,0.777,NODAL SITE(S) EXAMINED
6067,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
6068,llama4,0.778,VISCERAL PLEURA INVASION
6069,llama4,0.89,TUMOR SITE
6070,llama4,0.75,PROCEDURE
6071,llama4,0.821,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6072,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
6073,llama4,0.877,REGIONAL LYMPH NODE STATUS
6074,llama4,0.778,VISCERAL PLEURA INVASION
6075,llama4,0.759,MARGIN STATUS FOR INVASIVE CARCINOMA
6076,llama4,0.905,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6077,llama4,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
6078,llama4,0.72,NODAL SITE(S) EXAMINED
6079,llama4,0.697,SPECIMEN LATERALITY
6080,llama4,0.832,NUMBER OF LYMPH NODES EXAMINED
6081,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6082,llama4,0.736,SPREAD THROUGH AIR SPACES (STAS)
6083,llama4,0.811,TUMOR FOCALITY
6084,llama4,0.745,LYMPHOVASCULAR INVASION
6085,llama4,0.796,NODAL SITE(S) EXAMINED
6086,llama4,0.89,TUMOR SITE
6087,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
6088,llama4,0.788,PROCEDURE
6089,llama4,0.777,REGIONAL LYMPH NODE STATUS
6090,llama4,0.811,TUMOR FOCALITY
6091,llama4,0.698,VISCERAL PLEURA INVASION
6092,llama4,0.726,NODAL SITE(S) WITH TUMOR
6093,llama4,0.702,NUMBER OF LYMPH NODES EXAMINED
6094,llama4,0.713,NUMBER OF LYMPH NODES WITH TUMOR
6095,llama4,0.835,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6096,llama4,0.771,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6097,llama4,0.697,SPECIMEN LATERALITY
6098,llama4,0.745,LYMPHOVASCULAR INVASION
6099,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
6100,llama4,0.763,MARGIN STATUS FOR INVASIVE CARCINOMA
6101,llama4,0.715,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6102,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
6103,llama4,0.811,TUMOR FOCALITY
6104,llama4,0.877,REGIONAL LYMPH NODE STATUS
6105,llama4,0.697,SPECIMEN LATERALITY
6106,llama4,0.697,NODAL SITE(S) EXAMINED
6107,llama4,0.827,PROCEDURE
6108,llama4,0.798,TUMOR SITE
6109,llama4,0.797,HISTOLOGIC GRADE
6110,llama4,0.713,NUMBER OF LYMPH NODES EXAMINED
6111,llama4,0.729,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6112,llama4,0.738,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6113,llama4,0.78,VISCERAL PLEURA INVASION
6114,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
6115,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6116,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
6117,llama4,0.877,REGIONAL LYMPH NODE STATUS
6118,llama4,0.698,SPECIMEN LATERALITY
6119,llama4,0.726,ADDITIONAL FINDINGS
6120,llama4,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
6121,llama4,0.693,MARGIN STATUS FOR INVASIVE CARCINOMA
6122,llama4,0.705,TUMOR FOCALITY
6123,llama4,0.745,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6124,llama4,0.778,VISCERAL PLEURA INVASION
6125,llama4,0.691,TNM DESCRIPTORS
6126,llama4,0.763,NODAL SITE(S) EXAMINED
6127,llama4,0.695,HISTOLOGIC GRADE
6128,llama4,0.788,PROCEDURE
6129,llama4,0.683,TUMOR SITE
6130,llama4,0.877,REGIONAL LYMPH NODE STATUS
6131,llama4,0.743,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6132,llama4,0.808,PROCEDURE
6133,llama4,0.755,NUMBER OF LYMPH NODES EXAMINED
6134,llama4,0.89,TUMOR SITE
6135,llama4,0.698,SPECIMEN LATERALITY
6136,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
6137,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
6138,llama4,0.838,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6139,llama4,0.811,TUMOR FOCALITY
6140,llama4,0.778,HISTOLOGIC GRADE
6141,llama4,0.762,MARGIN STATUS FOR INVASIVE CARCINOMA
6142,llama4,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6143,llama4,0.778,VISCERAL PLEURA INVASION
6144,llama4,0.743,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6145,llama4,0.857,NODAL SITE(S) EXAMINED
6146,llama4,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6147,llama4,0.778,HISTOLOGIC GRADE
6148,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
6149,llama4,0.877,REGIONAL LYMPH NODE STATUS
6150,llama4,0.778,SPREAD THROUGH AIR SPACES (STAS)
6151,llama4,0.732,ADDITIONAL FINDINGS
6152,llama4,0.811,TUMOR FOCALITY
6153,llama4,0.778,VISCERAL PLEURA INVASION
6154,llama4,0.788,PROCEDURE
6155,llama4,0.704,NUMBER OF LYMPH NODES EXAMINED
6156,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
6157,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
6158,llama4,0.89,TUMOR SITE
6159,llama4,0.709,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6160,llama4,0.697,SPECIMEN LATERALITY
6161,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
6162,llama4,0.788,PROCEDURE
6163,llama4,0.778,HISTOLOGIC GRADE
6164,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
6165,llama4,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6166,llama4,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6167,llama4,0.828,TUMOR SITE
6168,llama4,0.828,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6169,llama4,0.778,VISCERAL PLEURA INVASION
6170,llama4,0.877,REGIONAL LYMPH NODE STATUS
6171,llama4,0.811,TUMOR FOCALITY
6172,llama4,0.737,NODAL SITE(S) EXAMINED
6173,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
6174,llama4,0.697,SPECIMEN LATERALITY
6175,llama4,0.797,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6176,llama4,0.697,SPECIMEN LATERALITY
6177,llama4,0.87,MARGIN STATUS FOR NON-INVASIVE TUMOR
6178,llama4,0.75,REGIONAL LYMPH NODE STATUS
6179,llama4,0.724,VISCERAL PLEURA INVASION
6180,llama4,0.774,NODAL SITE(S) WITH TUMOR
6181,llama4,0.752,NUMBER OF LYMPH NODES EXAMINED
6182,llama4,0.698,LYMPHOVASCULAR INVASION
6183,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
6184,llama4,0.718,NUMBER OF LYMPH NODES WITH TUMOR
6185,llama4,0.832,TUMOR SITE
6186,llama4,0.699,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6187,llama4,0.798,PROCEDURE
6188,llama4,0.736,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6189,llama4,0.852,NODAL SITE(S) EXAMINED
6190,llama4,0.687,TUMOR FOCALITY
6191,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
6192,llama4,0.731,LYMPHOVASCULAR INVASION
6193,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
6194,llama4,0.698,NUMBER OF LYMPH NODES EXAMINED
6195,llama4,0.687,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6196,llama4,0.742,MARGIN STATUS FOR INVASIVE CARCINOMA
6197,llama4,0.739,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6198,llama4,0.695,TNM DESCRIPTORS
6199,llama4,0.775,REGIONAL LYMPH NODE STATUS
6200,llama4,0.89,TUMOR SITE
6201,llama4,0.782,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6202,llama4,0.734,ADDITIONAL FINDINGS
6203,llama4,0.831,PROCEDURE
6204,llama4,0.697,SPECIMEN LATERALITY
6205,llama4,0.811,TUMOR FOCALITY
6206,llama4,0.775,NODAL SITE(S) EXAMINED
6207,llama4,0.78,VISCERAL PLEURA INVASION
6208,llama4,0.778,HISTOLOGIC GRADE
6209,llama4,0.72,NUMBER OF LYMPH NODES WITH TUMOR
6210,llama4,0.778,VISCERAL PLEURA INVASION
6211,llama4,0.829,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6212,llama4,0.705,NUMBER OF LYMPH NODES WITH TUMOR
6213,llama4,0.817,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6214,llama4,0.893,TUMOR SITE
6215,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
6216,llama4,0.697,SPECIMEN LATERALITY
6217,llama4,0.775,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6218,llama4,0.748,PROCEDURE
6219,llama4,0.811,TUMOR FOCALITY
6220,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
6221,llama4,0.856,REGIONAL LYMPH NODE STATUS
6222,llama4,0.8,HISTOLOGIC GRADE
6223,llama4,0.882,NODAL SITE(S) WITH TUMOR
6224,llama4,0.681,LYMPHOVASCULAR INVASION
6225,llama4,0.742,MARGIN STATUS FOR INVASIVE CARCINOMA
6226,llama4,0.692,NODAL SITE(S) EXAMINED
6227,llama4,0.698,SPECIMEN LATERALITY
6228,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
6229,llama4,0.798,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6230,llama4,0.811,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6231,llama4,0.89,TUMOR SITE
6232,llama4,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
6233,llama4,0.757,PROCEDURE
6234,llama4,0.778,VISCERAL PLEURA INVASION
6235,llama4,0.766,NODAL SITE(S) EXAMINED
6236,llama4,0.734,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6237,llama4,0.877,REGIONAL LYMPH NODE STATUS
6238,llama4,0.697,SPECIMEN LATERALITY
6239,llama4,0.714,PROCEDURE
6240,llama4,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
6241,llama4,0.811,TUMOR FOCALITY
6242,llama4,0.736,SPREAD THROUGH AIR SPACES (STAS)
6243,llama4,0.778,VISCERAL PLEURA INVASION
6244,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
6245,llama4,0.831,NODAL SITE(S) EXAMINED
6246,llama4,0.877,REGIONAL LYMPH NODE STATUS
6247,llama4,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
6248,llama4,0.788,PROCEDURE
6249,llama4,0.811,TUMOR FOCALITY
6250,llama4,0.698,SPECIMEN LATERALITY
6251,llama4,0.752,NODAL SITE(S) EXAMINED
6252,llama4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
6253,llama4,0.778,VISCERAL PLEURA INVASION
6254,llama4,0.738,ADDITIONAL FINDINGS
6255,llama4,0.89,TUMOR SITE
6256,llama4,0.877,REGIONAL LYMPH NODE STATUS
6257,llama4,0.699,NUMBER OF LYMPH NODES EXAMINED
6258,llama4,0.736,SPREAD THROUGH AIR SPACES (STAS)
6259,llama4,0.695,HISTOLOGIC GRADE
6260,llama4,0.788,PROCEDURE
6261,llama4,0.778,VISCERAL PLEURA INVASION
6262,llama4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
6263,llama4,0.877,REGIONAL LYMPH NODE STATUS
6264,llama4,0.802,TUMOR SITE
6265,llama4,0.754,LYMPH NODE(S) FROM PRIOR PROCEDURES
6266,llama4,0.727,NODAL SITE(S) EXAMINED
6267,llama4,0.692,SPREAD THROUGH AIR SPACES (STAS)
6268,llama4,0.715,ADDITIONAL FINDINGS
6269,llama4,0.704,NUMBER OF LYMPH NODES EXAMINED
6270,llama4,0.752,SPECIMEN LATERALITY
6271,llama4,0.94,TUMOR FOCALITY
0,claude37,0.782,HISTOLOGIC GRADE
1,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2,claude37,0.887,TUMOR SITE
3,claude37,0.767,LYMPHOVASCULAR INVASION
4,claude37,0.696,TUMOR FOCALITY
5,claude37,0.697,SPECIMEN LATERALITY
6,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
7,claude37,0.827,PROCEDURE
8,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
9,claude37,0.925,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
10,claude37,0.78,SPREAD THROUGH AIR SPACES (STAS)
11,claude37,0.78,VISCERAL PLEURA INVASION
12,claude37,0.938,ADDITIONAL FINDINGS
13,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
14,claude37,0.821,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
15,claude37,0.76,HISTOLOGIC GRADE
16,claude37,0.855,MARGIN STATUS FOR INVASIVE CARCINOMA
17,claude37,0.698,NUMBER OF LYMPH NODES WITH TUMOR
18,claude37,0.811,TUMOR FOCALITY
19,claude37,0.735,PROCEDURE
20,claude37,0.83,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
21,claude37,0.739,NUMBER OF LYMPH NODES EXAMINED
22,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
23,claude37,0.744,NODAL SITE(S) EXAMINED
24,claude37,0.681,LYMPHOVASCULAR INVASION
25,claude37,0.747,REGIONAL LYMPH NODE STATUS
26,claude37,0.78,VISCERAL PLEURA INVASION
27,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
28,claude37,0.78,SPREAD THROUGH AIR SPACES (STAS)
29,claude37,0.698,SPECIMEN LATERALITY
30,claude37,0.803,ADDITIONAL FINDINGS
31,claude37,0.71,NODAL SITE(S) WITH TUMOR
32,claude37,0.758,TUMOR SITE
33,claude37,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
34,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
35,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
36,claude37,0.698,SPECIMEN LATERALITY
37,claude37,0.811,TUMOR FOCALITY
38,claude37,0.832,NUMBER OF LYMPH NODES EXAMINED
39,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
40,claude37,0.859,NODAL SITE(S) EXAMINED
41,claude37,0.77,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
42,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
43,claude37,0.889,NODAL SITE(S) WITH TUMOR
44,claude37,0.788,PROCEDURE
45,claude37,0.703,NUMBER OF LYMPH NODES WITH TUMOR
46,claude37,0.722,REGIONAL LYMPH NODE STATUS
47,claude37,0.698,VISCERAL PLEURA INVASION
48,claude37,0.89,TUMOR SITE
49,claude37,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
50,claude37,0.788,PROCEDURE
51,claude37,0.815,REGIONAL LYMPH NODE STATUS
52,claude37,0.811,TUMOR FOCALITY
53,claude37,0.697,SPECIMEN LATERALITY
54,claude37,0.736,HISTOLOGIC GRADE
55,claude37,0.841,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
56,claude37,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
57,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
58,claude37,0.742,NODAL SITE(S) EXAMINED
59,claude37,0.838,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
60,claude37,0.887,TUMOR SITE
61,claude37,0.745,LYMPHOVASCULAR INVASION
62,claude37,0.698,VISCERAL PLEURA INVASION
63,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
64,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
65,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
66,claude37,0.862,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
67,claude37,0.787,ADDITIONAL FINDINGS
68,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
69,claude37,0.698,VISCERAL PLEURA INVASION
70,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
71,claude37,0.815,REGIONAL LYMPH NODE STATUS
72,claude37,0.72,NODAL SITE(S) EXAMINED
73,claude37,0.89,TUMOR SITE
74,claude37,0.714,NUMBER OF LYMPH NODES EXAMINED
75,claude37,0.815,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
76,claude37,0.827,PROCEDURE
77,claude37,0.7,SPREAD THROUGH AIR SPACES (STAS)
78,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
79,claude37,0.678,TUMOR FOCALITY
80,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
81,claude37,0.826,HISTOLOGIC GRADE
82,claude37,0.697,SPECIMEN LATERALITY
83,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
84,claude37,0.838,NODAL SITE(S) EXAMINED
85,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
86,claude37,0.904,HISTOLOGIC GRADE
87,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
88,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
89,claude37,0.757,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
90,claude37,0.841,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
91,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
92,claude37,0.887,TUMOR SITE
93,claude37,0.778,VISCERAL PLEURA INVASION
94,claude37,0.815,REGIONAL LYMPH NODE STATUS
95,claude37,0.697,SPECIMEN LATERALITY
96,claude37,0.752,PROCEDURE
97,claude37,0.75,TUMOR FOCALITY
98,claude37,0.884,NODAL SITE(S) EXAMINED
99,claude37,0.888,TUMOR SITE
100,claude37,0.698,SPECIMEN LATERALITY
101,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
102,claude37,0.698,VISCERAL PLEURA INVASION
103,claude37,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
104,claude37,0.844,ADDITIONAL FINDINGS
105,claude37,0.819,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
106,claude37,0.795,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
107,claude37,0.788,PROCEDURE
108,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
109,claude37,0.811,TUMOR FOCALITY
110,claude37,0.715,REGIONAL LYMPH NODE STATUS
111,claude37,0.892,HISTOLOGIC GRADE
112,claude37,0.714,NUMBER OF LYMPH NODES EXAMINED
113,claude37,0.795,TNM DESCRIPTORS
114,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
115,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
116,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
117,claude37,0.804,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
118,claude37,0.756,NODAL SITE(S) EXAMINED
119,claude37,0.824,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
120,claude37,0.778,VISCERAL PLEURA INVASION
121,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
122,claude37,0.811,TUMOR FOCALITY
123,claude37,0.89,TUMOR SITE
124,claude37,0.815,HISTOLOGIC GRADE
125,claude37,0.698,SPECIMEN LATERALITY
126,claude37,0.827,PROCEDURE
127,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
128,claude37,0.707,TNM DESCRIPTORS
129,claude37,0.815,REGIONAL LYMPH NODE STATUS
130,claude37,0.789,ADDITIONAL FINDINGS
131,claude37,0.823,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
132,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
133,claude37,0.788,HISTOLOGIC GRADE
134,claude37,0.775,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
135,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
136,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
137,claude37,0.811,TUMOR FOCALITY
138,claude37,0.788,PROCEDURE
139,claude37,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
140,claude37,0.861,ADDITIONAL FINDINGS
141,claude37,0.697,SPECIMEN LATERALITY
142,claude37,0.79,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
143,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
144,claude37,0.815,REGIONAL LYMPH NODE STATUS
145,claude37,0.855,NODAL SITE(S) EXAMINED
146,claude37,0.887,TUMOR SITE
147,claude37,0.778,VISCERAL PLEURA INVASION
148,claude37,0.691,HISTOLOGIC GRADE
149,claude37,0.697,SPECIMEN LATERALITY
150,claude37,0.808,NODAL SITE(S) EXAMINED
151,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
152,claude37,0.737,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
153,claude37,0.89,TUMOR SITE
154,claude37,0.863,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
155,claude37,0.811,TUMOR FOCALITY
156,claude37,0.698,ADDITIONAL FINDINGS
157,claude37,0.815,REGIONAL LYMPH NODE STATUS
158,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
159,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
160,claude37,0.83,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
161,claude37,0.697,NUMBER OF LYMPH NODES EXAMINED
162,claude37,0.778,VISCERAL PLEURA INVASION
163,claude37,0.788,PROCEDURE
164,claude37,0.775,TUMOR SITE
165,claude37,0.859,LYMPHOVASCULAR INVASION
166,claude37,0.698,SPECIMEN LATERALITY
167,claude37,0.829,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
168,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
169,claude37,0.718,REGIONAL LYMPH NODE STATUS
170,claude37,0.817,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
171,claude37,0.73,TNM DESCRIPTORS
172,claude37,0.703,NUMBER OF LYMPH NODES WITH TUMOR
173,claude37,0.686,ADDITIONAL FINDINGS
174,claude37,0.782,HISTOLOGIC GRADE
175,claude37,0.785,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
176,claude37,0.778,VISCERAL PLEURA INVASION
177,claude37,0.858,NODAL SITE(S) WITH TUMOR
178,claude37,0.836,NODAL SITE(S) EXAMINED
179,claude37,0.78,SPREAD THROUGH AIR SPACES (STAS)
180,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
181,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
182,claude37,0.788,PROCEDURE
183,claude37,0.811,TUMOR FOCALITY
184,claude37,0.753,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
185,claude37,0.827,PROCEDURE
186,claude37,0.696,TNM DESCRIPTORS
187,claude37,0.778,VISCERAL PLEURA INVASION
188,claude37,0.697,SPECIMEN LATERALITY
189,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
190,claude37,0.756,MARGIN STATUS FOR INVASIVE CARCINOMA
191,claude37,0.773,TUMOR SITE
192,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
193,claude37,0.761,HISTOLOGIC GRADE
194,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
195,claude37,0.775,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
196,claude37,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
197,claude37,0.904,HISTOLOGIC GRADE
198,claude37,0.697,SPECIMEN LATERALITY
199,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
200,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
201,claude37,0.887,TUMOR SITE
202,claude37,0.819,NODAL SITE(S) EXAMINED
203,claude37,0.811,TUMOR FOCALITY
204,claude37,0.815,REGIONAL LYMPH NODE STATUS
205,claude37,0.713,NUMBER OF LYMPH NODES EXAMINED
206,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
207,claude37,0.827,PROCEDURE
208,claude37,0.836,ADDITIONAL FINDINGS
209,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
210,claude37,0.778,VISCERAL PLEURA INVASION
211,claude37,0.797,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
212,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
213,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
214,claude37,0.811,TUMOR FOCALITY
215,claude37,0.803,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
216,claude37,0.697,NUMBER OF LYMPH NODES EXAMINED
217,claude37,0.728,NODAL SITE(S) EXAMINED
218,claude37,0.904,HISTOLOGIC GRADE
219,claude37,0.697,SPECIMEN LATERALITY
220,claude37,0.819,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
221,claude37,0.778,VISCERAL PLEURA INVASION
222,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
223,claude37,0.827,PROCEDURE
224,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
225,claude37,0.815,REGIONAL LYMPH NODE STATUS
226,claude37,0.887,TUMOR SITE
227,claude37,0.791,PROCEDURE
228,claude37,0.713,NUMBER OF LYMPH NODES EXAMINED
229,claude37,0.782,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
230,claude37,0.778,VISCERAL PLEURA INVASION
231,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
232,claude37,0.893,TUMOR SITE
233,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
234,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
235,claude37,0.811,TUMOR FOCALITY
236,claude37,0.76,HISTOLOGIC GRADE
237,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
238,claude37,0.735,NODAL SITE(S) EXAMINED
239,claude37,0.697,SPECIMEN LATERALITY
240,claude37,0.845,ADDITIONAL FINDINGS
241,claude37,0.802,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
242,claude37,0.815,REGIONAL LYMPH NODE STATUS
243,claude37,0.798,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
244,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
245,claude37,0.811,TUMOR FOCALITY
246,claude37,0.859,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
247,claude37,0.778,VISCERAL PLEURA INVASION
248,claude37,0.722,NODAL SITE(S) EXAMINED
249,claude37,0.837,REGIONAL LYMPH NODE STATUS
250,claude37,0.89,TUMOR SITE
251,claude37,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
252,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
253,claude37,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
254,claude37,0.76,HISTOLOGIC GRADE
255,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
256,claude37,0.697,SPECIMEN LATERALITY
257,claude37,0.788,PROCEDURE
258,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
259,claude37,0.699,NUMBER OF LYMPH NODES EXAMINED
260,claude37,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
261,claude37,0.802,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
262,claude37,0.811,TUMOR FOCALITY
263,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
264,claude37,0.697,SPECIMEN LATERALITY
265,claude37,0.78,VISCERAL PLEURA INVASION
266,claude37,0.819,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
267,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
268,claude37,0.78,SPREAD THROUGH AIR SPACES (STAS)
269,claude37,0.788,PROCEDURE
270,claude37,0.711,LYMPHOVASCULAR INVASION
271,claude37,0.89,TUMOR SITE
272,claude37,0.785,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
273,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
274,claude37,0.72,NUMBER OF LYMPH NODES WITH TUMOR
275,claude37,0.793,HISTOLOGIC GRADE
276,claude37,0.753,REGIONAL LYMPH NODE STATUS
277,claude37,0.698,VISCERAL PLEURA INVASION
278,claude37,0.855,NODAL SITE(S) EXAMINED
279,claude37,0.78,REGIONAL LYMPH NODE STATUS
280,claude37,0.752,NODAL SITE(S) WITH TUMOR
281,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
282,claude37,0.877,REGIONAL LYMPH NODE STATUS
283,claude37,0.788,NUMBER OF LYMPH NODES EXAMINED
284,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
285,claude37,0.81,NUMBER OF LYMPH NODES EXAMINED
286,claude37,0.808,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
287,claude37,0.742,PROCEDURE
288,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
289,claude37,0.731,LYMPHOVASCULAR INVASION
290,claude37,0.765,NODAL SITE(S) EXAMINED
291,claude37,0.7,SPREAD THROUGH AIR SPACES (STAS)
292,claude37,0.764,TUMOR SITE
293,claude37,0.778,VISCERAL PLEURA INVASION
294,claude37,0.743,PROCEDURE
295,claude37,0.733,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
296,claude37,0.822,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
297,claude37,0.697,SPECIMEN LATERALITY
298,claude37,0.811,TUMOR FOCALITY
299,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
300,claude37,0.78,VISCERAL PLEURA INVASION
301,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
302,claude37,0.827,PROCEDURE
303,claude37,0.697,SPECIMEN LATERALITY
304,claude37,0.76,ADDITIONAL FINDINGS
305,claude37,0.815,REGIONAL LYMPH NODE STATUS
306,claude37,0.811,TUMOR FOCALITY
307,claude37,0.76,HISTOLOGIC GRADE
308,claude37,0.741,NODAL SITE(S) EXAMINED
309,claude37,0.819,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
310,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
311,claude37,0.826,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
312,claude37,0.887,TUMOR SITE
313,claude37,0.811,TUMOR FOCALITY
314,claude37,0.815,REGIONAL LYMPH NODE STATUS
315,claude37,0.731,MARGIN STATUS FOR NON-INVASIVE TUMOR
316,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
317,claude37,0.734,NODAL SITE(S) EXAMINED
318,claude37,0.84,TUMOR SITE
319,claude37,0.825,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
320,claude37,0.806,PROCEDURE
321,claude37,0.697,SPECIMEN LATERALITY
322,claude37,0.838,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
323,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
324,claude37,0.782,HISTOLOGIC GRADE
325,claude37,0.778,VISCERAL PLEURA INVASION
326,claude37,0.803,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
327,claude37,0.904,HISTOLOGIC GRADE
328,claude37,0.726,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
329,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
330,claude37,0.827,PROCEDURE
331,claude37,0.811,TUMOR FOCALITY
332,claude37,0.697,SPECIMEN LATERALITY
333,claude37,0.815,REGIONAL LYMPH NODE STATUS
334,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
335,claude37,0.698,VISCERAL PLEURA INVASION
336,claude37,0.838,NODAL SITE(S) EXAMINED
337,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
338,claude37,0.829,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
339,claude37,0.872,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
340,claude37,0.89,TUMOR SITE
341,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
342,claude37,0.697,SPECIMEN LATERALITY
343,claude37,0.887,TUMOR SITE
344,claude37,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
345,claude37,0.778,VISCERAL PLEURA INVASION
346,claude37,0.837,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
347,claude37,0.772,ADDITIONAL FINDINGS
348,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
349,claude37,0.815,REGIONAL LYMPH NODE STATUS
350,claude37,0.811,TUMOR FOCALITY
351,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
352,claude37,0.827,PROCEDURE
353,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
354,claude37,0.72,NODAL SITE(S) EXAMINED
355,claude37,0.782,HISTOLOGIC GRADE
356,claude37,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
357,claude37,0.811,TUMOR FOCALITY
358,claude37,0.838,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
359,claude37,0.698,SPECIMEN LATERALITY
360,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
361,claude37,0.786,REGIONAL LYMPH NODE STATUS
362,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
363,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
364,claude37,0.722,NUMBER OF LYMPH NODES EXAMINED
365,claude37,0.77,PROCEDURE
366,claude37,0.779,NODAL SITE(S) EXAMINED
367,claude37,0.89,TUMOR SITE
368,claude37,0.778,VISCERAL PLEURA INVASION
369,claude37,0.824,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
370,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
371,claude37,0.806,PROCEDURE
372,claude37,0.815,REGIONAL LYMPH NODE STATUS
373,claude37,0.698,SPECIMEN LATERALITY
374,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
375,claude37,0.83,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
376,claude37,0.763,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
377,claude37,0.693,NUMBER OF LYMPH NODES EXAMINED
378,claude37,0.811,TUMOR FOCALITY
379,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
380,claude37,0.745,MARGIN STATUS FOR NON-INVASIVE TUMOR
381,claude37,0.778,VISCERAL PLEURA INVASION
382,claude37,0.782,HISTOLOGIC GRADE
383,claude37,0.89,TUMOR SITE
384,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
385,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
386,claude37,0.697,SPECIMEN LATERALITY
387,claude37,0.762,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
388,claude37,0.778,VISCERAL PLEURA INVASION
389,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
390,claude37,0.815,REGIONAL LYMPH NODE STATUS
391,claude37,0.714,ADDITIONAL FINDINGS
392,claude37,0.888,MARGIN STATUS FOR NON-INVASIVE TUMOR
393,claude37,0.86,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
394,claude37,0.774,TUMOR SITE
395,claude37,0.732,NODAL SITE(S) EXAMINED
396,claude37,0.798,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
397,claude37,0.787,TNM DESCRIPTORS
398,claude37,0.689,TUMOR FOCALITY
399,claude37,0.69,HISTOLOGIC GRADE
400,claude37,0.84,PROCEDURE
401,claude37,0.78,VISCERAL PLEURA INVASION
402,claude37,0.816,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
403,claude37,0.901,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
404,claude37,0.708,NUMBER OF LYMPH NODES EXAMINED
405,claude37,0.811,TUMOR FOCALITY
406,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
407,claude37,0.76,HISTOLOGIC GRADE
408,claude37,0.815,REGIONAL LYMPH NODE STATUS
409,claude37,0.697,SPECIMEN LATERALITY
410,claude37,0.884,TUMOR SITE
411,claude37,0.838,NODAL SITE(S) EXAMINED
412,claude37,0.788,PROCEDURE
413,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
414,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
415,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
416,claude37,0.812,NODAL SITE(S) EXAMINED
417,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
418,claude37,0.924,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
419,claude37,0.698,SPECIMEN LATERALITY
420,claude37,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
421,claude37,0.788,PROCEDURE
422,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
423,claude37,0.811,TUMOR FOCALITY
424,claude37,0.844,REGIONAL LYMPH NODE STATUS
425,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
426,claude37,0.821,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
427,claude37,0.778,VISCERAL PLEURA INVASION
428,claude37,0.865,TUMOR SITE
429,claude37,0.704,NUMBER OF LYMPH NODES EXAMINED
430,claude37,0.76,HISTOLOGIC GRADE
431,claude37,0.745,LYMPHOVASCULAR INVASION
432,claude37,0.725,NODAL SITE(S) WITH TUMOR
433,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
434,claude37,0.7,NUMBER OF LYMPH NODES WITH TUMOR
435,claude37,0.782,HISTOLOGIC GRADE
436,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
437,claude37,0.788,ADDITIONAL FINDINGS
438,claude37,0.78,REGIONAL LYMPH NODE STATUS
439,claude37,0.778,VISCERAL PLEURA INVASION
440,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
441,claude37,0.838,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
442,claude37,0.838,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
443,claude37,0.825,TUMOR SITE
444,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
445,claude37,0.697,SPECIMEN LATERALITY
446,claude37,0.811,TUMOR FOCALITY
447,claude37,0.843,NODAL SITE(S) EXAMINED
448,claude37,0.827,PROCEDURE
449,claude37,0.698,VISCERAL PLEURA INVASION
450,claude37,0.835,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
451,claude37,0.637,ADDITIONAL FINDINGS
452,claude37,0.802,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
453,claude37,0.811,TUMOR FOCALITY
454,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
455,claude37,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
456,claude37,0.696,NODAL SITE(S) EXAMINED
457,claude37,0.788,PROCEDURE
458,claude37,0.89,TUMOR SITE
459,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
460,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
461,claude37,0.697,SPECIMEN LATERALITY
462,claude37,0.904,HISTOLOGIC GRADE
463,claude37,0.762,NUMBER OF LYMPH NODES EXAMINED
464,claude37,0.68,HISTOLOGIC GRADE
465,claude37,0.698,SPECIMEN LATERALITY
466,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
467,claude37,0.798,PROCEDURE
468,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
469,claude37,0.698,VISCERAL PLEURA INVASION
470,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
471,claude37,0.732,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
472,claude37,0.821,NODAL SITE(S) EXAMINED
473,claude37,0.782,NODAL SITE(S) WITH TUMOR
474,claude37,0.798,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
475,claude37,0.705,REGIONAL LYMPH NODE STATUS
476,claude37,0.701,TUMOR FOCALITY
477,claude37,0.745,LYMPHOVASCULAR INVASION
478,claude37,0.713,NUMBER OF LYMPH NODES WITH TUMOR
479,claude37,0.824,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
480,claude37,0.779,TUMOR SITE
481,claude37,0.739,TNM DESCRIPTORS
482,claude37,0.847,MARGIN STATUS FOR NON-INVASIVE TUMOR
483,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
484,claude37,0.77,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
485,claude37,0.827,PROCEDURE
486,claude37,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
487,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
488,claude37,0.697,SPECIMEN LATERALITY
489,claude37,0.904,HISTOLOGIC GRADE
490,claude37,0.887,TUMOR SITE
491,claude37,0.826,ADDITIONAL FINDINGS
492,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
493,claude37,0.778,VISCERAL PLEURA INVASION
494,claude37,0.811,TUMOR FOCALITY
495,claude37,0.742,MARGIN STATUS FOR INVASIVE CARCINOMA
496,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
497,claude37,0.683,REGIONAL LYMPH NODE STATUS
498,claude37,0.788,PROCEDURE
499,claude37,0.802,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
500,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
501,claude37,0.745,LYMPHOVASCULAR INVASION
502,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
503,claude37,0.767,ADDITIONAL FINDINGS
504,claude37,0.754,HISTOLOGIC GRADE
505,claude37,0.811,TUMOR FOCALITY
506,claude37,0.883,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
507,claude37,0.72,NUMBER OF LYMPH NODES WITH TUMOR
508,claude37,0.697,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
509,claude37,0.73,NODAL SITE(S) EXAMINED
510,claude37,0.815,NODAL SITE(S) WITH TUMOR
511,claude37,0.697,SPECIMEN LATERALITY
512,claude37,0.698,VISCERAL PLEURA INVASION
513,claude37,0.893,TUMOR SITE
514,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
515,claude37,0.778,VISCERAL PLEURA INVASION
516,claude37,0.788,PROCEDURE
517,claude37,0.697,SPECIMEN LATERALITY
518,claude37,0.815,REGIONAL LYMPH NODE STATUS
519,claude37,0.89,TUMOR SITE
520,claude37,0.811,TUMOR FOCALITY
521,claude37,0.814,ADDITIONAL FINDINGS
522,claude37,0.824,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
523,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
524,claude37,0.703,NUMBER OF LYMPH NODES EXAMINED
525,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
526,claude37,0.733,NODAL SITE(S) EXAMINED
527,claude37,0.788,HISTOLOGIC GRADE
528,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
529,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
530,claude37,0.713,NUMBER OF LYMPH NODES EXAMINED
531,claude37,0.815,REGIONAL LYMPH NODE STATUS
532,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
533,claude37,0.788,HISTOLOGIC GRADE
534,claude37,0.811,TUMOR FOCALITY
535,claude37,0.698,SPECIMEN LATERALITY
536,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
537,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
538,claude37,0.698,VISCERAL PLEURA INVASION
539,claude37,0.702,TUMOR SITE
540,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
541,claude37,0.827,PROCEDURE
542,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
543,claude37,0.924,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
544,claude37,0.798,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
545,claude37,0.814,NODAL SITE(S) EXAMINED
546,claude37,0.811,TUMOR FOCALITY
547,claude37,0.89,TUMOR SITE
548,claude37,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
549,claude37,0.847,NODAL SITE(S) EXAMINED
550,claude37,0.841,MARGIN STATUS FOR INVASIVE CARCINOMA
551,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
552,claude37,0.698,SPECIMEN LATERALITY
553,claude37,0.815,REGIONAL LYMPH NODE STATUS
554,claude37,0.803,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
555,claude37,0.778,VISCERAL PLEURA INVASION
556,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
557,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
558,claude37,0.788,PROCEDURE
559,claude37,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
560,claude37,0.701,ADDITIONAL FINDINGS
561,claude37,0.811,TUMOR FOCALITY
562,claude37,0.698,SPECIMEN LATERALITY
563,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
564,claude37,0.792,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
565,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
566,claude37,0.785,REGIONAL LYMPH NODE STATUS
567,claude37,0.742,TUMOR SITE
568,claude37,0.86,NODAL SITE(S) EXAMINED
569,claude37,0.778,VISCERAL PLEURA INVASION
570,claude37,0.698,NUMBER OF LYMPH NODES EXAMINED
571,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
572,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
573,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
574,claude37,0.826,HISTOLOGIC GRADE
575,claude37,0.715,PROCEDURE
576,claude37,0.816,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
577,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
578,claude37,0.693,NODAL SITE(S) EXAMINED
579,claude37,0.839,HISTOLOGIC GRADE
580,claude37,0.782,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
581,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
582,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
583,claude37,0.815,REGIONAL LYMPH NODE STATUS
584,claude37,0.827,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
585,claude37,0.778,VISCERAL PLEURA INVASION
586,claude37,0.788,PROCEDURE
587,claude37,0.811,TUMOR FOCALITY
588,claude37,0.697,SPECIMEN LATERALITY
589,claude37,0.817,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
590,claude37,0.89,TUMOR SITE
591,claude37,0.811,TUMOR FOCALITY
592,claude37,0.76,HISTOLOGIC GRADE
593,claude37,0.839,NODAL SITE(S) EXAMINED
594,claude37,0.697,SPECIMEN LATERALITY
595,claude37,0.829,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
596,claude37,0.78,VISCERAL PLEURA INVASION
597,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
598,claude37,0.815,REGIONAL LYMPH NODE STATUS
599,claude37,0.808,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
600,claude37,0.887,TUMOR SITE
601,claude37,0.796,PROCEDURE
602,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
603,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
604,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
605,claude37,0.683,LYMPH NODE(S) FROM PRIOR PROCEDURES
606,claude37,0.788,PROCEDURE
607,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
608,claude37,0.874,NODAL SITE(S) WITH TUMOR
609,claude37,0.778,VISCERAL PLEURA INVASION
610,claude37,0.66,TUMOR FOCALITY
611,claude37,0.72,NUMBER OF LYMPH NODES WITH TUMOR
612,claude37,0.825,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
613,claude37,0.698,SPECIMEN LATERALITY
614,claude37,0.705,ADDITIONAL FINDINGS
615,claude37,0.705,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
616,claude37,0.677,HISTOLOGIC GRADE
617,claude37,0.791,NODAL SITE(S) EXAMINED
618,claude37,0.715,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
619,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
620,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
621,claude37,0.747,TNM DESCRIPTORS
622,claude37,0.888,TUMOR SITE
623,claude37,0.701,REGIONAL LYMPH NODE STATUS
624,claude37,0.821,NODAL SITE(S) EXAMINED
625,claude37,0.798,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
626,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
627,claude37,0.805,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
628,claude37,0.904,HISTOLOGIC GRADE
629,claude37,0.697,SPECIMEN LATERALITY
630,claude37,0.815,REGIONAL LYMPH NODE STATUS
631,claude37,0.793,PROCEDURE
632,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
633,claude37,0.811,TUMOR FOCALITY
634,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
635,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
636,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
637,claude37,0.89,TUMOR SITE
638,claude37,0.778,VISCERAL PLEURA INVASION
639,claude37,0.892,HISTOLOGIC GRADE
640,claude37,0.731,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
641,claude37,0.698,VISCERAL PLEURA INVASION
642,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
643,claude37,0.744,PROCEDURE
644,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
645,claude37,0.726,REGIONAL LYMPH NODE STATUS
646,claude37,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
647,claude37,0.781,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
648,claude37,0.887,NODAL SITE(S) WITH TUMOR
649,claude37,0.89,TUMOR SITE
650,claude37,0.745,LYMPHOVASCULAR INVASION
651,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
652,claude37,0.723,NODAL SITE(S) EXAMINED
653,claude37,0.697,SPECIMEN LATERALITY
654,claude37,0.811,TUMOR FOCALITY
655,claude37,0.793,HISTOLOGIC GRADE
656,claude37,0.745,LYMPHOVASCULAR INVASION
657,claude37,0.745,REGIONAL LYMPH NODE STATUS
658,claude37,0.778,VISCERAL PLEURA INVASION
659,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
660,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
661,claude37,0.804,NODAL SITE(S) EXAMINED
662,claude37,0.888,TUMOR SITE
663,claude37,0.788,PROCEDURE
664,claude37,0.698,SPECIMEN LATERALITY
665,claude37,0.835,NODAL SITE(S) WITH TUMOR
666,claude37,0.713,NUMBER OF LYMPH NODES WITH TUMOR
667,claude37,0.698,NUMBER OF LYMPH NODES EXAMINED
668,claude37,0.754,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
669,claude37,0.811,TUMOR FOCALITY
670,claude37,0.708,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
671,claude37,0.717,TNM DESCRIPTORS
672,claude37,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
673,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
674,claude37,0.778,VISCERAL PLEURA INVASION
675,claude37,0.697,SPECIMEN LATERALITY
676,claude37,0.798,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
677,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
678,claude37,0.686,LYMPHOVASCULAR INVASION
679,claude37,0.767,NODAL SITE(S) WITH TUMOR
680,claude37,0.809,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
681,claude37,0.892,HISTOLOGIC GRADE
682,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
683,claude37,0.78,SPREAD THROUGH AIR SPACES (STAS)
684,claude37,0.7,NUMBER OF LYMPH NODES WITH TUMOR
685,claude37,0.78,REGIONAL LYMPH NODE STATUS
686,claude37,0.793,PROCEDURE
687,claude37,0.755,NODAL SITE(S) EXAMINED
688,claude37,0.811,TUMOR FOCALITY
689,claude37,0.683,LYMPH NODE(S) FROM PRIOR PROCEDURES
690,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
691,claude37,0.728,TUMOR SITE
692,claude37,0.701,NUMBER OF LYMPH NODES EXAMINED
693,claude37,0.798,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
694,claude37,0.788,PROCEDURE
695,claude37,0.823,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
696,claude37,0.677,HISTOLOGIC GRADE
697,claude37,0.815,REGIONAL LYMPH NODE STATUS
698,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
699,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
700,claude37,0.698,SPECIMEN LATERALITY
701,claude37,0.718,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
702,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
703,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
704,claude37,0.811,TUMOR FOCALITY
705,claude37,0.694,NODAL SITE(S) EXAMINED
706,claude37,0.89,TUMOR SITE
707,claude37,0.778,VISCERAL PLEURA INVASION
708,claude37,0.778,VISCERAL PLEURA INVASION
709,claude37,0.773,PROCEDURE
710,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
711,claude37,0.811,TUMOR FOCALITY
712,claude37,0.815,REGIONAL LYMPH NODE STATUS
713,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
714,claude37,0.805,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
715,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
716,claude37,0.698,SPECIMEN LATERALITY
717,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
718,claude37,0.847,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
719,claude37,0.735,NODAL SITE(S) EXAMINED
720,claude37,0.89,TUMOR SITE
721,claude37,0.788,HISTOLOGIC GRADE
722,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
723,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
724,claude37,0.754,PROCEDURE
725,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
726,claude37,0.819,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
727,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
728,claude37,0.865,TUMOR SITE
729,claude37,0.836,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
730,claude37,0.67,NODAL SITE(S) EXAMINED
731,claude37,0.697,NUMBER OF LYMPH NODES EXAMINED
732,claude37,0.76,HISTOLOGIC GRADE
733,claude37,0.815,REGIONAL LYMPH NODE STATUS
734,claude37,0.811,TUMOR FOCALITY
735,claude37,0.778,VISCERAL PLEURA INVASION
736,claude37,0.698,SPECIMEN LATERALITY
737,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
738,claude37,0.757,PROCEDURE
739,claude37,0.789,TUMOR SITE
740,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
741,claude37,0.792,ADDITIONAL FINDINGS
742,claude37,0.742,HISTOLOGIC GRADE
743,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
744,claude37,0.815,REGIONAL LYMPH NODE STATUS
745,claude37,0.798,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
746,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
747,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
748,claude37,0.778,VISCERAL PLEURA INVASION
749,claude37,0.86,NODAL SITE(S) EXAMINED
750,claude37,0.697,SPECIMEN LATERALITY
751,claude37,0.712,NUMBER OF LYMPH NODES EXAMINED
752,claude37,0.792,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
753,claude37,0.683,TUMOR FOCALITY
754,claude37,0.841,MARGIN STATUS FOR INVASIVE CARCINOMA
755,claude37,0.76,HISTOLOGIC GRADE
756,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
757,claude37,0.72,NUMBER OF LYMPH NODES EXAMINED
758,claude37,0.717,REGIONAL LYMPH NODE STATUS
759,claude37,0.788,PROCEDURE
760,claude37,0.811,TUMOR FOCALITY
761,claude37,0.723,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
762,claude37,0.828,NODAL SITE(S) EXAMINED
763,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
764,claude37,0.697,SPECIMEN LATERALITY
765,claude37,0.709,ADDITIONAL FINDINGS
766,claude37,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
767,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
768,claude37,0.778,VISCERAL PLEURA INVASION
769,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
770,claude37,0.887,TUMOR SITE
771,claude37,0.819,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
772,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
773,claude37,0.698,VISCERAL PLEURA INVASION
774,claude37,0.828,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
775,claude37,0.703,NUMBER OF LYMPH NODES WITH TUMOR
776,claude37,0.811,TUMOR FOCALITY
777,claude37,0.703,NUMBER OF LYMPH NODES WITH TUMOR
778,claude37,0.734,NODAL SITE(S) EXAMINED
779,claude37,0.887,TUMOR SITE
780,claude37,0.866,NODAL SITE(S) WITH TUMOR
781,claude37,0.782,HISTOLOGIC GRADE
782,claude37,0.755,PROCEDURE
783,claude37,0.697,SPECIMEN LATERALITY
784,claude37,0.732,REGIONAL LYMPH NODE STATUS
785,claude37,0.7,SPREAD THROUGH AIR SPACES (STAS)
786,claude37,0.708,NODAL SITE(S) EXAMINED
787,claude37,0.763,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
788,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
789,claude37,0.738,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
790,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
791,claude37,0.702,NUMBER OF LYMPH NODES EXAMINED
792,claude37,0.782,HISTOLOGIC GRADE
793,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
794,claude37,0.89,TUMOR SITE
795,claude37,0.805,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
796,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
797,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
798,claude37,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
799,claude37,0.811,TUMOR FOCALITY
800,claude37,0.699,NUMBER OF LYMPH NODES EXAMINED
801,claude37,0.764,REGIONAL LYMPH NODE STATUS
802,claude37,0.813,NODAL SITE(S) EXAMINED
803,claude37,0.7,NUMBER OF LYMPH NODES WITH TUMOR
804,claude37,0.778,VISCERAL PLEURA INVASION
805,claude37,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
806,claude37,0.697,SPECIMEN LATERALITY
807,claude37,0.788,PROCEDURE
808,claude37,0.681,LYMPHOVASCULAR INVASION
809,claude37,0.887,TUMOR SITE
810,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
811,claude37,0.818,LYMPHOVASCULAR INVASION
812,claude37,0.733,NODAL SITE(S) EXAMINED
813,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
814,claude37,0.718,SPREAD THROUGH AIR SPACES (STAS)
815,claude37,0.782,HISTOLOGIC GRADE
816,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
817,claude37,0.788,PROCEDURE
818,claude37,0.697,SPECIMEN LATERALITY
819,claude37,0.699,NUMBER OF LYMPH NODES EXAMINED
820,claude37,0.787,REGIONAL LYMPH NODE STATUS
821,claude37,0.698,VISCERAL PLEURA INVASION
822,claude37,0.811,TUMOR FOCALITY
823,claude37,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
824,claude37,0.802,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
825,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
826,claude37,0.718,REGIONAL LYMPH NODE STATUS
827,claude37,0.698,SPECIMEN LATERALITY
828,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
829,claude37,0.778,VISCERAL PLEURA INVASION
830,claude37,0.811,TUMOR FOCALITY
831,claude37,0.72,NUMBER OF LYMPH NODES WITH TUMOR
832,claude37,0.83,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
833,claude37,0.739,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
834,claude37,0.847,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
835,claude37,0.697,NUMBER OF LYMPH NODES EXAMINED
836,claude37,0.788,PROCEDURE
837,claude37,0.81,NODAL SITE(S) EXAMINED
838,claude37,0.888,TUMOR SITE
839,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
840,claude37,0.874,NODAL SITE(S) WITH TUMOR
841,claude37,0.756,NODAL SITE(S) EXAMINED
842,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
843,claude37,0.843,ADDITIONAL FINDINGS
844,claude37,0.782,REGIONAL LYMPH NODE STATUS
845,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
846,claude37,0.675,TUMOR SITE
847,claude37,0.782,HISTOLOGIC GRADE
848,claude37,0.778,VISCERAL PLEURA INVASION
849,claude37,0.719,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
850,claude37,0.683,TUMOR FOCALITY
851,claude37,0.827,PROCEDURE
852,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
853,claude37,0.764,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
854,claude37,0.7,NUMBER OF LYMPH NODES EXAMINED
855,claude37,0.698,SPECIMEN LATERALITY
856,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
857,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
858,claude37,0.78,SPREAD THROUGH AIR SPACES (STAS)
859,claude37,0.782,HISTOLOGIC GRADE
860,claude37,0.698,LYMPHOVASCULAR INVASION
861,claude37,0.761,NODAL SITE(S) WITH TUMOR
862,claude37,0.681,VISCERAL PLEURA INVASION
863,claude37,0.683,LYMPH NODE(S) FROM PRIOR PROCEDURES
864,claude37,0.712,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
865,claude37,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
866,claude37,0.788,PROCEDURE
867,claude37,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
868,claude37,0.698,SPECIMEN LATERALITY
869,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
870,claude37,0.715,NUMBER OF LYMPH NODES EXAMINED
871,claude37,0.699,NODAL SITE(S) EXAMINED
872,claude37,0.721,REGIONAL LYMPH NODE STATUS
873,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
874,claude37,0.698,NUMBER OF LYMPH NODES WITH TUMOR
875,claude37,0.811,TUMOR FOCALITY
876,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
877,claude37,0.778,VISCERAL PLEURA INVASION
878,claude37,0.694,NODAL SITE(S) EXAMINED
879,claude37,0.698,SPECIMEN LATERALITY
880,claude37,0.827,PROCEDURE
881,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
882,claude37,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
883,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
884,claude37,0.782,HISTOLOGIC GRADE
885,claude37,0.815,REGIONAL LYMPH NODE STATUS
886,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
887,claude37,0.805,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
888,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
889,claude37,0.89,TUMOR SITE
890,claude37,0.811,TUMOR FOCALITY
891,claude37,0.704,NUMBER OF LYMPH NODES EXAMINED
892,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
893,claude37,0.788,PROCEDURE
894,claude37,0.811,TUMOR FOCALITY
895,claude37,0.697,SPECIMEN LATERALITY
896,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
897,claude37,0.703,NUMBER OF LYMPH NODES WITH TUMOR
898,claude37,0.78,VISCERAL PLEURA INVASION
899,claude37,0.809,LYMPHOVASCULAR INVASION
900,claude37,0.884,NODAL SITE(S) EXAMINED
901,claude37,0.76,HISTOLOGIC GRADE
902,claude37,0.761,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
903,claude37,0.78,SPREAD THROUGH AIR SPACES (STAS)
904,claude37,0.761,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
905,claude37,0.709,MARGIN STATUS FOR INVASIVE CARCINOMA
906,claude37,0.821,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
907,claude37,0.866,NODAL SITE(S) WITH TUMOR
908,claude37,0.724,REGIONAL LYMPH NODE STATUS
909,claude37,0.869,TUMOR SITE
910,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
911,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
912,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
913,claude37,0.782,HISTOLOGIC GRADE
914,claude37,0.842,REGIONAL LYMPH NODE STATUS
915,claude37,0.817,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
916,claude37,0.788,PROCEDURE
917,claude37,0.704,NUMBER OF LYMPH NODES EXAMINED
918,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
919,claude37,0.698,SPECIMEN LATERALITY
920,claude37,0.811,TUMOR FOCALITY
921,claude37,0.823,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
922,claude37,0.678,NODAL SITE(S) EXAMINED
923,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
924,claude37,0.778,VISCERAL PLEURA INVASION
925,claude37,0.865,TUMOR SITE
926,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
927,claude37,0.865,NODAL SITE(S) WITH TUMOR
928,claude37,0.838,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
929,claude37,0.89,TUMOR SITE
930,claude37,0.761,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
931,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
932,claude37,0.78,SPREAD THROUGH AIR SPACES (STAS)
933,claude37,0.76,HISTOLOGIC GRADE
934,claude37,0.724,REGIONAL LYMPH NODE STATUS
935,claude37,0.78,VISCERAL PLEURA INVASION
936,claude37,0.745,LYMPHOVASCULAR INVASION
937,claude37,0.773,NUMBER OF LYMPH NODES EXAMINED
938,claude37,0.698,SPECIMEN LATERALITY
939,claude37,0.756,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
940,claude37,0.869,NODAL SITE(S) EXAMINED
941,claude37,0.788,PROCEDURE
942,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
943,claude37,0.694,NUMBER OF LYMPH NODES WITH TUMOR
944,claude37,0.811,TUMOR FOCALITY
945,claude37,0.72,NUMBER OF LYMPH NODES WITH TUMOR
946,claude37,0.89,TUMOR SITE
947,claude37,0.726,NODAL SITE(S) EXAMINED
948,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
949,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
950,claude37,0.778,VISCERAL PLEURA INVASION
951,claude37,0.819,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
952,claude37,0.782,HISTOLOGIC GRADE
953,claude37,0.703,NUMBER OF LYMPH NODES EXAMINED
954,claude37,0.757,REGIONAL LYMPH NODE STATUS
955,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
956,claude37,0.757,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
957,claude37,0.788,PROCEDURE
958,claude37,0.886,NODAL SITE(S) WITH TUMOR
959,claude37,0.822,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
960,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
961,claude37,0.697,SPECIMEN LATERALITY
962,claude37,0.811,TUMOR FOCALITY
963,claude37,0.847,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
964,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
965,claude37,0.72,NUMBER OF LYMPH NODES WITH TUMOR
966,claude37,0.788,PROCEDURE
967,claude37,0.892,HISTOLOGIC GRADE
968,claude37,0.781,REGIONAL LYMPH NODE STATUS
969,claude37,0.701,NUMBER OF LYMPH NODES EXAMINED
970,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
971,claude37,0.821,NODAL SITE(S) EXAMINED
972,claude37,0.778,VISCERAL PLEURA INVASION
973,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
974,claude37,0.769,NODAL SITE(S) WITH TUMOR
975,claude37,0.808,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
976,claude37,0.811,TUMOR FOCALITY
977,claude37,0.754,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
978,claude37,0.757,TUMOR SITE
979,claude37,0.698,SPECIMEN LATERALITY
980,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
981,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
982,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
983,claude37,0.698,SPECIMEN LATERALITY
984,claude37,0.817,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
985,claude37,0.754,MARGIN STATUS FOR NON-INVASIVE TUMOR
986,claude37,0.725,NUMBER OF LYMPH NODES EXAMINED
987,claude37,0.778,VISCERAL PLEURA INVASION
988,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
989,claude37,0.89,TUMOR SITE
990,claude37,0.815,REGIONAL LYMPH NODE STATUS
991,claude37,0.782,HISTOLOGIC GRADE
992,claude37,0.811,TUMOR FOCALITY
993,claude37,0.709,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
994,claude37,0.694,NODAL SITE(S) EXAMINED
995,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
996,claude37,0.835,PROCEDURE
997,claude37,0.811,TUMOR FOCALITY
998,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
999,claude37,0.717,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1000,claude37,0.887,TUMOR SITE
1001,claude37,0.836,NODAL SITE(S) EXAMINED
1002,claude37,0.827,PROCEDURE
1003,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1004,claude37,0.892,HISTOLOGIC GRADE
1005,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1006,claude37,0.697,SPECIMEN LATERALITY
1007,claude37,0.839,REGIONAL LYMPH NODE STATUS
1008,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
1009,claude37,0.778,VISCERAL PLEURA INVASION
1010,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1011,claude37,0.826,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1012,claude37,0.745,LYMPHOVASCULAR INVASION
1013,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1014,claude37,0.788,PROCEDURE
1015,claude37,0.698,SPECIMEN LATERALITY
1016,claude37,0.769,HISTOLOGIC GRADE
1017,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1018,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1019,claude37,0.696,NUMBER OF LYMPH NODES EXAMINED
1020,claude37,0.888,TUMOR SITE
1021,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1022,claude37,0.778,VISCERAL PLEURA INVASION
1023,claude37,0.743,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1024,claude37,0.738,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1025,claude37,0.735,REGIONAL LYMPH NODE STATUS
1026,claude37,0.896,ADDITIONAL FINDINGS
1027,claude37,0.714,NODAL SITE(S) EXAMINED
1028,claude37,0.811,TUMOR FOCALITY
1029,claude37,0.798,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1030,claude37,0.904,HISTOLOGIC GRADE
1031,claude37,0.82,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1032,claude37,0.887,TUMOR SITE
1033,claude37,0.778,VISCERAL PLEURA INVASION
1034,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1035,claude37,0.841,REGIONAL LYMPH NODE STATUS
1036,claude37,0.72,NUMBER OF LYMPH NODES EXAMINED
1037,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1038,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
1039,claude37,0.811,TUMOR FOCALITY
1040,claude37,0.782,NODAL SITE(S) EXAMINED
1041,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1042,claude37,0.697,SPECIMEN LATERALITY
1043,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1044,claude37,0.827,PROCEDURE
1045,claude37,0.865,ADDITIONAL FINDINGS
1046,claude37,0.806,ADDITIONAL FINDINGS
1047,claude37,0.827,PROCEDURE
1048,claude37,0.778,VISCERAL PLEURA INVASION
1049,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1050,claude37,0.782,HISTOLOGIC GRADE
1051,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1052,claude37,0.815,REGIONAL LYMPH NODE STATUS
1053,claude37,0.835,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1054,claude37,0.697,SPECIMEN LATERALITY
1055,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1056,claude37,0.792,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1057,claude37,0.89,TUMOR SITE
1058,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1059,claude37,0.718,SPREAD THROUGH AIR SPACES (STAS)
1060,claude37,0.72,NODAL SITE(S) EXAMINED
1061,claude37,0.811,TUMOR FOCALITY
1062,claude37,0.788,PROCEDURE
1063,claude37,0.888,TUMOR SITE
1064,claude37,0.693,NODAL SITE(S) EXAMINED
1065,claude37,0.7,SPREAD THROUGH AIR SPACES (STAS)
1066,claude37,0.788,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1067,claude37,0.698,SPECIMEN LATERALITY
1068,claude37,0.78,VISCERAL PLEURA INVASION
1069,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1070,claude37,0.795,TNM DESCRIPTORS
1071,claude37,0.811,TUMOR FOCALITY
1072,claude37,0.778,ADDITIONAL FINDINGS
1073,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1074,claude37,0.681,HISTOLOGIC GRADE
1075,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1076,claude37,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1077,claude37,0.699,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1078,claude37,0.859,REGIONAL LYMPH NODE STATUS
1079,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1080,claude37,0.778,VISCERAL PLEURA INVASION
1081,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
1082,claude37,0.697,ADDITIONAL FINDINGS
1083,claude37,0.827,PROCEDURE
1084,claude37,0.698,SPECIMEN LATERALITY
1085,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1086,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1087,claude37,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1088,claude37,0.678,TUMOR FOCALITY
1089,claude37,0.89,TUMOR SITE
1090,claude37,0.805,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1091,claude37,0.76,HISTOLOGIC GRADE
1092,claude37,0.737,LYMPHOVASCULAR INVASION
1093,claude37,0.811,TUMOR FOCALITY
1094,claude37,0.78,VISCERAL PLEURA INVASION
1095,claude37,0.752,NODAL SITE(S) WITH TUMOR
1096,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
1097,claude37,0.697,SPECIMEN LATERALITY
1098,claude37,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1099,claude37,0.808,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1100,claude37,0.72,NUMBER OF LYMPH NODES WITH TUMOR
1101,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1102,claude37,0.762,REGIONAL LYMPH NODE STATUS
1103,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1104,claude37,0.887,TUMOR SITE
1105,claude37,0.745,PROCEDURE
1106,claude37,0.73,NODAL SITE(S) EXAMINED
1107,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1108,claude37,0.817,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1109,claude37,0.853,REGIONAL LYMPH NODE STATUS
1110,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1111,claude37,0.778,VISCERAL PLEURA INVASION
1112,claude37,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1113,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1114,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1115,claude37,0.89,TUMOR SITE
1116,claude37,0.826,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1117,claude37,0.698,SPECIMEN LATERALITY
1118,claude37,0.825,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1119,claude37,0.782,HISTOLOGIC GRADE
1120,claude37,0.703,NODAL SITE(S) EXAMINED
1121,claude37,0.788,PROCEDURE
1122,claude37,0.811,TUMOR FOCALITY
1123,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
1124,claude37,0.815,REGIONAL LYMPH NODE STATUS
1125,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1126,claude37,0.728,NODAL SITE(S) EXAMINED
1127,claude37,0.819,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1128,claude37,0.878,ADDITIONAL FINDINGS
1129,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1130,claude37,0.705,SPECIMEN LATERALITY
1131,claude37,0.89,TUMOR SITE
1132,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
1133,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1134,claude37,0.713,NUMBER OF LYMPH NODES EXAMINED
1135,claude37,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1136,claude37,0.778,VISCERAL PLEURA INVASION
1137,claude37,0.782,HISTOLOGIC GRADE
1138,claude37,0.827,PROCEDURE
1139,claude37,0.697,SPECIMEN LATERALITY
1140,claude37,0.811,TUMOR FOCALITY
1141,claude37,0.782,HISTOLOGIC GRADE
1142,claude37,0.827,PROCEDURE
1143,claude37,0.805,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1144,claude37,0.887,TUMOR SITE
1145,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1146,claude37,0.733,NODAL SITE(S) EXAMINED
1147,claude37,0.811,TUMOR FOCALITY
1148,claude37,0.697,SPECIMEN LATERALITY
1149,claude37,0.739,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1150,claude37,0.725,ADDITIONAL FINDINGS
1151,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1152,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1153,claude37,0.815,REGIONAL LYMPH NODE STATUS
1154,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1155,claude37,0.78,VISCERAL PLEURA INVASION
1156,claude37,0.742,REGIONAL LYMPH NODE STATUS
1157,claude37,0.782,HISTOLOGIC GRADE
1158,claude37,0.833,NODAL SITE(S) EXAMINED
1159,claude37,0.761,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1160,claude37,0.845,PROCEDURE
1161,claude37,0.697,NUMBER OF LYMPH NODES EXAMINED
1162,claude37,0.856,ADDITIONAL FINDINGS
1163,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1164,claude37,0.783,TUMOR SITE
1165,claude37,0.761,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1166,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1167,claude37,0.78,VISCERAL PLEURA INVASION
1168,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1169,claude37,0.7,SPREAD THROUGH AIR SPACES (STAS)
1170,claude37,0.735,TUMOR FOCALITY
1171,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1172,claude37,0.697,SPECIMEN LATERALITY
1173,claude37,0.835,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1174,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1175,claude37,0.715,NUMBER OF LYMPH NODES WITH TUMOR
1176,claude37,0.76,HISTOLOGIC GRADE
1177,claude37,0.669,NODAL SITE(S) WITH TUMOR
1178,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1179,claude37,0.73,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1180,claude37,0.697,SPECIMEN LATERALITY
1181,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
1182,claude37,0.708,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1183,claude37,0.893,TUMOR SITE
1184,claude37,0.78,SPREAD THROUGH AIR SPACES (STAS)
1185,claude37,0.798,NODAL SITE(S) EXAMINED
1186,claude37,0.738,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1187,claude37,0.811,TUMOR FOCALITY
1188,claude37,0.788,PROCEDURE
1189,claude37,0.686,LYMPHOVASCULAR INVASION
1190,claude37,0.676,REGIONAL LYMPH NODE STATUS
1191,claude37,0.707,NUMBER OF LYMPH NODES EXAMINED
1192,claude37,0.837,NODAL SITE(S) EXAMINED
1193,claude37,0.865,TUMOR SITE
1194,claude37,0.701,NUMBER OF LYMPH NODES EXAMINED
1195,claude37,0.832,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1196,claude37,0.892,HISTOLOGIC GRADE
1197,claude37,0.745,LYMPHOVASCULAR INVASION
1198,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
1199,claude37,0.78,VISCERAL PLEURA INVASION
1200,claude37,0.763,ADDITIONAL FINDINGS
1201,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1202,claude37,0.698,SPECIMEN LATERALITY
1203,claude37,0.811,TUMOR FOCALITY
1204,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1205,claude37,0.815,REGIONAL LYMPH NODE STATUS
1206,claude37,0.705,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1207,claude37,0.788,PROCEDURE
1208,claude37,0.782,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1209,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1210,claude37,0.782,HISTOLOGIC GRADE
1211,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1212,claude37,0.813,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1213,claude37,0.697,SPECIMEN LATERALITY
1214,claude37,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1215,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1216,claude37,0.887,TUMOR SITE
1217,claude37,0.778,VISCERAL PLEURA INVASION
1218,claude37,0.713,NUMBER OF LYMPH NODES EXAMINED
1219,claude37,0.782,ADDITIONAL FINDINGS
1220,claude37,0.827,PROCEDURE
1221,claude37,0.811,TUMOR FOCALITY
1222,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1223,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
1224,claude37,0.87,NODAL SITE(S) EXAMINED
1225,claude37,0.8,REGIONAL LYMPH NODE STATUS
1226,claude37,0.811,ADDITIONAL FINDINGS
1227,claude37,0.892,HISTOLOGIC GRADE
1228,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
1229,claude37,0.855,MARGIN STATUS FOR INVASIVE CARCINOMA
1230,claude37,0.679,NODAL SITE(S) EXAMINED
1231,claude37,0.698,NUMBER OF LYMPH NODES EXAMINED
1232,claude37,0.78,VISCERAL PLEURA INVASION
1233,claude37,0.888,TUMOR SITE
1234,claude37,0.714,MARGIN STATUS FOR NON-INVASIVE TUMOR
1235,claude37,0.811,TUMOR FOCALITY
1236,claude37,0.815,REGIONAL LYMPH NODE STATUS
1237,claude37,0.698,SPECIMEN LATERALITY
1238,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1239,claude37,0.838,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1240,claude37,0.773,PROCEDURE
1241,claude37,0.806,ADDITIONAL FINDINGS
1242,claude37,0.703,NUMBER OF LYMPH NODES EXAMINED
1243,claude37,0.815,REGIONAL LYMPH NODE STATUS
1244,claude37,0.697,SPECIMEN LATERALITY
1245,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1246,claude37,0.827,PROCEDURE
1247,claude37,0.781,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1248,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1249,claude37,0.778,VISCERAL PLEURA INVASION
1250,claude37,0.782,HISTOLOGIC GRADE
1251,claude37,0.838,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1252,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1253,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
1254,claude37,0.89,TUMOR SITE
1255,claude37,0.857,NODAL SITE(S) EXAMINED
1256,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1257,claude37,0.811,TUMOR FOCALITY
1258,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
1259,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1260,claude37,0.838,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1261,claude37,0.782,HISTOLOGIC GRADE
1262,claude37,0.844,ADDITIONAL FINDINGS
1263,claude37,0.78,SPREAD THROUGH AIR SPACES (STAS)
1264,claude37,0.871,NODAL SITE(S) EXAMINED
1265,claude37,0.815,REGIONAL LYMPH NODE STATUS
1266,claude37,0.788,PROCEDURE
1267,claude37,0.835,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1268,claude37,0.697,SPECIMEN LATERALITY
1269,claude37,0.89,TUMOR SITE
1270,claude37,0.698,VISCERAL PLEURA INVASION
1271,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1272,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1273,claude37,0.708,TUMOR FOCALITY
1274,claude37,0.79,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1275,claude37,0.752,TNM DESCRIPTORS
1276,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1277,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1278,claude37,0.87,NODAL SITE(S) EXAMINED
1279,claude37,0.678,TUMOR FOCALITY
1280,claude37,0.827,PROCEDURE
1281,claude37,0.851,TUMOR SITE
1282,claude37,0.693,MARGIN STATUS FOR INVASIVE CARCINOMA
1283,claude37,0.815,REGIONAL LYMPH NODE STATUS
1284,claude37,0.904,HISTOLOGIC GRADE
1285,claude37,0.778,VISCERAL PLEURA INVASION
1286,claude37,0.713,NUMBER OF LYMPH NODES EXAMINED
1287,claude37,0.697,SPECIMEN LATERALITY
1288,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
1289,claude37,0.835,NODAL SITE(S) EXAMINED
1290,claude37,0.778,VISCERAL PLEURA INVASION
1291,claude37,0.782,HISTOLOGIC GRADE
1292,claude37,0.692,NUMBER OF LYMPH NODES EXAMINED
1293,claude37,0.823,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1294,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
1295,claude37,0.78,REGIONAL LYMPH NODE STATUS
1296,claude37,0.849,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1297,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
1298,claude37,0.742,MARGIN STATUS FOR INVASIVE CARCINOMA
1299,claude37,0.713,NUMBER OF LYMPH NODES WITH TUMOR
1300,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1301,claude37,0.811,TUMOR FOCALITY
1302,claude37,0.755,PROCEDURE
1303,claude37,0.697,SPECIMEN LATERALITY
1304,claude37,0.778,TUMOR SITE
1305,claude37,0.761,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1306,claude37,0.796,NODAL SITE(S) EXAMINED
1307,claude37,0.89,TUMOR SITE
1308,claude37,0.685,ADDITIONAL FINDINGS
1309,claude37,0.71,TUMOR FOCALITY
1310,claude37,0.827,PROCEDURE
1311,claude37,0.78,SPREAD THROUGH AIR SPACES (STAS)
1312,claude37,0.778,VISCERAL PLEURA INVASION
1313,claude37,0.677,MARGIN STATUS FOR NON-INVASIVE TUMOR
1314,claude37,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1315,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1316,claude37,0.694,HISTOLOGIC GRADE
1317,claude37,0.855,MARGIN STATUS FOR INVASIVE CARCINOMA
1318,claude37,0.815,REGIONAL LYMPH NODE STATUS
1319,claude37,0.713,NUMBER OF LYMPH NODES EXAMINED
1320,claude37,0.698,SPECIMEN LATERALITY
1321,claude37,0.78,VISCERAL PLEURA INVASION
1322,claude37,0.89,TUMOR SITE
1323,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1324,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
1325,claude37,0.827,PROCEDURE
1326,claude37,0.697,SPECIMEN LATERALITY
1327,claude37,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1328,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1329,claude37,0.782,HISTOLOGIC GRADE
1330,claude37,0.811,TUMOR FOCALITY
1331,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1332,claude37,0.746,NODAL SITE(S) EXAMINED
1333,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
1334,claude37,0.815,REGIONAL LYMPH NODE STATUS
1335,claude37,0.825,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1336,claude37,0.732,ADDITIONAL FINDINGS
1337,claude37,0.818,NODAL SITE(S) EXAMINED
1338,claude37,0.755,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1339,claude37,0.815,REGIONAL LYMPH NODE STATUS
1340,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1341,claude37,0.78,VISCERAL PLEURA INVASION
1342,claude37,0.713,NUMBER OF LYMPH NODES EXAMINED
1343,claude37,0.827,PROCEDURE
1344,claude37,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1345,claude37,0.89,TUMOR SITE
1346,claude37,0.697,SPECIMEN LATERALITY
1347,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
1348,claude37,0.782,HISTOLOGIC GRADE
1349,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1350,claude37,0.811,TUMOR FOCALITY
1351,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1352,claude37,0.814,TNM DESCRIPTORS
1353,claude37,0.784,REGIONAL LYMPH NODE STATUS
1354,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1355,claude37,0.855,MARGIN STATUS FOR INVASIVE CARCINOMA
1356,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
1357,claude37,0.886,NODAL SITE(S) EXAMINED
1358,claude37,0.845,PROCEDURE
1359,claude37,0.77,NUMBER OF LYMPH NODES EXAMINED
1360,claude37,0.841,TUMOR FOCALITY
1361,claude37,0.78,VISCERAL PLEURA INVASION
1362,claude37,0.697,SPECIMEN LATERALITY
1363,claude37,0.838,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1364,claude37,0.687,TUMOR SITE
1365,claude37,0.782,HISTOLOGIC GRADE
1366,claude37,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1367,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
1368,claude37,0.869,NODAL SITE(S) EXAMINED
1369,claude37,0.811,TUMOR FOCALITY
1370,claude37,0.703,NUMBER OF LYMPH NODES EXAMINED
1371,claude37,0.893,TUMOR SITE
1372,claude37,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1373,claude37,0.778,VISCERAL PLEURA INVASION
1374,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1375,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1376,claude37,0.788,PROCEDURE
1377,claude37,0.815,REGIONAL LYMPH NODE STATUS
1378,claude37,0.697,SPECIMEN LATERALITY
1379,claude37,0.697,SPECIMEN LATERALITY
1380,claude37,0.685,TUMOR SITE
1381,claude37,0.73,TNM DESCRIPTORS
1382,claude37,0.838,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1383,claude37,0.827,PROCEDURE
1384,claude37,0.745,LYMPHOVASCULAR INVASION
1385,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
1386,claude37,0.841,TUMOR FOCALITY
1387,claude37,0.778,VISCERAL PLEURA INVASION
1388,claude37,0.855,MARGIN STATUS FOR INVASIVE CARCINOMA
1389,claude37,0.665,MARGIN STATUS FOR NON-INVASIVE TUMOR
1390,claude37,0.76,HISTOLOGIC GRADE
1391,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1392,claude37,0.726,REGIONAL LYMPH NODE STATUS
1393,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
1394,claude37,0.724,NODAL SITE(S) EXAMINED
1395,claude37,0.699,NUMBER OF LYMPH NODES WITH TUMOR
1396,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1397,claude37,0.788,PROCEDURE
1398,claude37,0.761,NUMBER OF LYMPH NODES EXAMINED
1399,claude37,0.824,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1400,claude37,0.811,TUMOR FOCALITY
1401,claude37,0.752,ADDITIONAL FINDINGS
1402,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1403,claude37,0.719,NODAL SITE(S) WITH TUMOR
1404,claude37,0.747,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1405,claude37,0.698,VISCERAL PLEURA INVASION
1406,claude37,0.698,SPECIMEN LATERALITY
1407,claude37,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1408,claude37,0.888,TUMOR SITE
1409,claude37,0.793,PROCEDURE
1410,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1411,claude37,0.887,TUMOR SITE
1412,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
1413,claude37,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1414,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1415,claude37,0.693,NUMBER OF LYMPH NODES EXAMINED
1416,claude37,0.893,ADDITIONAL FINDINGS
1417,claude37,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1418,claude37,0.76,HISTOLOGIC GRADE
1419,claude37,0.738,NODAL SITE(S) EXAMINED
1420,claude37,0.815,REGIONAL LYMPH NODE STATUS
1421,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
1422,claude37,0.697,SPECIMEN LATERALITY
1423,claude37,0.778,VISCERAL PLEURA INVASION
1424,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1425,claude37,0.811,TUMOR FOCALITY
1426,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1427,claude37,0.754,MARGIN STATUS FOR NON-INVASIVE TUMOR
1428,claude37,0.869,NODAL SITE(S) EXAMINED
1429,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
1430,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1431,claude37,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1432,claude37,0.749,TNM DESCRIPTORS
1433,claude37,0.823,ADDITIONAL FINDINGS
1434,claude37,0.795,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1435,claude37,0.788,PROCEDURE
1436,claude37,0.815,REGIONAL LYMPH NODE STATUS
1437,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1438,claude37,0.904,HISTOLOGIC GRADE
1439,claude37,0.697,SPECIMEN LATERALITY
1440,claude37,0.887,TUMOR SITE
1441,claude37,0.778,VISCERAL PLEURA INVASION
1442,claude37,0.841,TUMOR FOCALITY
1443,claude37,0.751,REGIONAL LYMPH NODE STATUS
1444,claude37,0.805,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1445,claude37,0.78,VISCERAL PLEURA INVASION
1446,claude37,0.938,ADDITIONAL FINDINGS
1447,claude37,0.698,SPECIMEN LATERALITY
1448,claude37,0.859,LYMPHOVASCULAR INVASION
1449,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1450,claude37,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
1451,claude37,0.767,NODAL SITE(S) WITH TUMOR
1452,claude37,0.788,PROCEDURE
1453,claude37,0.89,TUMOR SITE
1454,claude37,0.797,NODAL SITE(S) EXAMINED
1455,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1456,claude37,0.729,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1457,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
1458,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1459,claude37,0.698,NUMBER OF LYMPH NODES EXAMINED
1460,claude37,0.713,NUMBER OF LYMPH NODES WITH TUMOR
1461,claude37,0.811,TUMOR FOCALITY
1462,claude37,0.89,TUMOR SITE
1463,claude37,0.727,NODAL SITE(S) EXAMINED
1464,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1465,claude37,0.755,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1466,claude37,0.733,HISTOLOGIC GRADE
1467,claude37,0.802,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1468,claude37,0.724,REGIONAL LYMPH NODE STATUS
1469,claude37,0.698,SPECIMEN LATERALITY
1470,claude37,0.811,TUMOR FOCALITY
1471,claude37,0.78,VISCERAL PLEURA INVASION
1472,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1473,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1474,claude37,0.661,ADDITIONAL FINDINGS
1475,claude37,0.788,PROCEDURE
1476,claude37,0.826,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1477,claude37,0.753,LYMPHOVASCULAR INVASION
1478,claude37,0.7,SPREAD THROUGH AIR SPACES (STAS)
1479,claude37,0.815,REGIONAL LYMPH NODE STATUS
1480,claude37,0.678,TUMOR FOCALITY
1481,claude37,0.692,ADDITIONAL FINDINGS
1482,claude37,0.778,VISCERAL PLEURA INVASION
1483,claude37,0.841,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1484,claude37,0.72,PROCEDURE
1485,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1486,claude37,0.697,SPECIMEN LATERALITY
1487,claude37,0.792,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1488,claude37,0.858,TUMOR SITE
1489,claude37,0.812,NODAL SITE(S) EXAMINED
1490,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1491,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1492,claude37,0.693,NUMBER OF LYMPH NODES EXAMINED
1493,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1494,claude37,0.745,LYMPHOVASCULAR INVASION
1495,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1496,claude37,0.72,NUMBER OF LYMPH NODES WITH TUMOR
1497,claude37,0.684,REGIONAL LYMPH NODE STATUS
1498,claude37,0.701,HISTOLOGIC GRADE
1499,claude37,0.803,NODAL SITE(S) WITH TUMOR
1500,claude37,0.896,ADDITIONAL FINDINGS
1501,claude37,0.798,NODAL SITE(S) EXAMINED
1502,claude37,0.778,VISCERAL PLEURA INVASION
1503,claude37,0.697,SPECIMEN LATERALITY
1504,claude37,0.768,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1505,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
1506,claude37,0.808,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1507,claude37,0.845,PROCEDURE
1508,claude37,0.772,TUMOR SITE
1509,claude37,0.689,TUMOR FOCALITY
1510,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1511,claude37,0.801,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1512,claude37,0.791,TNM DESCRIPTORS
1513,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1514,claude37,0.782,HISTOLOGIC GRADE
1515,claude37,0.887,NODAL SITE(S) EXAMINED
1516,claude37,0.811,TUMOR FOCALITY
1517,claude37,0.745,LYMPHOVASCULAR INVASION
1518,claude37,0.709,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1519,claude37,0.778,VISCERAL PLEURA INVASION
1520,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1521,claude37,0.827,PROCEDURE
1522,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1523,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1524,claude37,0.697,SPECIMEN LATERALITY
1525,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
1526,claude37,0.887,TUMOR SITE
1527,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1528,claude37,0.735,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1529,claude37,0.815,REGIONAL LYMPH NODE STATUS
1530,claude37,0.697,SPECIMEN LATERALITY
1531,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1532,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1533,claude37,0.825,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1534,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1535,claude37,0.938,ADDITIONAL FINDINGS
1536,claude37,0.858,NODAL SITE(S) EXAMINED
1537,claude37,0.811,TUMOR FOCALITY
1538,claude37,0.782,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1539,claude37,0.769,REGIONAL LYMPH NODE STATUS
1540,claude37,0.78,VISCERAL PLEURA INVASION
1541,claude37,0.782,HISTOLOGIC GRADE
1542,claude37,0.788,PROCEDURE
1543,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
1544,claude37,0.824,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1545,claude37,0.89,TUMOR SITE
1546,claude37,0.7,SPREAD THROUGH AIR SPACES (STAS)
1547,claude37,0.692,TUMOR FOCALITY
1548,claude37,0.709,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1549,claude37,0.795,TNM DESCRIPTORS
1550,claude37,0.705,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1551,claude37,0.887,TUMOR SITE
1552,claude37,0.683,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1553,claude37,0.873,ADDITIONAL FINDINGS
1554,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1555,claude37,0.693,NUMBER OF LYMPH NODES EXAMINED
1556,claude37,0.778,VISCERAL PLEURA INVASION
1557,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1558,claude37,0.815,REGIONAL LYMPH NODE STATUS
1559,claude37,0.723,HISTOLOGIC GRADE
1560,claude37,0.866,NODAL SITE(S) EXAMINED
1561,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1562,claude37,0.697,SPECIMEN LATERALITY
1563,claude37,0.727,PROCEDURE
1564,claude37,0.787,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1565,claude37,0.69,NODAL SITE(S) EXAMINED
1566,claude37,0.815,REGIONAL LYMPH NODE STATUS
1567,claude37,0.698,SPECIMEN LATERALITY
1568,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
1569,claude37,0.811,TUMOR FOCALITY
1570,claude37,0.76,HISTOLOGIC GRADE
1571,claude37,0.788,PROCEDURE
1572,claude37,0.727,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1573,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1574,claude37,0.787,ADDITIONAL FINDINGS
1575,claude37,0.888,TUMOR SITE
1576,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
1577,claude37,0.78,VISCERAL PLEURA INVASION
1578,claude37,0.835,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1579,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1580,claude37,0.722,NUMBER OF LYMPH NODES EXAMINED
1581,claude37,0.698,SPECIMEN LATERALITY
1582,claude37,0.735,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1583,claude37,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1584,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1585,claude37,0.821,TUMOR SITE
1586,claude37,0.839,NODAL SITE(S) EXAMINED
1587,claude37,0.778,VISCERAL PLEURA INVASION
1588,claude37,0.847,REGIONAL LYMPH NODE STATUS
1589,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1590,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1591,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
1592,claude37,0.811,TUMOR FOCALITY
1593,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1594,claude37,0.736,HISTOLOGIC GRADE
1595,claude37,0.788,PROCEDURE
1596,claude37,0.815,REGIONAL LYMPH NODE STATUS
1597,claude37,0.816,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1598,claude37,0.78,VISCERAL PLEURA INVASION
1599,claude37,0.745,LYMPHOVASCULAR INVASION
1600,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1601,claude37,0.788,PROCEDURE
1602,claude37,0.783,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1603,claude37,0.736,HISTOLOGIC GRADE
1604,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1605,claude37,0.72,TNM DESCRIPTORS
1606,claude37,0.698,SPECIMEN LATERALITY
1607,claude37,0.679,NODAL SITE(S) EXAMINED
1608,claude37,0.708,TUMOR FOCALITY
1609,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1610,claude37,0.89,TUMOR SITE
1611,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
1612,claude37,0.843,ADDITIONAL FINDINGS
1613,claude37,0.712,LYMPHOVASCULAR INVASION
1614,claude37,0.788,PROCEDURE
1615,claude37,0.888,TUMOR SITE
1616,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1617,claude37,0.733,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1618,claude37,0.727,TNM DESCRIPTORS
1619,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1620,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1621,claude37,0.795,NODAL SITE(S) WITH TUMOR
1622,claude37,0.698,SPECIMEN LATERALITY
1623,claude37,0.778,VISCERAL PLEURA INVASION
1624,claude37,0.699,NODAL SITE(S) EXAMINED
1625,claude37,0.704,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1626,claude37,0.892,HISTOLOGIC GRADE
1627,claude37,0.771,REGIONAL LYMPH NODE STATUS
1628,claude37,0.72,NUMBER OF LYMPH NODES WITH TUMOR
1629,claude37,0.71,NUMBER OF LYMPH NODES EXAMINED
1630,claude37,0.75,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1631,claude37,0.811,TUMOR FOCALITY
1632,claude37,0.887,TUMOR SITE
1633,claude37,0.775,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1634,claude37,0.765,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1635,claude37,0.721,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1636,claude37,0.808,NODAL SITE(S) EXAMINED
1637,claude37,0.778,VISCERAL PLEURA INVASION
1638,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1639,claude37,0.819,ADDITIONAL FINDINGS
1640,claude37,0.791,PROCEDURE
1641,claude37,0.697,SPECIMEN LATERALITY
1642,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
1643,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1644,claude37,0.815,REGIONAL LYMPH NODE STATUS
1645,claude37,0.678,TUMOR FOCALITY
1646,claude37,0.703,NUMBER OF LYMPH NODES EXAMINED
1647,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
1648,claude37,0.904,HISTOLOGIC GRADE
1649,claude37,0.815,REGIONAL LYMPH NODE STATUS
1650,claude37,0.791,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1651,claude37,0.888,TUMOR SITE
1652,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1653,claude37,0.778,VISCERAL PLEURA INVASION
1654,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1655,claude37,0.693,NUMBER OF LYMPH NODES EXAMINED
1656,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1657,claude37,0.825,PROCEDURE
1658,claude37,0.698,SPECIMEN LATERALITY
1659,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1660,claude37,0.798,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1661,claude37,0.811,TUMOR FOCALITY
1662,claude37,0.787,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1663,claude37,0.788,PROCEDURE
1664,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1665,claude37,0.78,REGIONAL LYMPH NODE STATUS
1666,claude37,0.89,TUMOR SITE
1667,claude37,0.888,NODAL SITE(S) WITH TUMOR
1668,claude37,0.703,NUMBER OF LYMPH NODES WITH TUMOR
1669,claude37,0.76,HISTOLOGIC GRADE
1670,claude37,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1671,claude37,0.78,VISCERAL PLEURA INVASION
1672,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1673,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1674,claude37,0.745,LYMPHOVASCULAR INVASION
1675,claude37,0.841,NODAL SITE(S) EXAMINED
1676,claude37,0.902,ADDITIONAL FINDINGS
1677,claude37,0.697,SPECIMEN LATERALITY
1678,claude37,0.817,NUMBER OF LYMPH NODES EXAMINED
1679,claude37,0.811,TUMOR FOCALITY
1680,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1681,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1682,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1683,claude37,0.697,SPECIMEN LATERALITY
1684,claude37,0.874,NODAL SITE(S) EXAMINED
1685,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1686,claude37,0.887,TUMOR SITE
1687,claude37,0.77,ADDITIONAL FINDINGS
1688,claude37,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1689,claude37,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1690,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1691,claude37,0.815,REGIONAL LYMPH NODE STATUS
1692,claude37,0.76,HISTOLOGIC GRADE
1693,claude37,0.811,TUMOR FOCALITY
1694,claude37,0.78,SPREAD THROUGH AIR SPACES (STAS)
1695,claude37,0.788,PROCEDURE
1696,claude37,0.78,VISCERAL PLEURA INVASION
1697,claude37,0.699,NUMBER OF LYMPH NODES EXAMINED
1698,claude37,0.815,REGIONAL LYMPH NODE STATUS
1699,claude37,0.76,HISTOLOGIC GRADE
1700,claude37,0.727,NODAL SITE(S) EXAMINED
1701,claude37,0.738,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1702,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1703,claude37,0.811,TUMOR FOCALITY
1704,claude37,0.798,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1705,claude37,0.89,TUMOR SITE
1706,claude37,0.78,VISCERAL PLEURA INVASION
1707,claude37,0.761,PROCEDURE
1708,claude37,0.681,LYMPHOVASCULAR INVASION
1709,claude37,0.697,SPECIMEN LATERALITY
1710,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1711,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1712,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1713,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1714,claude37,0.808,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1715,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1716,claude37,0.811,TUMOR FOCALITY
1717,claude37,0.841,NODAL SITE(S) EXAMINED
1718,claude37,0.887,TUMOR SITE
1719,claude37,0.892,HISTOLOGIC GRADE
1720,claude37,0.843,ADDITIONAL FINDINGS
1721,claude37,0.796,PROCEDURE
1722,claude37,0.786,REGIONAL LYMPH NODE STATUS
1723,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
1724,claude37,0.697,SPECIMEN LATERALITY
1725,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1726,claude37,0.778,VISCERAL PLEURA INVASION
1727,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1728,claude37,0.835,NODAL SITE(S) EXAMINED
1729,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1730,claude37,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1731,claude37,0.825,PROCEDURE
1732,claude37,0.778,VISCERAL PLEURA INVASION
1733,claude37,0.782,HISTOLOGIC GRADE
1734,claude37,0.723,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1735,claude37,0.811,TUMOR FOCALITY
1736,claude37,0.698,SPECIMEN LATERALITY
1737,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
1738,claude37,0.815,REGIONAL LYMPH NODE STATUS
1739,claude37,0.888,TUMOR SITE
1740,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1741,claude37,0.782,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1742,claude37,0.782,HISTOLOGIC GRADE
1743,claude37,0.746,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1744,claude37,0.693,NUMBER OF LYMPH NODES EXAMINED
1745,claude37,0.697,SPECIMEN LATERALITY
1746,claude37,0.795,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1747,claude37,0.788,PROCEDURE
1748,claude37,0.817,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1749,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1750,claude37,0.887,TUMOR SITE
1751,claude37,0.871,NODAL SITE(S) EXAMINED
1752,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1753,claude37,0.811,TUMOR FOCALITY
1754,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1755,claude37,0.778,VISCERAL PLEURA INVASION
1756,claude37,0.835,REGIONAL LYMPH NODE STATUS
1757,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
1758,claude37,0.778,VISCERAL PLEURA INVASION
1759,claude37,0.697,SPECIMEN LATERALITY
1760,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1761,claude37,0.691,NUMBER OF LYMPH NODES EXAMINED
1762,claude37,0.851,TUMOR SITE
1763,claude37,0.815,REGIONAL LYMPH NODE STATUS
1764,claude37,0.793,PROCEDURE
1765,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1766,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1767,claude37,0.805,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1768,claude37,0.811,TUMOR FOCALITY
1769,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1770,claude37,0.782,HISTOLOGIC GRADE
1771,claude37,0.871,NODAL SITE(S) EXAMINED
1772,claude37,0.752,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1773,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1774,claude37,0.813,LYMPHOVASCULAR INVASION
1775,claude37,0.729,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1776,claude37,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1777,claude37,0.737,REGIONAL LYMPH NODE STATUS
1778,claude37,0.76,HISTOLOGIC GRADE
1779,claude37,0.763,NODAL SITE(S) EXAMINED
1780,claude37,0.778,VISCERAL PLEURA INVASION
1781,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1782,claude37,0.697,SPECIMEN LATERALITY
1783,claude37,0.832,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1784,claude37,0.811,TUMOR FOCALITY
1785,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
1786,claude37,0.788,PROCEDURE
1787,claude37,0.645,SPREAD THROUGH AIR SPACES (STAS)
1788,claude37,0.851,TUMOR SITE
1789,claude37,0.811,TUMOR FOCALITY
1790,claude37,0.887,TUMOR SITE
1791,claude37,0.697,SPECIMEN LATERALITY
1792,claude37,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1793,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1794,claude37,0.815,REGIONAL LYMPH NODE STATUS
1795,claude37,0.742,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1796,claude37,0.795,PROCEDURE
1797,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1798,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
1799,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1800,claude37,0.778,VISCERAL PLEURA INVASION
1801,claude37,0.74,NODAL SITE(S) EXAMINED
1802,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1803,claude37,0.74,HISTOLOGIC GRADE
1804,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1805,claude37,0.698,VISCERAL PLEURA INVASION
1806,claude37,0.811,TUMOR FOCALITY
1807,claude37,0.782,HISTOLOGIC GRADE
1808,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1809,claude37,0.827,PROCEDURE
1810,claude37,0.698,SPECIMEN LATERALITY
1811,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1812,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1813,claude37,0.7,NUMBER OF LYMPH NODES EXAMINED
1814,claude37,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1815,claude37,0.888,TUMOR SITE
1816,claude37,0.815,REGIONAL LYMPH NODE STATUS
1817,claude37,0.813,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1818,claude37,0.67,NODAL SITE(S) EXAMINED
1819,claude37,0.825,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1820,claude37,0.697,SPECIMEN LATERALITY
1821,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
1822,claude37,0.729,REGIONAL LYMPH NODE STATUS
1823,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1824,claude37,0.692,NUMBER OF LYMPH NODES EXAMINED
1825,claude37,0.778,VISCERAL PLEURA INVASION
1826,claude37,0.755,NODAL SITE(S) EXAMINED
1827,claude37,0.89,TUMOR SITE
1828,claude37,0.811,TUMOR FOCALITY
1829,claude37,0.788,PROCEDURE
1830,claude37,0.802,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1831,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1832,claude37,0.782,HISTOLOGIC GRADE
1833,claude37,0.805,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1834,claude37,0.7,NUMBER OF LYMPH NODES EXAMINED
1835,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
1836,claude37,0.78,VISCERAL PLEURA INVASION
1837,claude37,0.731,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1838,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1839,claude37,0.745,MARGIN STATUS FOR NON-INVASIVE TUMOR
1840,claude37,0.742,MARGIN STATUS FOR INVASIVE CARCINOMA
1841,claude37,0.827,PROCEDURE
1842,claude37,0.815,REGIONAL LYMPH NODE STATUS
1843,claude37,0.782,HISTOLOGIC GRADE
1844,claude37,0.715,ADDITIONAL FINDINGS
1845,claude37,0.697,SPECIMEN LATERALITY
1846,claude37,0.725,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1847,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1848,claude37,0.811,TUMOR FOCALITY
1849,claude37,0.748,NODAL SITE(S) EXAMINED
1850,claude37,0.887,TUMOR SITE
1851,claude37,0.745,LYMPHOVASCULAR INVASION
1852,claude37,0.811,TUMOR FOCALITY
1853,claude37,0.733,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1854,claude37,0.823,NODAL SITE(S) EXAMINED
1855,claude37,0.813,ADDITIONAL FINDINGS
1856,claude37,0.788,PROCEDURE
1857,claude37,0.887,TUMOR SITE
1858,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1859,claude37,0.84,REGIONAL LYMPH NODE STATUS
1860,claude37,0.775,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1861,claude37,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1862,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1863,claude37,0.697,SPECIMEN LATERALITY
1864,claude37,0.778,VISCERAL PLEURA INVASION
1865,claude37,0.832,NUMBER OF LYMPH NODES EXAMINED
1866,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1867,claude37,0.793,REGIONAL LYMPH NODE STATUS
1868,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1869,claude37,0.793,PROCEDURE
1870,claude37,0.811,TUMOR FOCALITY
1871,claude37,0.738,ADDITIONAL FINDINGS
1872,claude37,0.782,HISTOLOGIC GRADE
1873,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1874,claude37,0.698,SPECIMEN LATERALITY
1875,claude37,0.778,VISCERAL PLEURA INVASION
1876,claude37,0.888,TUMOR SITE
1877,claude37,0.775,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1878,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1879,claude37,0.817,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1880,claude37,0.8,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1881,claude37,0.77,NODAL SITE(S) EXAMINED
1882,claude37,0.698,SPECIMEN LATERALITY
1883,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1884,claude37,0.788,HISTOLOGIC GRADE
1885,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
1886,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1887,claude37,0.818,NODAL SITE(S) EXAMINED
1888,claude37,0.72,NUMBER OF LYMPH NODES WITH TUMOR
1889,claude37,0.814,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1890,claude37,0.82,NODAL SITE(S) WITH TUMOR
1891,claude37,0.74,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1892,claude37,0.76,REGIONAL LYMPH NODE STATUS
1893,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
1894,claude37,0.782,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1895,claude37,0.694,NUMBER OF LYMPH NODES EXAMINED
1896,claude37,0.704,TUMOR FOCALITY
1897,claude37,0.698,TUMOR SITE
1898,claude37,0.778,VISCERAL PLEURA INVASION
1899,claude37,0.724,PROCEDURE
1900,claude37,0.693,MARGIN STATUS FOR INVASIVE CARCINOMA
1901,claude37,0.882,REGIONAL LYMPH NODE STATUS
1902,claude37,0.698,SPECIMEN LATERALITY
1903,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1904,claude37,0.793,PROCEDURE
1905,claude37,0.751,TUMOR SITE
1906,claude37,0.811,TUMOR FOCALITY
1907,claude37,0.713,NUMBER OF LYMPH NODES EXAMINED
1908,claude37,0.799,NODAL SITE(S) EXAMINED
1909,claude37,0.792,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1910,claude37,0.778,VISCERAL PLEURA INVASION
1911,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
1912,claude37,0.76,HISTOLOGIC GRADE
1913,claude37,0.697,SPECIMEN LATERALITY
1914,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1915,claude37,0.816,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1916,claude37,0.841,REGIONAL LYMPH NODE STATUS
1917,claude37,0.878,NODAL SITE(S) EXAMINED
1918,claude37,0.78,VISCERAL PLEURA INVASION
1919,claude37,0.893,TUMOR SITE
1920,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1921,claude37,0.829,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1922,claude37,0.78,SPREAD THROUGH AIR SPACES (STAS)
1923,claude37,0.788,PROCEDURE
1924,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1925,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
1926,claude37,0.811,TUMOR FOCALITY
1927,claude37,0.783,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1928,claude37,0.788,HISTOLOGIC GRADE
1929,claude37,0.815,REGIONAL LYMPH NODE STATUS
1930,claude37,0.698,SPECIMEN LATERALITY
1931,claude37,0.788,PROCEDURE
1932,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
1933,claude37,0.808,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1934,claude37,0.826,TUMOR FOCALITY
1935,claude37,0.687,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1936,claude37,0.804,NODAL SITE(S) EXAMINED
1937,claude37,0.869,ADDITIONAL FINDINGS
1938,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1939,claude37,0.778,VISCERAL PLEURA INVASION
1940,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1941,claude37,0.888,TUMOR SITE
1942,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
1943,claude37,0.771,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1944,claude37,0.887,TUMOR SITE
1945,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1946,claude37,0.697,SPECIMEN LATERALITY
1947,claude37,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1948,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
1949,claude37,0.904,HISTOLOGIC GRADE
1950,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1951,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1952,claude37,0.778,VISCERAL PLEURA INVASION
1953,claude37,0.72,NUMBER OF LYMPH NODES EXAMINED
1954,claude37,0.811,TUMOR FOCALITY
1955,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1956,claude37,0.87,NODAL SITE(S) EXAMINED
1957,claude37,0.735,REGIONAL LYMPH NODE STATUS
1958,claude37,0.827,PROCEDURE
1959,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1960,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1961,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1962,claude37,0.782,HISTOLOGIC GRADE
1963,claude37,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1964,claude37,0.695,NUMBER OF LYMPH NODES EXAMINED
1965,claude37,0.697,SPECIMEN LATERALITY
1966,claude37,0.78,SPREAD THROUGH AIR SPACES (STAS)
1967,claude37,0.887,TUMOR SITE
1968,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1969,claude37,0.787,REGIONAL LYMPH NODE STATUS
1970,claude37,0.811,TUMOR FOCALITY
1971,claude37,0.831,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1972,claude37,0.788,PROCEDURE
1973,claude37,0.85,NODAL SITE(S) EXAMINED
1974,claude37,0.778,VISCERAL PLEURA INVASION
1975,claude37,0.89,TUMOR SITE
1976,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1977,claude37,0.697,SPECIMEN LATERALITY
1978,claude37,0.726,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1979,claude37,0.788,PROCEDURE
1980,claude37,0.76,NODAL SITE(S) EXAMINED
1981,claude37,0.709,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1982,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
1983,claude37,0.811,TUMOR FOCALITY
1984,claude37,0.705,NUMBER OF LYMPH NODES EXAMINED
1985,claude37,0.822,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1986,claude37,0.778,VISCERAL PLEURA INVASION
1987,claude37,0.683,LYMPH NODE(S) FROM PRIOR PROCEDURES
1988,claude37,0.745,LYMPHOVASCULAR INVASION
1989,claude37,0.72,NUMBER OF LYMPH NODES WITH TUMOR
1990,claude37,0.704,REGIONAL LYMPH NODE STATUS
1991,claude37,0.725,NODAL SITE(S) WITH TUMOR
1992,claude37,0.811,TUMOR FOCALITY
1993,claude37,0.778,VISCERAL PLEURA INVASION
1994,claude37,0.734,NODAL SITE(S) EXAMINED
1995,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
1996,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1997,claude37,0.782,HISTOLOGIC GRADE
1998,claude37,0.827,PROCEDURE
1999,claude37,0.697,SPECIMEN LATERALITY
2000,claude37,0.887,TUMOR SITE
2001,claude37,0.815,REGIONAL LYMPH NODE STATUS
2002,claude37,0.821,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2003,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2004,claude37,0.754,ADDITIONAL FINDINGS
2005,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
2006,claude37,0.697,NUMBER OF LYMPH NODES EXAMINED
2007,claude37,0.82,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2008,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
2009,claude37,0.681,TUMOR SITE
2010,claude37,0.811,TUMOR FOCALITY
2011,claude37,0.722,TNM DESCRIPTORS
2012,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
2013,claude37,0.786,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2014,claude37,0.788,HISTOLOGIC GRADE
2015,claude37,0.698,SPECIMEN LATERALITY
2016,claude37,0.72,NUMBER OF LYMPH NODES EXAMINED
2017,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2018,claude37,0.778,VISCERAL PLEURA INVASION
2019,claude37,0.775,REGIONAL LYMPH NODE STATUS
2020,claude37,0.666,ADDITIONAL FINDINGS
2021,claude37,0.778,NODAL SITE(S) EXAMINED
2022,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2023,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
2024,claude37,0.781,PROCEDURE
2025,claude37,0.793,PROCEDURE
2026,claude37,0.811,TUMOR FOCALITY
2027,claude37,0.834,NODAL SITE(S) EXAMINED
2028,claude37,0.679,ADDITIONAL FINDINGS
2029,claude37,0.778,VISCERAL PLEURA INVASION
2030,claude37,0.697,SPECIMEN LATERALITY
2031,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2032,claude37,0.823,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2033,claude37,0.75,TUMOR SITE
2034,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2035,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
2036,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2037,claude37,0.815,REGIONAL LYMPH NODE STATUS
2038,claude37,0.901,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2039,claude37,0.923,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2040,claude37,0.782,HISTOLOGIC GRADE
2041,claude37,0.888,TUMOR SITE
2042,claude37,0.778,VISCERAL PLEURA INVASION
2043,claude37,0.811,ADDITIONAL FINDINGS
2044,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2045,claude37,0.788,HISTOLOGIC GRADE
2046,claude37,0.765,NODAL SITE(S) EXAMINED
2047,claude37,0.698,SPECIMEN LATERALITY
2048,claude37,0.683,LYMPH NODE(S) FROM PRIOR PROCEDURES
2049,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
2050,claude37,0.702,NUMBER OF LYMPH NODES EXAMINED
2051,claude37,0.821,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2052,claude37,0.751,REGIONAL LYMPH NODE STATUS
2053,claude37,0.788,PROCEDURE
2054,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2055,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2056,claude37,0.837,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2057,claude37,0.811,TUMOR FOCALITY
2058,claude37,0.824,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2059,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2060,claude37,0.811,TUMOR FOCALITY
2061,claude37,0.888,TUMOR SITE
2062,claude37,0.698,SPECIMEN LATERALITY
2063,claude37,0.687,LYMPHOVASCULAR INVASION
2064,claude37,0.771,MARGIN STATUS FOR INVASIVE CARCINOMA
2065,claude37,0.703,NUMBER OF LYMPH NODES EXAMINED
2066,claude37,0.782,HISTOLOGIC GRADE
2067,claude37,0.809,NODAL SITE(S) EXAMINED
2068,claude37,0.778,VISCERAL PLEURA INVASION
2069,claude37,0.797,PROCEDURE
2070,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
2071,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
2072,claude37,0.725,TNM DESCRIPTORS
2073,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2074,claude37,0.855,NODAL SITE(S) EXAMINED
2075,claude37,0.72,NUMBER OF LYMPH NODES WITH TUMOR
2076,claude37,0.778,VISCERAL PLEURA INVASION
2077,claude37,0.787,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2078,claude37,0.797,TUMOR SITE
2079,claude37,0.701,HISTOLOGIC GRADE
2080,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2081,claude37,0.753,REGIONAL LYMPH NODE STATUS
2082,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2083,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
2084,claude37,0.708,TUMOR FOCALITY
2085,claude37,0.767,TNM DESCRIPTORS
2086,claude37,0.697,SPECIMEN LATERALITY
2087,claude37,0.733,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2088,claude37,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2089,claude37,0.815,NODAL SITE(S) WITH TUMOR
2090,claude37,0.738,PROCEDURE
2091,claude37,0.824,TUMOR SITE
2092,claude37,0.811,TUMOR FOCALITY
2093,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2094,claude37,0.778,VISCERAL PLEURA INVASION
2095,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
2096,claude37,0.838,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2097,claude37,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2098,claude37,0.843,NODAL SITE(S) EXAMINED
2099,claude37,0.793,PROCEDURE
2100,claude37,0.815,REGIONAL LYMPH NODE STATUS
2101,claude37,0.698,SPECIMEN LATERALITY
2102,claude37,0.782,HISTOLOGIC GRADE
2103,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2104,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2105,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2106,claude37,0.803,NODAL SITE(S) EXAMINED
2107,claude37,0.698,VISCERAL PLEURA INVASION
2108,claude37,0.817,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2109,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
2110,claude37,0.72,PROCEDURE
2111,claude37,0.808,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2112,claude37,0.811,TUMOR FOCALITY
2113,claude37,0.698,LYMPHOVASCULAR INVASION
2114,claude37,0.698,SPECIMEN LATERALITY
2115,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2116,claude37,0.734,NUMBER OF LYMPH NODES EXAMINED
2117,claude37,0.786,TUMOR SITE
2118,claude37,0.736,HISTOLOGIC GRADE
2119,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2120,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2121,claude37,0.815,REGIONAL LYMPH NODE STATUS
2122,claude37,0.754,ADDITIONAL FINDINGS
2123,claude37,0.811,TUMOR FOCALITY
2124,claude37,0.725,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2125,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
2126,claude37,0.816,NODAL SITE(S) EXAMINED
2127,claude37,0.777,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2128,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2129,claude37,0.822,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2130,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
2131,claude37,0.788,PROCEDURE
2132,claude37,0.78,VISCERAL PLEURA INVASION
2133,claude37,0.698,SPECIMEN LATERALITY
2134,claude37,0.691,NUMBER OF LYMPH NODES EXAMINED
2135,claude37,0.892,HISTOLOGIC GRADE
2136,claude37,0.789,REGIONAL LYMPH NODE STATUS
2137,claude37,0.89,TUMOR SITE
2138,claude37,0.778,VISCERAL PLEURA INVASION
2139,claude37,0.788,PROCEDURE
2140,claude37,0.782,HISTOLOGIC GRADE
2141,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2142,claude37,0.829,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2143,claude37,0.89,TUMOR SITE
2144,claude37,0.816,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2145,claude37,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2146,claude37,0.697,SPECIMEN LATERALITY
2147,claude37,0.815,REGIONAL LYMPH NODE STATUS
2148,claude37,0.811,TUMOR FOCALITY
2149,claude37,0.83,NODAL SITE(S) EXAMINED
2150,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2151,claude37,0.789,ADDITIONAL FINDINGS
2152,claude37,0.699,NUMBER OF LYMPH NODES EXAMINED
2153,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2154,claude37,0.811,TUMOR FOCALITY
2155,claude37,0.827,PROCEDURE
2156,claude37,0.893,TUMOR SITE
2157,claude37,0.782,HISTOLOGIC GRADE
2158,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2159,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2160,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2161,claude37,0.843,NODAL SITE(S) EXAMINED
2162,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2163,claude37,0.829,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2164,claude37,0.815,REGIONAL LYMPH NODE STATUS
2165,claude37,0.697,SPECIMEN LATERALITY
2166,claude37,0.758,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2167,claude37,0.778,VISCERAL PLEURA INVASION
2168,claude37,0.835,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2169,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
2170,claude37,0.778,VISCERAL PLEURA INVASION
2171,claude37,0.788,PROCEDURE
2172,claude37,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2173,claude37,0.744,NUMBER OF LYMPH NODES EXAMINED
2174,claude37,0.811,TUMOR FOCALITY
2175,claude37,0.89,TUMOR SITE
2176,claude37,0.903,ADDITIONAL FINDINGS
2177,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2178,claude37,0.698,SPECIMEN LATERALITY
2179,claude37,0.773,REGIONAL LYMPH NODE STATUS
2180,claude37,0.78,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2181,claude37,0.754,NODAL SITE(S) EXAMINED
2182,claude37,0.736,HISTOLOGIC GRADE
2183,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2184,claude37,0.703,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2185,claude37,0.657,LYMPHOVASCULAR INVASION
2186,claude37,0.698,SPECIMEN LATERALITY
2187,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2188,claude37,0.843,ADDITIONAL FINDINGS
2189,claude37,0.827,PROCEDURE
2190,claude37,0.692,LYMPH NODE(S) FROM PRIOR PROCEDURES
2191,claude37,0.72,NODAL SITE(S) EXAMINED
2192,claude37,0.678,TNM DESCRIPTORS
2193,claude37,0.78,VISCERAL PLEURA INVASION
2194,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2195,claude37,0.869,NODAL SITE(S) WITH TUMOR
2196,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
2197,claude37,0.678,TUMOR FOCALITY
2198,claude37,0.89,TUMOR SITE
2199,claude37,0.719,REGIONAL LYMPH NODE STATUS
2200,claude37,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2201,claude37,0.853,ADDITIONAL FINDINGS
2202,claude37,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2203,claude37,0.727,NODAL SITE(S) EXAMINED
2204,claude37,0.778,VISCERAL PLEURA INVASION
2205,claude37,0.788,PROCEDURE
2206,claude37,0.815,REGIONAL LYMPH NODE STATUS
2207,claude37,0.726,TNM DESCRIPTORS
2208,claude37,0.794,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2209,claude37,0.904,HISTOLOGIC GRADE
2210,claude37,0.888,MARGIN STATUS FOR NON-INVASIVE TUMOR
2211,claude37,0.766,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2212,claude37,0.728,TUMOR FOCALITY
2213,claude37,0.697,SPECIMEN LATERALITY
2214,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2215,claude37,0.89,TUMOR SITE
2216,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2217,claude37,0.887,TUMOR SITE
2218,claude37,0.742,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2219,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2220,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2221,claude37,0.827,PROCEDURE
2222,claude37,0.815,REGIONAL LYMPH NODE STATUS
2223,claude37,0.805,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2224,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2225,claude37,0.782,HISTOLOGIC GRADE
2226,claude37,0.778,VISCERAL PLEURA INVASION
2227,claude37,0.811,TUMOR FOCALITY
2228,claude37,0.865,NODAL SITE(S) EXAMINED
2229,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2230,claude37,0.7,NUMBER OF LYMPH NODES EXAMINED
2231,claude37,0.697,SPECIMEN LATERALITY
2232,claude37,0.731,REGIONAL LYMPH NODE STATUS
2233,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2234,claude37,0.892,HISTOLOGIC GRADE
2235,claude37,0.752,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2236,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2237,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2238,claude37,0.811,TUMOR FOCALITY
2239,claude37,0.838,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2240,claude37,0.788,PROCEDURE
2241,claude37,0.704,NUMBER OF LYMPH NODES EXAMINED
2242,claude37,0.697,SPECIMEN LATERALITY
2243,claude37,0.887,TUMOR SITE
2244,claude37,0.816,NODAL SITE(S) EXAMINED
2245,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2246,claude37,0.778,VISCERAL PLEURA INVASION
2247,claude37,0.713,LYMPHOVASCULAR INVASION
2248,claude37,0.734,PROCEDURE
2249,claude37,0.698,NUMBER OF LYMPH NODES WITH TUMOR
2250,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
2251,claude37,0.729,TUMOR SITE
2252,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2253,claude37,0.76,HISTOLOGIC GRADE
2254,claude37,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2255,claude37,0.742,MARGIN STATUS FOR INVASIVE CARCINOMA
2256,claude37,0.731,REGIONAL LYMPH NODE STATUS
2257,claude37,0.727,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2258,claude37,0.796,NODAL SITE(S) EXAMINED
2259,claude37,0.698,SPECIMEN LATERALITY
2260,claude37,0.708,TUMOR FOCALITY
2261,claude37,0.782,ADDITIONAL FINDINGS
2262,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
2263,claude37,0.729,MARGIN STATUS FOR NON-INVASIVE TUMOR
2264,claude37,0.714,NUMBER OF LYMPH NODES EXAMINED
2265,claude37,0.698,VISCERAL PLEURA INVASION
2266,claude37,0.795,TNM DESCRIPTORS
2267,claude37,0.798,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2268,claude37,0.887,TUMOR SITE
2269,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2270,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2271,claude37,0.781,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2272,claude37,0.762,ADDITIONAL FINDINGS
2273,claude37,0.815,NODAL SITE(S) EXAMINED
2274,claude37,0.827,PROCEDURE
2275,claude37,0.744,HISTOLOGIC GRADE
2276,claude37,0.78,SPREAD THROUGH AIR SPACES (STAS)
2277,claude37,0.869,TUMOR SITE
2278,claude37,0.811,TUMOR FOCALITY
2279,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2280,claude37,0.817,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2281,claude37,0.697,SPECIMEN LATERALITY
2282,claude37,0.78,VISCERAL PLEURA INVASION
2283,claude37,0.735,REGIONAL LYMPH NODE STATUS
2284,claude37,0.76,MARGIN STATUS FOR INVASIVE CARCINOMA
2285,claude37,0.697,SPECIMEN LATERALITY
2286,claude37,0.76,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2287,claude37,0.778,VISCERAL PLEURA INVASION
2288,claude37,0.677,HISTOLOGIC GRADE
2289,claude37,0.893,TUMOR SITE
2290,claude37,0.741,NODAL SITE(S) EXAMINED
2291,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
2292,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
2293,claude37,0.815,REGIONAL LYMPH NODE STATUS
2294,claude37,0.683,LYMPH NODE(S) FROM PRIOR PROCEDURES
2295,claude37,0.788,PROCEDURE
2296,claude37,0.811,TUMOR FOCALITY
2297,claude37,0.901,NODAL SITE(S) WITH TUMOR
2298,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2299,claude37,0.829,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2300,claude37,0.816,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2301,claude37,0.745,LYMPHOVASCULAR INVASION
2302,claude37,0.698,SPECIMEN LATERALITY
2303,claude37,0.705,TUMOR SITE
2304,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2305,claude37,0.778,VISCERAL PLEURA INVASION
2306,claude37,0.811,TUMOR FOCALITY
2307,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2308,claude37,0.705,NUMBER OF LYMPH NODES EXAMINED
2309,claude37,0.75,REGIONAL LYMPH NODE STATUS
2310,claude37,0.76,HISTOLOGIC GRADE
2311,claude37,0.801,NODAL SITE(S) EXAMINED
2312,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2313,claude37,0.713,NUMBER OF LYMPH NODES WITH TUMOR
2314,claude37,0.793,PROCEDURE
2315,claude37,0.778,VISCERAL PLEURA INVASION
2316,claude37,0.815,REGIONAL LYMPH NODE STATUS
2317,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2318,claude37,0.764,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2319,claude37,0.731,NODAL SITE(S) EXAMINED
2320,claude37,0.763,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2321,claude37,0.626,TUMOR SITE
2322,claude37,0.827,PROCEDURE
2323,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
2324,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2325,claude37,0.838,ADDITIONAL FINDINGS
2326,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2327,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
2328,claude37,0.712,HISTOLOGIC GRADE
2329,claude37,0.697,SPECIMEN LATERALITY
2330,claude37,0.713,NUMBER OF LYMPH NODES EXAMINED
2331,claude37,0.841,TUMOR FOCALITY
2332,claude37,0.713,NODAL SITE(S) EXAMINED
2333,claude37,0.681,TNM DESCRIPTORS
2334,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2335,claude37,0.796,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2336,claude37,0.746,TUMOR SITE
2337,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
2338,claude37,0.702,NUMBER OF LYMPH NODES EXAMINED
2339,claude37,0.827,PROCEDURE
2340,claude37,0.698,SPECIMEN LATERALITY
2341,claude37,0.714,HISTOLOGIC GRADE
2342,claude37,0.786,REGIONAL LYMPH NODE STATUS
2343,claude37,0.804,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2344,claude37,0.839,ADDITIONAL FINDINGS
2345,claude37,0.778,VISCERAL PLEURA INVASION
2346,claude37,0.71,TUMOR FOCALITY
2347,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2348,claude37,0.784,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2349,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
2350,claude37,0.699,NODAL SITE(S) WITH TUMOR
2351,claude37,0.76,REGIONAL LYMPH NODE STATUS
2352,claude37,0.712,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2353,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2354,claude37,0.89,TUMOR SITE
2355,claude37,0.788,PROCEDURE
2356,claude37,0.697,SPECIMEN LATERALITY
2357,claude37,0.778,VISCERAL PLEURA INVASION
2358,claude37,0.763,NUMBER OF LYMPH NODES EXAMINED
2359,claude37,0.808,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2360,claude37,0.698,LYMPHOVASCULAR INVASION
2361,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
2362,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2363,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2364,claude37,0.849,NODAL SITE(S) EXAMINED
2365,claude37,0.918,TUMOR FOCALITY
2366,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2367,claude37,0.76,HISTOLOGIC GRADE
2368,claude37,0.742,PROCEDURE
2369,claude37,0.78,VISCERAL PLEURA INVASION
2370,claude37,0.697,SPECIMEN LATERALITY
2371,claude37,0.855,MARGIN STATUS FOR INVASIVE CARCINOMA
2372,claude37,0.887,TUMOR SITE
2373,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2374,claude37,0.842,NODAL SITE(S) EXAMINED
2375,claude37,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2376,claude37,0.811,TUMOR FOCALITY
2377,claude37,0.815,REGIONAL LYMPH NODE STATUS
2378,claude37,0.733,LYMPHOVASCULAR INVASION
2379,claude37,0.706,NUMBER OF LYMPH NODES EXAMINED
2380,claude37,0.787,ADDITIONAL FINDINGS
2381,claude37,0.782,HISTOLOGIC GRADE
2382,claude37,0.781,REGIONAL LYMPH NODE STATUS
2383,claude37,0.887,TUMOR SITE
2384,claude37,0.855,MARGIN STATUS FOR INVASIVE CARCINOMA
2385,claude37,0.713,NUMBER OF LYMPH NODES EXAMINED
2386,claude37,0.753,NODAL SITE(S) EXAMINED
2387,claude37,0.811,TUMOR FOCALITY
2388,claude37,0.692,LYMPH NODE(S) FROM PRIOR PROCEDURES
2389,claude37,0.778,VISCERAL PLEURA INVASION
2390,claude37,0.837,PROCEDURE
2391,claude37,0.792,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2392,claude37,0.697,SPECIMEN LATERALITY
2393,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
2394,claude37,0.782,HISTOLOGIC GRADE
2395,claude37,0.828,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2396,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2397,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2398,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
2399,claude37,0.865,TUMOR SITE
2400,claude37,0.698,VISCERAL PLEURA INVASION
2401,claude37,0.703,NUMBER OF LYMPH NODES EXAMINED
2402,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2403,claude37,0.811,TUMOR FOCALITY
2404,claude37,0.821,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2405,claude37,0.698,SPECIMEN LATERALITY
2406,claude37,0.681,NODAL SITE(S) EXAMINED
2407,claude37,0.793,PROCEDURE
2408,claude37,0.815,REGIONAL LYMPH NODE STATUS
2409,claude37,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2410,claude37,0.798,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2411,claude37,0.782,HISTOLOGIC GRADE
2412,claude37,0.815,REGIONAL LYMPH NODE STATUS
2413,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2414,claude37,0.811,TUMOR FOCALITY
2415,claude37,0.697,SPECIMEN LATERALITY
2416,claude37,0.732,ADDITIONAL FINDINGS
2417,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2418,claude37,0.724,NODAL SITE(S) EXAMINED
2419,claude37,0.778,VISCERAL PLEURA INVASION
2420,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2421,claude37,0.703,NUMBER OF LYMPH NODES EXAMINED
2422,claude37,0.827,PROCEDURE
2423,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
2424,claude37,0.887,TUMOR SITE
2425,claude37,0.697,SPECIMEN LATERALITY
2426,claude37,0.692,TUMOR FOCALITY
2427,claude37,0.722,REGIONAL LYMPH NODE STATUS
2428,claude37,0.778,VISCERAL PLEURA INVASION
2429,claude37,0.705,NUMBER OF LYMPH NODES WITH TUMOR
2430,claude37,0.791,PROCEDURE
2431,claude37,0.687,NODAL SITE(S) WITH TUMOR
2432,claude37,0.795,TNM DESCRIPTORS
2433,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2434,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
2435,claude37,0.69,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2436,claude37,0.89,TUMOR SITE
2437,claude37,0.705,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2438,claude37,0.681,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2439,claude37,0.779,NODAL SITE(S) EXAMINED
2440,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2441,claude37,0.827,PROCEDURE
2442,claude37,0.698,SPECIMEN LATERALITY
2443,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2444,claude37,0.811,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2445,claude37,0.811,TUMOR FOCALITY
2446,claude37,0.904,HISTOLOGIC GRADE
2447,claude37,0.738,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2448,claude37,0.778,VISCERAL PLEURA INVASION
2449,claude37,0.888,TUMOR SITE
2450,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2451,claude37,0.709,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2452,claude37,0.73,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2453,claude37,0.85,NODAL SITE(S) EXAMINED
2454,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2455,claude37,0.698,SPECIMEN LATERALITY
2456,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2457,claude37,0.789,ADDITIONAL FINDINGS
2458,claude37,0.698,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2459,claude37,0.788,PROCEDURE
2460,claude37,0.835,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2461,claude37,0.782,HISTOLOGIC GRADE
2462,claude37,0.815,REGIONAL LYMPH NODE STATUS
2463,claude37,0.811,TUMOR FOCALITY
2464,claude37,0.698,VISCERAL PLEURA INVASION
2465,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2466,claude37,0.888,TUMOR SITE
2467,claude37,0.698,NUMBER OF LYMPH NODES EXAMINED
2468,claude37,0.826,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2469,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2470,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
2471,claude37,0.697,SPECIMEN LATERALITY
2472,claude37,0.872,ADDITIONAL FINDINGS
2473,claude37,0.89,TUMOR SITE
2474,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2475,claude37,0.782,HISTOLOGIC GRADE
2476,claude37,0.811,TUMOR FOCALITY
2477,claude37,0.827,PROCEDURE
2478,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2479,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2480,claude37,0.698,VISCERAL PLEURA INVASION
2481,claude37,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2482,claude37,0.887,TUMOR SITE
2483,claude37,0.742,NODAL SITE(S) WITH TUMOR
2484,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2485,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
2486,claude37,0.811,TUMOR FOCALITY
2487,claude37,0.892,HISTOLOGIC GRADE
2488,claude37,0.78,VISCERAL PLEURA INVASION
2489,claude37,0.824,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2490,claude37,0.856,PROCEDURE
2491,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2492,claude37,0.707,REGIONAL LYMPH NODE STATUS
2493,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
2494,claude37,0.887,NODAL SITE(S) EXAMINED
2495,claude37,0.697,SPECIMEN LATERALITY
2496,claude37,0.817,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2497,claude37,0.759,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2498,claude37,0.723,NODAL SITE(S) EXAMINED
2499,claude37,0.73,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2500,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2501,claude37,0.698,VISCERAL PLEURA INVASION
2502,claude37,0.815,REGIONAL LYMPH NODE STATUS
2503,claude37,0.811,TUMOR FOCALITY
2504,claude37,0.89,TUMOR SITE
2505,claude37,0.904,HISTOLOGIC GRADE
2506,claude37,0.826,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2507,claude37,0.824,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2508,claude37,0.718,SPREAD THROUGH AIR SPACES (STAS)
2509,claude37,0.816,ADDITIONAL FINDINGS
2510,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2511,claude37,0.788,PROCEDURE
2512,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2513,claude37,0.697,SPECIMEN LATERALITY
2514,claude37,0.811,TUMOR FOCALITY
2515,claude37,0.817,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2516,claude37,0.76,HISTOLOGIC GRADE
2517,claude37,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2518,claude37,0.853,NODAL SITE(S) EXAMINED
2519,claude37,0.697,SPECIMEN LATERALITY
2520,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
2521,claude37,0.856,TUMOR SITE
2522,claude37,0.815,REGIONAL LYMPH NODE STATUS
2523,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
2524,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2525,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2526,claude37,0.793,PROCEDURE
2527,claude37,0.778,VISCERAL PLEURA INVASION
2528,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2529,claude37,0.687,NUMBER OF LYMPH NODES EXAMINED
2530,claude37,0.818,ADDITIONAL FINDINGS
2531,claude37,0.782,HISTOLOGIC GRADE
2532,claude37,0.797,NODAL SITE(S) EXAMINED
2533,claude37,0.819,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2534,claude37,0.778,VISCERAL PLEURA INVASION
2535,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
2536,claude37,0.733,PROCEDURE
2537,claude37,0.815,REGIONAL LYMPH NODE STATUS
2538,claude37,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2539,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2540,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2541,claude37,0.811,TUMOR FOCALITY
2542,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2543,claude37,0.888,TUMOR SITE
2544,claude37,0.72,NUMBER OF LYMPH NODES EXAMINED
2545,claude37,0.698,SPECIMEN LATERALITY
2546,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2547,claude37,0.76,NODAL SITE(S) EXAMINED
2548,claude37,0.815,REGIONAL LYMPH NODE STATUS
2549,claude37,0.76,HISTOLOGIC GRADE
2550,claude37,0.811,TUMOR FOCALITY
2551,claude37,0.749,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2552,claude37,0.698,SPECIMEN LATERALITY
2553,claude37,0.788,PROCEDURE
2554,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
2555,claude37,0.694,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2556,claude37,0.681,MARGIN STATUS FOR INVASIVE CARCINOMA
2557,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2558,claude37,0.713,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2559,claude37,0.842,TUMOR SITE
2560,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2561,claude37,0.778,VISCERAL PLEURA INVASION
2562,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2563,claude37,0.816,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2564,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2565,claude37,0.698,SPECIMEN LATERALITY
2566,claude37,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2567,claude37,0.888,TUMOR SITE
2568,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
2569,claude37,0.827,PROCEDURE
2570,claude37,0.811,TUMOR FOCALITY
2571,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2572,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2573,claude37,0.778,VISCERAL PLEURA INVASION
2574,claude37,0.782,HISTOLOGIC GRADE
2575,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2576,claude37,0.798,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2577,claude37,0.827,PROCEDURE
2578,claude37,0.713,NUMBER OF LYMPH NODES EXAMINED
2579,claude37,0.698,SPECIMEN LATERALITY
2580,claude37,0.847,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2581,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2582,claude37,0.778,VISCERAL PLEURA INVASION
2583,claude37,0.815,REGIONAL LYMPH NODE STATUS
2584,claude37,0.811,TUMOR FOCALITY
2585,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2586,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2587,claude37,0.888,TUMOR SITE
2588,claude37,0.679,NODAL SITE(S) EXAMINED
2589,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
2590,claude37,0.728,NODAL SITE(S) EXAMINED
2591,claude37,0.782,HISTOLOGIC GRADE
2592,claude37,0.811,TUMOR FOCALITY
2593,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2594,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2595,claude37,0.696,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2596,claude37,0.778,VISCERAL PLEURA INVASION
2597,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2598,claude37,0.827,PROCEDURE
2599,claude37,0.697,SPECIMEN LATERALITY
2600,claude37,0.815,REGIONAL LYMPH NODE STATUS
2601,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2602,claude37,0.803,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2603,claude37,0.713,NUMBER OF LYMPH NODES EXAMINED
2604,claude37,0.893,TUMOR SITE
2605,claude37,0.697,SPECIMEN LATERALITY
2606,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2607,claude37,0.89,TUMOR SITE
2608,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2609,claude37,0.797,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2610,claude37,0.827,PROCEDURE
2611,claude37,0.811,TUMOR FOCALITY
2612,claude37,0.786,NODAL SITE(S) EXAMINED
2613,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2614,claude37,0.904,HISTOLOGIC GRADE
2615,claude37,0.784,REGIONAL LYMPH NODE STATUS
2616,claude37,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2617,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
2618,claude37,0.778,VISCERAL PLEURA INVASION
2619,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
2620,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2621,claude37,0.7,NUMBER OF LYMPH NODES WITH TUMOR
2622,claude37,0.809,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2623,claude37,0.728,PROCEDURE
2624,claude37,0.786,TUMOR SITE
2625,claude37,0.811,TUMOR FOCALITY
2626,claude37,0.72,TNM DESCRIPTORS
2627,claude37,0.697,SPECIMEN LATERALITY
2628,claude37,0.698,LYMPHOVASCULAR INVASION
2629,claude37,0.727,NODAL SITE(S) EXAMINED
2630,claude37,0.76,HISTOLOGIC GRADE
2631,claude37,0.882,NODAL SITE(S) WITH TUMOR
2632,claude37,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2633,claude37,0.816,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2634,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2635,claude37,0.778,VISCERAL PLEURA INVASION
2636,claude37,0.78,REGIONAL LYMPH NODE STATUS
2637,claude37,0.683,NODAL SITE(S) EXAMINED
2638,claude37,0.788,PROCEDURE
2639,claude37,0.778,VISCERAL PLEURA INVASION
2640,claude37,0.755,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2641,claude37,0.698,SPECIMEN LATERALITY
2642,claude37,0.685,ADDITIONAL FINDINGS
2643,claude37,0.838,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2644,claude37,0.78,SPREAD THROUGH AIR SPACES (STAS)
2645,claude37,0.697,NUMBER OF LYMPH NODES EXAMINED
2646,claude37,0.89,TUMOR SITE
2647,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2648,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2649,claude37,0.811,TUMOR FOCALITY
2650,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2651,claude37,0.815,REGIONAL LYMPH NODE STATUS
2652,claude37,0.782,HISTOLOGIC GRADE
2653,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2654,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2655,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2656,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
2657,claude37,0.888,NODAL SITE(S) EXAMINED
2658,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2659,claude37,0.788,PROCEDURE
2660,claude37,0.782,HISTOLOGIC GRADE
2661,claude37,0.811,TUMOR FOCALITY
2662,claude37,0.815,REGIONAL LYMPH NODE STATUS
2663,claude37,0.791,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2664,claude37,0.778,VISCERAL PLEURA INVASION
2665,claude37,0.698,NUMBER OF LYMPH NODES EXAMINED
2666,claude37,0.811,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2667,claude37,0.802,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2668,claude37,0.89,TUMOR SITE
2669,claude37,0.697,SPECIMEN LATERALITY
2670,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2671,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2672,claude37,0.783,ADDITIONAL FINDINGS
2673,claude37,0.756,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2674,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2675,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
2676,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
2677,claude37,0.888,TUMOR SITE
2678,claude37,0.675,NODAL SITE(S) EXAMINED
2679,claude37,0.892,HISTOLOGIC GRADE
2680,claude37,0.745,LYMPHOVASCULAR INVASION
2681,claude37,0.698,SPECIMEN LATERALITY
2682,claude37,0.713,NUMBER OF LYMPH NODES EXAMINED
2683,claude37,0.778,VISCERAL PLEURA INVASION
2684,claude37,0.793,PROCEDURE
2685,claude37,0.815,REGIONAL LYMPH NODE STATUS
2686,claude37,0.821,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2687,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2688,claude37,0.811,TUMOR FOCALITY
2689,claude37,0.778,VISCERAL PLEURA INVASION
2690,claude37,0.713,NUMBER OF LYMPH NODES WITH TUMOR
2691,claude37,0.788,HISTOLOGIC GRADE
2692,claude37,0.683,LYMPH NODE(S) FROM PRIOR PROCEDURES
2693,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
2694,claude37,0.828,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2695,claude37,0.811,TUMOR FOCALITY
2696,claude37,0.876,TUMOR SITE
2697,claude37,0.706,MARGIN STATUS FOR INVASIVE CARCINOMA
2698,claude37,0.693,NUMBER OF LYMPH NODES EXAMINED
2699,claude37,0.697,SPECIMEN LATERALITY
2700,claude37,0.709,REGIONAL LYMPH NODE STATUS
2701,claude37,0.747,NODAL SITE(S) EXAMINED
2702,claude37,0.788,PROCEDURE
2703,claude37,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
2704,claude37,0.736,SPREAD THROUGH AIR SPACES (STAS)
2705,claude37,0.75,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2706,claude37,0.823,NODAL SITE(S) EXAMINED
2707,claude37,0.855,MARGIN STATUS FOR INVASIVE CARCINOMA
2708,claude37,0.778,VISCERAL PLEURA INVASION
2709,claude37,0.739,ADDITIONAL FINDINGS
2710,claude37,0.765,PROCEDURE
2711,claude37,0.698,LYMPHOVASCULAR INVASION
2712,claude37,0.796,REGIONAL LYMPH NODE STATUS
2713,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2714,claude37,0.7,NUMBER OF LYMPH NODES WITH TUMOR
2715,claude37,0.697,SPECIMEN LATERALITY
2716,claude37,0.689,TUMOR SITE
2717,claude37,0.729,NUMBER OF LYMPH NODES EXAMINED
2718,claude37,0.73,NODAL SITE(S) WITH TUMOR
2719,claude37,0.811,TUMOR FOCALITY
2720,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2721,claude37,0.851,TUMOR SITE
2722,claude37,0.698,LYMPHOVASCULAR INVASION
2723,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2724,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2725,claude37,0.804,NODAL SITE(S) EXAMINED
2726,claude37,0.697,SPECIMEN LATERALITY
2727,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2728,claude37,0.778,VISCERAL PLEURA INVASION
2729,claude37,0.818,ADDITIONAL FINDINGS
2730,claude37,0.801,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2731,claude37,0.827,PROCEDURE
2732,claude37,0.708,TUMOR FOCALITY
2733,claude37,0.782,HISTOLOGIC GRADE
2734,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2735,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
2736,claude37,0.735,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2737,claude37,0.815,REGIONAL LYMPH NODE STATUS
2738,claude37,0.742,MARGIN STATUS FOR INVASIVE CARCINOMA
2739,claude37,0.771,LYMPHOVASCULAR INVASION
2740,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
2741,claude37,0.811,TUMOR FOCALITY
2742,claude37,0.788,PROCEDURE
2743,claude37,0.871,NODAL SITE(S) WITH TUMOR
2744,claude37,0.78,VISCERAL PLEURA INVASION
2745,claude37,0.72,NUMBER OF LYMPH NODES WITH TUMOR
2746,claude37,0.736,REGIONAL LYMPH NODE STATUS
2747,claude37,0.698,NUMBER OF LYMPH NODES EXAMINED
2748,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
2749,claude37,0.738,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2750,claude37,0.697,SPECIMEN LATERALITY
2751,claude37,0.775,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2752,claude37,0.76,HISTOLOGIC GRADE
2753,claude37,0.78,NODAL SITE(S) EXAMINED
2754,claude37,0.824,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2755,claude37,0.89,TUMOR SITE
2756,claude37,0.683,LYMPH NODE(S) FROM PRIOR PROCEDURES
2757,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2758,claude37,0.792,REGIONAL LYMPH NODE STATUS
2759,claude37,0.811,TUMOR FOCALITY
2760,claude37,0.708,LYMPHOVASCULAR INVASION
2761,claude37,0.849,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2762,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2763,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2764,claude37,0.89,TUMOR SITE
2765,claude37,0.761,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2766,claude37,0.698,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2767,claude37,0.778,VISCERAL PLEURA INVASION
2768,claude37,0.788,PROCEDURE
2769,claude37,0.876,NODAL SITE(S) EXAMINED
2770,claude37,0.697,SPECIMEN LATERALITY
2771,claude37,0.793,HISTOLOGIC GRADE
2772,claude37,0.717,REGIONAL LYMPH NODE STATUS
2773,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2774,claude37,0.851,TUMOR SITE
2775,claude37,0.691,NUMBER OF LYMPH NODES EXAMINED
2776,claude37,0.684,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2777,claude37,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2778,claude37,0.698,PROCEDURE
2779,claude37,0.78,VISCERAL PLEURA INVASION
2780,claude37,0.811,TUMOR FOCALITY
2781,claude37,0.78,SPREAD THROUGH AIR SPACES (STAS)
2782,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2783,claude37,0.751,NODAL SITE(S) EXAMINED
2784,claude37,0.713,NUMBER OF LYMPH NODES WITH TUMOR
2785,claude37,0.697,SPECIMEN LATERALITY
2786,claude37,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2787,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2788,claude37,0.892,NODAL SITE(S) WITH TUMOR
2789,claude37,0.797,NODAL SITE(S) EXAMINED
2790,claude37,0.778,VISCERAL PLEURA INVASION
2791,claude37,0.698,SPECIMEN LATERALITY
2792,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2793,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2794,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2795,claude37,0.888,TUMOR SITE
2796,claude37,0.811,TUMOR FOCALITY
2797,claude37,0.829,ADDITIONAL FINDINGS
2798,claude37,0.756,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2799,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2800,claude37,0.815,REGIONAL LYMPH NODE STATUS
2801,claude37,0.756,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2802,claude37,0.736,HISTOLOGIC GRADE
2803,claude37,0.756,PROCEDURE
2804,claude37,0.697,NUMBER OF LYMPH NODES EXAMINED
2805,claude37,0.815,REGIONAL LYMPH NODE STATUS
2806,claude37,0.888,TUMOR SITE
2807,claude37,0.782,HISTOLOGIC GRADE
2808,claude37,0.804,PROCEDURE
2809,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2810,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2811,claude37,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2812,claude37,0.766,ADDITIONAL FINDINGS
2813,claude37,0.747,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2814,claude37,0.698,SPECIMEN LATERALITY
2815,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
2816,claude37,0.78,VISCERAL PLEURA INVASION
2817,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2818,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2819,claude37,0.811,TUMOR FOCALITY
2820,claude37,0.791,NODAL SITE(S) EXAMINED
2821,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2822,claude37,0.89,TUMOR SITE
2823,claude37,0.782,HISTOLOGIC GRADE
2824,claude37,0.775,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2825,claude37,0.778,VISCERAL PLEURA INVASION
2826,claude37,0.811,TUMOR FOCALITY
2827,claude37,0.78,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2828,claude37,0.725,NUMBER OF LYMPH NODES EXAMINED
2829,claude37,0.698,SPECIMEN LATERALITY
2830,claude37,0.777,PROCEDURE
2831,claude37,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2832,claude37,0.69,ADDITIONAL FINDINGS
2833,claude37,0.798,NODAL SITE(S) EXAMINED
2834,claude37,0.815,REGIONAL LYMPH NODE STATUS
2835,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
2836,claude37,0.745,LYMPHOVASCULAR INVASION
2837,claude37,0.778,VISCERAL PLEURA INVASION
2838,claude37,0.796,PROCEDURE
2839,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2840,claude37,0.811,TUMOR FOCALITY
2841,claude37,0.697,SPECIMEN LATERALITY
2842,claude37,0.782,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2843,claude37,0.766,REGIONAL LYMPH NODE STATUS
2844,claude37,0.887,TUMOR SITE
2845,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2846,claude37,0.711,NUMBER OF LYMPH NODES EXAMINED
2847,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2848,claude37,0.821,NODAL SITE(S) EXAMINED
2849,claude37,0.892,HISTOLOGIC GRADE
2850,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
2851,claude37,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2852,claude37,0.739,ADDITIONAL FINDINGS
2853,claude37,0.697,SPECIMEN LATERALITY
2854,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2855,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2856,claude37,0.781,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2857,claude37,0.815,REGIONAL LYMPH NODE STATUS
2858,claude37,0.698,VISCERAL PLEURA INVASION
2859,claude37,0.818,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2860,claude37,0.746,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2861,claude37,0.698,LYMPHOVASCULAR INVASION
2862,claude37,0.788,PROCEDURE
2863,claude37,0.722,NODAL SITE(S) EXAMINED
2864,claude37,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2865,claude37,0.76,HISTOLOGIC GRADE
2866,claude37,0.811,TUMOR FOCALITY
2867,claude37,0.893,TUMOR SITE
2868,claude37,0.826,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2869,claude37,0.802,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2870,claude37,0.89,TUMOR SITE
2871,claude37,0.815,REGIONAL LYMPH NODE STATUS
2872,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
2873,claude37,0.778,VISCERAL PLEURA INVASION
2874,claude37,0.782,HISTOLOGIC GRADE
2875,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2876,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2877,claude37,0.697,SPECIMEN LATERALITY
2878,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2879,claude37,0.734,TUMOR FOCALITY
2880,claude37,0.85,NODAL SITE(S) EXAMINED
2881,claude37,0.782,ADDITIONAL FINDINGS
2882,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2883,claude37,0.788,PROCEDURE
2884,claude37,0.702,REGIONAL LYMPH NODE STATUS
2885,claude37,0.745,LYMPHOVASCULAR INVASION
2886,claude37,0.811,TUMOR FOCALITY
2887,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
2888,claude37,0.873,NODAL SITE(S) EXAMINED
2889,claude37,0.893,TUMOR SITE
2890,claude37,0.762,NODAL SITE(S) WITH TUMOR
2891,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2892,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2893,claude37,0.778,VISCERAL PLEURA INVASION
2894,claude37,0.76,HISTOLOGIC GRADE
2895,claude37,0.829,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2896,claude37,0.697,SPECIMEN LATERALITY
2897,claude37,0.798,NUMBER OF LYMPH NODES EXAMINED
2898,claude37,0.72,NUMBER OF LYMPH NODES WITH TUMOR
2899,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2900,claude37,0.788,PROCEDURE
2901,claude37,0.837,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2902,claude37,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2903,claude37,0.887,TUMOR SITE
2904,claude37,0.697,SPECIMEN LATERALITY
2905,claude37,0.782,HISTOLOGIC GRADE
2906,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2907,claude37,0.738,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2908,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2909,claude37,0.788,PROCEDURE
2910,claude37,0.778,VISCERAL PLEURA INVASION
2911,claude37,0.871,ADDITIONAL FINDINGS
2912,claude37,0.811,TUMOR FOCALITY
2913,claude37,0.767,REGIONAL LYMPH NODE STATUS
2914,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2915,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2916,claude37,0.841,NODAL SITE(S) EXAMINED
2917,claude37,0.698,SPECIMEN LATERALITY
2918,claude37,0.785,PROCEDURE
2919,claude37,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2920,claude37,0.811,TUMOR FOCALITY
2921,claude37,0.768,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2922,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
2923,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
2924,claude37,0.76,NUMBER OF LYMPH NODES EXAMINED
2925,claude37,0.778,VISCERAL PLEURA INVASION
2926,claude37,0.815,REGIONAL LYMPH NODE STATUS
2927,claude37,0.711,TUMOR SITE
2928,claude37,0.678,NODAL SITE(S) EXAMINED
2929,claude37,0.865,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2930,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2931,claude37,0.815,REGIONAL LYMPH NODE STATUS
2932,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2933,claude37,0.89,TUMOR SITE
2934,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2935,claude37,0.697,SPECIMEN LATERALITY
2936,claude37,0.798,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2937,claude37,0.829,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2938,claude37,0.827,PROCEDURE
2939,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2940,claude37,0.807,NODAL SITE(S) EXAMINED
2941,claude37,0.811,TUMOR FOCALITY
2942,claude37,0.778,VISCERAL PLEURA INVASION
2943,claude37,0.78,SPREAD THROUGH AIR SPACES (STAS)
2944,claude37,0.76,HISTOLOGIC GRADE
2945,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
2946,claude37,0.745,HISTOLOGIC GRADE
2947,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
2948,claude37,0.739,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2949,claude37,0.698,VISCERAL PLEURA INVASION
2950,claude37,0.795,TNM DESCRIPTORS
2951,claude37,0.693,NODAL SITE(S) EXAMINED
2952,claude37,0.7,SPREAD THROUGH AIR SPACES (STAS)
2953,claude37,0.709,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2954,claude37,0.698,SPECIMEN LATERALITY
2955,claude37,0.89,TUMOR SITE
2956,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
2957,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2958,claude37,0.722,NUMBER OF LYMPH NODES EXAMINED
2959,claude37,0.815,REGIONAL LYMPH NODE STATUS
2960,claude37,0.696,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2961,claude37,0.692,TUMOR FOCALITY
2962,claude37,0.697,SPECIMEN LATERALITY
2963,claude37,0.701,SPREAD THROUGH AIR SPACES (STAS)
2964,claude37,0.815,REGIONAL LYMPH NODE STATUS
2965,claude37,0.89,TUMOR SITE
2966,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
2967,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2968,claude37,0.811,TUMOR FOCALITY
2969,claude37,0.778,VISCERAL PLEURA INVASION
2970,claude37,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2971,claude37,0.775,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2972,claude37,0.871,NODAL SITE(S) EXAMINED
2973,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
2974,claude37,0.788,PROCEDURE
2975,claude37,0.763,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2976,claude37,0.811,TUMOR FOCALITY
2977,claude37,0.823,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2978,claude37,0.736,NODAL SITE(S) EXAMINED
2979,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
2980,claude37,0.785,ADDITIONAL FINDINGS
2981,claude37,0.698,SPECIMEN LATERALITY
2982,claude37,0.786,NUMBER OF LYMPH NODES EXAMINED
2983,claude37,0.788,PROCEDURE
2984,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2985,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2986,claude37,0.747,REGIONAL LYMPH NODE STATUS
2987,claude37,0.812,HISTOLOGIC GRADE
2988,claude37,0.698,VISCERAL PLEURA INVASION
2989,claude37,0.805,NODAL SITE(S) WITH TUMOR
2990,claude37,0.89,TUMOR SITE
2991,claude37,0.826,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2992,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2993,claude37,0.745,LYMPHOVASCULAR INVASION
2994,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2995,claude37,0.859,NODAL SITE(S) EXAMINED
2996,claude37,0.855,ADDITIONAL FINDINGS
2997,claude37,0.89,TUMOR SITE
2998,claude37,0.713,NUMBER OF LYMPH NODES WITH TUMOR
2999,claude37,0.683,LYMPH NODE(S) FROM PRIOR PROCEDURES
3000,claude37,0.78,SPREAD THROUGH AIR SPACES (STAS)
3001,claude37,0.829,NODAL SITE(S) WITH TUMOR
3002,claude37,0.743,REGIONAL LYMPH NODE STATUS
3003,claude37,0.697,SPECIMEN LATERALITY
3004,claude37,0.78,VISCERAL PLEURA INVASION
3005,claude37,0.736,HISTOLOGIC GRADE
3006,claude37,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3007,claude37,0.722,MARGIN STATUS FOR NON-INVASIVE TUMOR
3008,claude37,0.7,NUMBER OF LYMPH NODES EXAMINED
3009,claude37,0.816,PROCEDURE
3010,claude37,0.918,TUMOR FOCALITY
3011,claude37,0.698,LYMPHOVASCULAR INVASION
3012,claude37,0.819,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3013,claude37,0.72,NUMBER OF LYMPH NODES EXAMINED
3014,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3015,claude37,0.736,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3016,claude37,0.698,SPECIMEN LATERALITY
3017,claude37,0.78,VISCERAL PLEURA INVASION
3018,claude37,0.72,TUMOR SITE
3019,claude37,0.76,HISTOLOGIC GRADE
3020,claude37,0.793,PROCEDURE
3021,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3022,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3023,claude37,0.652,TUMOR FOCALITY
3024,claude37,0.756,REGIONAL LYMPH NODE STATUS
3025,claude37,0.72,LYMPHOVASCULAR INVASION
3026,claude37,0.78,SPREAD THROUGH AIR SPACES (STAS)
3027,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
3028,claude37,0.751,NODAL SITE(S) EXAMINED
3029,claude37,0.822,NODAL SITE(S) EXAMINED
3030,claude37,0.887,TUMOR SITE
3031,claude37,0.847,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3032,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3033,claude37,0.815,REGIONAL LYMPH NODE STATUS
3034,claude37,0.78,SPREAD THROUGH AIR SPACES (STAS)
3035,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3036,claude37,0.796,PROCEDURE
3037,claude37,0.697,SPECIMEN LATERALITY
3038,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3039,claude37,0.804,ADDITIONAL FINDINGS
3040,claude37,0.736,HISTOLOGIC GRADE
3041,claude37,0.824,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3042,claude37,0.811,TUMOR FOCALITY
3043,claude37,0.698,VISCERAL PLEURA INVASION
3044,claude37,0.75,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3045,claude37,0.782,HISTOLOGIC GRADE
3046,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
3047,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3048,claude37,0.788,PROCEDURE
3049,claude37,0.893,TUMOR SITE
3050,claude37,0.786,NUMBER OF LYMPH NODES EXAMINED
3051,claude37,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3052,claude37,0.778,VISCERAL PLEURA INVASION
3053,claude37,0.792,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3054,claude37,0.811,TUMOR FOCALITY
3055,claude37,0.815,REGIONAL LYMPH NODE STATUS
3056,claude37,0.783,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3057,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
3058,claude37,0.697,SPECIMEN LATERALITY
3059,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3060,claude37,0.866,NODAL SITE(S) EXAMINED
3061,claude37,0.692,LYMPH NODE(S) FROM PRIOR PROCEDURES
3062,claude37,0.76,HISTOLOGIC GRADE
3063,claude37,0.698,LYMPHOVASCULAR INVASION
3064,claude37,0.856,TUMOR SITE
3065,claude37,0.734,NODAL SITE(S) EXAMINED
3066,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3067,claude37,0.697,SPECIMEN LATERALITY
3068,claude37,0.78,VISCERAL PLEURA INVASION
3069,claude37,0.882,REGIONAL LYMPH NODE STATUS
3070,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3071,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3072,claude37,0.731,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3073,claude37,0.827,PROCEDURE
3074,claude37,0.918,TUMOR FOCALITY
3075,claude37,0.723,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3076,claude37,0.742,MARGIN STATUS FOR INVASIVE CARCINOMA
3077,claude37,0.887,TUMOR SITE
3078,claude37,0.798,PROCEDURE
3079,claude37,0.72,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3080,claude37,0.725,NODAL SITE(S) EXAMINED
3081,claude37,0.815,REGIONAL LYMPH NODE STATUS
3082,claude37,0.892,HISTOLOGIC GRADE
3083,claude37,0.695,NUMBER OF LYMPH NODES EXAMINED
3084,claude37,0.811,TUMOR FOCALITY
3085,claude37,0.825,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3086,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
3087,claude37,0.697,SPECIMEN LATERALITY
3088,claude37,0.698,VISCERAL PLEURA INVASION
3089,claude37,0.7,SPREAD THROUGH AIR SPACES (STAS)
3090,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3091,claude37,0.705,REGIONAL LYMPH NODE STATUS
3092,claude37,0.888,TUMOR SITE
3093,claude37,0.736,HISTOLOGIC GRADE
3094,claude37,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3095,claude37,0.811,TUMOR FOCALITY
3096,claude37,0.698,SPECIMEN LATERALITY
3097,claude37,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3098,claude37,0.786,PROCEDURE
3099,claude37,0.699,NUMBER OF LYMPH NODES EXAMINED
3100,claude37,0.683,LYMPH NODE(S) FROM PRIOR PROCEDURES
3101,claude37,0.7,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3102,claude37,0.706,NUMBER OF LYMPH NODES WITH TUMOR
3103,claude37,0.843,NODAL SITE(S) EXAMINED
3104,claude37,0.778,VISCERAL PLEURA INVASION
3105,claude37,0.881,NODAL SITE(S) WITH TUMOR
3106,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
3107,claude37,0.779,ADDITIONAL FINDINGS
3108,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3109,claude37,0.78,SPREAD THROUGH AIR SPACES (STAS)
3110,claude37,0.736,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3111,claude37,0.838,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3112,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3113,claude37,0.887,TUMOR SITE
3114,claude37,0.827,HISTOLOGIC GRADE
3115,claude37,0.711,NODAL SITE(S) WITH TUMOR
3116,claude37,0.811,TUMOR FOCALITY
3117,claude37,0.858,NODAL SITE(S) EXAMINED
3118,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
3119,claude37,0.672,REGIONAL LYMPH NODE STATUS
3120,claude37,0.778,VISCERAL PLEURA INVASION
3121,claude37,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3122,claude37,0.788,PROCEDURE
3123,claude37,0.72,NUMBER OF LYMPH NODES WITH TUMOR
3124,claude37,0.697,SPECIMEN LATERALITY
3125,claude37,0.788,PROCEDURE
3126,claude37,0.693,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3127,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3128,claude37,0.697,SPECIMEN LATERALITY
3129,claude37,0.838,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3130,claude37,0.74,NODAL SITE(S) EXAMINED
3131,claude37,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3132,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3133,claude37,0.811,TUMOR FOCALITY
3134,claude37,0.89,TUMOR SITE
3135,claude37,0.782,HISTOLOGIC GRADE
3136,claude37,0.689,NUMBER OF LYMPH NODES EXAMINED
3137,claude37,0.815,REGIONAL LYMPH NODE STATUS
3138,claude37,0.778,VISCERAL PLEURA INVASION
3139,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3140,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3141,claude37,0.713,REGIONAL LYMPH NODE STATUS
3142,claude37,0.824,NODAL SITE(S) EXAMINED
3143,claude37,0.788,PROCEDURE
3144,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3145,claude37,0.78,VISCERAL PLEURA INVASION
3146,claude37,0.72,NUMBER OF LYMPH NODES WITH TUMOR
3147,claude37,0.76,HISTOLOGIC GRADE
3148,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3149,claude37,0.887,TUMOR SITE
3150,claude37,0.697,SPECIMEN LATERALITY
3151,claude37,0.813,NODAL SITE(S) WITH TUMOR
3152,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3153,claude37,0.82,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3154,claude37,0.838,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3155,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
3156,claude37,0.811,TUMOR FOCALITY
3157,claude37,0.788,PROCEDURE
3158,claude37,0.819,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3159,claude37,0.811,TUMOR FOCALITY
3160,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3161,claude37,0.693,NUMBER OF LYMPH NODES EXAMINED
3162,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
3163,claude37,0.865,TUMOR SITE
3164,claude37,0.746,REGIONAL LYMPH NODE STATUS
3165,claude37,0.737,NODAL SITE(S) WITH TUMOR
3166,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3167,claude37,0.745,LYMPHOVASCULAR INVASION
3168,claude37,0.72,NUMBER OF LYMPH NODES WITH TUMOR
3169,claude37,0.769,HISTOLOGIC GRADE
3170,claude37,0.703,MARGIN STATUS FOR INVASIVE CARCINOMA
3171,claude37,0.778,VISCERAL PLEURA INVASION
3172,claude37,0.801,NODAL SITE(S) EXAMINED
3173,claude37,0.698,SPECIMEN LATERALITY
3174,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3175,claude37,0.811,TUMOR FOCALITY
3176,claude37,0.788,PROCEDURE
3177,claude37,0.825,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3178,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3179,claude37,0.78,VISCERAL PLEURA INVASION
3180,claude37,0.88,NODAL SITE(S) EXAMINED
3181,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3182,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
3183,claude37,0.841,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3184,claude37,0.815,REGIONAL LYMPH NODE STATUS
3185,claude37,0.89,TUMOR SITE
3186,claude37,0.697,SPECIMEN LATERALITY
3187,claude37,0.782,HISTOLOGIC GRADE
3188,claude37,0.693,NUMBER OF LYMPH NODES EXAMINED
3189,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3190,claude37,0.837,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3191,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
3192,claude37,0.816,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3193,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3194,claude37,0.827,PROCEDURE
3195,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3196,claude37,0.811,TUMOR FOCALITY
3197,claude37,0.786,NODAL SITE(S) EXAMINED
3198,claude37,0.904,HISTOLOGIC GRADE
3199,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3200,claude37,0.713,NUMBER OF LYMPH NODES EXAMINED
3201,claude37,0.815,REGIONAL LYMPH NODE STATUS
3202,claude37,0.89,TUMOR SITE
3203,claude37,0.778,VISCERAL PLEURA INVASION
3204,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3205,claude37,0.698,SPECIMEN LATERALITY
3206,claude37,0.855,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3207,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
3208,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3209,claude37,0.778,VISCERAL PLEURA INVASION
3210,claude37,0.815,REGIONAL LYMPH NODE STATUS
3211,claude37,0.755,NODAL SITE(S) EXAMINED
3212,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3213,claude37,0.782,HISTOLOGIC GRADE
3214,claude37,0.811,TUMOR FOCALITY
3215,claude37,0.839,ADDITIONAL FINDINGS
3216,claude37,0.793,PROCEDURE
3217,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3218,claude37,0.697,SPECIMEN LATERALITY
3219,claude37,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3220,claude37,0.698,NUMBER OF LYMPH NODES EXAMINED
3221,claude37,0.837,TUMOR SITE
3222,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3223,claude37,0.767,TNM DESCRIPTORS
3224,claude37,0.784,HISTOLOGIC GRADE
3225,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3226,claude37,0.831,ADDITIONAL FINDINGS
3227,claude37,0.678,TUMOR FOCALITY
3228,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3229,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
3230,claude37,0.747,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3231,claude37,0.89,TUMOR SITE
3232,claude37,0.815,REGIONAL LYMPH NODE STATUS
3233,claude37,0.793,PROCEDURE
3234,claude37,0.782,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3235,claude37,0.698,SPECIMEN LATERALITY
3236,claude37,0.676,NODAL SITE(S) EXAMINED
3237,claude37,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3238,claude37,0.701,NUMBER OF LYMPH NODES EXAMINED
3239,claude37,0.778,VISCERAL PLEURA INVASION
3240,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3241,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3242,claude37,0.728,REGIONAL LYMPH NODE STATUS
3243,claude37,0.704,NUMBER OF LYMPH NODES EXAMINED
3244,claude37,0.697,SPECIMEN LATERALITY
3245,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3246,claude37,0.835,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3247,claude37,0.823,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3248,claude37,0.808,ADDITIONAL FINDINGS
3249,claude37,0.842,NODAL SITE(S) EXAMINED
3250,claude37,0.788,PROCEDURE
3251,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3252,claude37,0.718,SPREAD THROUGH AIR SPACES (STAS)
3253,claude37,0.811,TUMOR FOCALITY
3254,claude37,0.893,TUMOR SITE
3255,claude37,0.778,VISCERAL PLEURA INVASION
3256,claude37,0.712,HISTOLOGIC GRADE
3257,claude37,0.7,SPREAD THROUGH AIR SPACES (STAS)
3258,claude37,0.766,ADDITIONAL FINDINGS
3259,claude37,0.692,TUMOR FOCALITY
3260,claude37,0.699,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3261,claude37,0.699,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3262,claude37,0.697,NUMBER OF LYMPH NODES EXAMINED
3263,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3264,claude37,0.836,NODAL SITE(S) EXAMINED
3265,claude37,0.698,SPECIMEN LATERALITY
3266,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3267,claude37,0.888,TUMOR SITE
3268,claude37,0.795,TNM DESCRIPTORS
3269,claude37,0.699,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3270,claude37,0.778,VISCERAL PLEURA INVASION
3271,claude37,0.735,REGIONAL LYMPH NODE STATUS
3272,claude37,0.788,PROCEDURE
3273,claude37,0.697,NUMBER OF LYMPH NODES EXAMINED
3274,claude37,0.78,REGIONAL LYMPH NODE STATUS
3275,claude37,0.759,ADDITIONAL FINDINGS
3276,claude37,0.729,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3277,claude37,0.708,NUMBER OF LYMPH NODES WITH TUMOR
3278,claude37,0.746,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3279,claude37,0.745,PROCEDURE
3280,claude37,0.716,NODAL SITE(S) EXAMINED
3281,claude37,0.811,TUMOR FOCALITY
3282,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3283,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3284,claude37,0.78,VISCERAL PLEURA INVASION
3285,claude37,0.893,TUMOR SITE
3286,claude37,0.837,NODAL SITE(S) WITH TUMOR
3287,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
3288,claude37,0.697,SPECIMEN LATERALITY
3289,claude37,0.736,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3290,claude37,0.781,ADDITIONAL FINDINGS
3291,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3292,claude37,0.888,TUMOR SITE
3293,claude37,0.699,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3294,claude37,0.699,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3295,claude37,0.705,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3296,claude37,0.815,REGIONAL LYMPH NODE STATUS
3297,claude37,0.757,PROCEDURE
3298,claude37,0.674,MARGIN STATUS FOR INVASIVE CARCINOMA
3299,claude37,0.675,NODAL SITE(S) EXAMINED
3300,claude37,0.692,TUMOR FOCALITY
3301,claude37,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
3302,claude37,0.778,VISCERAL PLEURA INVASION
3303,claude37,0.795,TNM DESCRIPTORS
3304,claude37,0.698,SPECIMEN LATERALITY
3305,claude37,0.837,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3306,claude37,0.698,SPECIMEN LATERALITY
3307,claude37,0.737,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3308,claude37,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3309,claude37,0.788,PROCEDURE
3310,claude37,0.811,TUMOR FOCALITY
3311,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3312,claude37,0.809,NODAL SITE(S) EXAMINED
3313,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3314,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3315,claude37,0.888,TUMOR SITE
3316,claude37,0.778,VISCERAL PLEURA INVASION
3317,claude37,0.815,REGIONAL LYMPH NODE STATUS
3318,claude37,0.788,PROCEDURE
3319,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3320,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3321,claude37,0.724,NODAL SITE(S) EXAMINED
3322,claude37,0.792,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3323,claude37,0.815,REGIONAL LYMPH NODE STATUS
3324,claude37,0.697,SPECIMEN LATERALITY
3325,claude37,0.7,SPREAD THROUGH AIR SPACES (STAS)
3326,claude37,0.658,ADDITIONAL FINDINGS
3327,claude37,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3328,claude37,0.698,VISCERAL PLEURA INVASION
3329,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3330,claude37,0.703,NUMBER OF LYMPH NODES EXAMINED
3331,claude37,0.89,TUMOR SITE
3332,claude37,0.811,TUMOR FOCALITY
3333,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
3334,claude37,0.675,TUMOR FOCALITY
3335,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3336,claude37,0.695,NUMBER OF LYMPH NODES EXAMINED
3337,claude37,0.712,HISTOLOGIC GRADE
3338,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3339,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
3340,claude37,0.777,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3341,claude37,0.788,PROCEDURE
3342,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3343,claude37,0.76,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3344,claude37,0.698,SPECIMEN LATERALITY
3345,claude37,0.815,REGIONAL LYMPH NODE STATUS
3346,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3347,claude37,0.89,TUMOR SITE
3348,claude37,0.778,VISCERAL PLEURA INVASION
3349,claude37,0.717,TNM DESCRIPTORS
3350,claude37,0.824,NODAL SITE(S) EXAMINED
3351,claude37,0.687,LYMPHOVASCULAR INVASION
3352,claude37,0.875,NODAL SITE(S) WITH TUMOR
3353,claude37,0.822,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3354,claude37,0.7,SPREAD THROUGH AIR SPACES (STAS)
3355,claude37,0.746,REGIONAL LYMPH NODE STATUS
3356,claude37,0.7,NUMBER OF LYMPH NODES WITH TUMOR
3357,claude37,0.89,TUMOR SITE
3358,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
3359,claude37,0.77,MARGIN STATUS FOR INVASIVE CARCINOMA
3360,claude37,0.76,HISTOLOGIC GRADE
3361,claude37,0.744,PROCEDURE
3362,claude37,0.778,VISCERAL PLEURA INVASION
3363,claude37,0.692,LYMPH NODE(S) FROM PRIOR PROCEDURES
3364,claude37,0.885,NODAL SITE(S) EXAMINED
3365,claude37,0.697,SPECIMEN LATERALITY
3366,claude37,0.811,TUMOR FOCALITY
3367,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3368,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3369,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3370,claude37,0.811,TUMOR FOCALITY
3371,claude37,0.9,ADDITIONAL FINDINGS
3372,claude37,0.851,NODAL SITE(S) EXAMINED
3373,claude37,0.825,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3374,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3375,claude37,0.73,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3376,claude37,0.782,HISTOLOGIC GRADE
3377,claude37,0.827,PROCEDURE
3378,claude37,0.697,SPECIMEN LATERALITY
3379,claude37,0.713,NUMBER OF LYMPH NODES EXAMINED
3380,claude37,0.778,VISCERAL PLEURA INVASION
3381,claude37,0.89,TUMOR SITE
3382,claude37,0.815,REGIONAL LYMPH NODE STATUS
3383,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
3384,claude37,0.704,NUMBER OF LYMPH NODES EXAMINED
3385,claude37,0.811,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3386,claude37,0.712,NODAL SITE(S) EXAMINED
3387,claude37,0.874,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3388,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3389,claude37,0.823,NODAL SITE(S) WITH TUMOR
3390,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3391,claude37,0.683,LYMPH NODE(S) FROM PRIOR PROCEDURES
3392,claude37,0.778,VISCERAL PLEURA INVASION
3393,claude37,0.888,TUMOR SITE
3394,claude37,0.76,HISTOLOGIC GRADE
3395,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
3396,claude37,0.713,NUMBER OF LYMPH NODES WITH TUMOR
3397,claude37,0.735,REGIONAL LYMPH NODE STATUS
3398,claude37,0.698,SPECIMEN LATERALITY
3399,claude37,0.788,PROCEDURE
3400,claude37,0.811,TUMOR FOCALITY
3401,claude37,0.838,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3402,claude37,0.741,PROCEDURE
3403,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
3404,claude37,0.811,TUMOR FOCALITY
3405,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
3406,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3407,claude37,0.819,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3408,claude37,0.88,NODAL SITE(S) WITH TUMOR
3409,claude37,0.738,REGIONAL LYMPH NODE STATUS
3410,claude37,0.778,VISCERAL PLEURA INVASION
3411,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3412,claude37,0.883,NODAL SITE(S) EXAMINED
3413,claude37,0.724,TNM DESCRIPTORS
3414,claude37,0.778,HISTOLOGIC GRADE
3415,claude37,0.697,SPECIMEN LATERALITY
3416,claude37,0.819,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3417,claude37,0.787,TUMOR SITE
3418,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3419,claude37,0.816,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3420,claude37,0.812,NODAL SITE(S) EXAMINED
3421,claude37,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3422,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3423,claude37,0.778,VISCERAL PLEURA INVASION
3424,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
3425,claude37,0.815,REGIONAL LYMPH NODE STATUS
3426,claude37,0.881,TUMOR SITE
3427,claude37,0.697,SPECIMEN LATERALITY
3428,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3429,claude37,0.827,PROCEDURE
3430,claude37,0.713,NUMBER OF LYMPH NODES EXAMINED
3431,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3432,claude37,0.811,TUMOR FOCALITY
3433,claude37,0.782,HISTOLOGIC GRADE
3434,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3435,claude37,0.89,TUMOR SITE
3436,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
3437,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3438,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3439,claude37,0.698,SPECIMEN LATERALITY
3440,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3441,claude37,0.888,TUMOR SITE
3442,claude37,0.782,HISTOLOGIC GRADE
3443,claude37,0.75,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3444,claude37,0.762,NODAL SITE(S) EXAMINED
3445,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
3446,claude37,0.817,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3447,claude37,0.811,TUMOR FOCALITY
3448,claude37,0.793,PROCEDURE
3449,claude37,0.778,VISCERAL PLEURA INVASION
3450,claude37,0.807,REGIONAL LYMPH NODE STATUS
3451,claude37,0.887,TUMOR SITE
3452,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3453,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3454,claude37,0.827,PROCEDURE
3455,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3456,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
3457,claude37,0.82,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3458,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3459,claude37,0.815,REGIONAL LYMPH NODE STATUS
3460,claude37,0.697,SPECIMEN LATERALITY
3461,claude37,0.878,NODAL SITE(S) EXAMINED
3462,claude37,0.78,VISCERAL PLEURA INVASION
3463,claude37,0.782,HISTOLOGIC GRADE
3464,claude37,0.724,TUMOR FOCALITY
3465,claude37,0.792,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3466,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3467,claude37,0.809,NODAL SITE(S) EXAMINED
3468,claude37,0.695,NUMBER OF LYMPH NODES EXAMINED
3469,claude37,0.829,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3470,claude37,0.762,TUMOR SITE
3471,claude37,0.805,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3472,claude37,0.811,TUMOR FOCALITY
3473,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3474,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3475,claude37,0.815,REGIONAL LYMPH NODE STATUS
3476,claude37,0.827,PROCEDURE
3477,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
3478,claude37,0.78,VISCERAL PLEURA INVASION
3479,claude37,0.698,SPECIMEN LATERALITY
3480,claude37,0.66,ADDITIONAL FINDINGS
3481,claude37,0.782,HISTOLOGIC GRADE
3482,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3483,claude37,0.738,PROCEDURE
3484,claude37,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3485,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3486,claude37,0.829,NODAL SITE(S) EXAMINED
3487,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3488,claude37,0.888,TUMOR SITE
3489,claude37,0.811,TUMOR FOCALITY
3490,claude37,0.778,VISCERAL PLEURA INVASION
3491,claude37,0.923,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3492,claude37,0.815,REGIONAL LYMPH NODE STATUS
3493,claude37,0.798,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3494,claude37,0.782,HISTOLOGIC GRADE
3495,claude37,0.698,SPECIMEN LATERALITY
3496,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3497,claude37,0.785,NUMBER OF LYMPH NODES EXAMINED
3498,claude37,0.78,VISCERAL PLEURA INVASION
3499,claude37,0.791,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3500,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3501,claude37,0.838,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3502,claude37,0.811,TUMOR FOCALITY
3503,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3504,claude37,0.788,PROCEDURE
3505,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3506,claude37,0.715,ADDITIONAL FINDINGS
3507,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
3508,claude37,0.83,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3509,claude37,0.815,REGIONAL LYMPH NODE STATUS
3510,claude37,0.887,TUMOR SITE
3511,claude37,0.697,SPECIMEN LATERALITY
3512,claude37,0.782,HISTOLOGIC GRADE
3513,claude37,0.725,NODAL SITE(S) EXAMINED
3514,claude37,0.778,VISCERAL PLEURA INVASION
3515,claude37,0.815,REGIONAL LYMPH NODE STATUS
3516,claude37,0.709,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3517,claude37,0.698,SPECIMEN LATERALITY
3518,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3519,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3520,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3521,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
3522,claude37,0.71,PROCEDURE
3523,claude37,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3524,claude37,0.888,TUMOR SITE
3525,claude37,0.673,NODAL SITE(S) EXAMINED
3526,claude37,0.811,TUMOR FOCALITY
3527,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3528,claude37,0.764,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3529,claude37,0.841,MARGIN STATUS FOR INVASIVE CARCINOMA
3530,claude37,0.678,TUMOR FOCALITY
3531,claude37,0.742,VISCERAL PLEURA INVASION
3532,claude37,0.897,ADDITIONAL FINDINGS
3533,claude37,0.697,SPECIMEN LATERALITY
3534,claude37,0.791,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3535,claude37,0.72,REGIONAL LYMPH NODE STATUS
3536,claude37,0.712,HISTOLOGIC GRADE
3537,claude37,0.897,LYMPH NODE(S) FROM PRIOR PROCEDURES
3538,claude37,0.773,TUMOR SITE
3539,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3540,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3541,claude37,0.717,NUMBER OF LYMPH NODES EXAMINED
3542,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
3543,claude37,0.833,NODAL SITE(S) EXAMINED
3544,claude37,0.84,PROCEDURE
3545,claude37,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3546,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3547,claude37,0.804,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3548,claude37,0.697,SPECIMEN LATERALITY
3549,claude37,0.778,VISCERAL PLEURA INVASION
3550,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3551,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3552,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
3553,claude37,0.726,NODAL SITE(S) EXAMINED
3554,claude37,0.887,TUMOR SITE
3555,claude37,0.827,PROCEDURE
3556,claude37,0.811,TUMOR FOCALITY
3557,claude37,0.815,REGIONAL LYMPH NODE STATUS
3558,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3559,claude37,0.788,HISTOLOGIC GRADE
3560,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3561,claude37,0.713,NUMBER OF LYMPH NODES EXAMINED
3562,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
3563,claude37,0.678,TUMOR FOCALITY
3564,claude37,0.697,SPECIMEN LATERALITY
3565,claude37,0.72,NUMBER OF LYMPH NODES WITH TUMOR
3566,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3567,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3568,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3569,claude37,0.825,NODAL SITE(S) EXAMINED
3570,claude37,0.893,TUMOR SITE
3571,claude37,0.827,PROCEDURE
3572,claude37,0.725,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3573,claude37,0.752,NODAL SITE(S) WITH TUMOR
3574,claude37,0.767,REGIONAL LYMPH NODE STATUS
3575,claude37,0.816,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3576,claude37,0.778,VISCERAL PLEURA INVASION
3577,claude37,0.719,ADDITIONAL FINDINGS
3578,claude37,0.698,MARGIN STATUS FOR INVASIVE CARCINOMA
3579,claude37,0.703,NUMBER OF LYMPH NODES EXAMINED
3580,claude37,0.692,LYMPH NODE(S) FROM PRIOR PROCEDURES
3581,claude37,0.7,SPREAD THROUGH AIR SPACES (STAS)
3582,claude37,0.701,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3583,claude37,0.812,NODAL SITE(S) EXAMINED
3584,claude37,0.698,SPECIMEN LATERALITY
3585,claude37,0.788,PROCEDURE
3586,claude37,0.695,TNM DESCRIPTORS
3587,claude37,0.89,TUMOR SITE
3588,claude37,0.701,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3589,claude37,0.701,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3590,claude37,0.717,MARGIN STATUS FOR NON-INVASIVE TUMOR
3591,claude37,0.703,TUMOR FOCALITY
3592,claude37,0.722,HISTOLOGIC GRADE
3593,claude37,0.7,VISCERAL PLEURA INVASION
3594,claude37,0.882,REGIONAL LYMPH NODE STATUS
3595,claude37,0.703,NUMBER OF LYMPH NODES EXAMINED
3596,claude37,0.838,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3597,claude37,0.808,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3598,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3599,claude37,0.827,PROCEDURE
3600,claude37,0.784,REGIONAL LYMPH NODE STATUS
3601,claude37,0.887,TUMOR SITE
3602,claude37,0.698,VISCERAL PLEURA INVASION
3603,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3604,claude37,0.804,HISTOLOGIC GRADE
3605,claude37,0.811,TUMOR FOCALITY
3606,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3607,claude37,0.733,NODAL SITE(S) EXAMINED
3608,claude37,0.697,SPECIMEN LATERALITY
3609,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
3610,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3611,claude37,0.89,TUMOR SITE
3612,claude37,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3613,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3614,claude37,0.7,NUMBER OF LYMPH NODES EXAMINED
3615,claude37,0.697,SPECIMEN LATERALITY
3616,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
3617,claude37,0.811,TUMOR FOCALITY
3618,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3619,claude37,0.817,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3620,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3621,claude37,0.827,PROCEDURE
3622,claude37,0.732,NODAL SITE(S) EXAMINED
3623,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3624,claude37,0.784,REGIONAL LYMPH NODE STATUS
3625,claude37,0.778,VISCERAL PLEURA INVASION
3626,claude37,0.904,HISTOLOGIC GRADE
3627,claude37,0.818,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3628,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
3629,claude37,0.745,TNM DESCRIPTORS
3630,claude37,0.785,REGIONAL LYMPH NODE STATUS
3631,claude37,0.778,VISCERAL PLEURA INVASION
3632,claude37,0.788,HISTOLOGIC GRADE
3633,claude37,0.863,NODAL SITE(S) EXAMINED
3634,claude37,0.887,TUMOR SITE
3635,claude37,0.727,NUMBER OF LYMPH NODES EXAMINED
3636,claude37,0.72,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3637,claude37,0.705,TUMOR FOCALITY
3638,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3639,claude37,0.753,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3640,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3641,claude37,0.697,SPECIMEN LATERALITY
3642,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3643,claude37,0.788,PROCEDURE
3644,claude37,0.815,REGIONAL LYMPH NODE STATUS
3645,claude37,0.89,TUMOR SITE
3646,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3647,claude37,0.789,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3648,claude37,0.918,TUMOR FOCALITY
3649,claude37,0.634,ADDITIONAL FINDINGS
3650,claude37,0.871,NODAL SITE(S) EXAMINED
3651,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3652,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3653,claude37,0.697,SPECIMEN LATERALITY
3654,claude37,0.787,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3655,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3656,claude37,0.778,VISCERAL PLEURA INVASION
3657,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
3658,claude37,0.788,PROCEDURE
3659,claude37,0.778,VISCERAL PLEURA INVASION
3660,claude37,0.799,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3661,claude37,0.788,PROCEDURE
3662,claude37,0.72,NUMBER OF LYMPH NODES WITH TUMOR
3663,claude37,0.701,ADDITIONAL FINDINGS
3664,claude37,0.811,TUMOR FOCALITY
3665,claude37,0.825,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3666,claude37,0.89,TUMOR SITE
3667,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3668,claude37,0.777,REGIONAL LYMPH NODE STATUS
3669,claude37,0.734,NODAL SITE(S) EXAMINED
3670,claude37,0.766,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3671,claude37,0.862,NODAL SITE(S) WITH TUMOR
3672,claude37,0.716,LYMPHOVASCULAR INVASION
3673,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3674,claude37,0.697,SPECIMEN LATERALITY
3675,claude37,0.688,NUMBER OF LYMPH NODES EXAMINED
3676,claude37,0.788,HISTOLOGIC GRADE
3677,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3678,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
3679,claude37,0.739,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3680,claude37,0.685,REGIONAL LYMPH NODE STATUS
3681,claude37,0.705,PROCEDURE
3682,claude37,0.697,SPECIMEN LATERALITY
3683,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3684,claude37,0.778,VISCERAL PLEURA INVASION
3685,claude37,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3686,claude37,0.782,NODAL SITE(S) EXAMINED
3687,claude37,0.745,LYMPHOVASCULAR INVASION
3688,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3689,claude37,0.811,TUMOR FOCALITY
3690,claude37,0.78,NODAL SITE(S) WITH TUMOR
3691,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3692,claude37,0.89,TUMOR SITE
3693,claude37,0.79,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3694,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
3695,claude37,0.788,HISTOLOGIC GRADE
3696,claude37,0.753,ADDITIONAL FINDINGS
3697,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3698,claude37,0.749,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3699,claude37,0.815,REGIONAL LYMPH NODE STATUS
3700,claude37,0.89,TUMOR SITE
3701,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
3702,claude37,0.76,HISTOLOGIC GRADE
3703,claude37,0.697,SPECIMEN LATERALITY
3704,claude37,0.745,LYMPHOVASCULAR INVASION
3705,claude37,0.78,SPREAD THROUGH AIR SPACES (STAS)
3706,claude37,0.918,TUMOR FOCALITY
3707,claude37,0.729,NODAL SITE(S) EXAMINED
3708,claude37,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3709,claude37,0.703,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3710,claude37,0.788,PROCEDURE
3711,claude37,0.723,TNM DESCRIPTORS
3712,claude37,0.78,VISCERAL PLEURA INVASION
3713,claude37,0.706,NUMBER OF LYMPH NODES EXAMINED
3714,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3715,claude37,0.829,ADDITIONAL FINDINGS
3716,claude37,0.838,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3717,claude37,0.78,VISCERAL PLEURA INVASION
3718,claude37,0.825,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3719,claude37,0.698,SPECIMEN LATERALITY
3720,claude37,0.888,TUMOR SITE
3721,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3722,claude37,0.815,REGIONAL LYMPH NODE STATUS
3723,claude37,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3724,claude37,0.782,HISTOLOGIC GRADE
3725,claude37,0.702,NODAL SITE(S) EXAMINED
3726,claude37,0.811,TUMOR FOCALITY
3727,claude37,0.788,PROCEDURE
3728,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
3729,claude37,0.786,PROCEDURE
3730,claude37,0.887,TUMOR SITE
3731,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
3732,claude37,0.78,VISCERAL PLEURA INVASION
3733,claude37,0.692,LYMPH NODE(S) FROM PRIOR PROCEDURES
3734,claude37,0.753,NODAL SITE(S) EXAMINED
3735,claude37,0.815,REGIONAL LYMPH NODE STATUS
3736,claude37,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3737,claude37,0.811,TUMOR FOCALITY
3738,claude37,0.696,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3739,claude37,0.782,HISTOLOGIC GRADE
3740,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
3741,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3742,claude37,0.697,SPECIMEN LATERALITY
3743,claude37,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3744,claude37,0.64,ADDITIONAL FINDINGS
3745,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
3746,claude37,0.843,NODAL SITE(S) EXAMINED
3747,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
3748,claude37,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3749,claude37,0.832,NUMBER OF LYMPH NODES EXAMINED
3750,claude37,0.754,HISTOLOGIC GRADE
3751,claude37,0.887,TUMOR SITE
3752,claude37,0.826,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3753,claude37,0.697,SPECIMEN LATERALITY
3754,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3755,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3756,claude37,0.788,PROCEDURE
3757,claude37,0.778,VISCERAL PLEURA INVASION
3758,claude37,0.811,TUMOR FOCALITY
3759,claude37,0.815,REGIONAL LYMPH NODE STATUS
3760,claude37,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3761,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3762,claude37,0.78,SPREAD THROUGH AIR SPACES (STAS)
3763,claude37,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3764,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3765,claude37,0.722,ADDITIONAL FINDINGS
3766,claude37,0.691,NUMBER OF LYMPH NODES EXAMINED
3767,claude37,0.78,VISCERAL PLEURA INVASION
3768,claude37,0.811,TUMOR FOCALITY
3769,claude37,0.819,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3770,claude37,0.749,REGIONAL LYMPH NODE STATUS
3771,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
3772,claude37,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3773,claude37,0.674,NODAL SITE(S) EXAMINED
3774,claude37,0.799,NODAL SITE(S) WITH TUMOR
3775,claude37,0.698,SPECIMEN LATERALITY
3776,claude37,0.72,NUMBER OF LYMPH NODES WITH TUMOR
3777,claude37,0.865,TUMOR SITE
3778,claude37,0.788,PROCEDURE
3779,claude37,0.745,LYMPHOVASCULAR INVASION
3780,claude37,0.892,HISTOLOGIC GRADE
3781,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
3782,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3783,claude37,0.81,NUMBER OF LYMPH NODES EXAMINED
3784,claude37,0.853,NODAL SITE(S) EXAMINED
3785,claude37,0.841,MARGIN STATUS FOR INVASIVE CARCINOMA
3786,claude37,0.922,ADDITIONAL FINDINGS
3787,claude37,0.778,VISCERAL PLEURA INVASION
3788,claude37,0.897,LYMPH NODE(S) FROM PRIOR PROCEDURES
3789,claude37,0.75,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3790,claude37,0.788,PROCEDURE
3791,claude37,0.782,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3792,claude37,0.786,REGIONAL LYMPH NODE STATUS
3793,claude37,0.697,SPECIMEN LATERALITY
3794,claude37,0.851,TUMOR SITE
3795,claude37,0.76,HISTOLOGIC GRADE
3796,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3797,claude37,0.732,TNM DESCRIPTORS
3798,claude37,0.678,TUMOR FOCALITY
3799,claude37,0.904,HISTOLOGIC GRADE
3800,claude37,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3801,claude37,0.697,SPECIMEN LATERALITY
3802,claude37,0.823,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3803,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
3804,claude37,0.815,REGIONAL LYMPH NODE STATUS
3805,claude37,0.778,VISCERAL PLEURA INVASION
3806,claude37,0.816,NODAL SITE(S) EXAMINED
3807,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3808,claude37,0.827,PROCEDURE
3809,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3810,claude37,0.89,TUMOR SITE
3811,claude37,0.811,TUMOR FOCALITY
3812,claude37,0.892,ADDITIONAL FINDINGS
3813,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3814,claude37,0.72,NUMBER OF LYMPH NODES EXAMINED
3815,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3816,claude37,0.731,NODAL SITE(S) EXAMINED
3817,claude37,0.788,PROCEDURE
3818,claude37,0.89,TUMOR SITE
3819,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3820,claude37,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3821,claude37,0.736,HISTOLOGIC GRADE
3822,claude37,0.715,NODAL SITE(S) WITH TUMOR
3823,claude37,0.778,VISCERAL PLEURA INVASION
3824,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3825,claude37,0.692,LYMPH NODE(S) FROM PRIOR PROCEDURES
3826,claude37,0.722,REGIONAL LYMPH NODE STATUS
3827,claude37,0.918,TUMOR FOCALITY
3828,claude37,0.717,NUMBER OF LYMPH NODES EXAMINED
3829,claude37,0.697,SPECIMEN LATERALITY
3830,claude37,0.736,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3831,claude37,0.775,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3832,claude37,0.716,NUMBER OF LYMPH NODES WITH TUMOR
3833,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
3834,claude37,0.811,TUMOR FOCALITY
3835,claude37,0.846,TUMOR SITE
3836,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3837,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3838,claude37,0.778,VISCERAL PLEURA INVASION
3839,claude37,0.798,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3840,claude37,0.782,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3841,claude37,0.826,HISTOLOGIC GRADE
3842,claude37,0.823,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3843,claude37,0.679,NODAL SITE(S) EXAMINED
3844,claude37,0.72,NUMBER OF LYMPH NODES WITH TUMOR
3845,claude37,0.788,PROCEDURE
3846,claude37,0.726,REGIONAL LYMPH NODE STATUS
3847,claude37,0.774,NODAL SITE(S) WITH TUMOR
3848,claude37,0.698,SPECIMEN LATERALITY
3849,claude37,0.722,ADDITIONAL FINDINGS
3850,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3851,claude37,0.89,TUMOR SITE
3852,claude37,0.78,VISCERAL PLEURA INVASION
3853,claude37,0.786,REGIONAL LYMPH NODE STATUS
3854,claude37,0.782,HISTOLOGIC GRADE
3855,claude37,0.867,NODAL SITE(S) EXAMINED
3856,claude37,0.83,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3857,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3858,claude37,0.788,PROCEDURE
3859,claude37,0.697,SPECIMEN LATERALITY
3860,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3861,claude37,0.784,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3862,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3863,claude37,0.811,TUMOR FOCALITY
3864,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
3865,claude37,0.816,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3866,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3867,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3868,claude37,0.749,PROCEDURE
3869,claude37,0.78,VISCERAL PLEURA INVASION
3870,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3871,claude37,0.89,TUMOR SITE
3872,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3873,claude37,0.815,REGIONAL LYMPH NODE STATUS
3874,claude37,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3875,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
3876,claude37,0.715,ADDITIONAL FINDINGS
3877,claude37,0.811,TUMOR FOCALITY
3878,claude37,0.697,SPECIMEN LATERALITY
3879,claude37,0.782,HISTOLOGIC GRADE
3880,claude37,0.728,NODAL SITE(S) EXAMINED
3881,claude37,0.732,ADDITIONAL FINDINGS
3882,claude37,0.728,NODAL SITE(S) EXAMINED
3883,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3884,claude37,0.788,PROCEDURE
3885,claude37,0.734,NUMBER OF LYMPH NODES EXAMINED
3886,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3887,claude37,0.815,REGIONAL LYMPH NODE STATUS
3888,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3889,claude37,0.697,SPECIMEN LATERALITY
3890,claude37,0.722,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3891,claude37,0.76,HISTOLOGIC GRADE
3892,claude37,0.826,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3893,claude37,0.811,TUMOR FOCALITY
3894,claude37,0.78,VISCERAL PLEURA INVASION
3895,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
3896,claude37,0.89,TUMOR SITE
3897,claude37,0.697,SPECIMEN LATERALITY
3898,claude37,0.715,NUMBER OF LYMPH NODES WITH TUMOR
3899,claude37,0.795,TNM DESCRIPTORS
3900,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
3901,claude37,0.736,REGIONAL LYMPH NODE STATUS
3902,claude37,0.74,NODAL SITE(S) EXAMINED
3903,claude37,0.904,HISTOLOGIC GRADE
3904,claude37,0.735,TUMOR SITE
3905,claude37,0.717,LYMPHOVASCULAR INVASION
3906,claude37,0.778,VISCERAL PLEURA INVASION
3907,claude37,0.7,SPREAD THROUGH AIR SPACES (STAS)
3908,claude37,0.743,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3909,claude37,0.787,NODAL SITE(S) WITH TUMOR
3910,claude37,0.855,MARGIN STATUS FOR INVASIVE CARCINOMA
3911,claude37,0.787,PROCEDURE
3912,claude37,0.811,TUMOR FOCALITY
3913,claude37,0.683,LYMPH NODE(S) FROM PRIOR PROCEDURES
3914,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3915,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3916,claude37,0.815,REGIONAL LYMPH NODE STATUS
3917,claude37,0.791,PROCEDURE
3918,claude37,0.858,TUMOR SITE
3919,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3920,claude37,0.798,NODAL SITE(S) EXAMINED
3921,claude37,0.678,TUMOR FOCALITY
3922,claude37,0.75,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3923,claude37,0.697,SPECIMEN LATERALITY
3924,claude37,0.853,ADDITIONAL FINDINGS
3925,claude37,0.703,VISCERAL PLEURA INVASION
3926,claude37,0.785,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3927,claude37,0.783,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3928,claude37,0.768,TNM DESCRIPTORS
3929,claude37,0.736,HISTOLOGIC GRADE
3930,claude37,0.724,SPREAD THROUGH AIR SPACES (STAS)
3931,claude37,0.78,VISCERAL PLEURA INVASION
3932,claude37,0.75,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3933,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3934,claude37,0.793,PROCEDURE
3935,claude37,0.817,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3936,claude37,0.734,NODAL SITE(S) EXAMINED
3937,claude37,0.697,SPECIMEN LATERALITY
3938,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3939,claude37,0.76,HISTOLOGIC GRADE
3940,claude37,0.887,TUMOR SITE
3941,claude37,0.698,LYMPHOVASCULAR INVASION
3942,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3943,claude37,0.663,ADDITIONAL FINDINGS
3944,claude37,0.811,TUMOR FOCALITY
3945,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3946,claude37,0.793,HISTOLOGIC GRADE
3947,claude37,0.811,TUMOR FOCALITY
3948,claude37,0.706,TNM DESCRIPTORS
3949,claude37,0.888,TUMOR SITE
3950,claude37,0.816,NODAL SITE(S) EXAMINED
3951,claude37,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3952,claude37,0.78,VISCERAL PLEURA INVASION
3953,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3954,claude37,0.873,NODAL SITE(S) WITH TUMOR
3955,claude37,0.855,MARGIN STATUS FOR INVASIVE CARCINOMA
3956,claude37,0.773,NUMBER OF LYMPH NODES EXAMINED
3957,claude37,0.728,REGIONAL LYMPH NODE STATUS
3958,claude37,0.809,NUMBER OF LYMPH NODES WITH TUMOR
3959,claude37,0.788,PROCEDURE
3960,claude37,0.698,SPECIMEN LATERALITY
3961,claude37,0.745,LYMPHOVASCULAR INVASION
3962,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3963,claude37,0.873,NODAL SITE(S) EXAMINED
3964,claude37,0.634,ADDITIONAL FINDINGS
3965,claude37,0.811,TUMOR FOCALITY
3966,claude37,0.788,REGIONAL LYMPH NODE STATUS
3967,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3968,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3969,claude37,0.697,SPECIMEN LATERALITY
3970,claude37,0.791,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3971,claude37,0.788,PROCEDURE
3972,claude37,0.703,NUMBER OF LYMPH NODES EXAMINED
3973,claude37,0.782,HISTOLOGIC GRADE
3974,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
3975,claude37,0.837,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3976,claude37,0.887,TUMOR SITE
3977,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
3978,claude37,0.778,VISCERAL PLEURA INVASION
3979,claude37,0.788,PROCEDURE
3980,claude37,0.78,SPREAD THROUGH AIR SPACES (STAS)
3981,claude37,0.791,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3982,claude37,0.695,NUMBER OF LYMPH NODES EXAMINED
3983,claude37,0.698,SPECIMEN LATERALITY
3984,claude37,0.778,VISCERAL PLEURA INVASION
3985,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3986,claude37,0.765,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3987,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3988,claude37,0.811,TUMOR FOCALITY
3989,claude37,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3990,claude37,0.805,NODAL SITE(S) EXAMINED
3991,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3992,claude37,0.892,HISTOLOGIC GRADE
3993,claude37,0.89,TUMOR SITE
3994,claude37,0.815,REGIONAL LYMPH NODE STATUS
3995,claude37,0.683,ADDITIONAL FINDINGS
3996,claude37,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3997,claude37,0.829,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3998,claude37,0.887,TUMOR SITE
3999,claude37,0.717,ADDITIONAL FINDINGS
4000,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4001,claude37,0.732,NODAL SITE(S) EXAMINED
4002,claude37,0.782,HISTOLOGIC GRADE
4003,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4004,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
4005,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4006,claude37,0.701,NUMBER OF LYMPH NODES EXAMINED
4007,claude37,0.697,SPECIMEN LATERALITY
4008,claude37,0.698,VISCERAL PLEURA INVASION
4009,claude37,0.815,REGIONAL LYMPH NODE STATUS
4010,claude37,0.811,TUMOR FOCALITY
4011,claude37,0.788,PROCEDURE
4012,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4013,claude37,0.788,PROCEDURE
4014,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4015,claude37,0.904,HISTOLOGIC GRADE
4016,claude37,0.811,TUMOR FOCALITY
4017,claude37,0.784,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4018,claude37,0.697,SPECIMEN LATERALITY
4019,claude37,0.893,TUMOR SITE
4020,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
4021,claude37,0.742,NODAL SITE(S) EXAMINED
4022,claude37,0.815,REGIONAL LYMPH NODE STATUS
4023,claude37,0.778,VISCERAL PLEURA INVASION
4024,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4025,claude37,0.826,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4026,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4027,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4028,claude37,0.778,VISCERAL PLEURA INVASION
4029,claude37,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4030,claude37,0.811,TUMOR FOCALITY
4031,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4032,claude37,0.697,SPECIMEN LATERALITY
4033,claude37,0.836,ADDITIONAL FINDINGS
4034,claude37,0.807,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4035,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4036,claude37,0.89,TUMOR SITE
4037,claude37,0.782,HISTOLOGIC GRADE
4038,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4039,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4040,claude37,0.827,PROCEDURE
4041,claude37,0.786,REGIONAL LYMPH NODE STATUS
4042,claude37,0.879,ADDITIONAL FINDINGS
4043,claude37,0.697,SPECIMEN LATERALITY
4044,claude37,0.767,TNM DESCRIPTORS
4045,claude37,0.807,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4046,claude37,0.77,PROCEDURE
4047,claude37,0.778,VISCERAL PLEURA INVASION
4048,claude37,0.876,NODAL SITE(S) EXAMINED
4049,claude37,0.782,HISTOLOGIC GRADE
4050,claude37,0.678,TUMOR SITE
4051,claude37,0.795,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4052,claude37,0.698,LYMPHOVASCULAR INVASION
4053,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4054,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4055,claude37,0.742,MARGIN STATUS FOR INVASIVE CARCINOMA
4056,claude37,0.689,TUMOR FOCALITY
4057,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4058,claude37,0.684,HISTOLOGIC GRADE
4059,claude37,0.703,VISCERAL PLEURA INVASION
4060,claude37,0.691,TUMOR FOCALITY
4061,claude37,0.735,TUMOR SITE
4062,claude37,0.827,PROCEDURE
4063,claude37,0.787,REGIONAL LYMPH NODE STATUS
4064,claude37,0.648,SPECIMEN LATERALITY
4065,claude37,0.823,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4066,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4067,claude37,0.775,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4068,claude37,0.715,NODAL SITE(S) EXAMINED
4069,claude37,0.754,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4070,claude37,0.701,NUMBER OF LYMPH NODES EXAMINED
4071,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4072,claude37,0.791,TNM DESCRIPTORS
4073,claude37,0.897,LYMPH NODE(S) FROM PRIOR PROCEDURES
4074,claude37,0.811,TUMOR FOCALITY
4075,claude37,0.697,SPECIMEN LATERALITY
4076,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4077,claude37,0.756,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4078,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4079,claude37,0.733,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4080,claude37,0.788,HISTOLOGIC GRADE
4081,claude37,0.882,REGIONAL LYMPH NODE STATUS
4082,claude37,0.858,NODAL SITE(S) EXAMINED
4083,claude37,0.648,TUMOR SITE
4084,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4085,claude37,0.778,VISCERAL PLEURA INVASION
4086,claude37,0.809,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4087,claude37,0.746,PROCEDURE
4088,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
4089,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4090,claude37,0.672,NODAL SITE(S) EXAMINED
4091,claude37,0.732,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4092,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4093,claude37,0.888,TUMOR SITE
4094,claude37,0.778,VISCERAL PLEURA INVASION
4095,claude37,0.698,SPECIMEN LATERALITY
4096,claude37,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4097,claude37,0.713,NUMBER OF LYMPH NODES EXAMINED
4098,claude37,0.815,REGIONAL LYMPH NODE STATUS
4099,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4100,claude37,0.811,TUMOR FOCALITY
4101,claude37,0.827,PROCEDURE
4102,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4103,claude37,0.683,LYMPH NODE(S) FROM PRIOR PROCEDURES
4104,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4105,claude37,0.734,TUMOR FOCALITY
4106,claude37,0.778,VISCERAL PLEURA INVASION
4107,claude37,0.819,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4108,claude37,0.775,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4109,claude37,0.713,TNM DESCRIPTORS
4110,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4111,claude37,0.697,SPECIMEN LATERALITY
4112,claude37,0.893,TUMOR SITE
4113,claude37,0.899,NODAL SITE(S) EXAMINED
4114,claude37,0.7,NUMBER OF LYMPH NODES WITH TUMOR
4115,claude37,0.788,PROCEDURE
4116,claude37,0.711,REGIONAL LYMPH NODE STATUS
4117,claude37,0.741,NUMBER OF LYMPH NODES EXAMINED
4118,claude37,0.742,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4119,claude37,0.768,NODAL SITE(S) WITH TUMOR
4120,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4121,claude37,0.697,SPECIMEN LATERALITY
4122,claude37,0.832,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4123,claude37,0.89,TUMOR SITE
4124,claude37,0.729,NODAL SITE(S) EXAMINED
4125,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4126,claude37,0.811,TUMOR FOCALITY
4127,claude37,0.755,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4128,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4129,claude37,0.788,PROCEDURE
4130,claude37,0.746,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4131,claude37,0.815,REGIONAL LYMPH NODE STATUS
4132,claude37,0.811,TUMOR FOCALITY
4133,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4134,claude37,0.817,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4135,claude37,0.678,NODAL SITE(S) EXAMINED
4136,claude37,0.703,NUMBER OF LYMPH NODES EXAMINED
4137,claude37,0.807,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4138,claude37,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4139,claude37,0.778,VISCERAL PLEURA INVASION
4140,claude37,0.824,TUMOR SITE
4141,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4142,claude37,0.815,REGIONAL LYMPH NODE STATUS
4143,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4144,claude37,0.782,HISTOLOGIC GRADE
4145,claude37,0.698,SPECIMEN LATERALITY
4146,claude37,0.793,PROCEDURE
4147,claude37,0.782,HISTOLOGIC GRADE
4148,claude37,0.815,REGIONAL LYMPH NODE STATUS
4149,claude37,0.788,PROCEDURE
4150,claude37,0.789,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4151,claude37,0.752,NODAL SITE(S) EXAMINED
4152,claude37,0.811,TUMOR FOCALITY
4153,claude37,0.808,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4154,claude37,0.83,TUMOR SITE
4155,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4156,claude37,0.778,VISCERAL PLEURA INVASION
4157,claude37,0.698,SPECIMEN LATERALITY
4158,claude37,0.701,NUMBER OF LYMPH NODES EXAMINED
4159,claude37,0.683,LYMPH NODE(S) FROM PRIOR PROCEDURES
4160,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
4161,claude37,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4162,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4163,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4164,claude37,0.775,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4165,claude37,0.819,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4166,claude37,0.698,VISCERAL PLEURA INVASION
4167,claude37,0.811,TUMOR FOCALITY
4168,claude37,0.89,TUMOR SITE
4169,claude37,0.697,SPECIMEN LATERALITY
4170,claude37,0.815,REGIONAL LYMPH NODE STATUS
4171,claude37,0.881,NODAL SITE(S) EXAMINED
4172,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4173,claude37,0.716,LYMPHOVASCULAR INVASION
4174,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4175,claude37,0.788,PROCEDURE
4176,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4177,claude37,0.697,SPECIMEN LATERALITY
4178,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
4179,claude37,0.828,ADDITIONAL FINDINGS
4180,claude37,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4181,claude37,0.778,VISCERAL PLEURA INVASION
4182,claude37,0.722,NODAL SITE(S) EXAMINED
4183,claude37,0.837,TUMOR SITE
4184,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4185,claude37,0.734,NUMBER OF LYMPH NODES EXAMINED
4186,claude37,0.746,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4187,claude37,0.788,PROCEDURE
4188,claude37,0.815,REGIONAL LYMPH NODE STATUS
4189,claude37,0.811,TUMOR FOCALITY
4190,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4191,claude37,0.824,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4192,claude37,0.786,TUMOR SITE
4193,claude37,0.815,REGIONAL LYMPH NODE STATUS
4194,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4195,claude37,0.693,NODAL SITE(S) EXAMINED
4196,claude37,0.746,TNM DESCRIPTORS
4197,claude37,0.698,VISCERAL PLEURA INVASION
4198,claude37,0.794,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4199,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4200,claude37,0.698,SPECIMEN LATERALITY
4201,claude37,0.792,ADDITIONAL FINDINGS
4202,claude37,0.808,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4203,claude37,0.755,PROCEDURE
4204,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
4205,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4206,claude37,0.781,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4207,claude37,0.689,TUMOR FOCALITY
4208,claude37,0.705,HISTOLOGIC GRADE
4209,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4210,claude37,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4211,claude37,0.757,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4212,claude37,0.811,TUMOR FOCALITY
4213,claude37,0.698,SPECIMEN LATERALITY
4214,claude37,0.778,VISCERAL PLEURA INVASION
4215,claude37,0.753,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4216,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4217,claude37,0.671,NODAL SITE(S) EXAMINED
4218,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
4219,claude37,0.788,HISTOLOGIC GRADE
4220,claude37,0.815,REGIONAL LYMPH NODE STATUS
4221,claude37,0.865,TUMOR SITE
4222,claude37,0.847,NODAL SITE(S) EXAMINED
4223,claude37,0.788,PROCEDURE
4224,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4225,claude37,0.788,PROCEDURE
4226,claude37,0.778,VISCERAL PLEURA INVASION
4227,claude37,0.815,REGIONAL LYMPH NODE STATUS
4228,claude37,0.838,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4229,claude37,0.811,TUMOR FOCALITY
4230,claude37,0.798,TUMOR SITE
4231,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4232,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4233,claude37,0.72,NODAL SITE(S) EXAMINED
4234,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4235,claude37,0.7,SPREAD THROUGH AIR SPACES (STAS)
4236,claude37,0.683,LYMPH NODE(S) FROM PRIOR PROCEDURES
4237,claude37,0.738,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4238,claude37,0.697,SPECIMEN LATERALITY
4239,claude37,0.728,HISTOLOGIC GRADE
4240,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4241,claude37,0.752,REGIONAL LYMPH NODE STATUS
4242,claude37,0.697,SPECIMEN LATERALITY
4243,claude37,0.778,VISCERAL PLEURA INVASION
4244,claude37,0.782,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4245,claude37,0.886,NODAL SITE(S) WITH TUMOR
4246,claude37,0.811,TUMOR FOCALITY
4247,claude37,0.838,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4248,claude37,0.651,NUMBER OF LYMPH NODES WITH TUMOR
4249,claude37,0.746,PROCEDURE
4250,claude37,0.707,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4251,claude37,0.795,TNM DESCRIPTORS
4252,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
4253,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4254,claude37,0.727,ADDITIONAL FINDINGS
4255,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4256,claude37,0.695,TUMOR SITE
4257,claude37,0.857,NODAL SITE(S) EXAMINED
4258,claude37,0.817,NODAL SITE(S) EXAMINED
4259,claude37,0.76,HISTOLOGIC GRADE
4260,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4261,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4262,claude37,0.819,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4263,claude37,0.698,SPECIMEN LATERALITY
4264,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4265,claude37,0.778,VISCERAL PLEURA INVASION
4266,claude37,0.815,REGIONAL LYMPH NODE STATUS
4267,claude37,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4268,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4269,claude37,0.788,PROCEDURE
4270,claude37,0.718,SPREAD THROUGH AIR SPACES (STAS)
4271,claude37,0.811,TUMOR FOCALITY
4272,claude37,0.706,NUMBER OF LYMPH NODES EXAMINED
4273,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4274,claude37,0.697,SPECIMEN LATERALITY
4275,claude37,0.904,HISTOLOGIC GRADE
4276,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
4277,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4278,claude37,0.711,NUMBER OF LYMPH NODES EXAMINED
4279,claude37,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4280,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4281,claude37,0.815,REGIONAL LYMPH NODE STATUS
4282,claude37,0.802,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4283,claude37,0.793,PROCEDURE
4284,claude37,0.733,NODAL SITE(S) EXAMINED
4285,claude37,0.811,TUMOR FOCALITY
4286,claude37,0.788,TUMOR SITE
4287,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4288,claude37,0.778,VISCERAL PLEURA INVASION
4289,claude37,0.803,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4290,claude37,0.775,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4291,claude37,0.789,REGIONAL LYMPH NODE STATUS
4292,claude37,0.89,TUMOR SITE
4293,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4294,claude37,0.843,ADDITIONAL FINDINGS
4295,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4296,claude37,0.764,NUMBER OF LYMPH NODES EXAMINED
4297,claude37,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4298,claude37,0.697,SPECIMEN LATERALITY
4299,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
4300,claude37,0.811,TUMOR FOCALITY
4301,claude37,0.782,HISTOLOGIC GRADE
4302,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4303,claude37,0.788,PROCEDURE
4304,claude37,0.837,NODAL SITE(S) EXAMINED
4305,claude37,0.778,VISCERAL PLEURA INVASION
4306,claude37,0.82,NODAL SITE(S) WITH TUMOR
4307,claude37,0.811,TUMOR FOCALITY
4308,claude37,0.739,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4309,claude37,0.872,NODAL SITE(S) EXAMINED
4310,claude37,0.78,VISCERAL PLEURA INVASION
4311,claude37,0.89,TUMOR SITE
4312,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4313,claude37,0.717,LYMPHOVASCULAR INVASION
4314,claude37,0.78,REGIONAL LYMPH NODE STATUS
4315,claude37,0.72,PROCEDURE
4316,claude37,0.736,HISTOLOGIC GRADE
4317,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4318,claude37,0.72,NUMBER OF LYMPH NODES WITH TUMOR
4319,claude37,0.65,SPREAD THROUGH AIR SPACES (STAS)
4320,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4321,claude37,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4322,claude37,0.713,NUMBER OF LYMPH NODES EXAMINED
4323,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4324,claude37,0.697,SPECIMEN LATERALITY
4325,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4326,claude37,0.697,SPECIMEN LATERALITY
4327,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
4328,claude37,0.827,PROCEDURE
4329,claude37,0.89,TUMOR SITE
4330,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4331,claude37,0.819,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4332,claude37,0.918,TUMOR FOCALITY
4333,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4334,claude37,0.712,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4335,claude37,0.782,HISTOLOGIC GRADE
4336,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4337,claude37,0.78,VISCERAL PLEURA INVASION
4338,claude37,0.815,REGIONAL LYMPH NODE STATUS
4339,claude37,0.782,HISTOLOGIC GRADE
4340,claude37,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4341,claude37,0.827,PROCEDURE
4342,claude37,0.698,SPECIMEN LATERALITY
4343,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4344,claude37,0.786,NODAL SITE(S) EXAMINED
4345,claude37,0.83,TUMOR SITE
4346,claude37,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4347,claude37,0.713,NUMBER OF LYMPH NODES EXAMINED
4348,claude37,0.78,VISCERAL PLEURA INVASION
4349,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4350,claude37,0.7,SPREAD THROUGH AIR SPACES (STAS)
4351,claude37,0.811,TUMOR FOCALITY
4352,claude37,0.664,ADDITIONAL FINDINGS
4353,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4354,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4355,claude37,0.78,SPREAD THROUGH AIR SPACES (STAS)
4356,claude37,0.76,HISTOLOGIC GRADE
4357,claude37,0.731,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4358,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4359,claude37,0.718,VISCERAL PLEURA INVASION
4360,claude37,0.821,ADDITIONAL FINDINGS
4361,claude37,0.706,NODAL SITE(S) EXAMINED
4362,claude37,0.89,TUMOR SITE
4363,claude37,0.745,LYMPHOVASCULAR INVASION
4364,claude37,0.811,TUMOR FOCALITY
4365,claude37,0.711,NUMBER OF LYMPH NODES EXAMINED
4366,claude37,0.692,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4367,claude37,0.8,PROCEDURE
4368,claude37,0.698,SPECIMEN LATERALITY
4369,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4370,claude37,0.835,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4371,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4372,claude37,0.735,TNM DESCRIPTORS
4373,claude37,0.76,HISTOLOGIC GRADE
4374,claude37,0.698,SPECIMEN LATERALITY
4375,claude37,0.811,TUMOR FOCALITY
4376,claude37,0.842,TUMOR SITE
4377,claude37,0.739,REGIONAL LYMPH NODE STATUS
4378,claude37,0.727,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4379,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4380,claude37,0.769,PROCEDURE
4381,claude37,0.883,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4382,claude37,0.788,LYMPHOVASCULAR INVASION
4383,claude37,0.721,TNM DESCRIPTORS
4384,claude37,0.838,NODAL SITE(S) EXAMINED
4385,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
4386,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4387,claude37,0.807,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4388,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4389,claude37,0.702,NODAL SITE(S) WITH TUMOR
4390,claude37,0.78,VISCERAL PLEURA INVASION
4391,claude37,0.794,NODAL SITE(S) WITH TUMOR
4392,claude37,0.733,NODAL SITE(S) EXAMINED
4393,claude37,0.72,NUMBER OF LYMPH NODES WITH TUMOR
4394,claude37,0.697,SPECIMEN LATERALITY
4395,claude37,0.808,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4396,claude37,0.811,TUMOR FOCALITY
4397,claude37,0.777,REGIONAL LYMPH NODE STATUS
4398,claude37,0.7,NUMBER OF LYMPH NODES EXAMINED
4399,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4400,claude37,0.938,ADDITIONAL FINDINGS
4401,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4402,claude37,0.893,TUMOR SITE
4403,claude37,0.788,PROCEDURE
4404,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
4405,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4406,claude37,0.735,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4407,claude37,0.76,HISTOLOGIC GRADE
4408,claude37,0.738,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4409,claude37,0.778,VISCERAL PLEURA INVASION
4410,claude37,0.735,REGIONAL LYMPH NODE STATUS
4411,claude37,0.735,NODAL SITE(S) EXAMINED
4412,claude37,0.68,HISTOLOGIC GRADE
4413,claude37,0.692,LYMPH NODE(S) FROM PRIOR PROCEDURES
4414,claude37,0.787,PROCEDURE
4415,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
4416,claude37,0.706,MARGIN STATUS FOR INVASIVE CARCINOMA
4417,claude37,0.711,ADDITIONAL FINDINGS
4418,claude37,0.811,TUMOR FOCALITY
4419,claude37,0.672,MARGIN STATUS FOR NON-INVASIVE TUMOR
4420,claude37,0.697,SPECIMEN LATERALITY
4421,claude37,0.795,TNM DESCRIPTORS
4422,claude37,0.778,VISCERAL PLEURA INVASION
4423,claude37,0.816,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4424,claude37,0.836,TUMOR SITE
4425,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4426,claude37,0.708,TUMOR FOCALITY
4427,claude37,0.788,PROCEDURE
4428,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4429,claude37,0.89,TUMOR SITE
4430,claude37,0.713,NUMBER OF LYMPH NODES WITH TUMOR
4431,claude37,0.779,REGIONAL LYMPH NODE STATUS
4432,claude37,0.745,LYMPHOVASCULAR INVASION
4433,claude37,0.697,SPECIMEN LATERALITY
4434,claude37,0.724,NODAL SITE(S) WITH TUMOR
4435,claude37,0.765,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4436,claude37,0.712,HISTOLOGIC GRADE
4437,claude37,0.78,VISCERAL PLEURA INVASION
4438,claude37,0.725,NODAL SITE(S) EXAMINED
4439,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
4440,claude37,0.777,NUMBER OF LYMPH NODES EXAMINED
4441,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4442,claude37,0.791,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4443,claude37,0.787,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4444,claude37,0.798,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4445,claude37,0.811,TUMOR FOCALITY
4446,claude37,0.789,ADDITIONAL FINDINGS
4447,claude37,0.788,PROCEDURE
4448,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4449,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4450,claude37,0.782,HISTOLOGIC GRADE
4451,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4452,claude37,0.815,REGIONAL LYMPH NODE STATUS
4453,claude37,0.795,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4454,claude37,0.697,SPECIMEN LATERALITY
4455,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
4456,claude37,0.89,TUMOR SITE
4457,claude37,0.869,NODAL SITE(S) EXAMINED
4458,claude37,0.739,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4459,claude37,0.778,VISCERAL PLEURA INVASION
4460,claude37,0.707,NUMBER OF LYMPH NODES EXAMINED
4461,claude37,0.863,NODAL SITE(S) EXAMINED
4462,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
4463,claude37,0.815,REGIONAL LYMPH NODE STATUS
4464,claude37,0.811,TUMOR FOCALITY
4465,claude37,0.698,VISCERAL PLEURA INVASION
4466,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4467,claude37,0.827,PROCEDURE
4468,claude37,0.851,TUMOR SITE
4469,claude37,0.814,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4470,claude37,0.782,HISTOLOGIC GRADE
4471,claude37,0.749,LYMPHOVASCULAR INVASION
4472,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4473,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4474,claude37,0.755,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4475,claude37,0.645,SPECIMEN LATERALITY
4476,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4477,claude37,0.745,LYMPHOVASCULAR INVASION
4478,claude37,0.773,NUMBER OF LYMPH NODES EXAMINED
4479,claude37,0.819,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4480,claude37,0.739,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4481,claude37,0.778,VISCERAL PLEURA INVASION
4482,claude37,0.788,PROCEDURE
4483,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4484,claude37,0.808,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4485,claude37,0.698,SPECIMEN LATERALITY
4486,claude37,0.76,HISTOLOGIC GRADE
4487,claude37,0.811,TUMOR FOCALITY
4488,claude37,0.677,NODAL SITE(S) EXAMINED
4489,claude37,0.89,TUMOR SITE
4490,claude37,0.815,REGIONAL LYMPH NODE STATUS
4491,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4492,claude37,0.849,ADDITIONAL FINDINGS
4493,claude37,0.707,NUMBER OF LYMPH NODES EXAMINED
4494,claude37,0.817,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4495,claude37,0.697,SPECIMEN LATERALITY
4496,claude37,0.811,TUMOR FOCALITY
4497,claude37,0.809,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4498,claude37,0.815,REGIONAL LYMPH NODE STATUS
4499,claude37,0.824,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4500,claude37,0.827,PROCEDURE
4501,claude37,0.745,LYMPHOVASCULAR INVASION
4502,claude37,0.818,NODAL SITE(S) EXAMINED
4503,claude37,0.698,VISCERAL PLEURA INVASION
4504,claude37,0.851,TUMOR SITE
4505,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4506,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
4507,claude37,0.698,VISCERAL PLEURA INVASION
4508,claude37,0.709,NODAL SITE(S) EXAMINED
4509,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4510,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4511,claude37,0.874,NODAL SITE(S) WITH TUMOR
4512,claude37,0.78,SPREAD THROUGH AIR SPACES (STAS)
4513,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4514,claude37,0.699,NUMBER OF LYMPH NODES EXAMINED
4515,claude37,0.817,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4516,claude37,0.779,LYMPHOVASCULAR INVASION
4517,claude37,0.72,NUMBER OF LYMPH NODES WITH TUMOR
4518,claude37,0.761,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4519,claude37,0.76,HISTOLOGIC GRADE
4520,claude37,0.722,REGIONAL LYMPH NODE STATUS
4521,claude37,0.698,SPECIMEN LATERALITY
4522,claude37,0.811,TUMOR FOCALITY
4523,claude37,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4524,claude37,0.833,TUMOR SITE
4525,claude37,0.788,PROCEDURE
4526,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
4527,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4528,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4529,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4530,claude37,0.815,REGIONAL LYMPH NODE STATUS
4531,claude37,0.697,SPECIMEN LATERALITY
4532,claude37,0.892,HISTOLOGIC GRADE
4533,claude37,0.811,TUMOR FOCALITY
4534,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4535,claude37,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4536,claude37,0.827,PROCEDURE
4537,claude37,0.72,NUMBER OF LYMPH NODES EXAMINED
4538,claude37,0.797,NODAL SITE(S) EXAMINED
4539,claude37,0.778,VISCERAL PLEURA INVASION
4540,claude37,0.798,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4541,claude37,0.89,TUMOR SITE
4542,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4543,claude37,0.816,NODAL SITE(S) EXAMINED
4544,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4545,claude37,0.698,SPECIMEN LATERALITY
4546,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4547,claude37,0.811,TUMOR FOCALITY
4548,claude37,0.698,VISCERAL PLEURA INVASION
4549,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4550,claude37,0.83,TUMOR SITE
4551,claude37,0.813,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4552,claude37,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4553,claude37,0.779,REGIONAL LYMPH NODE STATUS
4554,claude37,0.635,ADDITIONAL FINDINGS
4555,claude37,0.788,PROCEDURE
4556,claude37,0.775,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4557,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4558,claude37,0.811,TUMOR FOCALITY
4559,claude37,0.778,VISCERAL PLEURA INVASION
4560,claude37,0.815,REGIONAL LYMPH NODE STATUS
4561,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4562,claude37,0.727,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4563,claude37,0.714,NUMBER OF LYMPH NODES EXAMINED
4564,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4565,claude37,0.788,PROCEDURE
4566,claude37,0.782,HISTOLOGIC GRADE
4567,claude37,0.801,NODAL SITE(S) EXAMINED
4568,claude37,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4569,claude37,0.697,SPECIMEN LATERALITY
4570,claude37,0.89,TUMOR SITE
4571,claude37,0.778,VISCERAL PLEURA INVASION
4572,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4573,claude37,0.698,LYMPHOVASCULAR INVASION
4574,claude37,0.715,ADDITIONAL FINDINGS
4575,claude37,0.828,TUMOR SITE
4576,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4577,claude37,0.811,TUMOR FOCALITY
4578,claude37,0.712,NUMBER OF LYMPH NODES EXAMINED
4579,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4580,claude37,0.697,SPECIMEN LATERALITY
4581,claude37,0.807,NODAL SITE(S) EXAMINED
4582,claude37,0.815,REGIONAL LYMPH NODE STATUS
4583,claude37,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4584,claude37,0.78,SPREAD THROUGH AIR SPACES (STAS)
4585,claude37,0.847,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4586,claude37,0.793,PROCEDURE
4587,claude37,0.76,HISTOLOGIC GRADE
4588,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4589,claude37,0.78,VISCERAL PLEURA INVASION
4590,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4591,claude37,0.811,TUMOR FOCALITY
4592,claude37,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4593,claude37,0.667,ADDITIONAL FINDINGS
4594,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4595,claude37,0.791,PROCEDURE
4596,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4597,claude37,0.698,SPECIMEN LATERALITY
4598,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4599,claude37,0.865,TUMOR SITE
4600,claude37,0.829,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4601,claude37,0.76,HISTOLOGIC GRADE
4602,claude37,0.714,NODAL SITE(S) EXAMINED
4603,claude37,0.815,REGIONAL LYMPH NODE STATUS
4604,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4605,claude37,0.697,SPECIMEN LATERALITY
4606,claude37,0.827,PROCEDURE
4607,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4608,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
4609,claude37,0.782,HISTOLOGIC GRADE
4610,claude37,0.697,NUMBER OF LYMPH NODES EXAMINED
4611,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4612,claude37,0.815,REGIONAL LYMPH NODE STATUS
4613,claude37,0.887,TUMOR SITE
4614,claude37,0.811,TUMOR FOCALITY
4615,claude37,0.778,VISCERAL PLEURA INVASION
4616,claude37,0.829,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4617,claude37,0.825,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4618,claude37,0.845,NODAL SITE(S) EXAMINED
4619,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4620,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4621,claude37,0.815,REGIONAL LYMPH NODE STATUS
4622,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4623,claude37,0.798,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4624,claude37,0.786,PROCEDURE
4625,claude37,0.697,SPECIMEN LATERALITY
4626,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4627,claude37,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4628,claude37,0.782,HISTOLOGIC GRADE
4629,claude37,0.778,VISCERAL PLEURA INVASION
4630,claude37,0.887,TUMOR SITE
4631,claude37,0.699,NUMBER OF LYMPH NODES EXAMINED
4632,claude37,0.811,TUMOR FOCALITY
4633,claude37,0.753,NODAL SITE(S) EXAMINED
4634,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
4635,claude37,0.753,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4636,claude37,0.788,PROCEDURE
4637,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
4638,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4639,claude37,0.698,SPECIMEN LATERALITY
4640,claude37,0.792,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4641,claude37,0.701,NODAL SITE(S) EXAMINED
4642,claude37,0.738,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4643,claude37,0.815,REGIONAL LYMPH NODE STATUS
4644,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4645,claude37,0.811,TUMOR FOCALITY
4646,claude37,0.706,ADDITIONAL FINDINGS
4647,claude37,0.782,HISTOLOGIC GRADE
4648,claude37,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4649,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4650,claude37,0.778,VISCERAL PLEURA INVASION
4651,claude37,0.703,NUMBER OF LYMPH NODES EXAMINED
4652,claude37,0.888,TUMOR SITE
4653,claude37,0.827,PROCEDURE
4654,claude37,0.703,NUMBER OF LYMPH NODES EXAMINED
4655,claude37,0.89,TUMOR SITE
4656,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4657,claude37,0.815,REGIONAL LYMPH NODE STATUS
4658,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4659,claude37,0.697,SPECIMEN LATERALITY
4660,claude37,0.782,HISTOLOGIC GRADE
4661,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4662,claude37,0.813,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4663,claude37,0.811,TUMOR FOCALITY
4664,claude37,0.78,VISCERAL PLEURA INVASION
4665,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4666,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
4667,claude37,0.816,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4668,claude37,0.734,NODAL SITE(S) EXAMINED
4669,claude37,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4670,claude37,0.708,ADDITIONAL FINDINGS
4671,claude37,0.815,HISTOLOGIC GRADE
4672,claude37,0.742,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4673,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4674,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
4675,claude37,0.778,VISCERAL PLEURA INVASION
4676,claude37,0.788,PROCEDURE
4677,claude37,0.703,NUMBER OF LYMPH NODES EXAMINED
4678,claude37,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4679,claude37,0.804,NODAL SITE(S) EXAMINED
4680,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4681,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4682,claude37,0.865,TUMOR SITE
4683,claude37,0.811,TUMOR FOCALITY
4684,claude37,0.815,REGIONAL LYMPH NODE STATUS
4685,claude37,0.698,SPECIMEN LATERALITY
4686,claude37,0.841,REGIONAL LYMPH NODE STATUS
4687,claude37,0.697,SPECIMEN LATERALITY
4688,claude37,0.816,NODAL SITE(S) EXAMINED
4689,claude37,0.782,HISTOLOGIC GRADE
4690,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
4691,claude37,0.89,TUMOR SITE
4692,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4693,claude37,0.72,NUMBER OF LYMPH NODES EXAMINED
4694,claude37,0.811,TUMOR FOCALITY
4695,claude37,0.78,VISCERAL PLEURA INVASION
4696,claude37,0.827,PROCEDURE
4697,claude37,0.813,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4698,claude37,0.732,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4699,claude37,0.755,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4700,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4701,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4702,claude37,0.811,TUMOR FOCALITY
4703,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
4704,claude37,0.827,PROCEDURE
4705,claude37,0.904,HISTOLOGIC GRADE
4706,claude37,0.781,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4707,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4708,claude37,0.765,ADDITIONAL FINDINGS
4709,claude37,0.735,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4710,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4711,claude37,0.684,NODAL SITE(S) EXAMINED
4712,claude37,0.865,TUMOR SITE
4713,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4714,claude37,0.778,VISCERAL PLEURA INVASION
4715,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4716,claude37,0.815,REGIONAL LYMPH NODE STATUS
4717,claude37,0.713,NUMBER OF LYMPH NODES EXAMINED
4718,claude37,0.698,SPECIMEN LATERALITY
4719,claude37,0.697,SPECIMEN LATERALITY
4720,claude37,0.778,VISCERAL PLEURA INVASION
4721,claude37,0.788,HISTOLOGIC GRADE
4722,claude37,0.666,MARGIN STATUS FOR NON-INVASIVE TUMOR
4723,claude37,0.681,MARGIN STATUS FOR INVASIVE CARCINOMA
4724,claude37,0.799,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4725,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4726,claude37,0.84,PROCEDURE
4727,claude37,0.746,TNM DESCRIPTORS
4728,claude37,0.678,TUMOR FOCALITY
4729,claude37,0.813,ADDITIONAL FINDINGS
4730,claude37,0.833,NODAL SITE(S) EXAMINED
4731,claude37,0.786,REGIONAL LYMPH NODE STATUS
4732,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4733,claude37,0.698,SPECIMEN LATERALITY
4734,claude37,0.702,NODAL SITE(S) EXAMINED
4735,claude37,0.76,HISTOLOGIC GRADE
4736,claude37,0.734,ADDITIONAL FINDINGS
4737,claude37,0.78,SPREAD THROUGH AIR SPACES (STAS)
4738,claude37,0.78,VISCERAL PLEURA INVASION
4739,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4740,claude37,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4741,claude37,0.842,TUMOR SITE
4742,claude37,0.815,REGIONAL LYMPH NODE STATUS
4743,claude37,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4744,claude37,0.802,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4745,claude37,0.793,PROCEDURE
4746,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4747,claude37,0.745,LYMPHOVASCULAR INVASION
4748,claude37,0.811,TUMOR FOCALITY
4749,claude37,0.716,NUMBER OF LYMPH NODES EXAMINED
4750,claude37,0.863,NODAL SITE(S) EXAMINED
4751,claude37,0.89,TUMOR SITE
4752,claude37,0.713,NUMBER OF LYMPH NODES EXAMINED
4753,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4754,claude37,0.778,VISCERAL PLEURA INVASION
4755,claude37,0.782,HISTOLOGIC GRADE
4756,claude37,0.697,SPECIMEN LATERALITY
4757,claude37,0.841,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4758,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4759,claude37,0.827,PROCEDURE
4760,claude37,0.718,SPREAD THROUGH AIR SPACES (STAS)
4761,claude37,0.815,REGIONAL LYMPH NODE STATUS
4762,claude37,0.811,ADDITIONAL FINDINGS
4763,claude37,0.811,TUMOR FOCALITY
4764,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4765,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4766,claude37,0.825,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4767,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4768,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4769,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4770,claude37,0.892,HISTOLOGIC GRADE
4771,claude37,0.811,TUMOR FOCALITY
4772,claude37,0.839,NODAL SITE(S) EXAMINED
4773,claude37,0.697,SPECIMEN LATERALITY
4774,claude37,0.826,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4775,claude37,0.713,NUMBER OF LYMPH NODES EXAMINED
4776,claude37,0.815,REGIONAL LYMPH NODE STATUS
4777,claude37,0.698,VISCERAL PLEURA INVASION
4778,claude37,0.826,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4779,claude37,0.89,TUMOR SITE
4780,claude37,0.827,PROCEDURE
4781,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4782,claude37,0.761,NODAL SITE(S) EXAMINED
4783,claude37,0.798,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4784,claude37,0.698,SPECIMEN LATERALITY
4785,claude37,0.815,REGIONAL LYMPH NODE STATUS
4786,claude37,0.811,TUMOR FOCALITY
4787,claude37,0.89,TUMOR SITE
4788,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4789,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4790,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4791,claude37,0.698,VISCERAL PLEURA INVASION
4792,claude37,0.72,NUMBER OF LYMPH NODES EXAMINED
4793,claude37,0.847,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4794,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4795,claude37,0.827,PROCEDURE
4796,claude37,0.737,ADDITIONAL FINDINGS
4797,claude37,0.859,NODAL SITE(S) EXAMINED
4798,claude37,0.823,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4799,claude37,0.788,PROCEDURE
4800,claude37,0.89,TUMOR SITE
4801,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4802,claude37,0.677,HISTOLOGIC GRADE
4803,claude37,0.816,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4804,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4805,claude37,0.815,REGIONAL LYMPH NODE STATUS
4806,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4807,claude37,0.697,SPECIMEN LATERALITY
4808,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4809,claude37,0.778,VISCERAL PLEURA INVASION
4810,claude37,0.811,TUMOR FOCALITY
4811,claude37,0.815,REGIONAL LYMPH NODE STATUS
4812,claude37,0.697,SPECIMEN LATERALITY
4813,claude37,0.672,MARGIN STATUS FOR NON-INVASIVE TUMOR
4814,claude37,0.778,VISCERAL PLEURA INVASION
4815,claude37,0.838,NODAL SITE(S) EXAMINED
4816,claude37,0.768,PROCEDURE
4817,claude37,0.849,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4818,claude37,0.71,TUMOR SITE
4819,claude37,0.725,NUMBER OF LYMPH NODES EXAMINED
4820,claude37,0.855,MARGIN STATUS FOR INVASIVE CARCINOMA
4821,claude37,0.78,SPREAD THROUGH AIR SPACES (STAS)
4822,claude37,0.76,HISTOLOGIC GRADE
4823,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4824,claude37,0.873,TUMOR FOCALITY
4825,claude37,0.78,VISCERAL PLEURA INVASION
4826,claude37,0.698,SPECIMEN LATERALITY
4827,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4828,claude37,0.89,TUMOR SITE
4829,claude37,0.78,SPREAD THROUGH AIR SPACES (STAS)
4830,claude37,0.788,PROCEDURE
4831,claude37,0.698,LYMPHOVASCULAR INVASION
4832,claude37,0.789,NODAL SITE(S) WITH TUMOR
4833,claude37,0.771,REGIONAL LYMPH NODE STATUS
4834,claude37,0.713,NUMBER OF LYMPH NODES WITH TUMOR
4835,claude37,0.704,NODAL SITE(S) EXAMINED
4836,claude37,0.76,HISTOLOGIC GRADE
4837,claude37,0.838,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4838,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4839,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4840,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4841,claude37,0.811,TUMOR FOCALITY
4842,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
4843,claude37,0.78,VISCERAL PLEURA INVASION
4844,claude37,0.698,SPECIMEN LATERALITY
4845,claude37,0.725,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4846,claude37,0.766,REGIONAL LYMPH NODE STATUS
4847,claude37,0.879,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4848,claude37,0.755,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4849,claude37,0.811,TUMOR FOCALITY
4850,claude37,0.859,LYMPHOVASCULAR INVASION
4851,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4852,claude37,0.89,TUMOR SITE
4853,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4854,claude37,0.702,NODAL SITE(S) WITH TUMOR
4855,claude37,0.713,NUMBER OF LYMPH NODES WITH TUMOR
4856,claude37,0.864,NODAL SITE(S) EXAMINED
4857,claude37,0.722,NUMBER OF LYMPH NODES EXAMINED
4858,claude37,0.637,ADDITIONAL FINDINGS
4859,claude37,0.788,PROCEDURE
4860,claude37,0.76,HISTOLOGIC GRADE
4861,claude37,0.697,SPECIMEN LATERALITY
4862,claude37,0.811,TUMOR FOCALITY
4863,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4864,claude37,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
4865,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4866,claude37,0.78,REGIONAL LYMPH NODE STATUS
4867,claude37,0.78,SPREAD THROUGH AIR SPACES (STAS)
4868,claude37,0.847,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4869,claude37,0.892,HISTOLOGIC GRADE
4870,claude37,0.89,TUMOR SITE
4871,claude37,0.834,NODAL SITE(S) EXAMINED
4872,claude37,0.793,PROCEDURE
4873,claude37,0.697,ADDITIONAL FINDINGS
4874,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4875,claude37,0.693,NODAL SITE(S) EXAMINED
4876,claude37,0.778,VISCERAL PLEURA INVASION
4877,claude37,0.755,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4878,claude37,0.698,LYMPHOVASCULAR INVASION
4879,claude37,0.838,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4880,claude37,0.758,NODAL SITE(S) EXAMINED
4881,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
4882,claude37,0.822,ADDITIONAL FINDINGS
4883,claude37,0.697,SPECIMEN LATERALITY
4884,claude37,0.745,MARGIN STATUS FOR INVASIVE CARCINOMA
4885,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4886,claude37,0.887,TUMOR SITE
4887,claude37,0.791,REGIONAL LYMPH NODE STATUS
4888,claude37,0.811,TUMOR FOCALITY
4889,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4890,claude37,0.78,VISCERAL PLEURA INVASION
4891,claude37,0.782,HISTOLOGIC GRADE
4892,claude37,0.788,PROCEDURE
4893,claude37,0.815,REGIONAL LYMPH NODE STATUS
4894,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4895,claude37,0.697,SPECIMEN LATERALITY
4896,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4897,claude37,0.782,HISTOLOGIC GRADE
4898,claude37,0.726,NODAL SITE(S) EXAMINED
4899,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4900,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4901,claude37,0.811,TUMOR FOCALITY
4902,claude37,0.89,TUMOR SITE
4903,claude37,0.827,PROCEDURE
4904,claude37,0.835,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4905,claude37,0.778,VISCERAL PLEURA INVASION
4906,claude37,0.805,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4907,claude37,0.703,NUMBER OF LYMPH NODES EXAMINED
4908,claude37,0.856,ADDITIONAL FINDINGS
4909,claude37,0.78,SPREAD THROUGH AIR SPACES (STAS)
4910,claude37,0.832,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4911,claude37,0.778,VISCERAL PLEURA INVASION
4912,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4913,claude37,0.717,ADDITIONAL FINDINGS
4914,claude37,0.79,REGIONAL LYMPH NODE STATUS
4915,claude37,0.788,HISTOLOGIC GRADE
4916,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4917,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
4918,claude37,0.692,TUMOR SITE
4919,claude37,0.839,PROCEDURE
4920,claude37,0.815,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4921,claude37,0.697,SPECIMEN LATERALITY
4922,claude37,0.805,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4923,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4924,claude37,0.896,NODAL SITE(S) EXAMINED
4925,claude37,0.811,TUMOR FOCALITY
4926,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4927,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
4928,claude37,0.698,VISCERAL PLEURA INVASION
4929,claude37,0.685,ADDITIONAL FINDINGS
4930,claude37,0.698,SPECIMEN LATERALITY
4931,claude37,0.817,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4932,claude37,0.782,HISTOLOGIC GRADE
4933,claude37,0.815,REGIONAL LYMPH NODE STATUS
4934,claude37,0.672,NODAL SITE(S) EXAMINED
4935,claude37,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4936,claude37,0.713,NUMBER OF LYMPH NODES EXAMINED
4937,claude37,0.752,PROCEDURE
4938,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4939,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4940,claude37,0.811,TUMOR FOCALITY
4941,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4942,claude37,0.888,TUMOR SITE
4943,claude37,0.89,TUMOR SITE
4944,claude37,0.815,REGIONAL LYMPH NODE STATUS
4945,claude37,0.811,TUMOR FOCALITY
4946,claude37,0.741,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4947,claude37,0.698,SPECIMEN LATERALITY
4948,claude37,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4949,claude37,0.683,LYMPH NODE(S) FROM PRIOR PROCEDURES
4950,claude37,0.788,PROCEDURE
4951,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
4952,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4953,claude37,0.774,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4954,claude37,0.76,HISTOLOGIC GRADE
4955,claude37,0.714,NODAL SITE(S) EXAMINED
4956,claude37,0.778,VISCERAL PLEURA INVASION
4957,claude37,0.637,ADDITIONAL FINDINGS
4958,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4959,claude37,0.841,MARGIN STATUS FOR INVASIVE CARCINOMA
4960,claude37,0.734,NODAL SITE(S) EXAMINED
4961,claude37,0.706,ADDITIONAL FINDINGS
4962,claude37,0.697,SPECIMEN LATERALITY
4963,claude37,0.778,VISCERAL PLEURA INVASION
4964,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4965,claude37,0.815,REGIONAL LYMPH NODE STATUS
4966,claude37,0.772,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4967,claude37,0.788,PROCEDURE
4968,claude37,0.787,HISTOLOGIC GRADE
4969,claude37,0.798,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4970,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
4971,claude37,0.678,TUMOR FOCALITY
4972,claude37,0.78,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4973,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4974,claude37,0.887,TUMOR SITE
4975,claude37,0.827,PROCEDURE
4976,claude37,0.778,VISCERAL PLEURA INVASION
4977,claude37,0.89,TUMOR SITE
4978,claude37,0.789,NODAL SITE(S) EXAMINED
4979,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4980,claude37,0.782,HISTOLOGIC GRADE
4981,claude37,0.78,SPREAD THROUGH AIR SPACES (STAS)
4982,claude37,0.804,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4983,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4984,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4985,claude37,0.815,REGIONAL LYMPH NODE STATUS
4986,claude37,0.811,TUMOR FOCALITY
4987,claude37,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4988,claude37,0.713,NUMBER OF LYMPH NODES EXAMINED
4989,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4990,claude37,0.698,SPECIMEN LATERALITY
4991,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4992,claude37,0.697,SPECIMEN LATERALITY
4993,claude37,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4994,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4995,claude37,0.815,REGIONAL LYMPH NODE STATUS
4996,claude37,0.887,TUMOR SITE
4997,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4998,claude37,0.788,PROCEDURE
4999,claude37,0.698,VISCERAL PLEURA INVASION
5000,claude37,0.811,TUMOR FOCALITY
5001,claude37,0.837,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5002,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5003,claude37,0.81,NUMBER OF LYMPH NODES EXAMINED
5004,claude37,0.859,NODAL SITE(S) EXAMINED
5005,claude37,0.782,HISTOLOGIC GRADE
5006,claude37,0.778,ADDITIONAL FINDINGS
5007,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
5008,claude37,0.76,HISTOLOGIC GRADE
5009,claude37,0.698,LYMPHOVASCULAR INVASION
5010,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5011,claude37,0.758,REGIONAL LYMPH NODE STATUS
5012,claude37,0.713,NUMBER OF LYMPH NODES WITH TUMOR
5013,claude37,0.709,NODAL SITE(S) EXAMINED
5014,claude37,0.811,TUMOR FOCALITY
5015,claude37,0.707,NUMBER OF LYMPH NODES WITH TUMOR
5016,claude37,0.697,SPECIMEN LATERALITY
5017,claude37,0.926,NODAL SITE(S) WITH TUMOR
5018,claude37,0.887,TUMOR SITE
5019,claude37,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5020,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5021,claude37,0.768,NODAL SITE(S) WITH TUMOR
5022,claude37,0.778,VISCERAL PLEURA INVASION
5023,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5024,claude37,0.791,PROCEDURE
5025,claude37,0.725,NUMBER OF LYMPH NODES EXAMINED
5026,claude37,0.847,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5027,claude37,0.743,MARGIN STATUS FOR NON-INVASIVE TUMOR
5028,claude37,0.835,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5029,claude37,0.761,NUMBER OF LYMPH NODES EXAMINED
5030,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5031,claude37,0.704,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5032,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5033,claude37,0.778,VISCERAL PLEURA INVASION
5034,claude37,0.824,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5035,claude37,0.724,ADDITIONAL FINDINGS
5036,claude37,0.811,TUMOR FOCALITY
5037,claude37,0.788,PROCEDURE
5038,claude37,0.725,NODAL SITE(S) EXAMINED
5039,claude37,0.815,REGIONAL LYMPH NODE STATUS
5040,claude37,0.89,TUMOR SITE
5041,claude37,0.815,HISTOLOGIC GRADE
5042,claude37,0.697,SPECIMEN LATERALITY
5043,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5044,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5045,claude37,0.793,PROCEDURE
5046,claude37,0.825,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5047,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5048,claude37,0.815,REGIONAL LYMPH NODE STATUS
5049,claude37,0.869,TUMOR SITE
5050,claude37,0.732,ADDITIONAL FINDINGS
5051,claude37,0.718,SPREAD THROUGH AIR SPACES (STAS)
5052,claude37,0.811,TUMOR FOCALITY
5053,claude37,0.778,VISCERAL PLEURA INVASION
5054,claude37,0.76,HISTOLOGIC GRADE
5055,claude37,0.838,NODAL SITE(S) EXAMINED
5056,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5057,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5058,claude37,0.798,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5059,claude37,0.697,SPECIMEN LATERALITY
5060,claude37,0.697,SPECIMEN LATERALITY
5061,claude37,0.869,NODAL SITE(S) EXAMINED
5062,claude37,0.778,VISCERAL PLEURA INVASION
5063,claude37,0.72,NUMBER OF LYMPH NODES EXAMINED
5064,claude37,0.788,PROCEDURE
5065,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5066,claude37,0.838,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5067,claude37,0.678,TUMOR FOCALITY
5068,claude37,0.91,TUMOR SITE
5069,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5070,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5071,claude37,0.691,HISTOLOGIC GRADE
5072,claude37,0.877,REGIONAL LYMPH NODE STATUS
5073,claude37,0.735,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5074,claude37,0.781,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5075,claude37,0.704,ADDITIONAL FINDINGS
5076,claude37,0.815,REGIONAL LYMPH NODE STATUS
5077,claude37,0.862,NODAL SITE(S) EXAMINED
5078,claude37,0.738,HISTOLOGIC GRADE
5079,claude37,0.811,TUMOR FOCALITY
5080,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5081,claude37,0.89,TUMOR SITE
5082,claude37,0.743,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5083,claude37,0.737,ADDITIONAL FINDINGS
5084,claude37,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5085,claude37,0.788,PROCEDURE
5086,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5087,claude37,0.78,SPREAD THROUGH AIR SPACES (STAS)
5088,claude37,0.778,VISCERAL PLEURA INVASION
5089,claude37,0.698,SPECIMEN LATERALITY
5090,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5091,claude37,0.821,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5092,claude37,0.722,REGIONAL LYMPH NODE STATUS
5093,claude37,0.811,TUMOR FOCALITY
5094,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5095,claude37,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5096,claude37,0.767,ADDITIONAL FINDINGS
5097,claude37,0.732,NODAL SITE(S) WITH TUMOR
5098,claude37,0.78,SPREAD THROUGH AIR SPACES (STAS)
5099,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5100,claude37,0.698,SPECIMEN LATERALITY
5101,claude37,0.698,VISCERAL PLEURA INVASION
5102,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5103,claude37,0.698,LYMPHOVASCULAR INVASION
5104,claude37,0.816,NODAL SITE(S) EXAMINED
5105,claude37,0.713,NUMBER OF LYMPH NODES WITH TUMOR
5106,claude37,0.888,TUMOR SITE
5107,claude37,0.755,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5108,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5109,claude37,0.76,HISTOLOGIC GRADE
5110,claude37,0.694,NUMBER OF LYMPH NODES EXAMINED
5111,claude37,0.788,PROCEDURE
5112,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5113,claude37,0.838,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5114,claude37,0.778,VISCERAL PLEURA INVASION
5115,claude37,0.694,NUMBER OF LYMPH NODES EXAMINED
5116,claude37,0.773,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5117,claude37,0.811,TUMOR FOCALITY
5118,claude37,0.788,PROCEDURE
5119,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
5120,claude37,0.677,HISTOLOGIC GRADE
5121,claude37,0.743,NODAL SITE(S) EXAMINED
5122,claude37,0.746,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5123,claude37,0.815,REGIONAL LYMPH NODE STATUS
5124,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5125,claude37,0.698,SPECIMEN LATERALITY
5126,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5127,claude37,0.888,TUMOR SITE
5128,claude37,0.775,NODAL SITE(S) EXAMINED
5129,claude37,0.799,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5130,claude37,0.815,REGIONAL LYMPH NODE STATUS
5131,claude37,0.819,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5132,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5133,claude37,0.887,TUMOR SITE
5134,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5135,claude37,0.811,TUMOR FOCALITY
5136,claude37,0.788,PROCEDURE
5137,claude37,0.698,NUMBER OF LYMPH NODES EXAMINED
5138,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5139,claude37,0.697,SPECIMEN LATERALITY
5140,claude37,0.782,HISTOLOGIC GRADE
5141,claude37,0.778,VISCERAL PLEURA INVASION
5142,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5143,claude37,0.792,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5144,claude37,0.815,REGIONAL LYMPH NODE STATUS
5145,claude37,0.871,NODAL SITE(S) EXAMINED
5146,claude37,0.811,TUMOR FOCALITY
5147,claude37,0.793,PROCEDURE
5148,claude37,0.703,NUMBER OF LYMPH NODES EXAMINED
5149,claude37,0.734,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5150,claude37,0.697,SPECIMEN LATERALITY
5151,claude37,0.694,TUMOR SITE
5152,claude37,0.782,HISTOLOGIC GRADE
5153,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5154,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5155,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5156,claude37,0.778,VISCERAL PLEURA INVASION
5157,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5158,claude37,0.815,HISTOLOGIC GRADE
5159,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5160,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5161,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5162,claude37,0.7,NUMBER OF LYMPH NODES EXAMINED
5163,claude37,0.829,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5164,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5165,claude37,0.709,NODAL SITE(S) EXAMINED
5166,claude37,0.697,SPECIMEN LATERALITY
5167,claude37,0.815,REGIONAL LYMPH NODE STATUS
5168,claude37,0.89,TUMOR SITE
5169,claude37,0.827,PROCEDURE
5170,claude37,0.811,TUMOR FOCALITY
5171,claude37,0.825,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5172,claude37,0.778,VISCERAL PLEURA INVASION
5173,claude37,0.651,VISCERAL PLEURA INVASION
5174,claude37,0.773,TUMOR SITE
5175,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5176,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5177,claude37,0.78,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5178,claude37,0.827,PROCEDURE
5179,claude37,0.716,REGIONAL LYMPH NODE STATUS
5180,claude37,0.82,NODAL SITE(S) WITH TUMOR
5181,claude37,0.782,HISTOLOGIC GRADE
5182,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5183,claude37,0.697,SPECIMEN LATERALITY
5184,claude37,0.768,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5185,claude37,0.748,TNM DESCRIPTORS
5186,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5187,claude37,0.878,NODAL SITE(S) EXAMINED
5188,claude37,0.703,NUMBER OF LYMPH NODES EXAMINED
5189,claude37,0.72,NUMBER OF LYMPH NODES WITH TUMOR
5190,claude37,0.691,TUMOR FOCALITY
5191,claude37,0.693,NUMBER OF LYMPH NODES EXAMINED
5192,claude37,0.835,NODAL SITE(S) EXAMINED
5193,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5194,claude37,0.731,TUMOR FOCALITY
5195,claude37,0.786,REGIONAL LYMPH NODE STATUS
5196,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5197,claude37,0.791,PROCEDURE
5198,claude37,0.781,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5199,claude37,0.684,HISTOLOGIC GRADE
5200,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5201,claude37,0.778,VISCERAL PLEURA INVASION
5202,claude37,0.887,TUMOR SITE
5203,claude37,0.697,SPECIMEN LATERALITY
5204,claude37,0.798,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5205,claude37,0.788,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5206,claude37,0.89,TUMOR SITE
5207,claude37,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5208,claude37,0.738,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5209,claude37,0.683,LYMPH NODE(S) FROM PRIOR PROCEDURES
5210,claude37,0.736,HISTOLOGIC GRADE
5211,claude37,0.723,NUMBER OF LYMPH NODES EXAMINED
5212,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5213,claude37,0.714,REGIONAL LYMPH NODE STATUS
5214,claude37,0.71,NODAL SITE(S) WITH TUMOR
5215,claude37,0.698,SPECIMEN LATERALITY
5216,claude37,0.705,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5217,claude37,0.713,NUMBER OF LYMPH NODES WITH TUMOR
5218,claude37,0.787,LYMPHOVASCULAR INVASION
5219,claude37,0.788,PROCEDURE
5220,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5221,claude37,0.811,TUMOR FOCALITY
5222,claude37,0.778,VISCERAL PLEURA INVASION
5223,claude37,0.801,NODAL SITE(S) EXAMINED
5224,claude37,0.674,ADDITIONAL FINDINGS
5225,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5226,claude37,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5227,claude37,0.811,TUMOR FOCALITY
5228,claude37,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5229,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5230,claude37,0.89,TUMOR SITE
5231,claude37,0.778,VISCERAL PLEURA INVASION
5232,claude37,0.815,REGIONAL LYMPH NODE STATUS
5233,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
5234,claude37,0.791,PROCEDURE
5235,claude37,0.762,NUMBER OF LYMPH NODES EXAMINED
5236,claude37,0.787,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5237,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5238,claude37,0.831,NODAL SITE(S) EXAMINED
5239,claude37,0.697,SPECIMEN LATERALITY
5240,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5241,claude37,0.816,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5242,claude37,0.793,PROCEDURE
5243,claude37,0.678,TUMOR FOCALITY
5244,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5245,claude37,0.788,NODAL SITE(S) EXAMINED
5246,claude37,0.699,NUMBER OF LYMPH NODES EXAMINED
5247,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
5248,claude37,0.904,HISTOLOGIC GRADE
5249,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5250,claude37,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5251,claude37,0.698,SPECIMEN LATERALITY
5252,claude37,0.787,REGIONAL LYMPH NODE STATUS
5253,claude37,0.888,TUMOR SITE
5254,claude37,0.778,VISCERAL PLEURA INVASION
5255,claude37,0.813,ADDITIONAL FINDINGS
5256,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5257,claude37,0.698,SPECIMEN LATERALITY
5258,claude37,0.713,NUMBER OF LYMPH NODES EXAMINED
5259,claude37,0.902,ADDITIONAL FINDINGS
5260,claude37,0.819,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5261,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5262,claude37,0.857,TUMOR SITE
5263,claude37,0.827,PROCEDURE
5264,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5265,claude37,0.734,NODAL SITE(S) EXAMINED
5266,claude37,0.811,TUMOR FOCALITY
5267,claude37,0.78,VISCERAL PLEURA INVASION
5268,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5269,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
5270,claude37,0.836,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5271,claude37,0.815,REGIONAL LYMPH NODE STATUS
5272,claude37,0.818,HISTOLOGIC GRADE
5273,claude37,0.788,PROCEDURE
5274,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5275,claude37,0.697,SPECIMEN LATERALITY
5276,claude37,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5277,claude37,0.758,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5278,claude37,0.887,TUMOR SITE
5279,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5280,claude37,0.856,LYMPHOVASCULAR INVASION
5281,claude37,0.824,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5282,claude37,0.811,TUMOR FOCALITY
5283,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5284,claude37,0.842,NODAL SITE(S) EXAMINED
5285,claude37,0.736,HISTOLOGIC GRADE
5286,claude37,0.815,REGIONAL LYMPH NODE STATUS
5287,claude37,0.705,ADDITIONAL FINDINGS
5288,claude37,0.78,VISCERAL PLEURA INVASION
5289,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
5290,claude37,0.782,HISTOLOGIC GRADE
5291,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5292,claude37,0.855,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5293,claude37,0.749,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5294,claude37,0.735,NODAL SITE(S) EXAMINED
5295,claude37,0.699,NUMBER OF LYMPH NODES EXAMINED
5296,claude37,0.815,REGIONAL LYMPH NODE STATUS
5297,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5298,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5299,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5300,claude37,0.793,PROCEDURE
5301,claude37,0.839,TUMOR SITE
5302,claude37,0.697,SPECIMEN LATERALITY
5303,claude37,0.78,VISCERAL PLEURA INVASION
5304,claude37,0.811,TUMOR FOCALITY
5305,claude37,0.782,HISTOLOGIC GRADE
5306,claude37,0.744,NUMBER OF LYMPH NODES EXAMINED
5307,claude37,0.699,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5308,claude37,0.832,NODAL SITE(S) WITH TUMOR
5309,claude37,0.805,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5310,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5311,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5312,claude37,0.78,REGIONAL LYMPH NODE STATUS
5313,claude37,0.788,PROCEDURE
5314,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5315,claude37,0.811,TUMOR FOCALITY
5316,claude37,0.89,TUMOR SITE
5317,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5318,claude37,0.698,SPECIMEN LATERALITY
5319,claude37,0.694,NODAL SITE(S) EXAMINED
5320,claude37,0.72,NUMBER OF LYMPH NODES WITH TUMOR
5321,claude37,0.778,VISCERAL PLEURA INVASION
5322,claude37,0.811,TUMOR FOCALITY
5323,claude37,0.815,REGIONAL LYMPH NODE STATUS
5324,claude37,0.697,SPECIMEN LATERALITY
5325,claude37,0.788,PROCEDURE
5326,claude37,0.699,NUMBER OF LYMPH NODES EXAMINED
5327,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5328,claude37,0.782,HISTOLOGIC GRADE
5329,claude37,0.823,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5330,claude37,0.778,VISCERAL PLEURA INVASION
5331,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5332,claude37,0.754,NODAL SITE(S) EXAMINED
5333,claude37,0.89,TUMOR SITE
5334,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5335,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5336,claude37,0.867,NODAL SITE(S) EXAMINED
5337,claude37,0.89,TUMOR SITE
5338,claude37,0.802,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5339,claude37,0.807,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5340,claude37,0.697,SPECIMEN LATERALITY
5341,claude37,0.678,TUMOR FOCALITY
5342,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
5343,claude37,0.705,HISTOLOGIC GRADE
5344,claude37,0.798,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5345,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5346,claude37,0.888,MARGIN STATUS FOR NON-INVASIVE TUMOR
5347,claude37,0.788,PROCEDURE
5348,claude37,0.778,VISCERAL PLEURA INVASION
5349,claude37,0.815,REGIONAL LYMPH NODE STATUS
5350,claude37,0.767,ADDITIONAL FINDINGS
5351,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5352,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5353,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5354,claude37,0.811,TUMOR FOCALITY
5355,claude37,0.89,TUMOR SITE
5356,claude37,0.709,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5357,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5358,claude37,0.774,ADDITIONAL FINDINGS
5359,claude37,0.778,VISCERAL PLEURA INVASION
5360,claude37,0.697,SPECIMEN LATERALITY
5361,claude37,0.835,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5362,claude37,0.827,PROCEDURE
5363,claude37,0.735,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5364,claude37,0.7,SPREAD THROUGH AIR SPACES (STAS)
5365,claude37,0.887,TUMOR SITE
5366,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5367,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5368,claude37,0.798,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5369,claude37,0.782,HISTOLOGIC GRADE
5370,claude37,0.839,REGIONAL LYMPH NODE STATUS
5371,claude37,0.788,PROCEDURE
5372,claude37,0.807,NODAL SITE(S) EXAMINED
5373,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5374,claude37,0.811,TUMOR FOCALITY
5375,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5376,claude37,0.718,VISCERAL PLEURA INVASION
5377,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
5378,claude37,0.697,SPECIMEN LATERALITY
5379,claude37,0.83,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5380,claude37,0.788,HISTOLOGIC GRADE
5381,claude37,0.727,ADDITIONAL FINDINGS
5382,claude37,0.815,REGIONAL LYMPH NODE STATUS
5383,claude37,0.88,LYMPH NODE(S) FROM PRIOR PROCEDURES
5384,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5385,claude37,0.678,TUMOR FOCALITY
5386,claude37,0.794,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5387,claude37,0.703,NUMBER OF LYMPH NODES EXAMINED
5388,claude37,0.819,NODAL SITE(S) EXAMINED
5389,claude37,0.698,VISCERAL PLEURA INVASION
5390,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
5391,claude37,0.793,PROCEDURE
5392,claude37,0.698,SPECIMEN LATERALITY
5393,claude37,0.852,TUMOR SITE
5394,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5395,claude37,0.748,TNM DESCRIPTORS
5396,claude37,0.77,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5397,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5398,claude37,0.815,REGIONAL LYMPH NODE STATUS
5399,claude37,0.778,VISCERAL PLEURA INVASION
5400,claude37,0.697,SPECIMEN LATERALITY
5401,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5402,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5403,claude37,0.76,HISTOLOGIC GRADE
5404,claude37,0.818,LYMPHOVASCULAR INVASION
5405,claude37,0.83,NODAL SITE(S) EXAMINED
5406,claude37,0.902,ADDITIONAL FINDINGS
5407,claude37,0.89,TUMOR SITE
5408,claude37,0.783,PROCEDURE
5409,claude37,0.78,SPREAD THROUGH AIR SPACES (STAS)
5410,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5411,claude37,0.811,TUMOR FOCALITY
5412,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5413,claude37,0.717,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5414,claude37,0.825,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5415,claude37,0.87,MARGIN STATUS FOR NON-INVASIVE TUMOR
5416,claude37,0.751,PROCEDURE
5417,claude37,0.714,TUMOR FOCALITY
5418,claude37,0.713,NUMBER OF LYMPH NODES WITH TUMOR
5419,claude37,0.725,TNM DESCRIPTORS
5420,claude37,0.72,NODAL SITE(S) WITH TUMOR
5421,claude37,0.698,LYMPHOVASCULAR INVASION
5422,claude37,0.705,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5423,claude37,0.798,TUMOR SITE
5424,claude37,0.697,SPECIMEN LATERALITY
5425,claude37,0.8,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5426,claude37,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
5427,claude37,0.778,VISCERAL PLEURA INVASION
5428,claude37,0.753,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5429,claude37,0.76,HISTOLOGIC GRADE
5430,claude37,0.665,ADDITIONAL FINDINGS
5431,claude37,0.888,NODAL SITE(S) EXAMINED
5432,claude37,0.785,REGIONAL LYMPH NODE STATUS
5433,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5434,claude37,0.798,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5435,claude37,0.697,SPECIMEN LATERALITY
5436,claude37,0.692,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5437,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5438,claude37,0.852,PROCEDURE
5439,claude37,0.811,TUMOR FOCALITY
5440,claude37,0.778,VISCERAL PLEURA INVASION
5441,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5442,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5443,claude37,0.8,NUMBER OF LYMPH NODES EXAMINED
5444,claude37,0.815,REGIONAL LYMPH NODE STATUS
5445,claude37,0.773,NODAL SITE(S) EXAMINED
5446,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
5447,claude37,0.89,TUMOR SITE
5448,claude37,0.729,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5449,claude37,0.706,HISTOLOGIC GRADE
5450,claude37,0.76,HISTOLOGIC GRADE
5451,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5452,claude37,0.717,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5453,claude37,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5454,claude37,0.819,REGIONAL LYMPH NODE STATUS
5455,claude37,0.78,VISCERAL PLEURA INVASION
5456,claude37,0.785,NUMBER OF LYMPH NODES EXAMINED
5457,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5458,claude37,0.811,TUMOR FOCALITY
5459,claude37,0.833,NODAL SITE(S) EXAMINED
5460,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5461,claude37,0.762,PROCEDURE
5462,claude37,0.89,TUMOR SITE
5463,claude37,0.697,SPECIMEN LATERALITY
5464,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5465,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5466,claude37,0.742,PROCEDURE
5467,claude37,0.883,NODAL SITE(S) WITH TUMOR
5468,claude37,0.811,TUMOR FOCALITY
5469,claude37,0.734,NODAL SITE(S) EXAMINED
5470,claude37,0.78,REGIONAL LYMPH NODE STATUS
5471,claude37,0.848,TUMOR SITE
5472,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5473,claude37,0.697,SPECIMEN LATERALITY
5474,claude37,0.838,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5475,claude37,0.778,VISCERAL PLEURA INVASION
5476,claude37,0.72,NUMBER OF LYMPH NODES WITH TUMOR
5477,claude37,0.815,HISTOLOGIC GRADE
5478,claude37,0.855,MARGIN STATUS FOR INVASIVE CARCINOMA
5479,claude37,0.731,TNM DESCRIPTORS
5480,claude37,0.811,TUMOR FOCALITY
5481,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5482,claude37,0.892,NODAL SITE(S) WITH TUMOR
5483,claude37,0.824,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5484,claude37,0.745,LYMPHOVASCULAR INVASION
5485,claude37,0.679,NODAL SITE(S) EXAMINED
5486,claude37,0.705,NUMBER OF LYMPH NODES EXAMINED
5487,claude37,0.89,TUMOR SITE
5488,claude37,0.78,REGIONAL LYMPH NODE STATUS
5489,claude37,0.654,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5490,claude37,0.742,MARGIN STATUS FOR INVASIVE CARCINOMA
5491,claude37,0.76,HISTOLOGIC GRADE
5492,claude37,0.698,VISCERAL PLEURA INVASION
5493,claude37,0.784,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5494,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5495,claude37,0.801,PROCEDURE
5496,claude37,0.795,TNM DESCRIPTORS
5497,claude37,0.726,NUMBER OF LYMPH NODES WITH TUMOR
5498,claude37,0.827,PROCEDURE
5499,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5500,claude37,0.697,SPECIMEN LATERALITY
5501,claude37,0.811,TUMOR FOCALITY
5502,claude37,0.815,REGIONAL LYMPH NODE STATUS
5503,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5504,claude37,0.89,TUMOR SITE
5505,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5506,claude37,0.847,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5507,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5508,claude37,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5509,claude37,0.782,HISTOLOGIC GRADE
5510,claude37,0.863,NODAL SITE(S) EXAMINED
5511,claude37,0.778,VISCERAL PLEURA INVASION
5512,claude37,0.815,REGIONAL LYMPH NODE STATUS
5513,claude37,0.795,TNM DESCRIPTORS
5514,claude37,0.705,TUMOR FOCALITY
5515,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5516,claude37,0.7,SPREAD THROUGH AIR SPACES (STAS)
5517,claude37,0.89,TUMOR SITE
5518,claude37,0.711,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5519,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5520,claude37,0.761,NODAL SITE(S) EXAMINED
5521,claude37,0.705,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5522,claude37,0.778,VISCERAL PLEURA INVASION
5523,claude37,0.688,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5524,claude37,0.692,LYMPH NODE(S) FROM PRIOR PROCEDURES
5525,claude37,0.698,SPECIMEN LATERALITY
5526,claude37,0.718,PROCEDURE
5527,claude37,0.731,REGIONAL LYMPH NODE STATUS
5528,claude37,0.697,SPECIMEN LATERALITY
5529,claude37,0.752,PROCEDURE
5530,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5531,claude37,0.709,NODAL SITE(S) WITH TUMOR
5532,claude37,0.731,NODAL SITE(S) EXAMINED
5533,claude37,0.855,MARGIN STATUS FOR INVASIVE CARCINOMA
5534,claude37,0.893,TUMOR SITE
5535,claude37,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5536,claude37,0.811,TUMOR FOCALITY
5537,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5538,claude37,0.778,VISCERAL PLEURA INVASION
5539,claude37,0.887,TUMOR SITE
5540,claude37,0.762,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5541,claude37,0.782,HISTOLOGIC GRADE
5542,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5543,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5544,claude37,0.815,REGIONAL LYMPH NODE STATUS
5545,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5546,claude37,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5547,claude37,0.764,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5548,claude37,0.697,SPECIMEN LATERALITY
5549,claude37,0.835,NODAL SITE(S) EXAMINED
5550,claude37,0.778,VISCERAL PLEURA INVASION
5551,claude37,0.788,PROCEDURE
5552,claude37,0.841,TUMOR FOCALITY
5553,claude37,0.767,TNM DESCRIPTORS
5554,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5555,claude37,0.807,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5556,claude37,0.76,HISTOLOGIC GRADE
5557,claude37,0.811,TUMOR FOCALITY
5558,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5559,claude37,0.827,PROCEDURE
5560,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5561,claude37,0.697,SPECIMEN LATERALITY
5562,claude37,0.819,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5563,claude37,0.778,VISCERAL PLEURA INVASION
5564,claude37,0.713,NUMBER OF LYMPH NODES EXAMINED
5565,claude37,0.867,NODAL SITE(S) EXAMINED
5566,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5567,claude37,0.815,REGIONAL LYMPH NODE STATUS
5568,claude37,0.89,TUMOR SITE
5569,claude37,0.782,HISTOLOGIC GRADE
5570,claude37,0.827,PROCEDURE
5571,claude37,0.811,TUMOR FOCALITY
5572,claude37,0.665,NODAL SITE(S) EXAMINED
5573,claude37,0.778,VISCERAL PLEURA INVASION
5574,claude37,0.888,TUMOR SITE
5575,claude37,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5576,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5577,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5578,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5579,claude37,0.706,NUMBER OF LYMPH NODES EXAMINED
5580,claude37,0.755,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5581,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5582,claude37,0.882,REGIONAL LYMPH NODE STATUS
5583,claude37,0.698,SPECIMEN LATERALITY
5584,claude37,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5585,claude37,0.697,SPECIMEN LATERALITY
5586,claude37,0.815,REGIONAL LYMPH NODE STATUS
5587,claude37,0.778,VISCERAL PLEURA INVASION
5588,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5589,claude37,0.692,LYMPH NODE(S) FROM PRIOR PROCEDURES
5590,claude37,0.811,TUMOR FOCALITY
5591,claude37,0.89,TUMOR SITE
5592,claude37,0.703,NUMBER OF LYMPH NODES EXAMINED
5593,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5594,claude37,0.827,PROCEDURE
5595,claude37,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5596,claude37,0.705,NODAL SITE(S) EXAMINED
5597,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5598,claude37,0.72,PROCEDURE
5599,claude37,0.697,SPECIMEN LATERALITY
5600,claude37,0.887,TUMOR SITE
5601,claude37,0.855,MARGIN STATUS FOR INVASIVE CARCINOMA
5602,claude37,0.735,REGIONAL LYMPH NODE STATUS
5603,claude37,0.811,TUMOR FOCALITY
5604,claude37,0.656,NUMBER OF LYMPH NODES EXAMINED
5605,claude37,0.892,HISTOLOGIC GRADE
5606,claude37,0.649,SPREAD THROUGH AIR SPACES (STAS)
5607,claude37,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5608,claude37,0.747,NODAL SITE(S) EXAMINED
5609,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5610,claude37,0.698,VISCERAL PLEURA INVASION
5611,claude37,0.677,MARGIN STATUS FOR NON-INVASIVE TUMOR
5612,claude37,0.693,NUMBER OF LYMPH NODES EXAMINED
5613,claude37,0.697,SPECIMEN LATERALITY
5614,claude37,0.806,PROCEDURE
5615,claude37,0.73,TNM DESCRIPTORS
5616,claude37,0.87,NODAL SITE(S) EXAMINED
5617,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5618,claude37,0.699,MARGIN STATUS FOR INVASIVE CARCINOMA
5619,claude37,0.892,HISTOLOGIC GRADE
5620,claude37,0.784,REGIONAL LYMPH NODE STATUS
5621,claude37,0.78,VISCERAL PLEURA INVASION
5622,claude37,0.707,MARGIN STATUS FOR NON-INVASIVE TUMOR
5623,claude37,0.825,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5624,claude37,0.811,TUMOR FOCALITY
5625,claude37,0.887,TUMOR SITE
5626,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5627,claude37,0.778,VISCERAL PLEURA INVASION
5628,claude37,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5629,claude37,0.799,NODAL SITE(S) EXAMINED
5630,claude37,0.89,TUMOR SITE
5631,claude37,0.827,PROCEDURE
5632,claude37,0.815,REGIONAL LYMPH NODE STATUS
5633,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5634,claude37,0.7,NUMBER OF LYMPH NODES EXAMINED
5635,claude37,0.76,HISTOLOGIC GRADE
5636,claude37,0.698,SPECIMEN LATERALITY
5637,claude37,0.811,TUMOR FOCALITY
5638,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5639,claude37,0.826,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5640,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5641,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5642,claude37,0.89,TUMOR SITE
5643,claude37,0.74,HISTOLOGIC GRADE
5644,claude37,0.815,REGIONAL LYMPH NODE STATUS
5645,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5646,claude37,0.86,PROCEDURE
5647,claude37,0.818,NODAL SITE(S) EXAMINED
5648,claude37,0.697,SPECIMEN LATERALITY
5649,claude37,0.817,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5650,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5651,claude37,0.811,TUMOR FOCALITY
5652,claude37,0.778,VISCERAL PLEURA INVASION
5653,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5654,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
5655,claude37,0.719,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5656,claude37,0.805,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5657,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5658,claude37,0.815,HISTOLOGIC GRADE
5659,claude37,0.815,REGIONAL LYMPH NODE STATUS
5660,claude37,0.778,VISCERAL PLEURA INVASION
5661,claude37,0.811,TUMOR FOCALITY
5662,claude37,0.699,NUMBER OF LYMPH NODES EXAMINED
5663,claude37,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5664,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5665,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5666,claude37,0.697,SPECIMEN LATERALITY
5667,claude37,0.788,PROCEDURE
5668,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5669,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
5670,claude37,0.91,TUMOR SITE
5671,claude37,0.875,NODAL SITE(S) EXAMINED
5672,claude37,0.782,HISTOLOGIC GRADE
5673,claude37,0.888,TUMOR SITE
5674,claude37,0.778,VISCERAL PLEURA INVASION
5675,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5676,claude37,0.698,SPECIMEN LATERALITY
5677,claude37,0.83,NODAL SITE(S) EXAMINED
5678,claude37,0.823,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5679,claude37,0.84,REGIONAL LYMPH NODE STATUS
5680,claude37,0.797,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5681,claude37,0.829,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5682,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5683,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5684,claude37,0.734,PROCEDURE
5685,claude37,0.787,ADDITIONAL FINDINGS
5686,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
5687,claude37,0.811,TUMOR FOCALITY
5688,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5689,claude37,0.778,VISCERAL PLEURA INVASION
5690,claude37,0.745,LYMPHOVASCULAR INVASION
5691,claude37,0.83,TUMOR SITE
5692,claude37,0.74,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5693,claude37,0.7,NUMBER OF LYMPH NODES EXAMINED
5694,claude37,0.698,SPECIMEN LATERALITY
5695,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5696,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5697,claude37,0.668,HISTOLOGIC GRADE
5698,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5699,claude37,0.857,NODAL SITE(S) EXAMINED
5700,claude37,0.811,TUMOR FOCALITY
5701,claude37,0.741,HISTOLOGIC GRADE
5702,claude37,0.827,PROCEDURE
5703,claude37,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5704,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5705,claude37,0.815,REGIONAL LYMPH NODE STATUS
5706,claude37,0.735,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5707,claude37,0.668,HISTOLOGIC GRADE
5708,claude37,0.778,VISCERAL PLEURA INVASION
5709,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5710,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5711,claude37,0.791,NODAL SITE(S) WITH TUMOR
5712,claude37,0.741,PROCEDURE
5713,claude37,0.767,NODAL SITE(S) EXAMINED
5714,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5715,claude37,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5716,claude37,0.698,LYMPHOVASCULAR INVASION
5717,claude37,0.698,SPECIMEN LATERALITY
5718,claude37,0.888,TUMOR SITE
5719,claude37,0.703,NUMBER OF LYMPH NODES WITH TUMOR
5720,claude37,0.754,REGIONAL LYMPH NODE STATUS
5721,claude37,0.746,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5722,claude37,0.811,TUMOR FOCALITY
5723,claude37,0.892,HISTOLOGIC GRADE
5724,claude37,0.858,NODAL SITE(S) EXAMINED
5725,claude37,0.716,LYMPHOVASCULAR INVASION
5726,claude37,0.89,TUMOR SITE
5727,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5728,claude37,0.697,SPECIMEN LATERALITY
5729,claude37,0.883,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5730,claude37,0.719,PROCEDURE
5731,claude37,0.811,TUMOR FOCALITY
5732,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5733,claude37,0.703,NUMBER OF LYMPH NODES EXAMINED
5734,claude37,0.778,VISCERAL PLEURA INVASION
5735,claude37,0.817,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5736,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
5737,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5738,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5739,claude37,0.792,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5740,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5741,claude37,0.837,NODAL SITE(S) EXAMINED
5742,claude37,0.7,SPREAD THROUGH AIR SPACES (STAS)
5743,claude37,0.888,TUMOR SITE
5744,claude37,0.778,VISCERAL PLEURA INVASION
5745,claude37,0.811,TUMOR FOCALITY
5746,claude37,0.782,HISTOLOGIC GRADE
5747,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5748,claude37,0.735,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5749,claude37,0.735,REGIONAL LYMPH NODE STATUS
5750,claude37,0.698,SPECIMEN LATERALITY
5751,claude37,0.713,NUMBER OF LYMPH NODES EXAMINED
5752,claude37,0.831,ADDITIONAL FINDINGS
5753,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5754,claude37,0.827,PROCEDURE
5755,claude37,0.815,REGIONAL LYMPH NODE STATUS
5756,claude37,0.755,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5757,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5758,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5759,claude37,0.697,SPECIMEN LATERALITY
5760,claude37,0.817,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5761,claude37,0.76,HISTOLOGIC GRADE
5762,claude37,0.893,TUMOR SITE
5763,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5764,claude37,0.756,PROCEDURE
5765,claude37,0.778,VISCERAL PLEURA INVASION
5766,claude37,0.737,NODAL SITE(S) EXAMINED
5767,claude37,0.811,TUMOR FOCALITY
5768,claude37,0.77,NUMBER OF LYMPH NODES EXAMINED
5769,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5770,claude37,0.843,ADDITIONAL FINDINGS
5771,claude37,0.89,TUMOR SITE
5772,claude37,0.811,TUMOR FOCALITY
5773,claude37,0.698,VISCERAL PLEURA INVASION
5774,claude37,0.856,NODAL SITE(S) EXAMINED
5775,claude37,0.739,TNM DESCRIPTORS
5776,claude37,0.7,NUMBER OF LYMPH NODES EXAMINED
5777,claude37,0.828,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5778,claude37,0.815,REGIONAL LYMPH NODE STATUS
5779,claude37,0.733,PROCEDURE
5780,claude37,0.746,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5781,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5782,claude37,0.697,SPECIMEN LATERALITY
5783,claude37,0.892,HISTOLOGIC GRADE
5784,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5785,claude37,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5786,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5787,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5788,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5789,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5790,claude37,0.833,TUMOR SITE
5791,claude37,0.775,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5792,claude37,0.819,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5793,claude37,0.744,REGIONAL LYMPH NODE STATUS
5794,claude37,0.791,PROCEDURE
5795,claude37,0.811,TUMOR FOCALITY
5796,claude37,0.795,NODAL SITE(S) EXAMINED
5797,claude37,0.782,HISTOLOGIC GRADE
5798,claude37,0.741,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5799,claude37,0.78,VISCERAL PLEURA INVASION
5800,claude37,0.691,NUMBER OF LYMPH NODES EXAMINED
5801,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
5802,claude37,0.698,SPECIMEN LATERALITY
5803,claude37,0.683,NODAL SITE(S) EXAMINED
5804,claude37,0.782,HISTOLOGIC GRADE
5805,claude37,0.711,ADDITIONAL FINDINGS
5806,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5807,claude37,0.793,PROCEDURE
5808,claude37,0.837,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5809,claude37,0.888,TUMOR SITE
5810,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5811,claude37,0.786,REGIONAL LYMPH NODE STATUS
5812,claude37,0.811,TUMOR FOCALITY
5813,claude37,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5814,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5815,claude37,0.695,NUMBER OF LYMPH NODES EXAMINED
5816,claude37,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5817,claude37,0.778,VISCERAL PLEURA INVASION
5818,claude37,0.698,SPECIMEN LATERALITY
5819,claude37,0.815,REGIONAL LYMPH NODE STATUS
5820,claude37,0.811,TUMOR FOCALITY
5821,claude37,0.698,VISCERAL PLEURA INVASION
5822,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5823,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5824,claude37,0.893,TUMOR SITE
5825,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5826,claude37,0.826,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5827,claude37,0.697,SPECIMEN LATERALITY
5828,claude37,0.788,PROCEDURE
5829,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5830,claude37,0.694,NUMBER OF LYMPH NODES EXAMINED
5831,claude37,0.782,HISTOLOGIC GRADE
5832,claude37,0.85,NODAL SITE(S) EXAMINED
5833,claude37,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5834,claude37,0.811,TUMOR FOCALITY
5835,claude37,0.7,NUMBER OF LYMPH NODES EXAMINED
5836,claude37,0.78,VISCERAL PLEURA INVASION
5837,claude37,0.823,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5838,claude37,0.81,NODAL SITE(S) EXAMINED
5839,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5840,claude37,0.815,REGIONAL LYMPH NODE STATUS
5841,claude37,0.698,SPECIMEN LATERALITY
5842,claude37,0.89,TUMOR SITE
5843,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5844,claude37,0.827,PROCEDURE
5845,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5846,claude37,0.782,HISTOLOGIC GRADE
5847,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5848,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5849,claude37,0.888,TUMOR SITE
5850,claude37,0.835,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5851,claude37,0.827,PROCEDURE
5852,claude37,0.703,ADDITIONAL FINDINGS
5853,claude37,0.698,SPECIMEN LATERALITY
5854,claude37,0.788,HISTOLOGIC GRADE
5855,claude37,0.829,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5856,claude37,0.799,NODAL SITE(S) EXAMINED
5857,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5858,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5859,claude37,0.778,VISCERAL PLEURA INVASION
5860,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
5861,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5862,claude37,0.713,NUMBER OF LYMPH NODES EXAMINED
5863,claude37,0.815,REGIONAL LYMPH NODE STATUS
5864,claude37,0.811,TUMOR FOCALITY
5865,claude37,0.811,TUMOR FOCALITY
5866,claude37,0.731,NODAL SITE(S) EXAMINED
5867,claude37,0.778,VISCERAL PLEURA INVASION
5868,claude37,0.827,PROCEDURE
5869,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
5870,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5871,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5872,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5873,claude37,0.698,SPECIMEN LATERALITY
5874,claude37,0.782,HISTOLOGIC GRADE
5875,claude37,0.815,REGIONAL LYMPH NODE STATUS
5876,claude37,0.711,ADDITIONAL FINDINGS
5877,claude37,0.847,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5878,claude37,0.888,TUMOR SITE
5879,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5880,claude37,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5881,claude37,0.828,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5882,claude37,0.76,HISTOLOGIC GRADE
5883,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5884,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5885,claude37,0.888,TUMOR SITE
5886,claude37,0.686,LYMPHOVASCULAR INVASION
5887,claude37,0.798,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5888,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5889,claude37,0.827,PROCEDURE
5890,claude37,0.811,TUMOR FOCALITY
5891,claude37,0.877,REGIONAL LYMPH NODE STATUS
5892,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5893,claude37,0.84,NODAL SITE(S) EXAMINED
5894,claude37,0.698,SPECIMEN LATERALITY
5895,claude37,0.713,NUMBER OF LYMPH NODES EXAMINED
5896,claude37,0.78,SPREAD THROUGH AIR SPACES (STAS)
5897,claude37,0.778,VISCERAL PLEURA INVASION
5898,claude37,0.815,REGIONAL LYMPH NODE STATUS
5899,claude37,0.887,TUMOR SITE
5900,claude37,0.778,VISCERAL PLEURA INVASION
5901,claude37,0.692,TUMOR FOCALITY
5902,claude37,0.751,HISTOLOGIC GRADE
5903,claude37,0.795,TNM DESCRIPTORS
5904,claude37,0.709,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5905,claude37,0.691,ADDITIONAL FINDINGS
5906,claude37,0.745,MARGIN STATUS FOR NON-INVASIVE TUMOR
5907,claude37,0.697,SPECIMEN LATERALITY
5908,claude37,0.737,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5909,claude37,0.694,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5910,claude37,0.7,SPREAD THROUGH AIR SPACES (STAS)
5911,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5912,claude37,0.788,PROCEDURE
5913,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5914,claude37,0.745,NUMBER OF LYMPH NODES EXAMINED
5915,claude37,0.734,NODAL SITE(S) EXAMINED
5916,claude37,0.804,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5917,claude37,0.918,TUMOR FOCALITY
5918,claude37,0.832,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5919,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5920,claude37,0.698,VISCERAL PLEURA INVASION
5921,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5922,claude37,0.89,TUMOR SITE
5923,claude37,0.697,SPECIMEN LATERALITY
5924,claude37,0.788,PROCEDURE
5925,claude37,0.815,REGIONAL LYMPH NODE STATUS
5926,claude37,0.878,NODAL SITE(S) EXAMINED
5927,claude37,0.821,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5928,claude37,0.78,SPREAD THROUGH AIR SPACES (STAS)
5929,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5930,claude37,0.778,VISCERAL PLEURA INVASION
5931,claude37,0.811,TUMOR FOCALITY
5932,claude37,0.725,REGIONAL LYMPH NODE STATUS
5933,claude37,0.745,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5934,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5935,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5936,claude37,0.773,PROCEDURE
5937,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5938,claude37,0.698,SPECIMEN LATERALITY
5939,claude37,0.707,NUMBER OF LYMPH NODES EXAMINED
5940,claude37,0.888,TUMOR SITE
5941,claude37,0.698,NODAL SITE(S) EXAMINED
5942,claude37,0.782,HISTOLOGIC GRADE
5943,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
5944,claude37,0.697,SPECIMEN LATERALITY
5945,claude37,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5946,claude37,0.841,NODAL SITE(S) EXAMINED
5947,claude37,0.782,HISTOLOGIC GRADE
5948,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5949,claude37,0.817,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5950,claude37,0.887,TUMOR SITE
5951,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5952,claude37,0.938,ADDITIONAL FINDINGS
5953,claude37,0.778,VISCERAL PLEURA INVASION
5954,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5955,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5956,claude37,0.699,NUMBER OF LYMPH NODES EXAMINED
5957,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
5958,claude37,0.678,TUMOR FOCALITY
5959,claude37,0.788,PROCEDURE
5960,claude37,0.815,REGIONAL LYMPH NODE STATUS
5961,claude37,0.791,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5962,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
5963,claude37,0.698,SPECIMEN LATERALITY
5964,claude37,0.703,NUMBER OF LYMPH NODES EXAMINED
5965,claude37,0.778,VISCERAL PLEURA INVASION
5966,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5967,claude37,0.701,NODAL SITE(S) EXAMINED
5968,claude37,0.793,PROCEDURE
5969,claude37,0.76,HISTOLOGIC GRADE
5970,claude37,0.726,ADDITIONAL FINDINGS
5971,claude37,0.811,TUMOR FOCALITY
5972,claude37,0.888,TUMOR SITE
5973,claude37,0.815,REGIONAL LYMPH NODE STATUS
5974,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5975,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5976,claude37,0.835,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5977,claude37,0.698,SPECIMEN LATERALITY
5978,claude37,0.811,TUMOR FOCALITY
5979,claude37,0.815,REGIONAL LYMPH NODE STATUS
5980,claude37,0.837,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5981,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5982,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
5983,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5984,claude37,0.865,TUMOR SITE
5985,claude37,0.819,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5986,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5987,claude37,0.778,VISCERAL PLEURA INVASION
5988,claude37,0.76,HISTOLOGIC GRADE
5989,claude37,0.698,NUMBER OF LYMPH NODES EXAMINED
5990,claude37,0.788,PROCEDURE
5991,claude37,0.756,NODAL SITE(S) EXAMINED
5992,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5993,claude37,0.788,HISTOLOGIC GRADE
5994,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5995,claude37,0.811,TUMOR FOCALITY
5996,claude37,0.738,ADDITIONAL FINDINGS
5997,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5998,claude37,0.839,PROCEDURE
5999,claude37,0.74,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6000,claude37,0.778,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6001,claude37,0.815,REGIONAL LYMPH NODE STATUS
6002,claude37,0.697,SPECIMEN LATERALITY
6003,claude37,0.778,VISCERAL PLEURA INVASION
6004,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
6005,claude37,0.874,NODAL SITE(S) EXAMINED
6006,claude37,0.691,TUMOR SITE
6007,claude37,0.782,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6008,claude37,0.815,REGIONAL LYMPH NODE STATUS
6009,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
6010,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
6011,claude37,0.888,TUMOR SITE
6012,claude37,0.829,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6013,claude37,0.814,NODAL SITE(S) EXAMINED
6014,claude37,0.778,VISCERAL PLEURA INVASION
6015,claude37,0.782,HISTOLOGIC GRADE
6016,claude37,0.83,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6017,claude37,0.788,PROCEDURE
6018,claude37,0.698,SPECIMEN LATERALITY
6019,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
6020,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6021,claude37,0.811,TUMOR FOCALITY
6022,claude37,0.697,SPECIMEN LATERALITY
6023,claude37,0.742,MARGIN STATUS FOR INVASIVE CARCINOMA
6024,claude37,0.739,LYMPHOVASCULAR INVASION
6025,claude37,0.817,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6026,claude37,0.89,TUMOR SITE
6027,claude37,0.728,NODAL SITE(S) EXAMINED
6028,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
6029,claude37,0.76,HISTOLOGIC GRADE
6030,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
6031,claude37,0.811,TUMOR FOCALITY
6032,claude37,0.742,PROCEDURE
6033,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
6034,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6035,claude37,0.71,VISCERAL PLEURA INVASION
6036,claude37,0.815,REGIONAL LYMPH NODE STATUS
6037,claude37,0.818,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6038,claude37,0.78,VISCERAL PLEURA INVASION
6039,claude37,0.82,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6040,claude37,0.76,HISTOLOGIC GRADE
6041,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
6042,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
6043,claude37,0.89,TUMOR SITE
6044,claude37,0.697,SPECIMEN LATERALITY
6045,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
6046,claude37,0.696,NUMBER OF LYMPH NODES EXAMINED
6047,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
6048,claude37,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6049,claude37,0.815,REGIONAL LYMPH NODE STATUS
6050,claude37,0.811,TUMOR FOCALITY
6051,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6052,claude37,0.845,NODAL SITE(S) EXAMINED
6053,claude37,0.788,PROCEDURE
6054,claude37,0.846,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6055,claude37,0.786,REGIONAL LYMPH NODE STATUS
6056,claude37,0.811,TUMOR FOCALITY
6057,claude37,0.657,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6058,claude37,0.76,HISTOLOGIC GRADE
6059,claude37,0.7,NUMBER OF LYMPH NODES EXAMINED
6060,claude37,0.825,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6061,claude37,0.807,PROCEDURE
6062,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
6063,claude37,0.698,SPECIMEN LATERALITY
6064,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
6065,claude37,0.711,TUMOR SITE
6066,claude37,0.794,NODAL SITE(S) EXAMINED
6067,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
6068,claude37,0.778,VISCERAL PLEURA INVASION
6069,claude37,0.89,TUMOR SITE
6070,claude37,0.827,PROCEDURE
6071,claude37,0.821,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6072,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
6073,claude37,0.815,REGIONAL LYMPH NODE STATUS
6074,claude37,0.778,VISCERAL PLEURA INVASION
6075,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
6076,claude37,0.805,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6077,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
6078,claude37,0.85,NODAL SITE(S) EXAMINED
6079,claude37,0.697,SPECIMEN LATERALITY
6080,claude37,0.832,NUMBER OF LYMPH NODES EXAMINED
6081,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6082,claude37,0.7,SPREAD THROUGH AIR SPACES (STAS)
6083,claude37,0.811,TUMOR FOCALITY
6084,claude37,0.818,LYMPHOVASCULAR INVASION
6085,claude37,0.797,NODAL SITE(S) EXAMINED
6086,claude37,0.887,TUMOR SITE
6087,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
6088,claude37,0.757,PROCEDURE
6089,claude37,0.752,REGIONAL LYMPH NODE STATUS
6090,claude37,0.811,TUMOR FOCALITY
6091,claude37,0.698,VISCERAL PLEURA INVASION
6092,claude37,0.702,NODAL SITE(S) WITH TUMOR
6093,claude37,0.734,NUMBER OF LYMPH NODES EXAMINED
6094,claude37,0.713,NUMBER OF LYMPH NODES WITH TUMOR
6095,claude37,0.835,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6096,claude37,0.804,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6097,claude37,0.697,SPECIMEN LATERALITY
6098,claude37,0.745,LYMPHOVASCULAR INVASION
6099,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
6100,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
6101,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6102,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
6103,claude37,0.811,TUMOR FOCALITY
6104,claude37,0.815,REGIONAL LYMPH NODE STATUS
6105,claude37,0.697,SPECIMEN LATERALITY
6106,claude37,0.724,NODAL SITE(S) EXAMINED
6107,claude37,0.827,PROCEDURE
6108,claude37,0.89,TUMOR SITE
6109,claude37,0.904,HISTOLOGIC GRADE
6110,claude37,0.713,NUMBER OF LYMPH NODES EXAMINED
6111,claude37,0.729,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6112,claude37,0.734,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6113,claude37,0.78,VISCERAL PLEURA INVASION
6114,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
6115,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6116,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
6117,claude37,0.815,REGIONAL LYMPH NODE STATUS
6118,claude37,0.698,SPECIMEN LATERALITY
6119,claude37,0.742,ADDITIONAL FINDINGS
6120,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
6121,claude37,0.693,MARGIN STATUS FOR INVASIVE CARCINOMA
6122,claude37,0.685,TUMOR FOCALITY
6123,claude37,0.714,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6124,claude37,0.778,VISCERAL PLEURA INVASION
6125,claude37,0.795,TNM DESCRIPTORS
6126,claude37,0.677,NODAL SITE(S) EXAMINED
6127,claude37,0.68,HISTOLOGIC GRADE
6128,claude37,0.788,PROCEDURE
6129,claude37,0.89,TUMOR SITE
6130,claude37,0.815,REGIONAL LYMPH NODE STATUS
6131,claude37,0.759,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6132,claude37,0.872,PROCEDURE
6133,claude37,0.766,NUMBER OF LYMPH NODES EXAMINED
6134,claude37,0.89,TUMOR SITE
6135,claude37,0.698,SPECIMEN LATERALITY
6136,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
6137,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
6138,claude37,0.838,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6139,claude37,0.811,TUMOR FOCALITY
6140,claude37,0.76,HISTOLOGIC GRADE
6141,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
6142,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6143,claude37,0.778,VISCERAL PLEURA INVASION
6144,claude37,0.743,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6145,claude37,0.848,NODAL SITE(S) EXAMINED
6146,claude37,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6147,claude37,0.741,HISTOLOGIC GRADE
6148,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
6149,claude37,0.815,REGIONAL LYMPH NODE STATUS
6150,claude37,0.698,SPREAD THROUGH AIR SPACES (STAS)
6151,claude37,0.732,ADDITIONAL FINDINGS
6152,claude37,0.811,TUMOR FOCALITY
6153,claude37,0.778,VISCERAL PLEURA INVASION
6154,claude37,0.788,PROCEDURE
6155,claude37,0.704,NUMBER OF LYMPH NODES EXAMINED
6156,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
6157,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
6158,claude37,0.887,TUMOR SITE
6159,claude37,0.696,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6160,claude37,0.697,SPECIMEN LATERALITY
6161,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
6162,claude37,0.788,PROCEDURE
6163,claude37,0.76,HISTOLOGIC GRADE
6164,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
6165,claude37,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6166,claude37,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6167,claude37,0.89,TUMOR SITE
6168,claude37,0.828,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6169,claude37,0.778,VISCERAL PLEURA INVASION
6170,claude37,0.815,REGIONAL LYMPH NODE STATUS
6171,claude37,0.811,TUMOR FOCALITY
6172,claude37,0.828,NODAL SITE(S) EXAMINED
6173,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
6174,claude37,0.697,SPECIMEN LATERALITY
6175,claude37,0.797,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6176,claude37,0.697,SPECIMEN LATERALITY
6177,claude37,0.87,MARGIN STATUS FOR NON-INVASIVE TUMOR
6178,claude37,0.747,REGIONAL LYMPH NODE STATUS
6179,claude37,0.724,VISCERAL PLEURA INVASION
6180,claude37,0.843,NODAL SITE(S) WITH TUMOR
6181,claude37,0.698,NUMBER OF LYMPH NODES EXAMINED
6182,claude37,0.699,LYMPHOVASCULAR INVASION
6183,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
6184,claude37,0.703,NUMBER OF LYMPH NODES WITH TUMOR
6185,claude37,0.84,TUMOR SITE
6186,claude37,0.775,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6187,claude37,0.798,PROCEDURE
6188,claude37,0.706,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6189,claude37,0.897,NODAL SITE(S) EXAMINED
6190,claude37,0.708,TUMOR FOCALITY
6191,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
6192,claude37,0.753,LYMPHOVASCULAR INVASION
6193,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
6194,claude37,0.697,NUMBER OF LYMPH NODES EXAMINED
6195,claude37,0.783,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6196,claude37,0.742,MARGIN STATUS FOR INVASIVE CARCINOMA
6197,claude37,0.739,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6198,claude37,0.735,TNM DESCRIPTORS
6199,claude37,0.748,REGIONAL LYMPH NODE STATUS
6200,claude37,0.851,TUMOR SITE
6201,claude37,0.782,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6202,claude37,0.837,ADDITIONAL FINDINGS
6203,claude37,0.761,PROCEDURE
6204,claude37,0.697,SPECIMEN LATERALITY
6205,claude37,0.811,TUMOR FOCALITY
6206,claude37,0.775,NODAL SITE(S) EXAMINED
6207,claude37,0.78,VISCERAL PLEURA INVASION
6208,claude37,0.793,HISTOLOGIC GRADE
6209,claude37,0.72,NUMBER OF LYMPH NODES WITH TUMOR
6210,claude37,0.778,VISCERAL PLEURA INVASION
6211,claude37,0.829,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6212,claude37,0.7,NUMBER OF LYMPH NODES WITH TUMOR
6213,claude37,0.817,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6214,claude37,0.893,TUMOR SITE
6215,claude37,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
6216,claude37,0.697,SPECIMEN LATERALITY
6217,claude37,0.775,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6218,claude37,0.791,PROCEDURE
6219,claude37,0.811,TUMOR FOCALITY
6220,claude37,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
6221,claude37,0.745,REGIONAL LYMPH NODE STATUS
6222,claude37,0.788,HISTOLOGIC GRADE
6223,claude37,0.746,NODAL SITE(S) WITH TUMOR
6224,claude37,0.681,LYMPHOVASCULAR INVASION
6225,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
6226,claude37,0.719,NODAL SITE(S) EXAMINED
6227,claude37,0.698,SPECIMEN LATERALITY
6228,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
6229,claude37,0.798,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6230,claude37,0.743,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6231,claude37,0.888,TUMOR SITE
6232,claude37,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
6233,claude37,0.788,PROCEDURE
6234,claude37,0.778,VISCERAL PLEURA INVASION
6235,claude37,0.836,NODAL SITE(S) EXAMINED
6236,claude37,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6237,claude37,0.786,REGIONAL LYMPH NODE STATUS
6238,claude37,0.697,SPECIMEN LATERALITY
6239,claude37,0.791,PROCEDURE
6240,claude37,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
6241,claude37,0.811,TUMOR FOCALITY
6242,claude37,0.778,SPREAD THROUGH AIR SPACES (STAS)
6243,claude37,0.778,VISCERAL PLEURA INVASION
6244,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
6245,claude37,0.868,NODAL SITE(S) EXAMINED
6246,claude37,0.786,REGIONAL LYMPH NODE STATUS
6247,claude37,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
6248,claude37,0.788,PROCEDURE
6249,claude37,0.811,TUMOR FOCALITY
6250,claude37,0.698,SPECIMEN LATERALITY
6251,claude37,0.84,NODAL SITE(S) EXAMINED
6252,claude37,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
6253,claude37,0.778,VISCERAL PLEURA INVASION
6254,claude37,0.715,ADDITIONAL FINDINGS
6255,claude37,0.888,TUMOR SITE
6256,claude37,0.815,REGIONAL LYMPH NODE STATUS
6257,claude37,0.689,NUMBER OF LYMPH NODES EXAMINED
6258,claude37,0.7,SPREAD THROUGH AIR SPACES (STAS)
6259,claude37,0.733,HISTOLOGIC GRADE
6260,claude37,0.788,PROCEDURE
6261,claude37,0.778,VISCERAL PLEURA INVASION
6262,claude37,0.674,MARGIN STATUS FOR NON-INVASIVE TUMOR
6263,claude37,0.815,REGIONAL LYMPH NODE STATUS
6264,claude37,0.709,TUMOR SITE
6265,claude37,0.683,LYMPH NODE(S) FROM PRIOR PROCEDURES
6266,claude37,0.702,NODAL SITE(S) EXAMINED
6267,claude37,0.78,SPREAD THROUGH AIR SPACES (STAS)
6268,claude37,0.732,ADDITIONAL FINDINGS
6269,claude37,0.762,NUMBER OF LYMPH NODES EXAMINED
6270,claude37,0.698,SPECIMEN LATERALITY
6271,claude37,0.928,TUMOR FOCALITY
0,gemini20,0.764,HISTOLOGIC GRADE
1,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2,gemini20,0.837,TUMOR SITE
3,gemini20,0.695,LYMPHOVASCULAR INVASION
4,gemini20,0.811,TUMOR FOCALITY
5,gemini20,0.697,SPECIMEN LATERALITY
6,gemini20,0.765,MARGIN STATUS FOR INVASIVE CARCINOMA
7,gemini20,0.756,PROCEDURE
8,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
9,gemini20,0.925,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
10,gemini20,0.682,SPREAD THROUGH AIR SPACES (STAS)
11,gemini20,0.696,VISCERAL PLEURA INVASION
12,gemini20,0.866,ADDITIONAL FINDINGS
13,gemini20,0.713,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
14,gemini20,0.758,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
15,gemini20,0.742,HISTOLOGIC GRADE
16,gemini20,0.727,MARGIN STATUS FOR INVASIVE CARCINOMA
17,gemini20,0.698,NUMBER OF LYMPH NODES WITH TUMOR
18,gemini20,0.722,TUMOR FOCALITY
19,gemini20,0.756,PROCEDURE
20,gemini20,0.83,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
21,gemini20,0.739,NUMBER OF LYMPH NODES EXAMINED
22,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
23,gemini20,0.755,NODAL SITE(S) EXAMINED
24,gemini20,0.685,LYMPHOVASCULAR INVASION
25,gemini20,0.783,REGIONAL LYMPH NODE STATUS
26,gemini20,0.65,VISCERAL PLEURA INVASION
27,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
28,gemini20,0.667,SPREAD THROUGH AIR SPACES (STAS)
29,gemini20,0.698,SPECIMEN LATERALITY
30,gemini20,0.915,ADDITIONAL FINDINGS
31,gemini20,0.7,NODAL SITE(S) WITH TUMOR
32,gemini20,0.879,TUMOR SITE
33,gemini20,0.672,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
34,gemini20,0.683,MARGIN STATUS FOR INVASIVE CARCINOMA
35,gemini20,0.685,SPREAD THROUGH AIR SPACES (STAS)
36,gemini20,0.698,SPECIMEN LATERALITY
37,gemini20,0.702,TUMOR FOCALITY
38,gemini20,0.729,NUMBER OF LYMPH NODES EXAMINED
39,gemini20,0.705,MARGIN STATUS FOR NON-INVASIVE TUMOR
40,gemini20,0.795,NODAL SITE(S) EXAMINED
41,gemini20,0.726,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
42,gemini20,0.779,LYMPH NODE(S) FROM PRIOR PROCEDURES
43,gemini20,0.706,NODAL SITE(S) WITH TUMOR
44,gemini20,0.688,PROCEDURE
45,gemini20,0.712,NUMBER OF LYMPH NODES WITH TUMOR
46,gemini20,0.72,REGIONAL LYMPH NODE STATUS
47,gemini20,0.714,VISCERAL PLEURA INVASION
48,gemini20,0.793,TUMOR SITE
49,gemini20,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
50,gemini20,0.701,PROCEDURE
51,gemini20,0.815,REGIONAL LYMPH NODE STATUS
52,gemini20,0.706,TUMOR FOCALITY
53,gemini20,0.697,SPECIMEN LATERALITY
54,gemini20,0.729,HISTOLOGIC GRADE
55,gemini20,0.841,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
56,gemini20,0.723,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
57,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
58,gemini20,0.754,NODAL SITE(S) EXAMINED
59,gemini20,0.756,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
60,gemini20,0.887,TUMOR SITE
61,gemini20,0.723,LYMPHOVASCULAR INVASION
62,gemini20,0.705,VISCERAL PLEURA INVASION
63,gemini20,0.676,SPREAD THROUGH AIR SPACES (STAS)
64,gemini20,0.727,MARGIN STATUS FOR INVASIVE CARCINOMA
65,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
66,gemini20,0.759,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
67,gemini20,0.709,ADDITIONAL FINDINGS
68,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
69,gemini20,0.672,VISCERAL PLEURA INVASION
70,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
71,gemini20,0.829,REGIONAL LYMPH NODE STATUS
72,gemini20,0.744,NODAL SITE(S) EXAMINED
73,gemini20,0.882,TUMOR SITE
74,gemini20,0.703,NUMBER OF LYMPH NODES EXAMINED
75,gemini20,0.716,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
76,gemini20,0.715,PROCEDURE
77,gemini20,0.691,SPREAD THROUGH AIR SPACES (STAS)
78,gemini20,0.729,MARGIN STATUS FOR INVASIVE CARCINOMA
79,gemini20,0.672,TUMOR FOCALITY
80,gemini20,0.832,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
81,gemini20,0.697,HISTOLOGIC GRADE
82,gemini20,0.697,SPECIMEN LATERALITY
83,gemini20,0.676,SPREAD THROUGH AIR SPACES (STAS)
84,gemini20,0.727,NODAL SITE(S) EXAMINED
85,gemini20,0.753,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
86,gemini20,0.693,HISTOLOGIC GRADE
87,gemini20,0.764,MARGIN STATUS FOR INVASIVE CARCINOMA
88,gemini20,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
89,gemini20,0.74,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
90,gemini20,0.722,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
91,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
92,gemini20,0.851,TUMOR SITE
93,gemini20,0.686,VISCERAL PLEURA INVASION
94,gemini20,0.754,REGIONAL LYMPH NODE STATUS
95,gemini20,0.697,SPECIMEN LATERALITY
96,gemini20,0.713,PROCEDURE
97,gemini20,0.71,TUMOR FOCALITY
98,gemini20,0.785,NODAL SITE(S) EXAMINED
99,gemini20,0.879,TUMOR SITE
100,gemini20,0.698,SPECIMEN LATERALITY
101,gemini20,0.751,MARGIN STATUS FOR INVASIVE CARCINOMA
102,gemini20,0.699,VISCERAL PLEURA INVASION
103,gemini20,0.767,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
104,gemini20,0.783,ADDITIONAL FINDINGS
105,gemini20,0.708,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
106,gemini20,0.738,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
107,gemini20,0.788,PROCEDURE
108,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
109,gemini20,0.686,TUMOR FOCALITY
110,gemini20,0.796,REGIONAL LYMPH NODE STATUS
111,gemini20,0.718,HISTOLOGIC GRADE
112,gemini20,0.727,NUMBER OF LYMPH NODES EXAMINED
113,gemini20,0.708,TNM DESCRIPTORS
114,gemini20,0.685,SPREAD THROUGH AIR SPACES (STAS)
115,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
116,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
117,gemini20,0.826,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
118,gemini20,0.718,NODAL SITE(S) EXAMINED
119,gemini20,0.752,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
120,gemini20,0.726,VISCERAL PLEURA INVASION
121,gemini20,0.804,MARGIN STATUS FOR INVASIVE CARCINOMA
122,gemini20,0.811,TUMOR FOCALITY
123,gemini20,0.884,TUMOR SITE
124,gemini20,0.744,HISTOLOGIC GRADE
125,gemini20,0.698,SPECIMEN LATERALITY
126,gemini20,0.827,PROCEDURE
127,gemini20,0.685,SPREAD THROUGH AIR SPACES (STAS)
128,gemini20,0.659,TNM DESCRIPTORS
129,gemini20,0.822,REGIONAL LYMPH NODE STATUS
130,gemini20,0.718,ADDITIONAL FINDINGS
131,gemini20,0.823,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
132,gemini20,0.779,LYMPH NODE(S) FROM PRIOR PROCEDURES
133,gemini20,0.756,HISTOLOGIC GRADE
134,gemini20,0.76,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
135,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
136,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
137,gemini20,0.811,TUMOR FOCALITY
138,gemini20,0.721,PROCEDURE
139,gemini20,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
140,gemini20,0.875,ADDITIONAL FINDINGS
141,gemini20,0.697,SPECIMEN LATERALITY
142,gemini20,0.738,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
143,gemini20,0.752,MARGIN STATUS FOR INVASIVE CARCINOMA
144,gemini20,0.815,REGIONAL LYMPH NODE STATUS
145,gemini20,0.802,NODAL SITE(S) EXAMINED
146,gemini20,0.878,TUMOR SITE
147,gemini20,0.706,VISCERAL PLEURA INVASION
148,gemini20,0.691,HISTOLOGIC GRADE
149,gemini20,0.697,SPECIMEN LATERALITY
150,gemini20,0.837,NODAL SITE(S) EXAMINED
151,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
152,gemini20,0.7,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
153,gemini20,0.789,TUMOR SITE
154,gemini20,0.725,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
155,gemini20,0.811,TUMOR FOCALITY
156,gemini20,0.701,ADDITIONAL FINDINGS
157,gemini20,0.829,REGIONAL LYMPH NODE STATUS
158,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
159,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
160,gemini20,0.83,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
161,gemini20,0.694,NUMBER OF LYMPH NODES EXAMINED
162,gemini20,0.705,VISCERAL PLEURA INVASION
163,gemini20,0.717,PROCEDURE
164,gemini20,0.781,TUMOR SITE
165,gemini20,0.713,LYMPHOVASCULAR INVASION
166,gemini20,0.698,SPECIMEN LATERALITY
167,gemini20,0.755,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
168,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
169,gemini20,0.786,REGIONAL LYMPH NODE STATUS
170,gemini20,0.721,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
171,gemini20,0.719,TNM DESCRIPTORS
172,gemini20,0.715,NUMBER OF LYMPH NODES WITH TUMOR
173,gemini20,0.693,ADDITIONAL FINDINGS
174,gemini20,0.784,HISTOLOGIC GRADE
175,gemini20,0.752,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
176,gemini20,0.705,VISCERAL PLEURA INVASION
177,gemini20,0.716,NODAL SITE(S) WITH TUMOR
178,gemini20,0.745,NODAL SITE(S) EXAMINED
179,gemini20,0.677,SPREAD THROUGH AIR SPACES (STAS)
180,gemini20,0.762,MARGIN STATUS FOR INVASIVE CARCINOMA
181,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
182,gemini20,0.724,PROCEDURE
183,gemini20,0.811,TUMOR FOCALITY
184,gemini20,0.692,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
185,gemini20,0.693,PROCEDURE
186,gemini20,0.683,TNM DESCRIPTORS
187,gemini20,0.705,VISCERAL PLEURA INVASION
188,gemini20,0.697,SPECIMEN LATERALITY
189,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
190,gemini20,0.719,MARGIN STATUS FOR INVASIVE CARCINOMA
191,gemini20,0.758,TUMOR SITE
192,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
193,gemini20,0.725,HISTOLOGIC GRADE
194,gemini20,0.75,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
195,gemini20,0.775,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
196,gemini20,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
197,gemini20,0.712,HISTOLOGIC GRADE
198,gemini20,0.697,SPECIMEN LATERALITY
199,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
200,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
201,gemini20,0.89,TUMOR SITE
202,gemini20,0.694,NODAL SITE(S) EXAMINED
203,gemini20,0.811,TUMOR FOCALITY
204,gemini20,0.815,REGIONAL LYMPH NODE STATUS
205,gemini20,0.675,NUMBER OF LYMPH NODES EXAMINED
206,gemini20,0.718,MARGIN STATUS FOR INVASIVE CARCINOMA
207,gemini20,0.827,PROCEDURE
208,gemini20,0.831,ADDITIONAL FINDINGS
209,gemini20,0.804,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
210,gemini20,0.694,VISCERAL PLEURA INVASION
211,gemini20,0.797,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
212,gemini20,0.695,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
213,gemini20,0.699,SPREAD THROUGH AIR SPACES (STAS)
214,gemini20,0.811,TUMOR FOCALITY
215,gemini20,0.803,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
216,gemini20,0.688,NUMBER OF LYMPH NODES EXAMINED
217,gemini20,0.875,NODAL SITE(S) EXAMINED
218,gemini20,0.731,HISTOLOGIC GRADE
219,gemini20,0.697,SPECIMEN LATERALITY
220,gemini20,0.746,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
221,gemini20,0.685,VISCERAL PLEURA INVASION
222,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
223,gemini20,0.698,PROCEDURE
224,gemini20,0.798,MARGIN STATUS FOR INVASIVE CARCINOMA
225,gemini20,0.815,REGIONAL LYMPH NODE STATUS
226,gemini20,0.878,TUMOR SITE
227,gemini20,0.764,PROCEDURE
228,gemini20,0.713,NUMBER OF LYMPH NODES EXAMINED
229,gemini20,0.718,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
230,gemini20,0.7,VISCERAL PLEURA INVASION
231,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
232,gemini20,0.777,TUMOR SITE
233,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
234,gemini20,0.683,LYMPH NODE(S) FROM PRIOR PROCEDURES
235,gemini20,0.68,TUMOR FOCALITY
236,gemini20,0.771,HISTOLOGIC GRADE
237,gemini20,0.685,SPREAD THROUGH AIR SPACES (STAS)
238,gemini20,0.741,NODAL SITE(S) EXAMINED
239,gemini20,0.697,SPECIMEN LATERALITY
240,gemini20,0.798,ADDITIONAL FINDINGS
241,gemini20,0.663,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
242,gemini20,0.734,REGIONAL LYMPH NODE STATUS
243,gemini20,0.725,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
244,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
245,gemini20,0.811,TUMOR FOCALITY
246,gemini20,0.72,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
247,gemini20,0.778,VISCERAL PLEURA INVASION
248,gemini20,0.732,NODAL SITE(S) EXAMINED
249,gemini20,0.815,REGIONAL LYMPH NODE STATUS
250,gemini20,0.693,TUMOR SITE
251,gemini20,0.7,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
252,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
253,gemini20,0.742,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
254,gemini20,0.713,HISTOLOGIC GRADE
255,gemini20,0.699,SPREAD THROUGH AIR SPACES (STAS)
256,gemini20,0.697,SPECIMEN LATERALITY
257,gemini20,0.733,PROCEDURE
258,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
259,gemini20,0.697,NUMBER OF LYMPH NODES EXAMINED
260,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
261,gemini20,0.705,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
262,gemini20,0.811,TUMOR FOCALITY
263,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
264,gemini20,0.697,SPECIMEN LATERALITY
265,gemini20,0.681,VISCERAL PLEURA INVASION
266,gemini20,0.764,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
267,gemini20,0.685,SPREAD THROUGH AIR SPACES (STAS)
268,gemini20,0.677,SPREAD THROUGH AIR SPACES (STAS)
269,gemini20,0.709,PROCEDURE
270,gemini20,0.701,LYMPHOVASCULAR INVASION
271,gemini20,0.789,TUMOR SITE
272,gemini20,0.711,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
273,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
274,gemini20,0.72,NUMBER OF LYMPH NODES WITH TUMOR
275,gemini20,0.689,HISTOLOGIC GRADE
276,gemini20,0.729,REGIONAL LYMPH NODE STATUS
277,gemini20,0.672,VISCERAL PLEURA INVASION
278,gemini20,0.834,NODAL SITE(S) EXAMINED
279,gemini20,0.727,REGIONAL LYMPH NODE STATUS
280,gemini20,0.683,NODAL SITE(S) WITH TUMOR
281,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
282,gemini20,0.815,REGIONAL LYMPH NODE STATUS
283,gemini20,0.788,NUMBER OF LYMPH NODES EXAMINED
284,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
285,gemini20,0.81,NUMBER OF LYMPH NODES EXAMINED
286,gemini20,0.713,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
287,gemini20,0.657,PROCEDURE
288,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
289,gemini20,0.752,LYMPHOVASCULAR INVASION
290,gemini20,0.728,NODAL SITE(S) EXAMINED
291,gemini20,0.684,SPREAD THROUGH AIR SPACES (STAS)
292,gemini20,0.7,TUMOR SITE
293,gemini20,0.694,VISCERAL PLEURA INVASION
294,gemini20,0.742,PROCEDURE
295,gemini20,0.738,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
296,gemini20,0.76,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
297,gemini20,0.697,SPECIMEN LATERALITY
298,gemini20,0.811,TUMOR FOCALITY
299,gemini20,0.762,MARGIN STATUS FOR INVASIVE CARCINOMA
300,gemini20,0.732,VISCERAL PLEURA INVASION
301,gemini20,0.769,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
302,gemini20,0.744,PROCEDURE
303,gemini20,0.697,SPECIMEN LATERALITY
304,gemini20,0.753,ADDITIONAL FINDINGS
305,gemini20,0.815,REGIONAL LYMPH NODE STATUS
306,gemini20,0.811,TUMOR FOCALITY
307,gemini20,0.671,HISTOLOGIC GRADE
308,gemini20,0.733,NODAL SITE(S) EXAMINED
309,gemini20,0.741,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
310,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
311,gemini20,0.826,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
312,gemini20,0.837,TUMOR SITE
313,gemini20,0.695,TUMOR FOCALITY
314,gemini20,0.822,REGIONAL LYMPH NODE STATUS
315,gemini20,0.753,MARGIN STATUS FOR NON-INVASIVE TUMOR
316,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
317,gemini20,0.729,NODAL SITE(S) EXAMINED
318,gemini20,0.813,TUMOR SITE
319,gemini20,0.732,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
320,gemini20,0.826,PROCEDURE
321,gemini20,0.697,SPECIMEN LATERALITY
322,gemini20,0.838,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
323,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
324,gemini20,0.689,HISTOLOGIC GRADE
325,gemini20,0.705,VISCERAL PLEURA INVASION
326,gemini20,0.826,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
327,gemini20,0.717,HISTOLOGIC GRADE
328,gemini20,0.7,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
329,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
330,gemini20,0.706,PROCEDURE
331,gemini20,0.711,TUMOR FOCALITY
332,gemini20,0.697,SPECIMEN LATERALITY
333,gemini20,0.829,REGIONAL LYMPH NODE STATUS
334,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
335,gemini20,0.705,VISCERAL PLEURA INVASION
336,gemini20,0.759,NODAL SITE(S) EXAMINED
337,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
338,gemini20,0.745,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
339,gemini20,0.722,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
340,gemini20,0.782,TUMOR SITE
341,gemini20,0.707,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
342,gemini20,0.697,SPECIMEN LATERALITY
343,gemini20,0.791,TUMOR SITE
344,gemini20,0.737,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
345,gemini20,0.735,VISCERAL PLEURA INVASION
346,gemini20,0.837,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
347,gemini20,0.754,ADDITIONAL FINDINGS
348,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
349,gemini20,0.729,REGIONAL LYMPH NODE STATUS
350,gemini20,0.737,TUMOR FOCALITY
351,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
352,gemini20,0.722,PROCEDURE
353,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
354,gemini20,0.69,NODAL SITE(S) EXAMINED
355,gemini20,0.904,HISTOLOGIC GRADE
356,gemini20,0.699,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
357,gemini20,0.811,TUMOR FOCALITY
358,gemini20,0.76,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
359,gemini20,0.698,SPECIMEN LATERALITY
360,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
361,gemini20,0.829,REGIONAL LYMPH NODE STATUS
362,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
363,gemini20,0.699,SPREAD THROUGH AIR SPACES (STAS)
364,gemini20,0.704,NUMBER OF LYMPH NODES EXAMINED
365,gemini20,0.759,PROCEDURE
366,gemini20,0.8,NODAL SITE(S) EXAMINED
367,gemini20,0.89,TUMOR SITE
368,gemini20,0.669,VISCERAL PLEURA INVASION
369,gemini20,0.763,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
370,gemini20,0.714,MARGIN STATUS FOR INVASIVE CARCINOMA
371,gemini20,0.871,PROCEDURE
372,gemini20,0.804,REGIONAL LYMPH NODE STATUS
373,gemini20,0.698,SPECIMEN LATERALITY
374,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
375,gemini20,0.83,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
376,gemini20,0.763,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
377,gemini20,0.704,NUMBER OF LYMPH NODES EXAMINED
378,gemini20,0.677,TUMOR FOCALITY
379,gemini20,0.696,MARGIN STATUS FOR INVASIVE CARCINOMA
380,gemini20,0.696,MARGIN STATUS FOR NON-INVASIVE TUMOR
381,gemini20,0.688,VISCERAL PLEURA INVASION
382,gemini20,0.709,HISTOLOGIC GRADE
383,gemini20,0.762,TUMOR SITE
384,gemini20,0.702,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
385,gemini20,0.757,MARGIN STATUS FOR INVASIVE CARCINOMA
386,gemini20,0.697,SPECIMEN LATERALITY
387,gemini20,0.708,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
388,gemini20,0.705,VISCERAL PLEURA INVASION
389,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
390,gemini20,0.829,REGIONAL LYMPH NODE STATUS
391,gemini20,0.684,ADDITIONAL FINDINGS
392,gemini20,0.796,MARGIN STATUS FOR NON-INVASIVE TUMOR
393,gemini20,0.716,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
394,gemini20,0.765,TUMOR SITE
395,gemini20,0.797,NODAL SITE(S) EXAMINED
396,gemini20,0.654,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
397,gemini20,0.699,TNM DESCRIPTORS
398,gemini20,0.655,TUMOR FOCALITY
399,gemini20,0.738,HISTOLOGIC GRADE
400,gemini20,0.809,PROCEDURE
401,gemini20,0.704,VISCERAL PLEURA INVASION
402,gemini20,0.747,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
403,gemini20,0.773,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
404,gemini20,0.712,NUMBER OF LYMPH NODES EXAMINED
405,gemini20,0.811,TUMOR FOCALITY
406,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
407,gemini20,0.736,HISTOLOGIC GRADE
408,gemini20,0.815,REGIONAL LYMPH NODE STATUS
409,gemini20,0.697,SPECIMEN LATERALITY
410,gemini20,0.884,TUMOR SITE
411,gemini20,0.747,NODAL SITE(S) EXAMINED
412,gemini20,0.711,PROCEDURE
413,gemini20,0.717,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
414,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
415,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
416,gemini20,0.718,NODAL SITE(S) EXAMINED
417,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
418,gemini20,0.751,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
419,gemini20,0.698,SPECIMEN LATERALITY
420,gemini20,0.704,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
421,gemini20,0.723,PROCEDURE
422,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
423,gemini20,0.811,TUMOR FOCALITY
424,gemini20,0.815,REGIONAL LYMPH NODE STATUS
425,gemini20,0.733,MARGIN STATUS FOR INVASIVE CARCINOMA
426,gemini20,0.745,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
427,gemini20,0.768,VISCERAL PLEURA INVASION
428,gemini20,0.784,TUMOR SITE
429,gemini20,0.713,NUMBER OF LYMPH NODES EXAMINED
430,gemini20,0.904,HISTOLOGIC GRADE
431,gemini20,0.717,LYMPHOVASCULAR INVASION
432,gemini20,0.747,NODAL SITE(S) WITH TUMOR
433,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
434,gemini20,0.7,NUMBER OF LYMPH NODES WITH TUMOR
435,gemini20,0.689,HISTOLOGIC GRADE
436,gemini20,0.741,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
437,gemini20,0.726,ADDITIONAL FINDINGS
438,gemini20,0.783,REGIONAL LYMPH NODE STATUS
439,gemini20,0.705,VISCERAL PLEURA INVASION
440,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
441,gemini20,0.769,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
442,gemini20,0.759,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
443,gemini20,0.828,TUMOR SITE
444,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
445,gemini20,0.697,SPECIMEN LATERALITY
446,gemini20,0.722,TUMOR FOCALITY
447,gemini20,0.796,NODAL SITE(S) EXAMINED
448,gemini20,0.69,PROCEDURE
449,gemini20,0.698,VISCERAL PLEURA INVASION
450,gemini20,0.768,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
451,gemini20,0.738,ADDITIONAL FINDINGS
452,gemini20,0.784,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
453,gemini20,0.811,TUMOR FOCALITY
454,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
455,gemini20,0.74,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
456,gemini20,0.714,NODAL SITE(S) EXAMINED
457,gemini20,0.701,PROCEDURE
458,gemini20,0.887,TUMOR SITE
459,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
460,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
461,gemini20,0.697,SPECIMEN LATERALITY
462,gemini20,0.839,HISTOLOGIC GRADE
463,gemini20,0.762,NUMBER OF LYMPH NODES EXAMINED
464,gemini20,0.688,HISTOLOGIC GRADE
465,gemini20,0.698,SPECIMEN LATERALITY
466,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
467,gemini20,0.77,PROCEDURE
468,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
469,gemini20,0.705,VISCERAL PLEURA INVASION
470,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
471,gemini20,0.736,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
472,gemini20,0.774,NODAL SITE(S) EXAMINED
473,gemini20,0.761,NODAL SITE(S) WITH TUMOR
474,gemini20,0.739,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
475,gemini20,0.78,REGIONAL LYMPH NODE STATUS
476,gemini20,0.695,TUMOR FOCALITY
477,gemini20,0.663,LYMPHOVASCULAR INVASION
478,gemini20,0.713,NUMBER OF LYMPH NODES WITH TUMOR
479,gemini20,0.72,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
480,gemini20,0.752,TUMOR SITE
481,gemini20,0.719,TNM DESCRIPTORS
482,gemini20,0.724,MARGIN STATUS FOR NON-INVASIVE TUMOR
483,gemini20,0.826,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
484,gemini20,0.709,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
485,gemini20,0.731,PROCEDURE
486,gemini20,0.759,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
487,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
488,gemini20,0.697,SPECIMEN LATERALITY
489,gemini20,0.726,HISTOLOGIC GRADE
490,gemini20,0.851,TUMOR SITE
491,gemini20,0.746,ADDITIONAL FINDINGS
492,gemini20,0.687,SPREAD THROUGH AIR SPACES (STAS)
493,gemini20,0.71,VISCERAL PLEURA INVASION
494,gemini20,0.695,TUMOR FOCALITY
495,gemini20,0.729,MARGIN STATUS FOR INVASIVE CARCINOMA
496,gemini20,0.705,MARGIN STATUS FOR NON-INVASIVE TUMOR
497,gemini20,0.783,REGIONAL LYMPH NODE STATUS
498,gemini20,0.751,PROCEDURE
499,gemini20,0.677,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
500,gemini20,0.683,LYMPH NODE(S) FROM PRIOR PROCEDURES
501,gemini20,0.703,LYMPHOVASCULAR INVASION
502,gemini20,0.754,MARGIN STATUS FOR INVASIVE CARCINOMA
503,gemini20,0.753,ADDITIONAL FINDINGS
504,gemini20,0.686,HISTOLOGIC GRADE
505,gemini20,0.695,TUMOR FOCALITY
506,gemini20,0.779,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
507,gemini20,0.72,NUMBER OF LYMPH NODES WITH TUMOR
508,gemini20,0.678,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
509,gemini20,0.822,NODAL SITE(S) EXAMINED
510,gemini20,0.723,NODAL SITE(S) WITH TUMOR
511,gemini20,0.697,SPECIMEN LATERALITY
512,gemini20,0.689,VISCERAL PLEURA INVASION
513,gemini20,0.791,TUMOR SITE
514,gemini20,0.826,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
515,gemini20,0.678,VISCERAL PLEURA INVASION
516,gemini20,0.703,PROCEDURE
517,gemini20,0.697,SPECIMEN LATERALITY
518,gemini20,0.747,REGIONAL LYMPH NODE STATUS
519,gemini20,0.878,TUMOR SITE
520,gemini20,0.811,TUMOR FOCALITY
521,gemini20,0.817,ADDITIONAL FINDINGS
522,gemini20,0.742,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
523,gemini20,0.699,SPREAD THROUGH AIR SPACES (STAS)
524,gemini20,0.712,NUMBER OF LYMPH NODES EXAMINED
525,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
526,gemini20,0.75,NODAL SITE(S) EXAMINED
527,gemini20,0.733,HISTOLOGIC GRADE
528,gemini20,0.776,MARGIN STATUS FOR INVASIVE CARCINOMA
529,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
530,gemini20,0.713,NUMBER OF LYMPH NODES EXAMINED
531,gemini20,0.815,REGIONAL LYMPH NODE STATUS
532,gemini20,0.832,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
533,gemini20,0.788,HISTOLOGIC GRADE
534,gemini20,0.811,TUMOR FOCALITY
535,gemini20,0.698,SPECIMEN LATERALITY
536,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
537,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
538,gemini20,0.664,VISCERAL PLEURA INVASION
539,gemini20,0.768,TUMOR SITE
540,gemini20,0.691,SPREAD THROUGH AIR SPACES (STAS)
541,gemini20,0.74,PROCEDURE
542,gemini20,0.805,MARGIN STATUS FOR INVASIVE CARCINOMA
543,gemini20,0.924,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
544,gemini20,0.734,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
545,gemini20,0.891,NODAL SITE(S) EXAMINED
546,gemini20,0.691,TUMOR FOCALITY
547,gemini20,0.793,TUMOR SITE
548,gemini20,0.738,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
549,gemini20,0.802,NODAL SITE(S) EXAMINED
550,gemini20,0.841,MARGIN STATUS FOR INVASIVE CARCINOMA
551,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
552,gemini20,0.698,SPECIMEN LATERALITY
553,gemini20,0.815,REGIONAL LYMPH NODE STATUS
554,gemini20,0.74,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
555,gemini20,0.692,VISCERAL PLEURA INVASION
556,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
557,gemini20,0.694,SPREAD THROUGH AIR SPACES (STAS)
558,gemini20,0.744,PROCEDURE
559,gemini20,0.713,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
560,gemini20,0.714,ADDITIONAL FINDINGS
561,gemini20,0.811,TUMOR FOCALITY
562,gemini20,0.698,SPECIMEN LATERALITY
563,gemini20,0.694,SPREAD THROUGH AIR SPACES (STAS)
564,gemini20,0.739,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
565,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
566,gemini20,0.829,REGIONAL LYMPH NODE STATUS
567,gemini20,0.706,TUMOR SITE
568,gemini20,0.708,NODAL SITE(S) EXAMINED
569,gemini20,0.768,VISCERAL PLEURA INVASION
570,gemini20,0.704,NUMBER OF LYMPH NODES EXAMINED
571,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
572,gemini20,0.773,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
573,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
574,gemini20,0.826,HISTOLOGIC GRADE
575,gemini20,0.713,PROCEDURE
576,gemini20,0.816,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
577,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
578,gemini20,0.745,NODAL SITE(S) EXAMINED
579,gemini20,0.826,HISTOLOGIC GRADE
580,gemini20,0.708,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
581,gemini20,0.687,MARGIN STATUS FOR INVASIVE CARCINOMA
582,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
583,gemini20,0.755,REGIONAL LYMPH NODE STATUS
584,gemini20,0.827,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
585,gemini20,0.645,VISCERAL PLEURA INVASION
586,gemini20,0.698,PROCEDURE
587,gemini20,0.811,TUMOR FOCALITY
588,gemini20,0.697,SPECIMEN LATERALITY
589,gemini20,0.714,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
590,gemini20,0.798,TUMOR SITE
591,gemini20,0.811,TUMOR FOCALITY
592,gemini20,0.705,HISTOLOGIC GRADE
593,gemini20,0.761,NODAL SITE(S) EXAMINED
594,gemini20,0.697,SPECIMEN LATERALITY
595,gemini20,0.765,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
596,gemini20,0.78,VISCERAL PLEURA INVASION
597,gemini20,0.731,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
598,gemini20,0.815,REGIONAL LYMPH NODE STATUS
599,gemini20,0.724,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
600,gemini20,0.887,TUMOR SITE
601,gemini20,0.788,PROCEDURE
602,gemini20,0.779,LYMPH NODE(S) FROM PRIOR PROCEDURES
603,gemini20,0.755,MARGIN STATUS FOR INVASIVE CARCINOMA
604,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
605,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
606,gemini20,0.761,PROCEDURE
607,gemini20,0.896,MARGIN STATUS FOR INVASIVE CARCINOMA
608,gemini20,0.689,NODAL SITE(S) WITH TUMOR
609,gemini20,0.705,VISCERAL PLEURA INVASION
610,gemini20,0.62,TUMOR FOCALITY
611,gemini20,0.72,NUMBER OF LYMPH NODES WITH TUMOR
612,gemini20,0.703,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
613,gemini20,0.698,SPECIMEN LATERALITY
614,gemini20,0.743,ADDITIONAL FINDINGS
615,gemini20,0.72,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
616,gemini20,0.636,HISTOLOGIC GRADE
617,gemini20,0.781,NODAL SITE(S) EXAMINED
618,gemini20,0.689,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
619,gemini20,0.774,SPREAD THROUGH AIR SPACES (STAS)
620,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
621,gemini20,0.717,TNM DESCRIPTORS
622,gemini20,0.872,TUMOR SITE
623,gemini20,0.783,REGIONAL LYMPH NODE STATUS
624,gemini20,0.748,NODAL SITE(S) EXAMINED
625,gemini20,0.748,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
626,gemini20,0.694,MARGIN STATUS FOR INVASIVE CARCINOMA
627,gemini20,0.724,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
628,gemini20,0.718,HISTOLOGIC GRADE
629,gemini20,0.697,SPECIMEN LATERALITY
630,gemini20,0.822,REGIONAL LYMPH NODE STATUS
631,gemini20,0.773,PROCEDURE
632,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
633,gemini20,0.811,TUMOR FOCALITY
634,gemini20,0.826,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
635,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
636,gemini20,0.694,SPREAD THROUGH AIR SPACES (STAS)
637,gemini20,0.798,TUMOR SITE
638,gemini20,0.716,VISCERAL PLEURA INVASION
639,gemini20,0.702,HISTOLOGIC GRADE
640,gemini20,0.732,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
641,gemini20,0.705,VISCERAL PLEURA INVASION
642,gemini20,0.896,MARGIN STATUS FOR INVASIVE CARCINOMA
643,gemini20,0.695,PROCEDURE
644,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
645,gemini20,0.783,REGIONAL LYMPH NODE STATUS
646,gemini20,0.748,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
647,gemini20,0.691,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
648,gemini20,0.832,NODAL SITE(S) WITH TUMOR
649,gemini20,0.887,TUMOR SITE
650,gemini20,0.722,LYMPHOVASCULAR INVASION
651,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
652,gemini20,0.783,NODAL SITE(S) EXAMINED
653,gemini20,0.697,SPECIMEN LATERALITY
654,gemini20,0.811,TUMOR FOCALITY
655,gemini20,0.9,HISTOLOGIC GRADE
656,gemini20,0.765,LYMPHOVASCULAR INVASION
657,gemini20,0.738,REGIONAL LYMPH NODE STATUS
658,gemini20,0.705,VISCERAL PLEURA INVASION
659,gemini20,0.685,SPREAD THROUGH AIR SPACES (STAS)
660,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
661,gemini20,0.785,NODAL SITE(S) EXAMINED
662,gemini20,0.879,TUMOR SITE
663,gemini20,0.693,PROCEDURE
664,gemini20,0.698,SPECIMEN LATERALITY
665,gemini20,0.675,NODAL SITE(S) WITH TUMOR
666,gemini20,0.713,NUMBER OF LYMPH NODES WITH TUMOR
667,gemini20,0.685,NUMBER OF LYMPH NODES EXAMINED
668,gemini20,0.709,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
669,gemini20,0.692,TUMOR FOCALITY
670,gemini20,0.765,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
671,gemini20,0.7,TNM DESCRIPTORS
672,gemini20,0.755,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
673,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
674,gemini20,0.705,VISCERAL PLEURA INVASION
675,gemini20,0.697,SPECIMEN LATERALITY
676,gemini20,0.748,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
677,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
678,gemini20,0.699,LYMPHOVASCULAR INVASION
679,gemini20,0.709,NODAL SITE(S) WITH TUMOR
680,gemini20,0.706,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
681,gemini20,0.732,HISTOLOGIC GRADE
682,gemini20,0.705,MARGIN STATUS FOR NON-INVASIVE TUMOR
683,gemini20,0.668,SPREAD THROUGH AIR SPACES (STAS)
684,gemini20,0.705,NUMBER OF LYMPH NODES WITH TUMOR
685,gemini20,0.78,REGIONAL LYMPH NODE STATUS
686,gemini20,0.692,PROCEDURE
687,gemini20,0.814,NODAL SITE(S) EXAMINED
688,gemini20,0.709,TUMOR FOCALITY
689,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
690,gemini20,0.698,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
691,gemini20,0.708,TUMOR SITE
692,gemini20,0.705,NUMBER OF LYMPH NODES EXAMINED
693,gemini20,0.753,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
694,gemini20,0.698,PROCEDURE
695,gemini20,0.719,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
696,gemini20,0.687,HISTOLOGIC GRADE
697,gemini20,0.815,REGIONAL LYMPH NODE STATUS
698,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
699,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
700,gemini20,0.698,SPECIMEN LATERALITY
701,gemini20,0.734,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
702,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
703,gemini20,0.688,SPREAD THROUGH AIR SPACES (STAS)
704,gemini20,0.811,TUMOR FOCALITY
705,gemini20,0.779,NODAL SITE(S) EXAMINED
706,gemini20,0.762,TUMOR SITE
707,gemini20,0.707,VISCERAL PLEURA INVASION
708,gemini20,0.694,VISCERAL PLEURA INVASION
709,gemini20,0.706,PROCEDURE
710,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
711,gemini20,0.811,TUMOR FOCALITY
712,gemini20,0.815,REGIONAL LYMPH NODE STATUS
713,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
714,gemini20,0.752,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
715,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
716,gemini20,0.698,SPECIMEN LATERALITY
717,gemini20,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
718,gemini20,0.725,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
719,gemini20,0.785,NODAL SITE(S) EXAMINED
720,gemini20,0.817,TUMOR SITE
721,gemini20,0.904,HISTOLOGIC GRADE
722,gemini20,0.688,SPREAD THROUGH AIR SPACES (STAS)
723,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
724,gemini20,0.757,PROCEDURE
725,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
726,gemini20,0.764,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
727,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
728,gemini20,0.681,TUMOR SITE
729,gemini20,0.836,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
730,gemini20,0.698,NODAL SITE(S) EXAMINED
731,gemini20,0.694,NUMBER OF LYMPH NODES EXAMINED
732,gemini20,0.904,HISTOLOGIC GRADE
733,gemini20,0.815,REGIONAL LYMPH NODE STATUS
734,gemini20,0.811,TUMOR FOCALITY
735,gemini20,0.704,VISCERAL PLEURA INVASION
736,gemini20,0.698,SPECIMEN LATERALITY
737,gemini20,0.826,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
738,gemini20,0.802,PROCEDURE
739,gemini20,0.789,TUMOR SITE
740,gemini20,0.826,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
741,gemini20,0.788,ADDITIONAL FINDINGS
742,gemini20,0.831,HISTOLOGIC GRADE
743,gemini20,0.757,MARGIN STATUS FOR NON-INVASIVE TUMOR
744,gemini20,0.822,REGIONAL LYMPH NODE STATUS
745,gemini20,0.798,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
746,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
747,gemini20,0.689,SPREAD THROUGH AIR SPACES (STAS)
748,gemini20,0.754,VISCERAL PLEURA INVASION
749,gemini20,0.812,NODAL SITE(S) EXAMINED
750,gemini20,0.697,SPECIMEN LATERALITY
751,gemini20,0.703,NUMBER OF LYMPH NODES EXAMINED
752,gemini20,0.753,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
753,gemini20,0.811,TUMOR FOCALITY
754,gemini20,0.841,MARGIN STATUS FOR INVASIVE CARCINOMA
755,gemini20,0.785,HISTOLOGIC GRADE
756,gemini20,0.702,MARGIN STATUS FOR INVASIVE CARCINOMA
757,gemini20,0.694,NUMBER OF LYMPH NODES EXAMINED
758,gemini20,0.815,REGIONAL LYMPH NODE STATUS
759,gemini20,0.733,PROCEDURE
760,gemini20,0.811,TUMOR FOCALITY
761,gemini20,0.683,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
762,gemini20,0.779,NODAL SITE(S) EXAMINED
763,gemini20,0.685,SPREAD THROUGH AIR SPACES (STAS)
764,gemini20,0.697,SPECIMEN LATERALITY
765,gemini20,0.7,ADDITIONAL FINDINGS
766,gemini20,0.737,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
767,gemini20,0.717,MARGIN STATUS FOR NON-INVASIVE TUMOR
768,gemini20,0.694,VISCERAL PLEURA INVASION
769,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
770,gemini20,0.878,TUMOR SITE
771,gemini20,0.74,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
772,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
773,gemini20,0.7,VISCERAL PLEURA INVASION
774,gemini20,0.729,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
775,gemini20,0.703,NUMBER OF LYMPH NODES WITH TUMOR
776,gemini20,0.811,TUMOR FOCALITY
777,gemini20,0.703,NUMBER OF LYMPH NODES WITH TUMOR
778,gemini20,0.815,NODAL SITE(S) EXAMINED
779,gemini20,0.89,TUMOR SITE
780,gemini20,0.68,NODAL SITE(S) WITH TUMOR
781,gemini20,0.904,HISTOLOGIC GRADE
782,gemini20,0.738,PROCEDURE
783,gemini20,0.697,SPECIMEN LATERALITY
784,gemini20,0.811,REGIONAL LYMPH NODE STATUS
785,gemini20,0.69,SPREAD THROUGH AIR SPACES (STAS)
786,gemini20,0.7,NODAL SITE(S) EXAMINED
787,gemini20,0.756,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
788,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
789,gemini20,0.738,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
790,gemini20,0.692,MARGIN STATUS FOR INVASIVE CARCINOMA
791,gemini20,0.699,NUMBER OF LYMPH NODES EXAMINED
792,gemini20,0.814,HISTOLOGIC GRADE
793,gemini20,0.779,MARGIN STATUS FOR INVASIVE CARCINOMA
794,gemini20,0.785,TUMOR SITE
795,gemini20,0.759,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
796,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
797,gemini20,0.717,MARGIN STATUS FOR NON-INVASIVE TUMOR
798,gemini20,0.758,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
799,gemini20,0.811,TUMOR FOCALITY
800,gemini20,0.705,NUMBER OF LYMPH NODES EXAMINED
801,gemini20,0.771,REGIONAL LYMPH NODE STATUS
802,gemini20,0.752,NODAL SITE(S) EXAMINED
803,gemini20,0.7,NUMBER OF LYMPH NODES WITH TUMOR
804,gemini20,0.701,VISCERAL PLEURA INVASION
805,gemini20,0.697,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
806,gemini20,0.697,SPECIMEN LATERALITY
807,gemini20,0.7,PROCEDURE
808,gemini20,0.69,LYMPHOVASCULAR INVASION
809,gemini20,0.787,TUMOR SITE
810,gemini20,0.789,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
811,gemini20,0.708,LYMPHOVASCULAR INVASION
812,gemini20,0.817,NODAL SITE(S) EXAMINED
813,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
814,gemini20,0.677,SPREAD THROUGH AIR SPACES (STAS)
815,gemini20,0.717,HISTOLOGIC GRADE
816,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
817,gemini20,0.68,PROCEDURE
818,gemini20,0.697,SPECIMEN LATERALITY
819,gemini20,0.701,NUMBER OF LYMPH NODES EXAMINED
820,gemini20,0.815,REGIONAL LYMPH NODE STATUS
821,gemini20,0.729,VISCERAL PLEURA INVASION
822,gemini20,0.811,TUMOR FOCALITY
823,gemini20,0.733,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
824,gemini20,0.75,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
825,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
826,gemini20,0.73,REGIONAL LYMPH NODE STATUS
827,gemini20,0.698,SPECIMEN LATERALITY
828,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
829,gemini20,0.708,VISCERAL PLEURA INVASION
830,gemini20,0.811,TUMOR FOCALITY
831,gemini20,0.72,NUMBER OF LYMPH NODES WITH TUMOR
832,gemini20,0.778,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
833,gemini20,0.705,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
834,gemini20,0.847,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
835,gemini20,0.703,NUMBER OF LYMPH NODES EXAMINED
836,gemini20,0.788,PROCEDURE
837,gemini20,0.863,NODAL SITE(S) EXAMINED
838,gemini20,0.806,TUMOR SITE
839,gemini20,0.776,MARGIN STATUS FOR INVASIVE CARCINOMA
840,gemini20,0.874,NODAL SITE(S) WITH TUMOR
841,gemini20,0.868,NODAL SITE(S) EXAMINED
842,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
843,gemini20,0.725,ADDITIONAL FINDINGS
844,gemini20,0.815,REGIONAL LYMPH NODE STATUS
845,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
846,gemini20,0.683,TUMOR SITE
847,gemini20,0.679,HISTOLOGIC GRADE
848,gemini20,0.701,VISCERAL PLEURA INVASION
849,gemini20,0.715,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
850,gemini20,0.664,TUMOR FOCALITY
851,gemini20,0.71,PROCEDURE
852,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
853,gemini20,0.69,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
854,gemini20,0.7,NUMBER OF LYMPH NODES EXAMINED
855,gemini20,0.698,SPECIMEN LATERALITY
856,gemini20,0.826,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
857,gemini20,0.688,SPREAD THROUGH AIR SPACES (STAS)
858,gemini20,0.685,SPREAD THROUGH AIR SPACES (STAS)
859,gemini20,0.689,HISTOLOGIC GRADE
860,gemini20,0.647,LYMPHOVASCULAR INVASION
861,gemini20,0.706,NODAL SITE(S) WITH TUMOR
862,gemini20,0.69,VISCERAL PLEURA INVASION
863,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
864,gemini20,0.722,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
865,gemini20,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
866,gemini20,0.788,PROCEDURE
867,gemini20,0.725,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
868,gemini20,0.698,SPECIMEN LATERALITY
869,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
870,gemini20,0.715,NUMBER OF LYMPH NODES EXAMINED
871,gemini20,0.705,NODAL SITE(S) EXAMINED
872,gemini20,0.773,REGIONAL LYMPH NODE STATUS
873,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
874,gemini20,0.81,NUMBER OF LYMPH NODES WITH TUMOR
875,gemini20,0.704,TUMOR FOCALITY
876,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
877,gemini20,0.745,VISCERAL PLEURA INVASION
878,gemini20,0.818,NODAL SITE(S) EXAMINED
879,gemini20,0.698,SPECIMEN LATERALITY
880,gemini20,0.745,PROCEDURE
881,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
882,gemini20,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
883,gemini20,0.803,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
884,gemini20,0.904,HISTOLOGIC GRADE
885,gemini20,0.815,REGIONAL LYMPH NODE STATUS
886,gemini20,0.695,SPREAD THROUGH AIR SPACES (STAS)
887,gemini20,0.805,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
888,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
889,gemini20,0.884,TUMOR SITE
890,gemini20,0.811,TUMOR FOCALITY
891,gemini20,0.705,NUMBER OF LYMPH NODES EXAMINED
892,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
893,gemini20,0.704,PROCEDURE
894,gemini20,0.775,TUMOR FOCALITY
895,gemini20,0.697,SPECIMEN LATERALITY
896,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
897,gemini20,0.703,NUMBER OF LYMPH NODES WITH TUMOR
898,gemini20,0.732,VISCERAL PLEURA INVASION
899,gemini20,0.692,LYMPHOVASCULAR INVASION
900,gemini20,0.835,NODAL SITE(S) EXAMINED
901,gemini20,0.71,HISTOLOGIC GRADE
902,gemini20,0.67,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
903,gemini20,0.677,SPREAD THROUGH AIR SPACES (STAS)
904,gemini20,0.673,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
905,gemini20,0.709,MARGIN STATUS FOR INVASIVE CARCINOMA
906,gemini20,0.741,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
907,gemini20,0.844,NODAL SITE(S) WITH TUMOR
908,gemini20,0.78,REGIONAL LYMPH NODE STATUS
909,gemini20,0.857,TUMOR SITE
910,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
911,gemini20,0.685,SPREAD THROUGH AIR SPACES (STAS)
912,gemini20,0.691,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
913,gemini20,0.904,HISTOLOGIC GRADE
914,gemini20,0.815,REGIONAL LYMPH NODE STATUS
915,gemini20,0.74,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
916,gemini20,0.71,PROCEDURE
917,gemini20,0.697,NUMBER OF LYMPH NODES EXAMINED
918,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
919,gemini20,0.698,SPECIMEN LATERALITY
920,gemini20,0.811,TUMOR FOCALITY
921,gemini20,0.773,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
922,gemini20,0.865,NODAL SITE(S) EXAMINED
923,gemini20,0.718,MARGIN STATUS FOR INVASIVE CARCINOMA
924,gemini20,0.713,VISCERAL PLEURA INVASION
925,gemini20,0.884,TUMOR SITE
926,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
927,gemini20,0.852,NODAL SITE(S) WITH TUMOR
928,gemini20,0.838,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
929,gemini20,0.879,TUMOR SITE
930,gemini20,0.744,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
931,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
932,gemini20,0.677,SPREAD THROUGH AIR SPACES (STAS)
933,gemini20,0.713,HISTOLOGIC GRADE
934,gemini20,0.783,REGIONAL LYMPH NODE STATUS
935,gemini20,0.68,VISCERAL PLEURA INVASION
936,gemini20,0.709,LYMPHOVASCULAR INVASION
937,gemini20,0.704,NUMBER OF LYMPH NODES EXAMINED
938,gemini20,0.698,SPECIMEN LATERALITY
939,gemini20,0.687,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
940,gemini20,0.8,NODAL SITE(S) EXAMINED
941,gemini20,0.694,PROCEDURE
942,gemini20,0.733,MARGIN STATUS FOR INVASIVE CARCINOMA
943,gemini20,0.689,NUMBER OF LYMPH NODES WITH TUMOR
944,gemini20,0.704,TUMOR FOCALITY
945,gemini20,0.72,NUMBER OF LYMPH NODES WITH TUMOR
946,gemini20,0.789,TUMOR SITE
947,gemini20,0.752,NODAL SITE(S) EXAMINED
948,gemini20,0.729,MARGIN STATUS FOR INVASIVE CARCINOMA
949,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
950,gemini20,0.711,VISCERAL PLEURA INVASION
951,gemini20,0.707,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
952,gemini20,0.709,HISTOLOGIC GRADE
953,gemini20,0.715,NUMBER OF LYMPH NODES EXAMINED
954,gemini20,0.783,REGIONAL LYMPH NODE STATUS
955,gemini20,0.685,SPREAD THROUGH AIR SPACES (STAS)
956,gemini20,0.702,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
957,gemini20,0.788,PROCEDURE
958,gemini20,0.886,NODAL SITE(S) WITH TUMOR
959,gemini20,0.822,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
960,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
961,gemini20,0.697,SPECIMEN LATERALITY
962,gemini20,0.724,TUMOR FOCALITY
963,gemini20,0.719,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
964,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
965,gemini20,0.72,NUMBER OF LYMPH NODES WITH TUMOR
966,gemini20,0.712,PROCEDURE
967,gemini20,0.711,HISTOLOGIC GRADE
968,gemini20,0.751,REGIONAL LYMPH NODE STATUS
969,gemini20,0.704,NUMBER OF LYMPH NODES EXAMINED
970,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
971,gemini20,0.783,NODAL SITE(S) EXAMINED
972,gemini20,0.694,VISCERAL PLEURA INVASION
973,gemini20,0.788,MARGIN STATUS FOR INVASIVE CARCINOMA
974,gemini20,0.678,NODAL SITE(S) WITH TUMOR
975,gemini20,0.736,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
976,gemini20,0.707,TUMOR FOCALITY
977,gemini20,0.767,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
978,gemini20,0.715,TUMOR SITE
979,gemini20,0.698,SPECIMEN LATERALITY
980,gemini20,0.676,SPREAD THROUGH AIR SPACES (STAS)
981,gemini20,0.685,SPREAD THROUGH AIR SPACES (STAS)
982,gemini20,0.804,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
983,gemini20,0.698,SPECIMEN LATERALITY
984,gemini20,0.817,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
985,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
986,gemini20,0.735,NUMBER OF LYMPH NODES EXAMINED
987,gemini20,0.684,VISCERAL PLEURA INVASION
988,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
989,gemini20,0.884,TUMOR SITE
990,gemini20,0.815,REGIONAL LYMPH NODE STATUS
991,gemini20,0.814,HISTOLOGIC GRADE
992,gemini20,0.811,TUMOR FOCALITY
993,gemini20,0.709,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
994,gemini20,0.781,NODAL SITE(S) EXAMINED
995,gemini20,0.769,MARGIN STATUS FOR INVASIVE CARCINOMA
996,gemini20,0.81,PROCEDURE
997,gemini20,0.744,TUMOR FOCALITY
998,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
999,gemini20,0.717,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1000,gemini20,0.791,TUMOR SITE
1001,gemini20,0.817,NODAL SITE(S) EXAMINED
1002,gemini20,0.742,PROCEDURE
1003,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
1004,gemini20,0.732,HISTOLOGIC GRADE
1005,gemini20,0.763,MARGIN STATUS FOR INVASIVE CARCINOMA
1006,gemini20,0.697,SPECIMEN LATERALITY
1007,gemini20,0.747,REGIONAL LYMPH NODE STATUS
1008,gemini20,0.685,SPREAD THROUGH AIR SPACES (STAS)
1009,gemini20,0.761,VISCERAL PLEURA INVASION
1010,gemini20,0.712,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1011,gemini20,0.75,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1012,gemini20,0.692,LYMPHOVASCULAR INVASION
1013,gemini20,0.744,MARGIN STATUS FOR INVASIVE CARCINOMA
1014,gemini20,0.788,PROCEDURE
1015,gemini20,0.698,SPECIMEN LATERALITY
1016,gemini20,0.708,HISTOLOGIC GRADE
1017,gemini20,0.835,MARGIN STATUS FOR NON-INVASIVE TUMOR
1018,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
1019,gemini20,0.696,NUMBER OF LYMPH NODES EXAMINED
1020,gemini20,0.855,TUMOR SITE
1021,gemini20,0.696,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1022,gemini20,0.705,VISCERAL PLEURA INVASION
1023,gemini20,0.691,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1024,gemini20,0.724,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1025,gemini20,0.701,REGIONAL LYMPH NODE STATUS
1026,gemini20,0.857,ADDITIONAL FINDINGS
1027,gemini20,0.654,NODAL SITE(S) EXAMINED
1028,gemini20,0.713,TUMOR FOCALITY
1029,gemini20,0.798,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1030,gemini20,0.788,HISTOLOGIC GRADE
1031,gemini20,0.7,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1032,gemini20,0.837,TUMOR SITE
1033,gemini20,0.768,VISCERAL PLEURA INVASION
1034,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
1035,gemini20,0.815,REGIONAL LYMPH NODE STATUS
1036,gemini20,0.72,NUMBER OF LYMPH NODES EXAMINED
1037,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1038,gemini20,0.685,SPREAD THROUGH AIR SPACES (STAS)
1039,gemini20,0.811,TUMOR FOCALITY
1040,gemini20,0.926,NODAL SITE(S) EXAMINED
1041,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1042,gemini20,0.697,SPECIMEN LATERALITY
1043,gemini20,0.73,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1044,gemini20,0.748,PROCEDURE
1045,gemini20,0.805,ADDITIONAL FINDINGS
1046,gemini20,0.838,ADDITIONAL FINDINGS
1047,gemini20,0.729,PROCEDURE
1048,gemini20,0.768,VISCERAL PLEURA INVASION
1049,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1050,gemini20,0.904,HISTOLOGIC GRADE
1051,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1052,gemini20,0.822,REGIONAL LYMPH NODE STATUS
1053,gemini20,0.835,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1054,gemini20,0.697,SPECIMEN LATERALITY
1055,gemini20,0.826,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1056,gemini20,0.746,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1057,gemini20,0.882,TUMOR SITE
1058,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
1059,gemini20,0.677,SPREAD THROUGH AIR SPACES (STAS)
1060,gemini20,0.729,NODAL SITE(S) EXAMINED
1061,gemini20,0.811,TUMOR FOCALITY
1062,gemini20,0.788,PROCEDURE
1063,gemini20,0.785,TUMOR SITE
1064,gemini20,0.846,NODAL SITE(S) EXAMINED
1065,gemini20,0.685,SPREAD THROUGH AIR SPACES (STAS)
1066,gemini20,0.75,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1067,gemini20,0.698,SPECIMEN LATERALITY
1068,gemini20,0.691,VISCERAL PLEURA INVASION
1069,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
1070,gemini20,0.733,TNM DESCRIPTORS
1071,gemini20,0.733,TUMOR FOCALITY
1072,gemini20,0.781,ADDITIONAL FINDINGS
1073,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1074,gemini20,0.713,HISTOLOGIC GRADE
1075,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
1076,gemini20,0.719,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1077,gemini20,0.665,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1078,gemini20,0.822,REGIONAL LYMPH NODE STATUS
1079,gemini20,0.689,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1080,gemini20,0.699,VISCERAL PLEURA INVASION
1081,gemini20,0.779,LYMPH NODE(S) FROM PRIOR PROCEDURES
1082,gemini20,0.719,ADDITIONAL FINDINGS
1083,gemini20,0.827,PROCEDURE
1084,gemini20,0.698,SPECIMEN LATERALITY
1085,gemini20,0.77,MARGIN STATUS FOR INVASIVE CARCINOMA
1086,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
1087,gemini20,0.712,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1088,gemini20,0.669,TUMOR FOCALITY
1089,gemini20,0.691,TUMOR SITE
1090,gemini20,0.805,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1091,gemini20,0.713,HISTOLOGIC GRADE
1092,gemini20,0.694,LYMPHOVASCULAR INVASION
1093,gemini20,0.811,TUMOR FOCALITY
1094,gemini20,0.698,VISCERAL PLEURA INVASION
1095,gemini20,0.749,NODAL SITE(S) WITH TUMOR
1096,gemini20,0.685,SPREAD THROUGH AIR SPACES (STAS)
1097,gemini20,0.697,SPECIMEN LATERALITY
1098,gemini20,0.701,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1099,gemini20,0.736,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1100,gemini20,0.72,NUMBER OF LYMPH NODES WITH TUMOR
1101,gemini20,0.718,MARGIN STATUS FOR INVASIVE CARCINOMA
1102,gemini20,0.736,REGIONAL LYMPH NODE STATUS
1103,gemini20,0.826,MARGIN STATUS FOR NON-INVASIVE TUMOR
1104,gemini20,0.791,TUMOR SITE
1105,gemini20,0.685,PROCEDURE
1106,gemini20,0.738,NODAL SITE(S) EXAMINED
1107,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1108,gemini20,0.817,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1109,gemini20,0.815,REGIONAL LYMPH NODE STATUS
1110,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1111,gemini20,0.713,VISCERAL PLEURA INVASION
1112,gemini20,0.713,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1113,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
1114,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1115,gemini20,0.884,TUMOR SITE
1116,gemini20,0.755,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1117,gemini20,0.698,SPECIMEN LATERALITY
1118,gemini20,0.78,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1119,gemini20,0.904,HISTOLOGIC GRADE
1120,gemini20,0.746,NODAL SITE(S) EXAMINED
1121,gemini20,0.727,PROCEDURE
1122,gemini20,0.811,TUMOR FOCALITY
1123,gemini20,0.693,SPREAD THROUGH AIR SPACES (STAS)
1124,gemini20,0.815,REGIONAL LYMPH NODE STATUS
1125,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1126,gemini20,0.752,NODAL SITE(S) EXAMINED
1127,gemini20,0.819,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1128,gemini20,0.868,ADDITIONAL FINDINGS
1129,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1130,gemini20,0.705,SPECIMEN LATERALITY
1131,gemini20,0.887,TUMOR SITE
1132,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
1133,gemini20,0.826,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1134,gemini20,0.713,NUMBER OF LYMPH NODES EXAMINED
1135,gemini20,0.769,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1136,gemini20,0.761,VISCERAL PLEURA INVASION
1137,gemini20,0.9,HISTOLOGIC GRADE
1138,gemini20,0.718,PROCEDURE
1139,gemini20,0.697,SPECIMEN LATERALITY
1140,gemini20,0.811,TUMOR FOCALITY
1141,gemini20,0.769,HISTOLOGIC GRADE
1142,gemini20,0.715,PROCEDURE
1143,gemini20,0.726,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1144,gemini20,0.878,TUMOR SITE
1145,gemini20,0.767,MARGIN STATUS FOR INVASIVE CARCINOMA
1146,gemini20,0.77,NODAL SITE(S) EXAMINED
1147,gemini20,0.7,TUMOR FOCALITY
1148,gemini20,0.697,SPECIMEN LATERALITY
1149,gemini20,0.739,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1150,gemini20,0.698,ADDITIONAL FINDINGS
1151,gemini20,0.826,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1152,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
1153,gemini20,0.766,REGIONAL LYMPH NODE STATUS
1154,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1155,gemini20,0.687,VISCERAL PLEURA INVASION
1156,gemini20,0.738,REGIONAL LYMPH NODE STATUS
1157,gemini20,0.652,HISTOLOGIC GRADE
1158,gemini20,0.839,NODAL SITE(S) EXAMINED
1159,gemini20,0.721,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1160,gemini20,0.776,PROCEDURE
1161,gemini20,0.697,NUMBER OF LYMPH NODES EXAMINED
1162,gemini20,0.785,ADDITIONAL FINDINGS
1163,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1164,gemini20,0.776,TUMOR SITE
1165,gemini20,0.714,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1166,gemini20,0.702,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1167,gemini20,0.669,VISCERAL PLEURA INVASION
1168,gemini20,0.772,MARGIN STATUS FOR INVASIVE CARCINOMA
1169,gemini20,0.685,SPREAD THROUGH AIR SPACES (STAS)
1170,gemini20,0.671,TUMOR FOCALITY
1171,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
1172,gemini20,0.697,SPECIMEN LATERALITY
1173,gemini20,0.686,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1174,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
1175,gemini20,0.715,NUMBER OF LYMPH NODES WITH TUMOR
1176,gemini20,0.707,HISTOLOGIC GRADE
1177,gemini20,0.671,NODAL SITE(S) WITH TUMOR
1178,gemini20,0.752,MARGIN STATUS FOR INVASIVE CARCINOMA
1179,gemini20,0.73,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1180,gemini20,0.697,SPECIMEN LATERALITY
1181,gemini20,0.705,MARGIN STATUS FOR NON-INVASIVE TUMOR
1182,gemini20,0.697,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1183,gemini20,0.723,TUMOR SITE
1184,gemini20,0.78,SPREAD THROUGH AIR SPACES (STAS)
1185,gemini20,0.661,NODAL SITE(S) EXAMINED
1186,gemini20,0.723,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1187,gemini20,0.675,TUMOR FOCALITY
1188,gemini20,0.788,PROCEDURE
1189,gemini20,0.729,LYMPHOVASCULAR INVASION
1190,gemini20,0.718,REGIONAL LYMPH NODE STATUS
1191,gemini20,0.707,NUMBER OF LYMPH NODES EXAMINED
1192,gemini20,0.771,NODAL SITE(S) EXAMINED
1193,gemini20,0.884,TUMOR SITE
1194,gemini20,0.701,NUMBER OF LYMPH NODES EXAMINED
1195,gemini20,0.749,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1196,gemini20,0.713,HISTOLOGIC GRADE
1197,gemini20,0.68,LYMPHOVASCULAR INVASION
1198,gemini20,0.685,SPREAD THROUGH AIR SPACES (STAS)
1199,gemini20,0.724,VISCERAL PLEURA INVASION
1200,gemini20,0.742,ADDITIONAL FINDINGS
1201,gemini20,0.737,MARGIN STATUS FOR INVASIVE CARCINOMA
1202,gemini20,0.698,SPECIMEN LATERALITY
1203,gemini20,0.811,TUMOR FOCALITY
1204,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
1205,gemini20,0.815,REGIONAL LYMPH NODE STATUS
1206,gemini20,0.729,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1207,gemini20,0.735,PROCEDURE
1208,gemini20,0.784,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1209,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
1210,gemini20,0.814,HISTOLOGIC GRADE
1211,gemini20,0.826,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1212,gemini20,0.797,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1213,gemini20,0.697,SPECIMEN LATERALITY
1214,gemini20,0.757,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1215,gemini20,0.772,MARGIN STATUS FOR INVASIVE CARCINOMA
1216,gemini20,0.896,TUMOR SITE
1217,gemini20,0.714,VISCERAL PLEURA INVASION
1218,gemini20,0.71,NUMBER OF LYMPH NODES EXAMINED
1219,gemini20,0.765,ADDITIONAL FINDINGS
1220,gemini20,0.751,PROCEDURE
1221,gemini20,0.811,TUMOR FOCALITY
1222,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1223,gemini20,0.685,SPREAD THROUGH AIR SPACES (STAS)
1224,gemini20,0.747,NODAL SITE(S) EXAMINED
1225,gemini20,0.815,REGIONAL LYMPH NODE STATUS
1226,gemini20,0.735,ADDITIONAL FINDINGS
1227,gemini20,0.72,HISTOLOGIC GRADE
1228,gemini20,0.693,SPREAD THROUGH AIR SPACES (STAS)
1229,gemini20,0.811,MARGIN STATUS FOR INVASIVE CARCINOMA
1230,gemini20,0.805,NODAL SITE(S) EXAMINED
1231,gemini20,0.701,NUMBER OF LYMPH NODES EXAMINED
1232,gemini20,0.731,VISCERAL PLEURA INVASION
1233,gemini20,0.896,TUMOR SITE
1234,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
1235,gemini20,0.672,TUMOR FOCALITY
1236,gemini20,0.815,REGIONAL LYMPH NODE STATUS
1237,gemini20,0.698,SPECIMEN LATERALITY
1238,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1239,gemini20,0.739,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1240,gemini20,0.705,PROCEDURE
1241,gemini20,0.816,ADDITIONAL FINDINGS
1242,gemini20,0.712,NUMBER OF LYMPH NODES EXAMINED
1243,gemini20,0.815,REGIONAL LYMPH NODE STATUS
1244,gemini20,0.697,SPECIMEN LATERALITY
1245,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
1246,gemini20,0.738,PROCEDURE
1247,gemini20,0.75,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1248,gemini20,0.803,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1249,gemini20,0.728,VISCERAL PLEURA INVASION
1250,gemini20,0.766,HISTOLOGIC GRADE
1251,gemini20,0.838,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1252,gemini20,0.692,MARGIN STATUS FOR INVASIVE CARCINOMA
1253,gemini20,0.694,SPREAD THROUGH AIR SPACES (STAS)
1254,gemini20,0.837,TUMOR SITE
1255,gemini20,0.886,NODAL SITE(S) EXAMINED
1256,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1257,gemini20,0.811,TUMOR FOCALITY
1258,gemini20,0.694,MARGIN STATUS FOR NON-INVASIVE TUMOR
1259,gemini20,0.759,MARGIN STATUS FOR INVASIVE CARCINOMA
1260,gemini20,0.705,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1261,gemini20,0.764,HISTOLOGIC GRADE
1262,gemini20,0.805,ADDITIONAL FINDINGS
1263,gemini20,0.682,SPREAD THROUGH AIR SPACES (STAS)
1264,gemini20,0.697,NODAL SITE(S) EXAMINED
1265,gemini20,0.822,REGIONAL LYMPH NODE STATUS
1266,gemini20,0.69,PROCEDURE
1267,gemini20,0.72,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1268,gemini20,0.697,SPECIMEN LATERALITY
1269,gemini20,0.887,TUMOR SITE
1270,gemini20,0.667,VISCERAL PLEURA INVASION
1271,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1272,gemini20,0.78,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1273,gemini20,0.697,TUMOR FOCALITY
1274,gemini20,0.772,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1275,gemini20,0.699,TNM DESCRIPTORS
1276,gemini20,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1277,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1278,gemini20,0.735,NODAL SITE(S) EXAMINED
1279,gemini20,0.678,TUMOR FOCALITY
1280,gemini20,0.827,PROCEDURE
1281,gemini20,0.89,TUMOR SITE
1282,gemini20,0.681,MARGIN STATUS FOR INVASIVE CARCINOMA
1283,gemini20,0.769,REGIONAL LYMPH NODE STATUS
1284,gemini20,0.722,HISTOLOGIC GRADE
1285,gemini20,0.736,VISCERAL PLEURA INVASION
1286,gemini20,0.713,NUMBER OF LYMPH NODES EXAMINED
1287,gemini20,0.697,SPECIMEN LATERALITY
1288,gemini20,0.685,SPREAD THROUGH AIR SPACES (STAS)
1289,gemini20,0.783,NODAL SITE(S) EXAMINED
1290,gemini20,0.685,VISCERAL PLEURA INVASION
1291,gemini20,0.766,HISTOLOGIC GRADE
1292,gemini20,0.692,NUMBER OF LYMPH NODES EXAMINED
1293,gemini20,0.711,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1294,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
1295,gemini20,0.783,REGIONAL LYMPH NODE STATUS
1296,gemini20,0.849,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1297,gemini20,0.685,SPREAD THROUGH AIR SPACES (STAS)
1298,gemini20,0.702,MARGIN STATUS FOR INVASIVE CARCINOMA
1299,gemini20,0.713,NUMBER OF LYMPH NODES WITH TUMOR
1300,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1301,gemini20,0.811,TUMOR FOCALITY
1302,gemini20,0.765,PROCEDURE
1303,gemini20,0.697,SPECIMEN LATERALITY
1304,gemini20,0.878,TUMOR SITE
1305,gemini20,0.722,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1306,gemini20,0.857,NODAL SITE(S) EXAMINED
1307,gemini20,0.784,TUMOR SITE
1308,gemini20,0.693,ADDITIONAL FINDINGS
1309,gemini20,0.709,TUMOR FOCALITY
1310,gemini20,0.755,PROCEDURE
1311,gemini20,0.684,SPREAD THROUGH AIR SPACES (STAS)
1312,gemini20,0.705,VISCERAL PLEURA INVASION
1313,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
1314,gemini20,0.709,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1315,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
1316,gemini20,0.92,HISTOLOGIC GRADE
1317,gemini20,0.739,MARGIN STATUS FOR INVASIVE CARCINOMA
1318,gemini20,0.815,REGIONAL LYMPH NODE STATUS
1319,gemini20,0.713,NUMBER OF LYMPH NODES EXAMINED
1320,gemini20,0.698,SPECIMEN LATERALITY
1321,gemini20,0.732,VISCERAL PLEURA INVASION
1322,gemini20,0.882,TUMOR SITE
1323,gemini20,0.757,MARGIN STATUS FOR INVASIVE CARCINOMA
1324,gemini20,0.697,SPREAD THROUGH AIR SPACES (STAS)
1325,gemini20,0.711,PROCEDURE
1326,gemini20,0.697,SPECIMEN LATERALITY
1327,gemini20,0.826,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1328,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1329,gemini20,0.904,HISTOLOGIC GRADE
1330,gemini20,0.811,TUMOR FOCALITY
1331,gemini20,0.803,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1332,gemini20,0.789,NODAL SITE(S) EXAMINED
1333,gemini20,0.705,MARGIN STATUS FOR NON-INVASIVE TUMOR
1334,gemini20,0.752,REGIONAL LYMPH NODE STATUS
1335,gemini20,0.764,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1336,gemini20,0.684,ADDITIONAL FINDINGS
1337,gemini20,0.674,NODAL SITE(S) EXAMINED
1338,gemini20,0.689,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1339,gemini20,0.815,REGIONAL LYMPH NODE STATUS
1340,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1341,gemini20,0.695,VISCERAL PLEURA INVASION
1342,gemini20,0.713,NUMBER OF LYMPH NODES EXAMINED
1343,gemini20,0.827,PROCEDURE
1344,gemini20,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1345,gemini20,0.882,TUMOR SITE
1346,gemini20,0.697,SPECIMEN LATERALITY
1347,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
1348,gemini20,0.784,HISTOLOGIC GRADE
1349,gemini20,0.803,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1350,gemini20,0.713,TUMOR FOCALITY
1351,gemini20,0.768,MARGIN STATUS FOR INVASIVE CARCINOMA
1352,gemini20,0.703,TNM DESCRIPTORS
1353,gemini20,0.817,REGIONAL LYMPH NODE STATUS
1354,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1355,gemini20,0.693,MARGIN STATUS FOR INVASIVE CARCINOMA
1356,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
1357,gemini20,0.762,NODAL SITE(S) EXAMINED
1358,gemini20,0.806,PROCEDURE
1359,gemini20,0.712,NUMBER OF LYMPH NODES EXAMINED
1360,gemini20,0.764,TUMOR FOCALITY
1361,gemini20,0.648,VISCERAL PLEURA INVASION
1362,gemini20,0.697,SPECIMEN LATERALITY
1363,gemini20,0.689,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1364,gemini20,0.671,TUMOR SITE
1365,gemini20,0.717,HISTOLOGIC GRADE
1366,gemini20,0.757,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1367,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
1368,gemini20,0.791,NODAL SITE(S) EXAMINED
1369,gemini20,0.811,TUMOR FOCALITY
1370,gemini20,0.712,NUMBER OF LYMPH NODES EXAMINED
1371,gemini20,0.876,TUMOR SITE
1372,gemini20,0.728,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1373,gemini20,0.697,VISCERAL PLEURA INVASION
1374,gemini20,0.756,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1375,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1376,gemini20,0.735,PROCEDURE
1377,gemini20,0.745,REGIONAL LYMPH NODE STATUS
1378,gemini20,0.697,SPECIMEN LATERALITY
1379,gemini20,0.697,SPECIMEN LATERALITY
1380,gemini20,0.686,TUMOR SITE
1381,gemini20,0.702,TNM DESCRIPTORS
1382,gemini20,0.709,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1383,gemini20,0.72,PROCEDURE
1384,gemini20,0.72,LYMPHOVASCULAR INVASION
1385,gemini20,0.779,LYMPH NODE(S) FROM PRIOR PROCEDURES
1386,gemini20,0.694,TUMOR FOCALITY
1387,gemini20,0.707,VISCERAL PLEURA INVASION
1388,gemini20,0.72,MARGIN STATUS FOR INVASIVE CARCINOMA
1389,gemini20,0.663,MARGIN STATUS FOR NON-INVASIVE TUMOR
1390,gemini20,0.708,HISTOLOGIC GRADE
1391,gemini20,0.717,MARGIN STATUS FOR NON-INVASIVE TUMOR
1392,gemini20,0.783,REGIONAL LYMPH NODE STATUS
1393,gemini20,0.699,SPREAD THROUGH AIR SPACES (STAS)
1394,gemini20,0.697,NODAL SITE(S) EXAMINED
1395,gemini20,0.699,NUMBER OF LYMPH NODES WITH TUMOR
1396,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1397,gemini20,0.726,PROCEDURE
1398,gemini20,0.747,NUMBER OF LYMPH NODES EXAMINED
1399,gemini20,0.746,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1400,gemini20,0.811,TUMOR FOCALITY
1401,gemini20,0.748,ADDITIONAL FINDINGS
1402,gemini20,0.693,MARGIN STATUS FOR INVASIVE CARCINOMA
1403,gemini20,0.865,NODAL SITE(S) WITH TUMOR
1404,gemini20,0.749,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1405,gemini20,0.687,VISCERAL PLEURA INVASION
1406,gemini20,0.698,SPECIMEN LATERALITY
1407,gemini20,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1408,gemini20,0.879,TUMOR SITE
1409,gemini20,0.746,PROCEDURE
1410,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
1411,gemini20,0.896,TUMOR SITE
1412,gemini20,0.778,SPREAD THROUGH AIR SPACES (STAS)
1413,gemini20,0.751,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1414,gemini20,0.801,MARGIN STATUS FOR INVASIVE CARCINOMA
1415,gemini20,0.696,NUMBER OF LYMPH NODES EXAMINED
1416,gemini20,0.893,ADDITIONAL FINDINGS
1417,gemini20,0.767,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1418,gemini20,0.723,HISTOLOGIC GRADE
1419,gemini20,0.859,NODAL SITE(S) EXAMINED
1420,gemini20,0.815,REGIONAL LYMPH NODE STATUS
1421,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
1422,gemini20,0.697,SPECIMEN LATERALITY
1423,gemini20,0.735,VISCERAL PLEURA INVASION
1424,gemini20,0.78,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1425,gemini20,0.811,TUMOR FOCALITY
1426,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1427,gemini20,0.746,MARGIN STATUS FOR NON-INVASIVE TUMOR
1428,gemini20,0.798,NODAL SITE(S) EXAMINED
1429,gemini20,0.691,SPREAD THROUGH AIR SPACES (STAS)
1430,gemini20,0.826,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1431,gemini20,0.719,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1432,gemini20,0.701,TNM DESCRIPTORS
1433,gemini20,0.807,ADDITIONAL FINDINGS
1434,gemini20,0.701,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1435,gemini20,0.788,PROCEDURE
1436,gemini20,0.815,REGIONAL LYMPH NODE STATUS
1437,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1438,gemini20,0.723,HISTOLOGIC GRADE
1439,gemini20,0.697,SPECIMEN LATERALITY
1440,gemini20,0.791,TUMOR SITE
1441,gemini20,0.721,VISCERAL PLEURA INVASION
1442,gemini20,0.707,TUMOR FOCALITY
1443,gemini20,0.783,REGIONAL LYMPH NODE STATUS
1444,gemini20,0.734,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1445,gemini20,0.78,VISCERAL PLEURA INVASION
1446,gemini20,0.938,ADDITIONAL FINDINGS
1447,gemini20,0.698,SPECIMEN LATERALITY
1448,gemini20,0.709,LYMPHOVASCULAR INVASION
1449,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1450,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1451,gemini20,0.872,NODAL SITE(S) WITH TUMOR
1452,gemini20,0.719,PROCEDURE
1453,gemini20,0.89,TUMOR SITE
1454,gemini20,0.73,NODAL SITE(S) EXAMINED
1455,gemini20,0.755,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1456,gemini20,0.689,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1457,gemini20,0.691,SPREAD THROUGH AIR SPACES (STAS)
1458,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
1459,gemini20,0.698,NUMBER OF LYMPH NODES EXAMINED
1460,gemini20,0.713,NUMBER OF LYMPH NODES WITH TUMOR
1461,gemini20,0.811,TUMOR FOCALITY
1462,gemini20,0.884,TUMOR SITE
1463,gemini20,0.8,NODAL SITE(S) EXAMINED
1464,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
1465,gemini20,0.711,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1466,gemini20,0.706,HISTOLOGIC GRADE
1467,gemini20,0.784,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1468,gemini20,0.815,REGIONAL LYMPH NODE STATUS
1469,gemini20,0.698,SPECIMEN LATERALITY
1470,gemini20,0.811,TUMOR FOCALITY
1471,gemini20,0.688,VISCERAL PLEURA INVASION
1472,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1473,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
1474,gemini20,0.678,ADDITIONAL FINDINGS
1475,gemini20,0.722,PROCEDURE
1476,gemini20,0.743,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1477,gemini20,0.703,LYMPHOVASCULAR INVASION
1478,gemini20,0.685,SPREAD THROUGH AIR SPACES (STAS)
1479,gemini20,0.822,REGIONAL LYMPH NODE STATUS
1480,gemini20,0.678,TUMOR FOCALITY
1481,gemini20,0.735,ADDITIONAL FINDINGS
1482,gemini20,0.707,VISCERAL PLEURA INVASION
1483,gemini20,0.745,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1484,gemini20,0.726,PROCEDURE
1485,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1486,gemini20,0.697,SPECIMEN LATERALITY
1487,gemini20,0.792,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1488,gemini20,0.858,TUMOR SITE
1489,gemini20,0.773,NODAL SITE(S) EXAMINED
1490,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
1491,gemini20,0.826,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1492,gemini20,0.693,NUMBER OF LYMPH NODES EXAMINED
1493,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1494,gemini20,0.707,LYMPHOVASCULAR INVASION
1495,gemini20,0.801,MARGIN STATUS FOR INVASIVE CARCINOMA
1496,gemini20,0.72,NUMBER OF LYMPH NODES WITH TUMOR
1497,gemini20,0.783,REGIONAL LYMPH NODE STATUS
1498,gemini20,0.667,HISTOLOGIC GRADE
1499,gemini20,0.803,NODAL SITE(S) WITH TUMOR
1500,gemini20,0.875,ADDITIONAL FINDINGS
1501,gemini20,0.788,NODAL SITE(S) EXAMINED
1502,gemini20,0.641,VISCERAL PLEURA INVASION
1503,gemini20,0.697,SPECIMEN LATERALITY
1504,gemini20,0.689,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1505,gemini20,0.687,SPREAD THROUGH AIR SPACES (STAS)
1506,gemini20,0.662,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1507,gemini20,0.801,PROCEDURE
1508,gemini20,0.754,TUMOR SITE
1509,gemini20,0.693,TUMOR FOCALITY
1510,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
1511,gemini20,0.689,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1512,gemini20,0.688,TNM DESCRIPTORS
1513,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1514,gemini20,0.727,HISTOLOGIC GRADE
1515,gemini20,0.759,NODAL SITE(S) EXAMINED
1516,gemini20,0.811,TUMOR FOCALITY
1517,gemini20,0.715,LYMPHOVASCULAR INVASION
1518,gemini20,0.69,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1519,gemini20,0.669,VISCERAL PLEURA INVASION
1520,gemini20,0.804,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1521,gemini20,0.704,PROCEDURE
1522,gemini20,0.795,MARGIN STATUS FOR INVASIVE CARCINOMA
1523,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1524,gemini20,0.697,SPECIMEN LATERALITY
1525,gemini20,0.697,SPREAD THROUGH AIR SPACES (STAS)
1526,gemini20,0.791,TUMOR SITE
1527,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
1528,gemini20,0.735,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1529,gemini20,0.74,REGIONAL LYMPH NODE STATUS
1530,gemini20,0.697,SPECIMEN LATERALITY
1531,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
1532,gemini20,0.709,MARGIN STATUS FOR INVASIVE CARCINOMA
1533,gemini20,0.77,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1534,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
1535,gemini20,0.938,ADDITIONAL FINDINGS
1536,gemini20,0.802,NODAL SITE(S) EXAMINED
1537,gemini20,0.811,TUMOR FOCALITY
1538,gemini20,0.763,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1539,gemini20,0.815,REGIONAL LYMPH NODE STATUS
1540,gemini20,0.704,VISCERAL PLEURA INVASION
1541,gemini20,0.726,HISTOLOGIC GRADE
1542,gemini20,0.707,PROCEDURE
1543,gemini20,0.685,SPREAD THROUGH AIR SPACES (STAS)
1544,gemini20,0.746,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1545,gemini20,0.791,TUMOR SITE
1546,gemini20,0.676,SPREAD THROUGH AIR SPACES (STAS)
1547,gemini20,0.811,TUMOR FOCALITY
1548,gemini20,0.753,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1549,gemini20,0.686,TNM DESCRIPTORS
1550,gemini20,0.668,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1551,gemini20,0.787,TUMOR SITE
1552,gemini20,0.689,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1553,gemini20,0.882,ADDITIONAL FINDINGS
1554,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1555,gemini20,0.693,NUMBER OF LYMPH NODES EXAMINED
1556,gemini20,0.708,VISCERAL PLEURA INVASION
1557,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
1558,gemini20,0.815,REGIONAL LYMPH NODE STATUS
1559,gemini20,0.714,HISTOLOGIC GRADE
1560,gemini20,0.766,NODAL SITE(S) EXAMINED
1561,gemini20,0.744,MARGIN STATUS FOR NON-INVASIVE TUMOR
1562,gemini20,0.697,SPECIMEN LATERALITY
1563,gemini20,0.718,PROCEDURE
1564,gemini20,0.736,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1565,gemini20,0.781,NODAL SITE(S) EXAMINED
1566,gemini20,0.738,REGIONAL LYMPH NODE STATUS
1567,gemini20,0.698,SPECIMEN LATERALITY
1568,gemini20,0.701,SPREAD THROUGH AIR SPACES (STAS)
1569,gemini20,0.811,TUMOR FOCALITY
1570,gemini20,0.681,HISTOLOGIC GRADE
1571,gemini20,0.722,PROCEDURE
1572,gemini20,0.742,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1573,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1574,gemini20,0.842,ADDITIONAL FINDINGS
1575,gemini20,0.793,TUMOR SITE
1576,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
1577,gemini20,0.682,VISCERAL PLEURA INVASION
1578,gemini20,0.835,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1579,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1580,gemini20,0.706,NUMBER OF LYMPH NODES EXAMINED
1581,gemini20,0.698,SPECIMEN LATERALITY
1582,gemini20,0.681,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1583,gemini20,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1584,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1585,gemini20,0.884,TUMOR SITE
1586,gemini20,0.771,NODAL SITE(S) EXAMINED
1587,gemini20,0.688,VISCERAL PLEURA INVASION
1588,gemini20,0.815,REGIONAL LYMPH NODE STATUS
1589,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
1590,gemini20,0.775,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1591,gemini20,0.689,SPREAD THROUGH AIR SPACES (STAS)
1592,gemini20,0.811,TUMOR FOCALITY
1593,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1594,gemini20,0.727,HISTOLOGIC GRADE
1595,gemini20,0.704,PROCEDURE
1596,gemini20,0.815,REGIONAL LYMPH NODE STATUS
1597,gemini20,0.738,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1598,gemini20,0.732,VISCERAL PLEURA INVASION
1599,gemini20,0.697,LYMPHOVASCULAR INVASION
1600,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1601,gemini20,0.711,PROCEDURE
1602,gemini20,0.783,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1603,gemini20,0.689,HISTOLOGIC GRADE
1604,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
1605,gemini20,0.698,TNM DESCRIPTORS
1606,gemini20,0.698,SPECIMEN LATERALITY
1607,gemini20,0.722,NODAL SITE(S) EXAMINED
1608,gemini20,0.706,TUMOR FOCALITY
1609,gemini20,0.714,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1610,gemini20,0.89,TUMOR SITE
1611,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
1612,gemini20,0.843,ADDITIONAL FINDINGS
1613,gemini20,0.718,LYMPHOVASCULAR INVASION
1614,gemini20,0.751,PROCEDURE
1615,gemini20,0.879,TUMOR SITE
1616,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
1617,gemini20,0.734,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1618,gemini20,0.735,TNM DESCRIPTORS
1619,gemini20,0.746,MARGIN STATUS FOR INVASIVE CARCINOMA
1620,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1621,gemini20,0.681,NODAL SITE(S) WITH TUMOR
1622,gemini20,0.698,SPECIMEN LATERALITY
1623,gemini20,0.688,VISCERAL PLEURA INVASION
1624,gemini20,0.784,NODAL SITE(S) EXAMINED
1625,gemini20,0.692,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1626,gemini20,0.703,HISTOLOGIC GRADE
1627,gemini20,0.78,REGIONAL LYMPH NODE STATUS
1628,gemini20,0.72,NUMBER OF LYMPH NODES WITH TUMOR
1629,gemini20,0.777,NUMBER OF LYMPH NODES EXAMINED
1630,gemini20,0.75,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1631,gemini20,0.713,TUMOR FOCALITY
1632,gemini20,0.722,TUMOR SITE
1633,gemini20,0.746,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1634,gemini20,0.72,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1635,gemini20,0.694,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1636,gemini20,0.808,NODAL SITE(S) EXAMINED
1637,gemini20,0.722,VISCERAL PLEURA INVASION
1638,gemini20,0.896,MARGIN STATUS FOR INVASIVE CARCINOMA
1639,gemini20,0.846,ADDITIONAL FINDINGS
1640,gemini20,0.716,PROCEDURE
1641,gemini20,0.697,SPECIMEN LATERALITY
1642,gemini20,0.694,MARGIN STATUS FOR NON-INVASIVE TUMOR
1643,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1644,gemini20,0.815,REGIONAL LYMPH NODE STATUS
1645,gemini20,0.811,TUMOR FOCALITY
1646,gemini20,0.712,NUMBER OF LYMPH NODES EXAMINED
1647,gemini20,0.691,SPREAD THROUGH AIR SPACES (STAS)
1648,gemini20,0.788,HISTOLOGIC GRADE
1649,gemini20,0.815,REGIONAL LYMPH NODE STATUS
1650,gemini20,0.717,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1651,gemini20,0.83,TUMOR SITE
1652,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1653,gemini20,0.768,VISCERAL PLEURA INVASION
1654,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1655,gemini20,0.716,NUMBER OF LYMPH NODES EXAMINED
1656,gemini20,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1657,gemini20,0.725,PROCEDURE
1658,gemini20,0.698,SPECIMEN LATERALITY
1659,gemini20,0.932,MARGIN STATUS FOR NON-INVASIVE TUMOR
1660,gemini20,0.798,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1661,gemini20,0.811,TUMOR FOCALITY
1662,gemini20,0.716,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1663,gemini20,0.71,PROCEDURE
1664,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
1665,gemini20,0.783,REGIONAL LYMPH NODE STATUS
1666,gemini20,0.882,TUMOR SITE
1667,gemini20,0.695,NODAL SITE(S) WITH TUMOR
1668,gemini20,0.712,NUMBER OF LYMPH NODES WITH TUMOR
1669,gemini20,0.723,HISTOLOGIC GRADE
1670,gemini20,0.732,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1671,gemini20,0.691,VISCERAL PLEURA INVASION
1672,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1673,gemini20,0.765,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1674,gemini20,0.753,LYMPHOVASCULAR INVASION
1675,gemini20,0.867,NODAL SITE(S) EXAMINED
1676,gemini20,0.794,ADDITIONAL FINDINGS
1677,gemini20,0.697,SPECIMEN LATERALITY
1678,gemini20,0.768,NUMBER OF LYMPH NODES EXAMINED
1679,gemini20,0.811,TUMOR FOCALITY
1680,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1681,gemini20,0.737,MARGIN STATUS FOR INVASIVE CARCINOMA
1682,gemini20,0.771,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1683,gemini20,0.697,SPECIMEN LATERALITY
1684,gemini20,0.818,NODAL SITE(S) EXAMINED
1685,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
1686,gemini20,0.787,TUMOR SITE
1687,gemini20,0.764,ADDITIONAL FINDINGS
1688,gemini20,0.736,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1689,gemini20,0.737,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1690,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1691,gemini20,0.815,REGIONAL LYMPH NODE STATUS
1692,gemini20,0.731,HISTOLOGIC GRADE
1693,gemini20,0.811,TUMOR FOCALITY
1694,gemini20,0.681,SPREAD THROUGH AIR SPACES (STAS)
1695,gemini20,0.694,PROCEDURE
1696,gemini20,0.687,VISCERAL PLEURA INVASION
1697,gemini20,0.697,NUMBER OF LYMPH NODES EXAMINED
1698,gemini20,0.815,REGIONAL LYMPH NODE STATUS
1699,gemini20,0.788,HISTOLOGIC GRADE
1700,gemini20,0.791,NODAL SITE(S) EXAMINED
1701,gemini20,0.781,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1702,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1703,gemini20,0.723,TUMOR FOCALITY
1704,gemini20,0.723,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1705,gemini20,0.789,TUMOR SITE
1706,gemini20,0.739,VISCERAL PLEURA INVASION
1707,gemini20,0.709,PROCEDURE
1708,gemini20,0.702,LYMPHOVASCULAR INVASION
1709,gemini20,0.697,SPECIMEN LATERALITY
1710,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
1711,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
1712,gemini20,0.736,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1713,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1714,gemini20,0.787,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1715,gemini20,0.706,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1716,gemini20,0.811,TUMOR FOCALITY
1717,gemini20,0.846,NODAL SITE(S) EXAMINED
1718,gemini20,0.87,TUMOR SITE
1719,gemini20,0.892,HISTOLOGIC GRADE
1720,gemini20,0.819,ADDITIONAL FINDINGS
1721,gemini20,0.752,PROCEDURE
1722,gemini20,0.815,REGIONAL LYMPH NODE STATUS
1723,gemini20,0.689,SPREAD THROUGH AIR SPACES (STAS)
1724,gemini20,0.697,SPECIMEN LATERALITY
1725,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1726,gemini20,0.685,VISCERAL PLEURA INVASION
1727,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
1728,gemini20,0.795,NODAL SITE(S) EXAMINED
1729,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1730,gemini20,0.746,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1731,gemini20,0.772,PROCEDURE
1732,gemini20,0.723,VISCERAL PLEURA INVASION
1733,gemini20,0.68,HISTOLOGIC GRADE
1734,gemini20,0.714,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1735,gemini20,0.811,TUMOR FOCALITY
1736,gemini20,0.698,SPECIMEN LATERALITY
1737,gemini20,0.691,SPREAD THROUGH AIR SPACES (STAS)
1738,gemini20,0.815,REGIONAL LYMPH NODE STATUS
1739,gemini20,0.879,TUMOR SITE
1740,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
1741,gemini20,0.708,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1742,gemini20,0.708,HISTOLOGIC GRADE
1743,gemini20,0.763,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1744,gemini20,0.693,NUMBER OF LYMPH NODES EXAMINED
1745,gemini20,0.697,SPECIMEN LATERALITY
1746,gemini20,0.719,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1747,gemini20,0.754,PROCEDURE
1748,gemini20,0.773,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1749,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1750,gemini20,0.89,TUMOR SITE
1751,gemini20,0.744,NODAL SITE(S) EXAMINED
1752,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1753,gemini20,0.811,TUMOR FOCALITY
1754,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
1755,gemini20,0.684,VISCERAL PLEURA INVASION
1756,gemini20,0.815,REGIONAL LYMPH NODE STATUS
1757,gemini20,0.689,SPREAD THROUGH AIR SPACES (STAS)
1758,gemini20,0.764,VISCERAL PLEURA INVASION
1759,gemini20,0.697,SPECIMEN LATERALITY
1760,gemini20,0.679,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1761,gemini20,0.748,NUMBER OF LYMPH NODES EXAMINED
1762,gemini20,0.793,TUMOR SITE
1763,gemini20,0.829,REGIONAL LYMPH NODE STATUS
1764,gemini20,0.805,PROCEDURE
1765,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1766,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
1767,gemini20,0.805,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1768,gemini20,0.811,TUMOR FOCALITY
1769,gemini20,0.788,MARGIN STATUS FOR INVASIVE CARCINOMA
1770,gemini20,0.694,HISTOLOGIC GRADE
1771,gemini20,0.787,NODAL SITE(S) EXAMINED
1772,gemini20,0.752,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1773,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
1774,gemini20,0.716,LYMPHOVASCULAR INVASION
1775,gemini20,0.754,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1776,gemini20,0.71,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1777,gemini20,0.815,REGIONAL LYMPH NODE STATUS
1778,gemini20,0.723,HISTOLOGIC GRADE
1779,gemini20,0.811,NODAL SITE(S) EXAMINED
1780,gemini20,0.705,VISCERAL PLEURA INVASION
1781,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1782,gemini20,0.697,SPECIMEN LATERALITY
1783,gemini20,0.735,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1784,gemini20,0.679,TUMOR FOCALITY
1785,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
1786,gemini20,0.677,PROCEDURE
1787,gemini20,0.699,SPREAD THROUGH AIR SPACES (STAS)
1788,gemini20,0.791,TUMOR SITE
1789,gemini20,0.811,TUMOR FOCALITY
1790,gemini20,0.81,TUMOR SITE
1791,gemini20,0.697,SPECIMEN LATERALITY
1792,gemini20,0.755,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1793,gemini20,0.896,MARGIN STATUS FOR INVASIVE CARCINOMA
1794,gemini20,0.829,REGIONAL LYMPH NODE STATUS
1795,gemini20,0.742,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1796,gemini20,0.751,PROCEDURE
1797,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1798,gemini20,0.685,SPREAD THROUGH AIR SPACES (STAS)
1799,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
1800,gemini20,0.707,VISCERAL PLEURA INVASION
1801,gemini20,0.834,NODAL SITE(S) EXAMINED
1802,gemini20,0.76,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1803,gemini20,0.693,HISTOLOGIC GRADE
1804,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1805,gemini20,0.689,VISCERAL PLEURA INVASION
1806,gemini20,0.811,TUMOR FOCALITY
1807,gemini20,0.814,HISTOLOGIC GRADE
1808,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
1809,gemini20,0.719,PROCEDURE
1810,gemini20,0.698,SPECIMEN LATERALITY
1811,gemini20,0.832,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1812,gemini20,0.772,MARGIN STATUS FOR INVASIVE CARCINOMA
1813,gemini20,0.703,NUMBER OF LYMPH NODES EXAMINED
1814,gemini20,0.755,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1815,gemini20,0.83,TUMOR SITE
1816,gemini20,0.815,REGIONAL LYMPH NODE STATUS
1817,gemini20,0.813,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1818,gemini20,0.691,NODAL SITE(S) EXAMINED
1819,gemini20,0.749,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1820,gemini20,0.697,SPECIMEN LATERALITY
1821,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
1822,gemini20,0.786,REGIONAL LYMPH NODE STATUS
1823,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1824,gemini20,0.691,NUMBER OF LYMPH NODES EXAMINED
1825,gemini20,0.768,VISCERAL PLEURA INVASION
1826,gemini20,0.82,NODAL SITE(S) EXAMINED
1827,gemini20,0.798,TUMOR SITE
1828,gemini20,0.811,TUMOR FOCALITY
1829,gemini20,0.747,PROCEDURE
1830,gemini20,0.757,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1831,gemini20,0.759,MARGIN STATUS FOR NON-INVASIVE TUMOR
1832,gemini20,0.691,HISTOLOGIC GRADE
1833,gemini20,0.805,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1834,gemini20,0.714,NUMBER OF LYMPH NODES EXAMINED
1835,gemini20,0.694,SPREAD THROUGH AIR SPACES (STAS)
1836,gemini20,0.722,VISCERAL PLEURA INVASION
1837,gemini20,0.726,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1838,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1839,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
1840,gemini20,0.707,MARGIN STATUS FOR INVASIVE CARCINOMA
1841,gemini20,0.725,PROCEDURE
1842,gemini20,0.762,REGIONAL LYMPH NODE STATUS
1843,gemini20,0.904,HISTOLOGIC GRADE
1844,gemini20,0.693,ADDITIONAL FINDINGS
1845,gemini20,0.697,SPECIMEN LATERALITY
1846,gemini20,0.732,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1847,gemini20,0.697,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1848,gemini20,0.704,TUMOR FOCALITY
1849,gemini20,0.818,NODAL SITE(S) EXAMINED
1850,gemini20,0.896,TUMOR SITE
1851,gemini20,0.791,LYMPHOVASCULAR INVASION
1852,gemini20,0.811,TUMOR FOCALITY
1853,gemini20,0.716,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1854,gemini20,0.819,NODAL SITE(S) EXAMINED
1855,gemini20,0.678,ADDITIONAL FINDINGS
1856,gemini20,0.788,PROCEDURE
1857,gemini20,0.878,TUMOR SITE
1858,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
1859,gemini20,0.815,REGIONAL LYMPH NODE STATUS
1860,gemini20,0.701,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1861,gemini20,0.746,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1862,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1863,gemini20,0.697,SPECIMEN LATERALITY
1864,gemini20,0.721,VISCERAL PLEURA INVASION
1865,gemini20,0.729,NUMBER OF LYMPH NODES EXAMINED
1866,gemini20,0.722,MARGIN STATUS FOR INVASIVE CARCINOMA
1867,gemini20,0.815,REGIONAL LYMPH NODE STATUS
1868,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
1869,gemini20,0.7,PROCEDURE
1870,gemini20,0.811,TUMOR FOCALITY
1871,gemini20,0.713,ADDITIONAL FINDINGS
1872,gemini20,0.814,HISTOLOGIC GRADE
1873,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
1874,gemini20,0.698,SPECIMEN LATERALITY
1875,gemini20,0.713,VISCERAL PLEURA INVASION
1876,gemini20,0.793,TUMOR SITE
1877,gemini20,0.76,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1878,gemini20,0.757,MARGIN STATUS FOR INVASIVE CARCINOMA
1879,gemini20,0.758,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1880,gemini20,0.751,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1881,gemini20,0.796,NODAL SITE(S) EXAMINED
1882,gemini20,0.698,SPECIMEN LATERALITY
1883,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1884,gemini20,0.731,HISTOLOGIC GRADE
1885,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
1886,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1887,gemini20,0.76,NODAL SITE(S) EXAMINED
1888,gemini20,0.72,NUMBER OF LYMPH NODES WITH TUMOR
1889,gemini20,0.709,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1890,gemini20,0.886,NODAL SITE(S) WITH TUMOR
1891,gemini20,0.712,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1892,gemini20,0.779,REGIONAL LYMPH NODE STATUS
1893,gemini20,0.689,SPREAD THROUGH AIR SPACES (STAS)
1894,gemini20,0.68,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1895,gemini20,0.694,NUMBER OF LYMPH NODES EXAMINED
1896,gemini20,0.678,TUMOR FOCALITY
1897,gemini20,0.676,TUMOR SITE
1898,gemini20,0.68,VISCERAL PLEURA INVASION
1899,gemini20,0.705,PROCEDURE
1900,gemini20,0.693,MARGIN STATUS FOR INVASIVE CARCINOMA
1901,gemini20,0.815,REGIONAL LYMPH NODE STATUS
1902,gemini20,0.698,SPECIMEN LATERALITY
1903,gemini20,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1904,gemini20,0.793,PROCEDURE
1905,gemini20,0.77,TUMOR SITE
1906,gemini20,0.811,TUMOR FOCALITY
1907,gemini20,0.713,NUMBER OF LYMPH NODES EXAMINED
1908,gemini20,0.77,NODAL SITE(S) EXAMINED
1909,gemini20,0.722,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1910,gemini20,0.715,VISCERAL PLEURA INVASION
1911,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
1912,gemini20,0.742,HISTOLOGIC GRADE
1913,gemini20,0.697,SPECIMEN LATERALITY
1914,gemini20,0.75,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1915,gemini20,0.731,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1916,gemini20,0.829,REGIONAL LYMPH NODE STATUS
1917,gemini20,0.721,NODAL SITE(S) EXAMINED
1918,gemini20,0.732,VISCERAL PLEURA INVASION
1919,gemini20,0.876,TUMOR SITE
1920,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
1921,gemini20,0.75,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1922,gemini20,0.691,SPREAD THROUGH AIR SPACES (STAS)
1923,gemini20,0.711,PROCEDURE
1924,gemini20,0.81,MARGIN STATUS FOR INVASIVE CARCINOMA
1925,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
1926,gemini20,0.704,TUMOR FOCALITY
1927,gemini20,0.733,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1928,gemini20,0.697,HISTOLOGIC GRADE
1929,gemini20,0.822,REGIONAL LYMPH NODE STATUS
1930,gemini20,0.698,SPECIMEN LATERALITY
1931,gemini20,0.703,PROCEDURE
1932,gemini20,0.689,SPREAD THROUGH AIR SPACES (STAS)
1933,gemini20,0.761,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1934,gemini20,0.719,TUMOR FOCALITY
1935,gemini20,0.702,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1936,gemini20,0.769,NODAL SITE(S) EXAMINED
1937,gemini20,0.88,ADDITIONAL FINDINGS
1938,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
1939,gemini20,0.722,VISCERAL PLEURA INVASION
1940,gemini20,0.777,MARGIN STATUS FOR INVASIVE CARCINOMA
1941,gemini20,0.793,TUMOR SITE
1942,gemini20,0.779,LYMPH NODE(S) FROM PRIOR PROCEDURES
1943,gemini20,0.699,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1944,gemini20,0.837,TUMOR SITE
1945,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
1946,gemini20,0.697,SPECIMEN LATERALITY
1947,gemini20,0.763,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1948,gemini20,0.69,SPREAD THROUGH AIR SPACES (STAS)
1949,gemini20,0.904,HISTOLOGIC GRADE
1950,gemini20,0.826,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1951,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1952,gemini20,0.768,VISCERAL PLEURA INVASION
1953,gemini20,0.72,NUMBER OF LYMPH NODES EXAMINED
1954,gemini20,0.811,TUMOR FOCALITY
1955,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
1956,gemini20,0.926,NODAL SITE(S) EXAMINED
1957,gemini20,0.815,REGIONAL LYMPH NODE STATUS
1958,gemini20,0.704,PROCEDURE
1959,gemini20,0.772,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1960,gemini20,0.704,MARGIN STATUS FOR NON-INVASIVE TUMOR
1961,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1962,gemini20,0.705,HISTOLOGIC GRADE
1963,gemini20,0.722,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1964,gemini20,0.694,NUMBER OF LYMPH NODES EXAMINED
1965,gemini20,0.697,SPECIMEN LATERALITY
1966,gemini20,0.668,SPREAD THROUGH AIR SPACES (STAS)
1967,gemini20,0.878,TUMOR SITE
1968,gemini20,0.742,MARGIN STATUS FOR INVASIVE CARCINOMA
1969,gemini20,0.815,REGIONAL LYMPH NODE STATUS
1970,gemini20,0.811,TUMOR FOCALITY
1971,gemini20,0.767,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1972,gemini20,0.741,PROCEDURE
1973,gemini20,0.786,NODAL SITE(S) EXAMINED
1974,gemini20,0.724,VISCERAL PLEURA INVASION
1975,gemini20,0.882,TUMOR SITE
1976,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1977,gemini20,0.697,SPECIMEN LATERALITY
1978,gemini20,0.708,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1979,gemini20,0.788,PROCEDURE
1980,gemini20,0.763,NODAL SITE(S) EXAMINED
1981,gemini20,0.691,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1982,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
1983,gemini20,0.724,TUMOR FOCALITY
1984,gemini20,0.716,NUMBER OF LYMPH NODES EXAMINED
1985,gemini20,0.822,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1986,gemini20,0.705,VISCERAL PLEURA INVASION
1987,gemini20,0.683,LYMPH NODE(S) FROM PRIOR PROCEDURES
1988,gemini20,0.727,LYMPHOVASCULAR INVASION
1989,gemini20,0.72,NUMBER OF LYMPH NODES WITH TUMOR
1990,gemini20,0.753,REGIONAL LYMPH NODE STATUS
1991,gemini20,0.714,NODAL SITE(S) WITH TUMOR
1992,gemini20,0.725,TUMOR FOCALITY
1993,gemini20,0.677,VISCERAL PLEURA INVASION
1994,gemini20,0.872,NODAL SITE(S) EXAMINED
1995,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
1996,gemini20,0.769,MARGIN STATUS FOR INVASIVE CARCINOMA
1997,gemini20,0.689,HISTOLOGIC GRADE
1998,gemini20,0.708,PROCEDURE
1999,gemini20,0.697,SPECIMEN LATERALITY
2000,gemini20,0.791,TUMOR SITE
2001,gemini20,0.799,REGIONAL LYMPH NODE STATUS
2002,gemini20,0.786,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2003,gemini20,0.704,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2004,gemini20,0.721,ADDITIONAL FINDINGS
2005,gemini20,0.695,SPREAD THROUGH AIR SPACES (STAS)
2006,gemini20,0.697,NUMBER OF LYMPH NODES EXAMINED
2007,gemini20,0.82,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2008,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
2009,gemini20,0.699,TUMOR SITE
2010,gemini20,0.811,TUMOR FOCALITY
2011,gemini20,0.713,TNM DESCRIPTORS
2012,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
2013,gemini20,0.786,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2014,gemini20,0.723,HISTOLOGIC GRADE
2015,gemini20,0.698,SPECIMEN LATERALITY
2016,gemini20,0.782,NUMBER OF LYMPH NODES EXAMINED
2017,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2018,gemini20,0.695,VISCERAL PLEURA INVASION
2019,gemini20,0.815,REGIONAL LYMPH NODE STATUS
2020,gemini20,0.695,ADDITIONAL FINDINGS
2021,gemini20,0.845,NODAL SITE(S) EXAMINED
2022,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2023,gemini20,0.684,SPREAD THROUGH AIR SPACES (STAS)
2024,gemini20,0.7,PROCEDURE
2025,gemini20,0.774,PROCEDURE
2026,gemini20,0.811,TUMOR FOCALITY
2027,gemini20,0.873,NODAL SITE(S) EXAMINED
2028,gemini20,0.774,ADDITIONAL FINDINGS
2029,gemini20,0.759,VISCERAL PLEURA INVASION
2030,gemini20,0.697,SPECIMEN LATERALITY
2031,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
2032,gemini20,0.7,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2033,gemini20,0.783,TUMOR SITE
2034,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
2035,gemini20,0.685,SPREAD THROUGH AIR SPACES (STAS)
2036,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2037,gemini20,0.815,REGIONAL LYMPH NODE STATUS
2038,gemini20,0.901,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2039,gemini20,0.81,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2040,gemini20,0.679,HISTOLOGIC GRADE
2041,gemini20,0.896,TUMOR SITE
2042,gemini20,0.764,VISCERAL PLEURA INVASION
2043,gemini20,0.749,ADDITIONAL FINDINGS
2044,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2045,gemini20,0.87,HISTOLOGIC GRADE
2046,gemini20,0.833,NODAL SITE(S) EXAMINED
2047,gemini20,0.698,SPECIMEN LATERALITY
2048,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
2049,gemini20,0.829,SPREAD THROUGH AIR SPACES (STAS)
2050,gemini20,0.702,NUMBER OF LYMPH NODES EXAMINED
2051,gemini20,0.758,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2052,gemini20,0.719,REGIONAL LYMPH NODE STATUS
2053,gemini20,0.73,PROCEDURE
2054,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
2055,gemini20,0.68,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2056,gemini20,0.837,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2057,gemini20,0.811,TUMOR FOCALITY
2058,gemini20,0.785,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2059,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
2060,gemini20,0.667,TUMOR FOCALITY
2061,gemini20,0.793,TUMOR SITE
2062,gemini20,0.698,SPECIMEN LATERALITY
2063,gemini20,0.718,LYMPHOVASCULAR INVASION
2064,gemini20,0.845,MARGIN STATUS FOR INVASIVE CARCINOMA
2065,gemini20,0.712,NUMBER OF LYMPH NODES EXAMINED
2066,gemini20,0.699,HISTOLOGIC GRADE
2067,gemini20,0.82,NODAL SITE(S) EXAMINED
2068,gemini20,0.705,VISCERAL PLEURA INVASION
2069,gemini20,0.727,PROCEDURE
2070,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
2071,gemini20,0.694,SPREAD THROUGH AIR SPACES (STAS)
2072,gemini20,0.729,TNM DESCRIPTORS
2073,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
2074,gemini20,0.701,NODAL SITE(S) EXAMINED
2075,gemini20,0.72,NUMBER OF LYMPH NODES WITH TUMOR
2076,gemini20,0.658,VISCERAL PLEURA INVASION
2077,gemini20,0.694,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2078,gemini20,0.763,TUMOR SITE
2079,gemini20,0.657,HISTOLOGIC GRADE
2080,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
2081,gemini20,0.725,REGIONAL LYMPH NODE STATUS
2082,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2083,gemini20,0.688,SPREAD THROUGH AIR SPACES (STAS)
2084,gemini20,0.669,TUMOR FOCALITY
2085,gemini20,0.712,TNM DESCRIPTORS
2086,gemini20,0.697,SPECIMEN LATERALITY
2087,gemini20,0.702,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2088,gemini20,0.633,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2089,gemini20,0.815,NODAL SITE(S) WITH TUMOR
2090,gemini20,0.678,PROCEDURE
2091,gemini20,0.89,TUMOR SITE
2092,gemini20,0.811,TUMOR FOCALITY
2093,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2094,gemini20,0.761,VISCERAL PLEURA INVASION
2095,gemini20,0.692,SPREAD THROUGH AIR SPACES (STAS)
2096,gemini20,0.731,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2097,gemini20,0.732,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2098,gemini20,0.772,NODAL SITE(S) EXAMINED
2099,gemini20,0.793,PROCEDURE
2100,gemini20,0.829,REGIONAL LYMPH NODE STATUS
2101,gemini20,0.698,SPECIMEN LATERALITY
2102,gemini20,0.701,HISTOLOGIC GRADE
2103,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
2104,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2105,gemini20,0.759,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2106,gemini20,0.774,NODAL SITE(S) EXAMINED
2107,gemini20,0.693,VISCERAL PLEURA INVASION
2108,gemini20,0.777,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2109,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
2110,gemini20,0.732,PROCEDURE
2111,gemini20,0.808,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2112,gemini20,0.811,TUMOR FOCALITY
2113,gemini20,0.641,LYMPHOVASCULAR INVASION
2114,gemini20,0.698,SPECIMEN LATERALITY
2115,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2116,gemini20,0.734,NUMBER OF LYMPH NODES EXAMINED
2117,gemini20,0.804,TUMOR SITE
2118,gemini20,0.69,HISTOLOGIC GRADE
2119,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2120,gemini20,0.826,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2121,gemini20,0.81,REGIONAL LYMPH NODE STATUS
2122,gemini20,0.738,ADDITIONAL FINDINGS
2123,gemini20,0.811,TUMOR FOCALITY
2124,gemini20,0.719,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2125,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
2126,gemini20,0.732,NODAL SITE(S) EXAMINED
2127,gemini20,0.779,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2128,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2129,gemini20,0.73,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2130,gemini20,0.685,SPREAD THROUGH AIR SPACES (STAS)
2131,gemini20,0.788,PROCEDURE
2132,gemini20,0.684,VISCERAL PLEURA INVASION
2133,gemini20,0.698,SPECIMEN LATERALITY
2134,gemini20,0.694,NUMBER OF LYMPH NODES EXAMINED
2135,gemini20,0.689,HISTOLOGIC GRADE
2136,gemini20,0.719,REGIONAL LYMPH NODE STATUS
2137,gemini20,0.772,TUMOR SITE
2138,gemini20,0.704,VISCERAL PLEURA INVASION
2139,gemini20,0.713,PROCEDURE
2140,gemini20,0.904,HISTOLOGIC GRADE
2141,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
2142,gemini20,0.729,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2143,gemini20,0.791,TUMOR SITE
2144,gemini20,0.729,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2145,gemini20,0.686,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2146,gemini20,0.697,SPECIMEN LATERALITY
2147,gemini20,0.815,REGIONAL LYMPH NODE STATUS
2148,gemini20,0.717,TUMOR FOCALITY
2149,gemini20,0.733,NODAL SITE(S) EXAMINED
2150,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
2151,gemini20,0.684,ADDITIONAL FINDINGS
2152,gemini20,0.763,NUMBER OF LYMPH NODES EXAMINED
2153,gemini20,0.755,MARGIN STATUS FOR INVASIVE CARCINOMA
2154,gemini20,0.811,TUMOR FOCALITY
2155,gemini20,0.704,PROCEDURE
2156,gemini20,0.884,TUMOR SITE
2157,gemini20,0.766,HISTOLOGIC GRADE
2158,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2159,gemini20,0.826,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2160,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
2161,gemini20,0.871,NODAL SITE(S) EXAMINED
2162,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2163,gemini20,0.746,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2164,gemini20,0.815,REGIONAL LYMPH NODE STATUS
2165,gemini20,0.697,SPECIMEN LATERALITY
2166,gemini20,0.758,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2167,gemini20,0.764,VISCERAL PLEURA INVASION
2168,gemini20,0.765,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2169,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
2170,gemini20,0.678,VISCERAL PLEURA INVASION
2171,gemini20,0.71,PROCEDURE
2172,gemini20,0.723,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2173,gemini20,0.698,NUMBER OF LYMPH NODES EXAMINED
2174,gemini20,0.811,TUMOR FOCALITY
2175,gemini20,0.792,TUMOR SITE
2176,gemini20,0.86,ADDITIONAL FINDINGS
2177,gemini20,0.734,MARGIN STATUS FOR INVASIVE CARCINOMA
2178,gemini20,0.698,SPECIMEN LATERALITY
2179,gemini20,0.815,REGIONAL LYMPH NODE STATUS
2180,gemini20,0.701,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2181,gemini20,0.74,NODAL SITE(S) EXAMINED
2182,gemini20,0.709,HISTOLOGIC GRADE
2183,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
2184,gemini20,0.695,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2185,gemini20,0.683,LYMPHOVASCULAR INVASION
2186,gemini20,0.698,SPECIMEN LATERALITY
2187,gemini20,0.808,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2188,gemini20,0.721,ADDITIONAL FINDINGS
2189,gemini20,0.764,PROCEDURE
2190,gemini20,0.692,LYMPH NODE(S) FROM PRIOR PROCEDURES
2191,gemini20,0.709,NODAL SITE(S) EXAMINED
2192,gemini20,0.679,TNM DESCRIPTORS
2193,gemini20,0.683,VISCERAL PLEURA INVASION
2194,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2195,gemini20,0.705,NODAL SITE(S) WITH TUMOR
2196,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
2197,gemini20,0.63,TUMOR FOCALITY
2198,gemini20,0.792,TUMOR SITE
2199,gemini20,0.786,REGIONAL LYMPH NODE STATUS
2200,gemini20,0.684,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2201,gemini20,0.714,ADDITIONAL FINDINGS
2202,gemini20,0.65,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2203,gemini20,0.822,NODAL SITE(S) EXAMINED
2204,gemini20,0.694,VISCERAL PLEURA INVASION
2205,gemini20,0.735,PROCEDURE
2206,gemini20,0.815,REGIONAL LYMPH NODE STATUS
2207,gemini20,0.682,TNM DESCRIPTORS
2208,gemini20,0.696,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2209,gemini20,0.725,HISTOLOGIC GRADE
2210,gemini20,0.703,MARGIN STATUS FOR NON-INVASIVE TUMOR
2211,gemini20,0.766,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2212,gemini20,0.673,TUMOR FOCALITY
2213,gemini20,0.697,SPECIMEN LATERALITY
2214,gemini20,0.757,MARGIN STATUS FOR INVASIVE CARCINOMA
2215,gemini20,0.878,TUMOR SITE
2216,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2217,gemini20,0.89,TUMOR SITE
2218,gemini20,0.704,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2219,gemini20,0.826,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2220,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2221,gemini20,0.738,PROCEDURE
2222,gemini20,0.815,REGIONAL LYMPH NODE STATUS
2223,gemini20,0.752,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2224,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2225,gemini20,0.715,HISTOLOGIC GRADE
2226,gemini20,0.718,VISCERAL PLEURA INVASION
2227,gemini20,0.811,TUMOR FOCALITY
2228,gemini20,0.84,NODAL SITE(S) EXAMINED
2229,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
2230,gemini20,0.7,NUMBER OF LYMPH NODES EXAMINED
2231,gemini20,0.697,SPECIMEN LATERALITY
2232,gemini20,0.815,REGIONAL LYMPH NODE STATUS
2233,gemini20,0.697,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2234,gemini20,0.725,HISTOLOGIC GRADE
2235,gemini20,0.734,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2236,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
2237,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
2238,gemini20,0.811,TUMOR FOCALITY
2239,gemini20,0.838,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2240,gemini20,0.739,PROCEDURE
2241,gemini20,0.697,NUMBER OF LYMPH NODES EXAMINED
2242,gemini20,0.697,SPECIMEN LATERALITY
2243,gemini20,0.878,TUMOR SITE
2244,gemini20,0.783,NODAL SITE(S) EXAMINED
2245,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2246,gemini20,0.692,VISCERAL PLEURA INVASION
2247,gemini20,0.72,LYMPHOVASCULAR INVASION
2248,gemini20,0.689,PROCEDURE
2249,gemini20,0.698,NUMBER OF LYMPH NODES WITH TUMOR
2250,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
2251,gemini20,0.724,TUMOR SITE
2252,gemini20,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2253,gemini20,0.681,HISTOLOGIC GRADE
2254,gemini20,0.689,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2255,gemini20,0.721,MARGIN STATUS FOR INVASIVE CARCINOMA
2256,gemini20,0.783,REGIONAL LYMPH NODE STATUS
2257,gemini20,0.716,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2258,gemini20,0.8,NODAL SITE(S) EXAMINED
2259,gemini20,0.698,SPECIMEN LATERALITY
2260,gemini20,0.659,TUMOR FOCALITY
2261,gemini20,0.776,ADDITIONAL FINDINGS
2262,gemini20,0.689,SPREAD THROUGH AIR SPACES (STAS)
2263,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
2264,gemini20,0.667,NUMBER OF LYMPH NODES EXAMINED
2265,gemini20,0.711,VISCERAL PLEURA INVASION
2266,gemini20,0.69,TNM DESCRIPTORS
2267,gemini20,0.672,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2268,gemini20,0.729,TUMOR SITE
2269,gemini20,0.729,MARGIN STATUS FOR INVASIVE CARCINOMA
2270,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
2271,gemini20,0.696,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2272,gemini20,0.712,ADDITIONAL FINDINGS
2273,gemini20,0.8,NODAL SITE(S) EXAMINED
2274,gemini20,0.698,PROCEDURE
2275,gemini20,0.666,HISTOLOGIC GRADE
2276,gemini20,0.677,SPREAD THROUGH AIR SPACES (STAS)
2277,gemini20,0.719,TUMOR SITE
2278,gemini20,0.664,TUMOR FOCALITY
2279,gemini20,0.75,MARGIN STATUS FOR NON-INVASIVE TUMOR
2280,gemini20,0.717,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2281,gemini20,0.677,SPECIMEN LATERALITY
2282,gemini20,0.696,VISCERAL PLEURA INVASION
2283,gemini20,0.719,REGIONAL LYMPH NODE STATUS
2284,gemini20,0.743,MARGIN STATUS FOR INVASIVE CARCINOMA
2285,gemini20,0.697,SPECIMEN LATERALITY
2286,gemini20,0.766,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2287,gemini20,0.705,VISCERAL PLEURA INVASION
2288,gemini20,0.691,HISTOLOGIC GRADE
2289,gemini20,0.726,TUMOR SITE
2290,gemini20,0.832,NODAL SITE(S) EXAMINED
2291,gemini20,0.67,MARGIN STATUS FOR NON-INVASIVE TUMOR
2292,gemini20,0.684,SPREAD THROUGH AIR SPACES (STAS)
2293,gemini20,0.829,REGIONAL LYMPH NODE STATUS
2294,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
2295,gemini20,0.7,PROCEDURE
2296,gemini20,0.674,TUMOR FOCALITY
2297,gemini20,0.876,NODAL SITE(S) WITH TUMOR
2298,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
2299,gemini20,0.744,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2300,gemini20,0.738,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2301,gemini20,0.719,LYMPHOVASCULAR INVASION
2302,gemini20,0.698,SPECIMEN LATERALITY
2303,gemini20,0.716,TUMOR SITE
2304,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2305,gemini20,0.72,VISCERAL PLEURA INVASION
2306,gemini20,0.811,TUMOR FOCALITY
2307,gemini20,0.686,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2308,gemini20,0.784,NUMBER OF LYMPH NODES EXAMINED
2309,gemini20,0.78,REGIONAL LYMPH NODE STATUS
2310,gemini20,0.717,HISTOLOGIC GRADE
2311,gemini20,0.717,NODAL SITE(S) EXAMINED
2312,gemini20,0.896,MARGIN STATUS FOR INVASIVE CARCINOMA
2313,gemini20,0.713,NUMBER OF LYMPH NODES WITH TUMOR
2314,gemini20,0.793,PROCEDURE
2315,gemini20,0.711,VISCERAL PLEURA INVASION
2316,gemini20,0.829,REGIONAL LYMPH NODE STATUS
2317,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2318,gemini20,0.687,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2319,gemini20,0.766,NODAL SITE(S) EXAMINED
2320,gemini20,0.707,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2321,gemini20,0.648,TUMOR SITE
2322,gemini20,0.726,PROCEDURE
2323,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
2324,gemini20,0.804,MARGIN STATUS FOR NON-INVASIVE TUMOR
2325,gemini20,0.743,ADDITIONAL FINDINGS
2326,gemini20,0.695,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2327,gemini20,0.685,SPREAD THROUGH AIR SPACES (STAS)
2328,gemini20,0.687,HISTOLOGIC GRADE
2329,gemini20,0.697,SPECIMEN LATERALITY
2330,gemini20,0.704,NUMBER OF LYMPH NODES EXAMINED
2331,gemini20,0.689,TUMOR FOCALITY
2332,gemini20,0.774,NODAL SITE(S) EXAMINED
2333,gemini20,0.716,TNM DESCRIPTORS
2334,gemini20,0.718,MARGIN STATUS FOR INVASIVE CARCINOMA
2335,gemini20,0.682,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2336,gemini20,0.747,TUMOR SITE
2337,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
2338,gemini20,0.702,NUMBER OF LYMPH NODES EXAMINED
2339,gemini20,0.69,PROCEDURE
2340,gemini20,0.698,SPECIMEN LATERALITY
2341,gemini20,0.669,HISTOLOGIC GRADE
2342,gemini20,0.736,REGIONAL LYMPH NODE STATUS
2343,gemini20,0.734,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2344,gemini20,0.781,ADDITIONAL FINDINGS
2345,gemini20,0.7,VISCERAL PLEURA INVASION
2346,gemini20,0.641,TUMOR FOCALITY
2347,gemini20,0.717,MARGIN STATUS FOR NON-INVASIVE TUMOR
2348,gemini20,0.742,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2349,gemini20,0.676,SPREAD THROUGH AIR SPACES (STAS)
2350,gemini20,0.701,NODAL SITE(S) WITH TUMOR
2351,gemini20,0.783,REGIONAL LYMPH NODE STATUS
2352,gemini20,0.69,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2353,gemini20,0.717,MARGIN STATUS FOR NON-INVASIVE TUMOR
2354,gemini20,0.782,TUMOR SITE
2355,gemini20,0.711,PROCEDURE
2356,gemini20,0.697,SPECIMEN LATERALITY
2357,gemini20,0.695,VISCERAL PLEURA INVASION
2358,gemini20,0.686,NUMBER OF LYMPH NODES EXAMINED
2359,gemini20,0.808,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2360,gemini20,0.649,LYMPHOVASCULAR INVASION
2361,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
2362,gemini20,0.758,MARGIN STATUS FOR INVASIVE CARCINOMA
2363,gemini20,0.697,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2364,gemini20,0.773,NODAL SITE(S) EXAMINED
2365,gemini20,0.706,TUMOR FOCALITY
2366,gemini20,0.683,LYMPH NODE(S) FROM PRIOR PROCEDURES
2367,gemini20,0.892,HISTOLOGIC GRADE
2368,gemini20,0.754,PROCEDURE
2369,gemini20,0.686,VISCERAL PLEURA INVASION
2370,gemini20,0.697,SPECIMEN LATERALITY
2371,gemini20,0.797,MARGIN STATUS FOR INVASIVE CARCINOMA
2372,gemini20,0.708,TUMOR SITE
2373,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
2374,gemini20,0.821,NODAL SITE(S) EXAMINED
2375,gemini20,0.704,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2376,gemini20,0.659,TUMOR FOCALITY
2377,gemini20,0.817,REGIONAL LYMPH NODE STATUS
2378,gemini20,0.727,LYMPHOVASCULAR INVASION
2379,gemini20,0.713,NUMBER OF LYMPH NODES EXAMINED
2380,gemini20,0.676,ADDITIONAL FINDINGS
2381,gemini20,0.708,HISTOLOGIC GRADE
2382,gemini20,0.815,REGIONAL LYMPH NODE STATUS
2383,gemini20,0.896,TUMOR SITE
2384,gemini20,0.821,MARGIN STATUS FOR INVASIVE CARCINOMA
2385,gemini20,0.713,NUMBER OF LYMPH NODES EXAMINED
2386,gemini20,0.748,NODAL SITE(S) EXAMINED
2387,gemini20,0.654,TUMOR FOCALITY
2388,gemini20,0.779,LYMPH NODE(S) FROM PRIOR PROCEDURES
2389,gemini20,0.71,VISCERAL PLEURA INVASION
2390,gemini20,0.801,PROCEDURE
2391,gemini20,0.7,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2392,gemini20,0.697,SPECIMEN LATERALITY
2393,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
2394,gemini20,0.904,HISTOLOGIC GRADE
2395,gemini20,0.757,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2396,gemini20,0.734,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2397,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
2398,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
2399,gemini20,0.764,TUMOR SITE
2400,gemini20,0.669,VISCERAL PLEURA INVASION
2401,gemini20,0.745,NUMBER OF LYMPH NODES EXAMINED
2402,gemini20,0.76,MARGIN STATUS FOR INVASIVE CARCINOMA
2403,gemini20,0.725,TUMOR FOCALITY
2404,gemini20,0.753,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2405,gemini20,0.698,SPECIMEN LATERALITY
2406,gemini20,0.887,NODAL SITE(S) EXAMINED
2407,gemini20,0.716,PROCEDURE
2408,gemini20,0.822,REGIONAL LYMPH NODE STATUS
2409,gemini20,0.723,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2410,gemini20,0.798,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2411,gemini20,0.702,HISTOLOGIC GRADE
2412,gemini20,0.822,REGIONAL LYMPH NODE STATUS
2413,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
2414,gemini20,0.811,TUMOR FOCALITY
2415,gemini20,0.697,SPECIMEN LATERALITY
2416,gemini20,0.691,ADDITIONAL FINDINGS
2417,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2418,gemini20,0.734,NODAL SITE(S) EXAMINED
2419,gemini20,0.676,VISCERAL PLEURA INVASION
2420,gemini20,0.669,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2421,gemini20,0.703,NUMBER OF LYMPH NODES EXAMINED
2422,gemini20,0.744,PROCEDURE
2423,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
2424,gemini20,0.896,TUMOR SITE
2425,gemini20,0.697,SPECIMEN LATERALITY
2426,gemini20,0.66,TUMOR FOCALITY
2427,gemini20,0.745,REGIONAL LYMPH NODE STATUS
2428,gemini20,0.719,VISCERAL PLEURA INVASION
2429,gemini20,0.705,NUMBER OF LYMPH NODES WITH TUMOR
2430,gemini20,0.692,PROCEDURE
2431,gemini20,0.684,NODAL SITE(S) WITH TUMOR
2432,gemini20,0.692,TNM DESCRIPTORS
2433,gemini20,0.674,MARGIN STATUS FOR INVASIVE CARCINOMA
2434,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
2435,gemini20,0.691,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2436,gemini20,0.772,TUMOR SITE
2437,gemini20,0.696,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2438,gemini20,0.662,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2439,gemini20,0.764,NODAL SITE(S) EXAMINED
2440,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
2441,gemini20,0.827,PROCEDURE
2442,gemini20,0.698,SPECIMEN LATERALITY
2443,gemini20,0.782,MARGIN STATUS FOR INVASIVE CARCINOMA
2444,gemini20,0.738,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2445,gemini20,0.704,TUMOR FOCALITY
2446,gemini20,0.732,HISTOLOGIC GRADE
2447,gemini20,0.724,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2448,gemini20,0.705,VISCERAL PLEURA INVASION
2449,gemini20,0.83,TUMOR SITE
2450,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
2451,gemini20,0.696,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2452,gemini20,0.725,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2453,gemini20,0.781,NODAL SITE(S) EXAMINED
2454,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
2455,gemini20,0.698,SPECIMEN LATERALITY
2456,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2457,gemini20,0.767,ADDITIONAL FINDINGS
2458,gemini20,0.697,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2459,gemini20,0.709,PROCEDURE
2460,gemini20,0.835,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2461,gemini20,0.68,HISTOLOGIC GRADE
2462,gemini20,0.815,REGIONAL LYMPH NODE STATUS
2463,gemini20,0.811,TUMOR FOCALITY
2464,gemini20,0.694,VISCERAL PLEURA INVASION
2465,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2466,gemini20,0.879,TUMOR SITE
2467,gemini20,0.71,NUMBER OF LYMPH NODES EXAMINED
2468,gemini20,0.826,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2469,gemini20,0.792,MARGIN STATUS FOR INVASIVE CARCINOMA
2470,gemini20,0.778,SPREAD THROUGH AIR SPACES (STAS)
2471,gemini20,0.697,SPECIMEN LATERALITY
2472,gemini20,0.833,ADDITIONAL FINDINGS
2473,gemini20,0.895,TUMOR SITE
2474,gemini20,0.803,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2475,gemini20,0.683,HISTOLOGIC GRADE
2476,gemini20,0.811,TUMOR FOCALITY
2477,gemini20,0.827,PROCEDURE
2478,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2479,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
2480,gemini20,0.715,VISCERAL PLEURA INVASION
2481,gemini20,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2482,gemini20,0.719,TUMOR SITE
2483,gemini20,0.707,NODAL SITE(S) WITH TUMOR
2484,gemini20,0.773,MARGIN STATUS FOR INVASIVE CARCINOMA
2485,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
2486,gemini20,0.711,TUMOR FOCALITY
2487,gemini20,0.892,HISTOLOGIC GRADE
2488,gemini20,0.66,VISCERAL PLEURA INVASION
2489,gemini20,0.825,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2490,gemini20,0.852,PROCEDURE
2491,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
2492,gemini20,0.78,REGIONAL LYMPH NODE STATUS
2493,gemini20,0.676,SPREAD THROUGH AIR SPACES (STAS)
2494,gemini20,0.716,NODAL SITE(S) EXAMINED
2495,gemini20,0.697,SPECIMEN LATERALITY
2496,gemini20,0.817,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2497,gemini20,0.759,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2498,gemini20,0.77,NODAL SITE(S) EXAMINED
2499,gemini20,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2500,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
2501,gemini20,0.698,VISCERAL PLEURA INVASION
2502,gemini20,0.822,REGIONAL LYMPH NODE STATUS
2503,gemini20,0.811,TUMOR FOCALITY
2504,gemini20,0.887,TUMOR SITE
2505,gemini20,0.904,HISTOLOGIC GRADE
2506,gemini20,0.715,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2507,gemini20,0.741,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2508,gemini20,0.677,SPREAD THROUGH AIR SPACES (STAS)
2509,gemini20,0.681,ADDITIONAL FINDINGS
2510,gemini20,0.717,MARGIN STATUS FOR NON-INVASIVE TUMOR
2511,gemini20,0.711,PROCEDURE
2512,gemini20,0.708,MARGIN STATUS FOR INVASIVE CARCINOMA
2513,gemini20,0.697,SPECIMEN LATERALITY
2514,gemini20,0.811,TUMOR FOCALITY
2515,gemini20,0.733,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2516,gemini20,0.68,HISTOLOGIC GRADE
2517,gemini20,0.747,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2518,gemini20,0.807,NODAL SITE(S) EXAMINED
2519,gemini20,0.697,SPECIMEN LATERALITY
2520,gemini20,0.691,SPREAD THROUGH AIR SPACES (STAS)
2521,gemini20,0.789,TUMOR SITE
2522,gemini20,0.781,REGIONAL LYMPH NODE STATUS
2523,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
2524,gemini20,0.826,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2525,gemini20,0.896,MARGIN STATUS FOR INVASIVE CARCINOMA
2526,gemini20,0.793,PROCEDURE
2527,gemini20,0.724,VISCERAL PLEURA INVASION
2528,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
2529,gemini20,0.899,NUMBER OF LYMPH NODES EXAMINED
2530,gemini20,0.818,ADDITIONAL FINDINGS
2531,gemini20,0.766,HISTOLOGIC GRADE
2532,gemini20,0.886,NODAL SITE(S) EXAMINED
2533,gemini20,0.729,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2534,gemini20,0.697,VISCERAL PLEURA INVASION
2535,gemini20,0.675,SPREAD THROUGH AIR SPACES (STAS)
2536,gemini20,0.827,PROCEDURE
2537,gemini20,0.815,REGIONAL LYMPH NODE STATUS
2538,gemini20,0.746,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2539,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2540,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
2541,gemini20,0.811,TUMOR FOCALITY
2542,gemini20,0.754,MARGIN STATUS FOR INVASIVE CARCINOMA
2543,gemini20,0.89,TUMOR SITE
2544,gemini20,0.72,NUMBER OF LYMPH NODES EXAMINED
2545,gemini20,0.698,SPECIMEN LATERALITY
2546,gemini20,0.72,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2547,gemini20,0.767,NODAL SITE(S) EXAMINED
2548,gemini20,0.815,REGIONAL LYMPH NODE STATUS
2549,gemini20,0.693,HISTOLOGIC GRADE
2550,gemini20,0.726,TUMOR FOCALITY
2551,gemini20,0.715,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2552,gemini20,0.698,SPECIMEN LATERALITY
2553,gemini20,0.788,PROCEDURE
2554,gemini20,0.699,SPREAD THROUGH AIR SPACES (STAS)
2555,gemini20,0.789,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2556,gemini20,0.714,MARGIN STATUS FOR INVASIVE CARCINOMA
2557,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
2558,gemini20,0.677,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2559,gemini20,0.778,TUMOR SITE
2560,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
2561,gemini20,0.761,VISCERAL PLEURA INVASION
2562,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
2563,gemini20,0.816,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2564,gemini20,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2565,gemini20,0.698,SPECIMEN LATERALITY
2566,gemini20,0.754,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2567,gemini20,0.83,TUMOR SITE
2568,gemini20,0.693,SPREAD THROUGH AIR SPACES (STAS)
2569,gemini20,0.827,PROCEDURE
2570,gemini20,0.811,TUMOR FOCALITY
2571,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2572,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2573,gemini20,0.694,VISCERAL PLEURA INVASION
2574,gemini20,0.769,HISTOLOGIC GRADE
2575,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
2576,gemini20,0.76,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2577,gemini20,0.827,PROCEDURE
2578,gemini20,0.713,NUMBER OF LYMPH NODES EXAMINED
2579,gemini20,0.698,SPECIMEN LATERALITY
2580,gemini20,0.847,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2581,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2582,gemini20,0.761,VISCERAL PLEURA INVASION
2583,gemini20,0.815,REGIONAL LYMPH NODE STATUS
2584,gemini20,0.811,TUMOR FOCALITY
2585,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2586,gemini20,0.804,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2587,gemini20,0.855,TUMOR SITE
2588,gemini20,0.721,NODAL SITE(S) EXAMINED
2589,gemini20,0.689,SPREAD THROUGH AIR SPACES (STAS)
2590,gemini20,0.721,NODAL SITE(S) EXAMINED
2591,gemini20,0.7,HISTOLOGIC GRADE
2592,gemini20,0.811,TUMOR FOCALITY
2593,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
2594,gemini20,0.832,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2595,gemini20,0.665,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2596,gemini20,0.761,VISCERAL PLEURA INVASION
2597,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2598,gemini20,0.725,PROCEDURE
2599,gemini20,0.697,SPECIMEN LATERALITY
2600,gemini20,0.755,REGIONAL LYMPH NODE STATUS
2601,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2602,gemini20,0.803,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2603,gemini20,0.699,NUMBER OF LYMPH NODES EXAMINED
2604,gemini20,0.876,TUMOR SITE
2605,gemini20,0.697,SPECIMEN LATERALITY
2606,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2607,gemini20,0.89,TUMOR SITE
2608,gemini20,0.896,MARGIN STATUS FOR INVASIVE CARCINOMA
2609,gemini20,0.797,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2610,gemini20,0.742,PROCEDURE
2611,gemini20,0.811,TUMOR FOCALITY
2612,gemini20,0.714,NODAL SITE(S) EXAMINED
2613,gemini20,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2614,gemini20,0.718,HISTOLOGIC GRADE
2615,gemini20,0.711,REGIONAL LYMPH NODE STATUS
2616,gemini20,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2617,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
2618,gemini20,0.761,VISCERAL PLEURA INVASION
2619,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
2620,gemini20,0.896,MARGIN STATUS FOR INVASIVE CARCINOMA
2621,gemini20,0.7,NUMBER OF LYMPH NODES WITH TUMOR
2622,gemini20,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2623,gemini20,0.706,PROCEDURE
2624,gemini20,0.768,TUMOR SITE
2625,gemini20,0.707,TUMOR FOCALITY
2626,gemini20,0.722,TNM DESCRIPTORS
2627,gemini20,0.697,SPECIMEN LATERALITY
2628,gemini20,0.633,LYMPHOVASCULAR INVASION
2629,gemini20,0.762,NODAL SITE(S) EXAMINED
2630,gemini20,0.703,HISTOLOGIC GRADE
2631,gemini20,0.76,NODAL SITE(S) WITH TUMOR
2632,gemini20,0.771,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2633,gemini20,0.746,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2634,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
2635,gemini20,0.768,VISCERAL PLEURA INVASION
2636,gemini20,0.763,REGIONAL LYMPH NODE STATUS
2637,gemini20,0.713,NODAL SITE(S) EXAMINED
2638,gemini20,0.732,PROCEDURE
2639,gemini20,0.698,VISCERAL PLEURA INVASION
2640,gemini20,0.755,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2641,gemini20,0.698,SPECIMEN LATERALITY
2642,gemini20,0.676,ADDITIONAL FINDINGS
2643,gemini20,0.734,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2644,gemini20,0.78,SPREAD THROUGH AIR SPACES (STAS)
2645,gemini20,0.697,NUMBER OF LYMPH NODES EXAMINED
2646,gemini20,0.792,TUMOR SITE
2647,gemini20,0.685,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2648,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
2649,gemini20,0.729,TUMOR FOCALITY
2650,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2651,gemini20,0.815,REGIONAL LYMPH NODE STATUS
2652,gemini20,0.704,HISTOLOGIC GRADE
2653,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2654,gemini20,0.692,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2655,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2656,gemini20,0.698,SPREAD THROUGH AIR SPACES (STAS)
2657,gemini20,0.726,NODAL SITE(S) EXAMINED
2658,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
2659,gemini20,0.707,PROCEDURE
2660,gemini20,0.699,HISTOLOGIC GRADE
2661,gemini20,0.742,TUMOR FOCALITY
2662,gemini20,0.811,REGIONAL LYMPH NODE STATUS
2663,gemini20,0.826,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2664,gemini20,0.761,VISCERAL PLEURA INVASION
2665,gemini20,0.704,NUMBER OF LYMPH NODES EXAMINED
2666,gemini20,0.811,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2667,gemini20,0.802,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2668,gemini20,0.878,TUMOR SITE
2669,gemini20,0.697,SPECIMEN LATERALITY
2670,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2671,gemini20,0.826,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2672,gemini20,0.777,ADDITIONAL FINDINGS
2673,gemini20,0.756,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2674,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2675,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
2676,gemini20,0.694,SPREAD THROUGH AIR SPACES (STAS)
2677,gemini20,0.89,TUMOR SITE
2678,gemini20,0.7,NODAL SITE(S) EXAMINED
2679,gemini20,0.733,HISTOLOGIC GRADE
2680,gemini20,0.68,LYMPHOVASCULAR INVASION
2681,gemini20,0.698,SPECIMEN LATERALITY
2682,gemini20,0.697,NUMBER OF LYMPH NODES EXAMINED
2683,gemini20,0.768,VISCERAL PLEURA INVASION
2684,gemini20,0.752,PROCEDURE
2685,gemini20,0.815,REGIONAL LYMPH NODE STATUS
2686,gemini20,0.743,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2687,gemini20,0.756,MARGIN STATUS FOR INVASIVE CARCINOMA
2688,gemini20,0.811,TUMOR FOCALITY
2689,gemini20,0.705,VISCERAL PLEURA INVASION
2690,gemini20,0.726,NUMBER OF LYMPH NODES WITH TUMOR
2691,gemini20,0.741,HISTOLOGIC GRADE
2692,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
2693,gemini20,0.685,SPREAD THROUGH AIR SPACES (STAS)
2694,gemini20,0.828,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2695,gemini20,0.811,TUMOR FOCALITY
2696,gemini20,0.739,TUMOR SITE
2697,gemini20,0.671,MARGIN STATUS FOR INVASIVE CARCINOMA
2698,gemini20,0.705,NUMBER OF LYMPH NODES EXAMINED
2699,gemini20,0.697,SPECIMEN LATERALITY
2700,gemini20,0.717,REGIONAL LYMPH NODE STATUS
2701,gemini20,0.733,NODAL SITE(S) EXAMINED
2702,gemini20,0.788,PROCEDURE
2703,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
2704,gemini20,0.685,SPREAD THROUGH AIR SPACES (STAS)
2705,gemini20,0.723,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2706,gemini20,0.748,NODAL SITE(S) EXAMINED
2707,gemini20,0.759,MARGIN STATUS FOR INVASIVE CARCINOMA
2708,gemini20,0.709,VISCERAL PLEURA INVASION
2709,gemini20,0.679,ADDITIONAL FINDINGS
2710,gemini20,0.751,PROCEDURE
2711,gemini20,0.695,LYMPHOVASCULAR INVASION
2712,gemini20,0.783,REGIONAL LYMPH NODE STATUS
2713,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2714,gemini20,0.7,NUMBER OF LYMPH NODES WITH TUMOR
2715,gemini20,0.697,SPECIMEN LATERALITY
2716,gemini20,0.686,TUMOR SITE
2717,gemini20,0.729,NUMBER OF LYMPH NODES EXAMINED
2718,gemini20,0.675,NODAL SITE(S) WITH TUMOR
2719,gemini20,0.718,TUMOR FOCALITY
2720,gemini20,0.7,MARGIN STATUS FOR NON-INVASIVE TUMOR
2721,gemini20,0.736,TUMOR SITE
2722,gemini20,0.67,LYMPHOVASCULAR INVASION
2723,gemini20,0.729,MARGIN STATUS FOR INVASIVE CARCINOMA
2724,gemini20,0.826,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2725,gemini20,0.716,NODAL SITE(S) EXAMINED
2726,gemini20,0.697,SPECIMEN LATERALITY
2727,gemini20,0.762,MARGIN STATUS FOR NON-INVASIVE TUMOR
2728,gemini20,0.703,VISCERAL PLEURA INVASION
2729,gemini20,0.792,ADDITIONAL FINDINGS
2730,gemini20,0.684,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2731,gemini20,0.732,PROCEDURE
2732,gemini20,0.699,TUMOR FOCALITY
2733,gemini20,0.701,HISTOLOGIC GRADE
2734,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
2735,gemini20,0.693,SPREAD THROUGH AIR SPACES (STAS)
2736,gemini20,0.655,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2737,gemini20,0.723,REGIONAL LYMPH NODE STATUS
2738,gemini20,0.752,MARGIN STATUS FOR INVASIVE CARCINOMA
2739,gemini20,0.795,LYMPHOVASCULAR INVASION
2740,gemini20,0.694,SPREAD THROUGH AIR SPACES (STAS)
2741,gemini20,0.724,TUMOR FOCALITY
2742,gemini20,0.788,PROCEDURE
2743,gemini20,0.771,NODAL SITE(S) WITH TUMOR
2744,gemini20,0.723,VISCERAL PLEURA INVASION
2745,gemini20,0.72,NUMBER OF LYMPH NODES WITH TUMOR
2746,gemini20,0.783,REGIONAL LYMPH NODE STATUS
2747,gemini20,0.686,NUMBER OF LYMPH NODES EXAMINED
2748,gemini20,0.705,MARGIN STATUS FOR NON-INVASIVE TUMOR
2749,gemini20,0.723,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2750,gemini20,0.697,SPECIMEN LATERALITY
2751,gemini20,0.692,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2752,gemini20,0.715,HISTOLOGIC GRADE
2753,gemini20,0.691,NODAL SITE(S) EXAMINED
2754,gemini20,0.725,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2755,gemini20,0.882,TUMOR SITE
2756,gemini20,0.683,LYMPH NODE(S) FROM PRIOR PROCEDURES
2757,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2758,gemini20,0.815,REGIONAL LYMPH NODE STATUS
2759,gemini20,0.811,TUMOR FOCALITY
2760,gemini20,0.8,LYMPHOVASCULAR INVASION
2761,gemini20,0.782,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2762,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2763,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
2764,gemini20,0.878,TUMOR SITE
2765,gemini20,0.701,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2766,gemini20,0.659,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2767,gemini20,0.733,VISCERAL PLEURA INVASION
2768,gemini20,0.729,PROCEDURE
2769,gemini20,0.825,NODAL SITE(S) EXAMINED
2770,gemini20,0.697,SPECIMEN LATERALITY
2771,gemini20,0.904,HISTOLOGIC GRADE
2772,gemini20,0.78,REGIONAL LYMPH NODE STATUS
2773,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2774,gemini20,0.89,TUMOR SITE
2775,gemini20,0.7,NUMBER OF LYMPH NODES EXAMINED
2776,gemini20,0.696,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2777,gemini20,0.723,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2778,gemini20,0.701,PROCEDURE
2779,gemini20,0.697,VISCERAL PLEURA INVASION
2780,gemini20,0.811,TUMOR FOCALITY
2781,gemini20,0.677,SPREAD THROUGH AIR SPACES (STAS)
2782,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
2783,gemini20,0.845,NODAL SITE(S) EXAMINED
2784,gemini20,0.713,NUMBER OF LYMPH NODES WITH TUMOR
2785,gemini20,0.697,SPECIMEN LATERALITY
2786,gemini20,0.758,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2787,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2788,gemini20,0.712,NODAL SITE(S) WITH TUMOR
2789,gemini20,0.774,NODAL SITE(S) EXAMINED
2790,gemini20,0.736,VISCERAL PLEURA INVASION
2791,gemini20,0.698,SPECIMEN LATERALITY
2792,gemini20,0.717,MARGIN STATUS FOR NON-INVASIVE TUMOR
2793,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2794,gemini20,0.698,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2795,gemini20,0.759,TUMOR SITE
2796,gemini20,0.717,TUMOR FOCALITY
2797,gemini20,0.812,ADDITIONAL FINDINGS
2798,gemini20,0.718,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2799,gemini20,0.757,MARGIN STATUS FOR INVASIVE CARCINOMA
2800,gemini20,0.817,REGIONAL LYMPH NODE STATUS
2801,gemini20,0.713,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2802,gemini20,0.683,HISTOLOGIC GRADE
2803,gemini20,0.732,PROCEDURE
2804,gemini20,0.697,NUMBER OF LYMPH NODES EXAMINED
2805,gemini20,0.829,REGIONAL LYMPH NODE STATUS
2806,gemini20,0.879,TUMOR SITE
2807,gemini20,0.689,HISTOLOGIC GRADE
2808,gemini20,0.749,PROCEDURE
2809,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2810,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
2811,gemini20,0.714,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2812,gemini20,0.734,ADDITIONAL FINDINGS
2813,gemini20,0.747,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2814,gemini20,0.698,SPECIMEN LATERALITY
2815,gemini20,0.694,SPREAD THROUGH AIR SPACES (STAS)
2816,gemini20,0.693,VISCERAL PLEURA INVASION
2817,gemini20,0.732,MARGIN STATUS FOR INVASIVE CARCINOMA
2818,gemini20,0.826,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2819,gemini20,0.811,TUMOR FOCALITY
2820,gemini20,0.705,NODAL SITE(S) EXAMINED
2821,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2822,gemini20,0.793,TUMOR SITE
2823,gemini20,0.814,HISTOLOGIC GRADE
2824,gemini20,0.775,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2825,gemini20,0.694,VISCERAL PLEURA INVASION
2826,gemini20,0.811,TUMOR FOCALITY
2827,gemini20,0.724,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2828,gemini20,0.725,NUMBER OF LYMPH NODES EXAMINED
2829,gemini20,0.698,SPECIMEN LATERALITY
2830,gemini20,0.715,PROCEDURE
2831,gemini20,0.776,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2832,gemini20,0.8,ADDITIONAL FINDINGS
2833,gemini20,0.774,NODAL SITE(S) EXAMINED
2834,gemini20,0.815,REGIONAL LYMPH NODE STATUS
2835,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
2836,gemini20,0.766,LYMPHOVASCULAR INVASION
2837,gemini20,0.72,VISCERAL PLEURA INVASION
2838,gemini20,0.736,PROCEDURE
2839,gemini20,0.705,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2840,gemini20,0.811,TUMOR FOCALITY
2841,gemini20,0.697,SPECIMEN LATERALITY
2842,gemini20,0.715,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2843,gemini20,0.815,REGIONAL LYMPH NODE STATUS
2844,gemini20,0.887,TUMOR SITE
2845,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
2846,gemini20,0.7,NUMBER OF LYMPH NODES EXAMINED
2847,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2848,gemini20,0.855,NODAL SITE(S) EXAMINED
2849,gemini20,0.89,HISTOLOGIC GRADE
2850,gemini20,0.779,LYMPH NODE(S) FROM PRIOR PROCEDURES
2851,gemini20,0.738,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2852,gemini20,0.793,ADDITIONAL FINDINGS
2853,gemini20,0.697,SPECIMEN LATERALITY
2854,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2855,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
2856,gemini20,0.781,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2857,gemini20,0.715,REGIONAL LYMPH NODE STATUS
2858,gemini20,0.694,VISCERAL PLEURA INVASION
2859,gemini20,0.741,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2860,gemini20,0.713,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2861,gemini20,0.686,LYMPHOVASCULAR INVASION
2862,gemini20,0.718,PROCEDURE
2863,gemini20,0.82,NODAL SITE(S) EXAMINED
2864,gemini20,0.767,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2865,gemini20,0.733,HISTOLOGIC GRADE
2866,gemini20,0.719,TUMOR FOCALITY
2867,gemini20,0.876,TUMOR SITE
2868,gemini20,0.721,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2869,gemini20,0.802,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2870,gemini20,0.896,TUMOR SITE
2871,gemini20,0.719,REGIONAL LYMPH NODE STATUS
2872,gemini20,0.694,SPREAD THROUGH AIR SPACES (STAS)
2873,gemini20,0.764,VISCERAL PLEURA INVASION
2874,gemini20,0.732,HISTOLOGIC GRADE
2875,gemini20,0.896,MARGIN STATUS FOR INVASIVE CARCINOMA
2876,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
2877,gemini20,0.697,SPECIMEN LATERALITY
2878,gemini20,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2879,gemini20,0.918,TUMOR FOCALITY
2880,gemini20,0.798,NODAL SITE(S) EXAMINED
2881,gemini20,0.76,ADDITIONAL FINDINGS
2882,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2883,gemini20,0.688,PROCEDURE
2884,gemini20,0.783,REGIONAL LYMPH NODE STATUS
2885,gemini20,0.766,LYMPHOVASCULAR INVASION
2886,gemini20,0.729,TUMOR FOCALITY
2887,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
2888,gemini20,0.835,NODAL SITE(S) EXAMINED
2889,gemini20,0.884,TUMOR SITE
2890,gemini20,0.886,NODAL SITE(S) WITH TUMOR
2891,gemini20,0.766,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2892,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2893,gemini20,0.778,VISCERAL PLEURA INVASION
2894,gemini20,0.892,HISTOLOGIC GRADE
2895,gemini20,0.764,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2896,gemini20,0.697,SPECIMEN LATERALITY
2897,gemini20,0.788,NUMBER OF LYMPH NODES EXAMINED
2898,gemini20,0.72,NUMBER OF LYMPH NODES WITH TUMOR
2899,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
2900,gemini20,0.788,PROCEDURE
2901,gemini20,0.837,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2902,gemini20,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2903,gemini20,0.851,TUMOR SITE
2904,gemini20,0.697,SPECIMEN LATERALITY
2905,gemini20,0.904,HISTOLOGIC GRADE
2906,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
2907,gemini20,0.68,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2908,gemini20,0.826,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2909,gemini20,0.729,PROCEDURE
2910,gemini20,0.706,VISCERAL PLEURA INVASION
2911,gemini20,0.835,ADDITIONAL FINDINGS
2912,gemini20,0.811,TUMOR FOCALITY
2913,gemini20,0.815,REGIONAL LYMPH NODE STATUS
2914,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2915,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2916,gemini20,0.797,NODAL SITE(S) EXAMINED
2917,gemini20,0.698,SPECIMEN LATERALITY
2918,gemini20,0.786,PROCEDURE
2919,gemini20,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2920,gemini20,0.811,TUMOR FOCALITY
2921,gemini20,0.767,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2922,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
2923,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
2924,gemini20,0.76,NUMBER OF LYMPH NODES EXAMINED
2925,gemini20,0.713,VISCERAL PLEURA INVASION
2926,gemini20,0.822,REGIONAL LYMPH NODE STATUS
2927,gemini20,0.843,TUMOR SITE
2928,gemini20,0.656,NODAL SITE(S) EXAMINED
2929,gemini20,0.72,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2930,gemini20,0.896,MARGIN STATUS FOR INVASIVE CARCINOMA
2931,gemini20,0.815,REGIONAL LYMPH NODE STATUS
2932,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2933,gemini20,0.895,TUMOR SITE
2934,gemini20,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2935,gemini20,0.697,SPECIMEN LATERALITY
2936,gemini20,0.734,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2937,gemini20,0.829,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2938,gemini20,0.77,PROCEDURE
2939,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
2940,gemini20,0.689,NODAL SITE(S) EXAMINED
2941,gemini20,0.811,TUMOR FOCALITY
2942,gemini20,0.707,VISCERAL PLEURA INVASION
2943,gemini20,0.78,SPREAD THROUGH AIR SPACES (STAS)
2944,gemini20,0.76,HISTOLOGIC GRADE
2945,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
2946,gemini20,0.718,HISTOLOGIC GRADE
2947,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
2948,gemini20,0.754,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2949,gemini20,0.693,VISCERAL PLEURA INVASION
2950,gemini20,0.731,TNM DESCRIPTORS
2951,gemini20,0.803,NODAL SITE(S) EXAMINED
2952,gemini20,0.699,SPREAD THROUGH AIR SPACES (STAS)
2953,gemini20,0.792,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2954,gemini20,0.698,SPECIMEN LATERALITY
2955,gemini20,0.769,TUMOR SITE
2956,gemini20,0.779,LYMPH NODE(S) FROM PRIOR PROCEDURES
2957,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2958,gemini20,0.734,NUMBER OF LYMPH NODES EXAMINED
2959,gemini20,0.704,REGIONAL LYMPH NODE STATUS
2960,gemini20,0.673,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2961,gemini20,0.676,TUMOR FOCALITY
2962,gemini20,0.697,SPECIMEN LATERALITY
2963,gemini20,0.677,SPREAD THROUGH AIR SPACES (STAS)
2964,gemini20,0.817,REGIONAL LYMPH NODE STATUS
2965,gemini20,0.851,TUMOR SITE
2966,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
2967,gemini20,0.712,MARGIN STATUS FOR INVASIVE CARCINOMA
2968,gemini20,0.811,TUMOR FOCALITY
2969,gemini20,0.694,VISCERAL PLEURA INVASION
2970,gemini20,0.766,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2971,gemini20,0.769,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2972,gemini20,0.782,NODAL SITE(S) EXAMINED
2973,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
2974,gemini20,0.731,PROCEDURE
2975,gemini20,0.7,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2976,gemini20,0.811,TUMOR FOCALITY
2977,gemini20,0.756,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2978,gemini20,0.799,NODAL SITE(S) EXAMINED
2979,gemini20,0.685,SPREAD THROUGH AIR SPACES (STAS)
2980,gemini20,0.781,ADDITIONAL FINDINGS
2981,gemini20,0.698,SPECIMEN LATERALITY
2982,gemini20,0.727,NUMBER OF LYMPH NODES EXAMINED
2983,gemini20,0.716,PROCEDURE
2984,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2985,gemini20,0.819,MARGIN STATUS FOR NON-INVASIVE TUMOR
2986,gemini20,0.789,REGIONAL LYMPH NODE STATUS
2987,gemini20,0.814,HISTOLOGIC GRADE
2988,gemini20,0.672,VISCERAL PLEURA INVASION
2989,gemini20,0.872,NODAL SITE(S) WITH TUMOR
2990,gemini20,0.801,TUMOR SITE
2991,gemini20,0.75,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2992,gemini20,0.74,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2993,gemini20,0.706,LYMPHOVASCULAR INVASION
2994,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2995,gemini20,0.757,NODAL SITE(S) EXAMINED
2996,gemini20,0.859,ADDITIONAL FINDINGS
2997,gemini20,0.882,TUMOR SITE
2998,gemini20,0.713,NUMBER OF LYMPH NODES WITH TUMOR
2999,gemini20,0.683,LYMPH NODE(S) FROM PRIOR PROCEDURES
3000,gemini20,0.682,SPREAD THROUGH AIR SPACES (STAS)
3001,gemini20,0.74,NODAL SITE(S) WITH TUMOR
3002,gemini20,0.721,REGIONAL LYMPH NODE STATUS
3003,gemini20,0.697,SPECIMEN LATERALITY
3004,gemini20,0.691,VISCERAL PLEURA INVASION
3005,gemini20,0.705,HISTOLOGIC GRADE
3006,gemini20,0.697,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3007,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
3008,gemini20,0.7,NUMBER OF LYMPH NODES EXAMINED
3009,gemini20,0.775,PROCEDURE
3010,gemini20,0.713,TUMOR FOCALITY
3011,gemini20,0.684,LYMPHOVASCULAR INVASION
3012,gemini20,0.7,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3013,gemini20,0.72,NUMBER OF LYMPH NODES EXAMINED
3014,gemini20,0.69,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3015,gemini20,0.708,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3016,gemini20,0.698,SPECIMEN LATERALITY
3017,gemini20,0.641,VISCERAL PLEURA INVASION
3018,gemini20,0.676,TUMOR SITE
3019,gemini20,0.694,HISTOLOGIC GRADE
3020,gemini20,0.793,PROCEDURE
3021,gemini20,0.683,LYMPH NODE(S) FROM PRIOR PROCEDURES
3022,gemini20,0.704,MARGIN STATUS FOR INVASIVE CARCINOMA
3023,gemini20,0.664,TUMOR FOCALITY
3024,gemini20,0.815,REGIONAL LYMPH NODE STATUS
3025,gemini20,0.708,LYMPHOVASCULAR INVASION
3026,gemini20,0.645,SPREAD THROUGH AIR SPACES (STAS)
3027,gemini20,0.705,MARGIN STATUS FOR NON-INVASIVE TUMOR
3028,gemini20,0.747,NODAL SITE(S) EXAMINED
3029,gemini20,0.761,NODAL SITE(S) EXAMINED
3030,gemini20,0.791,TUMOR SITE
3031,gemini20,0.709,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3032,gemini20,0.693,MARGIN STATUS FOR INVASIVE CARCINOMA
3033,gemini20,0.815,REGIONAL LYMPH NODE STATUS
3034,gemini20,0.677,SPREAD THROUGH AIR SPACES (STAS)
3035,gemini20,0.717,MARGIN STATUS FOR NON-INVASIVE TUMOR
3036,gemini20,0.788,PROCEDURE
3037,gemini20,0.697,SPECIMEN LATERALITY
3038,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3039,gemini20,0.778,ADDITIONAL FINDINGS
3040,gemini20,0.702,HISTOLOGIC GRADE
3041,gemini20,0.749,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3042,gemini20,0.811,TUMOR FOCALITY
3043,gemini20,0.676,VISCERAL PLEURA INVASION
3044,gemini20,0.779,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3045,gemini20,0.698,HISTOLOGIC GRADE
3046,gemini20,0.694,SPREAD THROUGH AIR SPACES (STAS)
3047,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3048,gemini20,0.811,PROCEDURE
3049,gemini20,0.791,TUMOR SITE
3050,gemini20,0.708,NUMBER OF LYMPH NODES EXAMINED
3051,gemini20,0.754,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3052,gemini20,0.69,VISCERAL PLEURA INVASION
3053,gemini20,0.745,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3054,gemini20,0.811,TUMOR FOCALITY
3055,gemini20,0.815,REGIONAL LYMPH NODE STATUS
3056,gemini20,0.715,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3057,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
3058,gemini20,0.697,SPECIMEN LATERALITY
3059,gemini20,0.741,MARGIN STATUS FOR INVASIVE CARCINOMA
3060,gemini20,0.814,NODAL SITE(S) EXAMINED
3061,gemini20,0.692,LYMPH NODE(S) FROM PRIOR PROCEDURES
3062,gemini20,0.703,HISTOLOGIC GRADE
3063,gemini20,0.646,LYMPHOVASCULAR INVASION
3064,gemini20,0.789,TUMOR SITE
3065,gemini20,0.676,NODAL SITE(S) EXAMINED
3066,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
3067,gemini20,0.697,SPECIMEN LATERALITY
3068,gemini20,0.746,VISCERAL PLEURA INVASION
3069,gemini20,0.804,REGIONAL LYMPH NODE STATUS
3070,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3071,gemini20,0.718,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3072,gemini20,0.73,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3073,gemini20,0.735,PROCEDURE
3074,gemini20,0.776,TUMOR FOCALITY
3075,gemini20,0.719,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3076,gemini20,0.762,MARGIN STATUS FOR INVASIVE CARCINOMA
3077,gemini20,0.878,TUMOR SITE
3078,gemini20,0.753,PROCEDURE
3079,gemini20,0.73,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3080,gemini20,0.82,NODAL SITE(S) EXAMINED
3081,gemini20,0.822,REGIONAL LYMPH NODE STATUS
3082,gemini20,0.892,HISTOLOGIC GRADE
3083,gemini20,0.695,NUMBER OF LYMPH NODES EXAMINED
3084,gemini20,0.811,TUMOR FOCALITY
3085,gemini20,0.825,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3086,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
3087,gemini20,0.697,SPECIMEN LATERALITY
3088,gemini20,0.705,VISCERAL PLEURA INVASION
3089,gemini20,0.693,SPREAD THROUGH AIR SPACES (STAS)
3090,gemini20,0.744,MARGIN STATUS FOR INVASIVE CARCINOMA
3091,gemini20,0.783,REGIONAL LYMPH NODE STATUS
3092,gemini20,0.793,TUMOR SITE
3093,gemini20,0.716,HISTOLOGIC GRADE
3094,gemini20,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3095,gemini20,0.731,TUMOR FOCALITY
3096,gemini20,0.698,SPECIMEN LATERALITY
3097,gemini20,0.669,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3098,gemini20,0.697,PROCEDURE
3099,gemini20,0.774,NUMBER OF LYMPH NODES EXAMINED
3100,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
3101,gemini20,0.681,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3102,gemini20,0.713,NUMBER OF LYMPH NODES WITH TUMOR
3103,gemini20,0.701,NODAL SITE(S) EXAMINED
3104,gemini20,0.705,VISCERAL PLEURA INVASION
3105,gemini20,0.644,NODAL SITE(S) WITH TUMOR
3106,gemini20,0.705,MARGIN STATUS FOR NON-INVASIVE TUMOR
3107,gemini20,0.763,ADDITIONAL FINDINGS
3108,gemini20,0.789,MARGIN STATUS FOR INVASIVE CARCINOMA
3109,gemini20,0.67,SPREAD THROUGH AIR SPACES (STAS)
3110,gemini20,0.703,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3111,gemini20,0.722,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3112,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3113,gemini20,0.887,TUMOR SITE
3114,gemini20,0.728,HISTOLOGIC GRADE
3115,gemini20,0.788,NODAL SITE(S) WITH TUMOR
3116,gemini20,0.664,TUMOR FOCALITY
3117,gemini20,0.863,NODAL SITE(S) EXAMINED
3118,gemini20,0.705,MARGIN STATUS FOR NON-INVASIVE TUMOR
3119,gemini20,0.725,REGIONAL LYMPH NODE STATUS
3120,gemini20,0.663,VISCERAL PLEURA INVASION
3121,gemini20,0.669,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3122,gemini20,0.714,PROCEDURE
3123,gemini20,0.72,NUMBER OF LYMPH NODES WITH TUMOR
3124,gemini20,0.697,SPECIMEN LATERALITY
3125,gemini20,0.788,PROCEDURE
3126,gemini20,0.713,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3127,gemini20,0.717,MARGIN STATUS FOR NON-INVASIVE TUMOR
3128,gemini20,0.697,SPECIMEN LATERALITY
3129,gemini20,0.718,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3130,gemini20,0.776,NODAL SITE(S) EXAMINED
3131,gemini20,0.678,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3132,gemini20,0.757,MARGIN STATUS FOR INVASIVE CARCINOMA
3133,gemini20,0.796,TUMOR FOCALITY
3134,gemini20,0.789,TUMOR SITE
3135,gemini20,0.769,HISTOLOGIC GRADE
3136,gemini20,0.693,NUMBER OF LYMPH NODES EXAMINED
3137,gemini20,0.815,REGIONAL LYMPH NODE STATUS
3138,gemini20,0.726,VISCERAL PLEURA INVASION
3139,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
3140,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3141,gemini20,0.783,REGIONAL LYMPH NODE STATUS
3142,gemini20,0.84,NODAL SITE(S) EXAMINED
3143,gemini20,0.717,PROCEDURE
3144,gemini20,0.764,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3145,gemini20,0.732,VISCERAL PLEURA INVASION
3146,gemini20,0.72,NUMBER OF LYMPH NODES WITH TUMOR
3147,gemini20,0.892,HISTOLOGIC GRADE
3148,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
3149,gemini20,0.87,TUMOR SITE
3150,gemini20,0.697,SPECIMEN LATERALITY
3151,gemini20,0.872,NODAL SITE(S) WITH TUMOR
3152,gemini20,0.75,MARGIN STATUS FOR INVASIVE CARCINOMA
3153,gemini20,0.745,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3154,gemini20,0.758,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3155,gemini20,0.685,SPREAD THROUGH AIR SPACES (STAS)
3156,gemini20,0.811,TUMOR FOCALITY
3157,gemini20,0.788,PROCEDURE
3158,gemini20,0.771,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3159,gemini20,0.811,TUMOR FOCALITY
3160,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
3161,gemini20,0.7,NUMBER OF LYMPH NODES EXAMINED
3162,gemini20,0.676,SPREAD THROUGH AIR SPACES (STAS)
3163,gemini20,0.792,TUMOR SITE
3164,gemini20,0.773,REGIONAL LYMPH NODE STATUS
3165,gemini20,0.722,NODAL SITE(S) WITH TUMOR
3166,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3167,gemini20,0.676,LYMPHOVASCULAR INVASION
3168,gemini20,0.72,NUMBER OF LYMPH NODES WITH TUMOR
3169,gemini20,0.711,HISTOLOGIC GRADE
3170,gemini20,0.663,MARGIN STATUS FOR INVASIVE CARCINOMA
3171,gemini20,0.673,VISCERAL PLEURA INVASION
3172,gemini20,0.779,NODAL SITE(S) EXAMINED
3173,gemini20,0.698,SPECIMEN LATERALITY
3174,gemini20,0.768,MARGIN STATUS FOR INVASIVE CARCINOMA
3175,gemini20,0.811,TUMOR FOCALITY
3176,gemini20,0.708,PROCEDURE
3177,gemini20,0.747,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3178,gemini20,0.75,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3179,gemini20,0.693,VISCERAL PLEURA INVASION
3180,gemini20,0.832,NODAL SITE(S) EXAMINED
3181,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3182,gemini20,0.699,SPREAD THROUGH AIR SPACES (STAS)
3183,gemini20,0.724,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3184,gemini20,0.778,REGIONAL LYMPH NODE STATUS
3185,gemini20,0.789,TUMOR SITE
3186,gemini20,0.697,SPECIMEN LATERALITY
3187,gemini20,0.769,HISTOLOGIC GRADE
3188,gemini20,0.693,NUMBER OF LYMPH NODES EXAMINED
3189,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
3190,gemini20,0.768,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3191,gemini20,0.676,SPREAD THROUGH AIR SPACES (STAS)
3192,gemini20,0.76,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3193,gemini20,0.747,MARGIN STATUS FOR INVASIVE CARCINOMA
3194,gemini20,0.73,PROCEDURE
3195,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3196,gemini20,0.811,TUMOR FOCALITY
3197,gemini20,0.697,NODAL SITE(S) EXAMINED
3198,gemini20,0.788,HISTOLOGIC GRADE
3199,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
3200,gemini20,0.713,NUMBER OF LYMPH NODES EXAMINED
3201,gemini20,0.815,REGIONAL LYMPH NODE STATUS
3202,gemini20,0.884,TUMOR SITE
3203,gemini20,0.713,VISCERAL PLEURA INVASION
3204,gemini20,0.711,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3205,gemini20,0.698,SPECIMEN LATERALITY
3206,gemini20,0.855,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3207,gemini20,0.692,MARGIN STATUS FOR NON-INVASIVE TUMOR
3208,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3209,gemini20,0.705,VISCERAL PLEURA INVASION
3210,gemini20,0.815,REGIONAL LYMPH NODE STATUS
3211,gemini20,0.801,NODAL SITE(S) EXAMINED
3212,gemini20,0.792,MARGIN STATUS FOR INVASIVE CARCINOMA
3213,gemini20,0.814,HISTOLOGIC GRADE
3214,gemini20,0.811,TUMOR FOCALITY
3215,gemini20,0.841,ADDITIONAL FINDINGS
3216,gemini20,0.714,PROCEDURE
3217,gemini20,0.733,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3218,gemini20,0.697,SPECIMEN LATERALITY
3219,gemini20,0.741,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3220,gemini20,0.698,NUMBER OF LYMPH NODES EXAMINED
3221,gemini20,0.737,TUMOR SITE
3222,gemini20,0.699,MARGIN STATUS FOR INVASIVE CARCINOMA
3223,gemini20,0.68,TNM DESCRIPTORS
3224,gemini20,0.782,HISTOLOGIC GRADE
3225,gemini20,0.73,MARGIN STATUS FOR NON-INVASIVE TUMOR
3226,gemini20,0.819,ADDITIONAL FINDINGS
3227,gemini20,0.671,TUMOR FOCALITY
3228,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3229,gemini20,0.685,SPREAD THROUGH AIR SPACES (STAS)
3230,gemini20,0.674,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3231,gemini20,0.771,TUMOR SITE
3232,gemini20,0.815,REGIONAL LYMPH NODE STATUS
3233,gemini20,0.718,PROCEDURE
3234,gemini20,0.746,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3235,gemini20,0.698,SPECIMEN LATERALITY
3236,gemini20,0.696,NODAL SITE(S) EXAMINED
3237,gemini20,0.735,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3238,gemini20,0.707,NUMBER OF LYMPH NODES EXAMINED
3239,gemini20,0.694,VISCERAL PLEURA INVASION
3240,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3241,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
3242,gemini20,0.815,REGIONAL LYMPH NODE STATUS
3243,gemini20,0.698,NUMBER OF LYMPH NODES EXAMINED
3244,gemini20,0.697,SPECIMEN LATERALITY
3245,gemini20,0.707,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3246,gemini20,0.77,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3247,gemini20,0.708,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3248,gemini20,0.782,ADDITIONAL FINDINGS
3249,gemini20,0.724,NODAL SITE(S) EXAMINED
3250,gemini20,0.788,PROCEDURE
3251,gemini20,0.756,MARGIN STATUS FOR INVASIVE CARCINOMA
3252,gemini20,0.683,SPREAD THROUGH AIR SPACES (STAS)
3253,gemini20,0.811,TUMOR FOCALITY
3254,gemini20,0.91,TUMOR SITE
3255,gemini20,0.707,VISCERAL PLEURA INVASION
3256,gemini20,0.735,HISTOLOGIC GRADE
3257,gemini20,0.704,SPREAD THROUGH AIR SPACES (STAS)
3258,gemini20,0.792,ADDITIONAL FINDINGS
3259,gemini20,0.811,TUMOR FOCALITY
3260,gemini20,0.71,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3261,gemini20,0.693,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3262,gemini20,0.696,NUMBER OF LYMPH NODES EXAMINED
3263,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
3264,gemini20,0.821,NODAL SITE(S) EXAMINED
3265,gemini20,0.698,SPECIMEN LATERALITY
3266,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3267,gemini20,0.77,TUMOR SITE
3268,gemini20,0.719,TNM DESCRIPTORS
3269,gemini20,0.685,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3270,gemini20,0.706,VISCERAL PLEURA INVASION
3271,gemini20,0.676,REGIONAL LYMPH NODE STATUS
3272,gemini20,0.712,PROCEDURE
3273,gemini20,0.688,NUMBER OF LYMPH NODES EXAMINED
3274,gemini20,0.783,REGIONAL LYMPH NODE STATUS
3275,gemini20,0.759,ADDITIONAL FINDINGS
3276,gemini20,0.698,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3277,gemini20,0.72,NUMBER OF LYMPH NODES WITH TUMOR
3278,gemini20,0.723,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3279,gemini20,0.683,PROCEDURE
3280,gemini20,0.775,NODAL SITE(S) EXAMINED
3281,gemini20,0.68,TUMOR FOCALITY
3282,gemini20,0.746,MARGIN STATUS FOR INVASIVE CARCINOMA
3283,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3284,gemini20,0.746,VISCERAL PLEURA INVASION
3285,gemini20,0.876,TUMOR SITE
3286,gemini20,0.751,NODAL SITE(S) WITH TUMOR
3287,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
3288,gemini20,0.697,SPECIMEN LATERALITY
3289,gemini20,0.668,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3290,gemini20,0.734,ADDITIONAL FINDINGS
3291,gemini20,0.779,LYMPH NODE(S) FROM PRIOR PROCEDURES
3292,gemini20,0.793,TUMOR SITE
3293,gemini20,0.704,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3294,gemini20,0.681,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3295,gemini20,0.676,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3296,gemini20,0.815,REGIONAL LYMPH NODE STATUS
3297,gemini20,0.713,PROCEDURE
3298,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3299,gemini20,0.78,NODAL SITE(S) EXAMINED
3300,gemini20,0.677,TUMOR FOCALITY
3301,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
3302,gemini20,0.673,VISCERAL PLEURA INVASION
3303,gemini20,0.699,TNM DESCRIPTORS
3304,gemini20,0.698,SPECIMEN LATERALITY
3305,gemini20,0.748,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3306,gemini20,0.698,SPECIMEN LATERALITY
3307,gemini20,0.709,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3308,gemini20,0.754,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3309,gemini20,0.71,PROCEDURE
3310,gemini20,0.811,TUMOR FOCALITY
3311,gemini20,0.779,LYMPH NODE(S) FROM PRIOR PROCEDURES
3312,gemini20,0.858,NODAL SITE(S) EXAMINED
3313,gemini20,0.761,MARGIN STATUS FOR INVASIVE CARCINOMA
3314,gemini20,0.755,MARGIN STATUS FOR NON-INVASIVE TUMOR
3315,gemini20,0.849,TUMOR SITE
3316,gemini20,0.764,VISCERAL PLEURA INVASION
3317,gemini20,0.815,REGIONAL LYMPH NODE STATUS
3318,gemini20,0.714,PROCEDURE
3319,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3320,gemini20,0.745,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3321,gemini20,0.706,NODAL SITE(S) EXAMINED
3322,gemini20,0.696,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3323,gemini20,0.822,REGIONAL LYMPH NODE STATUS
3324,gemini20,0.697,SPECIMEN LATERALITY
3325,gemini20,0.694,SPREAD THROUGH AIR SPACES (STAS)
3326,gemini20,0.729,ADDITIONAL FINDINGS
3327,gemini20,0.755,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3328,gemini20,0.729,VISCERAL PLEURA INVASION
3329,gemini20,0.712,MARGIN STATUS FOR INVASIVE CARCINOMA
3330,gemini20,0.712,NUMBER OF LYMPH NODES EXAMINED
3331,gemini20,0.896,TUMOR SITE
3332,gemini20,0.811,TUMOR FOCALITY
3333,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
3334,gemini20,0.647,TUMOR FOCALITY
3335,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3336,gemini20,0.694,NUMBER OF LYMPH NODES EXAMINED
3337,gemini20,0.668,HISTOLOGIC GRADE
3338,gemini20,0.785,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3339,gemini20,0.699,SPREAD THROUGH AIR SPACES (STAS)
3340,gemini20,0.709,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3341,gemini20,0.716,PROCEDURE
3342,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3343,gemini20,0.76,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3344,gemini20,0.698,SPECIMEN LATERALITY
3345,gemini20,0.815,REGIONAL LYMPH NODE STATUS
3346,gemini20,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3347,gemini20,0.89,TUMOR SITE
3348,gemini20,0.761,VISCERAL PLEURA INVASION
3349,gemini20,0.705,TNM DESCRIPTORS
3350,gemini20,0.801,NODAL SITE(S) EXAMINED
3351,gemini20,0.685,LYMPHOVASCULAR INVASION
3352,gemini20,0.76,NODAL SITE(S) WITH TUMOR
3353,gemini20,0.822,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3354,gemini20,0.694,SPREAD THROUGH AIR SPACES (STAS)
3355,gemini20,0.78,REGIONAL LYMPH NODE STATUS
3356,gemini20,0.7,NUMBER OF LYMPH NODES WITH TUMOR
3357,gemini20,0.865,TUMOR SITE
3358,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
3359,gemini20,0.772,MARGIN STATUS FOR INVASIVE CARCINOMA
3360,gemini20,0.692,HISTOLOGIC GRADE
3361,gemini20,0.788,PROCEDURE
3362,gemini20,0.694,VISCERAL PLEURA INVASION
3363,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3364,gemini20,0.79,NODAL SITE(S) EXAMINED
3365,gemini20,0.697,SPECIMEN LATERALITY
3366,gemini20,0.811,TUMOR FOCALITY
3367,gemini20,0.804,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3368,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
3369,gemini20,0.799,MARGIN STATUS FOR INVASIVE CARCINOMA
3370,gemini20,0.811,TUMOR FOCALITY
3371,gemini20,0.876,ADDITIONAL FINDINGS
3372,gemini20,0.75,NODAL SITE(S) EXAMINED
3373,gemini20,0.764,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3374,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3375,gemini20,0.73,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3376,gemini20,0.698,HISTOLOGIC GRADE
3377,gemini20,0.753,PROCEDURE
3378,gemini20,0.697,SPECIMEN LATERALITY
3379,gemini20,0.713,NUMBER OF LYMPH NODES EXAMINED
3380,gemini20,0.721,VISCERAL PLEURA INVASION
3381,gemini20,0.837,TUMOR SITE
3382,gemini20,0.815,REGIONAL LYMPH NODE STATUS
3383,gemini20,0.689,SPREAD THROUGH AIR SPACES (STAS)
3384,gemini20,0.701,NUMBER OF LYMPH NODES EXAMINED
3385,gemini20,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3386,gemini20,0.826,NODAL SITE(S) EXAMINED
3387,gemini20,0.874,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3388,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3389,gemini20,0.879,NODAL SITE(S) WITH TUMOR
3390,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
3391,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
3392,gemini20,0.768,VISCERAL PLEURA INVASION
3393,gemini20,0.785,TUMOR SITE
3394,gemini20,0.692,HISTOLOGIC GRADE
3395,gemini20,0.778,SPREAD THROUGH AIR SPACES (STAS)
3396,gemini20,0.713,NUMBER OF LYMPH NODES WITH TUMOR
3397,gemini20,0.797,REGIONAL LYMPH NODE STATUS
3398,gemini20,0.698,SPECIMEN LATERALITY
3399,gemini20,0.788,PROCEDURE
3400,gemini20,0.724,TUMOR FOCALITY
3401,gemini20,0.769,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3402,gemini20,0.738,PROCEDURE
3403,gemini20,0.689,SPREAD THROUGH AIR SPACES (STAS)
3404,gemini20,0.682,TUMOR FOCALITY
3405,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
3406,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3407,gemini20,0.734,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3408,gemini20,0.734,NODAL SITE(S) WITH TUMOR
3409,gemini20,0.783,REGIONAL LYMPH NODE STATUS
3410,gemini20,0.721,VISCERAL PLEURA INVASION
3411,gemini20,0.785,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3412,gemini20,0.771,NODAL SITE(S) EXAMINED
3413,gemini20,0.712,TNM DESCRIPTORS
3414,gemini20,0.696,HISTOLOGIC GRADE
3415,gemini20,0.697,SPECIMEN LATERALITY
3416,gemini20,0.76,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3417,gemini20,0.773,TUMOR SITE
3418,gemini20,0.896,MARGIN STATUS FOR INVASIVE CARCINOMA
3419,gemini20,0.75,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3420,gemini20,0.713,NODAL SITE(S) EXAMINED
3421,gemini20,0.761,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3422,gemini20,0.781,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3423,gemini20,0.687,VISCERAL PLEURA INVASION
3424,gemini20,0.684,SPREAD THROUGH AIR SPACES (STAS)
3425,gemini20,0.815,REGIONAL LYMPH NODE STATUS
3426,gemini20,0.873,TUMOR SITE
3427,gemini20,0.697,SPECIMEN LATERALITY
3428,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
3429,gemini20,0.754,PROCEDURE
3430,gemini20,0.713,NUMBER OF LYMPH NODES EXAMINED
3431,gemini20,0.763,MARGIN STATUS FOR INVASIVE CARCINOMA
3432,gemini20,0.811,TUMOR FOCALITY
3433,gemini20,0.689,HISTOLOGIC GRADE
3434,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3435,gemini20,0.882,TUMOR SITE
3436,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
3437,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3438,gemini20,0.759,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3439,gemini20,0.698,SPECIMEN LATERALITY
3440,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3441,gemini20,0.83,TUMOR SITE
3442,gemini20,0.697,HISTOLOGIC GRADE
3443,gemini20,0.75,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3444,gemini20,0.706,NODAL SITE(S) EXAMINED
3445,gemini20,0.778,SPREAD THROUGH AIR SPACES (STAS)
3446,gemini20,0.741,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3447,gemini20,0.811,TUMOR FOCALITY
3448,gemini20,0.733,PROCEDURE
3449,gemini20,0.711,VISCERAL PLEURA INVASION
3450,gemini20,0.815,REGIONAL LYMPH NODE STATUS
3451,gemini20,0.896,TUMOR SITE
3452,gemini20,0.7,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3453,gemini20,0.737,MARGIN STATUS FOR INVASIVE CARCINOMA
3454,gemini20,0.817,PROCEDURE
3455,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3456,gemini20,0.691,SPREAD THROUGH AIR SPACES (STAS)
3457,gemini20,0.699,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3458,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
3459,gemini20,0.744,REGIONAL LYMPH NODE STATUS
3460,gemini20,0.697,SPECIMEN LATERALITY
3461,gemini20,0.85,NODAL SITE(S) EXAMINED
3462,gemini20,0.705,VISCERAL PLEURA INVASION
3463,gemini20,0.701,HISTOLOGIC GRADE
3464,gemini20,0.689,TUMOR FOCALITY
3465,gemini20,0.711,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3466,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
3467,gemini20,0.791,NODAL SITE(S) EXAMINED
3468,gemini20,0.694,NUMBER OF LYMPH NODES EXAMINED
3469,gemini20,0.751,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3470,gemini20,0.759,TUMOR SITE
3471,gemini20,0.805,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3472,gemini20,0.811,TUMOR FOCALITY
3473,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3474,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3475,gemini20,0.815,REGIONAL LYMPH NODE STATUS
3476,gemini20,0.703,PROCEDURE
3477,gemini20,0.693,SPREAD THROUGH AIR SPACES (STAS)
3478,gemini20,0.729,VISCERAL PLEURA INVASION
3479,gemini20,0.698,SPECIMEN LATERALITY
3480,gemini20,0.687,ADDITIONAL FINDINGS
3481,gemini20,0.702,HISTOLOGIC GRADE
3482,gemini20,0.826,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3483,gemini20,0.741,PROCEDURE
3484,gemini20,0.679,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3485,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3486,gemini20,0.699,NODAL SITE(S) EXAMINED
3487,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3488,gemini20,0.879,TUMOR SITE
3489,gemini20,0.811,TUMOR FOCALITY
3490,gemini20,0.713,VISCERAL PLEURA INVASION
3491,gemini20,0.767,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3492,gemini20,0.817,REGIONAL LYMPH NODE STATUS
3493,gemini20,0.725,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3494,gemini20,0.701,HISTOLOGIC GRADE
3495,gemini20,0.698,SPECIMEN LATERALITY
3496,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
3497,gemini20,0.697,NUMBER OF LYMPH NODES EXAMINED
3498,gemini20,0.78,VISCERAL PLEURA INVASION
3499,gemini20,0.696,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3500,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3501,gemini20,0.7,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3502,gemini20,0.734,TUMOR FOCALITY
3503,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3504,gemini20,0.702,PROCEDURE
3505,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
3506,gemini20,0.757,ADDITIONAL FINDINGS
3507,gemini20,0.697,SPREAD THROUGH AIR SPACES (STAS)
3508,gemini20,0.781,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3509,gemini20,0.815,REGIONAL LYMPH NODE STATUS
3510,gemini20,0.87,TUMOR SITE
3511,gemini20,0.697,SPECIMEN LATERALITY
3512,gemini20,0.699,HISTOLOGIC GRADE
3513,gemini20,0.787,NODAL SITE(S) EXAMINED
3514,gemini20,0.768,VISCERAL PLEURA INVASION
3515,gemini20,0.829,REGIONAL LYMPH NODE STATUS
3516,gemini20,0.682,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3517,gemini20,0.698,SPECIMEN LATERALITY
3518,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
3519,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3520,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3521,gemini20,0.699,SPREAD THROUGH AIR SPACES (STAS)
3522,gemini20,0.726,PROCEDURE
3523,gemini20,0.801,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3524,gemini20,0.849,TUMOR SITE
3525,gemini20,0.712,NODAL SITE(S) EXAMINED
3526,gemini20,0.811,TUMOR FOCALITY
3527,gemini20,0.714,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3528,gemini20,0.733,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3529,gemini20,0.841,MARGIN STATUS FOR INVASIVE CARCINOMA
3530,gemini20,0.645,TUMOR FOCALITY
3531,gemini20,0.68,VISCERAL PLEURA INVASION
3532,gemini20,0.813,ADDITIONAL FINDINGS
3533,gemini20,0.697,SPECIMEN LATERALITY
3534,gemini20,0.722,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3535,gemini20,0.829,REGIONAL LYMPH NODE STATUS
3536,gemini20,0.667,HISTOLOGIC GRADE
3537,gemini20,0.897,LYMPH NODE(S) FROM PRIOR PROCEDURES
3538,gemini20,0.749,TUMOR SITE
3539,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
3540,gemini20,0.681,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3541,gemini20,0.699,NUMBER OF LYMPH NODES EXAMINED
3542,gemini20,0.693,SPREAD THROUGH AIR SPACES (STAS)
3543,gemini20,0.787,NODAL SITE(S) EXAMINED
3544,gemini20,0.766,PROCEDURE
3545,gemini20,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3546,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3547,gemini20,0.82,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3548,gemini20,0.697,SPECIMEN LATERALITY
3549,gemini20,0.761,VISCERAL PLEURA INVASION
3550,gemini20,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3551,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
3552,gemini20,0.695,SPREAD THROUGH AIR SPACES (STAS)
3553,gemini20,0.788,NODAL SITE(S) EXAMINED
3554,gemini20,0.896,TUMOR SITE
3555,gemini20,0.72,PROCEDURE
3556,gemini20,0.811,TUMOR FOCALITY
3557,gemini20,0.822,REGIONAL LYMPH NODE STATUS
3558,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3559,gemini20,0.738,HISTOLOGIC GRADE
3560,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3561,gemini20,0.713,NUMBER OF LYMPH NODES EXAMINED
3562,gemini20,0.689,SPREAD THROUGH AIR SPACES (STAS)
3563,gemini20,0.694,TUMOR FOCALITY
3564,gemini20,0.697,SPECIMEN LATERALITY
3565,gemini20,0.72,NUMBER OF LYMPH NODES WITH TUMOR
3566,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
3567,gemini20,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3568,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3569,gemini20,0.691,NODAL SITE(S) EXAMINED
3570,gemini20,0.893,TUMOR SITE
3571,gemini20,0.761,PROCEDURE
3572,gemini20,0.672,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3573,gemini20,0.883,NODAL SITE(S) WITH TUMOR
3574,gemini20,0.783,REGIONAL LYMPH NODE STATUS
3575,gemini20,0.732,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3576,gemini20,0.736,VISCERAL PLEURA INVASION
3577,gemini20,0.731,ADDITIONAL FINDINGS
3578,gemini20,0.789,MARGIN STATUS FOR INVASIVE CARCINOMA
3579,gemini20,0.703,NUMBER OF LYMPH NODES EXAMINED
3580,gemini20,0.779,LYMPH NODE(S) FROM PRIOR PROCEDURES
3581,gemini20,0.684,SPREAD THROUGH AIR SPACES (STAS)
3582,gemini20,0.701,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3583,gemini20,0.8,NODAL SITE(S) EXAMINED
3584,gemini20,0.698,SPECIMEN LATERALITY
3585,gemini20,0.666,PROCEDURE
3586,gemini20,0.698,TNM DESCRIPTORS
3587,gemini20,0.792,TUMOR SITE
3588,gemini20,0.772,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3589,gemini20,0.706,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3590,gemini20,0.809,MARGIN STATUS FOR NON-INVASIVE TUMOR
3591,gemini20,0.714,TUMOR FOCALITY
3592,gemini20,0.701,HISTOLOGIC GRADE
3593,gemini20,0.7,VISCERAL PLEURA INVASION
3594,gemini20,0.695,REGIONAL LYMPH NODE STATUS
3595,gemini20,0.703,NUMBER OF LYMPH NODES EXAMINED
3596,gemini20,0.737,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3597,gemini20,0.808,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3598,gemini20,0.732,MARGIN STATUS FOR INVASIVE CARCINOMA
3599,gemini20,0.729,PROCEDURE
3600,gemini20,0.829,REGIONAL LYMPH NODE STATUS
3601,gemini20,0.89,TUMOR SITE
3602,gemini20,0.699,VISCERAL PLEURA INVASION
3603,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
3604,gemini20,0.727,HISTOLOGIC GRADE
3605,gemini20,0.779,TUMOR FOCALITY
3606,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3607,gemini20,0.816,NODAL SITE(S) EXAMINED
3608,gemini20,0.697,SPECIMEN LATERALITY
3609,gemini20,0.695,SPREAD THROUGH AIR SPACES (STAS)
3610,gemini20,0.826,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3611,gemini20,0.882,TUMOR SITE
3612,gemini20,0.769,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3613,gemini20,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3614,gemini20,0.7,NUMBER OF LYMPH NODES EXAMINED
3615,gemini20,0.697,SPECIMEN LATERALITY
3616,gemini20,0.688,SPREAD THROUGH AIR SPACES (STAS)
3617,gemini20,0.811,TUMOR FOCALITY
3618,gemini20,0.896,MARGIN STATUS FOR INVASIVE CARCINOMA
3619,gemini20,0.817,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3620,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3621,gemini20,0.827,PROCEDURE
3622,gemini20,0.701,NODAL SITE(S) EXAMINED
3623,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
3624,gemini20,0.817,REGIONAL LYMPH NODE STATUS
3625,gemini20,0.713,VISCERAL PLEURA INVASION
3626,gemini20,0.696,HISTOLOGIC GRADE
3627,gemini20,0.722,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3628,gemini20,0.684,SPREAD THROUGH AIR SPACES (STAS)
3629,gemini20,0.689,TNM DESCRIPTORS
3630,gemini20,0.815,REGIONAL LYMPH NODE STATUS
3631,gemini20,0.685,VISCERAL PLEURA INVASION
3632,gemini20,0.713,HISTOLOGIC GRADE
3633,gemini20,0.856,NODAL SITE(S) EXAMINED
3634,gemini20,0.878,TUMOR SITE
3635,gemini20,0.77,NUMBER OF LYMPH NODES EXAMINED
3636,gemini20,0.677,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3637,gemini20,0.705,TUMOR FOCALITY
3638,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
3639,gemini20,0.684,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3640,gemini20,0.779,LYMPH NODE(S) FROM PRIOR PROCEDURES
3641,gemini20,0.697,SPECIMEN LATERALITY
3642,gemini20,0.896,MARGIN STATUS FOR INVASIVE CARCINOMA
3643,gemini20,0.788,PROCEDURE
3644,gemini20,0.815,REGIONAL LYMPH NODE STATUS
3645,gemini20,0.789,TUMOR SITE
3646,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
3647,gemini20,0.725,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3648,gemini20,0.918,TUMOR FOCALITY
3649,gemini20,0.672,ADDITIONAL FINDINGS
3650,gemini20,0.776,NODAL SITE(S) EXAMINED
3651,gemini20,0.794,MARGIN STATUS FOR INVASIVE CARCINOMA
3652,gemini20,0.779,LYMPH NODE(S) FROM PRIOR PROCEDURES
3653,gemini20,0.697,SPECIMEN LATERALITY
3654,gemini20,0.743,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3655,gemini20,0.826,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3656,gemini20,0.734,VISCERAL PLEURA INVASION
3657,gemini20,0.693,SPREAD THROUGH AIR SPACES (STAS)
3658,gemini20,0.7,PROCEDURE
3659,gemini20,0.707,VISCERAL PLEURA INVASION
3660,gemini20,0.702,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3661,gemini20,0.688,PROCEDURE
3662,gemini20,0.72,NUMBER OF LYMPH NODES WITH TUMOR
3663,gemini20,0.743,ADDITIONAL FINDINGS
3664,gemini20,0.811,TUMOR FOCALITY
3665,gemini20,0.775,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3666,gemini20,0.882,TUMOR SITE
3667,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
3668,gemini20,0.78,REGIONAL LYMPH NODE STATUS
3669,gemini20,0.847,NODAL SITE(S) EXAMINED
3670,gemini20,0.727,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3671,gemini20,0.862,NODAL SITE(S) WITH TUMOR
3672,gemini20,0.709,LYMPHOVASCULAR INVASION
3673,gemini20,0.779,LYMPH NODE(S) FROM PRIOR PROCEDURES
3674,gemini20,0.697,SPECIMEN LATERALITY
3675,gemini20,0.692,NUMBER OF LYMPH NODES EXAMINED
3676,gemini20,0.839,HISTOLOGIC GRADE
3677,gemini20,0.751,MARGIN STATUS FOR INVASIVE CARCINOMA
3678,gemini20,0.692,SPREAD THROUGH AIR SPACES (STAS)
3679,gemini20,0.751,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3680,gemini20,0.78,REGIONAL LYMPH NODE STATUS
3681,gemini20,0.705,PROCEDURE
3682,gemini20,0.697,SPECIMEN LATERALITY
3683,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
3684,gemini20,0.714,VISCERAL PLEURA INVASION
3685,gemini20,0.738,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3686,gemini20,0.776,NODAL SITE(S) EXAMINED
3687,gemini20,0.714,LYMPHOVASCULAR INVASION
3688,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3689,gemini20,0.811,TUMOR FOCALITY
3690,gemini20,0.707,NODAL SITE(S) WITH TUMOR
3691,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3692,gemini20,0.789,TUMOR SITE
3693,gemini20,0.739,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3694,gemini20,0.699,SPREAD THROUGH AIR SPACES (STAS)
3695,gemini20,0.839,HISTOLOGIC GRADE
3696,gemini20,0.704,ADDITIONAL FINDINGS
3697,gemini20,0.789,MARGIN STATUS FOR INVASIVE CARCINOMA
3698,gemini20,0.682,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3699,gemini20,0.719,REGIONAL LYMPH NODE STATUS
3700,gemini20,0.89,TUMOR SITE
3701,gemini20,0.705,MARGIN STATUS FOR NON-INVASIVE TUMOR
3702,gemini20,0.704,HISTOLOGIC GRADE
3703,gemini20,0.697,SPECIMEN LATERALITY
3704,gemini20,0.662,LYMPHOVASCULAR INVASION
3705,gemini20,0.684,SPREAD THROUGH AIR SPACES (STAS)
3706,gemini20,0.809,TUMOR FOCALITY
3707,gemini20,0.786,NODAL SITE(S) EXAMINED
3708,gemini20,0.681,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3709,gemini20,0.674,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3710,gemini20,0.788,PROCEDURE
3711,gemini20,0.697,TNM DESCRIPTORS
3712,gemini20,0.727,VISCERAL PLEURA INVASION
3713,gemini20,0.832,NUMBER OF LYMPH NODES EXAMINED
3714,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
3715,gemini20,0.866,ADDITIONAL FINDINGS
3716,gemini20,0.71,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3717,gemini20,0.732,VISCERAL PLEURA INVASION
3718,gemini20,0.75,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3719,gemini20,0.698,SPECIMEN LATERALITY
3720,gemini20,0.793,TUMOR SITE
3721,gemini20,0.771,MARGIN STATUS FOR INVASIVE CARCINOMA
3722,gemini20,0.815,REGIONAL LYMPH NODE STATUS
3723,gemini20,0.705,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3724,gemini20,0.699,HISTOLOGIC GRADE
3725,gemini20,0.79,NODAL SITE(S) EXAMINED
3726,gemini20,0.73,TUMOR FOCALITY
3727,gemini20,0.716,PROCEDURE
3728,gemini20,0.685,SPREAD THROUGH AIR SPACES (STAS)
3729,gemini20,0.779,PROCEDURE
3730,gemini20,0.752,TUMOR SITE
3731,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
3732,gemini20,0.675,VISCERAL PLEURA INVASION
3733,gemini20,0.779,LYMPH NODE(S) FROM PRIOR PROCEDURES
3734,gemini20,0.726,NODAL SITE(S) EXAMINED
3735,gemini20,0.719,REGIONAL LYMPH NODE STATUS
3736,gemini20,0.769,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3737,gemini20,0.665,TUMOR FOCALITY
3738,gemini20,0.636,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3739,gemini20,0.723,HISTOLOGIC GRADE
3740,gemini20,0.691,SPREAD THROUGH AIR SPACES (STAS)
3741,gemini20,0.708,MARGIN STATUS FOR INVASIVE CARCINOMA
3742,gemini20,0.697,SPECIMEN LATERALITY
3743,gemini20,0.715,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3744,gemini20,0.687,ADDITIONAL FINDINGS
3745,gemini20,0.685,SPREAD THROUGH AIR SPACES (STAS)
3746,gemini20,0.715,NODAL SITE(S) EXAMINED
3747,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
3748,gemini20,0.756,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3749,gemini20,0.782,NUMBER OF LYMPH NODES EXAMINED
3750,gemini20,0.713,HISTOLOGIC GRADE
3751,gemini20,0.837,TUMOR SITE
3752,gemini20,0.694,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3753,gemini20,0.697,SPECIMEN LATERALITY
3754,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3755,gemini20,0.729,MARGIN STATUS FOR INVASIVE CARCINOMA
3756,gemini20,0.735,PROCEDURE
3757,gemini20,0.694,VISCERAL PLEURA INVASION
3758,gemini20,0.811,TUMOR FOCALITY
3759,gemini20,0.815,REGIONAL LYMPH NODE STATUS
3760,gemini20,0.696,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3761,gemini20,0.779,LYMPH NODE(S) FROM PRIOR PROCEDURES
3762,gemini20,0.683,SPREAD THROUGH AIR SPACES (STAS)
3763,gemini20,0.684,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3764,gemini20,0.781,MARGIN STATUS FOR INVASIVE CARCINOMA
3765,gemini20,0.679,ADDITIONAL FINDINGS
3766,gemini20,0.686,NUMBER OF LYMPH NODES EXAMINED
3767,gemini20,0.658,VISCERAL PLEURA INVASION
3768,gemini20,0.811,TUMOR FOCALITY
3769,gemini20,0.74,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3770,gemini20,0.731,REGIONAL LYMPH NODE STATUS
3771,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
3772,gemini20,0.705,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3773,gemini20,0.7,NODAL SITE(S) EXAMINED
3774,gemini20,0.835,NODAL SITE(S) WITH TUMOR
3775,gemini20,0.698,SPECIMEN LATERALITY
3776,gemini20,0.72,NUMBER OF LYMPH NODES WITH TUMOR
3777,gemini20,0.884,TUMOR SITE
3778,gemini20,0.734,PROCEDURE
3779,gemini20,0.699,LYMPHOVASCULAR INVASION
3780,gemini20,0.68,HISTOLOGIC GRADE
3781,gemini20,0.684,SPREAD THROUGH AIR SPACES (STAS)
3782,gemini20,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3783,gemini20,0.81,NUMBER OF LYMPH NODES EXAMINED
3784,gemini20,0.827,NODAL SITE(S) EXAMINED
3785,gemini20,0.841,MARGIN STATUS FOR INVASIVE CARCINOMA
3786,gemini20,0.877,ADDITIONAL FINDINGS
3787,gemini20,0.676,VISCERAL PLEURA INVASION
3788,gemini20,0.897,LYMPH NODE(S) FROM PRIOR PROCEDURES
3789,gemini20,0.673,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3790,gemini20,0.733,PROCEDURE
3791,gemini20,0.707,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3792,gemini20,0.815,REGIONAL LYMPH NODE STATUS
3793,gemini20,0.697,SPECIMEN LATERALITY
3794,gemini20,0.896,TUMOR SITE
3795,gemini20,0.72,HISTOLOGIC GRADE
3796,gemini20,0.826,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3797,gemini20,0.72,TNM DESCRIPTORS
3798,gemini20,0.668,TUMOR FOCALITY
3799,gemini20,0.904,HISTOLOGIC GRADE
3800,gemini20,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3801,gemini20,0.697,SPECIMEN LATERALITY
3802,gemini20,0.719,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3803,gemini20,0.694,SPREAD THROUGH AIR SPACES (STAS)
3804,gemini20,0.822,REGIONAL LYMPH NODE STATUS
3805,gemini20,0.668,VISCERAL PLEURA INVASION
3806,gemini20,0.886,NODAL SITE(S) EXAMINED
3807,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3808,gemini20,0.725,PROCEDURE
3809,gemini20,0.826,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3810,gemini20,0.789,TUMOR SITE
3811,gemini20,0.811,TUMOR FOCALITY
3812,gemini20,0.892,ADDITIONAL FINDINGS
3813,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3814,gemini20,0.705,NUMBER OF LYMPH NODES EXAMINED
3815,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
3816,gemini20,0.736,NODAL SITE(S) EXAMINED
3817,gemini20,0.661,PROCEDURE
3818,gemini20,0.882,TUMOR SITE
3819,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
3820,gemini20,0.706,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3821,gemini20,0.696,HISTOLOGIC GRADE
3822,gemini20,0.732,NODAL SITE(S) WITH TUMOR
3823,gemini20,0.705,VISCERAL PLEURA INVASION
3824,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3825,gemini20,0.692,LYMPH NODE(S) FROM PRIOR PROCEDURES
3826,gemini20,0.753,REGIONAL LYMPH NODE STATUS
3827,gemini20,0.703,TUMOR FOCALITY
3828,gemini20,0.65,NUMBER OF LYMPH NODES EXAMINED
3829,gemini20,0.697,SPECIMEN LATERALITY
3830,gemini20,0.722,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3831,gemini20,0.715,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3832,gemini20,0.701,NUMBER OF LYMPH NODES WITH TUMOR
3833,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
3834,gemini20,0.811,TUMOR FOCALITY
3835,gemini20,0.774,TUMOR SITE
3836,gemini20,0.785,MARGIN STATUS FOR INVASIVE CARCINOMA
3837,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3838,gemini20,0.706,VISCERAL PLEURA INVASION
3839,gemini20,0.798,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3840,gemini20,0.745,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3841,gemini20,0.826,HISTOLOGIC GRADE
3842,gemini20,0.739,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3843,gemini20,0.84,NODAL SITE(S) EXAMINED
3844,gemini20,0.72,NUMBER OF LYMPH NODES WITH TUMOR
3845,gemini20,0.757,PROCEDURE
3846,gemini20,0.783,REGIONAL LYMPH NODE STATUS
3847,gemini20,0.799,NODAL SITE(S) WITH TUMOR
3848,gemini20,0.698,SPECIMEN LATERALITY
3849,gemini20,0.767,ADDITIONAL FINDINGS
3850,gemini20,0.753,MARGIN STATUS FOR INVASIVE CARCINOMA
3851,gemini20,0.787,TUMOR SITE
3852,gemini20,0.746,VISCERAL PLEURA INVASION
3853,gemini20,0.817,REGIONAL LYMPH NODE STATUS
3854,gemini20,0.716,HISTOLOGIC GRADE
3855,gemini20,0.851,NODAL SITE(S) EXAMINED
3856,gemini20,0.747,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3857,gemini20,0.73,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3858,gemini20,0.716,PROCEDURE
3859,gemini20,0.697,SPECIMEN LATERALITY
3860,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3861,gemini20,0.72,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3862,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
3863,gemini20,0.735,TUMOR FOCALITY
3864,gemini20,0.685,SPREAD THROUGH AIR SPACES (STAS)
3865,gemini20,0.742,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3866,gemini20,0.78,MARGIN STATUS FOR INVASIVE CARCINOMA
3867,gemini20,0.826,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3868,gemini20,0.717,PROCEDURE
3869,gemini20,0.78,VISCERAL PLEURA INVASION
3870,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
3871,gemini20,0.89,TUMOR SITE
3872,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
3873,gemini20,0.829,REGIONAL LYMPH NODE STATUS
3874,gemini20,0.748,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3875,gemini20,0.685,SPREAD THROUGH AIR SPACES (STAS)
3876,gemini20,0.689,ADDITIONAL FINDINGS
3877,gemini20,0.811,TUMOR FOCALITY
3878,gemini20,0.697,SPECIMEN LATERALITY
3879,gemini20,0.766,HISTOLOGIC GRADE
3880,gemini20,0.845,NODAL SITE(S) EXAMINED
3881,gemini20,0.712,ADDITIONAL FINDINGS
3882,gemini20,0.805,NODAL SITE(S) EXAMINED
3883,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
3884,gemini20,0.716,PROCEDURE
3885,gemini20,0.734,NUMBER OF LYMPH NODES EXAMINED
3886,gemini20,0.772,MARGIN STATUS FOR INVASIVE CARCINOMA
3887,gemini20,0.817,REGIONAL LYMPH NODE STATUS
3888,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3889,gemini20,0.697,SPECIMEN LATERALITY
3890,gemini20,0.731,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3891,gemini20,0.76,HISTOLOGIC GRADE
3892,gemini20,0.744,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3893,gemini20,0.811,TUMOR FOCALITY
3894,gemini20,0.681,VISCERAL PLEURA INVASION
3895,gemini20,0.699,SPREAD THROUGH AIR SPACES (STAS)
3896,gemini20,0.882,TUMOR SITE
3897,gemini20,0.697,SPECIMEN LATERALITY
3898,gemini20,0.712,NUMBER OF LYMPH NODES WITH TUMOR
3899,gemini20,0.691,TNM DESCRIPTORS
3900,gemini20,0.705,MARGIN STATUS FOR NON-INVASIVE TUMOR
3901,gemini20,0.78,REGIONAL LYMPH NODE STATUS
3902,gemini20,0.766,NODAL SITE(S) EXAMINED
3903,gemini20,0.711,HISTOLOGIC GRADE
3904,gemini20,0.784,TUMOR SITE
3905,gemini20,0.658,LYMPHOVASCULAR INVASION
3906,gemini20,0.705,VISCERAL PLEURA INVASION
3907,gemini20,0.685,SPREAD THROUGH AIR SPACES (STAS)
3908,gemini20,0.743,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3909,gemini20,0.711,NODAL SITE(S) WITH TUMOR
3910,gemini20,0.782,MARGIN STATUS FOR INVASIVE CARCINOMA
3911,gemini20,0.787,PROCEDURE
3912,gemini20,0.713,TUMOR FOCALITY
3913,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
3914,gemini20,0.757,MARGIN STATUS FOR INVASIVE CARCINOMA
3915,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
3916,gemini20,0.815,REGIONAL LYMPH NODE STATUS
3917,gemini20,0.717,PROCEDURE
3918,gemini20,0.89,TUMOR SITE
3919,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3920,gemini20,0.752,NODAL SITE(S) EXAMINED
3921,gemini20,0.683,TUMOR FOCALITY
3922,gemini20,0.75,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3923,gemini20,0.697,SPECIMEN LATERALITY
3924,gemini20,0.732,ADDITIONAL FINDINGS
3925,gemini20,0.703,VISCERAL PLEURA INVASION
3926,gemini20,0.742,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3927,gemini20,0.689,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3928,gemini20,0.749,TNM DESCRIPTORS
3929,gemini20,0.699,HISTOLOGIC GRADE
3930,gemini20,0.679,SPREAD THROUGH AIR SPACES (STAS)
3931,gemini20,0.746,VISCERAL PLEURA INVASION
3932,gemini20,0.717,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3933,gemini20,0.686,MARGIN STATUS FOR INVASIVE CARCINOMA
3934,gemini20,0.683,PROCEDURE
3935,gemini20,0.748,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3936,gemini20,0.733,NODAL SITE(S) EXAMINED
3937,gemini20,0.697,SPECIMEN LATERALITY
3938,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
3939,gemini20,0.694,HISTOLOGIC GRADE
3940,gemini20,0.89,TUMOR SITE
3941,gemini20,0.706,LYMPHOVASCULAR INVASION
3942,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3943,gemini20,0.705,ADDITIONAL FINDINGS
3944,gemini20,0.811,TUMOR FOCALITY
3945,gemini20,0.734,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3946,gemini20,0.814,HISTOLOGIC GRADE
3947,gemini20,0.811,TUMOR FOCALITY
3948,gemini20,0.668,TNM DESCRIPTORS
3949,gemini20,0.849,TUMOR SITE
3950,gemini20,0.76,NODAL SITE(S) EXAMINED
3951,gemini20,0.714,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3952,gemini20,0.732,VISCERAL PLEURA INVASION
3953,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
3954,gemini20,0.695,NODAL SITE(S) WITH TUMOR
3955,gemini20,0.75,MARGIN STATUS FOR INVASIVE CARCINOMA
3956,gemini20,0.773,NUMBER OF LYMPH NODES EXAMINED
3957,gemini20,0.756,REGIONAL LYMPH NODE STATUS
3958,gemini20,0.744,NUMBER OF LYMPH NODES WITH TUMOR
3959,gemini20,0.71,PROCEDURE
3960,gemini20,0.698,SPECIMEN LATERALITY
3961,gemini20,0.694,LYMPHOVASCULAR INVASION
3962,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3963,gemini20,0.872,NODAL SITE(S) EXAMINED
3964,gemini20,0.668,ADDITIONAL FINDINGS
3965,gemini20,0.811,TUMOR FOCALITY
3966,gemini20,0.829,REGIONAL LYMPH NODE STATUS
3967,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
3968,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3969,gemini20,0.697,SPECIMEN LATERALITY
3970,gemini20,0.781,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3971,gemini20,0.717,PROCEDURE
3972,gemini20,0.699,NUMBER OF LYMPH NODES EXAMINED
3973,gemini20,0.689,HISTOLOGIC GRADE
3974,gemini20,0.693,SPREAD THROUGH AIR SPACES (STAS)
3975,gemini20,0.748,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3976,gemini20,0.851,TUMOR SITE
3977,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
3978,gemini20,0.703,VISCERAL PLEURA INVASION
3979,gemini20,0.715,PROCEDURE
3980,gemini20,0.677,SPREAD THROUGH AIR SPACES (STAS)
3981,gemini20,0.743,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3982,gemini20,0.699,NUMBER OF LYMPH NODES EXAMINED
3983,gemini20,0.698,SPECIMEN LATERALITY
3984,gemini20,0.701,VISCERAL PLEURA INVASION
3985,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3986,gemini20,0.765,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3987,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
3988,gemini20,0.811,TUMOR FOCALITY
3989,gemini20,0.734,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3990,gemini20,0.84,NODAL SITE(S) EXAMINED
3991,gemini20,0.786,MARGIN STATUS FOR INVASIVE CARCINOMA
3992,gemini20,0.728,HISTOLOGIC GRADE
3993,gemini20,0.884,TUMOR SITE
3994,gemini20,0.829,REGIONAL LYMPH NODE STATUS
3995,gemini20,0.673,ADDITIONAL FINDINGS
3996,gemini20,0.766,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3997,gemini20,0.722,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3998,gemini20,0.89,TUMOR SITE
3999,gemini20,0.667,ADDITIONAL FINDINGS
4000,gemini20,0.774,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4001,gemini20,0.827,NODAL SITE(S) EXAMINED
4002,gemini20,0.689,HISTOLOGIC GRADE
4003,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
4004,gemini20,0.691,SPREAD THROUGH AIR SPACES (STAS)
4005,gemini20,0.742,MARGIN STATUS FOR INVASIVE CARCINOMA
4006,gemini20,0.698,NUMBER OF LYMPH NODES EXAMINED
4007,gemini20,0.697,SPECIMEN LATERALITY
4008,gemini20,0.706,VISCERAL PLEURA INVASION
4009,gemini20,0.815,REGIONAL LYMPH NODE STATUS
4010,gemini20,0.811,TUMOR FOCALITY
4011,gemini20,0.713,PROCEDURE
4012,gemini20,0.779,LYMPH NODE(S) FROM PRIOR PROCEDURES
4013,gemini20,0.711,PROCEDURE
4014,gemini20,0.761,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4015,gemini20,0.726,HISTOLOGIC GRADE
4016,gemini20,0.811,TUMOR FOCALITY
4017,gemini20,0.716,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4018,gemini20,0.697,SPECIMEN LATERALITY
4019,gemini20,0.876,TUMOR SITE
4020,gemini20,0.694,SPREAD THROUGH AIR SPACES (STAS)
4021,gemini20,0.891,NODAL SITE(S) EXAMINED
4022,gemini20,0.736,REGIONAL LYMPH NODE STATUS
4023,gemini20,0.716,VISCERAL PLEURA INVASION
4024,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
4025,gemini20,0.826,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4026,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4027,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4028,gemini20,0.729,VISCERAL PLEURA INVASION
4029,gemini20,0.772,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4030,gemini20,0.811,TUMOR FOCALITY
4031,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
4032,gemini20,0.697,SPECIMEN LATERALITY
4033,gemini20,0.782,ADDITIONAL FINDINGS
4034,gemini20,0.807,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4035,gemini20,0.826,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4036,gemini20,0.89,TUMOR SITE
4037,gemini20,0.703,HISTOLOGIC GRADE
4038,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4039,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4040,gemini20,0.712,PROCEDURE
4041,gemini20,0.815,REGIONAL LYMPH NODE STATUS
4042,gemini20,0.909,ADDITIONAL FINDINGS
4043,gemini20,0.697,SPECIMEN LATERALITY
4044,gemini20,0.699,TNM DESCRIPTORS
4045,gemini20,0.731,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4046,gemini20,0.789,PROCEDURE
4047,gemini20,0.705,VISCERAL PLEURA INVASION
4048,gemini20,0.831,NODAL SITE(S) EXAMINED
4049,gemini20,0.698,HISTOLOGIC GRADE
4050,gemini20,0.677,TUMOR SITE
4051,gemini20,0.694,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4052,gemini20,0.687,LYMPHOVASCULAR INVASION
4053,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
4054,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4055,gemini20,0.756,MARGIN STATUS FOR INVASIVE CARCINOMA
4056,gemini20,0.708,TUMOR FOCALITY
4057,gemini20,0.76,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4058,gemini20,0.675,HISTOLOGIC GRADE
4059,gemini20,0.632,VISCERAL PLEURA INVASION
4060,gemini20,0.656,TUMOR FOCALITY
4061,gemini20,0.795,TUMOR SITE
4062,gemini20,0.721,PROCEDURE
4063,gemini20,0.817,REGIONAL LYMPH NODE STATUS
4064,gemini20,0.793,SPECIMEN LATERALITY
4065,gemini20,0.675,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4066,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
4067,gemini20,0.712,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4068,gemini20,0.765,NODAL SITE(S) EXAMINED
4069,gemini20,0.666,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4070,gemini20,0.701,NUMBER OF LYMPH NODES EXAMINED
4071,gemini20,0.759,MARGIN STATUS FOR INVASIVE CARCINOMA
4072,gemini20,0.681,TNM DESCRIPTORS
4073,gemini20,0.897,LYMPH NODE(S) FROM PRIOR PROCEDURES
4074,gemini20,0.679,TUMOR FOCALITY
4075,gemini20,0.697,SPECIMEN LATERALITY
4076,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4077,gemini20,0.756,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4078,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4079,gemini20,0.737,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4080,gemini20,0.826,HISTOLOGIC GRADE
4081,gemini20,0.815,REGIONAL LYMPH NODE STATUS
4082,gemini20,0.802,NODAL SITE(S) EXAMINED
4083,gemini20,0.664,TUMOR SITE
4084,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
4085,gemini20,0.694,VISCERAL PLEURA INVASION
4086,gemini20,0.716,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4087,gemini20,0.69,PROCEDURE
4088,gemini20,0.697,SPREAD THROUGH AIR SPACES (STAS)
4089,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
4090,gemini20,0.776,NODAL SITE(S) EXAMINED
4091,gemini20,0.732,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4092,gemini20,0.826,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4093,gemini20,0.83,TUMOR SITE
4094,gemini20,0.761,VISCERAL PLEURA INVASION
4095,gemini20,0.698,SPECIMEN LATERALITY
4096,gemini20,0.745,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4097,gemini20,0.713,NUMBER OF LYMPH NODES EXAMINED
4098,gemini20,0.815,REGIONAL LYMPH NODE STATUS
4099,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4100,gemini20,0.811,TUMOR FOCALITY
4101,gemini20,0.725,PROCEDURE
4102,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4103,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
4104,gemini20,0.771,MARGIN STATUS FOR INVASIVE CARCINOMA
4105,gemini20,0.703,TUMOR FOCALITY
4106,gemini20,0.699,VISCERAL PLEURA INVASION
4107,gemini20,0.716,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4108,gemini20,0.692,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4109,gemini20,0.671,TNM DESCRIPTORS
4110,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
4111,gemini20,0.697,SPECIMEN LATERALITY
4112,gemini20,0.688,TUMOR SITE
4113,gemini20,0.843,NODAL SITE(S) EXAMINED
4114,gemini20,0.7,NUMBER OF LYMPH NODES WITH TUMOR
4115,gemini20,0.788,PROCEDURE
4116,gemini20,0.78,REGIONAL LYMPH NODE STATUS
4117,gemini20,0.714,NUMBER OF LYMPH NODES EXAMINED
4118,gemini20,0.727,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4119,gemini20,0.751,NODAL SITE(S) WITH TUMOR
4120,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4121,gemini20,0.697,SPECIMEN LATERALITY
4122,gemini20,0.776,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4123,gemini20,0.882,TUMOR SITE
4124,gemini20,0.743,NODAL SITE(S) EXAMINED
4125,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
4126,gemini20,0.811,TUMOR FOCALITY
4127,gemini20,0.718,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4128,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
4129,gemini20,0.697,PROCEDURE
4130,gemini20,0.729,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4131,gemini20,0.815,REGIONAL LYMPH NODE STATUS
4132,gemini20,0.811,TUMOR FOCALITY
4133,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
4134,gemini20,0.74,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4135,gemini20,0.781,NODAL SITE(S) EXAMINED
4136,gemini20,0.703,NUMBER OF LYMPH NODES EXAMINED
4137,gemini20,0.805,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4138,gemini20,0.768,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4139,gemini20,0.778,VISCERAL PLEURA INVASION
4140,gemini20,0.799,TUMOR SITE
4141,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4142,gemini20,0.815,REGIONAL LYMPH NODE STATUS
4143,gemini20,0.748,MARGIN STATUS FOR INVASIVE CARCINOMA
4144,gemini20,0.904,HISTOLOGIC GRADE
4145,gemini20,0.698,SPECIMEN LATERALITY
4146,gemini20,0.693,PROCEDURE
4147,gemini20,0.715,HISTOLOGIC GRADE
4148,gemini20,0.815,REGIONAL LYMPH NODE STATUS
4149,gemini20,0.788,PROCEDURE
4150,gemini20,0.735,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4151,gemini20,0.694,NODAL SITE(S) EXAMINED
4152,gemini20,0.69,TUMOR FOCALITY
4153,gemini20,0.757,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4154,gemini20,0.89,TUMOR SITE
4155,gemini20,0.717,MARGIN STATUS FOR NON-INVASIVE TUMOR
4156,gemini20,0.7,VISCERAL PLEURA INVASION
4157,gemini20,0.698,SPECIMEN LATERALITY
4158,gemini20,0.701,NUMBER OF LYMPH NODES EXAMINED
4159,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
4160,gemini20,0.694,SPREAD THROUGH AIR SPACES (STAS)
4161,gemini20,0.681,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4162,gemini20,0.698,MARGIN STATUS FOR INVASIVE CARCINOMA
4163,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4164,gemini20,0.696,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4165,gemini20,0.712,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4166,gemini20,0.705,VISCERAL PLEURA INVASION
4167,gemini20,0.811,TUMOR FOCALITY
4168,gemini20,0.89,TUMOR SITE
4169,gemini20,0.697,SPECIMEN LATERALITY
4170,gemini20,0.743,REGIONAL LYMPH NODE STATUS
4171,gemini20,0.745,NODAL SITE(S) EXAMINED
4172,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4173,gemini20,0.694,LYMPHOVASCULAR INVASION
4174,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
4175,gemini20,0.686,PROCEDURE
4176,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4177,gemini20,0.697,SPECIMEN LATERALITY
4178,gemini20,0.684,SPREAD THROUGH AIR SPACES (STAS)
4179,gemini20,0.833,ADDITIONAL FINDINGS
4180,gemini20,0.772,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4181,gemini20,0.764,VISCERAL PLEURA INVASION
4182,gemini20,0.722,NODAL SITE(S) EXAMINED
4183,gemini20,0.87,TUMOR SITE
4184,gemini20,0.761,MARGIN STATUS FOR INVASIVE CARCINOMA
4185,gemini20,0.722,NUMBER OF LYMPH NODES EXAMINED
4186,gemini20,0.748,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4187,gemini20,0.703,PROCEDURE
4188,gemini20,0.815,REGIONAL LYMPH NODE STATUS
4189,gemini20,0.7,TUMOR FOCALITY
4190,gemini20,0.705,MARGIN STATUS FOR NON-INVASIVE TUMOR
4191,gemini20,0.749,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4192,gemini20,0.753,TUMOR SITE
4193,gemini20,0.707,REGIONAL LYMPH NODE STATUS
4194,gemini20,0.734,MARGIN STATUS FOR INVASIVE CARCINOMA
4195,gemini20,0.778,NODAL SITE(S) EXAMINED
4196,gemini20,0.7,TNM DESCRIPTORS
4197,gemini20,0.649,VISCERAL PLEURA INVASION
4198,gemini20,0.713,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4199,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4200,gemini20,0.698,SPECIMEN LATERALITY
4201,gemini20,0.711,ADDITIONAL FINDINGS
4202,gemini20,0.735,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4203,gemini20,0.765,PROCEDURE
4204,gemini20,0.692,SPREAD THROUGH AIR SPACES (STAS)
4205,gemini20,0.817,MARGIN STATUS FOR NON-INVASIVE TUMOR
4206,gemini20,0.716,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4207,gemini20,0.694,TUMOR FOCALITY
4208,gemini20,0.733,HISTOLOGIC GRADE
4209,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4210,gemini20,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4211,gemini20,0.714,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4212,gemini20,0.811,TUMOR FOCALITY
4213,gemini20,0.698,SPECIMEN LATERALITY
4214,gemini20,0.768,VISCERAL PLEURA INVASION
4215,gemini20,0.71,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4216,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
4217,gemini20,0.672,NODAL SITE(S) EXAMINED
4218,gemini20,0.778,SPREAD THROUGH AIR SPACES (STAS)
4219,gemini20,0.788,HISTOLOGIC GRADE
4220,gemini20,0.815,REGIONAL LYMPH NODE STATUS
4221,gemini20,0.811,TUMOR SITE
4222,gemini20,0.843,NODAL SITE(S) EXAMINED
4223,gemini20,0.692,PROCEDURE
4224,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
4225,gemini20,0.788,PROCEDURE
4226,gemini20,0.698,VISCERAL PLEURA INVASION
4227,gemini20,0.716,REGIONAL LYMPH NODE STATUS
4228,gemini20,0.725,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4229,gemini20,0.693,TUMOR FOCALITY
4230,gemini20,0.726,TUMOR SITE
4231,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
4232,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4233,gemini20,0.771,NODAL SITE(S) EXAMINED
4234,gemini20,0.709,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4235,gemini20,0.691,SPREAD THROUGH AIR SPACES (STAS)
4236,gemini20,0.683,LYMPH NODE(S) FROM PRIOR PROCEDURES
4237,gemini20,0.75,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4238,gemini20,0.697,SPECIMEN LATERALITY
4239,gemini20,0.713,HISTOLOGIC GRADE
4240,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4241,gemini20,0.783,REGIONAL LYMPH NODE STATUS
4242,gemini20,0.697,SPECIMEN LATERALITY
4243,gemini20,0.694,VISCERAL PLEURA INVASION
4244,gemini20,0.715,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4245,gemini20,0.886,NODAL SITE(S) WITH TUMOR
4246,gemini20,0.811,TUMOR FOCALITY
4247,gemini20,0.733,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4248,gemini20,0.651,NUMBER OF LYMPH NODES WITH TUMOR
4249,gemini20,0.714,PROCEDURE
4250,gemini20,0.719,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4251,gemini20,0.676,TNM DESCRIPTORS
4252,gemini20,0.697,SPREAD THROUGH AIR SPACES (STAS)
4253,gemini20,0.779,LYMPH NODE(S) FROM PRIOR PROCEDURES
4254,gemini20,0.764,ADDITIONAL FINDINGS
4255,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
4256,gemini20,0.674,TUMOR SITE
4257,gemini20,0.797,NODAL SITE(S) EXAMINED
4258,gemini20,0.776,NODAL SITE(S) EXAMINED
4259,gemini20,0.724,HISTOLOGIC GRADE
4260,gemini20,0.773,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4261,gemini20,0.692,MARGIN STATUS FOR NON-INVASIVE TUMOR
4262,gemini20,0.732,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4263,gemini20,0.698,SPECIMEN LATERALITY
4264,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4265,gemini20,0.722,VISCERAL PLEURA INVASION
4266,gemini20,0.815,REGIONAL LYMPH NODE STATUS
4267,gemini20,0.744,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4268,gemini20,0.688,MARGIN STATUS FOR INVASIVE CARCINOMA
4269,gemini20,0.788,PROCEDURE
4270,gemini20,0.7,SPREAD THROUGH AIR SPACES (STAS)
4271,gemini20,0.711,TUMOR FOCALITY
4272,gemini20,0.729,NUMBER OF LYMPH NODES EXAMINED
4273,gemini20,0.753,MARGIN STATUS FOR NON-INVASIVE TUMOR
4274,gemini20,0.697,SPECIMEN LATERALITY
4275,gemini20,0.726,HISTOLOGIC GRADE
4276,gemini20,0.699,SPREAD THROUGH AIR SPACES (STAS)
4277,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4278,gemini20,0.7,NUMBER OF LYMPH NODES EXAMINED
4279,gemini20,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4280,gemini20,0.706,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4281,gemini20,0.781,REGIONAL LYMPH NODE STATUS
4282,gemini20,0.837,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4283,gemini20,0.719,PROCEDURE
4284,gemini20,0.779,NODAL SITE(S) EXAMINED
4285,gemini20,0.811,TUMOR FOCALITY
4286,gemini20,0.789,TUMOR SITE
4287,gemini20,0.749,MARGIN STATUS FOR INVASIVE CARCINOMA
4288,gemini20,0.764,VISCERAL PLEURA INVASION
4289,gemini20,0.706,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4290,gemini20,0.711,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4291,gemini20,0.822,REGIONAL LYMPH NODE STATUS
4292,gemini20,0.887,TUMOR SITE
4293,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
4294,gemini20,0.807,ADDITIONAL FINDINGS
4295,gemini20,0.74,MARGIN STATUS FOR INVASIVE CARCINOMA
4296,gemini20,0.702,NUMBER OF LYMPH NODES EXAMINED
4297,gemini20,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4298,gemini20,0.697,SPECIMEN LATERALITY
4299,gemini20,0.688,SPREAD THROUGH AIR SPACES (STAS)
4300,gemini20,0.811,TUMOR FOCALITY
4301,gemini20,0.678,HISTOLOGIC GRADE
4302,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4303,gemini20,0.741,PROCEDURE
4304,gemini20,0.862,NODAL SITE(S) EXAMINED
4305,gemini20,0.764,VISCERAL PLEURA INVASION
4306,gemini20,0.793,NODAL SITE(S) WITH TUMOR
4307,gemini20,0.679,TUMOR FOCALITY
4308,gemini20,0.757,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4309,gemini20,0.78,NODAL SITE(S) EXAMINED
4310,gemini20,0.743,VISCERAL PLEURA INVASION
4311,gemini20,0.826,TUMOR SITE
4312,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
4313,gemini20,0.687,LYMPHOVASCULAR INVASION
4314,gemini20,0.783,REGIONAL LYMPH NODE STATUS
4315,gemini20,0.679,PROCEDURE
4316,gemini20,0.686,HISTOLOGIC GRADE
4317,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4318,gemini20,0.72,NUMBER OF LYMPH NODES WITH TUMOR
4319,gemini20,0.78,SPREAD THROUGH AIR SPACES (STAS)
4320,gemini20,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4321,gemini20,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4322,gemini20,0.713,NUMBER OF LYMPH NODES EXAMINED
4323,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
4324,gemini20,0.697,SPECIMEN LATERALITY
4325,gemini20,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4326,gemini20,0.697,SPECIMEN LATERALITY
4327,gemini20,0.685,SPREAD THROUGH AIR SPACES (STAS)
4328,gemini20,0.827,PROCEDURE
4329,gemini20,0.791,TUMOR SITE
4330,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
4331,gemini20,0.719,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4332,gemini20,0.726,TUMOR FOCALITY
4333,gemini20,0.779,LYMPH NODE(S) FROM PRIOR PROCEDURES
4334,gemini20,0.712,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4335,gemini20,0.691,HISTOLOGIC GRADE
4336,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4337,gemini20,0.746,VISCERAL PLEURA INVASION
4338,gemini20,0.815,REGIONAL LYMPH NODE STATUS
4339,gemini20,0.689,HISTOLOGIC GRADE
4340,gemini20,0.745,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4341,gemini20,0.707,PROCEDURE
4342,gemini20,0.698,SPECIMEN LATERALITY
4343,gemini20,0.896,MARGIN STATUS FOR INVASIVE CARCINOMA
4344,gemini20,0.698,NODAL SITE(S) EXAMINED
4345,gemini20,0.83,TUMOR SITE
4346,gemini20,0.76,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4347,gemini20,0.713,NUMBER OF LYMPH NODES EXAMINED
4348,gemini20,0.78,VISCERAL PLEURA INVASION
4349,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
4350,gemini20,0.692,SPREAD THROUGH AIR SPACES (STAS)
4351,gemini20,0.811,TUMOR FOCALITY
4352,gemini20,0.685,ADDITIONAL FINDINGS
4353,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4354,gemini20,0.826,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4355,gemini20,0.691,SPREAD THROUGH AIR SPACES (STAS)
4356,gemini20,0.718,HISTOLOGIC GRADE
4357,gemini20,0.724,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4358,gemini20,0.704,MARGIN STATUS FOR INVASIVE CARCINOMA
4359,gemini20,0.699,VISCERAL PLEURA INVASION
4360,gemini20,0.833,ADDITIONAL FINDINGS
4361,gemini20,0.788,NODAL SITE(S) EXAMINED
4362,gemini20,0.793,TUMOR SITE
4363,gemini20,0.694,LYMPHOVASCULAR INVASION
4364,gemini20,0.722,TUMOR FOCALITY
4365,gemini20,0.768,NUMBER OF LYMPH NODES EXAMINED
4366,gemini20,0.696,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4367,gemini20,0.7,PROCEDURE
4368,gemini20,0.698,SPECIMEN LATERALITY
4369,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
4370,gemini20,0.737,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4371,gemini20,0.779,LYMPH NODE(S) FROM PRIOR PROCEDURES
4372,gemini20,0.71,TNM DESCRIPTORS
4373,gemini20,0.711,HISTOLOGIC GRADE
4374,gemini20,0.698,SPECIMEN LATERALITY
4375,gemini20,0.811,TUMOR FOCALITY
4376,gemini20,0.879,TUMOR SITE
4377,gemini20,0.777,REGIONAL LYMPH NODE STATUS
4378,gemini20,0.702,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4379,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
4380,gemini20,0.7,PROCEDURE
4381,gemini20,0.757,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4382,gemini20,0.688,LYMPHOVASCULAR INVASION
4383,gemini20,0.702,TNM DESCRIPTORS
4384,gemini20,0.785,NODAL SITE(S) EXAMINED
4385,gemini20,0.697,SPREAD THROUGH AIR SPACES (STAS)
4386,gemini20,0.762,MARGIN STATUS FOR INVASIVE CARCINOMA
4387,gemini20,0.717,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4388,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4389,gemini20,0.702,NODAL SITE(S) WITH TUMOR
4390,gemini20,0.683,VISCERAL PLEURA INVASION
4391,gemini20,0.765,NODAL SITE(S) WITH TUMOR
4392,gemini20,0.81,NODAL SITE(S) EXAMINED
4393,gemini20,0.72,NUMBER OF LYMPH NODES WITH TUMOR
4394,gemini20,0.697,SPECIMEN LATERALITY
4395,gemini20,0.737,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4396,gemini20,0.811,TUMOR FOCALITY
4397,gemini20,0.774,REGIONAL LYMPH NODE STATUS
4398,gemini20,0.698,NUMBER OF LYMPH NODES EXAMINED
4399,gemini20,0.896,MARGIN STATUS FOR INVASIVE CARCINOMA
4400,gemini20,0.938,ADDITIONAL FINDINGS
4401,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4402,gemini20,0.876,TUMOR SITE
4403,gemini20,0.788,PROCEDURE
4404,gemini20,0.701,SPREAD THROUGH AIR SPACES (STAS)
4405,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
4406,gemini20,0.68,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4407,gemini20,0.76,HISTOLOGIC GRADE
4408,gemini20,0.753,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4409,gemini20,0.768,VISCERAL PLEURA INVASION
4410,gemini20,0.815,REGIONAL LYMPH NODE STATUS
4411,gemini20,0.795,NODAL SITE(S) EXAMINED
4412,gemini20,0.715,HISTOLOGIC GRADE
4413,gemini20,0.779,LYMPH NODE(S) FROM PRIOR PROCEDURES
4414,gemini20,0.787,PROCEDURE
4415,gemini20,0.676,SPREAD THROUGH AIR SPACES (STAS)
4416,gemini20,0.679,MARGIN STATUS FOR INVASIVE CARCINOMA
4417,gemini20,0.693,ADDITIONAL FINDINGS
4418,gemini20,0.687,TUMOR FOCALITY
4419,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
4420,gemini20,0.697,SPECIMEN LATERALITY
4421,gemini20,0.715,TNM DESCRIPTORS
4422,gemini20,0.705,VISCERAL PLEURA INVASION
4423,gemini20,0.722,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4424,gemini20,0.815,TUMOR SITE
4425,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
4426,gemini20,0.648,TUMOR FOCALITY
4427,gemini20,0.73,PROCEDURE
4428,gemini20,0.779,LYMPH NODE(S) FROM PRIOR PROCEDURES
4429,gemini20,0.789,TUMOR SITE
4430,gemini20,0.713,NUMBER OF LYMPH NODES WITH TUMOR
4431,gemini20,0.723,REGIONAL LYMPH NODE STATUS
4432,gemini20,0.707,LYMPHOVASCULAR INVASION
4433,gemini20,0.697,SPECIMEN LATERALITY
4434,gemini20,0.692,NODAL SITE(S) WITH TUMOR
4435,gemini20,0.724,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4436,gemini20,0.731,HISTOLOGIC GRADE
4437,gemini20,0.674,VISCERAL PLEURA INVASION
4438,gemini20,0.771,NODAL SITE(S) EXAMINED
4439,gemini20,0.699,SPREAD THROUGH AIR SPACES (STAS)
4440,gemini20,0.774,NUMBER OF LYMPH NODES EXAMINED
4441,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4442,gemini20,0.687,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4443,gemini20,0.721,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4444,gemini20,0.798,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4445,gemini20,0.811,TUMOR FOCALITY
4446,gemini20,0.706,ADDITIONAL FINDINGS
4447,gemini20,0.736,PROCEDURE
4448,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4449,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
4450,gemini20,0.678,HISTOLOGIC GRADE
4451,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
4452,gemini20,0.815,REGIONAL LYMPH NODE STATUS
4453,gemini20,0.735,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4454,gemini20,0.697,SPECIMEN LATERALITY
4455,gemini20,0.778,SPREAD THROUGH AIR SPACES (STAS)
4456,gemini20,0.89,TUMOR SITE
4457,gemini20,0.745,NODAL SITE(S) EXAMINED
4458,gemini20,0.69,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4459,gemini20,0.735,VISCERAL PLEURA INVASION
4460,gemini20,0.698,NUMBER OF LYMPH NODES EXAMINED
4461,gemini20,0.833,NODAL SITE(S) EXAMINED
4462,gemini20,0.688,SPREAD THROUGH AIR SPACES (STAS)
4463,gemini20,0.705,REGIONAL LYMPH NODE STATUS
4464,gemini20,0.649,TUMOR FOCALITY
4465,gemini20,0.698,VISCERAL PLEURA INVASION
4466,gemini20,0.826,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4467,gemini20,0.71,PROCEDURE
4468,gemini20,0.696,TUMOR SITE
4469,gemini20,0.698,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4470,gemini20,0.679,HISTOLOGIC GRADE
4471,gemini20,0.674,LYMPHOVASCULAR INVASION
4472,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
4473,gemini20,0.729,MARGIN STATUS FOR INVASIVE CARCINOMA
4474,gemini20,0.653,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4475,gemini20,0.749,SPECIMEN LATERALITY
4476,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4477,gemini20,0.706,LYMPHOVASCULAR INVASION
4478,gemini20,0.7,NUMBER OF LYMPH NODES EXAMINED
4479,gemini20,0.745,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4480,gemini20,0.721,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4481,gemini20,0.703,VISCERAL PLEURA INVASION
4482,gemini20,0.743,PROCEDURE
4483,gemini20,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4484,gemini20,0.762,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4485,gemini20,0.698,SPECIMEN LATERALITY
4486,gemini20,0.702,HISTOLOGIC GRADE
4487,gemini20,0.811,TUMOR FOCALITY
4488,gemini20,0.83,NODAL SITE(S) EXAMINED
4489,gemini20,0.896,TUMOR SITE
4490,gemini20,0.815,REGIONAL LYMPH NODE STATUS
4491,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
4492,gemini20,0.862,ADDITIONAL FINDINGS
4493,gemini20,0.707,NUMBER OF LYMPH NODES EXAMINED
4494,gemini20,0.765,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4495,gemini20,0.697,SPECIMEN LATERALITY
4496,gemini20,0.811,TUMOR FOCALITY
4497,gemini20,0.698,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4498,gemini20,0.829,REGIONAL LYMPH NODE STATUS
4499,gemini20,0.824,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4500,gemini20,0.827,PROCEDURE
4501,gemini20,0.723,LYMPHOVASCULAR INVASION
4502,gemini20,0.876,NODAL SITE(S) EXAMINED
4503,gemini20,0.698,VISCERAL PLEURA INVASION
4504,gemini20,0.896,TUMOR SITE
4505,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4506,gemini20,0.684,SPREAD THROUGH AIR SPACES (STAS)
4507,gemini20,0.671,VISCERAL PLEURA INVASION
4508,gemini20,0.662,NODAL SITE(S) EXAMINED
4509,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
4510,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4511,gemini20,0.689,NODAL SITE(S) WITH TUMOR
4512,gemini20,0.687,SPREAD THROUGH AIR SPACES (STAS)
4513,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
4514,gemini20,0.696,NUMBER OF LYMPH NODES EXAMINED
4515,gemini20,0.729,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4516,gemini20,0.695,LYMPHOVASCULAR INVASION
4517,gemini20,0.72,NUMBER OF LYMPH NODES WITH TUMOR
4518,gemini20,0.736,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4519,gemini20,0.703,HISTOLOGIC GRADE
4520,gemini20,0.783,REGIONAL LYMPH NODE STATUS
4521,gemini20,0.698,SPECIMEN LATERALITY
4522,gemini20,0.811,TUMOR FOCALITY
4523,gemini20,0.697,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4524,gemini20,0.792,TUMOR SITE
4525,gemini20,0.71,PROCEDURE
4526,gemini20,0.69,SPREAD THROUGH AIR SPACES (STAS)
4527,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4528,gemini20,0.826,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4529,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
4530,gemini20,0.815,REGIONAL LYMPH NODE STATUS
4531,gemini20,0.697,SPECIMEN LATERALITY
4532,gemini20,0.707,HISTOLOGIC GRADE
4533,gemini20,0.811,TUMOR FOCALITY
4534,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
4535,gemini20,0.742,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4536,gemini20,0.77,PROCEDURE
4537,gemini20,0.72,NUMBER OF LYMPH NODES EXAMINED
4538,gemini20,0.886,NODAL SITE(S) EXAMINED
4539,gemini20,0.71,VISCERAL PLEURA INVASION
4540,gemini20,0.798,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4541,gemini20,0.882,TUMOR SITE
4542,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
4543,gemini20,0.895,NODAL SITE(S) EXAMINED
4544,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4545,gemini20,0.698,SPECIMEN LATERALITY
4546,gemini20,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4547,gemini20,0.811,TUMOR FOCALITY
4548,gemini20,0.698,VISCERAL PLEURA INVASION
4549,gemini20,0.779,LYMPH NODE(S) FROM PRIOR PROCEDURES
4550,gemini20,0.896,TUMOR SITE
4551,gemini20,0.752,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4552,gemini20,0.782,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4553,gemini20,0.815,REGIONAL LYMPH NODE STATUS
4554,gemini20,0.726,ADDITIONAL FINDINGS
4555,gemini20,0.704,PROCEDURE
4556,gemini20,0.76,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4557,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4558,gemini20,0.811,TUMOR FOCALITY
4559,gemini20,0.712,VISCERAL PLEURA INVASION
4560,gemini20,0.815,REGIONAL LYMPH NODE STATUS
4561,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
4562,gemini20,0.736,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4563,gemini20,0.714,NUMBER OF LYMPH NODES EXAMINED
4564,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4565,gemini20,0.788,PROCEDURE
4566,gemini20,0.72,HISTOLOGIC GRADE
4567,gemini20,0.718,NODAL SITE(S) EXAMINED
4568,gemini20,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4569,gemini20,0.697,SPECIMEN LATERALITY
4570,gemini20,0.882,TUMOR SITE
4571,gemini20,0.694,VISCERAL PLEURA INVASION
4572,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4573,gemini20,0.68,LYMPHOVASCULAR INVASION
4574,gemini20,0.767,ADDITIONAL FINDINGS
4575,gemini20,0.896,TUMOR SITE
4576,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
4577,gemini20,0.811,TUMOR FOCALITY
4578,gemini20,0.703,NUMBER OF LYMPH NODES EXAMINED
4579,gemini20,0.826,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4580,gemini20,0.697,SPECIMEN LATERALITY
4581,gemini20,0.791,NODAL SITE(S) EXAMINED
4582,gemini20,0.822,REGIONAL LYMPH NODE STATUS
4583,gemini20,0.739,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4584,gemini20,0.665,SPREAD THROUGH AIR SPACES (STAS)
4585,gemini20,0.847,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4586,gemini20,0.703,PROCEDURE
4587,gemini20,0.721,HISTOLOGIC GRADE
4588,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4589,gemini20,0.78,VISCERAL PLEURA INVASION
4590,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
4591,gemini20,0.811,TUMOR FOCALITY
4592,gemini20,0.782,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4593,gemini20,0.668,ADDITIONAL FINDINGS
4594,gemini20,0.72,MARGIN STATUS FOR INVASIVE CARCINOMA
4595,gemini20,0.755,PROCEDURE
4596,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4597,gemini20,0.698,SPECIMEN LATERALITY
4598,gemini20,0.775,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4599,gemini20,0.884,TUMOR SITE
4600,gemini20,0.804,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4601,gemini20,0.89,HISTOLOGIC GRADE
4602,gemini20,0.774,NODAL SITE(S) EXAMINED
4603,gemini20,0.822,REGIONAL LYMPH NODE STATUS
4604,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4605,gemini20,0.697,SPECIMEN LATERALITY
4606,gemini20,0.742,PROCEDURE
4607,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4608,gemini20,0.778,SPREAD THROUGH AIR SPACES (STAS)
4609,gemini20,0.701,HISTOLOGIC GRADE
4610,gemini20,0.697,NUMBER OF LYMPH NODES EXAMINED
4611,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
4612,gemini20,0.715,REGIONAL LYMPH NODE STATUS
4613,gemini20,0.89,TUMOR SITE
4614,gemini20,0.811,TUMOR FOCALITY
4615,gemini20,0.697,VISCERAL PLEURA INVASION
4616,gemini20,0.756,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4617,gemini20,0.772,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4618,gemini20,0.789,NODAL SITE(S) EXAMINED
4619,gemini20,0.832,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4620,gemini20,0.717,MARGIN STATUS FOR NON-INVASIVE TUMOR
4621,gemini20,0.815,REGIONAL LYMPH NODE STATUS
4622,gemini20,0.757,MARGIN STATUS FOR INVASIVE CARCINOMA
4623,gemini20,0.723,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4624,gemini20,0.775,PROCEDURE
4625,gemini20,0.697,SPECIMEN LATERALITY
4626,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
4627,gemini20,0.673,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4628,gemini20,0.698,HISTOLOGIC GRADE
4629,gemini20,0.713,VISCERAL PLEURA INVASION
4630,gemini20,0.861,TUMOR SITE
4631,gemini20,0.713,NUMBER OF LYMPH NODES EXAMINED
4632,gemini20,0.811,TUMOR FOCALITY
4633,gemini20,0.846,NODAL SITE(S) EXAMINED
4634,gemini20,0.778,SPREAD THROUGH AIR SPACES (STAS)
4635,gemini20,0.715,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4636,gemini20,0.753,PROCEDURE
4637,gemini20,0.688,SPREAD THROUGH AIR SPACES (STAS)
4638,gemini20,0.716,MARGIN STATUS FOR INVASIVE CARCINOMA
4639,gemini20,0.698,SPECIMEN LATERALITY
4640,gemini20,0.739,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4641,gemini20,0.742,NODAL SITE(S) EXAMINED
4642,gemini20,0.658,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4643,gemini20,0.815,REGIONAL LYMPH NODE STATUS
4644,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
4645,gemini20,0.727,TUMOR FOCALITY
4646,gemini20,0.702,ADDITIONAL FINDINGS
4647,gemini20,0.702,HISTOLOGIC GRADE
4648,gemini20,0.735,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4649,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4650,gemini20,0.735,VISCERAL PLEURA INVASION
4651,gemini20,0.705,NUMBER OF LYMPH NODES EXAMINED
4652,gemini20,0.879,TUMOR SITE
4653,gemini20,0.715,PROCEDURE
4654,gemini20,0.712,NUMBER OF LYMPH NODES EXAMINED
4655,gemini20,0.865,TUMOR SITE
4656,gemini20,0.826,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4657,gemini20,0.815,REGIONAL LYMPH NODE STATUS
4658,gemini20,0.819,MARGIN STATUS FOR INVASIVE CARCINOMA
4659,gemini20,0.697,SPECIMEN LATERALITY
4660,gemini20,0.689,HISTOLOGIC GRADE
4661,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
4662,gemini20,0.771,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4663,gemini20,0.811,TUMOR FOCALITY
4664,gemini20,0.698,VISCERAL PLEURA INVASION
4665,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4666,gemini20,0.778,SPREAD THROUGH AIR SPACES (STAS)
4667,gemini20,0.726,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4668,gemini20,0.744,NODAL SITE(S) EXAMINED
4669,gemini20,0.69,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4670,gemini20,0.692,ADDITIONAL FINDINGS
4671,gemini20,0.689,HISTOLOGIC GRADE
4672,gemini20,0.688,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4673,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
4674,gemini20,0.694,SPREAD THROUGH AIR SPACES (STAS)
4675,gemini20,0.702,VISCERAL PLEURA INVASION
4676,gemini20,0.75,PROCEDURE
4677,gemini20,0.712,NUMBER OF LYMPH NODES EXAMINED
4678,gemini20,0.753,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4679,gemini20,0.713,NODAL SITE(S) EXAMINED
4680,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4681,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4682,gemini20,0.843,TUMOR SITE
4683,gemini20,0.811,TUMOR FOCALITY
4684,gemini20,0.815,REGIONAL LYMPH NODE STATUS
4685,gemini20,0.698,SPECIMEN LATERALITY
4686,gemini20,0.815,REGIONAL LYMPH NODE STATUS
4687,gemini20,0.697,SPECIMEN LATERALITY
4688,gemini20,0.749,NODAL SITE(S) EXAMINED
4689,gemini20,0.689,HISTOLOGIC GRADE
4690,gemini20,0.699,SPREAD THROUGH AIR SPACES (STAS)
4691,gemini20,0.842,TUMOR SITE
4692,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
4693,gemini20,0.72,NUMBER OF LYMPH NODES EXAMINED
4694,gemini20,0.811,TUMOR FOCALITY
4695,gemini20,0.672,VISCERAL PLEURA INVASION
4696,gemini20,0.691,PROCEDURE
4697,gemini20,0.813,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4698,gemini20,0.726,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4699,gemini20,0.713,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4700,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4701,gemini20,0.779,LYMPH NODE(S) FROM PRIOR PROCEDURES
4702,gemini20,0.811,TUMOR FOCALITY
4703,gemini20,0.701,SPREAD THROUGH AIR SPACES (STAS)
4704,gemini20,0.827,PROCEDURE
4705,gemini20,0.749,HISTOLOGIC GRADE
4706,gemini20,0.781,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4707,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4708,gemini20,0.753,ADDITIONAL FINDINGS
4709,gemini20,0.735,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4710,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
4711,gemini20,0.7,NODAL SITE(S) EXAMINED
4712,gemini20,0.884,TUMOR SITE
4713,gemini20,0.826,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4714,gemini20,0.707,VISCERAL PLEURA INVASION
4715,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4716,gemini20,0.815,REGIONAL LYMPH NODE STATUS
4717,gemini20,0.699,NUMBER OF LYMPH NODES EXAMINED
4718,gemini20,0.698,SPECIMEN LATERALITY
4719,gemini20,0.697,SPECIMEN LATERALITY
4720,gemini20,0.719,VISCERAL PLEURA INVASION
4721,gemini20,0.726,HISTOLOGIC GRADE
4722,gemini20,0.695,MARGIN STATUS FOR NON-INVASIVE TUMOR
4723,gemini20,0.645,MARGIN STATUS FOR INVASIVE CARCINOMA
4724,gemini20,0.726,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4725,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4726,gemini20,0.769,PROCEDURE
4727,gemini20,0.66,TNM DESCRIPTORS
4728,gemini20,0.67,TUMOR FOCALITY
4729,gemini20,0.793,ADDITIONAL FINDINGS
4730,gemini20,0.755,NODAL SITE(S) EXAMINED
4731,gemini20,0.815,REGIONAL LYMPH NODE STATUS
4732,gemini20,0.896,MARGIN STATUS FOR INVASIVE CARCINOMA
4733,gemini20,0.698,SPECIMEN LATERALITY
4734,gemini20,0.674,NODAL SITE(S) EXAMINED
4735,gemini20,0.79,HISTOLOGIC GRADE
4736,gemini20,0.747,ADDITIONAL FINDINGS
4737,gemini20,0.692,SPREAD THROUGH AIR SPACES (STAS)
4738,gemini20,0.78,VISCERAL PLEURA INVASION
4739,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
4740,gemini20,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4741,gemini20,0.89,TUMOR SITE
4742,gemini20,0.815,REGIONAL LYMPH NODE STATUS
4743,gemini20,0.786,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4744,gemini20,0.731,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4745,gemini20,0.734,PROCEDURE
4746,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4747,gemini20,0.766,LYMPHOVASCULAR INVASION
4748,gemini20,0.811,TUMOR FOCALITY
4749,gemini20,0.7,NUMBER OF LYMPH NODES EXAMINED
4750,gemini20,0.839,NODAL SITE(S) EXAMINED
4751,gemini20,0.851,TUMOR SITE
4752,gemini20,0.713,NUMBER OF LYMPH NODES EXAMINED
4753,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
4754,gemini20,0.723,VISCERAL PLEURA INVASION
4755,gemini20,0.689,HISTOLOGIC GRADE
4756,gemini20,0.697,SPECIMEN LATERALITY
4757,gemini20,0.743,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4758,gemini20,0.826,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4759,gemini20,0.697,PROCEDURE
4760,gemini20,0.691,SPREAD THROUGH AIR SPACES (STAS)
4761,gemini20,0.822,REGIONAL LYMPH NODE STATUS
4762,gemini20,0.748,ADDITIONAL FINDINGS
4763,gemini20,0.674,TUMOR FOCALITY
4764,gemini20,0.757,MARGIN STATUS FOR INVASIVE CARCINOMA
4765,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4766,gemini20,0.825,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4767,gemini20,0.701,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4768,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4769,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4770,gemini20,0.704,HISTOLOGIC GRADE
4771,gemini20,0.778,TUMOR FOCALITY
4772,gemini20,0.865,NODAL SITE(S) EXAMINED
4773,gemini20,0.697,SPECIMEN LATERALITY
4774,gemini20,0.747,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4775,gemini20,0.713,NUMBER OF LYMPH NODES EXAMINED
4776,gemini20,0.815,REGIONAL LYMPH NODE STATUS
4777,gemini20,0.703,VISCERAL PLEURA INVASION
4778,gemini20,0.826,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4779,gemini20,0.887,TUMOR SITE
4780,gemini20,0.737,PROCEDURE
4781,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
4782,gemini20,0.75,NODAL SITE(S) EXAMINED
4783,gemini20,0.738,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4784,gemini20,0.698,SPECIMEN LATERALITY
4785,gemini20,0.754,REGIONAL LYMPH NODE STATUS
4786,gemini20,0.811,TUMOR FOCALITY
4787,gemini20,0.884,TUMOR SITE
4788,gemini20,0.779,MARGIN STATUS FOR INVASIVE CARCINOMA
4789,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
4790,gemini20,0.826,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4791,gemini20,0.729,VISCERAL PLEURA INVASION
4792,gemini20,0.72,NUMBER OF LYMPH NODES EXAMINED
4793,gemini20,0.847,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4794,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
4795,gemini20,0.827,PROCEDURE
4796,gemini20,0.889,ADDITIONAL FINDINGS
4797,gemini20,0.819,NODAL SITE(S) EXAMINED
4798,gemini20,0.747,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4799,gemini20,0.688,PROCEDURE
4800,gemini20,0.851,TUMOR SITE
4801,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4802,gemini20,0.691,HISTOLOGIC GRADE
4803,gemini20,0.761,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4804,gemini20,0.784,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4805,gemini20,0.815,REGIONAL LYMPH NODE STATUS
4806,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
4807,gemini20,0.697,SPECIMEN LATERALITY
4808,gemini20,0.784,MARGIN STATUS FOR INVASIVE CARCINOMA
4809,gemini20,0.713,VISCERAL PLEURA INVASION
4810,gemini20,0.811,TUMOR FOCALITY
4811,gemini20,0.705,REGIONAL LYMPH NODE STATUS
4812,gemini20,0.697,SPECIMEN LATERALITY
4813,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
4814,gemini20,0.682,VISCERAL PLEURA INVASION
4815,gemini20,0.802,NODAL SITE(S) EXAMINED
4816,gemini20,0.79,PROCEDURE
4817,gemini20,0.738,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4818,gemini20,0.721,TUMOR SITE
4819,gemini20,0.758,NUMBER OF LYMPH NODES EXAMINED
4820,gemini20,0.743,MARGIN STATUS FOR INVASIVE CARCINOMA
4821,gemini20,0.677,SPREAD THROUGH AIR SPACES (STAS)
4822,gemini20,0.734,HISTOLOGIC GRADE
4823,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4824,gemini20,0.873,TUMOR FOCALITY
4825,gemini20,0.78,VISCERAL PLEURA INVASION
4826,gemini20,0.698,SPECIMEN LATERALITY
4827,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
4828,gemini20,0.884,TUMOR SITE
4829,gemini20,0.688,SPREAD THROUGH AIR SPACES (STAS)
4830,gemini20,0.714,PROCEDURE
4831,gemini20,0.689,LYMPHOVASCULAR INVASION
4832,gemini20,0.735,NODAL SITE(S) WITH TUMOR
4833,gemini20,0.783,REGIONAL LYMPH NODE STATUS
4834,gemini20,0.699,NUMBER OF LYMPH NODES WITH TUMOR
4835,gemini20,0.799,NODAL SITE(S) EXAMINED
4836,gemini20,0.728,HISTOLOGIC GRADE
4837,gemini20,0.838,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4838,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4839,gemini20,0.826,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4840,gemini20,0.774,MARGIN STATUS FOR INVASIVE CARCINOMA
4841,gemini20,0.811,TUMOR FOCALITY
4842,gemini20,0.693,SPREAD THROUGH AIR SPACES (STAS)
4843,gemini20,0.668,VISCERAL PLEURA INVASION
4844,gemini20,0.698,SPECIMEN LATERALITY
4845,gemini20,0.759,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4846,gemini20,0.783,REGIONAL LYMPH NODE STATUS
4847,gemini20,0.713,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4848,gemini20,0.707,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4849,gemini20,0.811,TUMOR FOCALITY
4850,gemini20,0.714,LYMPHOVASCULAR INVASION
4851,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4852,gemini20,0.884,TUMOR SITE
4853,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
4854,gemini20,0.769,NODAL SITE(S) WITH TUMOR
4855,gemini20,0.713,NUMBER OF LYMPH NODES WITH TUMOR
4856,gemini20,0.844,NODAL SITE(S) EXAMINED
4857,gemini20,0.773,NUMBER OF LYMPH NODES EXAMINED
4858,gemini20,0.705,ADDITIONAL FINDINGS
4859,gemini20,0.7,PROCEDURE
4860,gemini20,0.704,HISTOLOGIC GRADE
4861,gemini20,0.697,SPECIMEN LATERALITY
4862,gemini20,0.711,TUMOR FOCALITY
4863,gemini20,0.72,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4864,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4865,gemini20,0.758,MARGIN STATUS FOR INVASIVE CARCINOMA
4866,gemini20,0.706,REGIONAL LYMPH NODE STATUS
4867,gemini20,0.677,SPREAD THROUGH AIR SPACES (STAS)
4868,gemini20,0.7,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4869,gemini20,0.708,HISTOLOGIC GRADE
4870,gemini20,0.789,TUMOR SITE
4871,gemini20,0.731,NODAL SITE(S) EXAMINED
4872,gemini20,0.674,PROCEDURE
4873,gemini20,0.718,ADDITIONAL FINDINGS
4874,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
4875,gemini20,0.707,NODAL SITE(S) EXAMINED
4876,gemini20,0.702,VISCERAL PLEURA INVASION
4877,gemini20,0.755,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4878,gemini20,0.687,LYMPHOVASCULAR INVASION
4879,gemini20,0.777,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4880,gemini20,0.78,NODAL SITE(S) EXAMINED
4881,gemini20,0.699,SPREAD THROUGH AIR SPACES (STAS)
4882,gemini20,0.814,ADDITIONAL FINDINGS
4883,gemini20,0.697,SPECIMEN LATERALITY
4884,gemini20,0.758,MARGIN STATUS FOR INVASIVE CARCINOMA
4885,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
4886,gemini20,0.878,TUMOR SITE
4887,gemini20,0.734,REGIONAL LYMPH NODE STATUS
4888,gemini20,0.708,TUMOR FOCALITY
4889,gemini20,0.663,MARGIN STATUS FOR NON-INVASIVE TUMOR
4890,gemini20,0.717,VISCERAL PLEURA INVASION
4891,gemini20,0.773,HISTOLOGIC GRADE
4892,gemini20,0.788,PROCEDURE
4893,gemini20,0.822,REGIONAL LYMPH NODE STATUS
4894,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
4895,gemini20,0.697,SPECIMEN LATERALITY
4896,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4897,gemini20,0.689,HISTOLOGIC GRADE
4898,gemini20,0.744,NODAL SITE(S) EXAMINED
4899,gemini20,0.826,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4900,gemini20,0.767,MARGIN STATUS FOR INVASIVE CARCINOMA
4901,gemini20,0.811,TUMOR FOCALITY
4902,gemini20,0.842,TUMOR SITE
4903,gemini20,0.737,PROCEDURE
4904,gemini20,0.733,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4905,gemini20,0.72,VISCERAL PLEURA INVASION
4906,gemini20,0.805,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4907,gemini20,0.699,NUMBER OF LYMPH NODES EXAMINED
4908,gemini20,0.823,ADDITIONAL FINDINGS
4909,gemini20,0.681,SPREAD THROUGH AIR SPACES (STAS)
4910,gemini20,0.832,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4911,gemini20,0.669,VISCERAL PLEURA INVASION
4912,gemini20,0.761,MARGIN STATUS FOR INVASIVE CARCINOMA
4913,gemini20,0.78,ADDITIONAL FINDINGS
4914,gemini20,0.822,REGIONAL LYMPH NODE STATUS
4915,gemini20,0.826,HISTOLOGIC GRADE
4916,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
4917,gemini20,0.688,SPREAD THROUGH AIR SPACES (STAS)
4918,gemini20,0.681,TUMOR SITE
4919,gemini20,0.699,PROCEDURE
4920,gemini20,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4921,gemini20,0.697,SPECIMEN LATERALITY
4922,gemini20,0.705,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4923,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4924,gemini20,0.72,NODAL SITE(S) EXAMINED
4925,gemini20,0.811,TUMOR FOCALITY
4926,gemini20,0.826,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4927,gemini20,0.691,SPREAD THROUGH AIR SPACES (STAS)
4928,gemini20,0.69,VISCERAL PLEURA INVASION
4929,gemini20,0.685,ADDITIONAL FINDINGS
4930,gemini20,0.698,SPECIMEN LATERALITY
4931,gemini20,0.817,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4932,gemini20,0.686,HISTOLOGIC GRADE
4933,gemini20,0.815,REGIONAL LYMPH NODE STATUS
4934,gemini20,0.776,NODAL SITE(S) EXAMINED
4935,gemini20,0.762,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4936,gemini20,0.713,NUMBER OF LYMPH NODES EXAMINED
4937,gemini20,0.744,PROCEDURE
4938,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
4939,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4940,gemini20,0.811,TUMOR FOCALITY
4941,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4942,gemini20,0.83,TUMOR SITE
4943,gemini20,0.792,TUMOR SITE
4944,gemini20,0.815,REGIONAL LYMPH NODE STATUS
4945,gemini20,0.811,TUMOR FOCALITY
4946,gemini20,0.802,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4947,gemini20,0.698,SPECIMEN LATERALITY
4948,gemini20,0.699,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4949,gemini20,0.683,LYMPH NODE(S) FROM PRIOR PROCEDURES
4950,gemini20,0.749,PROCEDURE
4951,gemini20,0.676,SPREAD THROUGH AIR SPACES (STAS)
4952,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
4953,gemini20,0.721,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4954,gemini20,0.763,HISTOLOGIC GRADE
4955,gemini20,0.708,NODAL SITE(S) EXAMINED
4956,gemini20,0.705,VISCERAL PLEURA INVASION
4957,gemini20,0.704,ADDITIONAL FINDINGS
4958,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4959,gemini20,0.727,MARGIN STATUS FOR INVASIVE CARCINOMA
4960,gemini20,0.747,NODAL SITE(S) EXAMINED
4961,gemini20,0.701,ADDITIONAL FINDINGS
4962,gemini20,0.697,SPECIMEN LATERALITY
4963,gemini20,0.705,VISCERAL PLEURA INVASION
4964,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
4965,gemini20,0.815,REGIONAL LYMPH NODE STATUS
4966,gemini20,0.772,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4967,gemini20,0.767,PROCEDURE
4968,gemini20,0.689,HISTOLOGIC GRADE
4969,gemini20,0.775,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4970,gemini20,0.691,SPREAD THROUGH AIR SPACES (STAS)
4971,gemini20,0.67,TUMOR FOCALITY
4972,gemini20,0.74,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4973,gemini20,0.779,LYMPH NODE(S) FROM PRIOR PROCEDURES
4974,gemini20,0.89,TUMOR SITE
4975,gemini20,0.739,PROCEDURE
4976,gemini20,0.707,VISCERAL PLEURA INVASION
4977,gemini20,0.879,TUMOR SITE
4978,gemini20,0.85,NODAL SITE(S) EXAMINED
4979,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
4980,gemini20,0.689,HISTOLOGIC GRADE
4981,gemini20,0.78,SPREAD THROUGH AIR SPACES (STAS)
4982,gemini20,0.804,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4983,gemini20,0.779,LYMPH NODE(S) FROM PRIOR PROCEDURES
4984,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4985,gemini20,0.822,REGIONAL LYMPH NODE STATUS
4986,gemini20,0.811,TUMOR FOCALITY
4987,gemini20,0.751,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4988,gemini20,0.713,NUMBER OF LYMPH NODES EXAMINED
4989,gemini20,0.826,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4990,gemini20,0.698,SPECIMEN LATERALITY
4991,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
4992,gemini20,0.697,SPECIMEN LATERALITY
4993,gemini20,0.743,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4994,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4995,gemini20,0.815,REGIONAL LYMPH NODE STATUS
4996,gemini20,0.837,TUMOR SITE
4997,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4998,gemini20,0.741,PROCEDURE
4999,gemini20,0.675,VISCERAL PLEURA INVASION
5000,gemini20,0.811,TUMOR FOCALITY
5001,gemini20,0.837,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5002,gemini20,0.826,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5003,gemini20,0.78,NUMBER OF LYMPH NODES EXAMINED
5004,gemini20,0.822,NODAL SITE(S) EXAMINED
5005,gemini20,0.769,HISTOLOGIC GRADE
5006,gemini20,0.688,ADDITIONAL FINDINGS
5007,gemini20,0.691,SPREAD THROUGH AIR SPACES (STAS)
5008,gemini20,0.68,HISTOLOGIC GRADE
5009,gemini20,0.684,LYMPHOVASCULAR INVASION
5010,gemini20,0.826,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5011,gemini20,0.78,REGIONAL LYMPH NODE STATUS
5012,gemini20,0.713,NUMBER OF LYMPH NODES WITH TUMOR
5013,gemini20,0.788,NODAL SITE(S) EXAMINED
5014,gemini20,0.811,TUMOR FOCALITY
5015,gemini20,0.707,NUMBER OF LYMPH NODES WITH TUMOR
5016,gemini20,0.697,SPECIMEN LATERALITY
5017,gemini20,0.776,NODAL SITE(S) WITH TUMOR
5018,gemini20,0.878,TUMOR SITE
5019,gemini20,0.777,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5020,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5021,gemini20,0.802,NODAL SITE(S) WITH TUMOR
5022,gemini20,0.733,VISCERAL PLEURA INVASION
5023,gemini20,0.751,MARGIN STATUS FOR INVASIVE CARCINOMA
5024,gemini20,0.71,PROCEDURE
5025,gemini20,0.701,NUMBER OF LYMPH NODES EXAMINED
5026,gemini20,0.847,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5027,gemini20,0.67,MARGIN STATUS FOR NON-INVASIVE TUMOR
5028,gemini20,0.745,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5029,gemini20,0.761,NUMBER OF LYMPH NODES EXAMINED
5030,gemini20,0.779,LYMPH NODE(S) FROM PRIOR PROCEDURES
5031,gemini20,0.734,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5032,gemini20,0.787,MARGIN STATUS FOR INVASIVE CARCINOMA
5033,gemini20,0.738,VISCERAL PLEURA INVASION
5034,gemini20,0.739,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5035,gemini20,0.774,ADDITIONAL FINDINGS
5036,gemini20,0.811,TUMOR FOCALITY
5037,gemini20,0.71,PROCEDURE
5038,gemini20,0.842,NODAL SITE(S) EXAMINED
5039,gemini20,0.815,REGIONAL LYMPH NODE STATUS
5040,gemini20,0.789,TUMOR SITE
5041,gemini20,0.718,HISTOLOGIC GRADE
5042,gemini20,0.697,SPECIMEN LATERALITY
5043,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
5044,gemini20,0.794,MARGIN STATUS FOR INVASIVE CARCINOMA
5045,gemini20,0.739,PROCEDURE
5046,gemini20,0.825,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5047,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
5048,gemini20,0.822,REGIONAL LYMPH NODE STATUS
5049,gemini20,0.737,TUMOR SITE
5050,gemini20,0.706,ADDITIONAL FINDINGS
5051,gemini20,0.685,SPREAD THROUGH AIR SPACES (STAS)
5052,gemini20,0.811,TUMOR FOCALITY
5053,gemini20,0.707,VISCERAL PLEURA INVASION
5054,gemini20,0.711,HISTOLOGIC GRADE
5055,gemini20,0.848,NODAL SITE(S) EXAMINED
5056,gemini20,0.743,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5057,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5058,gemini20,0.798,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5059,gemini20,0.697,SPECIMEN LATERALITY
5060,gemini20,0.697,SPECIMEN LATERALITY
5061,gemini20,0.841,NODAL SITE(S) EXAMINED
5062,gemini20,0.667,VISCERAL PLEURA INVASION
5063,gemini20,0.705,NUMBER OF LYMPH NODES EXAMINED
5064,gemini20,0.788,PROCEDURE
5065,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
5066,gemini20,0.838,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5067,gemini20,0.811,TUMOR FOCALITY
5068,gemini20,0.7,TUMOR SITE
5069,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5070,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
5071,gemini20,0.632,HISTOLOGIC GRADE
5072,gemini20,0.815,REGIONAL LYMPH NODE STATUS
5073,gemini20,0.667,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5074,gemini20,0.732,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5075,gemini20,0.781,ADDITIONAL FINDINGS
5076,gemini20,0.735,REGIONAL LYMPH NODE STATUS
5077,gemini20,0.791,NODAL SITE(S) EXAMINED
5078,gemini20,0.705,HISTOLOGIC GRADE
5079,gemini20,0.811,TUMOR FOCALITY
5080,gemini20,0.708,MARGIN STATUS FOR INVASIVE CARCINOMA
5081,gemini20,0.884,TUMOR SITE
5082,gemini20,0.743,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5083,gemini20,0.727,ADDITIONAL FINDINGS
5084,gemini20,0.721,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5085,gemini20,0.725,PROCEDURE
5086,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5087,gemini20,0.684,SPREAD THROUGH AIR SPACES (STAS)
5088,gemini20,0.768,VISCERAL PLEURA INVASION
5089,gemini20,0.698,SPECIMEN LATERALITY
5090,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
5091,gemini20,0.715,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5092,gemini20,0.783,REGIONAL LYMPH NODE STATUS
5093,gemini20,0.811,TUMOR FOCALITY
5094,gemini20,0.771,MARGIN STATUS FOR INVASIVE CARCINOMA
5095,gemini20,0.785,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5096,gemini20,0.803,ADDITIONAL FINDINGS
5097,gemini20,0.711,NODAL SITE(S) WITH TUMOR
5098,gemini20,0.677,SPREAD THROUGH AIR SPACES (STAS)
5099,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
5100,gemini20,0.698,SPECIMEN LATERALITY
5101,gemini20,0.729,VISCERAL PLEURA INVASION
5102,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5103,gemini20,0.684,LYMPHOVASCULAR INVASION
5104,gemini20,0.788,NODAL SITE(S) EXAMINED
5105,gemini20,0.713,NUMBER OF LYMPH NODES WITH TUMOR
5106,gemini20,0.89,TUMOR SITE
5107,gemini20,0.684,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5108,gemini20,0.788,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5109,gemini20,0.708,HISTOLOGIC GRADE
5110,gemini20,0.696,NUMBER OF LYMPH NODES EXAMINED
5111,gemini20,0.708,PROCEDURE
5112,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5113,gemini20,0.778,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5114,gemini20,0.699,VISCERAL PLEURA INVASION
5115,gemini20,0.694,NUMBER OF LYMPH NODES EXAMINED
5116,gemini20,0.74,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5117,gemini20,0.739,TUMOR FOCALITY
5118,gemini20,0.734,PROCEDURE
5119,gemini20,0.681,SPREAD THROUGH AIR SPACES (STAS)
5120,gemini20,0.691,HISTOLOGIC GRADE
5121,gemini20,0.845,NODAL SITE(S) EXAMINED
5122,gemini20,0.734,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5123,gemini20,0.829,REGIONAL LYMPH NODE STATUS
5124,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5125,gemini20,0.698,SPECIMEN LATERALITY
5126,gemini20,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5127,gemini20,0.793,TUMOR SITE
5128,gemini20,0.837,NODAL SITE(S) EXAMINED
5129,gemini20,0.717,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5130,gemini20,0.815,REGIONAL LYMPH NODE STATUS
5131,gemini20,0.819,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5132,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5133,gemini20,0.887,TUMOR SITE
5134,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
5135,gemini20,0.811,TUMOR FOCALITY
5136,gemini20,0.718,PROCEDURE
5137,gemini20,0.701,NUMBER OF LYMPH NODES EXAMINED
5138,gemini20,0.761,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5139,gemini20,0.697,SPECIMEN LATERALITY
5140,gemini20,0.703,HISTOLOGIC GRADE
5141,gemini20,0.725,VISCERAL PLEURA INVASION
5142,gemini20,0.779,LYMPH NODE(S) FROM PRIOR PROCEDURES
5143,gemini20,0.792,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5144,gemini20,0.822,REGIONAL LYMPH NODE STATUS
5145,gemini20,0.832,NODAL SITE(S) EXAMINED
5146,gemini20,0.811,TUMOR FOCALITY
5147,gemini20,0.737,PROCEDURE
5148,gemini20,0.699,NUMBER OF LYMPH NODES EXAMINED
5149,gemini20,0.734,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5150,gemini20,0.697,SPECIMEN LATERALITY
5151,gemini20,0.722,TUMOR SITE
5152,gemini20,0.695,HISTOLOGIC GRADE
5153,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
5154,gemini20,0.826,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5155,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5156,gemini20,0.761,VISCERAL PLEURA INVASION
5157,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5158,gemini20,0.694,HISTOLOGIC GRADE
5159,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5160,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
5161,gemini20,0.826,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5162,gemini20,0.7,NUMBER OF LYMPH NODES EXAMINED
5163,gemini20,0.829,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5164,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5165,gemini20,0.746,NODAL SITE(S) EXAMINED
5166,gemini20,0.697,SPECIMEN LATERALITY
5167,gemini20,0.829,REGIONAL LYMPH NODE STATUS
5168,gemini20,0.887,TUMOR SITE
5169,gemini20,0.728,PROCEDURE
5170,gemini20,0.811,TUMOR FOCALITY
5171,gemini20,0.825,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5172,gemini20,0.708,VISCERAL PLEURA INVASION
5173,gemini20,0.638,VISCERAL PLEURA INVASION
5174,gemini20,0.741,TUMOR SITE
5175,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5176,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5177,gemini20,0.757,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5178,gemini20,0.705,PROCEDURE
5179,gemini20,0.783,REGIONAL LYMPH NODE STATUS
5180,gemini20,0.886,NODAL SITE(S) WITH TUMOR
5181,gemini20,0.689,HISTOLOGIC GRADE
5182,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
5183,gemini20,0.779,SPECIMEN LATERALITY
5184,gemini20,0.725,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5185,gemini20,0.705,TNM DESCRIPTORS
5186,gemini20,0.702,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5187,gemini20,0.839,NODAL SITE(S) EXAMINED
5188,gemini20,0.706,NUMBER OF LYMPH NODES EXAMINED
5189,gemini20,0.72,NUMBER OF LYMPH NODES WITH TUMOR
5190,gemini20,0.674,TUMOR FOCALITY
5191,gemini20,0.691,NUMBER OF LYMPH NODES EXAMINED
5192,gemini20,0.818,NODAL SITE(S) EXAMINED
5193,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5194,gemini20,0.703,TUMOR FOCALITY
5195,gemini20,0.815,REGIONAL LYMPH NODE STATUS
5196,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
5197,gemini20,0.788,PROCEDURE
5198,gemini20,0.768,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5199,gemini20,0.669,HISTOLOGIC GRADE
5200,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5201,gemini20,0.801,VISCERAL PLEURA INVASION
5202,gemini20,0.791,TUMOR SITE
5203,gemini20,0.697,SPECIMEN LATERALITY
5204,gemini20,0.775,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5205,gemini20,0.715,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5206,gemini20,0.821,TUMOR SITE
5207,gemini20,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5208,gemini20,0.724,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5209,gemini20,0.683,LYMPH NODE(S) FROM PRIOR PROCEDURES
5210,gemini20,0.818,HISTOLOGIC GRADE
5211,gemini20,0.707,NUMBER OF LYMPH NODES EXAMINED
5212,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
5213,gemini20,0.713,REGIONAL LYMPH NODE STATUS
5214,gemini20,0.71,NODAL SITE(S) WITH TUMOR
5215,gemini20,0.698,SPECIMEN LATERALITY
5216,gemini20,0.697,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5217,gemini20,0.713,NUMBER OF LYMPH NODES WITH TUMOR
5218,gemini20,0.712,LYMPHOVASCULAR INVASION
5219,gemini20,0.788,PROCEDURE
5220,gemini20,0.757,MARGIN STATUS FOR INVASIVE CARCINOMA
5221,gemini20,0.811,TUMOR FOCALITY
5222,gemini20,0.764,VISCERAL PLEURA INVASION
5223,gemini20,0.75,NODAL SITE(S) EXAMINED
5224,gemini20,0.645,ADDITIONAL FINDINGS
5225,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
5226,gemini20,0.699,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5227,gemini20,0.811,TUMOR FOCALITY
5228,gemini20,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5229,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5230,gemini20,0.89,TUMOR SITE
5231,gemini20,0.735,VISCERAL PLEURA INVASION
5232,gemini20,0.815,REGIONAL LYMPH NODE STATUS
5233,gemini20,0.67,SPREAD THROUGH AIR SPACES (STAS)
5234,gemini20,0.716,PROCEDURE
5235,gemini20,0.762,NUMBER OF LYMPH NODES EXAMINED
5236,gemini20,0.715,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5237,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5238,gemini20,0.832,NODAL SITE(S) EXAMINED
5239,gemini20,0.697,SPECIMEN LATERALITY
5240,gemini20,0.699,MARGIN STATUS FOR NON-INVASIVE TUMOR
5241,gemini20,0.683,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5242,gemini20,0.706,PROCEDURE
5243,gemini20,0.645,TUMOR FOCALITY
5244,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5245,gemini20,0.754,NODAL SITE(S) EXAMINED
5246,gemini20,0.699,NUMBER OF LYMPH NODES EXAMINED
5247,gemini20,0.709,SPREAD THROUGH AIR SPACES (STAS)
5248,gemini20,0.704,HISTOLOGIC GRADE
5249,gemini20,0.896,MARGIN STATUS FOR INVASIVE CARCINOMA
5250,gemini20,0.681,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5251,gemini20,0.698,SPECIMEN LATERALITY
5252,gemini20,0.815,REGIONAL LYMPH NODE STATUS
5253,gemini20,0.89,TUMOR SITE
5254,gemini20,0.726,VISCERAL PLEURA INVASION
5255,gemini20,0.813,ADDITIONAL FINDINGS
5256,gemini20,0.804,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5257,gemini20,0.698,SPECIMEN LATERALITY
5258,gemini20,0.713,NUMBER OF LYMPH NODES EXAMINED
5259,gemini20,0.78,ADDITIONAL FINDINGS
5260,gemini20,0.747,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5261,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5262,gemini20,0.843,TUMOR SITE
5263,gemini20,0.714,PROCEDURE
5264,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
5265,gemini20,0.816,NODAL SITE(S) EXAMINED
5266,gemini20,0.811,TUMOR FOCALITY
5267,gemini20,0.73,VISCERAL PLEURA INVASION
5268,gemini20,0.772,MARGIN STATUS FOR INVASIVE CARCINOMA
5269,gemini20,0.697,SPREAD THROUGH AIR SPACES (STAS)
5270,gemini20,0.836,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5271,gemini20,0.815,REGIONAL LYMPH NODE STATUS
5272,gemini20,0.707,HISTOLOGIC GRADE
5273,gemini20,0.714,PROCEDURE
5274,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5275,gemini20,0.697,SPECIMEN LATERALITY
5276,gemini20,0.744,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5277,gemini20,0.712,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5278,gemini20,0.896,TUMOR SITE
5279,gemini20,0.896,MARGIN STATUS FOR INVASIVE CARCINOMA
5280,gemini20,0.739,LYMPHOVASCULAR INVASION
5281,gemini20,0.767,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5282,gemini20,0.811,TUMOR FOCALITY
5283,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
5284,gemini20,0.815,NODAL SITE(S) EXAMINED
5285,gemini20,0.735,HISTOLOGIC GRADE
5286,gemini20,0.815,REGIONAL LYMPH NODE STATUS
5287,gemini20,0.657,ADDITIONAL FINDINGS
5288,gemini20,0.78,VISCERAL PLEURA INVASION
5289,gemini20,0.696,SPREAD THROUGH AIR SPACES (STAS)
5290,gemini20,0.698,HISTOLOGIC GRADE
5291,gemini20,0.777,MARGIN STATUS FOR INVASIVE CARCINOMA
5292,gemini20,0.855,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5293,gemini20,0.731,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5294,gemini20,0.712,NODAL SITE(S) EXAMINED
5295,gemini20,0.699,NUMBER OF LYMPH NODES EXAMINED
5296,gemini20,0.815,REGIONAL LYMPH NODE STATUS
5297,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
5298,gemini20,0.779,LYMPH NODE(S) FROM PRIOR PROCEDURES
5299,gemini20,0.826,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5300,gemini20,0.762,PROCEDURE
5301,gemini20,0.775,TUMOR SITE
5302,gemini20,0.697,SPECIMEN LATERALITY
5303,gemini20,0.737,VISCERAL PLEURA INVASION
5304,gemini20,0.811,TUMOR FOCALITY
5305,gemini20,0.722,HISTOLOGIC GRADE
5306,gemini20,0.699,NUMBER OF LYMPH NODES EXAMINED
5307,gemini20,0.693,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5308,gemini20,0.882,NODAL SITE(S) WITH TUMOR
5309,gemini20,0.73,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5310,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5311,gemini20,0.896,MARGIN STATUS FOR INVASIVE CARCINOMA
5312,gemini20,0.783,REGIONAL LYMPH NODE STATUS
5313,gemini20,0.706,PROCEDURE
5314,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
5315,gemini20,0.811,TUMOR FOCALITY
5316,gemini20,0.884,TUMOR SITE
5317,gemini20,0.734,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5318,gemini20,0.698,SPECIMEN LATERALITY
5319,gemini20,0.791,NODAL SITE(S) EXAMINED
5320,gemini20,0.72,NUMBER OF LYMPH NODES WITH TUMOR
5321,gemini20,0.698,VISCERAL PLEURA INVASION
5322,gemini20,0.69,TUMOR FOCALITY
5323,gemini20,0.815,REGIONAL LYMPH NODE STATUS
5324,gemini20,0.697,SPECIMEN LATERALITY
5325,gemini20,0.788,PROCEDURE
5326,gemini20,0.701,NUMBER OF LYMPH NODES EXAMINED
5327,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5328,gemini20,0.725,HISTOLOGIC GRADE
5329,gemini20,0.707,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5330,gemini20,0.761,VISCERAL PLEURA INVASION
5331,gemini20,0.696,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5332,gemini20,0.853,NODAL SITE(S) EXAMINED
5333,gemini20,0.896,TUMOR SITE
5334,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5335,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
5336,gemini20,0.843,NODAL SITE(S) EXAMINED
5337,gemini20,0.89,TUMOR SITE
5338,gemini20,0.718,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5339,gemini20,0.705,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5340,gemini20,0.697,SPECIMEN LATERALITY
5341,gemini20,0.67,TUMOR FOCALITY
5342,gemini20,0.691,SPREAD THROUGH AIR SPACES (STAS)
5343,gemini20,0.705,HISTOLOGIC GRADE
5344,gemini20,0.775,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5345,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5346,gemini20,0.763,MARGIN STATUS FOR NON-INVASIVE TUMOR
5347,gemini20,0.788,PROCEDURE
5348,gemini20,0.676,VISCERAL PLEURA INVASION
5349,gemini20,0.815,REGIONAL LYMPH NODE STATUS
5350,gemini20,0.775,ADDITIONAL FINDINGS
5351,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5352,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5353,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
5354,gemini20,0.811,TUMOR FOCALITY
5355,gemini20,0.882,TUMOR SITE
5356,gemini20,0.718,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5357,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5358,gemini20,0.662,ADDITIONAL FINDINGS
5359,gemini20,0.698,VISCERAL PLEURA INVASION
5360,gemini20,0.697,SPECIMEN LATERALITY
5361,gemini20,0.741,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5362,gemini20,0.827,PROCEDURE
5363,gemini20,0.733,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5364,gemini20,0.699,SPREAD THROUGH AIR SPACES (STAS)
5365,gemini20,0.87,TUMOR SITE
5366,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5367,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
5368,gemini20,0.736,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5369,gemini20,0.689,HISTOLOGIC GRADE
5370,gemini20,0.815,REGIONAL LYMPH NODE STATUS
5371,gemini20,0.742,PROCEDURE
5372,gemini20,0.798,NODAL SITE(S) EXAMINED
5373,gemini20,0.724,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5374,gemini20,0.695,TUMOR FOCALITY
5375,gemini20,0.699,MARGIN STATUS FOR INVASIVE CARCINOMA
5376,gemini20,0.683,VISCERAL PLEURA INVASION
5377,gemini20,0.699,SPREAD THROUGH AIR SPACES (STAS)
5378,gemini20,0.697,SPECIMEN LATERALITY
5379,gemini20,0.756,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5380,gemini20,0.826,HISTOLOGIC GRADE
5381,gemini20,0.787,ADDITIONAL FINDINGS
5382,gemini20,0.815,REGIONAL LYMPH NODE STATUS
5383,gemini20,0.88,LYMPH NODE(S) FROM PRIOR PROCEDURES
5384,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5385,gemini20,0.678,TUMOR FOCALITY
5386,gemini20,0.744,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5387,gemini20,0.77,NUMBER OF LYMPH NODES EXAMINED
5388,gemini20,0.78,NODAL SITE(S) EXAMINED
5389,gemini20,0.689,VISCERAL PLEURA INVASION
5390,gemini20,0.694,SPREAD THROUGH AIR SPACES (STAS)
5391,gemini20,0.726,PROCEDURE
5392,gemini20,0.698,SPECIMEN LATERALITY
5393,gemini20,0.771,TUMOR SITE
5394,gemini20,0.774,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5395,gemini20,0.704,TNM DESCRIPTORS
5396,gemini20,0.702,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5397,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
5398,gemini20,0.815,REGIONAL LYMPH NODE STATUS
5399,gemini20,0.754,VISCERAL PLEURA INVASION
5400,gemini20,0.697,SPECIMEN LATERALITY
5401,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
5402,gemini20,0.779,LYMPH NODE(S) FROM PRIOR PROCEDURES
5403,gemini20,0.827,HISTOLOGIC GRADE
5404,gemini20,0.692,LYMPHOVASCULAR INVASION
5405,gemini20,0.798,NODAL SITE(S) EXAMINED
5406,gemini20,0.691,ADDITIONAL FINDINGS
5407,gemini20,0.882,TUMOR SITE
5408,gemini20,0.731,PROCEDURE
5409,gemini20,0.687,SPREAD THROUGH AIR SPACES (STAS)
5410,gemini20,0.76,MARGIN STATUS FOR INVASIVE CARCINOMA
5411,gemini20,0.696,TUMOR FOCALITY
5412,gemini20,0.741,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5413,gemini20,0.668,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5414,gemini20,0.733,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5415,gemini20,0.769,MARGIN STATUS FOR NON-INVASIVE TUMOR
5416,gemini20,0.714,PROCEDURE
5417,gemini20,0.663,TUMOR FOCALITY
5418,gemini20,0.713,NUMBER OF LYMPH NODES WITH TUMOR
5419,gemini20,0.689,TNM DESCRIPTORS
5420,gemini20,0.688,NODAL SITE(S) WITH TUMOR
5421,gemini20,0.664,LYMPHOVASCULAR INVASION
5422,gemini20,0.733,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5423,gemini20,0.789,TUMOR SITE
5424,gemini20,0.697,SPECIMEN LATERALITY
5425,gemini20,0.74,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5426,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5427,gemini20,0.692,VISCERAL PLEURA INVASION
5428,gemini20,0.637,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5429,gemini20,0.693,HISTOLOGIC GRADE
5430,gemini20,0.66,ADDITIONAL FINDINGS
5431,gemini20,0.832,NODAL SITE(S) EXAMINED
5432,gemini20,0.783,REGIONAL LYMPH NODE STATUS
5433,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5434,gemini20,0.718,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5435,gemini20,0.697,SPECIMEN LATERALITY
5436,gemini20,0.753,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5437,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5438,gemini20,0.825,PROCEDURE
5439,gemini20,0.709,TUMOR FOCALITY
5440,gemini20,0.731,VISCERAL PLEURA INVASION
5441,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
5442,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
5443,gemini20,0.8,NUMBER OF LYMPH NODES EXAMINED
5444,gemini20,0.781,REGIONAL LYMPH NODE STATUS
5445,gemini20,0.654,NODAL SITE(S) EXAMINED
5446,gemini20,0.694,SPREAD THROUGH AIR SPACES (STAS)
5447,gemini20,0.789,TUMOR SITE
5448,gemini20,0.713,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5449,gemini20,0.693,HISTOLOGIC GRADE
5450,gemini20,0.703,HISTOLOGIC GRADE
5451,gemini20,0.721,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5452,gemini20,0.659,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5453,gemini20,0.74,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5454,gemini20,0.81,REGIONAL LYMPH NODE STATUS
5455,gemini20,0.682,VISCERAL PLEURA INVASION
5456,gemini20,0.689,NUMBER OF LYMPH NODES EXAMINED
5457,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
5458,gemini20,0.696,TUMOR FOCALITY
5459,gemini20,0.798,NODAL SITE(S) EXAMINED
5460,gemini20,0.717,MARGIN STATUS FOR NON-INVASIVE TUMOR
5461,gemini20,0.692,PROCEDURE
5462,gemini20,0.785,TUMOR SITE
5463,gemini20,0.697,SPECIMEN LATERALITY
5464,gemini20,0.703,MARGIN STATUS FOR INVASIVE CARCINOMA
5465,gemini20,0.779,LYMPH NODE(S) FROM PRIOR PROCEDURES
5466,gemini20,0.679,PROCEDURE
5467,gemini20,0.858,NODAL SITE(S) WITH TUMOR
5468,gemini20,0.696,TUMOR FOCALITY
5469,gemini20,0.833,NODAL SITE(S) EXAMINED
5470,gemini20,0.783,REGIONAL LYMPH NODE STATUS
5471,gemini20,0.785,TUMOR SITE
5472,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
5473,gemini20,0.697,SPECIMEN LATERALITY
5474,gemini20,0.714,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5475,gemini20,0.705,VISCERAL PLEURA INVASION
5476,gemini20,0.707,NUMBER OF LYMPH NODES WITH TUMOR
5477,gemini20,0.721,HISTOLOGIC GRADE
5478,gemini20,0.721,MARGIN STATUS FOR INVASIVE CARCINOMA
5479,gemini20,0.707,TNM DESCRIPTORS
5480,gemini20,0.811,TUMOR FOCALITY
5481,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5482,gemini20,0.892,NODAL SITE(S) WITH TUMOR
5483,gemini20,0.769,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5484,gemini20,0.766,LYMPHOVASCULAR INVASION
5485,gemini20,0.897,NODAL SITE(S) EXAMINED
5486,gemini20,0.705,NUMBER OF LYMPH NODES EXAMINED
5487,gemini20,0.89,TUMOR SITE
5488,gemini20,0.78,REGIONAL LYMPH NODE STATUS
5489,gemini20,0.648,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5490,gemini20,0.742,MARGIN STATUS FOR INVASIVE CARCINOMA
5491,gemini20,0.754,HISTOLOGIC GRADE
5492,gemini20,0.705,VISCERAL PLEURA INVASION
5493,gemini20,0.799,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5494,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
5495,gemini20,0.744,PROCEDURE
5496,gemini20,0.725,TNM DESCRIPTORS
5497,gemini20,0.726,NUMBER OF LYMPH NODES WITH TUMOR
5498,gemini20,0.761,PROCEDURE
5499,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5500,gemini20,0.697,SPECIMEN LATERALITY
5501,gemini20,0.811,TUMOR FOCALITY
5502,gemini20,0.815,REGIONAL LYMPH NODE STATUS
5503,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5504,gemini20,0.887,TUMOR SITE
5505,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
5506,gemini20,0.847,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5507,gemini20,0.788,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5508,gemini20,0.763,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5509,gemini20,0.904,HISTOLOGIC GRADE
5510,gemini20,0.75,NODAL SITE(S) EXAMINED
5511,gemini20,0.72,VISCERAL PLEURA INVASION
5512,gemini20,0.822,REGIONAL LYMPH NODE STATUS
5513,gemini20,0.724,TNM DESCRIPTORS
5514,gemini20,0.648,TUMOR FOCALITY
5515,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
5516,gemini20,0.676,SPREAD THROUGH AIR SPACES (STAS)
5517,gemini20,0.783,TUMOR SITE
5518,gemini20,0.712,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5519,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5520,gemini20,0.773,NODAL SITE(S) EXAMINED
5521,gemini20,0.666,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5522,gemini20,0.723,VISCERAL PLEURA INVASION
5523,gemini20,0.674,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5524,gemini20,0.675,LYMPH NODE(S) FROM PRIOR PROCEDURES
5525,gemini20,0.698,SPECIMEN LATERALITY
5526,gemini20,0.729,PROCEDURE
5527,gemini20,0.78,REGIONAL LYMPH NODE STATUS
5528,gemini20,0.697,SPECIMEN LATERALITY
5529,gemini20,0.704,PROCEDURE
5530,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5531,gemini20,0.814,NODAL SITE(S) WITH TUMOR
5532,gemini20,0.8,NODAL SITE(S) EXAMINED
5533,gemini20,0.81,MARGIN STATUS FOR INVASIVE CARCINOMA
5534,gemini20,0.806,TUMOR SITE
5535,gemini20,0.759,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5536,gemini20,0.811,TUMOR FOCALITY
5537,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
5538,gemini20,0.707,VISCERAL PLEURA INVASION
5539,gemini20,0.791,TUMOR SITE
5540,gemini20,0.718,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5541,gemini20,0.655,HISTOLOGIC GRADE
5542,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5543,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5544,gemini20,0.815,REGIONAL LYMPH NODE STATUS
5545,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
5546,gemini20,0.702,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5547,gemini20,0.686,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5548,gemini20,0.697,SPECIMEN LATERALITY
5549,gemini20,0.712,NODAL SITE(S) EXAMINED
5550,gemini20,0.691,VISCERAL PLEURA INVASION
5551,gemini20,0.744,PROCEDURE
5552,gemini20,0.707,TUMOR FOCALITY
5553,gemini20,0.688,TNM DESCRIPTORS
5554,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
5555,gemini20,0.731,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5556,gemini20,0.709,HISTOLOGIC GRADE
5557,gemini20,0.811,TUMOR FOCALITY
5558,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5559,gemini20,0.704,PROCEDURE
5560,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
5561,gemini20,0.697,SPECIMEN LATERALITY
5562,gemini20,0.751,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5563,gemini20,0.754,VISCERAL PLEURA INVASION
5564,gemini20,0.713,NUMBER OF LYMPH NODES EXAMINED
5565,gemini20,0.819,NODAL SITE(S) EXAMINED
5566,gemini20,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5567,gemini20,0.815,REGIONAL LYMPH NODE STATUS
5568,gemini20,0.89,TUMOR SITE
5569,gemini20,0.696,HISTOLOGIC GRADE
5570,gemini20,0.712,PROCEDURE
5571,gemini20,0.811,TUMOR FOCALITY
5572,gemini20,0.747,NODAL SITE(S) EXAMINED
5573,gemini20,0.761,VISCERAL PLEURA INVASION
5574,gemini20,0.896,TUMOR SITE
5575,gemini20,0.729,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5576,gemini20,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5577,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
5578,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
5579,gemini20,0.713,NUMBER OF LYMPH NODES EXAMINED
5580,gemini20,0.755,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5581,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5582,gemini20,0.815,REGIONAL LYMPH NODE STATUS
5583,gemini20,0.698,SPECIMEN LATERALITY
5584,gemini20,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5585,gemini20,0.697,SPECIMEN LATERALITY
5586,gemini20,0.815,REGIONAL LYMPH NODE STATUS
5587,gemini20,0.715,VISCERAL PLEURA INVASION
5588,gemini20,0.826,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5589,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5590,gemini20,0.811,TUMOR FOCALITY
5591,gemini20,0.89,TUMOR SITE
5592,gemini20,0.703,NUMBER OF LYMPH NODES EXAMINED
5593,gemini20,0.772,MARGIN STATUS FOR INVASIVE CARCINOMA
5594,gemini20,0.721,PROCEDURE
5595,gemini20,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5596,gemini20,0.747,NODAL SITE(S) EXAMINED
5597,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
5598,gemini20,0.72,PROCEDURE
5599,gemini20,0.697,SPECIMEN LATERALITY
5600,gemini20,0.784,TUMOR SITE
5601,gemini20,0.787,MARGIN STATUS FOR INVASIVE CARCINOMA
5602,gemini20,0.735,REGIONAL LYMPH NODE STATUS
5603,gemini20,0.707,TUMOR FOCALITY
5604,gemini20,0.656,NUMBER OF LYMPH NODES EXAMINED
5605,gemini20,0.703,HISTOLOGIC GRADE
5606,gemini20,0.677,SPREAD THROUGH AIR SPACES (STAS)
5607,gemini20,0.723,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5608,gemini20,0.653,NODAL SITE(S) EXAMINED
5609,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
5610,gemini20,0.705,VISCERAL PLEURA INVASION
5611,gemini20,0.695,MARGIN STATUS FOR NON-INVASIVE TUMOR
5612,gemini20,0.693,NUMBER OF LYMPH NODES EXAMINED
5613,gemini20,0.697,SPECIMEN LATERALITY
5614,gemini20,0.7,PROCEDURE
5615,gemini20,0.711,TNM DESCRIPTORS
5616,gemini20,0.763,NODAL SITE(S) EXAMINED
5617,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5618,gemini20,0.699,MARGIN STATUS FOR INVASIVE CARCINOMA
5619,gemini20,0.691,HISTOLOGIC GRADE
5620,gemini20,0.815,REGIONAL LYMPH NODE STATUS
5621,gemini20,0.7,VISCERAL PLEURA INVASION
5622,gemini20,0.683,MARGIN STATUS FOR NON-INVASIVE TUMOR
5623,gemini20,0.769,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5624,gemini20,0.725,TUMOR FOCALITY
5625,gemini20,0.791,TUMOR SITE
5626,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5627,gemini20,0.761,VISCERAL PLEURA INVASION
5628,gemini20,0.756,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5629,gemini20,0.686,NODAL SITE(S) EXAMINED
5630,gemini20,0.884,TUMOR SITE
5631,gemini20,0.713,PROCEDURE
5632,gemini20,0.815,REGIONAL LYMPH NODE STATUS
5633,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5634,gemini20,0.714,NUMBER OF LYMPH NODES EXAMINED
5635,gemini20,0.722,HISTOLOGIC GRADE
5636,gemini20,0.698,SPECIMEN LATERALITY
5637,gemini20,0.811,TUMOR FOCALITY
5638,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
5639,gemini20,0.826,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5640,gemini20,0.826,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5641,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
5642,gemini20,0.896,TUMOR SITE
5643,gemini20,0.683,HISTOLOGIC GRADE
5644,gemini20,0.763,REGIONAL LYMPH NODE STATUS
5645,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5646,gemini20,0.734,PROCEDURE
5647,gemini20,0.897,NODAL SITE(S) EXAMINED
5648,gemini20,0.697,SPECIMEN LATERALITY
5649,gemini20,0.73,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5650,gemini20,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5651,gemini20,0.811,TUMOR FOCALITY
5652,gemini20,0.719,VISCERAL PLEURA INVASION
5653,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5654,gemini20,0.691,SPREAD THROUGH AIR SPACES (STAS)
5655,gemini20,0.715,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5656,gemini20,0.74,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5657,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5658,gemini20,0.689,HISTOLOGIC GRADE
5659,gemini20,0.815,REGIONAL LYMPH NODE STATUS
5660,gemini20,0.768,VISCERAL PLEURA INVASION
5661,gemini20,0.811,TUMOR FOCALITY
5662,gemini20,0.699,NUMBER OF LYMPH NODES EXAMINED
5663,gemini20,0.765,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5664,gemini20,0.763,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5665,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5666,gemini20,0.697,SPECIMEN LATERALITY
5667,gemini20,0.741,PROCEDURE
5668,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
5669,gemini20,0.691,SPREAD THROUGH AIR SPACES (STAS)
5670,gemini20,0.902,TUMOR SITE
5671,gemini20,0.803,NODAL SITE(S) EXAMINED
5672,gemini20,0.669,HISTOLOGIC GRADE
5673,gemini20,0.879,TUMOR SITE
5674,gemini20,0.713,VISCERAL PLEURA INVASION
5675,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5676,gemini20,0.698,SPECIMEN LATERALITY
5677,gemini20,0.811,NODAL SITE(S) EXAMINED
5678,gemini20,0.74,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5679,gemini20,0.815,REGIONAL LYMPH NODE STATUS
5680,gemini20,0.773,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5681,gemini20,0.765,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5682,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5683,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
5684,gemini20,0.74,PROCEDURE
5685,gemini20,0.849,ADDITIONAL FINDINGS
5686,gemini20,0.698,SPREAD THROUGH AIR SPACES (STAS)
5687,gemini20,0.811,TUMOR FOCALITY
5688,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
5689,gemini20,0.694,VISCERAL PLEURA INVASION
5690,gemini20,0.774,LYMPHOVASCULAR INVASION
5691,gemini20,0.86,TUMOR SITE
5692,gemini20,0.76,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5693,gemini20,0.7,NUMBER OF LYMPH NODES EXAMINED
5694,gemini20,0.698,SPECIMEN LATERALITY
5695,gemini20,0.697,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5696,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
5697,gemini20,0.668,HISTOLOGIC GRADE
5698,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5699,gemini20,0.773,NODAL SITE(S) EXAMINED
5700,gemini20,0.811,TUMOR FOCALITY
5701,gemini20,0.741,HISTOLOGIC GRADE
5702,gemini20,0.827,PROCEDURE
5703,gemini20,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5704,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
5705,gemini20,0.829,REGIONAL LYMPH NODE STATUS
5706,gemini20,0.669,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5707,gemini20,0.633,HISTOLOGIC GRADE
5708,gemini20,0.696,VISCERAL PLEURA INVASION
5709,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
5710,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5711,gemini20,0.703,NODAL SITE(S) WITH TUMOR
5712,gemini20,0.708,PROCEDURE
5713,gemini20,0.855,NODAL SITE(S) EXAMINED
5714,gemini20,0.779,LYMPH NODE(S) FROM PRIOR PROCEDURES
5715,gemini20,0.786,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5716,gemini20,0.679,LYMPHOVASCULAR INVASION
5717,gemini20,0.698,SPECIMEN LATERALITY
5718,gemini20,0.793,TUMOR SITE
5719,gemini20,0.703,NUMBER OF LYMPH NODES WITH TUMOR
5720,gemini20,0.78,REGIONAL LYMPH NODE STATUS
5721,gemini20,0.725,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5722,gemini20,0.811,TUMOR FOCALITY
5723,gemini20,0.715,HISTOLOGIC GRADE
5724,gemini20,0.812,NODAL SITE(S) EXAMINED
5725,gemini20,0.692,LYMPHOVASCULAR INVASION
5726,gemini20,0.747,TUMOR SITE
5727,gemini20,0.717,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5728,gemini20,0.697,SPECIMEN LATERALITY
5729,gemini20,0.737,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5730,gemini20,0.717,PROCEDURE
5731,gemini20,0.811,TUMOR FOCALITY
5732,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5733,gemini20,0.693,NUMBER OF LYMPH NODES EXAMINED
5734,gemini20,0.723,VISCERAL PLEURA INVASION
5735,gemini20,0.739,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5736,gemini20,0.689,SPREAD THROUGH AIR SPACES (STAS)
5737,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
5738,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
5739,gemini20,0.718,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5740,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5741,gemini20,0.667,NODAL SITE(S) EXAMINED
5742,gemini20,0.699,SPREAD THROUGH AIR SPACES (STAS)
5743,gemini20,0.83,TUMOR SITE
5744,gemini20,0.693,VISCERAL PLEURA INVASION
5745,gemini20,0.811,TUMOR FOCALITY
5746,gemini20,0.715,HISTOLOGIC GRADE
5747,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5748,gemini20,0.735,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5749,gemini20,0.807,REGIONAL LYMPH NODE STATUS
5750,gemini20,0.698,SPECIMEN LATERALITY
5751,gemini20,0.713,NUMBER OF LYMPH NODES EXAMINED
5752,gemini20,0.817,ADDITIONAL FINDINGS
5753,gemini20,0.826,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5754,gemini20,0.72,PROCEDURE
5755,gemini20,0.815,REGIONAL LYMPH NODE STATUS
5756,gemini20,0.755,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5757,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5758,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
5759,gemini20,0.697,SPECIMEN LATERALITY
5760,gemini20,0.749,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5761,gemini20,0.707,HISTOLOGIC GRADE
5762,gemini20,0.686,TUMOR SITE
5763,gemini20,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5764,gemini20,0.743,PROCEDURE
5765,gemini20,0.761,VISCERAL PLEURA INVASION
5766,gemini20,0.814,NODAL SITE(S) EXAMINED
5767,gemini20,0.811,TUMOR FOCALITY
5768,gemini20,0.694,NUMBER OF LYMPH NODES EXAMINED
5769,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5770,gemini20,0.794,ADDITIONAL FINDINGS
5771,gemini20,0.895,TUMOR SITE
5772,gemini20,0.811,TUMOR FOCALITY
5773,gemini20,0.676,VISCERAL PLEURA INVASION
5774,gemini20,0.85,NODAL SITE(S) EXAMINED
5775,gemini20,0.679,TNM DESCRIPTORS
5776,gemini20,0.7,NUMBER OF LYMPH NODES EXAMINED
5777,gemini20,0.754,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5778,gemini20,0.815,REGIONAL LYMPH NODE STATUS
5779,gemini20,0.686,PROCEDURE
5780,gemini20,0.765,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5781,gemini20,0.779,LYMPH NODE(S) FROM PRIOR PROCEDURES
5782,gemini20,0.697,SPECIMEN LATERALITY
5783,gemini20,0.892,HISTOLOGIC GRADE
5784,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5785,gemini20,0.764,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5786,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
5787,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5788,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
5789,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5790,gemini20,0.89,TUMOR SITE
5791,gemini20,0.729,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5792,gemini20,0.757,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5793,gemini20,0.815,REGIONAL LYMPH NODE STATUS
5794,gemini20,0.666,PROCEDURE
5795,gemini20,0.811,TUMOR FOCALITY
5796,gemini20,0.722,NODAL SITE(S) EXAMINED
5797,gemini20,0.718,HISTOLOGIC GRADE
5798,gemini20,0.676,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5799,gemini20,0.78,VISCERAL PLEURA INVASION
5800,gemini20,0.691,NUMBER OF LYMPH NODES EXAMINED
5801,gemini20,0.69,SPREAD THROUGH AIR SPACES (STAS)
5802,gemini20,0.698,SPECIMEN LATERALITY
5803,gemini20,0.779,NODAL SITE(S) EXAMINED
5804,gemini20,0.762,HISTOLOGIC GRADE
5805,gemini20,0.823,ADDITIONAL FINDINGS
5806,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
5807,gemini20,0.721,PROCEDURE
5808,gemini20,0.762,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5809,gemini20,0.89,TUMOR SITE
5810,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5811,gemini20,0.829,REGIONAL LYMPH NODE STATUS
5812,gemini20,0.811,TUMOR FOCALITY
5813,gemini20,0.717,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5814,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5815,gemini20,0.702,NUMBER OF LYMPH NODES EXAMINED
5816,gemini20,0.726,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5817,gemini20,0.722,VISCERAL PLEURA INVASION
5818,gemini20,0.698,SPECIMEN LATERALITY
5819,gemini20,0.815,REGIONAL LYMPH NODE STATUS
5820,gemini20,0.811,TUMOR FOCALITY
5821,gemini20,0.694,VISCERAL PLEURA INVASION
5822,gemini20,0.759,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5823,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5824,gemini20,0.884,TUMOR SITE
5825,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5826,gemini20,0.716,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5827,gemini20,0.697,SPECIMEN LATERALITY
5828,gemini20,0.73,PROCEDURE
5829,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
5830,gemini20,0.699,NUMBER OF LYMPH NODES EXAMINED
5831,gemini20,0.696,HISTOLOGIC GRADE
5832,gemini20,0.747,NODAL SITE(S) EXAMINED
5833,gemini20,0.755,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5834,gemini20,0.778,TUMOR FOCALITY
5835,gemini20,0.7,NUMBER OF LYMPH NODES EXAMINED
5836,gemini20,0.78,VISCERAL PLEURA INVASION
5837,gemini20,0.823,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5838,gemini20,0.696,NODAL SITE(S) EXAMINED
5839,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5840,gemini20,0.764,REGIONAL LYMPH NODE STATUS
5841,gemini20,0.698,SPECIMEN LATERALITY
5842,gemini20,0.792,TUMOR SITE
5843,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
5844,gemini20,0.744,PROCEDURE
5845,gemini20,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5846,gemini20,0.814,HISTOLOGIC GRADE
5847,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
5848,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5849,gemini20,0.83,TUMOR SITE
5850,gemini20,0.835,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5851,gemini20,0.738,PROCEDURE
5852,gemini20,0.746,ADDITIONAL FINDINGS
5853,gemini20,0.698,SPECIMEN LATERALITY
5854,gemini20,0.741,HISTOLOGIC GRADE
5855,gemini20,0.761,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5856,gemini20,0.876,NODAL SITE(S) EXAMINED
5857,gemini20,0.826,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5858,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
5859,gemini20,0.694,VISCERAL PLEURA INVASION
5860,gemini20,0.778,SPREAD THROUGH AIR SPACES (STAS)
5861,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5862,gemini20,0.706,NUMBER OF LYMPH NODES EXAMINED
5863,gemini20,0.815,REGIONAL LYMPH NODE STATUS
5864,gemini20,0.811,TUMOR FOCALITY
5865,gemini20,0.811,TUMOR FOCALITY
5866,gemini20,0.763,NODAL SITE(S) EXAMINED
5867,gemini20,0.699,VISCERAL PLEURA INVASION
5868,gemini20,0.713,PROCEDURE
5869,gemini20,0.689,SPREAD THROUGH AIR SPACES (STAS)
5870,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
5871,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5872,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5873,gemini20,0.698,SPECIMEN LATERALITY
5874,gemini20,0.9,HISTOLOGIC GRADE
5875,gemini20,0.815,REGIONAL LYMPH NODE STATUS
5876,gemini20,0.68,ADDITIONAL FINDINGS
5877,gemini20,0.793,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5878,gemini20,0.83,TUMOR SITE
5879,gemini20,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5880,gemini20,0.726,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5881,gemini20,0.828,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5882,gemini20,0.715,HISTOLOGIC GRADE
5883,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5884,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5885,gemini20,0.896,TUMOR SITE
5886,gemini20,0.731,LYMPHOVASCULAR INVASION
5887,gemini20,0.724,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5888,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
5889,gemini20,0.827,PROCEDURE
5890,gemini20,0.811,TUMOR FOCALITY
5891,gemini20,0.815,REGIONAL LYMPH NODE STATUS
5892,gemini20,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5893,gemini20,0.934,NODAL SITE(S) EXAMINED
5894,gemini20,0.698,SPECIMEN LATERALITY
5895,gemini20,0.713,NUMBER OF LYMPH NODES EXAMINED
5896,gemini20,0.685,SPREAD THROUGH AIR SPACES (STAS)
5897,gemini20,0.768,VISCERAL PLEURA INVASION
5898,gemini20,0.822,REGIONAL LYMPH NODE STATUS
5899,gemini20,0.851,TUMOR SITE
5900,gemini20,0.705,VISCERAL PLEURA INVASION
5901,gemini20,0.721,TUMOR FOCALITY
5902,gemini20,0.694,HISTOLOGIC GRADE
5903,gemini20,0.725,TNM DESCRIPTORS
5904,gemini20,0.69,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5905,gemini20,0.677,ADDITIONAL FINDINGS
5906,gemini20,0.677,MARGIN STATUS FOR NON-INVASIVE TUMOR
5907,gemini20,0.697,SPECIMEN LATERALITY
5908,gemini20,0.755,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5909,gemini20,0.681,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5910,gemini20,0.676,SPREAD THROUGH AIR SPACES (STAS)
5911,gemini20,0.779,LYMPH NODE(S) FROM PRIOR PROCEDURES
5912,gemini20,0.706,PROCEDURE
5913,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5914,gemini20,0.729,NUMBER OF LYMPH NODES EXAMINED
5915,gemini20,0.767,NODAL SITE(S) EXAMINED
5916,gemini20,0.826,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5917,gemini20,0.74,TUMOR FOCALITY
5918,gemini20,0.744,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5919,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
5920,gemini20,0.687,VISCERAL PLEURA INVASION
5921,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5922,gemini20,0.791,TUMOR SITE
5923,gemini20,0.697,SPECIMEN LATERALITY
5924,gemini20,0.742,PROCEDURE
5925,gemini20,0.829,REGIONAL LYMPH NODE STATUS
5926,gemini20,0.827,NODAL SITE(S) EXAMINED
5927,gemini20,0.821,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5928,gemini20,0.677,SPREAD THROUGH AIR SPACES (STAS)
5929,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
5930,gemini20,0.681,VISCERAL PLEURA INVASION
5931,gemini20,0.811,TUMOR FOCALITY
5932,gemini20,0.829,REGIONAL LYMPH NODE STATUS
5933,gemini20,0.681,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5934,gemini20,0.766,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5935,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5936,gemini20,0.726,PROCEDURE
5937,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5938,gemini20,0.698,SPECIMEN LATERALITY
5939,gemini20,0.698,NUMBER OF LYMPH NODES EXAMINED
5940,gemini20,0.89,TUMOR SITE
5941,gemini20,0.773,NODAL SITE(S) EXAMINED
5942,gemini20,0.676,HISTOLOGIC GRADE
5943,gemini20,0.692,SPREAD THROUGH AIR SPACES (STAS)
5944,gemini20,0.697,SPECIMEN LATERALITY
5945,gemini20,0.741,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5946,gemini20,0.818,NODAL SITE(S) EXAMINED
5947,gemini20,0.687,HISTOLOGIC GRADE
5948,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5949,gemini20,0.755,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5950,gemini20,0.896,TUMOR SITE
5951,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5952,gemini20,0.938,ADDITIONAL FINDINGS
5953,gemini20,0.723,VISCERAL PLEURA INVASION
5954,gemini20,0.826,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5955,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
5956,gemini20,0.699,NUMBER OF LYMPH NODES EXAMINED
5957,gemini20,0.685,SPREAD THROUGH AIR SPACES (STAS)
5958,gemini20,0.811,TUMOR FOCALITY
5959,gemini20,0.659,PROCEDURE
5960,gemini20,0.817,REGIONAL LYMPH NODE STATUS
5961,gemini20,0.725,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5962,gemini20,0.689,SPREAD THROUGH AIR SPACES (STAS)
5963,gemini20,0.698,SPECIMEN LATERALITY
5964,gemini20,0.691,NUMBER OF LYMPH NODES EXAMINED
5965,gemini20,0.705,VISCERAL PLEURA INVASION
5966,gemini20,0.705,MARGIN STATUS FOR NON-INVASIVE TUMOR
5967,gemini20,0.718,NODAL SITE(S) EXAMINED
5968,gemini20,0.793,PROCEDURE
5969,gemini20,0.683,HISTOLOGIC GRADE
5970,gemini20,0.672,ADDITIONAL FINDINGS
5971,gemini20,0.811,TUMOR FOCALITY
5972,gemini20,0.89,TUMOR SITE
5973,gemini20,0.753,REGIONAL LYMPH NODE STATUS
5974,gemini20,0.698,MARGIN STATUS FOR INVASIVE CARCINOMA
5975,gemini20,0.7,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5976,gemini20,0.765,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5977,gemini20,0.698,SPECIMEN LATERALITY
5978,gemini20,0.678,TUMOR FOCALITY
5979,gemini20,0.829,REGIONAL LYMPH NODE STATUS
5980,gemini20,0.731,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5981,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
5982,gemini20,0.697,SPREAD THROUGH AIR SPACES (STAS)
5983,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5984,gemini20,0.792,TUMOR SITE
5985,gemini20,0.774,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5986,gemini20,0.768,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5987,gemini20,0.714,VISCERAL PLEURA INVASION
5988,gemini20,0.892,HISTOLOGIC GRADE
5989,gemini20,0.701,NUMBER OF LYMPH NODES EXAMINED
5990,gemini20,0.743,PROCEDURE
5991,gemini20,0.878,NODAL SITE(S) EXAMINED
5992,gemini20,0.779,LYMPH NODE(S) FROM PRIOR PROCEDURES
5993,gemini20,0.839,HISTOLOGIC GRADE
5994,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
5995,gemini20,0.811,TUMOR FOCALITY
5996,gemini20,0.845,ADDITIONAL FINDINGS
5997,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
5998,gemini20,0.76,PROCEDURE
5999,gemini20,0.813,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6000,gemini20,0.746,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6001,gemini20,0.817,REGIONAL LYMPH NODE STATUS
6002,gemini20,0.697,SPECIMEN LATERALITY
6003,gemini20,0.707,VISCERAL PLEURA INVASION
6004,gemini20,0.789,MARGIN STATUS FOR INVASIVE CARCINOMA
6005,gemini20,0.845,NODAL SITE(S) EXAMINED
6006,gemini20,0.694,TUMOR SITE
6007,gemini20,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6008,gemini20,0.815,REGIONAL LYMPH NODE STATUS
6009,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
6010,gemini20,0.727,MARGIN STATUS FOR INVASIVE CARCINOMA
6011,gemini20,0.849,TUMOR SITE
6012,gemini20,0.728,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6013,gemini20,0.773,NODAL SITE(S) EXAMINED
6014,gemini20,0.7,VISCERAL PLEURA INVASION
6015,gemini20,0.904,HISTOLOGIC GRADE
6016,gemini20,0.749,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6017,gemini20,0.788,PROCEDURE
6018,gemini20,0.698,SPECIMEN LATERALITY
6019,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
6020,gemini20,0.758,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6021,gemini20,0.811,TUMOR FOCALITY
6022,gemini20,0.697,SPECIMEN LATERALITY
6023,gemini20,0.756,MARGIN STATUS FOR INVASIVE CARCINOMA
6024,gemini20,0.726,LYMPHOVASCULAR INVASION
6025,gemini20,0.729,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6026,gemini20,0.865,TUMOR SITE
6027,gemini20,0.839,NODAL SITE(S) EXAMINED
6028,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
6029,gemini20,0.707,HISTOLOGIC GRADE
6030,gemini20,0.691,SPREAD THROUGH AIR SPACES (STAS)
6031,gemini20,0.811,TUMOR FOCALITY
6032,gemini20,0.788,PROCEDURE
6033,gemini20,0.779,LYMPH NODE(S) FROM PRIOR PROCEDURES
6034,gemini20,0.832,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6035,gemini20,0.71,VISCERAL PLEURA INVASION
6036,gemini20,0.815,REGIONAL LYMPH NODE STATUS
6037,gemini20,0.763,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6038,gemini20,0.679,VISCERAL PLEURA INVASION
6039,gemini20,0.712,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6040,gemini20,0.691,HISTOLOGIC GRADE
6041,gemini20,0.742,MARGIN STATUS FOR INVASIVE CARCINOMA
6042,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
6043,gemini20,0.789,TUMOR SITE
6044,gemini20,0.697,SPECIMEN LATERALITY
6045,gemini20,0.691,SPREAD THROUGH AIR SPACES (STAS)
6046,gemini20,0.757,NUMBER OF LYMPH NODES EXAMINED
6047,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
6048,gemini20,0.752,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6049,gemini20,0.741,REGIONAL LYMPH NODE STATUS
6050,gemini20,0.811,TUMOR FOCALITY
6051,gemini20,0.763,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6052,gemini20,0.853,NODAL SITE(S) EXAMINED
6053,gemini20,0.725,PROCEDURE
6054,gemini20,0.815,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6055,gemini20,0.822,REGIONAL LYMPH NODE STATUS
6056,gemini20,0.811,TUMOR FOCALITY
6057,gemini20,0.672,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6058,gemini20,0.703,HISTOLOGIC GRADE
6059,gemini20,0.785,NUMBER OF LYMPH NODES EXAMINED
6060,gemini20,0.847,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6061,gemini20,0.717,PROCEDURE
6062,gemini20,0.719,MARGIN STATUS FOR INVASIVE CARCINOMA
6063,gemini20,0.698,SPECIMEN LATERALITY
6064,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
6065,gemini20,0.794,TUMOR SITE
6066,gemini20,0.808,NODAL SITE(S) EXAMINED
6067,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
6068,gemini20,0.684,VISCERAL PLEURA INVASION
6069,gemini20,0.789,TUMOR SITE
6070,gemini20,0.722,PROCEDURE
6071,gemini20,0.821,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6072,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
6073,gemini20,0.829,REGIONAL LYMPH NODE STATUS
6074,gemini20,0.764,VISCERAL PLEURA INVASION
6075,gemini20,0.807,MARGIN STATUS FOR INVASIVE CARCINOMA
6076,gemini20,0.743,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6077,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
6078,gemini20,0.739,NODAL SITE(S) EXAMINED
6079,gemini20,0.697,SPECIMEN LATERALITY
6080,gemini20,0.685,NUMBER OF LYMPH NODES EXAMINED
6081,gemini20,0.697,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6082,gemini20,0.692,SPREAD THROUGH AIR SPACES (STAS)
6083,gemini20,0.693,TUMOR FOCALITY
6084,gemini20,0.693,LYMPHOVASCULAR INVASION
6085,gemini20,0.806,NODAL SITE(S) EXAMINED
6086,gemini20,0.89,TUMOR SITE
6087,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
6088,gemini20,0.7,PROCEDURE
6089,gemini20,0.78,REGIONAL LYMPH NODE STATUS
6090,gemini20,0.811,TUMOR FOCALITY
6091,gemini20,0.682,VISCERAL PLEURA INVASION
6092,gemini20,0.74,NODAL SITE(S) WITH TUMOR
6093,gemini20,0.702,NUMBER OF LYMPH NODES EXAMINED
6094,gemini20,0.713,NUMBER OF LYMPH NODES WITH TUMOR
6095,gemini20,0.737,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6096,gemini20,0.736,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6097,gemini20,0.697,SPECIMEN LATERALITY
6098,gemini20,0.694,LYMPHOVASCULAR INVASION
6099,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
6100,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
6101,gemini20,0.71,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6102,gemini20,0.717,MARGIN STATUS FOR NON-INVASIVE TUMOR
6103,gemini20,0.688,TUMOR FOCALITY
6104,gemini20,0.815,REGIONAL LYMPH NODE STATUS
6105,gemini20,0.697,SPECIMEN LATERALITY
6106,gemini20,0.711,NODAL SITE(S) EXAMINED
6107,gemini20,0.827,PROCEDURE
6108,gemini20,0.887,TUMOR SITE
6109,gemini20,0.722,HISTOLOGIC GRADE
6110,gemini20,0.697,NUMBER OF LYMPH NODES EXAMINED
6111,gemini20,0.703,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6112,gemini20,0.738,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6113,gemini20,0.732,VISCERAL PLEURA INVASION
6114,gemini20,0.754,MARGIN STATUS FOR INVASIVE CARCINOMA
6115,gemini20,0.69,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6116,gemini20,0.779,LYMPH NODE(S) FROM PRIOR PROCEDURES
6117,gemini20,0.829,REGIONAL LYMPH NODE STATUS
6118,gemini20,0.698,SPECIMEN LATERALITY
6119,gemini20,0.774,ADDITIONAL FINDINGS
6120,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
6121,gemini20,0.693,MARGIN STATUS FOR INVASIVE CARCINOMA
6122,gemini20,0.705,TUMOR FOCALITY
6123,gemini20,0.68,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6124,gemini20,0.719,VISCERAL PLEURA INVASION
6125,gemini20,0.73,TNM DESCRIPTORS
6126,gemini20,0.779,NODAL SITE(S) EXAMINED
6127,gemini20,0.711,HISTOLOGIC GRADE
6128,gemini20,0.714,PROCEDURE
6129,gemini20,0.792,TUMOR SITE
6130,gemini20,0.815,REGIONAL LYMPH NODE STATUS
6131,gemini20,0.711,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6132,gemini20,0.762,PROCEDURE
6133,gemini20,0.695,NUMBER OF LYMPH NODES EXAMINED
6134,gemini20,0.83,TUMOR SITE
6135,gemini20,0.698,SPECIMEN LATERALITY
6136,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
6137,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
6138,gemini20,0.78,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6139,gemini20,0.811,TUMOR FOCALITY
6140,gemini20,0.76,HISTOLOGIC GRADE
6141,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
6142,gemini20,0.832,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6143,gemini20,0.778,VISCERAL PLEURA INVASION
6144,gemini20,0.727,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6145,gemini20,0.701,NODAL SITE(S) EXAMINED
6146,gemini20,0.712,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6147,gemini20,0.669,HISTOLOGIC GRADE
6148,gemini20,0.717,MARGIN STATUS FOR NON-INVASIVE TUMOR
6149,gemini20,0.829,REGIONAL LYMPH NODE STATUS
6150,gemini20,0.679,SPREAD THROUGH AIR SPACES (STAS)
6151,gemini20,0.693,ADDITIONAL FINDINGS
6152,gemini20,0.722,TUMOR FOCALITY
6153,gemini20,0.705,VISCERAL PLEURA INVASION
6154,gemini20,0.788,PROCEDURE
6155,gemini20,0.704,NUMBER OF LYMPH NODES EXAMINED
6156,gemini20,0.757,MARGIN STATUS FOR INVASIVE CARCINOMA
6157,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
6158,gemini20,0.89,TUMOR SITE
6159,gemini20,0.709,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6160,gemini20,0.697,SPECIMEN LATERALITY
6161,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
6162,gemini20,0.684,PROCEDURE
6163,gemini20,0.694,HISTOLOGIC GRADE
6164,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
6165,gemini20,0.724,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6166,gemini20,0.755,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6167,gemini20,0.789,TUMOR SITE
6168,gemini20,0.725,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6169,gemini20,0.683,VISCERAL PLEURA INVASION
6170,gemini20,0.815,REGIONAL LYMPH NODE STATUS
6171,gemini20,0.811,TUMOR FOCALITY
6172,gemini20,0.781,NODAL SITE(S) EXAMINED
6173,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
6174,gemini20,0.697,SPECIMEN LATERALITY
6175,gemini20,0.726,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6176,gemini20,0.697,SPECIMEN LATERALITY
6177,gemini20,0.769,MARGIN STATUS FOR NON-INVASIVE TUMOR
6178,gemini20,0.814,REGIONAL LYMPH NODE STATUS
6179,gemini20,0.67,VISCERAL PLEURA INVASION
6180,gemini20,0.712,NODAL SITE(S) WITH TUMOR
6181,gemini20,0.694,NUMBER OF LYMPH NODES EXAMINED
6182,gemini20,0.671,LYMPHOVASCULAR INVASION
6183,gemini20,0.896,MARGIN STATUS FOR INVASIVE CARCINOMA
6184,gemini20,0.703,NUMBER OF LYMPH NODES WITH TUMOR
6185,gemini20,0.847,TUMOR SITE
6186,gemini20,0.786,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6187,gemini20,0.755,PROCEDURE
6188,gemini20,0.696,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6189,gemini20,0.872,NODAL SITE(S) EXAMINED
6190,gemini20,0.681,TUMOR FOCALITY
6191,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
6192,gemini20,0.701,LYMPHOVASCULAR INVASION
6193,gemini20,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
6194,gemini20,0.694,NUMBER OF LYMPH NODES EXAMINED
6195,gemini20,0.731,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6196,gemini20,0.896,MARGIN STATUS FOR INVASIVE CARCINOMA
6197,gemini20,0.739,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6198,gemini20,0.698,TNM DESCRIPTORS
6199,gemini20,0.78,REGIONAL LYMPH NODE STATUS
6200,gemini20,0.823,TUMOR SITE
6201,gemini20,0.763,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6202,gemini20,0.68,ADDITIONAL FINDINGS
6203,gemini20,0.718,PROCEDURE
6204,gemini20,0.697,SPECIMEN LATERALITY
6205,gemini20,0.811,TUMOR FOCALITY
6206,gemini20,0.798,NODAL SITE(S) EXAMINED
6207,gemini20,0.78,VISCERAL PLEURA INVASION
6208,gemini20,0.818,HISTOLOGIC GRADE
6209,gemini20,0.72,NUMBER OF LYMPH NODES WITH TUMOR
6210,gemini20,0.694,VISCERAL PLEURA INVASION
6211,gemini20,0.73,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6212,gemini20,0.7,NUMBER OF LYMPH NODES WITH TUMOR
6213,gemini20,0.766,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6214,gemini20,0.876,TUMOR SITE
6215,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
6216,gemini20,0.697,SPECIMEN LATERALITY
6217,gemini20,0.711,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6218,gemini20,0.702,PROCEDURE
6219,gemini20,0.811,TUMOR FOCALITY
6220,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
6221,gemini20,0.78,REGIONAL LYMPH NODE STATUS
6222,gemini20,0.788,HISTOLOGIC GRADE
6223,gemini20,0.766,NODAL SITE(S) WITH TUMOR
6224,gemini20,0.702,LYMPHOVASCULAR INVASION
6225,gemini20,0.697,MARGIN STATUS FOR INVASIVE CARCINOMA
6226,gemini20,0.8,NODAL SITE(S) EXAMINED
6227,gemini20,0.698,SPECIMEN LATERALITY
6228,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
6229,gemini20,0.722,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6230,gemini20,0.706,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6231,gemini20,0.89,TUMOR SITE
6232,gemini20,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
6233,gemini20,0.708,PROCEDURE
6234,gemini20,0.759,VISCERAL PLEURA INVASION
6235,gemini20,0.776,NODAL SITE(S) EXAMINED
6236,gemini20,0.713,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6237,gemini20,0.815,REGIONAL LYMPH NODE STATUS
6238,gemini20,0.697,SPECIMEN LATERALITY
6239,gemini20,0.723,PROCEDURE
6240,gemini20,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
6241,gemini20,0.811,TUMOR FOCALITY
6242,gemini20,0.676,SPREAD THROUGH AIR SPACES (STAS)
6243,gemini20,0.768,VISCERAL PLEURA INVASION
6244,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
6245,gemini20,0.784,NODAL SITE(S) EXAMINED
6246,gemini20,0.815,REGIONAL LYMPH NODE STATUS
6247,gemini20,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
6248,gemini20,0.788,PROCEDURE
6249,gemini20,0.811,TUMOR FOCALITY
6250,gemini20,0.698,SPECIMEN LATERALITY
6251,gemini20,0.781,NODAL SITE(S) EXAMINED
6252,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
6253,gemini20,0.694,VISCERAL PLEURA INVASION
6254,gemini20,0.713,ADDITIONAL FINDINGS
6255,gemini20,0.89,TUMOR SITE
6256,gemini20,0.815,REGIONAL LYMPH NODE STATUS
6257,gemini20,0.689,NUMBER OF LYMPH NODES EXAMINED
6258,gemini20,0.685,SPREAD THROUGH AIR SPACES (STAS)
6259,gemini20,0.705,HISTOLOGIC GRADE
6260,gemini20,0.788,PROCEDURE
6261,gemini20,0.7,VISCERAL PLEURA INVASION
6262,gemini20,0.823,MARGIN STATUS FOR NON-INVASIVE TUMOR
6263,gemini20,0.815,REGIONAL LYMPH NODE STATUS
6264,gemini20,0.707,TUMOR SITE
6265,gemini20,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
6266,gemini20,0.758,NODAL SITE(S) EXAMINED
6267,gemini20,0.684,SPREAD THROUGH AIR SPACES (STAS)
6268,gemini20,0.72,ADDITIONAL FINDINGS
6269,gemini20,0.764,NUMBER OF LYMPH NODES EXAMINED
6270,gemini20,0.777,SPECIMEN LATERALITY
6271,gemini20,0.756,TUMOR FOCALITY
0,medgemma,0.818,HISTOLOGIC GRADE
1,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2,medgemma,0.89,TUMOR SITE
3,medgemma,0.741,LYMPHOVASCULAR INVASION
4,medgemma,0.698,TUMOR FOCALITY
5,medgemma,0.697,SPECIMEN LATERALITY
6,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
7,medgemma,0.827,PROCEDURE
8,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
9,medgemma,0.925,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
10,medgemma,0.701,SPREAD THROUGH AIR SPACES (STAS)
11,medgemma,0.78,VISCERAL PLEURA INVASION
12,medgemma,0.706,ADDITIONAL FINDINGS
13,medgemma,0.713,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
14,medgemma,0.821,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
15,medgemma,0.892,HISTOLOGIC GRADE
16,medgemma,0.774,MARGIN STATUS FOR INVASIVE CARCINOMA
17,medgemma,0.711,NUMBER OF LYMPH NODES WITH TUMOR
18,medgemma,0.811,TUMOR FOCALITY
19,medgemma,0.807,PROCEDURE
20,medgemma,0.83,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
21,medgemma,0.739,NUMBER OF LYMPH NODES EXAMINED
22,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
23,medgemma,0.683,NODAL SITE(S) EXAMINED
24,medgemma,0.755,LYMPHOVASCULAR INVASION
25,medgemma,0.78,REGIONAL LYMPH NODE STATUS
26,medgemma,0.78,VISCERAL PLEURA INVASION
27,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
28,medgemma,0.689,SPREAD THROUGH AIR SPACES (STAS)
29,medgemma,0.698,SPECIMEN LATERALITY
30,medgemma,0.869,ADDITIONAL FINDINGS
31,medgemma,0.702,NODAL SITE(S) WITH TUMOR
32,medgemma,0.786,TUMOR SITE
33,medgemma,0.679,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
34,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
35,medgemma,0.7,SPREAD THROUGH AIR SPACES (STAS)
36,medgemma,0.698,SPECIMEN LATERALITY
37,medgemma,0.811,TUMOR FOCALITY
38,medgemma,0.729,NUMBER OF LYMPH NODES EXAMINED
39,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
40,medgemma,0.818,NODAL SITE(S) EXAMINED
41,medgemma,0.77,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
42,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
43,medgemma,0.691,NODAL SITE(S) WITH TUMOR
44,medgemma,0.723,PROCEDURE
45,medgemma,0.712,NUMBER OF LYMPH NODES WITH TUMOR
46,medgemma,0.78,REGIONAL LYMPH NODE STATUS
47,medgemma,0.698,VISCERAL PLEURA INVASION
48,medgemma,0.89,TUMOR SITE
49,medgemma,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
50,medgemma,0.711,PROCEDURE
51,medgemma,0.815,REGIONAL LYMPH NODE STATUS
52,medgemma,0.811,TUMOR FOCALITY
53,medgemma,0.697,SPECIMEN LATERALITY
54,medgemma,0.75,HISTOLOGIC GRADE
55,medgemma,0.841,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
56,medgemma,0.701,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
57,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
58,medgemma,0.747,NODAL SITE(S) EXAMINED
59,medgemma,0.829,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
60,medgemma,0.89,TUMOR SITE
61,medgemma,0.716,LYMPHOVASCULAR INVASION
62,medgemma,0.778,VISCERAL PLEURA INVASION
63,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
64,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
65,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
66,medgemma,0.881,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
67,medgemma,0.751,ADDITIONAL FINDINGS
68,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
69,medgemma,0.778,VISCERAL PLEURA INVASION
70,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
71,medgemma,0.815,REGIONAL LYMPH NODE STATUS
72,medgemma,0.72,NODAL SITE(S) EXAMINED
73,medgemma,0.89,TUMOR SITE
74,medgemma,0.703,NUMBER OF LYMPH NODES EXAMINED
75,medgemma,0.726,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
76,medgemma,0.827,PROCEDURE
77,medgemma,0.7,SPREAD THROUGH AIR SPACES (STAS)
78,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
79,medgemma,0.712,TUMOR FOCALITY
80,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
81,medgemma,0.744,HISTOLOGIC GRADE
82,medgemma,0.697,SPECIMEN LATERALITY
83,medgemma,0.7,SPREAD THROUGH AIR SPACES (STAS)
84,medgemma,0.724,NODAL SITE(S) EXAMINED
85,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
86,medgemma,0.904,HISTOLOGIC GRADE
87,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
88,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
89,medgemma,0.711,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
90,medgemma,0.817,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
91,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
92,medgemma,0.89,TUMOR SITE
93,medgemma,0.778,VISCERAL PLEURA INVASION
94,medgemma,0.815,REGIONAL LYMPH NODE STATUS
95,medgemma,0.697,SPECIMEN LATERALITY
96,medgemma,0.81,PROCEDURE
97,medgemma,0.682,TUMOR FOCALITY
98,medgemma,0.692,NODAL SITE(S) EXAMINED
99,medgemma,0.89,TUMOR SITE
100,medgemma,0.698,SPECIMEN LATERALITY
101,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
102,medgemma,0.778,VISCERAL PLEURA INVASION
103,medgemma,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
104,medgemma,0.736,ADDITIONAL FINDINGS
105,medgemma,0.819,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
106,medgemma,0.757,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
107,medgemma,0.801,PROCEDURE
108,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
109,medgemma,0.811,TUMOR FOCALITY
110,medgemma,0.815,REGIONAL LYMPH NODE STATUS
111,medgemma,0.778,HISTOLOGIC GRADE
112,medgemma,0.727,NUMBER OF LYMPH NODES EXAMINED
113,medgemma,0.707,TNM DESCRIPTORS
114,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
115,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
116,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
117,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
118,medgemma,0.709,NODAL SITE(S) EXAMINED
119,medgemma,0.824,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
120,medgemma,0.778,VISCERAL PLEURA INVASION
121,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
122,medgemma,0.811,TUMOR FOCALITY
123,medgemma,0.865,TUMOR SITE
124,medgemma,0.815,HISTOLOGIC GRADE
125,medgemma,0.698,SPECIMEN LATERALITY
126,medgemma,0.827,PROCEDURE
127,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
128,medgemma,0.695,TNM DESCRIPTORS
129,medgemma,0.716,REGIONAL LYMPH NODE STATUS
130,medgemma,0.687,ADDITIONAL FINDINGS
131,medgemma,0.823,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
132,medgemma,0.716,LYMPH NODE(S) FROM PRIOR PROCEDURES
133,medgemma,0.904,HISTOLOGIC GRADE
134,medgemma,0.775,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
135,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
136,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
137,medgemma,0.811,TUMOR FOCALITY
138,medgemma,0.831,PROCEDURE
139,medgemma,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
140,medgemma,0.809,ADDITIONAL FINDINGS
141,medgemma,0.697,SPECIMEN LATERALITY
142,medgemma,0.721,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
143,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
144,medgemma,0.815,REGIONAL LYMPH NODE STATUS
145,medgemma,0.712,NODAL SITE(S) EXAMINED
146,medgemma,0.89,TUMOR SITE
147,medgemma,0.778,VISCERAL PLEURA INVASION
148,medgemma,0.677,HISTOLOGIC GRADE
149,medgemma,0.697,SPECIMEN LATERALITY
150,medgemma,0.774,NODAL SITE(S) EXAMINED
151,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
152,medgemma,0.733,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
153,medgemma,0.865,TUMOR SITE
154,medgemma,0.863,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
155,medgemma,0.692,TUMOR FOCALITY
156,medgemma,0.729,ADDITIONAL FINDINGS
157,medgemma,0.815,REGIONAL LYMPH NODE STATUS
158,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
159,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
160,medgemma,0.83,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
161,medgemma,0.697,NUMBER OF LYMPH NODES EXAMINED
162,medgemma,0.778,VISCERAL PLEURA INVASION
163,medgemma,0.831,PROCEDURE
164,medgemma,0.781,TUMOR SITE
165,medgemma,0.745,LYMPHOVASCULAR INVASION
166,medgemma,0.698,SPECIMEN LATERALITY
167,medgemma,0.74,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
168,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
169,medgemma,0.78,REGIONAL LYMPH NODE STATUS
170,medgemma,0.817,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
171,medgemma,0.743,TNM DESCRIPTORS
172,medgemma,0.715,NUMBER OF LYMPH NODES WITH TUMOR
173,medgemma,0.716,ADDITIONAL FINDINGS
174,medgemma,0.904,HISTOLOGIC GRADE
175,medgemma,0.698,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
176,medgemma,0.778,VISCERAL PLEURA INVASION
177,medgemma,0.701,NODAL SITE(S) WITH TUMOR
178,medgemma,0.692,NODAL SITE(S) EXAMINED
179,medgemma,0.701,SPREAD THROUGH AIR SPACES (STAS)
180,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
181,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
182,medgemma,0.788,PROCEDURE
183,medgemma,0.811,TUMOR FOCALITY
184,medgemma,0.738,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
185,medgemma,0.827,PROCEDURE
186,medgemma,0.71,TNM DESCRIPTORS
187,medgemma,0.7,VISCERAL PLEURA INVASION
188,medgemma,0.697,SPECIMEN LATERALITY
189,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
190,medgemma,0.677,MARGIN STATUS FOR INVASIVE CARCINOMA
191,medgemma,0.738,TUMOR SITE
192,medgemma,0.696,LYMPH NODE(S) FROM PRIOR PROCEDURES
193,medgemma,0.761,HISTOLOGIC GRADE
194,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
195,medgemma,0.775,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
196,medgemma,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
197,medgemma,0.904,HISTOLOGIC GRADE
198,medgemma,0.697,SPECIMEN LATERALITY
199,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
200,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
201,medgemma,0.89,TUMOR SITE
202,medgemma,0.775,NODAL SITE(S) EXAMINED
203,medgemma,0.811,TUMOR FOCALITY
204,medgemma,0.815,REGIONAL LYMPH NODE STATUS
205,medgemma,0.713,NUMBER OF LYMPH NODES EXAMINED
206,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
207,medgemma,0.827,PROCEDURE
208,medgemma,0.828,ADDITIONAL FINDINGS
209,medgemma,0.723,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
210,medgemma,0.778,VISCERAL PLEURA INVASION
211,medgemma,0.797,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
212,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
213,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
214,medgemma,0.692,TUMOR FOCALITY
215,medgemma,0.803,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
216,medgemma,0.693,NUMBER OF LYMPH NODES EXAMINED
217,medgemma,0.705,NODAL SITE(S) EXAMINED
218,medgemma,0.744,HISTOLOGIC GRADE
219,medgemma,0.697,SPECIMEN LATERALITY
220,medgemma,0.738,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
221,medgemma,0.778,VISCERAL PLEURA INVASION
222,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
223,medgemma,0.827,PROCEDURE
224,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
225,medgemma,0.815,REGIONAL LYMPH NODE STATUS
226,medgemma,0.89,TUMOR SITE
227,medgemma,0.765,PROCEDURE
228,medgemma,0.713,NUMBER OF LYMPH NODES EXAMINED
229,medgemma,0.739,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
230,medgemma,0.778,VISCERAL PLEURA INVASION
231,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
232,medgemma,0.893,TUMOR SITE
233,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
234,medgemma,0.683,LYMPH NODE(S) FROM PRIOR PROCEDURES
235,medgemma,0.692,TUMOR FOCALITY
236,medgemma,0.904,HISTOLOGIC GRADE
237,medgemma,0.7,SPREAD THROUGH AIR SPACES (STAS)
238,medgemma,0.729,NODAL SITE(S) EXAMINED
239,medgemma,0.697,SPECIMEN LATERALITY
240,medgemma,0.757,ADDITIONAL FINDINGS
241,medgemma,0.677,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
242,medgemma,0.815,REGIONAL LYMPH NODE STATUS
243,medgemma,0.738,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
244,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
245,medgemma,0.811,TUMOR FOCALITY
246,medgemma,0.859,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
247,medgemma,0.778,VISCERAL PLEURA INVASION
248,medgemma,0.725,NODAL SITE(S) EXAMINED
249,medgemma,0.716,REGIONAL LYMPH NODE STATUS
250,medgemma,0.865,TUMOR SITE
251,medgemma,0.753,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
252,medgemma,0.879,MARGIN STATUS FOR INVASIVE CARCINOMA
253,medgemma,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
254,medgemma,0.892,HISTOLOGIC GRADE
255,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
256,medgemma,0.697,SPECIMEN LATERALITY
257,medgemma,0.801,PROCEDURE
258,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
259,medgemma,0.717,NUMBER OF LYMPH NODES EXAMINED
260,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
261,medgemma,0.754,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
262,medgemma,0.811,TUMOR FOCALITY
263,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
264,medgemma,0.697,SPECIMEN LATERALITY
265,medgemma,0.78,VISCERAL PLEURA INVASION
266,medgemma,0.764,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
267,medgemma,0.733,SPREAD THROUGH AIR SPACES (STAS)
268,medgemma,0.769,SPREAD THROUGH AIR SPACES (STAS)
269,medgemma,0.749,PROCEDURE
270,medgemma,0.687,LYMPHOVASCULAR INVASION
271,medgemma,0.865,TUMOR SITE
272,medgemma,0.785,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
273,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
274,medgemma,0.707,NUMBER OF LYMPH NODES WITH TUMOR
275,medgemma,0.818,HISTOLOGIC GRADE
276,medgemma,0.753,REGIONAL LYMPH NODE STATUS
277,medgemma,0.698,VISCERAL PLEURA INVASION
278,medgemma,0.729,NODAL SITE(S) EXAMINED
279,medgemma,0.78,REGIONAL LYMPH NODE STATUS
280,medgemma,0.752,NODAL SITE(S) WITH TUMOR
281,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
282,medgemma,0.716,REGIONAL LYMPH NODE STATUS
283,medgemma,0.812,NUMBER OF LYMPH NODES EXAMINED
284,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
285,medgemma,0.779,NUMBER OF LYMPH NODES EXAMINED
286,medgemma,0.808,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
287,medgemma,0.717,PROCEDURE
288,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
289,medgemma,0.724,LYMPHOVASCULAR INVASION
290,medgemma,0.784,NODAL SITE(S) EXAMINED
291,medgemma,0.676,SPREAD THROUGH AIR SPACES (STAS)
292,medgemma,0.71,TUMOR SITE
293,medgemma,0.778,VISCERAL PLEURA INVASION
294,medgemma,0.711,PROCEDURE
295,medgemma,0.727,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
296,medgemma,0.822,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
297,medgemma,0.697,SPECIMEN LATERALITY
298,medgemma,0.811,TUMOR FOCALITY
299,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
300,medgemma,0.78,VISCERAL PLEURA INVASION
301,medgemma,0.734,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
302,medgemma,0.827,PROCEDURE
303,medgemma,0.697,SPECIMEN LATERALITY
304,medgemma,0.76,ADDITIONAL FINDINGS
305,medgemma,0.815,REGIONAL LYMPH NODE STATUS
306,medgemma,0.811,TUMOR FOCALITY
307,medgemma,0.778,HISTOLOGIC GRADE
308,medgemma,0.746,NODAL SITE(S) EXAMINED
309,medgemma,0.819,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
310,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
311,medgemma,0.826,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
312,medgemma,0.89,TUMOR SITE
313,medgemma,0.811,TUMOR FOCALITY
314,medgemma,0.716,REGIONAL LYMPH NODE STATUS
315,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
316,medgemma,0.716,LYMPH NODE(S) FROM PRIOR PROCEDURES
317,medgemma,0.715,NODAL SITE(S) EXAMINED
318,medgemma,0.89,TUMOR SITE
319,medgemma,0.742,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
320,medgemma,0.841,PROCEDURE
321,medgemma,0.697,SPECIMEN LATERALITY
322,medgemma,0.838,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
323,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
324,medgemma,0.818,HISTOLOGIC GRADE
325,medgemma,0.778,VISCERAL PLEURA INVASION
326,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
327,medgemma,0.75,HISTOLOGIC GRADE
328,medgemma,0.718,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
329,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
330,medgemma,0.827,PROCEDURE
331,medgemma,0.811,TUMOR FOCALITY
332,medgemma,0.697,SPECIMEN LATERALITY
333,medgemma,0.815,REGIONAL LYMPH NODE STATUS
334,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
335,medgemma,0.778,VISCERAL PLEURA INVASION
336,medgemma,0.726,NODAL SITE(S) EXAMINED
337,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
338,medgemma,0.777,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
339,medgemma,0.872,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
340,medgemma,0.865,TUMOR SITE
341,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
342,medgemma,0.697,SPECIMEN LATERALITY
343,medgemma,0.89,TUMOR SITE
344,medgemma,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
345,medgemma,0.778,VISCERAL PLEURA INVASION
346,medgemma,0.837,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
347,medgemma,0.716,ADDITIONAL FINDINGS
348,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
349,medgemma,0.815,REGIONAL LYMPH NODE STATUS
350,medgemma,0.811,TUMOR FOCALITY
351,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
352,medgemma,0.827,PROCEDURE
353,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
354,medgemma,0.705,NODAL SITE(S) EXAMINED
355,medgemma,0.904,HISTOLOGIC GRADE
356,medgemma,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
357,medgemma,0.811,TUMOR FOCALITY
358,medgemma,0.735,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
359,medgemma,0.698,SPECIMEN LATERALITY
360,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
361,medgemma,0.815,REGIONAL LYMPH NODE STATUS
362,medgemma,0.716,LYMPH NODE(S) FROM PRIOR PROCEDURES
363,medgemma,0.7,SPREAD THROUGH AIR SPACES (STAS)
364,medgemma,0.734,NUMBER OF LYMPH NODES EXAMINED
365,medgemma,0.73,PROCEDURE
366,medgemma,0.706,NODAL SITE(S) EXAMINED
367,medgemma,0.865,TUMOR SITE
368,medgemma,0.778,VISCERAL PLEURA INVASION
369,medgemma,0.794,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
370,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
371,medgemma,0.86,PROCEDURE
372,medgemma,0.716,REGIONAL LYMPH NODE STATUS
373,medgemma,0.698,SPECIMEN LATERALITY
374,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
375,medgemma,0.83,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
376,medgemma,0.763,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
377,medgemma,0.704,NUMBER OF LYMPH NODES EXAMINED
378,medgemma,0.811,TUMOR FOCALITY
379,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
380,medgemma,0.735,MARGIN STATUS FOR NON-INVASIVE TUMOR
381,medgemma,0.778,VISCERAL PLEURA INVASION
382,medgemma,0.75,HISTOLOGIC GRADE
383,medgemma,0.881,TUMOR SITE
384,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
385,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
386,medgemma,0.697,SPECIMEN LATERALITY
387,medgemma,0.712,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
388,medgemma,0.778,VISCERAL PLEURA INVASION
389,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
390,medgemma,0.815,REGIONAL LYMPH NODE STATUS
391,medgemma,0.716,ADDITIONAL FINDINGS
392,medgemma,0.888,MARGIN STATUS FOR NON-INVASIVE TUMOR
393,medgemma,0.86,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
394,medgemma,0.872,TUMOR SITE
395,medgemma,0.691,NODAL SITE(S) EXAMINED
396,medgemma,0.798,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
397,medgemma,0.659,TNM DESCRIPTORS
398,medgemma,0.708,TUMOR FOCALITY
399,medgemma,0.728,HISTOLOGIC GRADE
400,medgemma,0.758,PROCEDURE
401,medgemma,0.78,VISCERAL PLEURA INVASION
402,medgemma,0.816,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
403,medgemma,0.901,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
404,medgemma,0.703,NUMBER OF LYMPH NODES EXAMINED
405,medgemma,0.811,TUMOR FOCALITY
406,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
407,medgemma,0.904,HISTOLOGIC GRADE
408,medgemma,0.815,REGIONAL LYMPH NODE STATUS
409,medgemma,0.697,SPECIMEN LATERALITY
410,medgemma,0.893,TUMOR SITE
411,medgemma,0.698,NODAL SITE(S) EXAMINED
412,medgemma,0.756,PROCEDURE
413,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
414,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
415,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
416,medgemma,0.703,NODAL SITE(S) EXAMINED
417,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
418,medgemma,0.871,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
419,medgemma,0.698,SPECIMEN LATERALITY
420,medgemma,0.702,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
421,medgemma,0.763,PROCEDURE
422,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
423,medgemma,0.692,TUMOR FOCALITY
424,medgemma,0.815,REGIONAL LYMPH NODE STATUS
425,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
426,medgemma,0.821,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
427,medgemma,0.778,VISCERAL PLEURA INVASION
428,medgemma,0.865,TUMOR SITE
429,medgemma,0.699,NUMBER OF LYMPH NODES EXAMINED
430,medgemma,0.904,HISTOLOGIC GRADE
431,medgemma,0.745,LYMPHOVASCULAR INVASION
432,medgemma,0.734,NODAL SITE(S) WITH TUMOR
433,medgemma,0.716,LYMPH NODE(S) FROM PRIOR PROCEDURES
434,medgemma,0.7,NUMBER OF LYMPH NODES WITH TUMOR
435,medgemma,0.75,HISTOLOGIC GRADE
436,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
437,medgemma,0.784,ADDITIONAL FINDINGS
438,medgemma,0.78,REGIONAL LYMPH NODE STATUS
439,medgemma,0.778,VISCERAL PLEURA INVASION
440,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
441,medgemma,0.838,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
442,medgemma,0.817,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
443,medgemma,0.865,TUMOR SITE
444,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
445,medgemma,0.697,SPECIMEN LATERALITY
446,medgemma,0.811,TUMOR FOCALITY
447,medgemma,0.716,NODAL SITE(S) EXAMINED
448,medgemma,0.707,PROCEDURE
449,medgemma,0.698,VISCERAL PLEURA INVASION
450,medgemma,0.835,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
451,medgemma,0.774,ADDITIONAL FINDINGS
452,medgemma,0.802,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
453,medgemma,0.811,TUMOR FOCALITY
454,medgemma,0.906,MARGIN STATUS FOR INVASIVE CARCINOMA
455,medgemma,0.738,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
456,medgemma,0.684,NODAL SITE(S) EXAMINED
457,medgemma,0.761,PROCEDURE
458,medgemma,0.865,TUMOR SITE
459,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
460,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
461,medgemma,0.697,SPECIMEN LATERALITY
462,medgemma,0.832,HISTOLOGIC GRADE
463,medgemma,0.701,NUMBER OF LYMPH NODES EXAMINED
464,medgemma,0.733,HISTOLOGIC GRADE
465,medgemma,0.698,SPECIMEN LATERALITY
466,medgemma,0.906,MARGIN STATUS FOR INVASIVE CARCINOMA
467,medgemma,0.798,PROCEDURE
468,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
469,medgemma,0.778,VISCERAL PLEURA INVASION
470,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
471,medgemma,0.709,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
472,medgemma,0.686,NODAL SITE(S) EXAMINED
473,medgemma,0.711,NODAL SITE(S) WITH TUMOR
474,medgemma,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
475,medgemma,0.78,REGIONAL LYMPH NODE STATUS
476,medgemma,0.871,TUMOR FOCALITY
477,medgemma,0.745,LYMPHOVASCULAR INVASION
478,medgemma,0.713,NUMBER OF LYMPH NODES WITH TUMOR
479,medgemma,0.737,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
480,medgemma,0.754,TUMOR SITE
481,medgemma,0.742,TNM DESCRIPTORS
482,medgemma,0.743,MARGIN STATUS FOR NON-INVASIVE TUMOR
483,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
484,medgemma,0.738,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
485,medgemma,0.827,PROCEDURE
486,medgemma,0.732,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
487,medgemma,0.702,LYMPH NODE(S) FROM PRIOR PROCEDURES
488,medgemma,0.697,SPECIMEN LATERALITY
489,medgemma,0.904,HISTOLOGIC GRADE
490,medgemma,0.689,TUMOR SITE
491,medgemma,0.853,ADDITIONAL FINDINGS
492,medgemma,0.676,SPREAD THROUGH AIR SPACES (STAS)
493,medgemma,0.778,VISCERAL PLEURA INVASION
494,medgemma,0.712,TUMOR FOCALITY
495,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
496,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
497,medgemma,0.78,REGIONAL LYMPH NODE STATUS
498,medgemma,0.831,PROCEDURE
499,medgemma,0.677,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
500,medgemma,0.683,LYMPH NODE(S) FROM PRIOR PROCEDURES
501,medgemma,0.702,LYMPHOVASCULAR INVASION
502,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
503,medgemma,0.754,ADDITIONAL FINDINGS
504,medgemma,0.837,HISTOLOGIC GRADE
505,medgemma,0.811,TUMOR FOCALITY
506,medgemma,0.883,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
507,medgemma,0.72,NUMBER OF LYMPH NODES WITH TUMOR
508,medgemma,0.697,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
509,medgemma,0.771,NODAL SITE(S) EXAMINED
510,medgemma,0.755,NODAL SITE(S) WITH TUMOR
511,medgemma,0.697,SPECIMEN LATERALITY
512,medgemma,0.778,VISCERAL PLEURA INVASION
513,medgemma,0.893,TUMOR SITE
514,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
515,medgemma,0.778,VISCERAL PLEURA INVASION
516,medgemma,0.761,PROCEDURE
517,medgemma,0.697,SPECIMEN LATERALITY
518,medgemma,0.815,REGIONAL LYMPH NODE STATUS
519,medgemma,0.89,TUMOR SITE
520,medgemma,0.811,TUMOR FOCALITY
521,medgemma,0.814,ADDITIONAL FINDINGS
522,medgemma,0.824,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
523,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
524,medgemma,0.718,NUMBER OF LYMPH NODES EXAMINED
525,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
526,medgemma,0.748,NODAL SITE(S) EXAMINED
527,medgemma,0.904,HISTOLOGIC GRADE
528,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
529,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
530,medgemma,0.699,NUMBER OF LYMPH NODES EXAMINED
531,medgemma,0.815,REGIONAL LYMPH NODE STATUS
532,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
533,medgemma,0.904,HISTOLOGIC GRADE
534,medgemma,0.692,TUMOR FOCALITY
535,medgemma,0.698,SPECIMEN LATERALITY
536,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
537,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
538,medgemma,0.778,VISCERAL PLEURA INVASION
539,medgemma,0.746,TUMOR SITE
540,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
541,medgemma,0.827,PROCEDURE
542,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
543,medgemma,0.924,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
544,medgemma,0.795,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
545,medgemma,0.877,NODAL SITE(S) EXAMINED
546,medgemma,0.811,TUMOR FOCALITY
547,medgemma,0.89,TUMOR SITE
548,medgemma,0.762,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
549,medgemma,0.679,NODAL SITE(S) EXAMINED
550,medgemma,0.841,MARGIN STATUS FOR INVASIVE CARCINOMA
551,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
552,medgemma,0.698,SPECIMEN LATERALITY
553,medgemma,0.716,REGIONAL LYMPH NODE STATUS
554,medgemma,0.719,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
555,medgemma,0.778,VISCERAL PLEURA INVASION
556,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
557,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
558,medgemma,0.801,PROCEDURE
559,medgemma,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
560,medgemma,0.714,ADDITIONAL FINDINGS
561,medgemma,0.692,TUMOR FOCALITY
562,medgemma,0.698,SPECIMEN LATERALITY
563,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
564,medgemma,0.772,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
565,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
566,medgemma,0.815,REGIONAL LYMPH NODE STATUS
567,medgemma,0.746,TUMOR SITE
568,medgemma,0.688,NODAL SITE(S) EXAMINED
569,medgemma,0.778,VISCERAL PLEURA INVASION
570,medgemma,0.704,NUMBER OF LYMPH NODES EXAMINED
571,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
572,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
573,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
574,medgemma,0.904,HISTOLOGIC GRADE
575,medgemma,0.787,PROCEDURE
576,medgemma,0.816,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
577,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
578,medgemma,0.712,NODAL SITE(S) EXAMINED
579,medgemma,0.904,HISTOLOGIC GRADE
580,medgemma,0.782,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
581,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
582,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
583,medgemma,0.815,REGIONAL LYMPH NODE STATUS
584,medgemma,0.827,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
585,medgemma,0.778,VISCERAL PLEURA INVASION
586,medgemma,0.801,PROCEDURE
587,medgemma,0.811,TUMOR FOCALITY
588,medgemma,0.697,SPECIMEN LATERALITY
589,medgemma,0.817,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
590,medgemma,0.865,TUMOR SITE
591,medgemma,0.811,TUMOR FOCALITY
592,medgemma,0.904,HISTOLOGIC GRADE
593,medgemma,0.734,NODAL SITE(S) EXAMINED
594,medgemma,0.697,SPECIMEN LATERALITY
595,medgemma,0.829,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
596,medgemma,0.78,VISCERAL PLEURA INVASION
597,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
598,medgemma,0.815,REGIONAL LYMPH NODE STATUS
599,medgemma,0.796,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
600,medgemma,0.89,TUMOR SITE
601,medgemma,0.775,PROCEDURE
602,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
603,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
604,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
605,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
606,medgemma,0.788,PROCEDURE
607,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
608,medgemma,0.792,NODAL SITE(S) WITH TUMOR
609,medgemma,0.778,VISCERAL PLEURA INVASION
610,medgemma,0.715,TUMOR FOCALITY
611,medgemma,0.72,NUMBER OF LYMPH NODES WITH TUMOR
612,medgemma,0.742,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
613,medgemma,0.698,SPECIMEN LATERALITY
614,medgemma,0.741,ADDITIONAL FINDINGS
615,medgemma,0.782,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
616,medgemma,0.706,HISTOLOGIC GRADE
617,medgemma,0.672,NODAL SITE(S) EXAMINED
618,medgemma,0.715,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
619,medgemma,0.676,SPREAD THROUGH AIR SPACES (STAS)
620,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
621,medgemma,0.768,TNM DESCRIPTORS
622,medgemma,0.89,TUMOR SITE
623,medgemma,0.78,REGIONAL LYMPH NODE STATUS
624,medgemma,0.753,NODAL SITE(S) EXAMINED
625,medgemma,0.798,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
626,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
627,medgemma,0.776,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
628,medgemma,0.904,HISTOLOGIC GRADE
629,medgemma,0.697,SPECIMEN LATERALITY
630,medgemma,0.829,REGIONAL LYMPH NODE STATUS
631,medgemma,0.793,PROCEDURE
632,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
633,medgemma,0.692,TUMOR FOCALITY
634,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
635,medgemma,0.716,LYMPH NODE(S) FROM PRIOR PROCEDURES
636,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
637,medgemma,0.865,TUMOR SITE
638,medgemma,0.778,VISCERAL PLEURA INVASION
639,medgemma,0.892,HISTOLOGIC GRADE
640,medgemma,0.731,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
641,medgemma,0.778,VISCERAL PLEURA INVASION
642,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
643,medgemma,0.831,PROCEDURE
644,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
645,medgemma,0.78,REGIONAL LYMPH NODE STATUS
646,medgemma,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
647,medgemma,0.757,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
648,medgemma,0.736,NODAL SITE(S) WITH TUMOR
649,medgemma,0.875,TUMOR SITE
650,medgemma,0.745,LYMPHOVASCULAR INVASION
651,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
652,medgemma,0.705,NODAL SITE(S) EXAMINED
653,medgemma,0.697,SPECIMEN LATERALITY
654,medgemma,0.811,TUMOR FOCALITY
655,medgemma,0.797,HISTOLOGIC GRADE
656,medgemma,0.765,LYMPHOVASCULAR INVASION
657,medgemma,0.78,REGIONAL LYMPH NODE STATUS
658,medgemma,0.695,VISCERAL PLEURA INVASION
659,medgemma,0.676,SPREAD THROUGH AIR SPACES (STAS)
660,medgemma,0.896,MARGIN STATUS FOR INVASIVE CARCINOMA
661,medgemma,0.72,NODAL SITE(S) EXAMINED
662,medgemma,0.89,TUMOR SITE
663,medgemma,0.707,PROCEDURE
664,medgemma,0.698,SPECIMEN LATERALITY
665,medgemma,0.729,NODAL SITE(S) WITH TUMOR
666,medgemma,0.713,NUMBER OF LYMPH NODES WITH TUMOR
667,medgemma,0.764,NUMBER OF LYMPH NODES EXAMINED
668,medgemma,0.677,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
669,medgemma,0.78,TUMOR FOCALITY
670,medgemma,0.708,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
671,medgemma,0.654,TNM DESCRIPTORS
672,medgemma,0.739,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
673,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
674,medgemma,0.778,VISCERAL PLEURA INVASION
675,medgemma,0.697,SPECIMEN LATERALITY
676,medgemma,0.798,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
677,medgemma,0.723,MARGIN STATUS FOR INVASIVE CARCINOMA
678,medgemma,0.695,LYMPHOVASCULAR INVASION
679,medgemma,0.704,NODAL SITE(S) WITH TUMOR
680,medgemma,0.738,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
681,medgemma,0.718,HISTOLOGIC GRADE
682,medgemma,0.705,MARGIN STATUS FOR NON-INVASIVE TUMOR
683,medgemma,0.701,SPREAD THROUGH AIR SPACES (STAS)
684,medgemma,0.7,NUMBER OF LYMPH NODES WITH TUMOR
685,medgemma,0.78,REGIONAL LYMPH NODE STATUS
686,medgemma,0.793,PROCEDURE
687,medgemma,0.776,NODAL SITE(S) EXAMINED
688,medgemma,0.692,TUMOR FOCALITY
689,medgemma,0.683,LYMPH NODE(S) FROM PRIOR PROCEDURES
690,medgemma,0.709,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
691,medgemma,0.723,TUMOR SITE
692,medgemma,0.705,NUMBER OF LYMPH NODES EXAMINED
693,medgemma,0.798,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
694,medgemma,0.831,PROCEDURE
695,medgemma,0.823,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
696,medgemma,0.706,HISTOLOGIC GRADE
697,medgemma,0.815,REGIONAL LYMPH NODE STATUS
698,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
699,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
700,medgemma,0.698,SPECIMEN LATERALITY
701,medgemma,0.782,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
702,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
703,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
704,medgemma,0.692,TUMOR FOCALITY
705,medgemma,0.73,NODAL SITE(S) EXAMINED
706,medgemma,0.89,TUMOR SITE
707,medgemma,0.778,VISCERAL PLEURA INVASION
708,medgemma,0.778,VISCERAL PLEURA INVASION
709,medgemma,0.872,PROCEDURE
710,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
711,medgemma,0.811,TUMOR FOCALITY
712,medgemma,0.829,REGIONAL LYMPH NODE STATUS
713,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
714,medgemma,0.738,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
715,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
716,medgemma,0.698,SPECIMEN LATERALITY
717,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
718,medgemma,0.847,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
719,medgemma,0.675,NODAL SITE(S) EXAMINED
720,medgemma,0.89,TUMOR SITE
721,medgemma,0.904,HISTOLOGIC GRADE
722,medgemma,0.691,SPREAD THROUGH AIR SPACES (STAS)
723,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
724,medgemma,0.716,PROCEDURE
725,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
726,medgemma,0.742,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
727,medgemma,0.716,LYMPH NODE(S) FROM PRIOR PROCEDURES
728,medgemma,0.865,TUMOR SITE
729,medgemma,0.836,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
730,medgemma,0.688,NODAL SITE(S) EXAMINED
731,medgemma,0.699,NUMBER OF LYMPH NODES EXAMINED
732,medgemma,0.904,HISTOLOGIC GRADE
733,medgemma,0.815,REGIONAL LYMPH NODE STATUS
734,medgemma,0.811,TUMOR FOCALITY
735,medgemma,0.778,VISCERAL PLEURA INVASION
736,medgemma,0.698,SPECIMEN LATERALITY
737,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
738,medgemma,0.845,PROCEDURE
739,medgemma,0.89,TUMOR SITE
740,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
741,medgemma,0.902,ADDITIONAL FINDINGS
742,medgemma,0.831,HISTOLOGIC GRADE
743,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
744,medgemma,0.815,REGIONAL LYMPH NODE STATUS
745,medgemma,0.798,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
746,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
747,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
748,medgemma,0.778,VISCERAL PLEURA INVASION
749,medgemma,0.749,NODAL SITE(S) EXAMINED
750,medgemma,0.697,SPECIMEN LATERALITY
751,medgemma,0.709,NUMBER OF LYMPH NODES EXAMINED
752,medgemma,0.716,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
753,medgemma,0.811,TUMOR FOCALITY
754,medgemma,0.841,MARGIN STATUS FOR INVASIVE CARCINOMA
755,medgemma,0.904,HISTOLOGIC GRADE
756,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
757,medgemma,0.7,NUMBER OF LYMPH NODES EXAMINED
758,medgemma,0.829,REGIONAL LYMPH NODE STATUS
759,medgemma,0.694,PROCEDURE
760,medgemma,0.811,TUMOR FOCALITY
761,medgemma,0.702,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
762,medgemma,0.705,NODAL SITE(S) EXAMINED
763,medgemma,0.691,SPREAD THROUGH AIR SPACES (STAS)
764,medgemma,0.697,SPECIMEN LATERALITY
765,medgemma,0.694,ADDITIONAL FINDINGS
766,medgemma,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
767,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
768,medgemma,0.778,VISCERAL PLEURA INVASION
769,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
770,medgemma,0.89,TUMOR SITE
771,medgemma,0.79,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
772,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
773,medgemma,0.778,VISCERAL PLEURA INVASION
774,medgemma,0.742,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
775,medgemma,0.7,NUMBER OF LYMPH NODES WITH TUMOR
776,medgemma,0.811,TUMOR FOCALITY
777,medgemma,0.701,NUMBER OF LYMPH NODES WITH TUMOR
778,medgemma,0.736,NODAL SITE(S) EXAMINED
779,medgemma,0.89,TUMOR SITE
780,medgemma,0.739,NODAL SITE(S) WITH TUMOR
781,medgemma,0.797,HISTOLOGIC GRADE
782,medgemma,0.796,PROCEDURE
783,medgemma,0.697,SPECIMEN LATERALITY
784,medgemma,0.78,REGIONAL LYMPH NODE STATUS
785,medgemma,0.7,SPREAD THROUGH AIR SPACES (STAS)
786,medgemma,0.714,NODAL SITE(S) EXAMINED
787,medgemma,0.82,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
788,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
789,medgemma,0.757,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
790,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
791,medgemma,0.699,NUMBER OF LYMPH NODES EXAMINED
792,medgemma,0.797,HISTOLOGIC GRADE
793,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
794,medgemma,0.89,TUMOR SITE
795,medgemma,0.738,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
796,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
797,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
798,medgemma,0.831,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
799,medgemma,0.811,TUMOR FOCALITY
800,medgemma,0.701,NUMBER OF LYMPH NODES EXAMINED
801,medgemma,0.78,REGIONAL LYMPH NODE STATUS
802,medgemma,0.728,NODAL SITE(S) EXAMINED
803,medgemma,0.7,NUMBER OF LYMPH NODES WITH TUMOR
804,medgemma,0.778,VISCERAL PLEURA INVASION
805,medgemma,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
806,medgemma,0.697,SPECIMEN LATERALITY
807,medgemma,0.788,PROCEDURE
808,medgemma,0.69,LYMPHOVASCULAR INVASION
809,medgemma,0.778,TUMOR SITE
810,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
811,medgemma,0.714,LYMPHOVASCULAR INVASION
812,medgemma,0.721,NODAL SITE(S) EXAMINED
813,medgemma,0.716,LYMPH NODE(S) FROM PRIOR PROCEDURES
814,medgemma,0.701,SPREAD THROUGH AIR SPACES (STAS)
815,medgemma,0.818,HISTOLOGIC GRADE
816,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
817,medgemma,0.767,PROCEDURE
818,medgemma,0.697,SPECIMEN LATERALITY
819,medgemma,0.701,NUMBER OF LYMPH NODES EXAMINED
820,medgemma,0.716,REGIONAL LYMPH NODE STATUS
821,medgemma,0.698,VISCERAL PLEURA INVASION
822,medgemma,0.811,TUMOR FOCALITY
823,medgemma,0.741,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
824,medgemma,0.824,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
825,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
826,medgemma,0.78,REGIONAL LYMPH NODE STATUS
827,medgemma,0.698,SPECIMEN LATERALITY
828,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
829,medgemma,0.778,VISCERAL PLEURA INVASION
830,medgemma,0.692,TUMOR FOCALITY
831,medgemma,0.72,NUMBER OF LYMPH NODES WITH TUMOR
832,medgemma,0.83,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
833,medgemma,0.739,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
834,medgemma,0.847,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
835,medgemma,0.697,NUMBER OF LYMPH NODES EXAMINED
836,medgemma,0.788,PROCEDURE
837,medgemma,0.722,NODAL SITE(S) EXAMINED
838,medgemma,0.89,TUMOR SITE
839,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
840,medgemma,0.73,NODAL SITE(S) WITH TUMOR
841,medgemma,0.709,NODAL SITE(S) EXAMINED
842,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
843,medgemma,0.843,ADDITIONAL FINDINGS
844,medgemma,0.815,REGIONAL LYMPH NODE STATUS
845,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
846,medgemma,0.671,TUMOR SITE
847,medgemma,0.815,HISTOLOGIC GRADE
848,medgemma,0.778,VISCERAL PLEURA INVASION
849,medgemma,0.736,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
850,medgemma,0.712,TUMOR FOCALITY
851,medgemma,0.827,PROCEDURE
852,medgemma,0.874,MARGIN STATUS FOR INVASIVE CARCINOMA
853,medgemma,0.764,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
854,medgemma,0.7,NUMBER OF LYMPH NODES EXAMINED
855,medgemma,0.698,SPECIMEN LATERALITY
856,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
857,medgemma,0.679,SPREAD THROUGH AIR SPACES (STAS)
858,medgemma,0.701,SPREAD THROUGH AIR SPACES (STAS)
859,medgemma,0.705,HISTOLOGIC GRADE
860,medgemma,0.672,LYMPHOVASCULAR INVASION
861,medgemma,0.65,NODAL SITE(S) WITH TUMOR
862,medgemma,0.704,VISCERAL PLEURA INVASION
863,medgemma,0.683,LYMPH NODE(S) FROM PRIOR PROCEDURES
864,medgemma,0.711,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
865,medgemma,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
866,medgemma,0.788,PROCEDURE
867,medgemma,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
868,medgemma,0.698,SPECIMEN LATERALITY
869,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
870,medgemma,0.715,NUMBER OF LYMPH NODES EXAMINED
871,medgemma,0.698,NODAL SITE(S) EXAMINED
872,medgemma,0.78,REGIONAL LYMPH NODE STATUS
873,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
874,medgemma,0.698,NUMBER OF LYMPH NODES WITH TUMOR
875,medgemma,0.712,TUMOR FOCALITY
876,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
877,medgemma,0.778,VISCERAL PLEURA INVASION
878,medgemma,0.666,NODAL SITE(S) EXAMINED
879,medgemma,0.698,SPECIMEN LATERALITY
880,medgemma,0.827,PROCEDURE
881,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
882,medgemma,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
883,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
884,medgemma,0.797,HISTOLOGIC GRADE
885,medgemma,0.815,REGIONAL LYMPH NODE STATUS
886,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
887,medgemma,0.805,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
888,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
889,medgemma,0.865,TUMOR SITE
890,medgemma,0.692,TUMOR FOCALITY
891,medgemma,0.701,NUMBER OF LYMPH NODES EXAMINED
892,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
893,medgemma,0.831,PROCEDURE
894,medgemma,0.811,TUMOR FOCALITY
895,medgemma,0.697,SPECIMEN LATERALITY
896,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
897,medgemma,0.715,NUMBER OF LYMPH NODES WITH TUMOR
898,medgemma,0.78,VISCERAL PLEURA INVASION
899,medgemma,0.745,LYMPHOVASCULAR INVASION
900,medgemma,0.714,NODAL SITE(S) EXAMINED
901,medgemma,0.892,HISTOLOGIC GRADE
902,medgemma,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
903,medgemma,0.701,SPREAD THROUGH AIR SPACES (STAS)
904,medgemma,0.761,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
905,medgemma,0.709,MARGIN STATUS FOR INVASIVE CARCINOMA
906,medgemma,0.739,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
907,medgemma,0.719,NODAL SITE(S) WITH TUMOR
908,medgemma,0.78,REGIONAL LYMPH NODE STATUS
909,medgemma,0.881,TUMOR SITE
910,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
911,medgemma,0.676,SPREAD THROUGH AIR SPACES (STAS)
912,medgemma,0.733,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
913,medgemma,0.904,HISTOLOGIC GRADE
914,medgemma,0.815,REGIONAL LYMPH NODE STATUS
915,medgemma,0.817,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
916,medgemma,0.818,PROCEDURE
917,medgemma,0.693,NUMBER OF LYMPH NODES EXAMINED
918,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
919,medgemma,0.698,SPECIMEN LATERALITY
920,medgemma,0.811,TUMOR FOCALITY
921,medgemma,0.823,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
922,medgemma,0.697,NODAL SITE(S) EXAMINED
923,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
924,medgemma,0.778,VISCERAL PLEURA INVASION
925,medgemma,0.865,TUMOR SITE
926,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
927,medgemma,0.735,NODAL SITE(S) WITH TUMOR
928,medgemma,0.735,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
929,medgemma,0.89,TUMOR SITE
930,medgemma,0.739,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
931,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
932,medgemma,0.67,SPREAD THROUGH AIR SPACES (STAS)
933,medgemma,0.892,HISTOLOGIC GRADE
934,medgemma,0.78,REGIONAL LYMPH NODE STATUS
935,medgemma,0.78,VISCERAL PLEURA INVASION
936,medgemma,0.745,LYMPHOVASCULAR INVASION
937,medgemma,0.704,NUMBER OF LYMPH NODES EXAMINED
938,medgemma,0.698,SPECIMEN LATERALITY
939,medgemma,0.756,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
940,medgemma,0.684,NODAL SITE(S) EXAMINED
941,medgemma,0.759,PROCEDURE
942,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
943,medgemma,0.699,NUMBER OF LYMPH NODES WITH TUMOR
944,medgemma,0.811,TUMOR FOCALITY
945,medgemma,0.707,NUMBER OF LYMPH NODES WITH TUMOR
946,medgemma,0.865,TUMOR SITE
947,medgemma,0.742,NODAL SITE(S) EXAMINED
948,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
949,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
950,medgemma,0.778,VISCERAL PLEURA INVASION
951,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
952,medgemma,0.818,HISTOLOGIC GRADE
953,medgemma,0.703,NUMBER OF LYMPH NODES EXAMINED
954,medgemma,0.78,REGIONAL LYMPH NODE STATUS
955,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
956,medgemma,0.795,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
957,medgemma,0.831,PROCEDURE
958,medgemma,0.784,NODAL SITE(S) WITH TUMOR
959,medgemma,0.822,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
960,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
961,medgemma,0.697,SPECIMEN LATERALITY
962,medgemma,0.811,TUMOR FOCALITY
963,medgemma,0.847,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
964,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
965,medgemma,0.72,NUMBER OF LYMPH NODES WITH TUMOR
966,medgemma,0.788,PROCEDURE
967,medgemma,0.892,HISTOLOGIC GRADE
968,medgemma,0.78,REGIONAL LYMPH NODE STATUS
969,medgemma,0.722,NUMBER OF LYMPH NODES EXAMINED
970,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
971,medgemma,0.68,NODAL SITE(S) EXAMINED
972,medgemma,0.778,VISCERAL PLEURA INVASION
973,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
974,medgemma,0.687,NODAL SITE(S) WITH TUMOR
975,medgemma,0.741,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
976,medgemma,0.811,TUMOR FOCALITY
977,medgemma,0.802,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
978,medgemma,0.712,TUMOR SITE
979,medgemma,0.698,SPECIMEN LATERALITY
980,medgemma,0.7,SPREAD THROUGH AIR SPACES (STAS)
981,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
982,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
983,medgemma,0.698,SPECIMEN LATERALITY
984,medgemma,0.817,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
985,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
986,medgemma,0.695,NUMBER OF LYMPH NODES EXAMINED
987,medgemma,0.778,VISCERAL PLEURA INVASION
988,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
989,medgemma,0.89,TUMOR SITE
990,medgemma,0.815,REGIONAL LYMPH NODE STATUS
991,medgemma,0.797,HISTOLOGIC GRADE
992,medgemma,0.811,TUMOR FOCALITY
993,medgemma,0.709,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
994,medgemma,0.68,NODAL SITE(S) EXAMINED
995,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
996,medgemma,0.872,PROCEDURE
997,medgemma,0.811,TUMOR FOCALITY
998,medgemma,0.716,LYMPH NODE(S) FROM PRIOR PROCEDURES
999,medgemma,0.717,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1000,medgemma,0.89,TUMOR SITE
1001,medgemma,0.754,NODAL SITE(S) EXAMINED
1002,medgemma,0.827,PROCEDURE
1003,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1004,medgemma,0.892,HISTOLOGIC GRADE
1005,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1006,medgemma,0.697,SPECIMEN LATERALITY
1007,medgemma,0.716,REGIONAL LYMPH NODE STATUS
1008,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
1009,medgemma,0.778,VISCERAL PLEURA INVASION
1010,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1011,medgemma,0.826,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1012,medgemma,0.702,LYMPHOVASCULAR INVASION
1013,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1014,medgemma,0.788,PROCEDURE
1015,medgemma,0.698,SPECIMEN LATERALITY
1016,medgemma,0.797,HISTOLOGIC GRADE
1017,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1018,medgemma,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
1019,medgemma,0.696,NUMBER OF LYMPH NODES EXAMINED
1020,medgemma,0.89,TUMOR SITE
1021,medgemma,0.709,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1022,medgemma,0.7,VISCERAL PLEURA INVASION
1023,medgemma,0.715,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1024,medgemma,0.738,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1025,medgemma,0.815,REGIONAL LYMPH NODE STATUS
1026,medgemma,0.896,ADDITIONAL FINDINGS
1027,medgemma,0.638,NODAL SITE(S) EXAMINED
1028,medgemma,0.811,TUMOR FOCALITY
1029,medgemma,0.798,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1030,medgemma,0.904,HISTOLOGIC GRADE
1031,medgemma,0.793,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1032,medgemma,0.89,TUMOR SITE
1033,medgemma,0.778,VISCERAL PLEURA INVASION
1034,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1035,medgemma,0.815,REGIONAL LYMPH NODE STATUS
1036,medgemma,0.72,NUMBER OF LYMPH NODES EXAMINED
1037,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1038,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
1039,medgemma,0.811,TUMOR FOCALITY
1040,medgemma,0.804,NODAL SITE(S) EXAMINED
1041,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1042,medgemma,0.697,SPECIMEN LATERALITY
1043,medgemma,0.734,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1044,medgemma,0.827,PROCEDURE
1045,medgemma,0.698,ADDITIONAL FINDINGS
1046,medgemma,0.868,ADDITIONAL FINDINGS
1047,medgemma,0.827,PROCEDURE
1048,medgemma,0.778,VISCERAL PLEURA INVASION
1049,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1050,medgemma,0.904,HISTOLOGIC GRADE
1051,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1052,medgemma,0.815,REGIONAL LYMPH NODE STATUS
1053,medgemma,0.835,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1054,medgemma,0.697,SPECIMEN LATERALITY
1055,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1056,medgemma,0.792,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1057,medgemma,0.89,TUMOR SITE
1058,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1059,medgemma,0.718,SPREAD THROUGH AIR SPACES (STAS)
1060,medgemma,0.778,NODAL SITE(S) EXAMINED
1061,medgemma,0.811,TUMOR FOCALITY
1062,medgemma,0.831,PROCEDURE
1063,medgemma,0.89,TUMOR SITE
1064,medgemma,0.691,NODAL SITE(S) EXAMINED
1065,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
1066,medgemma,0.738,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1067,medgemma,0.698,SPECIMEN LATERALITY
1068,medgemma,0.78,VISCERAL PLEURA INVASION
1069,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1070,medgemma,0.707,TNM DESCRIPTORS
1071,medgemma,0.811,TUMOR FOCALITY
1072,medgemma,0.713,ADDITIONAL FINDINGS
1073,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1074,medgemma,0.725,HISTOLOGIC GRADE
1075,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1076,medgemma,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1077,medgemma,0.745,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1078,medgemma,0.716,REGIONAL LYMPH NODE STATUS
1079,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1080,medgemma,0.7,VISCERAL PLEURA INVASION
1081,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
1082,medgemma,0.822,ADDITIONAL FINDINGS
1083,medgemma,0.827,PROCEDURE
1084,medgemma,0.698,SPECIMEN LATERALITY
1085,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1086,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1087,medgemma,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1088,medgemma,0.649,TUMOR FOCALITY
1089,medgemma,0.865,TUMOR SITE
1090,medgemma,0.777,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1091,medgemma,0.892,HISTOLOGIC GRADE
1092,medgemma,0.702,LYMPHOVASCULAR INVASION
1093,medgemma,0.811,TUMOR FOCALITY
1094,medgemma,0.78,VISCERAL PLEURA INVASION
1095,medgemma,0.749,NODAL SITE(S) WITH TUMOR
1096,medgemma,0.707,SPREAD THROUGH AIR SPACES (STAS)
1097,medgemma,0.697,SPECIMEN LATERALITY
1098,medgemma,0.739,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1099,medgemma,0.808,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1100,medgemma,0.72,NUMBER OF LYMPH NODES WITH TUMOR
1101,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1102,medgemma,0.78,REGIONAL LYMPH NODE STATUS
1103,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1104,medgemma,0.89,TUMOR SITE
1105,medgemma,0.831,PROCEDURE
1106,medgemma,0.706,NODAL SITE(S) EXAMINED
1107,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1108,medgemma,0.817,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1109,medgemma,0.716,REGIONAL LYMPH NODE STATUS
1110,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1111,medgemma,0.778,VISCERAL PLEURA INVASION
1112,medgemma,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1113,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1114,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1115,medgemma,0.865,TUMOR SITE
1116,medgemma,0.826,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1117,medgemma,0.698,SPECIMEN LATERALITY
1118,medgemma,0.825,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1119,medgemma,0.797,HISTOLOGIC GRADE
1120,medgemma,0.696,NODAL SITE(S) EXAMINED
1121,medgemma,0.803,PROCEDURE
1122,medgemma,0.692,TUMOR FOCALITY
1123,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
1124,medgemma,0.815,REGIONAL LYMPH NODE STATUS
1125,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1126,medgemma,0.712,NODAL SITE(S) EXAMINED
1127,medgemma,0.819,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1128,medgemma,0.851,ADDITIONAL FINDINGS
1129,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1130,medgemma,0.705,SPECIMEN LATERALITY
1131,medgemma,0.89,TUMOR SITE
1132,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
1133,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1134,medgemma,0.713,NUMBER OF LYMPH NODES EXAMINED
1135,medgemma,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1136,medgemma,0.778,VISCERAL PLEURA INVASION
1137,medgemma,0.797,HISTOLOGIC GRADE
1138,medgemma,0.827,PROCEDURE
1139,medgemma,0.697,SPECIMEN LATERALITY
1140,medgemma,0.811,TUMOR FOCALITY
1141,medgemma,0.797,HISTOLOGIC GRADE
1142,medgemma,0.827,PROCEDURE
1143,medgemma,0.805,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1144,medgemma,0.89,TUMOR SITE
1145,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1146,medgemma,0.745,NODAL SITE(S) EXAMINED
1147,medgemma,0.811,TUMOR FOCALITY
1148,medgemma,0.698,SPECIMEN LATERALITY
1149,medgemma,0.739,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1150,medgemma,0.707,ADDITIONAL FINDINGS
1151,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1152,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1153,medgemma,0.815,REGIONAL LYMPH NODE STATUS
1154,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1155,medgemma,0.78,VISCERAL PLEURA INVASION
1156,medgemma,0.716,REGIONAL LYMPH NODE STATUS
1157,medgemma,0.75,HISTOLOGIC GRADE
1158,medgemma,0.71,NODAL SITE(S) EXAMINED
1159,medgemma,0.761,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1160,medgemma,0.898,PROCEDURE
1161,medgemma,0.704,NUMBER OF LYMPH NODES EXAMINED
1162,medgemma,0.782,ADDITIONAL FINDINGS
1163,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1164,medgemma,0.885,TUMOR SITE
1165,medgemma,0.71,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1166,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1167,medgemma,0.675,VISCERAL PLEURA INVASION
1168,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1169,medgemma,0.676,SPREAD THROUGH AIR SPACES (STAS)
1170,medgemma,0.712,TUMOR FOCALITY
1171,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1172,medgemma,0.697,SPECIMEN LATERALITY
1173,medgemma,0.726,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1174,medgemma,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
1175,medgemma,0.715,NUMBER OF LYMPH NODES WITH TUMOR
1176,medgemma,0.892,HISTOLOGIC GRADE
1177,medgemma,0.669,NODAL SITE(S) WITH TUMOR
1178,medgemma,0.698,MARGIN STATUS FOR INVASIVE CARCINOMA
1179,medgemma,0.73,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1180,medgemma,0.697,SPECIMEN LATERALITY
1181,medgemma,0.705,MARGIN STATUS FOR NON-INVASIVE TUMOR
1182,medgemma,0.708,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1183,medgemma,0.697,TUMOR SITE
1184,medgemma,0.78,SPREAD THROUGH AIR SPACES (STAS)
1185,medgemma,0.638,NODAL SITE(S) EXAMINED
1186,medgemma,0.738,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1187,medgemma,0.811,TUMOR FOCALITY
1188,medgemma,0.788,PROCEDURE
1189,medgemma,0.686,LYMPHOVASCULAR INVASION
1190,medgemma,0.676,REGIONAL LYMPH NODE STATUS
1191,medgemma,0.707,NUMBER OF LYMPH NODES EXAMINED
1192,medgemma,0.666,NODAL SITE(S) EXAMINED
1193,medgemma,0.865,TUMOR SITE
1194,medgemma,0.803,NUMBER OF LYMPH NODES EXAMINED
1195,medgemma,0.732,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1196,medgemma,0.892,HISTOLOGIC GRADE
1197,medgemma,0.745,LYMPHOVASCULAR INVASION
1198,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
1199,medgemma,0.78,VISCERAL PLEURA INVASION
1200,medgemma,0.736,ADDITIONAL FINDINGS
1201,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1202,medgemma,0.698,SPECIMEN LATERALITY
1203,medgemma,0.811,TUMOR FOCALITY
1204,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1205,medgemma,0.716,REGIONAL LYMPH NODE STATUS
1206,medgemma,0.729,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1207,medgemma,0.813,PROCEDURE
1208,medgemma,0.782,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1209,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1210,medgemma,0.904,HISTOLOGIC GRADE
1211,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1212,medgemma,0.813,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1213,medgemma,0.697,SPECIMEN LATERALITY
1214,medgemma,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1215,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1216,medgemma,0.89,TUMOR SITE
1217,medgemma,0.778,VISCERAL PLEURA INVASION
1218,medgemma,0.713,NUMBER OF LYMPH NODES EXAMINED
1219,medgemma,0.716,ADDITIONAL FINDINGS
1220,medgemma,0.827,PROCEDURE
1221,medgemma,0.811,TUMOR FOCALITY
1222,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1223,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
1224,medgemma,0.785,NODAL SITE(S) EXAMINED
1225,medgemma,0.815,REGIONAL LYMPH NODE STATUS
1226,medgemma,0.735,ADDITIONAL FINDINGS
1227,medgemma,0.778,HISTOLOGIC GRADE
1228,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
1229,medgemma,0.774,MARGIN STATUS FOR INVASIVE CARCINOMA
1230,medgemma,0.678,NODAL SITE(S) EXAMINED
1231,medgemma,0.717,NUMBER OF LYMPH NODES EXAMINED
1232,medgemma,0.718,VISCERAL PLEURA INVASION
1233,medgemma,0.89,TUMOR SITE
1234,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1235,medgemma,0.712,TUMOR FOCALITY
1236,medgemma,0.716,REGIONAL LYMPH NODE STATUS
1237,medgemma,0.698,SPECIMEN LATERALITY
1238,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1239,medgemma,0.735,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1240,medgemma,0.872,PROCEDURE
1241,medgemma,0.699,ADDITIONAL FINDINGS
1242,medgemma,0.703,NUMBER OF LYMPH NODES EXAMINED
1243,medgemma,0.815,REGIONAL LYMPH NODE STATUS
1244,medgemma,0.697,SPECIMEN LATERALITY
1245,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1246,medgemma,0.827,PROCEDURE
1247,medgemma,0.792,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1248,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1249,medgemma,0.778,VISCERAL PLEURA INVASION
1250,medgemma,0.904,HISTOLOGIC GRADE
1251,medgemma,0.838,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1252,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1253,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
1254,medgemma,0.89,TUMOR SITE
1255,medgemma,0.748,NODAL SITE(S) EXAMINED
1256,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1257,medgemma,0.811,TUMOR FOCALITY
1258,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
1259,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1260,medgemma,0.735,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1261,medgemma,0.904,HISTOLOGIC GRADE
1262,medgemma,0.844,ADDITIONAL FINDINGS
1263,medgemma,0.701,SPREAD THROUGH AIR SPACES (STAS)
1264,medgemma,0.746,NODAL SITE(S) EXAMINED
1265,medgemma,0.716,REGIONAL LYMPH NODE STATUS
1266,medgemma,0.801,PROCEDURE
1267,medgemma,0.803,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1268,medgemma,0.697,SPECIMEN LATERALITY
1269,medgemma,0.865,TUMOR SITE
1270,medgemma,0.778,VISCERAL PLEURA INVASION
1271,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1272,medgemma,0.734,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1273,medgemma,0.712,TUMOR FOCALITY
1274,medgemma,0.705,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1275,medgemma,0.651,TNM DESCRIPTORS
1276,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1277,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1278,medgemma,0.727,NODAL SITE(S) EXAMINED
1279,medgemma,0.712,TUMOR FOCALITY
1280,medgemma,0.827,PROCEDURE
1281,medgemma,0.89,TUMOR SITE
1282,medgemma,0.693,MARGIN STATUS FOR INVASIVE CARCINOMA
1283,medgemma,0.815,REGIONAL LYMPH NODE STATUS
1284,medgemma,0.904,HISTOLOGIC GRADE
1285,medgemma,0.778,VISCERAL PLEURA INVASION
1286,medgemma,0.713,NUMBER OF LYMPH NODES EXAMINED
1287,medgemma,0.697,SPECIMEN LATERALITY
1288,medgemma,0.7,SPREAD THROUGH AIR SPACES (STAS)
1289,medgemma,0.705,NODAL SITE(S) EXAMINED
1290,medgemma,0.778,VISCERAL PLEURA INVASION
1291,medgemma,0.797,HISTOLOGIC GRADE
1292,medgemma,0.692,NUMBER OF LYMPH NODES EXAMINED
1293,medgemma,0.823,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1294,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
1295,medgemma,0.78,REGIONAL LYMPH NODE STATUS
1296,medgemma,0.849,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1297,medgemma,0.676,SPREAD THROUGH AIR SPACES (STAS)
1298,medgemma,0.906,MARGIN STATUS FOR INVASIVE CARCINOMA
1299,medgemma,0.713,NUMBER OF LYMPH NODES WITH TUMOR
1300,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1301,medgemma,0.811,TUMOR FOCALITY
1302,medgemma,0.813,PROCEDURE
1303,medgemma,0.697,SPECIMEN LATERALITY
1304,medgemma,0.89,TUMOR SITE
1305,medgemma,0.761,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1306,medgemma,0.739,NODAL SITE(S) EXAMINED
1307,medgemma,0.865,TUMOR SITE
1308,medgemma,0.716,ADDITIONAL FINDINGS
1309,medgemma,0.708,TUMOR FOCALITY
1310,medgemma,0.827,PROCEDURE
1311,medgemma,0.703,SPREAD THROUGH AIR SPACES (STAS)
1312,medgemma,0.778,VISCERAL PLEURA INVASION
1313,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
1314,medgemma,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1315,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1316,medgemma,0.804,HISTOLOGIC GRADE
1317,medgemma,0.821,MARGIN STATUS FOR INVASIVE CARCINOMA
1318,medgemma,0.716,REGIONAL LYMPH NODE STATUS
1319,medgemma,0.713,NUMBER OF LYMPH NODES EXAMINED
1320,medgemma,0.698,SPECIMEN LATERALITY
1321,medgemma,0.78,VISCERAL PLEURA INVASION
1322,medgemma,0.89,TUMOR SITE
1323,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1324,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
1325,medgemma,0.827,PROCEDURE
1326,medgemma,0.697,SPECIMEN LATERALITY
1327,medgemma,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1328,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1329,medgemma,0.756,HISTOLOGIC GRADE
1330,medgemma,0.811,TUMOR FOCALITY
1331,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1332,medgemma,0.715,NODAL SITE(S) EXAMINED
1333,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
1334,medgemma,0.716,REGIONAL LYMPH NODE STATUS
1335,medgemma,0.825,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1336,medgemma,0.716,ADDITIONAL FINDINGS
1337,medgemma,0.734,NODAL SITE(S) EXAMINED
1338,medgemma,0.755,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1339,medgemma,0.716,REGIONAL LYMPH NODE STATUS
1340,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1341,medgemma,0.78,VISCERAL PLEURA INVASION
1342,medgemma,0.706,NUMBER OF LYMPH NODES EXAMINED
1343,medgemma,0.827,PROCEDURE
1344,medgemma,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1345,medgemma,0.89,TUMOR SITE
1346,medgemma,0.697,SPECIMEN LATERALITY
1347,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
1348,medgemma,0.904,HISTOLOGIC GRADE
1349,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1350,medgemma,0.811,TUMOR FOCALITY
1351,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1352,medgemma,0.734,TNM DESCRIPTORS
1353,medgemma,0.716,REGIONAL LYMPH NODE STATUS
1354,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1355,medgemma,0.774,MARGIN STATUS FOR INVASIVE CARCINOMA
1356,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
1357,medgemma,0.692,NODAL SITE(S) EXAMINED
1358,medgemma,0.887,PROCEDURE
1359,medgemma,0.702,NUMBER OF LYMPH NODES EXAMINED
1360,medgemma,0.747,TUMOR FOCALITY
1361,medgemma,0.78,VISCERAL PLEURA INVASION
1362,medgemma,0.697,SPECIMEN LATERALITY
1363,medgemma,0.735,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1364,medgemma,0.712,TUMOR SITE
1365,medgemma,0.797,HISTOLOGIC GRADE
1366,medgemma,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1367,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
1368,medgemma,0.722,NODAL SITE(S) EXAMINED
1369,medgemma,0.692,TUMOR FOCALITY
1370,medgemma,0.712,NUMBER OF LYMPH NODES EXAMINED
1371,medgemma,0.91,TUMOR SITE
1372,medgemma,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1373,medgemma,0.778,VISCERAL PLEURA INVASION
1374,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1375,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1376,medgemma,0.765,PROCEDURE
1377,medgemma,0.815,REGIONAL LYMPH NODE STATUS
1378,medgemma,0.697,SPECIMEN LATERALITY
1379,medgemma,0.697,SPECIMEN LATERALITY
1380,medgemma,0.681,TUMOR SITE
1381,medgemma,0.694,TNM DESCRIPTORS
1382,medgemma,0.735,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1383,medgemma,0.827,PROCEDURE
1384,medgemma,0.766,LYMPHOVASCULAR INVASION
1385,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
1386,medgemma,0.71,TUMOR FOCALITY
1387,medgemma,0.778,VISCERAL PLEURA INVASION
1388,medgemma,0.774,MARGIN STATUS FOR INVASIVE CARCINOMA
1389,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
1390,medgemma,0.778,HISTOLOGIC GRADE
1391,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1392,medgemma,0.78,REGIONAL LYMPH NODE STATUS
1393,medgemma,0.676,SPREAD THROUGH AIR SPACES (STAS)
1394,medgemma,0.657,NODAL SITE(S) EXAMINED
1395,medgemma,0.699,NUMBER OF LYMPH NODES WITH TUMOR
1396,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1397,medgemma,0.831,PROCEDURE
1398,medgemma,0.703,NUMBER OF LYMPH NODES EXAMINED
1399,medgemma,0.825,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1400,medgemma,0.811,TUMOR FOCALITY
1401,medgemma,0.716,ADDITIONAL FINDINGS
1402,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1403,medgemma,0.711,NODAL SITE(S) WITH TUMOR
1404,medgemma,0.754,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1405,medgemma,0.778,VISCERAL PLEURA INVASION
1406,medgemma,0.698,SPECIMEN LATERALITY
1407,medgemma,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1408,medgemma,0.89,TUMOR SITE
1409,medgemma,0.793,PROCEDURE
1410,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1411,medgemma,0.887,TUMOR SITE
1412,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
1413,medgemma,0.737,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1414,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1415,medgemma,0.693,NUMBER OF LYMPH NODES EXAMINED
1416,medgemma,0.716,ADDITIONAL FINDINGS
1417,medgemma,0.809,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1418,medgemma,0.892,HISTOLOGIC GRADE
1419,medgemma,0.723,NODAL SITE(S) EXAMINED
1420,medgemma,0.815,REGIONAL LYMPH NODE STATUS
1421,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
1422,medgemma,0.697,SPECIMEN LATERALITY
1423,medgemma,0.778,VISCERAL PLEURA INVASION
1424,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1425,medgemma,0.811,TUMOR FOCALITY
1426,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1427,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1428,medgemma,0.739,NODAL SITE(S) EXAMINED
1429,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
1430,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1431,medgemma,0.735,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1432,medgemma,0.644,TNM DESCRIPTORS
1433,medgemma,0.794,ADDITIONAL FINDINGS
1434,medgemma,0.829,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1435,medgemma,0.831,PROCEDURE
1436,medgemma,0.815,REGIONAL LYMPH NODE STATUS
1437,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1438,medgemma,0.904,HISTOLOGIC GRADE
1439,medgemma,0.697,SPECIMEN LATERALITY
1440,medgemma,0.89,TUMOR SITE
1441,medgemma,0.778,VISCERAL PLEURA INVASION
1442,medgemma,0.705,TUMOR FOCALITY
1443,medgemma,0.78,REGIONAL LYMPH NODE STATUS
1444,medgemma,0.738,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1445,medgemma,0.78,VISCERAL PLEURA INVASION
1446,medgemma,0.938,ADDITIONAL FINDINGS
1447,medgemma,0.698,SPECIMEN LATERALITY
1448,medgemma,0.745,LYMPHOVASCULAR INVASION
1449,medgemma,0.879,MARGIN STATUS FOR INVASIVE CARCINOMA
1450,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1451,medgemma,0.699,NODAL SITE(S) WITH TUMOR
1452,medgemma,0.831,PROCEDURE
1453,medgemma,0.685,TUMOR SITE
1454,medgemma,0.699,NODAL SITE(S) EXAMINED
1455,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1456,medgemma,0.729,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1457,medgemma,0.692,SPREAD THROUGH AIR SPACES (STAS)
1458,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1459,medgemma,0.729,NUMBER OF LYMPH NODES EXAMINED
1460,medgemma,0.713,NUMBER OF LYMPH NODES WITH TUMOR
1461,medgemma,0.811,TUMOR FOCALITY
1462,medgemma,0.865,TUMOR SITE
1463,medgemma,0.724,NODAL SITE(S) EXAMINED
1464,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1465,medgemma,0.755,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1466,medgemma,0.733,HISTOLOGIC GRADE
1467,medgemma,0.802,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1468,medgemma,0.716,REGIONAL LYMPH NODE STATUS
1469,medgemma,0.698,SPECIMEN LATERALITY
1470,medgemma,0.811,TUMOR FOCALITY
1471,medgemma,0.78,VISCERAL PLEURA INVASION
1472,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1473,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1474,medgemma,0.672,ADDITIONAL FINDINGS
1475,medgemma,0.788,PROCEDURE
1476,medgemma,0.826,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1477,medgemma,0.731,LYMPHOVASCULAR INVASION
1478,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
1479,medgemma,0.815,REGIONAL LYMPH NODE STATUS
1480,medgemma,0.811,TUMOR FOCALITY
1481,medgemma,0.795,ADDITIONAL FINDINGS
1482,medgemma,0.778,VISCERAL PLEURA INVASION
1483,medgemma,0.841,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1484,medgemma,0.806,PROCEDURE
1485,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1486,medgemma,0.697,SPECIMEN LATERALITY
1487,medgemma,0.792,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1488,medgemma,0.755,TUMOR SITE
1489,medgemma,0.687,NODAL SITE(S) EXAMINED
1490,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1491,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1492,medgemma,0.699,NUMBER OF LYMPH NODES EXAMINED
1493,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1494,medgemma,0.745,LYMPHOVASCULAR INVASION
1495,medgemma,0.879,MARGIN STATUS FOR INVASIVE CARCINOMA
1496,medgemma,0.707,NUMBER OF LYMPH NODES WITH TUMOR
1497,medgemma,0.78,REGIONAL LYMPH NODE STATUS
1498,medgemma,0.692,HISTOLOGIC GRADE
1499,medgemma,0.682,NODAL SITE(S) WITH TUMOR
1500,medgemma,0.896,ADDITIONAL FINDINGS
1501,medgemma,0.687,NODAL SITE(S) EXAMINED
1502,medgemma,0.778,VISCERAL PLEURA INVASION
1503,medgemma,0.697,SPECIMEN LATERALITY
1504,medgemma,0.768,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1505,medgemma,0.721,SPREAD THROUGH AIR SPACES (STAS)
1506,medgemma,0.808,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1507,medgemma,0.898,PROCEDURE
1508,medgemma,0.749,TUMOR SITE
1509,medgemma,0.688,TUMOR FOCALITY
1510,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1511,medgemma,0.713,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1512,medgemma,0.669,TNM DESCRIPTORS
1513,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1514,medgemma,0.818,HISTOLOGIC GRADE
1515,medgemma,0.723,NODAL SITE(S) EXAMINED
1516,medgemma,0.811,TUMOR FOCALITY
1517,medgemma,0.767,LYMPHOVASCULAR INVASION
1518,medgemma,0.735,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1519,medgemma,0.778,VISCERAL PLEURA INVASION
1520,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1521,medgemma,0.827,PROCEDURE
1522,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1523,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1524,medgemma,0.697,SPECIMEN LATERALITY
1525,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
1526,medgemma,0.89,TUMOR SITE
1527,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1528,medgemma,0.735,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1529,medgemma,0.815,REGIONAL LYMPH NODE STATUS
1530,medgemma,0.697,SPECIMEN LATERALITY
1531,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1532,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1533,medgemma,0.825,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1534,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1535,medgemma,0.938,ADDITIONAL FINDINGS
1536,medgemma,0.718,NODAL SITE(S) EXAMINED
1537,medgemma,0.811,TUMOR FOCALITY
1538,medgemma,0.782,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1539,medgemma,0.716,REGIONAL LYMPH NODE STATUS
1540,medgemma,0.78,VISCERAL PLEURA INVASION
1541,medgemma,0.904,HISTOLOGIC GRADE
1542,medgemma,0.796,PROCEDURE
1543,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
1544,medgemma,0.824,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1545,medgemma,0.89,TUMOR SITE
1546,medgemma,0.69,SPREAD THROUGH AIR SPACES (STAS)
1547,medgemma,0.692,TUMOR FOCALITY
1548,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1549,medgemma,0.696,TNM DESCRIPTORS
1550,medgemma,0.705,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1551,medgemma,0.89,TUMOR SITE
1552,medgemma,0.696,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1553,medgemma,0.938,ADDITIONAL FINDINGS
1554,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1555,medgemma,0.693,NUMBER OF LYMPH NODES EXAMINED
1556,medgemma,0.778,VISCERAL PLEURA INVASION
1557,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1558,medgemma,0.815,REGIONAL LYMPH NODE STATUS
1559,medgemma,0.703,HISTOLOGIC GRADE
1560,medgemma,0.72,NODAL SITE(S) EXAMINED
1561,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1562,medgemma,0.697,SPECIMEN LATERALITY
1563,medgemma,0.731,PROCEDURE
1564,medgemma,0.798,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1565,medgemma,0.689,NODAL SITE(S) EXAMINED
1566,medgemma,0.716,REGIONAL LYMPH NODE STATUS
1567,medgemma,0.698,SPECIMEN LATERALITY
1568,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
1569,medgemma,0.811,TUMOR FOCALITY
1570,medgemma,0.778,HISTOLOGIC GRADE
1571,medgemma,0.801,PROCEDURE
1572,medgemma,0.709,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1573,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1574,medgemma,0.819,ADDITIONAL FINDINGS
1575,medgemma,0.89,TUMOR SITE
1576,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
1577,medgemma,0.78,VISCERAL PLEURA INVASION
1578,medgemma,0.835,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1579,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1580,medgemma,0.734,NUMBER OF LYMPH NODES EXAMINED
1581,medgemma,0.698,SPECIMEN LATERALITY
1582,medgemma,0.735,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1583,medgemma,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1584,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1585,medgemma,0.89,TUMOR SITE
1586,medgemma,0.699,NODAL SITE(S) EXAMINED
1587,medgemma,0.778,VISCERAL PLEURA INVASION
1588,medgemma,0.815,REGIONAL LYMPH NODE STATUS
1589,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1590,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1591,medgemma,0.805,SPREAD THROUGH AIR SPACES (STAS)
1592,medgemma,0.811,TUMOR FOCALITY
1593,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1594,medgemma,0.818,HISTOLOGIC GRADE
1595,medgemma,0.792,PROCEDURE
1596,medgemma,0.716,REGIONAL LYMPH NODE STATUS
1597,medgemma,0.816,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1598,medgemma,0.78,VISCERAL PLEURA INVASION
1599,medgemma,0.766,LYMPHOVASCULAR INVASION
1600,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1601,medgemma,0.711,PROCEDURE
1602,medgemma,0.783,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1603,medgemma,0.818,HISTOLOGIC GRADE
1604,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1605,medgemma,0.707,TNM DESCRIPTORS
1606,medgemma,0.698,SPECIMEN LATERALITY
1607,medgemma,0.712,NODAL SITE(S) EXAMINED
1608,medgemma,0.708,TUMOR FOCALITY
1609,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1610,medgemma,0.865,TUMOR SITE
1611,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
1612,medgemma,0.843,ADDITIONAL FINDINGS
1613,medgemma,0.712,LYMPHOVASCULAR INVASION
1614,medgemma,0.801,PROCEDURE
1615,medgemma,0.89,TUMOR SITE
1616,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1617,medgemma,0.692,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1618,medgemma,0.696,TNM DESCRIPTORS
1619,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1620,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1621,medgemma,0.74,NODAL SITE(S) WITH TUMOR
1622,medgemma,0.698,SPECIMEN LATERALITY
1623,medgemma,0.778,VISCERAL PLEURA INVASION
1624,medgemma,0.688,NODAL SITE(S) EXAMINED
1625,medgemma,0.704,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1626,medgemma,0.892,HISTOLOGIC GRADE
1627,medgemma,0.78,REGIONAL LYMPH NODE STATUS
1628,medgemma,0.72,NUMBER OF LYMPH NODES WITH TUMOR
1629,medgemma,0.688,NUMBER OF LYMPH NODES EXAMINED
1630,medgemma,0.74,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1631,medgemma,0.811,TUMOR FOCALITY
1632,medgemma,0.89,TUMOR SITE
1633,medgemma,0.775,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1634,medgemma,0.737,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1635,medgemma,0.739,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1636,medgemma,0.735,NODAL SITE(S) EXAMINED
1637,medgemma,0.778,VISCERAL PLEURA INVASION
1638,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1639,medgemma,0.757,ADDITIONAL FINDINGS
1640,medgemma,0.743,PROCEDURE
1641,medgemma,0.697,SPECIMEN LATERALITY
1642,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
1643,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1644,medgemma,0.815,REGIONAL LYMPH NODE STATUS
1645,medgemma,0.811,TUMOR FOCALITY
1646,medgemma,0.718,NUMBER OF LYMPH NODES EXAMINED
1647,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
1648,medgemma,0.904,HISTOLOGIC GRADE
1649,medgemma,0.815,REGIONAL LYMPH NODE STATUS
1650,medgemma,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1651,medgemma,0.89,TUMOR SITE
1652,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1653,medgemma,0.778,VISCERAL PLEURA INVASION
1654,medgemma,0.879,MARGIN STATUS FOR INVASIVE CARCINOMA
1655,medgemma,0.695,NUMBER OF LYMPH NODES EXAMINED
1656,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1657,medgemma,0.776,PROCEDURE
1658,medgemma,0.698,SPECIMEN LATERALITY
1659,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1660,medgemma,0.798,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1661,medgemma,0.811,TUMOR FOCALITY
1662,medgemma,0.808,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1663,medgemma,0.801,PROCEDURE
1664,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1665,medgemma,0.78,REGIONAL LYMPH NODE STATUS
1666,medgemma,0.865,TUMOR SITE
1667,medgemma,0.741,NODAL SITE(S) WITH TUMOR
1668,medgemma,0.712,NUMBER OF LYMPH NODES WITH TUMOR
1669,medgemma,0.892,HISTOLOGIC GRADE
1670,medgemma,0.741,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1671,medgemma,0.78,VISCERAL PLEURA INVASION
1672,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1673,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1674,medgemma,0.766,LYMPHOVASCULAR INVASION
1675,medgemma,0.743,NODAL SITE(S) EXAMINED
1676,medgemma,0.902,ADDITIONAL FINDINGS
1677,medgemma,0.697,SPECIMEN LATERALITY
1678,medgemma,0.701,NUMBER OF LYMPH NODES EXAMINED
1679,medgemma,0.811,TUMOR FOCALITY
1680,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1681,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1682,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1683,medgemma,0.697,SPECIMEN LATERALITY
1684,medgemma,0.722,NODAL SITE(S) EXAMINED
1685,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1686,medgemma,0.89,TUMOR SITE
1687,medgemma,0.736,ADDITIONAL FINDINGS
1688,medgemma,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1689,medgemma,0.732,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1690,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1691,medgemma,0.716,REGIONAL LYMPH NODE STATUS
1692,medgemma,0.892,HISTOLOGIC GRADE
1693,medgemma,0.811,TUMOR FOCALITY
1694,medgemma,0.718,SPREAD THROUGH AIR SPACES (STAS)
1695,medgemma,0.788,PROCEDURE
1696,medgemma,0.78,VISCERAL PLEURA INVASION
1697,medgemma,0.702,NUMBER OF LYMPH NODES EXAMINED
1698,medgemma,0.716,REGIONAL LYMPH NODE STATUS
1699,medgemma,0.837,HISTOLOGIC GRADE
1700,medgemma,0.735,NODAL SITE(S) EXAMINED
1701,medgemma,0.738,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1702,medgemma,0.717,MARGIN STATUS FOR INVASIVE CARCINOMA
1703,medgemma,0.692,TUMOR FOCALITY
1704,medgemma,0.738,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1705,medgemma,0.865,TUMOR SITE
1706,medgemma,0.78,VISCERAL PLEURA INVASION
1707,medgemma,0.761,PROCEDURE
1708,medgemma,0.69,LYMPHOVASCULAR INVASION
1709,medgemma,0.697,SPECIMEN LATERALITY
1710,medgemma,0.696,LYMPH NODE(S) FROM PRIOR PROCEDURES
1711,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1712,medgemma,0.709,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1713,medgemma,0.879,MARGIN STATUS FOR INVASIVE CARCINOMA
1714,medgemma,0.808,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1715,medgemma,0.734,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1716,medgemma,0.692,TUMOR FOCALITY
1717,medgemma,0.737,NODAL SITE(S) EXAMINED
1718,medgemma,0.89,TUMOR SITE
1719,medgemma,0.892,HISTOLOGIC GRADE
1720,medgemma,0.843,ADDITIONAL FINDINGS
1721,medgemma,0.831,PROCEDURE
1722,medgemma,0.815,REGIONAL LYMPH NODE STATUS
1723,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
1724,medgemma,0.697,SPECIMEN LATERALITY
1725,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1726,medgemma,0.778,VISCERAL PLEURA INVASION
1727,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1728,medgemma,0.694,NODAL SITE(S) EXAMINED
1729,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1730,medgemma,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1731,medgemma,0.825,PROCEDURE
1732,medgemma,0.778,VISCERAL PLEURA INVASION
1733,medgemma,0.904,HISTOLOGIC GRADE
1734,medgemma,0.762,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1735,medgemma,0.692,TUMOR FOCALITY
1736,medgemma,0.698,SPECIMEN LATERALITY
1737,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
1738,medgemma,0.716,REGIONAL LYMPH NODE STATUS
1739,medgemma,0.89,TUMOR SITE
1740,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1741,medgemma,0.782,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1742,medgemma,0.904,HISTOLOGIC GRADE
1743,medgemma,0.782,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1744,medgemma,0.711,NUMBER OF LYMPH NODES EXAMINED
1745,medgemma,0.697,SPECIMEN LATERALITY
1746,medgemma,0.861,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1747,medgemma,0.764,PROCEDURE
1748,medgemma,0.817,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1749,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1750,medgemma,0.89,TUMOR SITE
1751,medgemma,0.787,NODAL SITE(S) EXAMINED
1752,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1753,medgemma,0.692,TUMOR FOCALITY
1754,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1755,medgemma,0.778,VISCERAL PLEURA INVASION
1756,medgemma,0.815,REGIONAL LYMPH NODE STATUS
1757,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
1758,medgemma,0.778,VISCERAL PLEURA INVASION
1759,medgemma,0.697,SPECIMEN LATERALITY
1760,medgemma,0.734,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1761,medgemma,0.712,NUMBER OF LYMPH NODES EXAMINED
1762,medgemma,0.89,TUMOR SITE
1763,medgemma,0.815,REGIONAL LYMPH NODE STATUS
1764,medgemma,0.661,PROCEDURE
1765,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1766,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1767,medgemma,0.738,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1768,medgemma,0.811,TUMOR FOCALITY
1769,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1770,medgemma,0.797,HISTOLOGIC GRADE
1771,medgemma,0.73,NODAL SITE(S) EXAMINED
1772,medgemma,0.752,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1773,medgemma,0.683,LYMPH NODE(S) FROM PRIOR PROCEDURES
1774,medgemma,0.781,LYMPHOVASCULAR INVASION
1775,medgemma,0.729,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1776,medgemma,0.681,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1777,medgemma,0.716,REGIONAL LYMPH NODE STATUS
1778,medgemma,0.892,HISTOLOGIC GRADE
1779,medgemma,0.726,NODAL SITE(S) EXAMINED
1780,medgemma,0.778,VISCERAL PLEURA INVASION
1781,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1782,medgemma,0.697,SPECIMEN LATERALITY
1783,medgemma,0.735,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1784,medgemma,0.692,TUMOR FOCALITY
1785,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
1786,medgemma,0.819,PROCEDURE
1787,medgemma,0.7,SPREAD THROUGH AIR SPACES (STAS)
1788,medgemma,0.89,TUMOR SITE
1789,medgemma,0.811,TUMOR FOCALITY
1790,medgemma,0.89,TUMOR SITE
1791,medgemma,0.697,SPECIMEN LATERALITY
1792,medgemma,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1793,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1794,medgemma,0.815,REGIONAL LYMPH NODE STATUS
1795,medgemma,0.742,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1796,medgemma,0.898,PROCEDURE
1797,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1798,medgemma,0.676,SPREAD THROUGH AIR SPACES (STAS)
1799,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1800,medgemma,0.778,VISCERAL PLEURA INVASION
1801,medgemma,0.724,NODAL SITE(S) EXAMINED
1802,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1803,medgemma,0.815,HISTOLOGIC GRADE
1804,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1805,medgemma,0.778,VISCERAL PLEURA INVASION
1806,medgemma,0.811,TUMOR FOCALITY
1807,medgemma,0.904,HISTOLOGIC GRADE
1808,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1809,medgemma,0.827,PROCEDURE
1810,medgemma,0.698,SPECIMEN LATERALITY
1811,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1812,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1813,medgemma,0.7,NUMBER OF LYMPH NODES EXAMINED
1814,medgemma,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1815,medgemma,0.89,TUMOR SITE
1816,medgemma,0.815,REGIONAL LYMPH NODE STATUS
1817,medgemma,0.813,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1818,medgemma,0.689,NODAL SITE(S) EXAMINED
1819,medgemma,0.786,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1820,medgemma,0.697,SPECIMEN LATERALITY
1821,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
1822,medgemma,0.815,REGIONAL LYMPH NODE STATUS
1823,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1824,medgemma,0.693,NUMBER OF LYMPH NODES EXAMINED
1825,medgemma,0.778,VISCERAL PLEURA INVASION
1826,medgemma,0.717,NODAL SITE(S) EXAMINED
1827,medgemma,0.865,TUMOR SITE
1828,medgemma,0.811,TUMOR FOCALITY
1829,medgemma,0.747,PROCEDURE
1830,medgemma,0.754,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1831,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1832,medgemma,0.818,HISTOLOGIC GRADE
1833,medgemma,0.805,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1834,medgemma,0.714,NUMBER OF LYMPH NODES EXAMINED
1835,medgemma,0.7,SPREAD THROUGH AIR SPACES (STAS)
1836,medgemma,0.78,VISCERAL PLEURA INVASION
1837,medgemma,0.731,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1838,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1839,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1840,medgemma,0.721,MARGIN STATUS FOR INVASIVE CARCINOMA
1841,medgemma,0.715,PROCEDURE
1842,medgemma,0.716,REGIONAL LYMPH NODE STATUS
1843,medgemma,0.797,HISTOLOGIC GRADE
1844,medgemma,0.716,ADDITIONAL FINDINGS
1845,medgemma,0.697,SPECIMEN LATERALITY
1846,medgemma,0.732,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1847,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1848,medgemma,0.811,TUMOR FOCALITY
1849,medgemma,0.744,NODAL SITE(S) EXAMINED
1850,medgemma,0.89,TUMOR SITE
1851,medgemma,0.745,LYMPHOVASCULAR INVASION
1852,medgemma,0.811,TUMOR FOCALITY
1853,medgemma,0.742,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1854,medgemma,0.736,NODAL SITE(S) EXAMINED
1855,medgemma,0.7,ADDITIONAL FINDINGS
1856,medgemma,0.796,PROCEDURE
1857,medgemma,0.89,TUMOR SITE
1858,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1859,medgemma,0.716,REGIONAL LYMPH NODE STATUS
1860,medgemma,0.775,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1861,medgemma,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1862,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1863,medgemma,0.697,SPECIMEN LATERALITY
1864,medgemma,0.778,VISCERAL PLEURA INVASION
1865,medgemma,0.729,NUMBER OF LYMPH NODES EXAMINED
1866,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1867,medgemma,0.815,REGIONAL LYMPH NODE STATUS
1868,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1869,medgemma,0.843,PROCEDURE
1870,medgemma,0.811,TUMOR FOCALITY
1871,medgemma,0.712,ADDITIONAL FINDINGS
1872,medgemma,0.904,HISTOLOGIC GRADE
1873,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1874,medgemma,0.698,SPECIMEN LATERALITY
1875,medgemma,0.778,VISCERAL PLEURA INVASION
1876,medgemma,0.89,TUMOR SITE
1877,medgemma,0.775,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1878,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1879,medgemma,0.817,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1880,medgemma,0.8,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1881,medgemma,0.681,NODAL SITE(S) EXAMINED
1882,medgemma,0.698,SPECIMEN LATERALITY
1883,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1884,medgemma,0.832,HISTOLOGIC GRADE
1885,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
1886,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1887,medgemma,0.7,NODAL SITE(S) EXAMINED
1888,medgemma,0.72,NUMBER OF LYMPH NODES WITH TUMOR
1889,medgemma,0.814,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1890,medgemma,0.784,NODAL SITE(S) WITH TUMOR
1891,medgemma,0.751,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1892,medgemma,0.78,REGIONAL LYMPH NODE STATUS
1893,medgemma,0.676,SPREAD THROUGH AIR SPACES (STAS)
1894,medgemma,0.782,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1895,medgemma,0.694,NUMBER OF LYMPH NODES EXAMINED
1896,medgemma,0.682,TUMOR FOCALITY
1897,medgemma,0.678,TUMOR SITE
1898,medgemma,0.778,VISCERAL PLEURA INVASION
1899,medgemma,0.83,PROCEDURE
1900,medgemma,0.693,MARGIN STATUS FOR INVASIVE CARCINOMA
1901,medgemma,0.815,REGIONAL LYMPH NODE STATUS
1902,medgemma,0.698,SPECIMEN LATERALITY
1903,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1904,medgemma,0.793,PROCEDURE
1905,medgemma,0.721,TUMOR SITE
1906,medgemma,0.692,TUMOR FOCALITY
1907,medgemma,0.699,NUMBER OF LYMPH NODES EXAMINED
1908,medgemma,0.711,NODAL SITE(S) EXAMINED
1909,medgemma,0.797,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1910,medgemma,0.778,VISCERAL PLEURA INVASION
1911,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
1912,medgemma,0.892,HISTOLOGIC GRADE
1913,medgemma,0.697,SPECIMEN LATERALITY
1914,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1915,medgemma,0.816,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1916,medgemma,0.815,REGIONAL LYMPH NODE STATUS
1917,medgemma,0.736,NODAL SITE(S) EXAMINED
1918,medgemma,0.78,VISCERAL PLEURA INVASION
1919,medgemma,0.893,TUMOR SITE
1920,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1921,medgemma,0.829,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1922,medgemma,0.718,SPREAD THROUGH AIR SPACES (STAS)
1923,medgemma,0.755,PROCEDURE
1924,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1925,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
1926,medgemma,0.811,TUMOR FOCALITY
1927,medgemma,0.712,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1928,medgemma,0.904,HISTOLOGIC GRADE
1929,medgemma,0.716,REGIONAL LYMPH NODE STATUS
1930,medgemma,0.698,SPECIMEN LATERALITY
1931,medgemma,0.778,PROCEDURE
1932,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
1933,medgemma,0.808,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1934,medgemma,0.727,TUMOR FOCALITY
1935,medgemma,0.76,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1936,medgemma,0.682,NODAL SITE(S) EXAMINED
1937,medgemma,0.87,ADDITIONAL FINDINGS
1938,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1939,medgemma,0.778,VISCERAL PLEURA INVASION
1940,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1941,medgemma,0.89,TUMOR SITE
1942,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
1943,medgemma,0.803,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1944,medgemma,0.89,TUMOR SITE
1945,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1946,medgemma,0.697,SPECIMEN LATERALITY
1947,medgemma,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1948,medgemma,0.676,SPREAD THROUGH AIR SPACES (STAS)
1949,medgemma,0.904,HISTOLOGIC GRADE
1950,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1951,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1952,medgemma,0.778,VISCERAL PLEURA INVASION
1953,medgemma,0.72,NUMBER OF LYMPH NODES EXAMINED
1954,medgemma,0.811,TUMOR FOCALITY
1955,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1956,medgemma,0.777,NODAL SITE(S) EXAMINED
1957,medgemma,0.815,REGIONAL LYMPH NODE STATUS
1958,medgemma,0.827,PROCEDURE
1959,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1960,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
1961,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
1962,medgemma,0.904,HISTOLOGIC GRADE
1963,medgemma,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1964,medgemma,0.695,NUMBER OF LYMPH NODES EXAMINED
1965,medgemma,0.697,SPECIMEN LATERALITY
1966,medgemma,0.718,SPREAD THROUGH AIR SPACES (STAS)
1967,medgemma,0.89,TUMOR SITE
1968,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1969,medgemma,0.815,REGIONAL LYMPH NODE STATUS
1970,medgemma,0.811,TUMOR FOCALITY
1971,medgemma,0.848,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1972,medgemma,0.775,PROCEDURE
1973,medgemma,0.719,NODAL SITE(S) EXAMINED
1974,medgemma,0.778,VISCERAL PLEURA INVASION
1975,medgemma,0.89,TUMOR SITE
1976,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1977,medgemma,0.697,SPECIMEN LATERALITY
1978,medgemma,0.726,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1979,medgemma,0.711,PROCEDURE
1980,medgemma,0.706,NODAL SITE(S) EXAMINED
1981,medgemma,0.757,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1982,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
1983,medgemma,0.811,TUMOR FOCALITY
1984,medgemma,0.716,NUMBER OF LYMPH NODES EXAMINED
1985,medgemma,0.822,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1986,medgemma,0.778,VISCERAL PLEURA INVASION
1987,medgemma,0.683,LYMPH NODE(S) FROM PRIOR PROCEDURES
1988,medgemma,0.814,LYMPHOVASCULAR INVASION
1989,medgemma,0.72,NUMBER OF LYMPH NODES WITH TUMOR
1990,medgemma,0.78,REGIONAL LYMPH NODE STATUS
1991,medgemma,0.829,NODAL SITE(S) WITH TUMOR
1992,medgemma,0.811,TUMOR FOCALITY
1993,medgemma,0.778,VISCERAL PLEURA INVASION
1994,medgemma,0.709,NODAL SITE(S) EXAMINED
1995,medgemma,0.716,LYMPH NODE(S) FROM PRIOR PROCEDURES
1996,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
1997,medgemma,0.818,HISTOLOGIC GRADE
1998,medgemma,0.827,PROCEDURE
1999,medgemma,0.697,SPECIMEN LATERALITY
2000,medgemma,0.89,TUMOR SITE
2001,medgemma,0.815,REGIONAL LYMPH NODE STATUS
2002,medgemma,0.821,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2003,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2004,medgemma,0.695,ADDITIONAL FINDINGS
2005,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
2006,medgemma,0.693,NUMBER OF LYMPH NODES EXAMINED
2007,medgemma,0.82,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2008,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
2009,medgemma,0.681,TUMOR SITE
2010,medgemma,0.692,TUMOR FOCALITY
2011,medgemma,0.706,TNM DESCRIPTORS
2012,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
2013,medgemma,0.713,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2014,medgemma,0.904,HISTOLOGIC GRADE
2015,medgemma,0.698,SPECIMEN LATERALITY
2016,medgemma,0.72,NUMBER OF LYMPH NODES EXAMINED
2017,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2018,medgemma,0.778,VISCERAL PLEURA INVASION
2019,medgemma,0.716,REGIONAL LYMPH NODE STATUS
2020,medgemma,0.695,ADDITIONAL FINDINGS
2021,medgemma,0.681,NODAL SITE(S) EXAMINED
2022,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2023,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
2024,medgemma,0.806,PROCEDURE
2025,medgemma,0.71,PROCEDURE
2026,medgemma,0.811,TUMOR FOCALITY
2027,medgemma,0.721,NODAL SITE(S) EXAMINED
2028,medgemma,0.774,ADDITIONAL FINDINGS
2029,medgemma,0.778,VISCERAL PLEURA INVASION
2030,medgemma,0.697,SPECIMEN LATERALITY
2031,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2032,medgemma,0.7,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2033,medgemma,0.719,TUMOR SITE
2034,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2035,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
2036,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2037,medgemma,0.716,REGIONAL LYMPH NODE STATUS
2038,medgemma,0.901,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2039,medgemma,0.923,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2040,medgemma,0.75,HISTOLOGIC GRADE
2041,medgemma,0.89,TUMOR SITE
2042,medgemma,0.778,VISCERAL PLEURA INVASION
2043,medgemma,0.741,ADDITIONAL FINDINGS
2044,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2045,medgemma,0.904,HISTOLOGIC GRADE
2046,medgemma,0.667,NODAL SITE(S) EXAMINED
2047,medgemma,0.698,SPECIMEN LATERALITY
2048,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2049,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
2050,medgemma,0.768,NUMBER OF LYMPH NODES EXAMINED
2051,medgemma,0.821,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2052,medgemma,0.716,REGIONAL LYMPH NODE STATUS
2053,medgemma,0.801,PROCEDURE
2054,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2055,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2056,medgemma,0.837,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2057,medgemma,0.811,TUMOR FOCALITY
2058,medgemma,0.824,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2059,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2060,medgemma,0.811,TUMOR FOCALITY
2061,medgemma,0.89,TUMOR SITE
2062,medgemma,0.698,SPECIMEN LATERALITY
2063,medgemma,0.687,LYMPHOVASCULAR INVASION
2064,medgemma,0.828,MARGIN STATUS FOR INVASIVE CARCINOMA
2065,medgemma,0.718,NUMBER OF LYMPH NODES EXAMINED
2066,medgemma,0.818,HISTOLOGIC GRADE
2067,medgemma,0.7,NODAL SITE(S) EXAMINED
2068,medgemma,0.778,VISCERAL PLEURA INVASION
2069,medgemma,0.805,PROCEDURE
2070,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
2071,medgemma,0.733,SPREAD THROUGH AIR SPACES (STAS)
2072,medgemma,0.744,TNM DESCRIPTORS
2073,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2074,medgemma,0.732,NODAL SITE(S) EXAMINED
2075,medgemma,0.72,NUMBER OF LYMPH NODES WITH TUMOR
2076,medgemma,0.778,VISCERAL PLEURA INVASION
2077,medgemma,0.716,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2078,medgemma,0.766,TUMOR SITE
2079,medgemma,0.723,HISTOLOGIC GRADE
2080,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2081,medgemma,0.745,REGIONAL LYMPH NODE STATUS
2082,medgemma,0.902,MARGIN STATUS FOR INVASIVE CARCINOMA
2083,medgemma,0.692,SPREAD THROUGH AIR SPACES (STAS)
2084,medgemma,0.712,TUMOR FOCALITY
2085,medgemma,0.647,TNM DESCRIPTORS
2086,medgemma,0.697,SPECIMEN LATERALITY
2087,medgemma,0.772,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2088,medgemma,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2089,medgemma,0.775,NODAL SITE(S) WITH TUMOR
2090,medgemma,0.743,PROCEDURE
2091,medgemma,0.89,TUMOR SITE
2092,medgemma,0.811,TUMOR FOCALITY
2093,medgemma,0.879,MARGIN STATUS FOR INVASIVE CARCINOMA
2094,medgemma,0.778,VISCERAL PLEURA INVASION
2095,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
2096,medgemma,0.838,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2097,medgemma,0.731,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2098,medgemma,0.703,NODAL SITE(S) EXAMINED
2099,medgemma,0.793,PROCEDURE
2100,medgemma,0.815,REGIONAL LYMPH NODE STATUS
2101,medgemma,0.698,SPECIMEN LATERALITY
2102,medgemma,0.815,HISTOLOGIC GRADE
2103,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2104,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2105,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2106,medgemma,0.71,NODAL SITE(S) EXAMINED
2107,medgemma,0.778,VISCERAL PLEURA INVASION
2108,medgemma,0.743,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2109,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
2110,medgemma,0.827,PROCEDURE
2111,medgemma,0.775,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2112,medgemma,0.811,TUMOR FOCALITY
2113,medgemma,0.698,LYMPHOVASCULAR INVASION
2114,medgemma,0.698,SPECIMEN LATERALITY
2115,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2116,medgemma,0.8,NUMBER OF LYMPH NODES EXAMINED
2117,medgemma,0.801,TUMOR SITE
2118,medgemma,0.75,HISTOLOGIC GRADE
2119,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2120,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2121,medgemma,0.815,REGIONAL LYMPH NODE STATUS
2122,medgemma,0.843,ADDITIONAL FINDINGS
2123,medgemma,0.718,TUMOR FOCALITY
2124,medgemma,0.73,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2125,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
2126,medgemma,0.706,NODAL SITE(S) EXAMINED
2127,medgemma,0.757,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2128,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2129,medgemma,0.822,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2130,medgemma,0.679,SPREAD THROUGH AIR SPACES (STAS)
2131,medgemma,0.741,PROCEDURE
2132,medgemma,0.78,VISCERAL PLEURA INVASION
2133,medgemma,0.698,SPECIMEN LATERALITY
2134,medgemma,0.694,NUMBER OF LYMPH NODES EXAMINED
2135,medgemma,0.892,HISTOLOGIC GRADE
2136,medgemma,0.716,REGIONAL LYMPH NODE STATUS
2137,medgemma,0.89,TUMOR SITE
2138,medgemma,0.778,VISCERAL PLEURA INVASION
2139,medgemma,0.801,PROCEDURE
2140,medgemma,0.797,HISTOLOGIC GRADE
2141,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2142,medgemma,0.829,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2143,medgemma,0.865,TUMOR SITE
2144,medgemma,0.785,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2145,medgemma,0.702,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2146,medgemma,0.697,SPECIMEN LATERALITY
2147,medgemma,0.815,REGIONAL LYMPH NODE STATUS
2148,medgemma,0.692,TUMOR FOCALITY
2149,medgemma,0.71,NODAL SITE(S) EXAMINED
2150,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2151,medgemma,0.706,ADDITIONAL FINDINGS
2152,medgemma,0.763,NUMBER OF LYMPH NODES EXAMINED
2153,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2154,medgemma,0.811,TUMOR FOCALITY
2155,medgemma,0.827,PROCEDURE
2156,medgemma,0.893,TUMOR SITE
2157,medgemma,0.797,HISTOLOGIC GRADE
2158,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2159,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2160,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2161,medgemma,0.722,NODAL SITE(S) EXAMINED
2162,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2163,medgemma,0.829,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2164,medgemma,0.815,REGIONAL LYMPH NODE STATUS
2165,medgemma,0.697,SPECIMEN LATERALITY
2166,medgemma,0.758,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2167,medgemma,0.778,VISCERAL PLEURA INVASION
2168,medgemma,0.726,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2169,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
2170,medgemma,0.778,VISCERAL PLEURA INVASION
2171,medgemma,0.76,PROCEDURE
2172,medgemma,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2173,medgemma,0.698,NUMBER OF LYMPH NODES EXAMINED
2174,medgemma,0.811,TUMOR FOCALITY
2175,medgemma,0.865,TUMOR SITE
2176,medgemma,0.817,ADDITIONAL FINDINGS
2177,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2178,medgemma,0.698,SPECIMEN LATERALITY
2179,medgemma,0.716,REGIONAL LYMPH NODE STATUS
2180,medgemma,0.785,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2181,medgemma,0.71,NODAL SITE(S) EXAMINED
2182,medgemma,0.818,HISTOLOGIC GRADE
2183,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2184,medgemma,0.725,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2185,medgemma,0.698,LYMPHOVASCULAR INVASION
2186,medgemma,0.698,SPECIMEN LATERALITY
2187,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2188,medgemma,0.902,ADDITIONAL FINDINGS
2189,medgemma,0.827,PROCEDURE
2190,medgemma,0.692,LYMPH NODE(S) FROM PRIOR PROCEDURES
2191,medgemma,0.774,NODAL SITE(S) EXAMINED
2192,medgemma,0.679,TNM DESCRIPTORS
2193,medgemma,0.78,VISCERAL PLEURA INVASION
2194,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2195,medgemma,0.767,NODAL SITE(S) WITH TUMOR
2196,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
2197,medgemma,0.647,TUMOR FOCALITY
2198,medgemma,0.865,TUMOR SITE
2199,medgemma,0.78,REGIONAL LYMPH NODE STATUS
2200,medgemma,0.742,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2201,medgemma,0.853,ADDITIONAL FINDINGS
2202,medgemma,0.739,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2203,medgemma,0.711,NODAL SITE(S) EXAMINED
2204,medgemma,0.778,VISCERAL PLEURA INVASION
2205,medgemma,0.735,PROCEDURE
2206,medgemma,0.815,REGIONAL LYMPH NODE STATUS
2207,medgemma,0.644,TNM DESCRIPTORS
2208,medgemma,0.748,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2209,medgemma,0.904,HISTOLOGIC GRADE
2210,medgemma,0.888,MARGIN STATUS FOR NON-INVASIVE TUMOR
2211,medgemma,0.766,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2212,medgemma,0.811,TUMOR FOCALITY
2213,medgemma,0.697,SPECIMEN LATERALITY
2214,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2215,medgemma,0.89,TUMOR SITE
2216,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2217,medgemma,0.89,TUMOR SITE
2218,medgemma,0.742,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2219,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2220,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2221,medgemma,0.827,PROCEDURE
2222,medgemma,0.815,REGIONAL LYMPH NODE STATUS
2223,medgemma,0.738,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2224,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2225,medgemma,0.797,HISTOLOGIC GRADE
2226,medgemma,0.778,VISCERAL PLEURA INVASION
2227,medgemma,0.811,TUMOR FOCALITY
2228,medgemma,0.766,NODAL SITE(S) EXAMINED
2229,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2230,medgemma,0.714,NUMBER OF LYMPH NODES EXAMINED
2231,medgemma,0.697,SPECIMEN LATERALITY
2232,medgemma,0.716,REGIONAL LYMPH NODE STATUS
2233,medgemma,0.719,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2234,medgemma,0.892,HISTOLOGIC GRADE
2235,medgemma,0.791,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2236,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2237,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2238,medgemma,0.692,TUMOR FOCALITY
2239,medgemma,0.838,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2240,medgemma,0.759,PROCEDURE
2241,medgemma,0.708,NUMBER OF LYMPH NODES EXAMINED
2242,medgemma,0.697,SPECIMEN LATERALITY
2243,medgemma,0.89,TUMOR SITE
2244,medgemma,0.731,NODAL SITE(S) EXAMINED
2245,medgemma,0.888,MARGIN STATUS FOR INVASIVE CARCINOMA
2246,medgemma,0.778,VISCERAL PLEURA INVASION
2247,medgemma,0.703,LYMPHOVASCULAR INVASION
2248,medgemma,0.803,PROCEDURE
2249,medgemma,0.698,NUMBER OF LYMPH NODES WITH TUMOR
2250,medgemma,0.716,LYMPH NODE(S) FROM PRIOR PROCEDURES
2251,medgemma,0.677,TUMOR SITE
2252,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2253,medgemma,0.778,HISTOLOGIC GRADE
2254,medgemma,0.742,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2255,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2256,medgemma,0.78,REGIONAL LYMPH NODE STATUS
2257,medgemma,0.72,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2258,medgemma,0.696,NODAL SITE(S) EXAMINED
2259,medgemma,0.702,SPECIMEN LATERALITY
2260,medgemma,0.708,TUMOR FOCALITY
2261,medgemma,0.9,ADDITIONAL FINDINGS
2262,medgemma,0.666,SPREAD THROUGH AIR SPACES (STAS)
2263,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2264,medgemma,0.763,NUMBER OF LYMPH NODES EXAMINED
2265,medgemma,0.778,VISCERAL PLEURA INVASION
2266,medgemma,0.747,TNM DESCRIPTORS
2267,medgemma,0.715,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2268,medgemma,0.791,TUMOR SITE
2269,medgemma,0.906,MARGIN STATUS FOR INVASIVE CARCINOMA
2270,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2271,medgemma,0.688,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2272,medgemma,0.681,ADDITIONAL FINDINGS
2273,medgemma,0.699,NODAL SITE(S) EXAMINED
2274,medgemma,0.756,PROCEDURE
2275,medgemma,0.663,HISTOLOGIC GRADE
2276,medgemma,0.67,SPREAD THROUGH AIR SPACES (STAS)
2277,medgemma,0.779,TUMOR SITE
2278,medgemma,0.712,TUMOR FOCALITY
2279,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2280,medgemma,0.743,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2281,medgemma,0.69,SPECIMEN LATERALITY
2282,medgemma,0.701,VISCERAL PLEURA INVASION
2283,medgemma,0.815,REGIONAL LYMPH NODE STATUS
2284,medgemma,0.725,MARGIN STATUS FOR INVASIVE CARCINOMA
2285,medgemma,0.698,SPECIMEN LATERALITY
2286,medgemma,0.76,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2287,medgemma,0.7,VISCERAL PLEURA INVASION
2288,medgemma,0.706,HISTOLOGIC GRADE
2289,medgemma,0.791,TUMOR SITE
2290,medgemma,0.649,NODAL SITE(S) EXAMINED
2291,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
2292,medgemma,0.7,SPREAD THROUGH AIR SPACES (STAS)
2293,medgemma,0.815,REGIONAL LYMPH NODE STATUS
2294,medgemma,0.683,LYMPH NODE(S) FROM PRIOR PROCEDURES
2295,medgemma,0.711,PROCEDURE
2296,medgemma,0.712,TUMOR FOCALITY
2297,medgemma,0.722,NODAL SITE(S) WITH TUMOR
2298,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2299,medgemma,0.829,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2300,medgemma,0.776,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2301,medgemma,0.766,LYMPHOVASCULAR INVASION
2302,medgemma,0.698,SPECIMEN LATERALITY
2303,medgemma,0.714,TUMOR SITE
2304,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2305,medgemma,0.778,VISCERAL PLEURA INVASION
2306,medgemma,0.811,TUMOR FOCALITY
2307,medgemma,0.757,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2308,medgemma,0.713,NUMBER OF LYMPH NODES EXAMINED
2309,medgemma,0.78,REGIONAL LYMPH NODE STATUS
2310,medgemma,0.892,HISTOLOGIC GRADE
2311,medgemma,0.705,NODAL SITE(S) EXAMINED
2312,medgemma,0.906,MARGIN STATUS FOR INVASIVE CARCINOMA
2313,medgemma,0.713,NUMBER OF LYMPH NODES WITH TUMOR
2314,medgemma,0.767,PROCEDURE
2315,medgemma,0.778,VISCERAL PLEURA INVASION
2316,medgemma,0.815,REGIONAL LYMPH NODE STATUS
2317,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2318,medgemma,0.764,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2319,medgemma,0.727,NODAL SITE(S) EXAMINED
2320,medgemma,0.691,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2321,medgemma,0.626,TUMOR SITE
2322,medgemma,0.827,PROCEDURE
2323,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
2324,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2325,medgemma,0.685,ADDITIONAL FINDINGS
2326,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2327,medgemma,0.676,SPREAD THROUGH AIR SPACES (STAS)
2328,medgemma,0.679,HISTOLOGIC GRADE
2329,medgemma,0.697,SPECIMEN LATERALITY
2330,medgemma,0.712,NUMBER OF LYMPH NODES EXAMINED
2331,medgemma,0.75,TUMOR FOCALITY
2332,medgemma,0.682,NODAL SITE(S) EXAMINED
2333,medgemma,0.744,TNM DESCRIPTORS
2334,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2335,medgemma,0.786,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2336,medgemma,0.737,TUMOR SITE
2337,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
2338,medgemma,0.712,NUMBER OF LYMPH NODES EXAMINED
2339,medgemma,0.792,PROCEDURE
2340,medgemma,0.698,SPECIMEN LATERALITY
2341,medgemma,0.743,HISTOLOGIC GRADE
2342,medgemma,0.815,REGIONAL LYMPH NODE STATUS
2343,medgemma,0.804,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2344,medgemma,0.842,ADDITIONAL FINDINGS
2345,medgemma,0.778,VISCERAL PLEURA INVASION
2346,medgemma,0.712,TUMOR FOCALITY
2347,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2348,medgemma,0.71,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2349,medgemma,0.7,SPREAD THROUGH AIR SPACES (STAS)
2350,medgemma,0.7,NODAL SITE(S) WITH TUMOR
2351,medgemma,0.78,REGIONAL LYMPH NODE STATUS
2352,medgemma,0.704,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2353,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2354,medgemma,0.865,TUMOR SITE
2355,medgemma,0.831,PROCEDURE
2356,medgemma,0.697,SPECIMEN LATERALITY
2357,medgemma,0.778,VISCERAL PLEURA INVASION
2358,medgemma,0.787,NUMBER OF LYMPH NODES EXAMINED
2359,medgemma,0.741,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2360,medgemma,0.698,LYMPHOVASCULAR INVASION
2361,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
2362,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2363,medgemma,0.721,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2364,medgemma,0.724,NODAL SITE(S) EXAMINED
2365,medgemma,0.918,TUMOR FOCALITY
2366,medgemma,0.683,LYMPH NODE(S) FROM PRIOR PROCEDURES
2367,medgemma,0.892,HISTOLOGIC GRADE
2368,medgemma,0.717,PROCEDURE
2369,medgemma,0.78,VISCERAL PLEURA INVASION
2370,medgemma,0.697,SPECIMEN LATERALITY
2371,medgemma,0.774,MARGIN STATUS FOR INVASIVE CARCINOMA
2372,medgemma,0.89,TUMOR SITE
2373,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2374,medgemma,0.703,NODAL SITE(S) EXAMINED
2375,medgemma,0.798,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2376,medgemma,0.703,TUMOR FOCALITY
2377,medgemma,0.716,REGIONAL LYMPH NODE STATUS
2378,medgemma,0.681,LYMPHOVASCULAR INVASION
2379,medgemma,0.713,NUMBER OF LYMPH NODES EXAMINED
2380,medgemma,0.699,ADDITIONAL FINDINGS
2381,medgemma,0.904,HISTOLOGIC GRADE
2382,medgemma,0.815,REGIONAL LYMPH NODE STATUS
2383,medgemma,0.89,TUMOR SITE
2384,medgemma,0.801,MARGIN STATUS FOR INVASIVE CARCINOMA
2385,medgemma,0.713,NUMBER OF LYMPH NODES EXAMINED
2386,medgemma,0.707,NODAL SITE(S) EXAMINED
2387,medgemma,0.699,TUMOR FOCALITY
2388,medgemma,0.692,LYMPH NODE(S) FROM PRIOR PROCEDURES
2389,medgemma,0.778,VISCERAL PLEURA INVASION
2390,medgemma,0.801,PROCEDURE
2391,medgemma,0.738,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2392,medgemma,0.697,SPECIMEN LATERALITY
2393,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
2394,medgemma,0.904,HISTOLOGIC GRADE
2395,medgemma,0.828,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2396,medgemma,0.721,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2397,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2398,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
2399,medgemma,0.865,TUMOR SITE
2400,medgemma,0.778,VISCERAL PLEURA INVASION
2401,medgemma,0.704,NUMBER OF LYMPH NODES EXAMINED
2402,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2403,medgemma,0.692,TUMOR FOCALITY
2404,medgemma,0.821,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2405,medgemma,0.698,SPECIMEN LATERALITY
2406,medgemma,0.684,NODAL SITE(S) EXAMINED
2407,medgemma,0.804,PROCEDURE
2408,medgemma,0.815,REGIONAL LYMPH NODE STATUS
2409,medgemma,0.732,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2410,medgemma,0.798,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2411,medgemma,0.797,HISTOLOGIC GRADE
2412,medgemma,0.815,REGIONAL LYMPH NODE STATUS
2413,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2414,medgemma,0.811,TUMOR FOCALITY
2415,medgemma,0.697,SPECIMEN LATERALITY
2416,medgemma,0.716,ADDITIONAL FINDINGS
2417,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2418,medgemma,0.719,NODAL SITE(S) EXAMINED
2419,medgemma,0.778,VISCERAL PLEURA INVASION
2420,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2421,medgemma,0.712,NUMBER OF LYMPH NODES EXAMINED
2422,medgemma,0.827,PROCEDURE
2423,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
2424,medgemma,0.89,TUMOR SITE
2425,medgemma,0.697,SPECIMEN LATERALITY
2426,medgemma,0.712,TUMOR FOCALITY
2427,medgemma,0.722,REGIONAL LYMPH NODE STATUS
2428,medgemma,0.778,VISCERAL PLEURA INVASION
2429,medgemma,0.705,NUMBER OF LYMPH NODES WITH TUMOR
2430,medgemma,0.816,PROCEDURE
2431,medgemma,0.708,NODAL SITE(S) WITH TUMOR
2432,medgemma,0.696,TNM DESCRIPTORS
2433,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2434,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
2435,medgemma,0.705,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2436,medgemma,0.89,TUMOR SITE
2437,medgemma,0.706,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2438,medgemma,0.702,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2439,medgemma,0.713,NODAL SITE(S) EXAMINED
2440,medgemma,0.717,MARGIN STATUS FOR NON-INVASIVE TUMOR
2441,medgemma,0.827,PROCEDURE
2442,medgemma,0.698,SPECIMEN LATERALITY
2443,medgemma,0.698,MARGIN STATUS FOR INVASIVE CARCINOMA
2444,medgemma,0.738,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2445,medgemma,0.692,TUMOR FOCALITY
2446,medgemma,0.73,HISTOLOGIC GRADE
2447,medgemma,0.738,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2448,medgemma,0.7,VISCERAL PLEURA INVASION
2449,medgemma,0.689,TUMOR SITE
2450,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2451,medgemma,0.709,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2452,medgemma,0.73,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2453,medgemma,0.68,NODAL SITE(S) EXAMINED
2454,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2455,medgemma,0.698,SPECIMEN LATERALITY
2456,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2457,medgemma,0.706,ADDITIONAL FINDINGS
2458,medgemma,0.705,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2459,medgemma,0.801,PROCEDURE
2460,medgemma,0.835,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2461,medgemma,0.75,HISTOLOGIC GRADE
2462,medgemma,0.716,REGIONAL LYMPH NODE STATUS
2463,medgemma,0.811,TUMOR FOCALITY
2464,medgemma,0.778,VISCERAL PLEURA INVASION
2465,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2466,medgemma,0.89,TUMOR SITE
2467,medgemma,0.72,NUMBER OF LYMPH NODES EXAMINED
2468,medgemma,0.826,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2469,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2470,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
2471,medgemma,0.697,SPECIMEN LATERALITY
2472,medgemma,0.938,ADDITIONAL FINDINGS
2473,medgemma,0.865,TUMOR SITE
2474,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2475,medgemma,0.815,HISTOLOGIC GRADE
2476,medgemma,0.811,TUMOR FOCALITY
2477,medgemma,0.827,PROCEDURE
2478,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2479,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2480,medgemma,0.778,VISCERAL PLEURA INVASION
2481,medgemma,0.903,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2482,medgemma,0.89,TUMOR SITE
2483,medgemma,0.702,NODAL SITE(S) WITH TUMOR
2484,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2485,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
2486,medgemma,0.811,TUMOR FOCALITY
2487,medgemma,0.892,HISTOLOGIC GRADE
2488,medgemma,0.78,VISCERAL PLEURA INVASION
2489,medgemma,0.716,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2490,medgemma,0.769,PROCEDURE
2491,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2492,medgemma,0.78,REGIONAL LYMPH NODE STATUS
2493,medgemma,0.676,SPREAD THROUGH AIR SPACES (STAS)
2494,medgemma,0.694,NODAL SITE(S) EXAMINED
2495,medgemma,0.697,SPECIMEN LATERALITY
2496,medgemma,0.817,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2497,medgemma,0.759,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2498,medgemma,0.71,NODAL SITE(S) EXAMINED
2499,medgemma,0.73,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2500,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2501,medgemma,0.778,VISCERAL PLEURA INVASION
2502,medgemma,0.815,REGIONAL LYMPH NODE STATUS
2503,medgemma,0.811,TUMOR FOCALITY
2504,medgemma,0.865,TUMOR SITE
2505,medgemma,0.904,HISTOLOGIC GRADE
2506,medgemma,0.826,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2507,medgemma,0.733,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2508,medgemma,0.67,SPREAD THROUGH AIR SPACES (STAS)
2509,medgemma,0.704,ADDITIONAL FINDINGS
2510,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2511,medgemma,0.777,PROCEDURE
2512,medgemma,0.896,MARGIN STATUS FOR INVASIVE CARCINOMA
2513,medgemma,0.697,SPECIMEN LATERALITY
2514,medgemma,0.811,TUMOR FOCALITY
2515,medgemma,0.817,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2516,medgemma,0.778,HISTOLOGIC GRADE
2517,medgemma,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2518,medgemma,0.697,NODAL SITE(S) EXAMINED
2519,medgemma,0.697,SPECIMEN LATERALITY
2520,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
2521,medgemma,0.865,TUMOR SITE
2522,medgemma,0.815,REGIONAL LYMPH NODE STATUS
2523,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
2524,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2525,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2526,medgemma,0.793,PROCEDURE
2527,medgemma,0.778,VISCERAL PLEURA INVASION
2528,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2529,medgemma,0.687,NUMBER OF LYMPH NODES EXAMINED
2530,medgemma,0.809,ADDITIONAL FINDINGS
2531,medgemma,0.904,HISTOLOGIC GRADE
2532,medgemma,0.784,NODAL SITE(S) EXAMINED
2533,medgemma,0.819,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2534,medgemma,0.778,VISCERAL PLEURA INVASION
2535,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
2536,medgemma,0.827,PROCEDURE
2537,medgemma,0.815,REGIONAL LYMPH NODE STATUS
2538,medgemma,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2539,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2540,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2541,medgemma,0.692,TUMOR FOCALITY
2542,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2543,medgemma,0.888,TUMOR SITE
2544,medgemma,0.72,NUMBER OF LYMPH NODES EXAMINED
2545,medgemma,0.698,SPECIMEN LATERALITY
2546,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2547,medgemma,0.757,NODAL SITE(S) EXAMINED
2548,medgemma,0.716,REGIONAL LYMPH NODE STATUS
2549,medgemma,0.778,HISTOLOGIC GRADE
2550,medgemma,0.712,TUMOR FOCALITY
2551,medgemma,0.731,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2552,medgemma,0.698,SPECIMEN LATERALITY
2553,medgemma,0.788,PROCEDURE
2554,medgemma,0.676,SPREAD THROUGH AIR SPACES (STAS)
2555,medgemma,0.695,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2556,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2557,medgemma,0.717,MARGIN STATUS FOR NON-INVASIVE TUMOR
2558,medgemma,0.713,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2559,medgemma,0.89,TUMOR SITE
2560,medgemma,0.683,LYMPH NODE(S) FROM PRIOR PROCEDURES
2561,medgemma,0.778,VISCERAL PLEURA INVASION
2562,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2563,medgemma,0.816,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2564,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2565,medgemma,0.698,SPECIMEN LATERALITY
2566,medgemma,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2567,medgemma,0.89,TUMOR SITE
2568,medgemma,0.7,SPREAD THROUGH AIR SPACES (STAS)
2569,medgemma,0.827,PROCEDURE
2570,medgemma,0.692,TUMOR FOCALITY
2571,medgemma,0.696,LYMPH NODE(S) FROM PRIOR PROCEDURES
2572,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2573,medgemma,0.778,VISCERAL PLEURA INVASION
2574,medgemma,0.904,HISTOLOGIC GRADE
2575,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2576,medgemma,0.798,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2577,medgemma,0.827,PROCEDURE
2578,medgemma,0.713,NUMBER OF LYMPH NODES EXAMINED
2579,medgemma,0.698,SPECIMEN LATERALITY
2580,medgemma,0.831,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2581,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2582,medgemma,0.778,VISCERAL PLEURA INVASION
2583,medgemma,0.815,REGIONAL LYMPH NODE STATUS
2584,medgemma,0.692,TUMOR FOCALITY
2585,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2586,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2587,medgemma,0.89,TUMOR SITE
2588,medgemma,0.699,NODAL SITE(S) EXAMINED
2589,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
2590,medgemma,0.709,NODAL SITE(S) EXAMINED
2591,medgemma,0.75,HISTOLOGIC GRADE
2592,medgemma,0.811,TUMOR FOCALITY
2593,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2594,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2595,medgemma,0.696,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2596,medgemma,0.778,VISCERAL PLEURA INVASION
2597,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2598,medgemma,0.827,PROCEDURE
2599,medgemma,0.697,SPECIMEN LATERALITY
2600,medgemma,0.815,REGIONAL LYMPH NODE STATUS
2601,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2602,medgemma,0.803,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2603,medgemma,0.699,NUMBER OF LYMPH NODES EXAMINED
2604,medgemma,0.893,TUMOR SITE
2605,medgemma,0.697,SPECIMEN LATERALITY
2606,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2607,medgemma,0.865,TUMOR SITE
2608,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2609,medgemma,0.797,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2610,medgemma,0.827,PROCEDURE
2611,medgemma,0.692,TUMOR FOCALITY
2612,medgemma,0.694,NODAL SITE(S) EXAMINED
2613,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2614,medgemma,0.818,HISTOLOGIC GRADE
2615,medgemma,0.815,REGIONAL LYMPH NODE STATUS
2616,medgemma,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2617,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
2618,medgemma,0.778,VISCERAL PLEURA INVASION
2619,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
2620,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2621,medgemma,0.7,NUMBER OF LYMPH NODES WITH TUMOR
2622,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2623,medgemma,0.725,PROCEDURE
2624,medgemma,0.766,TUMOR SITE
2625,medgemma,0.811,TUMOR FOCALITY
2626,medgemma,0.657,TNM DESCRIPTORS
2627,medgemma,0.697,SPECIMEN LATERALITY
2628,medgemma,0.682,LYMPHOVASCULAR INVASION
2629,medgemma,0.71,NODAL SITE(S) EXAMINED
2630,medgemma,0.892,HISTOLOGIC GRADE
2631,medgemma,0.705,NODAL SITE(S) WITH TUMOR
2632,medgemma,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2633,medgemma,0.816,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2634,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2635,medgemma,0.778,VISCERAL PLEURA INVASION
2636,medgemma,0.78,REGIONAL LYMPH NODE STATUS
2637,medgemma,0.709,NODAL SITE(S) EXAMINED
2638,medgemma,0.76,PROCEDURE
2639,medgemma,0.778,VISCERAL PLEURA INVASION
2640,medgemma,0.755,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2641,medgemma,0.698,SPECIMEN LATERALITY
2642,medgemma,0.729,ADDITIONAL FINDINGS
2643,medgemma,0.808,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2644,medgemma,0.703,SPREAD THROUGH AIR SPACES (STAS)
2645,medgemma,0.693,NUMBER OF LYMPH NODES EXAMINED
2646,medgemma,0.865,TUMOR SITE
2647,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2648,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2649,medgemma,0.811,TUMOR FOCALITY
2650,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2651,medgemma,0.815,REGIONAL LYMPH NODE STATUS
2652,medgemma,0.904,HISTOLOGIC GRADE
2653,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2654,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2655,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2656,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
2657,medgemma,0.731,NODAL SITE(S) EXAMINED
2658,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2659,medgemma,0.788,PROCEDURE
2660,medgemma,0.818,HISTOLOGIC GRADE
2661,medgemma,0.811,TUMOR FOCALITY
2662,medgemma,0.815,REGIONAL LYMPH NODE STATUS
2663,medgemma,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2664,medgemma,0.778,VISCERAL PLEURA INVASION
2665,medgemma,0.698,NUMBER OF LYMPH NODES EXAMINED
2666,medgemma,0.811,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2667,medgemma,0.802,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2668,medgemma,0.89,TUMOR SITE
2669,medgemma,0.697,SPECIMEN LATERALITY
2670,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2671,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2672,medgemma,0.716,ADDITIONAL FINDINGS
2673,medgemma,0.756,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2674,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2675,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
2676,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
2677,medgemma,0.89,TUMOR SITE
2678,medgemma,0.721,NODAL SITE(S) EXAMINED
2679,medgemma,0.892,HISTOLOGIC GRADE
2680,medgemma,0.714,LYMPHOVASCULAR INVASION
2681,medgemma,0.698,SPECIMEN LATERALITY
2682,medgemma,0.713,NUMBER OF LYMPH NODES EXAMINED
2683,medgemma,0.778,VISCERAL PLEURA INVASION
2684,medgemma,0.793,PROCEDURE
2685,medgemma,0.815,REGIONAL LYMPH NODE STATUS
2686,medgemma,0.821,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2687,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2688,medgemma,0.811,TUMOR FOCALITY
2689,medgemma,0.778,VISCERAL PLEURA INVASION
2690,medgemma,0.713,NUMBER OF LYMPH NODES WITH TUMOR
2691,medgemma,0.788,HISTOLOGIC GRADE
2692,medgemma,0.683,LYMPH NODE(S) FROM PRIOR PROCEDURES
2693,medgemma,0.676,SPREAD THROUGH AIR SPACES (STAS)
2694,medgemma,0.742,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2695,medgemma,0.811,TUMOR FOCALITY
2696,medgemma,0.876,TUMOR SITE
2697,medgemma,0.699,MARGIN STATUS FOR INVASIVE CARCINOMA
2698,medgemma,0.703,NUMBER OF LYMPH NODES EXAMINED
2699,medgemma,0.697,SPECIMEN LATERALITY
2700,medgemma,0.78,REGIONAL LYMPH NODE STATUS
2701,medgemma,0.737,NODAL SITE(S) EXAMINED
2702,medgemma,0.788,PROCEDURE
2703,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2704,medgemma,0.676,SPREAD THROUGH AIR SPACES (STAS)
2705,medgemma,0.75,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2706,medgemma,0.698,NODAL SITE(S) EXAMINED
2707,medgemma,0.774,MARGIN STATUS FOR INVASIVE CARCINOMA
2708,medgemma,0.778,VISCERAL PLEURA INVASION
2709,medgemma,0.753,ADDITIONAL FINDINGS
2710,medgemma,0.798,PROCEDURE
2711,medgemma,0.698,LYMPHOVASCULAR INVASION
2712,medgemma,0.78,REGIONAL LYMPH NODE STATUS
2713,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2714,medgemma,0.7,NUMBER OF LYMPH NODES WITH TUMOR
2715,medgemma,0.697,SPECIMEN LATERALITY
2716,medgemma,0.673,TUMOR SITE
2717,medgemma,0.691,NUMBER OF LYMPH NODES EXAMINED
2718,medgemma,0.68,NODAL SITE(S) WITH TUMOR
2719,medgemma,0.811,TUMOR FOCALITY
2720,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2721,medgemma,0.89,TUMOR SITE
2722,medgemma,0.698,LYMPHOVASCULAR INVASION
2723,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2724,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2725,medgemma,0.756,NODAL SITE(S) EXAMINED
2726,medgemma,0.697,SPECIMEN LATERALITY
2727,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2728,medgemma,0.778,VISCERAL PLEURA INVASION
2729,medgemma,0.858,ADDITIONAL FINDINGS
2730,medgemma,0.801,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2731,medgemma,0.827,PROCEDURE
2732,medgemma,0.708,TUMOR FOCALITY
2733,medgemma,0.797,HISTOLOGIC GRADE
2734,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2735,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
2736,medgemma,0.735,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2737,medgemma,0.716,REGIONAL LYMPH NODE STATUS
2738,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2739,medgemma,0.745,LYMPHOVASCULAR INVASION
2740,medgemma,0.676,SPREAD THROUGH AIR SPACES (STAS)
2741,medgemma,0.712,TUMOR FOCALITY
2742,medgemma,0.788,PROCEDURE
2743,medgemma,0.771,NODAL SITE(S) WITH TUMOR
2744,medgemma,0.78,VISCERAL PLEURA INVASION
2745,medgemma,0.707,NUMBER OF LYMPH NODES WITH TUMOR
2746,medgemma,0.78,REGIONAL LYMPH NODE STATUS
2747,medgemma,0.698,NUMBER OF LYMPH NODES EXAMINED
2748,medgemma,0.705,MARGIN STATUS FOR NON-INVASIVE TUMOR
2749,medgemma,0.738,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2750,medgemma,0.697,SPECIMEN LATERALITY
2751,medgemma,0.69,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2752,medgemma,0.892,HISTOLOGIC GRADE
2753,medgemma,0.692,NODAL SITE(S) EXAMINED
2754,medgemma,0.824,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2755,medgemma,0.89,TUMOR SITE
2756,medgemma,0.77,LYMPH NODE(S) FROM PRIOR PROCEDURES
2757,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2758,medgemma,0.815,REGIONAL LYMPH NODE STATUS
2759,medgemma,0.811,TUMOR FOCALITY
2760,medgemma,0.8,LYMPHOVASCULAR INVASION
2761,medgemma,0.849,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2762,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2763,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2764,medgemma,0.89,TUMOR SITE
2765,medgemma,0.666,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2766,medgemma,0.678,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2767,medgemma,0.778,VISCERAL PLEURA INVASION
2768,medgemma,0.78,PROCEDURE
2769,medgemma,0.727,NODAL SITE(S) EXAMINED
2770,medgemma,0.697,SPECIMEN LATERALITY
2771,medgemma,0.797,HISTOLOGIC GRADE
2772,medgemma,0.78,REGIONAL LYMPH NODE STATUS
2773,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2774,medgemma,0.89,TUMOR SITE
2775,medgemma,0.711,NUMBER OF LYMPH NODES EXAMINED
2776,medgemma,0.708,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2777,medgemma,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2778,medgemma,0.742,PROCEDURE
2779,medgemma,0.78,VISCERAL PLEURA INVASION
2780,medgemma,0.811,TUMOR FOCALITY
2781,medgemma,0.75,SPREAD THROUGH AIR SPACES (STAS)
2782,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2783,medgemma,0.715,NODAL SITE(S) EXAMINED
2784,medgemma,0.713,NUMBER OF LYMPH NODES WITH TUMOR
2785,medgemma,0.697,SPECIMEN LATERALITY
2786,medgemma,0.738,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2787,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2788,medgemma,0.711,NODAL SITE(S) WITH TUMOR
2789,medgemma,0.709,NODAL SITE(S) EXAMINED
2790,medgemma,0.778,VISCERAL PLEURA INVASION
2791,medgemma,0.698,SPECIMEN LATERALITY
2792,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2793,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2794,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2795,medgemma,0.89,TUMOR SITE
2796,medgemma,0.811,TUMOR FOCALITY
2797,medgemma,0.68,ADDITIONAL FINDINGS
2798,medgemma,0.711,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2799,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2800,medgemma,0.716,REGIONAL LYMPH NODE STATUS
2801,medgemma,0.756,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2802,medgemma,0.818,HISTOLOGIC GRADE
2803,medgemma,0.75,PROCEDURE
2804,medgemma,0.693,NUMBER OF LYMPH NODES EXAMINED
2805,medgemma,0.716,REGIONAL LYMPH NODE STATUS
2806,medgemma,0.89,TUMOR SITE
2807,medgemma,0.815,HISTOLOGIC GRADE
2808,medgemma,0.804,PROCEDURE
2809,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2810,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2811,medgemma,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2812,medgemma,0.677,ADDITIONAL FINDINGS
2813,medgemma,0.747,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2814,medgemma,0.698,SPECIMEN LATERALITY
2815,medgemma,0.7,SPREAD THROUGH AIR SPACES (STAS)
2816,medgemma,0.78,VISCERAL PLEURA INVASION
2817,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2818,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2819,medgemma,0.811,TUMOR FOCALITY
2820,medgemma,0.702,NODAL SITE(S) EXAMINED
2821,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2822,medgemma,0.89,TUMOR SITE
2823,medgemma,0.797,HISTOLOGIC GRADE
2824,medgemma,0.775,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2825,medgemma,0.778,VISCERAL PLEURA INVASION
2826,medgemma,0.811,TUMOR FOCALITY
2827,medgemma,0.774,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2828,medgemma,0.695,NUMBER OF LYMPH NODES EXAMINED
2829,medgemma,0.698,SPECIMEN LATERALITY
2830,medgemma,0.792,PROCEDURE
2831,medgemma,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2832,medgemma,0.814,ADDITIONAL FINDINGS
2833,medgemma,0.69,NODAL SITE(S) EXAMINED
2834,medgemma,0.815,REGIONAL LYMPH NODE STATUS
2835,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
2836,medgemma,0.73,LYMPHOVASCULAR INVASION
2837,medgemma,0.778,VISCERAL PLEURA INVASION
2838,medgemma,0.725,PROCEDURE
2839,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2840,medgemma,0.811,TUMOR FOCALITY
2841,medgemma,0.698,SPECIMEN LATERALITY
2842,medgemma,0.794,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2843,medgemma,0.716,REGIONAL LYMPH NODE STATUS
2844,medgemma,0.89,TUMOR SITE
2845,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2846,medgemma,0.711,NUMBER OF LYMPH NODES EXAMINED
2847,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2848,medgemma,0.701,NODAL SITE(S) EXAMINED
2849,medgemma,0.778,HISTOLOGIC GRADE
2850,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
2851,medgemma,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2852,medgemma,0.736,ADDITIONAL FINDINGS
2853,medgemma,0.697,SPECIMEN LATERALITY
2854,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2855,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2856,medgemma,0.809,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2857,medgemma,0.815,REGIONAL LYMPH NODE STATUS
2858,medgemma,0.778,VISCERAL PLEURA INVASION
2859,medgemma,0.818,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2860,medgemma,0.746,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2861,medgemma,0.692,LYMPHOVASCULAR INVASION
2862,medgemma,0.758,PROCEDURE
2863,medgemma,0.715,NODAL SITE(S) EXAMINED
2864,medgemma,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2865,medgemma,0.892,HISTOLOGIC GRADE
2866,medgemma,0.692,TUMOR FOCALITY
2867,medgemma,0.884,TUMOR SITE
2868,medgemma,0.743,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2869,medgemma,0.802,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2870,medgemma,0.89,TUMOR SITE
2871,medgemma,0.815,REGIONAL LYMPH NODE STATUS
2872,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
2873,medgemma,0.778,VISCERAL PLEURA INVASION
2874,medgemma,0.797,HISTOLOGIC GRADE
2875,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2876,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2877,medgemma,0.697,SPECIMEN LATERALITY
2878,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2879,medgemma,0.708,TUMOR FOCALITY
2880,medgemma,0.719,NODAL SITE(S) EXAMINED
2881,medgemma,0.851,ADDITIONAL FINDINGS
2882,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2883,medgemma,0.755,PROCEDURE
2884,medgemma,0.78,REGIONAL LYMPH NODE STATUS
2885,medgemma,0.745,LYMPHOVASCULAR INVASION
2886,medgemma,0.811,TUMOR FOCALITY
2887,medgemma,0.716,LYMPH NODE(S) FROM PRIOR PROCEDURES
2888,medgemma,0.728,NODAL SITE(S) EXAMINED
2889,medgemma,0.884,TUMOR SITE
2890,medgemma,0.784,NODAL SITE(S) WITH TUMOR
2891,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2892,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2893,medgemma,0.778,VISCERAL PLEURA INVASION
2894,medgemma,0.778,HISTOLOGIC GRADE
2895,medgemma,0.829,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2896,medgemma,0.697,SPECIMEN LATERALITY
2897,medgemma,0.761,NUMBER OF LYMPH NODES EXAMINED
2898,medgemma,0.72,NUMBER OF LYMPH NODES WITH TUMOR
2899,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2900,medgemma,0.831,PROCEDURE
2901,medgemma,0.837,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2902,medgemma,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2903,medgemma,0.89,TUMOR SITE
2904,medgemma,0.697,SPECIMEN LATERALITY
2905,medgemma,0.818,HISTOLOGIC GRADE
2906,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2907,medgemma,0.738,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2908,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2909,medgemma,0.813,PROCEDURE
2910,medgemma,0.778,VISCERAL PLEURA INVASION
2911,medgemma,0.938,ADDITIONAL FINDINGS
2912,medgemma,0.811,TUMOR FOCALITY
2913,medgemma,0.716,REGIONAL LYMPH NODE STATUS
2914,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2915,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2916,medgemma,0.778,NODAL SITE(S) EXAMINED
2917,medgemma,0.698,SPECIMEN LATERALITY
2918,medgemma,0.798,PROCEDURE
2919,medgemma,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2920,medgemma,0.811,TUMOR FOCALITY
2921,medgemma,0.717,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2922,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
2923,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
2924,medgemma,0.76,NUMBER OF LYMPH NODES EXAMINED
2925,medgemma,0.778,VISCERAL PLEURA INVASION
2926,medgemma,0.815,REGIONAL LYMPH NODE STATUS
2927,medgemma,0.741,TUMOR SITE
2928,medgemma,0.67,NODAL SITE(S) EXAMINED
2929,medgemma,0.865,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2930,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2931,medgemma,0.716,REGIONAL LYMPH NODE STATUS
2932,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2933,medgemma,0.865,TUMOR SITE
2934,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2935,medgemma,0.697,SPECIMEN LATERALITY
2936,medgemma,0.798,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2937,medgemma,0.829,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2938,medgemma,0.827,PROCEDURE
2939,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2940,medgemma,0.716,NODAL SITE(S) EXAMINED
2941,medgemma,0.692,TUMOR FOCALITY
2942,medgemma,0.778,VISCERAL PLEURA INVASION
2943,medgemma,0.78,SPREAD THROUGH AIR SPACES (STAS)
2944,medgemma,0.892,HISTOLOGIC GRADE
2945,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
2946,medgemma,0.826,HISTOLOGIC GRADE
2947,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
2948,medgemma,0.828,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2949,medgemma,0.71,VISCERAL PLEURA INVASION
2950,medgemma,0.648,TNM DESCRIPTORS
2951,medgemma,0.701,NODAL SITE(S) EXAMINED
2952,medgemma,0.7,SPREAD THROUGH AIR SPACES (STAS)
2953,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2954,medgemma,0.698,SPECIMEN LATERALITY
2955,medgemma,0.865,TUMOR SITE
2956,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
2957,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2958,medgemma,0.734,NUMBER OF LYMPH NODES EXAMINED
2959,medgemma,0.815,REGIONAL LYMPH NODE STATUS
2960,medgemma,0.696,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2961,medgemma,0.692,TUMOR FOCALITY
2962,medgemma,0.697,SPECIMEN LATERALITY
2963,medgemma,0.701,SPREAD THROUGH AIR SPACES (STAS)
2964,medgemma,0.716,REGIONAL LYMPH NODE STATUS
2965,medgemma,0.89,TUMOR SITE
2966,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
2967,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
2968,medgemma,0.692,TUMOR FOCALITY
2969,medgemma,0.778,VISCERAL PLEURA INVASION
2970,medgemma,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2971,medgemma,0.782,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2972,medgemma,0.722,NODAL SITE(S) EXAMINED
2973,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
2974,medgemma,0.796,PROCEDURE
2975,medgemma,0.751,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2976,medgemma,0.811,TUMOR FOCALITY
2977,medgemma,0.823,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2978,medgemma,0.704,NODAL SITE(S) EXAMINED
2979,medgemma,0.679,SPREAD THROUGH AIR SPACES (STAS)
2980,medgemma,0.785,ADDITIONAL FINDINGS
2981,medgemma,0.698,SPECIMEN LATERALITY
2982,medgemma,0.701,NUMBER OF LYMPH NODES EXAMINED
2983,medgemma,0.788,PROCEDURE
2984,medgemma,0.879,MARGIN STATUS FOR INVASIVE CARCINOMA
2985,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
2986,medgemma,0.78,REGIONAL LYMPH NODE STATUS
2987,medgemma,0.785,HISTOLOGIC GRADE
2988,medgemma,0.778,VISCERAL PLEURA INVASION
2989,medgemma,0.726,NODAL SITE(S) WITH TUMOR
2990,medgemma,0.865,TUMOR SITE
2991,medgemma,0.826,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2992,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2993,medgemma,0.753,LYMPHOVASCULAR INVASION
2994,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
2995,medgemma,0.76,NODAL SITE(S) EXAMINED
2996,medgemma,0.757,ADDITIONAL FINDINGS
2997,medgemma,0.89,TUMOR SITE
2998,medgemma,0.706,NUMBER OF LYMPH NODES WITH TUMOR
2999,medgemma,0.683,LYMPH NODE(S) FROM PRIOR PROCEDURES
3000,medgemma,0.676,SPREAD THROUGH AIR SPACES (STAS)
3001,medgemma,0.717,NODAL SITE(S) WITH TUMOR
3002,medgemma,0.78,REGIONAL LYMPH NODE STATUS
3003,medgemma,0.697,SPECIMEN LATERALITY
3004,medgemma,0.743,VISCERAL PLEURA INVASION
3005,medgemma,0.705,HISTOLOGIC GRADE
3006,medgemma,0.732,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3007,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3008,medgemma,0.717,NUMBER OF LYMPH NODES EXAMINED
3009,medgemma,0.816,PROCEDURE
3010,medgemma,0.915,TUMOR FOCALITY
3011,medgemma,0.692,LYMPHOVASCULAR INVASION
3012,medgemma,0.742,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3013,medgemma,0.72,NUMBER OF LYMPH NODES EXAMINED
3014,medgemma,0.734,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3015,medgemma,0.736,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3016,medgemma,0.698,SPECIMEN LATERALITY
3017,medgemma,0.78,VISCERAL PLEURA INVASION
3018,medgemma,0.673,TUMOR SITE
3019,medgemma,0.892,HISTOLOGIC GRADE
3020,medgemma,0.793,PROCEDURE
3021,medgemma,0.77,LYMPH NODE(S) FROM PRIOR PROCEDURES
3022,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3023,medgemma,0.712,TUMOR FOCALITY
3024,medgemma,0.815,REGIONAL LYMPH NODE STATUS
3025,medgemma,0.759,LYMPHOVASCULAR INVASION
3026,medgemma,0.67,SPREAD THROUGH AIR SPACES (STAS)
3027,medgemma,0.705,MARGIN STATUS FOR NON-INVASIVE TUMOR
3028,medgemma,0.746,NODAL SITE(S) EXAMINED
3029,medgemma,0.75,NODAL SITE(S) EXAMINED
3030,medgemma,0.89,TUMOR SITE
3031,medgemma,0.807,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3032,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3033,medgemma,0.815,REGIONAL LYMPH NODE STATUS
3034,medgemma,0.701,SPREAD THROUGH AIR SPACES (STAS)
3035,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3036,medgemma,0.831,PROCEDURE
3037,medgemma,0.697,SPECIMEN LATERALITY
3038,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3039,medgemma,0.804,ADDITIONAL FINDINGS
3040,medgemma,0.818,HISTOLOGIC GRADE
3041,medgemma,0.824,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3042,medgemma,0.811,TUMOR FOCALITY
3043,medgemma,0.778,VISCERAL PLEURA INVASION
3044,medgemma,0.782,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3045,medgemma,0.815,HISTOLOGIC GRADE
3046,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
3047,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3048,medgemma,0.789,PROCEDURE
3049,medgemma,0.802,TUMOR SITE
3050,medgemma,0.714,NUMBER OF LYMPH NODES EXAMINED
3051,medgemma,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3052,medgemma,0.778,VISCERAL PLEURA INVASION
3053,medgemma,0.792,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3054,medgemma,0.811,TUMOR FOCALITY
3055,medgemma,0.829,REGIONAL LYMPH NODE STATUS
3056,medgemma,0.783,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3057,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
3058,medgemma,0.697,SPECIMEN LATERALITY
3059,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3060,medgemma,0.765,NODAL SITE(S) EXAMINED
3061,medgemma,0.728,LYMPH NODE(S) FROM PRIOR PROCEDURES
3062,medgemma,0.892,HISTOLOGIC GRADE
3063,medgemma,0.692,LYMPHOVASCULAR INVASION
3064,medgemma,0.89,TUMOR SITE
3065,medgemma,0.638,NODAL SITE(S) EXAMINED
3066,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3067,medgemma,0.697,SPECIMEN LATERALITY
3068,medgemma,0.78,VISCERAL PLEURA INVASION
3069,medgemma,0.716,REGIONAL LYMPH NODE STATUS
3070,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3071,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3072,medgemma,0.739,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3073,medgemma,0.827,PROCEDURE
3074,medgemma,0.915,TUMOR FOCALITY
3075,medgemma,0.731,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3076,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3077,medgemma,0.887,TUMOR SITE
3078,medgemma,0.798,PROCEDURE
3079,medgemma,0.72,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3080,medgemma,0.641,NODAL SITE(S) EXAMINED
3081,medgemma,0.716,REGIONAL LYMPH NODE STATUS
3082,medgemma,0.778,HISTOLOGIC GRADE
3083,medgemma,0.696,NUMBER OF LYMPH NODES EXAMINED
3084,medgemma,0.712,TUMOR FOCALITY
3085,medgemma,0.825,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3086,medgemma,0.705,MARGIN STATUS FOR NON-INVASIVE TUMOR
3087,medgemma,0.697,SPECIMEN LATERALITY
3088,medgemma,0.7,VISCERAL PLEURA INVASION
3089,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
3090,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3091,medgemma,0.78,REGIONAL LYMPH NODE STATUS
3092,medgemma,0.89,TUMOR SITE
3093,medgemma,0.818,HISTOLOGIC GRADE
3094,medgemma,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3095,medgemma,0.692,TUMOR FOCALITY
3096,medgemma,0.698,SPECIMEN LATERALITY
3097,medgemma,0.681,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3098,medgemma,0.765,PROCEDURE
3099,medgemma,0.709,NUMBER OF LYMPH NODES EXAMINED
3100,medgemma,0.77,LYMPH NODE(S) FROM PRIOR PROCEDURES
3101,medgemma,0.7,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3102,medgemma,0.713,NUMBER OF LYMPH NODES WITH TUMOR
3103,medgemma,0.701,NODAL SITE(S) EXAMINED
3104,medgemma,0.778,VISCERAL PLEURA INVASION
3105,medgemma,0.698,NODAL SITE(S) WITH TUMOR
3106,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
3107,medgemma,0.7,ADDITIONAL FINDINGS
3108,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3109,medgemma,0.718,SPREAD THROUGH AIR SPACES (STAS)
3110,medgemma,0.727,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3111,medgemma,0.735,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3112,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3113,medgemma,0.89,TUMOR SITE
3114,medgemma,0.892,HISTOLOGIC GRADE
3115,medgemma,0.767,NODAL SITE(S) WITH TUMOR
3116,medgemma,0.811,TUMOR FOCALITY
3117,medgemma,0.725,NODAL SITE(S) EXAMINED
3118,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
3119,medgemma,0.78,REGIONAL LYMPH NODE STATUS
3120,medgemma,0.778,VISCERAL PLEURA INVASION
3121,medgemma,0.702,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3122,medgemma,0.788,PROCEDURE
3123,medgemma,0.72,NUMBER OF LYMPH NODES WITH TUMOR
3124,medgemma,0.697,SPECIMEN LATERALITY
3125,medgemma,0.788,PROCEDURE
3126,medgemma,0.693,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3127,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3128,medgemma,0.697,SPECIMEN LATERALITY
3129,medgemma,0.735,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3130,medgemma,0.753,NODAL SITE(S) EXAMINED
3131,medgemma,0.681,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3132,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3133,medgemma,0.811,TUMOR FOCALITY
3134,medgemma,0.865,TUMOR SITE
3135,medgemma,0.797,HISTOLOGIC GRADE
3136,medgemma,0.693,NUMBER OF LYMPH NODES EXAMINED
3137,medgemma,0.815,REGIONAL LYMPH NODE STATUS
3138,medgemma,0.778,VISCERAL PLEURA INVASION
3139,medgemma,0.683,LYMPH NODE(S) FROM PRIOR PROCEDURES
3140,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3141,medgemma,0.78,REGIONAL LYMPH NODE STATUS
3142,medgemma,0.776,NODAL SITE(S) EXAMINED
3143,medgemma,0.796,PROCEDURE
3144,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3145,medgemma,0.78,VISCERAL PLEURA INVASION
3146,medgemma,0.72,NUMBER OF LYMPH NODES WITH TUMOR
3147,medgemma,0.892,HISTOLOGIC GRADE
3148,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3149,medgemma,0.89,TUMOR SITE
3150,medgemma,0.697,SPECIMEN LATERALITY
3151,medgemma,0.803,NODAL SITE(S) WITH TUMOR
3152,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3153,medgemma,0.82,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3154,medgemma,0.735,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3155,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
3156,medgemma,0.811,TUMOR FOCALITY
3157,medgemma,0.788,PROCEDURE
3158,medgemma,0.888,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3159,medgemma,0.811,TUMOR FOCALITY
3160,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3161,medgemma,0.711,NUMBER OF LYMPH NODES EXAMINED
3162,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
3163,medgemma,0.865,TUMOR SITE
3164,medgemma,0.78,REGIONAL LYMPH NODE STATUS
3165,medgemma,0.737,NODAL SITE(S) WITH TUMOR
3166,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3167,medgemma,0.745,LYMPHOVASCULAR INVASION
3168,medgemma,0.72,NUMBER OF LYMPH NODES WITH TUMOR
3169,medgemma,0.75,HISTOLOGIC GRADE
3170,medgemma,0.693,MARGIN STATUS FOR INVASIVE CARCINOMA
3171,medgemma,0.778,VISCERAL PLEURA INVASION
3172,medgemma,0.69,NODAL SITE(S) EXAMINED
3173,medgemma,0.698,SPECIMEN LATERALITY
3174,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3175,medgemma,0.811,TUMOR FOCALITY
3176,medgemma,0.779,PROCEDURE
3177,medgemma,0.825,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3178,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3179,medgemma,0.78,VISCERAL PLEURA INVASION
3180,medgemma,0.721,NODAL SITE(S) EXAMINED
3181,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3182,medgemma,0.7,SPREAD THROUGH AIR SPACES (STAS)
3183,medgemma,0.841,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3184,medgemma,0.815,REGIONAL LYMPH NODE STATUS
3185,medgemma,0.865,TUMOR SITE
3186,medgemma,0.697,SPECIMEN LATERALITY
3187,medgemma,0.797,HISTOLOGIC GRADE
3188,medgemma,0.693,NUMBER OF LYMPH NODES EXAMINED
3189,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3190,medgemma,0.826,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3191,medgemma,0.7,SPREAD THROUGH AIR SPACES (STAS)
3192,medgemma,0.816,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3193,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3194,medgemma,0.827,PROCEDURE
3195,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3196,medgemma,0.811,TUMOR FOCALITY
3197,medgemma,0.726,NODAL SITE(S) EXAMINED
3198,medgemma,0.904,HISTOLOGIC GRADE
3199,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3200,medgemma,0.713,NUMBER OF LYMPH NODES EXAMINED
3201,medgemma,0.815,REGIONAL LYMPH NODE STATUS
3202,medgemma,0.865,TUMOR SITE
3203,medgemma,0.778,VISCERAL PLEURA INVASION
3204,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3205,medgemma,0.698,SPECIMEN LATERALITY
3206,medgemma,0.855,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3207,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
3208,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3209,medgemma,0.778,VISCERAL PLEURA INVASION
3210,medgemma,0.815,REGIONAL LYMPH NODE STATUS
3211,medgemma,0.738,NODAL SITE(S) EXAMINED
3212,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3213,medgemma,0.75,HISTOLOGIC GRADE
3214,medgemma,0.811,TUMOR FOCALITY
3215,medgemma,0.703,ADDITIONAL FINDINGS
3216,medgemma,0.821,PROCEDURE
3217,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3218,medgemma,0.697,SPECIMEN LATERALITY
3219,medgemma,0.791,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3220,medgemma,0.698,NUMBER OF LYMPH NODES EXAMINED
3221,medgemma,0.89,TUMOR SITE
3222,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3223,medgemma,0.768,TNM DESCRIPTORS
3224,medgemma,0.76,HISTOLOGIC GRADE
3225,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3226,medgemma,0.783,ADDITIONAL FINDINGS
3227,medgemma,0.811,TUMOR FOCALITY
3228,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3229,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
3230,medgemma,0.747,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3231,medgemma,0.801,TUMOR SITE
3232,medgemma,0.815,REGIONAL LYMPH NODE STATUS
3233,medgemma,0.793,PROCEDURE
3234,medgemma,0.705,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3235,medgemma,0.698,SPECIMEN LATERALITY
3236,medgemma,0.728,NODAL SITE(S) EXAMINED
3237,medgemma,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3238,medgemma,0.711,NUMBER OF LYMPH NODES EXAMINED
3239,medgemma,0.778,VISCERAL PLEURA INVASION
3240,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3241,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3242,medgemma,0.815,REGIONAL LYMPH NODE STATUS
3243,medgemma,0.707,NUMBER OF LYMPH NODES EXAMINED
3244,medgemma,0.697,SPECIMEN LATERALITY
3245,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3246,medgemma,0.835,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3247,medgemma,0.823,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3248,medgemma,0.683,ADDITIONAL FINDINGS
3249,medgemma,0.742,NODAL SITE(S) EXAMINED
3250,medgemma,0.786,PROCEDURE
3251,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3252,medgemma,0.718,SPREAD THROUGH AIR SPACES (STAS)
3253,medgemma,0.811,TUMOR FOCALITY
3254,medgemma,0.884,TUMOR SITE
3255,medgemma,0.778,VISCERAL PLEURA INVASION
3256,medgemma,0.701,HISTOLOGIC GRADE
3257,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
3258,medgemma,0.7,ADDITIONAL FINDINGS
3259,medgemma,0.692,TUMOR FOCALITY
3260,medgemma,0.699,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3261,medgemma,0.699,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3262,medgemma,0.703,NUMBER OF LYMPH NODES EXAMINED
3263,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3264,medgemma,0.685,NODAL SITE(S) EXAMINED
3265,medgemma,0.698,SPECIMEN LATERALITY
3266,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3267,medgemma,0.89,TUMOR SITE
3268,medgemma,0.696,TNM DESCRIPTORS
3269,medgemma,0.678,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3270,medgemma,0.778,VISCERAL PLEURA INVASION
3271,medgemma,0.728,REGIONAL LYMPH NODE STATUS
3272,medgemma,0.801,PROCEDURE
3273,medgemma,0.699,NUMBER OF LYMPH NODES EXAMINED
3274,medgemma,0.78,REGIONAL LYMPH NODE STATUS
3275,medgemma,0.759,ADDITIONAL FINDINGS
3276,medgemma,0.782,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3277,medgemma,0.72,NUMBER OF LYMPH NODES WITH TUMOR
3278,medgemma,0.743,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3279,medgemma,0.759,PROCEDURE
3280,medgemma,0.7,NODAL SITE(S) EXAMINED
3281,medgemma,0.811,TUMOR FOCALITY
3282,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3283,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3284,medgemma,0.78,VISCERAL PLEURA INVASION
3285,medgemma,0.802,TUMOR SITE
3286,medgemma,0.769,NODAL SITE(S) WITH TUMOR
3287,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
3288,medgemma,0.697,SPECIMEN LATERALITY
3289,medgemma,0.736,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3290,medgemma,0.71,ADDITIONAL FINDINGS
3291,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3292,medgemma,0.89,TUMOR SITE
3293,medgemma,0.68,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3294,medgemma,0.699,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3295,medgemma,0.705,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3296,medgemma,0.815,REGIONAL LYMPH NODE STATUS
3297,medgemma,0.757,PROCEDURE
3298,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3299,medgemma,0.675,NODAL SITE(S) EXAMINED
3300,medgemma,0.692,TUMOR FOCALITY
3301,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
3302,medgemma,0.778,VISCERAL PLEURA INVASION
3303,medgemma,0.733,TNM DESCRIPTORS
3304,medgemma,0.698,SPECIMEN LATERALITY
3305,medgemma,0.837,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3306,medgemma,0.698,SPECIMEN LATERALITY
3307,medgemma,0.782,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3308,medgemma,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3309,medgemma,0.801,PROCEDURE
3310,medgemma,0.811,TUMOR FOCALITY
3311,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3312,medgemma,0.679,NODAL SITE(S) EXAMINED
3313,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3314,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3315,medgemma,0.89,TUMOR SITE
3316,medgemma,0.778,VISCERAL PLEURA INVASION
3317,medgemma,0.815,REGIONAL LYMPH NODE STATUS
3318,medgemma,0.761,PROCEDURE
3319,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3320,medgemma,0.757,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3321,medgemma,0.703,NODAL SITE(S) EXAMINED
3322,medgemma,0.792,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3323,medgemma,0.716,REGIONAL LYMPH NODE STATUS
3324,medgemma,0.697,SPECIMEN LATERALITY
3325,medgemma,0.7,SPREAD THROUGH AIR SPACES (STAS)
3326,medgemma,0.774,ADDITIONAL FINDINGS
3327,medgemma,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3328,medgemma,0.778,VISCERAL PLEURA INVASION
3329,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3330,medgemma,0.718,NUMBER OF LYMPH NODES EXAMINED
3331,medgemma,0.89,TUMOR SITE
3332,medgemma,0.692,TUMOR FOCALITY
3333,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
3334,medgemma,0.811,TUMOR FOCALITY
3335,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3336,medgemma,0.695,NUMBER OF LYMPH NODES EXAMINED
3337,medgemma,0.718,HISTOLOGIC GRADE
3338,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3339,medgemma,0.69,SPREAD THROUGH AIR SPACES (STAS)
3340,medgemma,0.704,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3341,medgemma,0.831,PROCEDURE
3342,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3343,medgemma,0.751,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3344,medgemma,0.698,SPECIMEN LATERALITY
3345,medgemma,0.716,REGIONAL LYMPH NODE STATUS
3346,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3347,medgemma,0.89,TUMOR SITE
3348,medgemma,0.778,VISCERAL PLEURA INVASION
3349,medgemma,0.726,TNM DESCRIPTORS
3350,medgemma,0.688,NODAL SITE(S) EXAMINED
3351,medgemma,0.698,LYMPHOVASCULAR INVASION
3352,medgemma,0.715,NODAL SITE(S) WITH TUMOR
3353,medgemma,0.822,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3354,medgemma,0.676,SPREAD THROUGH AIR SPACES (STAS)
3355,medgemma,0.78,REGIONAL LYMPH NODE STATUS
3356,medgemma,0.7,NUMBER OF LYMPH NODES WITH TUMOR
3357,medgemma,0.89,TUMOR SITE
3358,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
3359,medgemma,0.739,MARGIN STATUS FOR INVASIVE CARCINOMA
3360,medgemma,0.892,HISTOLOGIC GRADE
3361,medgemma,0.788,PROCEDURE
3362,medgemma,0.778,VISCERAL PLEURA INVASION
3363,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3364,medgemma,0.69,NODAL SITE(S) EXAMINED
3365,medgemma,0.697,SPECIMEN LATERALITY
3366,medgemma,0.811,TUMOR FOCALITY
3367,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3368,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3369,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3370,medgemma,0.811,TUMOR FOCALITY
3371,medgemma,0.838,ADDITIONAL FINDINGS
3372,medgemma,0.703,NODAL SITE(S) EXAMINED
3373,medgemma,0.825,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3374,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3375,medgemma,0.73,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3376,medgemma,0.818,HISTOLOGIC GRADE
3377,medgemma,0.827,PROCEDURE
3378,medgemma,0.697,SPECIMEN LATERALITY
3379,medgemma,0.713,NUMBER OF LYMPH NODES EXAMINED
3380,medgemma,0.778,VISCERAL PLEURA INVASION
3381,medgemma,0.89,TUMOR SITE
3382,medgemma,0.815,REGIONAL LYMPH NODE STATUS
3383,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
3384,medgemma,0.704,NUMBER OF LYMPH NODES EXAMINED
3385,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3386,medgemma,0.659,NODAL SITE(S) EXAMINED
3387,medgemma,0.874,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3388,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3389,medgemma,0.869,NODAL SITE(S) WITH TUMOR
3390,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3391,medgemma,0.683,LYMPH NODE(S) FROM PRIOR PROCEDURES
3392,medgemma,0.778,VISCERAL PLEURA INVASION
3393,medgemma,0.89,TUMOR SITE
3394,medgemma,0.892,HISTOLOGIC GRADE
3395,medgemma,0.707,SPREAD THROUGH AIR SPACES (STAS)
3396,medgemma,0.713,NUMBER OF LYMPH NODES WITH TUMOR
3397,medgemma,0.78,REGIONAL LYMPH NODE STATUS
3398,medgemma,0.698,SPECIMEN LATERALITY
3399,medgemma,0.788,PROCEDURE
3400,medgemma,0.811,TUMOR FOCALITY
3401,medgemma,0.838,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3402,medgemma,0.813,PROCEDURE
3403,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
3404,medgemma,0.811,TUMOR FOCALITY
3405,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
3406,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3407,medgemma,0.819,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3408,medgemma,0.753,NODAL SITE(S) WITH TUMOR
3409,medgemma,0.78,REGIONAL LYMPH NODE STATUS
3410,medgemma,0.778,VISCERAL PLEURA INVASION
3411,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3412,medgemma,0.722,NODAL SITE(S) EXAMINED
3413,medgemma,0.651,TNM DESCRIPTORS
3414,medgemma,0.75,HISTOLOGIC GRADE
3415,medgemma,0.697,SPECIMEN LATERALITY
3416,medgemma,0.742,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3417,medgemma,0.89,TUMOR SITE
3418,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3419,medgemma,0.816,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3420,medgemma,0.741,NODAL SITE(S) EXAMINED
3421,medgemma,0.794,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3422,medgemma,0.713,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3423,medgemma,0.778,VISCERAL PLEURA INVASION
3424,medgemma,0.7,SPREAD THROUGH AIR SPACES (STAS)
3425,medgemma,0.815,REGIONAL LYMPH NODE STATUS
3426,medgemma,0.864,TUMOR SITE
3427,medgemma,0.697,SPECIMEN LATERALITY
3428,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3429,medgemma,0.827,PROCEDURE
3430,medgemma,0.706,NUMBER OF LYMPH NODES EXAMINED
3431,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3432,medgemma,0.692,TUMOR FOCALITY
3433,medgemma,0.818,HISTOLOGIC GRADE
3434,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3435,medgemma,0.865,TUMOR SITE
3436,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
3437,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3438,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3439,medgemma,0.698,SPECIMEN LATERALITY
3440,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3441,medgemma,0.89,TUMOR SITE
3442,medgemma,0.815,HISTOLOGIC GRADE
3443,medgemma,0.75,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3444,medgemma,0.745,NODAL SITE(S) EXAMINED
3445,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
3446,medgemma,0.817,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3447,medgemma,0.811,TUMOR FOCALITY
3448,medgemma,0.793,PROCEDURE
3449,medgemma,0.757,VISCERAL PLEURA INVASION
3450,medgemma,0.716,REGIONAL LYMPH NODE STATUS
3451,medgemma,0.89,TUMOR SITE
3452,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3453,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3454,medgemma,0.843,PROCEDURE
3455,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3456,medgemma,0.7,SPREAD THROUGH AIR SPACES (STAS)
3457,medgemma,0.82,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3458,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3459,medgemma,0.716,REGIONAL LYMPH NODE STATUS
3460,medgemma,0.697,SPECIMEN LATERALITY
3461,medgemma,0.736,NODAL SITE(S) EXAMINED
3462,medgemma,0.78,VISCERAL PLEURA INVASION
3463,medgemma,0.75,HISTOLOGIC GRADE
3464,medgemma,0.915,TUMOR FOCALITY
3465,medgemma,0.738,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3466,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3467,medgemma,0.681,NODAL SITE(S) EXAMINED
3468,medgemma,0.695,NUMBER OF LYMPH NODES EXAMINED
3469,medgemma,0.74,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3470,medgemma,0.823,TUMOR SITE
3471,medgemma,0.805,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3472,medgemma,0.811,TUMOR FOCALITY
3473,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3474,medgemma,0.713,MARGIN STATUS FOR INVASIVE CARCINOMA
3475,medgemma,0.716,REGIONAL LYMPH NODE STATUS
3476,medgemma,0.827,PROCEDURE
3477,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
3478,medgemma,0.743,VISCERAL PLEURA INVASION
3479,medgemma,0.698,SPECIMEN LATERALITY
3480,medgemma,0.687,ADDITIONAL FINDINGS
3481,medgemma,0.818,HISTOLOGIC GRADE
3482,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3483,medgemma,0.853,PROCEDURE
3484,medgemma,0.733,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3485,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3486,medgemma,0.679,NODAL SITE(S) EXAMINED
3487,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3488,medgemma,0.89,TUMOR SITE
3489,medgemma,0.811,TUMOR FOCALITY
3490,medgemma,0.778,VISCERAL PLEURA INVASION
3491,medgemma,0.916,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3492,medgemma,0.716,REGIONAL LYMPH NODE STATUS
3493,medgemma,0.798,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3494,medgemma,0.818,HISTOLOGIC GRADE
3495,medgemma,0.698,SPECIMEN LATERALITY
3496,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3497,medgemma,0.7,NUMBER OF LYMPH NODES EXAMINED
3498,medgemma,0.78,VISCERAL PLEURA INVASION
3499,medgemma,0.835,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3500,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3501,medgemma,0.838,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3502,medgemma,0.811,TUMOR FOCALITY
3503,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3504,medgemma,0.761,PROCEDURE
3505,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3506,medgemma,0.864,ADDITIONAL FINDINGS
3507,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
3508,medgemma,0.802,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3509,medgemma,0.716,REGIONAL LYMPH NODE STATUS
3510,medgemma,0.89,TUMOR SITE
3511,medgemma,0.697,SPECIMEN LATERALITY
3512,medgemma,0.818,HISTOLOGIC GRADE
3513,medgemma,0.742,NODAL SITE(S) EXAMINED
3514,medgemma,0.778,VISCERAL PLEURA INVASION
3515,medgemma,0.815,REGIONAL LYMPH NODE STATUS
3516,medgemma,0.738,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3517,medgemma,0.698,SPECIMEN LATERALITY
3518,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3519,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3520,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3521,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
3522,medgemma,0.722,PROCEDURE
3523,medgemma,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3524,medgemma,0.89,TUMOR SITE
3525,medgemma,0.669,NODAL SITE(S) EXAMINED
3526,medgemma,0.811,TUMOR FOCALITY
3527,medgemma,0.726,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3528,medgemma,0.687,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3529,medgemma,0.841,MARGIN STATUS FOR INVASIVE CARCINOMA
3530,medgemma,0.736,TUMOR FOCALITY
3531,medgemma,0.742,VISCERAL PLEURA INVASION
3532,medgemma,0.897,ADDITIONAL FINDINGS
3533,medgemma,0.697,SPECIMEN LATERALITY
3534,medgemma,0.791,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3535,medgemma,0.815,REGIONAL LYMPH NODE STATUS
3536,medgemma,0.679,HISTOLOGIC GRADE
3537,medgemma,0.897,LYMPH NODE(S) FROM PRIOR PROCEDURES
3538,medgemma,0.741,TUMOR SITE
3539,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3540,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3541,medgemma,0.702,NUMBER OF LYMPH NODES EXAMINED
3542,medgemma,0.676,SPREAD THROUGH AIR SPACES (STAS)
3543,medgemma,0.709,NODAL SITE(S) EXAMINED
3544,medgemma,0.899,PROCEDURE
3545,medgemma,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3546,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3547,medgemma,0.82,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3548,medgemma,0.697,SPECIMEN LATERALITY
3549,medgemma,0.778,VISCERAL PLEURA INVASION
3550,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3551,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3552,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
3553,medgemma,0.708,NODAL SITE(S) EXAMINED
3554,medgemma,0.89,TUMOR SITE
3555,medgemma,0.827,PROCEDURE
3556,medgemma,0.811,TUMOR FOCALITY
3557,medgemma,0.815,REGIONAL LYMPH NODE STATUS
3558,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3559,medgemma,0.904,HISTOLOGIC GRADE
3560,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3561,medgemma,0.699,NUMBER OF LYMPH NODES EXAMINED
3562,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
3563,medgemma,0.811,TUMOR FOCALITY
3564,medgemma,0.697,SPECIMEN LATERALITY
3565,medgemma,0.72,NUMBER OF LYMPH NODES WITH TUMOR
3566,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3567,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3568,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3569,medgemma,0.741,NODAL SITE(S) EXAMINED
3570,medgemma,0.91,TUMOR SITE
3571,medgemma,0.827,PROCEDURE
3572,medgemma,0.727,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3573,medgemma,0.749,NODAL SITE(S) WITH TUMOR
3574,medgemma,0.78,REGIONAL LYMPH NODE STATUS
3575,medgemma,0.816,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3576,medgemma,0.778,VISCERAL PLEURA INVASION
3577,medgemma,0.671,ADDITIONAL FINDINGS
3578,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3579,medgemma,0.713,NUMBER OF LYMPH NODES EXAMINED
3580,medgemma,0.692,LYMPH NODE(S) FROM PRIOR PROCEDURES
3581,medgemma,0.7,SPREAD THROUGH AIR SPACES (STAS)
3582,medgemma,0.701,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3583,medgemma,0.635,NODAL SITE(S) EXAMINED
3584,medgemma,0.702,SPECIMEN LATERALITY
3585,medgemma,0.691,PROCEDURE
3586,medgemma,0.648,TNM DESCRIPTORS
3587,medgemma,0.69,TUMOR SITE
3588,medgemma,0.701,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3589,medgemma,0.701,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3590,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3591,medgemma,0.712,TUMOR FOCALITY
3592,medgemma,0.701,HISTOLOGIC GRADE
3593,medgemma,0.7,VISCERAL PLEURA INVASION
3594,medgemma,0.815,REGIONAL LYMPH NODE STATUS
3595,medgemma,0.703,NUMBER OF LYMPH NODES EXAMINED
3596,medgemma,0.838,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3597,medgemma,0.808,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3598,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3599,medgemma,0.827,PROCEDURE
3600,medgemma,0.815,REGIONAL LYMPH NODE STATUS
3601,medgemma,0.89,TUMOR SITE
3602,medgemma,0.778,VISCERAL PLEURA INVASION
3603,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3604,medgemma,0.904,HISTOLOGIC GRADE
3605,medgemma,0.811,TUMOR FOCALITY
3606,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3607,medgemma,0.719,NODAL SITE(S) EXAMINED
3608,medgemma,0.697,SPECIMEN LATERALITY
3609,medgemma,0.7,SPREAD THROUGH AIR SPACES (STAS)
3610,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3611,medgemma,0.865,TUMOR SITE
3612,medgemma,0.736,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3613,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3614,medgemma,0.7,NUMBER OF LYMPH NODES EXAMINED
3615,medgemma,0.697,SPECIMEN LATERALITY
3616,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
3617,medgemma,0.811,TUMOR FOCALITY
3618,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3619,medgemma,0.817,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3620,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3621,medgemma,0.827,PROCEDURE
3622,medgemma,0.728,NODAL SITE(S) EXAMINED
3623,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3624,medgemma,0.716,REGIONAL LYMPH NODE STATUS
3625,medgemma,0.778,VISCERAL PLEURA INVASION
3626,medgemma,0.832,HISTOLOGIC GRADE
3627,medgemma,0.739,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3628,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
3629,medgemma,0.696,TNM DESCRIPTORS
3630,medgemma,0.829,REGIONAL LYMPH NODE STATUS
3631,medgemma,0.778,VISCERAL PLEURA INVASION
3632,medgemma,0.904,HISTOLOGIC GRADE
3633,medgemma,0.715,NODAL SITE(S) EXAMINED
3634,medgemma,0.89,TUMOR SITE
3635,medgemma,0.691,NUMBER OF LYMPH NODES EXAMINED
3636,medgemma,0.722,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3637,medgemma,0.685,TUMOR FOCALITY
3638,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3639,medgemma,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3640,medgemma,0.716,LYMPH NODE(S) FROM PRIOR PROCEDURES
3641,medgemma,0.697,SPECIMEN LATERALITY
3642,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3643,medgemma,0.831,PROCEDURE
3644,medgemma,0.815,REGIONAL LYMPH NODE STATUS
3645,medgemma,0.865,TUMOR SITE
3646,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3647,medgemma,0.74,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3648,medgemma,0.918,TUMOR FOCALITY
3649,medgemma,0.641,ADDITIONAL FINDINGS
3650,medgemma,0.715,NODAL SITE(S) EXAMINED
3651,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3652,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3653,medgemma,0.697,SPECIMEN LATERALITY
3654,medgemma,0.82,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3655,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3656,medgemma,0.778,VISCERAL PLEURA INVASION
3657,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
3658,medgemma,0.788,PROCEDURE
3659,medgemma,0.778,VISCERAL PLEURA INVASION
3660,medgemma,0.799,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3661,medgemma,0.734,PROCEDURE
3662,medgemma,0.72,NUMBER OF LYMPH NODES WITH TUMOR
3663,medgemma,0.702,ADDITIONAL FINDINGS
3664,medgemma,0.692,TUMOR FOCALITY
3665,medgemma,0.825,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3666,medgemma,0.865,TUMOR SITE
3667,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3668,medgemma,0.78,REGIONAL LYMPH NODE STATUS
3669,medgemma,0.726,NODAL SITE(S) EXAMINED
3670,medgemma,0.766,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3671,medgemma,0.734,NODAL SITE(S) WITH TUMOR
3672,medgemma,0.716,LYMPHOVASCULAR INVASION
3673,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3674,medgemma,0.697,SPECIMEN LATERALITY
3675,medgemma,0.692,NUMBER OF LYMPH NODES EXAMINED
3676,medgemma,0.904,HISTOLOGIC GRADE
3677,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3678,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
3679,medgemma,0.739,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3680,medgemma,0.78,REGIONAL LYMPH NODE STATUS
3681,medgemma,0.738,PROCEDURE
3682,medgemma,0.697,SPECIMEN LATERALITY
3683,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3684,medgemma,0.778,VISCERAL PLEURA INVASION
3685,medgemma,0.736,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3686,medgemma,0.703,NODAL SITE(S) EXAMINED
3687,medgemma,0.745,LYMPHOVASCULAR INVASION
3688,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3689,medgemma,0.811,TUMOR FOCALITY
3690,medgemma,0.741,NODAL SITE(S) WITH TUMOR
3691,medgemma,0.716,LYMPH NODE(S) FROM PRIOR PROCEDURES
3692,medgemma,0.68,TUMOR SITE
3693,medgemma,0.824,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3694,medgemma,0.679,SPREAD THROUGH AIR SPACES (STAS)
3695,medgemma,0.8,HISTOLOGIC GRADE
3696,medgemma,0.843,ADDITIONAL FINDINGS
3697,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3698,medgemma,0.749,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3699,medgemma,0.716,REGIONAL LYMPH NODE STATUS
3700,medgemma,0.89,TUMOR SITE
3701,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
3702,medgemma,0.892,HISTOLOGIC GRADE
3703,medgemma,0.697,SPECIMEN LATERALITY
3704,medgemma,0.698,LYMPHOVASCULAR INVASION
3705,medgemma,0.688,SPREAD THROUGH AIR SPACES (STAS)
3706,medgemma,0.915,TUMOR FOCALITY
3707,medgemma,0.732,NODAL SITE(S) EXAMINED
3708,medgemma,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3709,medgemma,0.703,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3710,medgemma,0.831,PROCEDURE
3711,medgemma,0.652,TNM DESCRIPTORS
3712,medgemma,0.78,VISCERAL PLEURA INVASION
3713,medgemma,0.7,NUMBER OF LYMPH NODES EXAMINED
3714,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3715,medgemma,0.689,ADDITIONAL FINDINGS
3716,medgemma,0.838,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3717,medgemma,0.78,VISCERAL PLEURA INVASION
3718,medgemma,0.825,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3719,medgemma,0.698,SPECIMEN LATERALITY
3720,medgemma,0.89,TUMOR SITE
3721,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3722,medgemma,0.716,REGIONAL LYMPH NODE STATUS
3723,medgemma,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3724,medgemma,0.818,HISTOLOGIC GRADE
3725,medgemma,0.686,NODAL SITE(S) EXAMINED
3726,medgemma,0.811,TUMOR FOCALITY
3727,medgemma,0.831,PROCEDURE
3728,medgemma,0.676,SPREAD THROUGH AIR SPACES (STAS)
3729,medgemma,0.793,PROCEDURE
3730,medgemma,0.89,TUMOR SITE
3731,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
3732,medgemma,0.743,VISCERAL PLEURA INVASION
3733,medgemma,0.728,LYMPH NODE(S) FROM PRIOR PROCEDURES
3734,medgemma,0.78,NODAL SITE(S) EXAMINED
3735,medgemma,0.815,REGIONAL LYMPH NODE STATUS
3736,medgemma,0.735,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3737,medgemma,0.712,TUMOR FOCALITY
3738,medgemma,0.7,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3739,medgemma,0.75,HISTOLOGIC GRADE
3740,medgemma,0.676,SPREAD THROUGH AIR SPACES (STAS)
3741,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3742,medgemma,0.697,SPECIMEN LATERALITY
3743,medgemma,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3744,medgemma,0.708,ADDITIONAL FINDINGS
3745,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
3746,medgemma,0.73,NODAL SITE(S) EXAMINED
3747,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
3748,medgemma,0.737,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3749,medgemma,0.782,NUMBER OF LYMPH NODES EXAMINED
3750,medgemma,0.892,HISTOLOGIC GRADE
3751,medgemma,0.89,TUMOR SITE
3752,medgemma,0.826,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3753,medgemma,0.697,SPECIMEN LATERALITY
3754,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3755,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3756,medgemma,0.813,PROCEDURE
3757,medgemma,0.778,VISCERAL PLEURA INVASION
3758,medgemma,0.811,TUMOR FOCALITY
3759,medgemma,0.815,REGIONAL LYMPH NODE STATUS
3760,medgemma,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3761,medgemma,0.728,LYMPH NODE(S) FROM PRIOR PROCEDURES
3762,medgemma,0.693,SPREAD THROUGH AIR SPACES (STAS)
3763,medgemma,0.762,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3764,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3765,medgemma,0.706,ADDITIONAL FINDINGS
3766,medgemma,0.7,NUMBER OF LYMPH NODES EXAMINED
3767,medgemma,0.746,VISCERAL PLEURA INVASION
3768,medgemma,0.811,TUMOR FOCALITY
3769,medgemma,0.742,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3770,medgemma,0.78,REGIONAL LYMPH NODE STATUS
3771,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
3772,medgemma,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3773,medgemma,0.698,NODAL SITE(S) EXAMINED
3774,medgemma,0.734,NODAL SITE(S) WITH TUMOR
3775,medgemma,0.698,SPECIMEN LATERALITY
3776,medgemma,0.72,NUMBER OF LYMPH NODES WITH TUMOR
3777,medgemma,0.865,TUMOR SITE
3778,medgemma,0.803,PROCEDURE
3779,medgemma,0.817,LYMPHOVASCULAR INVASION
3780,medgemma,0.892,HISTOLOGIC GRADE
3781,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
3782,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3783,medgemma,0.81,NUMBER OF LYMPH NODES EXAMINED
3784,medgemma,0.734,NODAL SITE(S) EXAMINED
3785,medgemma,0.841,MARGIN STATUS FOR INVASIVE CARCINOMA
3786,medgemma,0.783,ADDITIONAL FINDINGS
3787,medgemma,0.778,VISCERAL PLEURA INVASION
3788,medgemma,0.897,LYMPH NODE(S) FROM PRIOR PROCEDURES
3789,medgemma,0.679,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3790,medgemma,0.831,PROCEDURE
3791,medgemma,0.782,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3792,medgemma,0.716,REGIONAL LYMPH NODE STATUS
3793,medgemma,0.697,SPECIMEN LATERALITY
3794,medgemma,0.89,TUMOR SITE
3795,medgemma,0.775,HISTOLOGIC GRADE
3796,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3797,medgemma,0.695,TNM DESCRIPTORS
3798,medgemma,0.742,TUMOR FOCALITY
3799,medgemma,0.904,HISTOLOGIC GRADE
3800,medgemma,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3801,medgemma,0.697,SPECIMEN LATERALITY
3802,medgemma,0.823,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3803,medgemma,0.7,SPREAD THROUGH AIR SPACES (STAS)
3804,medgemma,0.815,REGIONAL LYMPH NODE STATUS
3805,medgemma,0.778,VISCERAL PLEURA INVASION
3806,medgemma,0.784,NODAL SITE(S) EXAMINED
3807,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3808,medgemma,0.827,PROCEDURE
3809,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3810,medgemma,0.865,TUMOR SITE
3811,medgemma,0.692,TUMOR FOCALITY
3812,medgemma,0.892,ADDITIONAL FINDINGS
3813,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3814,medgemma,0.72,NUMBER OF LYMPH NODES EXAMINED
3815,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3816,medgemma,0.71,NODAL SITE(S) EXAMINED
3817,medgemma,0.715,PROCEDURE
3818,medgemma,0.89,TUMOR SITE
3819,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3820,medgemma,0.743,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3821,medgemma,0.818,HISTOLOGIC GRADE
3822,medgemma,0.727,NODAL SITE(S) WITH TUMOR
3823,medgemma,0.778,VISCERAL PLEURA INVASION
3824,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3825,medgemma,0.728,LYMPH NODE(S) FROM PRIOR PROCEDURES
3826,medgemma,0.78,REGIONAL LYMPH NODE STATUS
3827,medgemma,0.699,TUMOR FOCALITY
3828,medgemma,0.705,NUMBER OF LYMPH NODES EXAMINED
3829,medgemma,0.697,SPECIMEN LATERALITY
3830,medgemma,0.736,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3831,medgemma,0.705,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3832,medgemma,0.701,NUMBER OF LYMPH NODES WITH TUMOR
3833,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
3834,medgemma,0.811,TUMOR FOCALITY
3835,medgemma,0.89,TUMOR SITE
3836,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3837,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3838,medgemma,0.778,VISCERAL PLEURA INVASION
3839,medgemma,0.798,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3840,medgemma,0.782,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3841,medgemma,0.904,HISTOLOGIC GRADE
3842,medgemma,0.823,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3843,medgemma,0.689,NODAL SITE(S) EXAMINED
3844,medgemma,0.72,NUMBER OF LYMPH NODES WITH TUMOR
3845,medgemma,0.801,PROCEDURE
3846,medgemma,0.78,REGIONAL LYMPH NODE STATUS
3847,medgemma,0.743,NODAL SITE(S) WITH TUMOR
3848,medgemma,0.698,SPECIMEN LATERALITY
3849,medgemma,0.802,ADDITIONAL FINDINGS
3850,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3851,medgemma,0.89,TUMOR SITE
3852,medgemma,0.78,VISCERAL PLEURA INVASION
3853,medgemma,0.815,REGIONAL LYMPH NODE STATUS
3854,medgemma,0.75,HISTOLOGIC GRADE
3855,medgemma,0.721,NODAL SITE(S) EXAMINED
3856,medgemma,0.744,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3857,medgemma,0.806,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3858,medgemma,0.788,PROCEDURE
3859,medgemma,0.697,SPECIMEN LATERALITY
3860,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3861,medgemma,0.789,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3862,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3863,medgemma,0.811,TUMOR FOCALITY
3864,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
3865,medgemma,0.816,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3866,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3867,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3868,medgemma,0.75,PROCEDURE
3869,medgemma,0.78,VISCERAL PLEURA INVASION
3870,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3871,medgemma,0.89,TUMOR SITE
3872,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3873,medgemma,0.815,REGIONAL LYMPH NODE STATUS
3874,medgemma,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3875,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
3876,medgemma,0.717,ADDITIONAL FINDINGS
3877,medgemma,0.811,TUMOR FOCALITY
3878,medgemma,0.697,SPECIMEN LATERALITY
3879,medgemma,0.797,HISTOLOGIC GRADE
3880,medgemma,0.714,NODAL SITE(S) EXAMINED
3881,medgemma,0.716,ADDITIONAL FINDINGS
3882,medgemma,0.698,NODAL SITE(S) EXAMINED
3883,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3884,medgemma,0.788,PROCEDURE
3885,medgemma,0.8,NUMBER OF LYMPH NODES EXAMINED
3886,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3887,medgemma,0.815,REGIONAL LYMPH NODE STATUS
3888,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3889,medgemma,0.697,SPECIMEN LATERALITY
3890,medgemma,0.731,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3891,medgemma,0.778,HISTOLOGIC GRADE
3892,medgemma,0.743,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3893,medgemma,0.811,TUMOR FOCALITY
3894,medgemma,0.718,VISCERAL PLEURA INVASION
3895,medgemma,0.7,SPREAD THROUGH AIR SPACES (STAS)
3896,medgemma,0.865,TUMOR SITE
3897,medgemma,0.698,SPECIMEN LATERALITY
3898,medgemma,0.703,NUMBER OF LYMPH NODES WITH TUMOR
3899,medgemma,0.66,TNM DESCRIPTORS
3900,medgemma,0.705,MARGIN STATUS FOR NON-INVASIVE TUMOR
3901,medgemma,0.78,REGIONAL LYMPH NODE STATUS
3902,medgemma,0.625,NODAL SITE(S) EXAMINED
3903,medgemma,0.818,HISTOLOGIC GRADE
3904,medgemma,0.657,TUMOR SITE
3905,medgemma,0.672,LYMPHOVASCULAR INVASION
3906,medgemma,0.7,VISCERAL PLEURA INVASION
3907,medgemma,0.7,SPREAD THROUGH AIR SPACES (STAS)
3908,medgemma,0.743,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3909,medgemma,0.745,NODAL SITE(S) WITH TUMOR
3910,medgemma,0.762,MARGIN STATUS FOR INVASIVE CARCINOMA
3911,medgemma,0.787,PROCEDURE
3912,medgemma,0.712,TUMOR FOCALITY
3913,medgemma,0.683,LYMPH NODE(S) FROM PRIOR PROCEDURES
3914,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3915,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3916,medgemma,0.716,REGIONAL LYMPH NODE STATUS
3917,medgemma,0.831,PROCEDURE
3918,medgemma,0.89,TUMOR SITE
3919,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3920,medgemma,0.722,NODAL SITE(S) EXAMINED
3921,medgemma,0.711,TUMOR FOCALITY
3922,medgemma,0.686,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3923,medgemma,0.697,SPECIMEN LATERALITY
3924,medgemma,0.732,ADDITIONAL FINDINGS
3925,medgemma,0.703,VISCERAL PLEURA INVASION
3926,medgemma,0.7,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3927,medgemma,0.783,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3928,medgemma,0.659,TNM DESCRIPTORS
3929,medgemma,0.818,HISTOLOGIC GRADE
3930,medgemma,0.665,SPREAD THROUGH AIR SPACES (STAS)
3931,medgemma,0.78,VISCERAL PLEURA INVASION
3932,medgemma,0.75,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3933,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3934,medgemma,0.836,PROCEDURE
3935,medgemma,0.817,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3936,medgemma,0.716,NODAL SITE(S) EXAMINED
3937,medgemma,0.697,SPECIMEN LATERALITY
3938,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3939,medgemma,0.892,HISTOLOGIC GRADE
3940,medgemma,0.89,TUMOR SITE
3941,medgemma,0.705,LYMPHOVASCULAR INVASION
3942,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3943,medgemma,0.692,ADDITIONAL FINDINGS
3944,medgemma,0.811,TUMOR FOCALITY
3945,medgemma,0.815,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3946,medgemma,0.818,HISTOLOGIC GRADE
3947,medgemma,0.811,TUMOR FOCALITY
3948,medgemma,0.656,TNM DESCRIPTORS
3949,medgemma,0.89,TUMOR SITE
3950,medgemma,0.696,NODAL SITE(S) EXAMINED
3951,medgemma,0.738,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3952,medgemma,0.78,VISCERAL PLEURA INVASION
3953,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3954,medgemma,0.685,NODAL SITE(S) WITH TUMOR
3955,medgemma,0.856,MARGIN STATUS FOR INVASIVE CARCINOMA
3956,medgemma,0.729,NUMBER OF LYMPH NODES EXAMINED
3957,medgemma,0.78,REGIONAL LYMPH NODE STATUS
3958,medgemma,0.698,NUMBER OF LYMPH NODES WITH TUMOR
3959,medgemma,0.801,PROCEDURE
3960,medgemma,0.698,SPECIMEN LATERALITY
3961,medgemma,0.745,LYMPHOVASCULAR INVASION
3962,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
3963,medgemma,0.756,NODAL SITE(S) EXAMINED
3964,medgemma,0.774,ADDITIONAL FINDINGS
3965,medgemma,0.811,TUMOR FOCALITY
3966,medgemma,0.815,REGIONAL LYMPH NODE STATUS
3967,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3968,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3969,medgemma,0.697,SPECIMEN LATERALITY
3970,medgemma,0.802,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3971,medgemma,0.796,PROCEDURE
3972,medgemma,0.708,NUMBER OF LYMPH NODES EXAMINED
3973,medgemma,0.818,HISTOLOGIC GRADE
3974,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
3975,medgemma,0.837,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3976,medgemma,0.89,TUMOR SITE
3977,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
3978,medgemma,0.778,VISCERAL PLEURA INVASION
3979,medgemma,0.803,PROCEDURE
3980,medgemma,0.718,SPREAD THROUGH AIR SPACES (STAS)
3981,medgemma,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3982,medgemma,0.699,NUMBER OF LYMPH NODES EXAMINED
3983,medgemma,0.698,SPECIMEN LATERALITY
3984,medgemma,0.778,VISCERAL PLEURA INVASION
3985,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
3986,medgemma,0.775,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3987,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
3988,medgemma,0.811,TUMOR FOCALITY
3989,medgemma,0.741,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3990,medgemma,0.698,NODAL SITE(S) EXAMINED
3991,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
3992,medgemma,0.776,HISTOLOGIC GRADE
3993,medgemma,0.865,TUMOR SITE
3994,medgemma,0.815,REGIONAL LYMPH NODE STATUS
3995,medgemma,0.774,ADDITIONAL FINDINGS
3996,medgemma,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3997,medgemma,0.829,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3998,medgemma,0.89,TUMOR SITE
3999,medgemma,0.689,ADDITIONAL FINDINGS
4000,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4001,medgemma,0.732,NODAL SITE(S) EXAMINED
4002,medgemma,0.818,HISTOLOGIC GRADE
4003,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4004,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
4005,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4006,medgemma,0.707,NUMBER OF LYMPH NODES EXAMINED
4007,medgemma,0.697,SPECIMEN LATERALITY
4008,medgemma,0.778,VISCERAL PLEURA INVASION
4009,medgemma,0.815,REGIONAL LYMPH NODE STATUS
4010,medgemma,0.692,TUMOR FOCALITY
4011,medgemma,0.796,PROCEDURE
4012,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4013,medgemma,0.786,PROCEDURE
4014,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4015,medgemma,0.904,HISTOLOGIC GRADE
4016,medgemma,0.811,TUMOR FOCALITY
4017,medgemma,0.816,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4018,medgemma,0.697,SPECIMEN LATERALITY
4019,medgemma,0.91,TUMOR SITE
4020,medgemma,0.679,SPREAD THROUGH AIR SPACES (STAS)
4021,medgemma,0.689,NODAL SITE(S) EXAMINED
4022,medgemma,0.815,REGIONAL LYMPH NODE STATUS
4023,medgemma,0.778,VISCERAL PLEURA INVASION
4024,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4025,medgemma,0.826,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4026,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4027,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4028,medgemma,0.778,VISCERAL PLEURA INVASION
4029,medgemma,0.737,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4030,medgemma,0.811,TUMOR FOCALITY
4031,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4032,medgemma,0.697,SPECIMEN LATERALITY
4033,medgemma,0.711,ADDITIONAL FINDINGS
4034,medgemma,0.829,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4035,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4036,medgemma,0.89,TUMOR SITE
4037,medgemma,0.815,HISTOLOGIC GRADE
4038,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4039,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4040,medgemma,0.827,PROCEDURE
4041,medgemma,0.716,REGIONAL LYMPH NODE STATUS
4042,medgemma,0.855,ADDITIONAL FINDINGS
4043,medgemma,0.697,SPECIMEN LATERALITY
4044,medgemma,0.659,TNM DESCRIPTORS
4045,medgemma,0.716,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4046,medgemma,0.899,PROCEDURE
4047,medgemma,0.778,VISCERAL PLEURA INVASION
4048,medgemma,0.757,NODAL SITE(S) EXAMINED
4049,medgemma,0.818,HISTOLOGIC GRADE
4050,medgemma,0.677,TUMOR SITE
4051,medgemma,0.795,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4052,medgemma,0.692,LYMPHOVASCULAR INVASION
4053,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4054,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4055,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4056,medgemma,0.712,TUMOR FOCALITY
4057,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4058,medgemma,0.734,HISTOLOGIC GRADE
4059,medgemma,0.67,VISCERAL PLEURA INVASION
4060,medgemma,0.712,TUMOR FOCALITY
4061,medgemma,0.877,TUMOR SITE
4062,medgemma,0.717,PROCEDURE
4063,medgemma,0.716,REGIONAL LYMPH NODE STATUS
4064,medgemma,0.663,SPECIMEN LATERALITY
4065,medgemma,0.823,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4066,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4067,medgemma,0.712,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4068,medgemma,0.712,NODAL SITE(S) EXAMINED
4069,medgemma,0.767,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4070,medgemma,0.713,NUMBER OF LYMPH NODES EXAMINED
4071,medgemma,0.708,MARGIN STATUS FOR INVASIVE CARCINOMA
4072,medgemma,0.668,TNM DESCRIPTORS
4073,medgemma,0.897,LYMPH NODE(S) FROM PRIOR PROCEDURES
4074,medgemma,0.692,TUMOR FOCALITY
4075,medgemma,0.697,SPECIMEN LATERALITY
4076,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4077,medgemma,0.756,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4078,medgemma,0.879,MARGIN STATUS FOR INVASIVE CARCINOMA
4079,medgemma,0.727,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4080,medgemma,0.904,HISTOLOGIC GRADE
4081,medgemma,0.829,REGIONAL LYMPH NODE STATUS
4082,medgemma,0.721,NODAL SITE(S) EXAMINED
4083,medgemma,0.658,TUMOR SITE
4084,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4085,medgemma,0.778,VISCERAL PLEURA INVASION
4086,medgemma,0.809,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4087,medgemma,0.827,PROCEDURE
4088,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
4089,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4090,medgemma,0.699,NODAL SITE(S) EXAMINED
4091,medgemma,0.732,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4092,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4093,medgemma,0.89,TUMOR SITE
4094,medgemma,0.778,VISCERAL PLEURA INVASION
4095,medgemma,0.698,SPECIMEN LATERALITY
4096,medgemma,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4097,medgemma,0.699,NUMBER OF LYMPH NODES EXAMINED
4098,medgemma,0.716,REGIONAL LYMPH NODE STATUS
4099,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4100,medgemma,0.811,TUMOR FOCALITY
4101,medgemma,0.827,PROCEDURE
4102,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4103,medgemma,0.683,LYMPH NODE(S) FROM PRIOR PROCEDURES
4104,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4105,medgemma,0.689,TUMOR FOCALITY
4106,medgemma,0.778,VISCERAL PLEURA INVASION
4107,medgemma,0.742,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4108,medgemma,0.705,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4109,medgemma,0.734,TNM DESCRIPTORS
4110,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4111,medgemma,0.697,SPECIMEN LATERALITY
4112,medgemma,0.893,TUMOR SITE
4113,medgemma,0.776,NODAL SITE(S) EXAMINED
4114,medgemma,0.7,NUMBER OF LYMPH NODES WITH TUMOR
4115,medgemma,0.788,PROCEDURE
4116,medgemma,0.78,REGIONAL LYMPH NODE STATUS
4117,medgemma,0.73,NUMBER OF LYMPH NODES EXAMINED
4118,medgemma,0.742,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4119,medgemma,0.768,NODAL SITE(S) WITH TUMOR
4120,medgemma,0.879,MARGIN STATUS FOR INVASIVE CARCINOMA
4121,medgemma,0.697,SPECIMEN LATERALITY
4122,medgemma,0.832,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4123,medgemma,0.865,TUMOR SITE
4124,medgemma,0.733,NODAL SITE(S) EXAMINED
4125,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4126,medgemma,0.692,TUMOR FOCALITY
4127,medgemma,0.755,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4128,medgemma,0.677,LYMPH NODE(S) FROM PRIOR PROCEDURES
4129,medgemma,0.759,PROCEDURE
4130,medgemma,0.782,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4131,medgemma,0.815,REGIONAL LYMPH NODE STATUS
4132,medgemma,0.811,TUMOR FOCALITY
4133,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4134,medgemma,0.749,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4135,medgemma,0.712,NODAL SITE(S) EXAMINED
4136,medgemma,0.712,NUMBER OF LYMPH NODES EXAMINED
4137,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4138,medgemma,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4139,medgemma,0.778,VISCERAL PLEURA INVASION
4140,medgemma,0.89,TUMOR SITE
4141,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4142,medgemma,0.815,REGIONAL LYMPH NODE STATUS
4143,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4144,medgemma,0.904,HISTOLOGIC GRADE
4145,medgemma,0.698,SPECIMEN LATERALITY
4146,medgemma,0.793,PROCEDURE
4147,medgemma,0.904,HISTOLOGIC GRADE
4148,medgemma,0.815,REGIONAL LYMPH NODE STATUS
4149,medgemma,0.788,PROCEDURE
4150,medgemma,0.735,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4151,medgemma,0.7,NODAL SITE(S) EXAMINED
4152,medgemma,0.811,TUMOR FOCALITY
4153,medgemma,0.808,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4154,medgemma,0.89,TUMOR SITE
4155,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4156,medgemma,0.778,VISCERAL PLEURA INVASION
4157,medgemma,0.698,SPECIMEN LATERALITY
4158,medgemma,0.756,NUMBER OF LYMPH NODES EXAMINED
4159,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4160,medgemma,0.7,SPREAD THROUGH AIR SPACES (STAS)
4161,medgemma,0.681,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4162,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4163,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4164,medgemma,0.775,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4165,medgemma,0.819,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4166,medgemma,0.778,VISCERAL PLEURA INVASION
4167,medgemma,0.811,TUMOR FOCALITY
4168,medgemma,0.89,TUMOR SITE
4169,medgemma,0.697,SPECIMEN LATERALITY
4170,medgemma,0.716,REGIONAL LYMPH NODE STATUS
4171,medgemma,0.725,NODAL SITE(S) EXAMINED
4172,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4173,medgemma,0.716,LYMPHOVASCULAR INVASION
4174,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4175,medgemma,0.796,PROCEDURE
4176,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4177,medgemma,0.697,SPECIMEN LATERALITY
4178,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
4179,medgemma,0.828,ADDITIONAL FINDINGS
4180,medgemma,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4181,medgemma,0.778,VISCERAL PLEURA INVASION
4182,medgemma,0.711,NODAL SITE(S) EXAMINED
4183,medgemma,0.89,TUMOR SITE
4184,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4185,medgemma,0.722,NUMBER OF LYMPH NODES EXAMINED
4186,medgemma,0.746,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4187,medgemma,0.796,PROCEDURE
4188,medgemma,0.716,REGIONAL LYMPH NODE STATUS
4189,medgemma,0.811,TUMOR FOCALITY
4190,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4191,medgemma,0.787,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4192,medgemma,0.89,TUMOR SITE
4193,medgemma,0.815,REGIONAL LYMPH NODE STATUS
4194,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4195,medgemma,0.675,NODAL SITE(S) EXAMINED
4196,medgemma,0.768,TNM DESCRIPTORS
4197,medgemma,0.778,VISCERAL PLEURA INVASION
4198,medgemma,0.69,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4199,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4200,medgemma,0.698,SPECIMEN LATERALITY
4201,medgemma,0.843,ADDITIONAL FINDINGS
4202,medgemma,0.808,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4203,medgemma,0.711,PROCEDURE
4204,medgemma,0.7,SPREAD THROUGH AIR SPACES (STAS)
4205,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4206,medgemma,0.716,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4207,medgemma,0.718,TUMOR FOCALITY
4208,medgemma,0.718,HISTOLOGIC GRADE
4209,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4210,medgemma,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4211,medgemma,0.713,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4212,medgemma,0.692,TUMOR FOCALITY
4213,medgemma,0.698,SPECIMEN LATERALITY
4214,medgemma,0.778,VISCERAL PLEURA INVASION
4215,medgemma,0.774,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4216,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4217,medgemma,0.705,NODAL SITE(S) EXAMINED
4218,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
4219,medgemma,0.904,HISTOLOGIC GRADE
4220,medgemma,0.815,REGIONAL LYMPH NODE STATUS
4221,medgemma,0.865,TUMOR SITE
4222,medgemma,0.7,NODAL SITE(S) EXAMINED
4223,medgemma,0.788,PROCEDURE
4224,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4225,medgemma,0.717,PROCEDURE
4226,medgemma,0.7,VISCERAL PLEURA INVASION
4227,medgemma,0.716,REGIONAL LYMPH NODE STATUS
4228,medgemma,0.735,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4229,medgemma,0.712,TUMOR FOCALITY
4230,medgemma,0.881,TUMOR SITE
4231,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4232,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4233,medgemma,0.785,NODAL SITE(S) EXAMINED
4234,medgemma,0.709,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4235,medgemma,0.7,SPREAD THROUGH AIR SPACES (STAS)
4236,medgemma,0.683,LYMPH NODE(S) FROM PRIOR PROCEDURES
4237,medgemma,0.738,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4238,medgemma,0.697,SPECIMEN LATERALITY
4239,medgemma,0.728,HISTOLOGIC GRADE
4240,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4241,medgemma,0.78,REGIONAL LYMPH NODE STATUS
4242,medgemma,0.697,SPECIMEN LATERALITY
4243,medgemma,0.778,VISCERAL PLEURA INVASION
4244,medgemma,0.782,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4245,medgemma,0.662,NODAL SITE(S) WITH TUMOR
4246,medgemma,0.811,TUMOR FOCALITY
4247,medgemma,0.838,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4248,medgemma,0.648,NUMBER OF LYMPH NODES WITH TUMOR
4249,medgemma,0.738,PROCEDURE
4250,medgemma,0.714,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4251,medgemma,0.744,TNM DESCRIPTORS
4252,medgemma,0.679,SPREAD THROUGH AIR SPACES (STAS)
4253,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4254,medgemma,0.771,ADDITIONAL FINDINGS
4255,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4256,medgemma,0.722,TUMOR SITE
4257,medgemma,0.708,NODAL SITE(S) EXAMINED
4258,medgemma,0.689,NODAL SITE(S) EXAMINED
4259,medgemma,0.892,HISTOLOGIC GRADE
4260,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4261,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4262,medgemma,0.819,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4263,medgemma,0.698,SPECIMEN LATERALITY
4264,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4265,medgemma,0.778,VISCERAL PLEURA INVASION
4266,medgemma,0.815,REGIONAL LYMPH NODE STATUS
4267,medgemma,0.735,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4268,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4269,medgemma,0.831,PROCEDURE
4270,medgemma,0.718,SPREAD THROUGH AIR SPACES (STAS)
4271,medgemma,0.811,TUMOR FOCALITY
4272,medgemma,0.782,NUMBER OF LYMPH NODES EXAMINED
4273,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4274,medgemma,0.697,SPECIMEN LATERALITY
4275,medgemma,0.904,HISTOLOGIC GRADE
4276,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
4277,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4278,medgemma,0.7,NUMBER OF LYMPH NODES EXAMINED
4279,medgemma,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4280,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4281,medgemma,0.716,REGIONAL LYMPH NODE STATUS
4282,medgemma,0.837,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4283,medgemma,0.793,PROCEDURE
4284,medgemma,0.726,NODAL SITE(S) EXAMINED
4285,medgemma,0.811,TUMOR FOCALITY
4286,medgemma,0.89,TUMOR SITE
4287,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4288,medgemma,0.778,VISCERAL PLEURA INVASION
4289,medgemma,0.782,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4290,medgemma,0.741,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4291,medgemma,0.815,REGIONAL LYMPH NODE STATUS
4292,medgemma,0.865,TUMOR SITE
4293,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4294,medgemma,0.716,ADDITIONAL FINDINGS
4295,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4296,medgemma,0.788,NUMBER OF LYMPH NODES EXAMINED
4297,medgemma,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4298,medgemma,0.697,SPECIMEN LATERALITY
4299,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
4300,medgemma,0.811,TUMOR FOCALITY
4301,medgemma,0.818,HISTOLOGIC GRADE
4302,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4303,medgemma,0.816,PROCEDURE
4304,medgemma,0.694,NODAL SITE(S) EXAMINED
4305,medgemma,0.778,VISCERAL PLEURA INVASION
4306,medgemma,0.784,NODAL SITE(S) WITH TUMOR
4307,medgemma,0.811,TUMOR FOCALITY
4308,medgemma,0.739,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4309,medgemma,0.72,NODAL SITE(S) EXAMINED
4310,medgemma,0.78,VISCERAL PLEURA INVASION
4311,medgemma,0.865,TUMOR SITE
4312,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4313,medgemma,0.672,LYMPHOVASCULAR INVASION
4314,medgemma,0.78,REGIONAL LYMPH NODE STATUS
4315,medgemma,0.776,PROCEDURE
4316,medgemma,0.75,HISTOLOGIC GRADE
4317,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4318,medgemma,0.707,NUMBER OF LYMPH NODES WITH TUMOR
4319,medgemma,0.688,SPREAD THROUGH AIR SPACES (STAS)
4320,medgemma,0.771,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4321,medgemma,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4322,medgemma,0.706,NUMBER OF LYMPH NODES EXAMINED
4323,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4324,medgemma,0.697,SPECIMEN LATERALITY
4325,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4326,medgemma,0.698,SPECIMEN LATERALITY
4327,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
4328,medgemma,0.827,PROCEDURE
4329,medgemma,0.89,TUMOR SITE
4330,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4331,medgemma,0.738,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4332,medgemma,0.915,TUMOR FOCALITY
4333,medgemma,0.737,LYMPH NODE(S) FROM PRIOR PROCEDURES
4334,medgemma,0.712,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4335,medgemma,0.705,HISTOLOGIC GRADE
4336,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4337,medgemma,0.78,VISCERAL PLEURA INVASION
4338,medgemma,0.815,REGIONAL LYMPH NODE STATUS
4339,medgemma,0.818,HISTOLOGIC GRADE
4340,medgemma,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4341,medgemma,0.827,PROCEDURE
4342,medgemma,0.698,SPECIMEN LATERALITY
4343,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4344,medgemma,0.702,NODAL SITE(S) EXAMINED
4345,medgemma,0.89,TUMOR SITE
4346,medgemma,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4347,medgemma,0.706,NUMBER OF LYMPH NODES EXAMINED
4348,medgemma,0.78,VISCERAL PLEURA INVASION
4349,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4350,medgemma,0.7,SPREAD THROUGH AIR SPACES (STAS)
4351,medgemma,0.692,TUMOR FOCALITY
4352,medgemma,0.717,ADDITIONAL FINDINGS
4353,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4354,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4355,medgemma,0.701,SPREAD THROUGH AIR SPACES (STAS)
4356,medgemma,0.778,HISTOLOGIC GRADE
4357,medgemma,0.738,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4358,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4359,medgemma,0.718,VISCERAL PLEURA INVASION
4360,medgemma,0.702,ADDITIONAL FINDINGS
4361,medgemma,0.725,NODAL SITE(S) EXAMINED
4362,medgemma,0.89,TUMOR SITE
4363,medgemma,0.716,LYMPHOVASCULAR INVASION
4364,medgemma,0.811,TUMOR FOCALITY
4365,medgemma,0.76,NUMBER OF LYMPH NODES EXAMINED
4366,medgemma,0.692,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4367,medgemma,0.782,PROCEDURE
4368,medgemma,0.698,SPECIMEN LATERALITY
4369,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4370,medgemma,0.835,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4371,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4372,medgemma,0.654,TNM DESCRIPTORS
4373,medgemma,0.892,HISTOLOGIC GRADE
4374,medgemma,0.698,SPECIMEN LATERALITY
4375,medgemma,0.811,TUMOR FOCALITY
4376,medgemma,0.89,TUMOR SITE
4377,medgemma,0.78,REGIONAL LYMPH NODE STATUS
4378,medgemma,0.732,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4379,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4380,medgemma,0.801,PROCEDURE
4381,medgemma,0.883,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4382,medgemma,0.743,LYMPHOVASCULAR INVASION
4383,medgemma,0.643,TNM DESCRIPTORS
4384,medgemma,0.691,NODAL SITE(S) EXAMINED
4385,medgemma,0.805,SPREAD THROUGH AIR SPACES (STAS)
4386,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4387,medgemma,0.807,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4388,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4389,medgemma,0.685,NODAL SITE(S) WITH TUMOR
4390,medgemma,0.78,VISCERAL PLEURA INVASION
4391,medgemma,0.736,NODAL SITE(S) WITH TUMOR
4392,medgemma,0.72,NODAL SITE(S) EXAMINED
4393,medgemma,0.72,NUMBER OF LYMPH NODES WITH TUMOR
4394,medgemma,0.697,SPECIMEN LATERALITY
4395,medgemma,0.808,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4396,medgemma,0.811,TUMOR FOCALITY
4397,medgemma,0.78,REGIONAL LYMPH NODE STATUS
4398,medgemma,0.713,NUMBER OF LYMPH NODES EXAMINED
4399,medgemma,0.708,MARGIN STATUS FOR INVASIVE CARCINOMA
4400,medgemma,0.938,ADDITIONAL FINDINGS
4401,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4402,medgemma,0.884,TUMOR SITE
4403,medgemma,0.765,PROCEDURE
4404,medgemma,0.805,SPREAD THROUGH AIR SPACES (STAS)
4405,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4406,medgemma,0.735,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4407,medgemma,0.892,HISTOLOGIC GRADE
4408,medgemma,0.739,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4409,medgemma,0.778,VISCERAL PLEURA INVASION
4410,medgemma,0.815,REGIONAL LYMPH NODE STATUS
4411,medgemma,0.632,NODAL SITE(S) EXAMINED
4412,medgemma,0.722,HISTOLOGIC GRADE
4413,medgemma,0.692,LYMPH NODE(S) FROM PRIOR PROCEDURES
4414,medgemma,0.791,PROCEDURE
4415,medgemma,0.7,SPREAD THROUGH AIR SPACES (STAS)
4416,medgemma,0.677,MARGIN STATUS FOR INVASIVE CARCINOMA
4417,medgemma,0.716,ADDITIONAL FINDINGS
4418,medgemma,0.692,TUMOR FOCALITY
4419,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4420,medgemma,0.697,SPECIMEN LATERALITY
4421,medgemma,0.73,TNM DESCRIPTORS
4422,medgemma,0.778,VISCERAL PLEURA INVASION
4423,medgemma,0.738,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4424,medgemma,0.884,TUMOR SITE
4425,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4426,medgemma,0.708,TUMOR FOCALITY
4427,medgemma,0.741,PROCEDURE
4428,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4429,medgemma,0.865,TUMOR SITE
4430,medgemma,0.713,NUMBER OF LYMPH NODES WITH TUMOR
4431,medgemma,0.78,REGIONAL LYMPH NODE STATUS
4432,medgemma,0.745,LYMPHOVASCULAR INVASION
4433,medgemma,0.697,SPECIMEN LATERALITY
4434,medgemma,0.726,NODAL SITE(S) WITH TUMOR
4435,medgemma,0.746,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4436,medgemma,0.679,HISTOLOGIC GRADE
4437,medgemma,0.78,VISCERAL PLEURA INVASION
4438,medgemma,0.717,NODAL SITE(S) EXAMINED
4439,medgemma,0.733,SPREAD THROUGH AIR SPACES (STAS)
4440,medgemma,0.756,NUMBER OF LYMPH NODES EXAMINED
4441,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4442,medgemma,0.713,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4443,medgemma,0.718,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4444,medgemma,0.798,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4445,medgemma,0.811,TUMOR FOCALITY
4446,medgemma,0.706,ADDITIONAL FINDINGS
4447,medgemma,0.796,PROCEDURE
4448,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4449,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4450,medgemma,0.815,HISTOLOGIC GRADE
4451,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4452,medgemma,0.829,REGIONAL LYMPH NODE STATUS
4453,medgemma,0.835,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4454,medgemma,0.697,SPECIMEN LATERALITY
4455,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
4456,medgemma,0.89,TUMOR SITE
4457,medgemma,0.725,NODAL SITE(S) EXAMINED
4458,medgemma,0.739,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4459,medgemma,0.778,VISCERAL PLEURA INVASION
4460,medgemma,0.698,NUMBER OF LYMPH NODES EXAMINED
4461,medgemma,0.704,NODAL SITE(S) EXAMINED
4462,medgemma,0.691,SPREAD THROUGH AIR SPACES (STAS)
4463,medgemma,0.716,REGIONAL LYMPH NODE STATUS
4464,medgemma,0.692,TUMOR FOCALITY
4465,medgemma,0.698,VISCERAL PLEURA INVASION
4466,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4467,medgemma,0.716,PROCEDURE
4468,medgemma,0.756,TUMOR SITE
4469,medgemma,0.814,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4470,medgemma,0.797,HISTOLOGIC GRADE
4471,medgemma,0.731,LYMPHOVASCULAR INVASION
4472,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4473,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4474,medgemma,0.715,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4475,medgemma,0.697,SPECIMEN LATERALITY
4476,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4477,medgemma,0.714,LYMPHOVASCULAR INVASION
4478,medgemma,0.722,NUMBER OF LYMPH NODES EXAMINED
4479,medgemma,0.819,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4480,medgemma,0.739,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4481,medgemma,0.778,VISCERAL PLEURA INVASION
4482,medgemma,0.801,PROCEDURE
4483,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4484,medgemma,0.808,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4485,medgemma,0.698,SPECIMEN LATERALITY
4486,medgemma,0.778,HISTOLOGIC GRADE
4487,medgemma,0.692,TUMOR FOCALITY
4488,medgemma,0.699,NODAL SITE(S) EXAMINED
4489,medgemma,0.89,TUMOR SITE
4490,medgemma,0.815,REGIONAL LYMPH NODE STATUS
4491,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4492,medgemma,0.871,ADDITIONAL FINDINGS
4493,medgemma,0.701,NUMBER OF LYMPH NODES EXAMINED
4494,medgemma,0.817,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4495,medgemma,0.697,SPECIMEN LATERALITY
4496,medgemma,0.811,TUMOR FOCALITY
4497,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4498,medgemma,0.716,REGIONAL LYMPH NODE STATUS
4499,medgemma,0.824,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4500,medgemma,0.827,PROCEDURE
4501,medgemma,0.745,LYMPHOVASCULAR INVASION
4502,medgemma,0.737,NODAL SITE(S) EXAMINED
4503,medgemma,0.698,VISCERAL PLEURA INVASION
4504,medgemma,0.89,TUMOR SITE
4505,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4506,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
4507,medgemma,0.698,VISCERAL PLEURA INVASION
4508,medgemma,0.722,NODAL SITE(S) EXAMINED
4509,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4510,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4511,medgemma,0.734,NODAL SITE(S) WITH TUMOR
4512,medgemma,0.701,SPREAD THROUGH AIR SPACES (STAS)
4513,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4514,medgemma,0.696,NUMBER OF LYMPH NODES EXAMINED
4515,medgemma,0.817,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4516,medgemma,0.695,LYMPHOVASCULAR INVASION
4517,medgemma,0.72,NUMBER OF LYMPH NODES WITH TUMOR
4518,medgemma,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4519,medgemma,0.892,HISTOLOGIC GRADE
4520,medgemma,0.78,REGIONAL LYMPH NODE STATUS
4521,medgemma,0.698,SPECIMEN LATERALITY
4522,medgemma,0.811,TUMOR FOCALITY
4523,medgemma,0.769,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4524,medgemma,0.865,TUMOR SITE
4525,medgemma,0.803,PROCEDURE
4526,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
4527,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4528,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4529,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4530,medgemma,0.815,REGIONAL LYMPH NODE STATUS
4531,medgemma,0.697,SPECIMEN LATERALITY
4532,medgemma,0.892,HISTOLOGIC GRADE
4533,medgemma,0.811,TUMOR FOCALITY
4534,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4535,medgemma,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4536,medgemma,0.827,PROCEDURE
4537,medgemma,0.72,NUMBER OF LYMPH NODES EXAMINED
4538,medgemma,0.784,NODAL SITE(S) EXAMINED
4539,medgemma,0.778,VISCERAL PLEURA INVASION
4540,medgemma,0.798,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4541,medgemma,0.865,TUMOR SITE
4542,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4543,medgemma,0.731,NODAL SITE(S) EXAMINED
4544,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4545,medgemma,0.698,SPECIMEN LATERALITY
4546,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4547,medgemma,0.712,TUMOR FOCALITY
4548,medgemma,0.778,VISCERAL PLEURA INVASION
4549,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4550,medgemma,0.89,TUMOR SITE
4551,medgemma,0.838,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4552,medgemma,0.738,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4553,medgemma,0.815,REGIONAL LYMPH NODE STATUS
4554,medgemma,0.774,ADDITIONAL FINDINGS
4555,medgemma,0.757,PROCEDURE
4556,medgemma,0.775,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4557,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4558,medgemma,0.811,TUMOR FOCALITY
4559,medgemma,0.778,VISCERAL PLEURA INVASION
4560,medgemma,0.716,REGIONAL LYMPH NODE STATUS
4561,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4562,medgemma,0.825,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4563,medgemma,0.714,NUMBER OF LYMPH NODES EXAMINED
4564,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4565,medgemma,0.788,PROCEDURE
4566,medgemma,0.797,HISTOLOGIC GRADE
4567,medgemma,0.732,NODAL SITE(S) EXAMINED
4568,medgemma,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4569,medgemma,0.697,SPECIMEN LATERALITY
4570,medgemma,0.865,TUMOR SITE
4571,medgemma,0.778,VISCERAL PLEURA INVASION
4572,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4573,medgemma,0.692,LYMPHOVASCULAR INVASION
4574,medgemma,0.772,ADDITIONAL FINDINGS
4575,medgemma,0.89,TUMOR SITE
4576,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4577,medgemma,0.811,TUMOR FOCALITY
4578,medgemma,0.703,NUMBER OF LYMPH NODES EXAMINED
4579,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4580,medgemma,0.697,SPECIMEN LATERALITY
4581,medgemma,0.753,NODAL SITE(S) EXAMINED
4582,medgemma,0.815,REGIONAL LYMPH NODE STATUS
4583,medgemma,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4584,medgemma,0.718,SPREAD THROUGH AIR SPACES (STAS)
4585,medgemma,0.847,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4586,medgemma,0.793,PROCEDURE
4587,medgemma,0.892,HISTOLOGIC GRADE
4588,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4589,medgemma,0.78,VISCERAL PLEURA INVASION
4590,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4591,medgemma,0.811,TUMOR FOCALITY
4592,medgemma,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4593,medgemma,0.686,ADDITIONAL FINDINGS
4594,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4595,medgemma,0.813,PROCEDURE
4596,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4597,medgemma,0.698,SPECIMEN LATERALITY
4598,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4599,medgemma,0.865,TUMOR SITE
4600,medgemma,0.829,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4601,medgemma,0.892,HISTOLOGIC GRADE
4602,medgemma,0.679,NODAL SITE(S) EXAMINED
4603,medgemma,0.815,REGIONAL LYMPH NODE STATUS
4604,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4605,medgemma,0.697,SPECIMEN LATERALITY
4606,medgemma,0.827,PROCEDURE
4607,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4608,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
4609,medgemma,0.815,HISTOLOGIC GRADE
4610,medgemma,0.693,NUMBER OF LYMPH NODES EXAMINED
4611,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4612,medgemma,0.815,REGIONAL LYMPH NODE STATUS
4613,medgemma,0.89,TUMOR SITE
4614,medgemma,0.811,TUMOR FOCALITY
4615,medgemma,0.778,VISCERAL PLEURA INVASION
4616,medgemma,0.829,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4617,medgemma,0.825,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4618,medgemma,0.758,NODAL SITE(S) EXAMINED
4619,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4620,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4621,medgemma,0.815,REGIONAL LYMPH NODE STATUS
4622,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4623,medgemma,0.738,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4624,medgemma,0.786,PROCEDURE
4625,medgemma,0.697,SPECIMEN LATERALITY
4626,medgemma,0.683,LYMPH NODE(S) FROM PRIOR PROCEDURES
4627,medgemma,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4628,medgemma,0.904,HISTOLOGIC GRADE
4629,medgemma,0.778,VISCERAL PLEURA INVASION
4630,medgemma,0.89,TUMOR SITE
4631,medgemma,0.699,NUMBER OF LYMPH NODES EXAMINED
4632,medgemma,0.811,TUMOR FOCALITY
4633,medgemma,0.677,NODAL SITE(S) EXAMINED
4634,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
4635,medgemma,0.715,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4636,medgemma,0.801,PROCEDURE
4637,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
4638,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4639,medgemma,0.698,SPECIMEN LATERALITY
4640,medgemma,0.787,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4641,medgemma,0.702,NODAL SITE(S) EXAMINED
4642,medgemma,0.738,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4643,medgemma,0.815,REGIONAL LYMPH NODE STATUS
4644,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4645,medgemma,0.811,TUMOR FOCALITY
4646,medgemma,0.788,ADDITIONAL FINDINGS
4647,medgemma,0.797,HISTOLOGIC GRADE
4648,medgemma,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4649,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4650,medgemma,0.778,VISCERAL PLEURA INVASION
4651,medgemma,0.703,NUMBER OF LYMPH NODES EXAMINED
4652,medgemma,0.89,TUMOR SITE
4653,medgemma,0.827,PROCEDURE
4654,medgemma,0.703,NUMBER OF LYMPH NODES EXAMINED
4655,medgemma,0.89,TUMOR SITE
4656,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4657,medgemma,0.815,REGIONAL LYMPH NODE STATUS
4658,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4659,medgemma,0.697,SPECIMEN LATERALITY
4660,medgemma,0.818,HISTOLOGIC GRADE
4661,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4662,medgemma,0.813,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4663,medgemma,0.811,TUMOR FOCALITY
4664,medgemma,0.78,VISCERAL PLEURA INVASION
4665,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4666,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
4667,medgemma,0.738,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4668,medgemma,0.716,NODAL SITE(S) EXAMINED
4669,medgemma,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4670,medgemma,0.702,ADDITIONAL FINDINGS
4671,medgemma,0.818,HISTOLOGIC GRADE
4672,medgemma,0.742,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4673,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4674,medgemma,0.7,SPREAD THROUGH AIR SPACES (STAS)
4675,medgemma,0.778,VISCERAL PLEURA INVASION
4676,medgemma,0.803,PROCEDURE
4677,medgemma,0.712,NUMBER OF LYMPH NODES EXAMINED
4678,medgemma,0.735,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4679,medgemma,0.724,NODAL SITE(S) EXAMINED
4680,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4681,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4682,medgemma,0.865,TUMOR SITE
4683,medgemma,0.811,TUMOR FOCALITY
4684,medgemma,0.815,REGIONAL LYMPH NODE STATUS
4685,medgemma,0.698,SPECIMEN LATERALITY
4686,medgemma,0.815,REGIONAL LYMPH NODE STATUS
4687,medgemma,0.697,SPECIMEN LATERALITY
4688,medgemma,0.784,NODAL SITE(S) EXAMINED
4689,medgemma,0.818,HISTOLOGIC GRADE
4690,medgemma,0.7,SPREAD THROUGH AIR SPACES (STAS)
4691,medgemma,0.865,TUMOR SITE
4692,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4693,medgemma,0.72,NUMBER OF LYMPH NODES EXAMINED
4694,medgemma,0.811,TUMOR FOCALITY
4695,medgemma,0.78,VISCERAL PLEURA INVASION
4696,medgemma,0.827,PROCEDURE
4697,medgemma,0.813,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4698,medgemma,0.732,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4699,medgemma,0.755,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4700,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4701,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4702,medgemma,0.692,TUMOR FOCALITY
4703,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
4704,medgemma,0.827,PROCEDURE
4705,medgemma,0.904,HISTOLOGIC GRADE
4706,medgemma,0.781,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4707,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4708,medgemma,0.71,ADDITIONAL FINDINGS
4709,medgemma,0.735,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4710,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4711,medgemma,0.724,NODAL SITE(S) EXAMINED
4712,medgemma,0.865,TUMOR SITE
4713,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4714,medgemma,0.778,VISCERAL PLEURA INVASION
4715,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4716,medgemma,0.815,REGIONAL LYMPH NODE STATUS
4717,medgemma,0.699,NUMBER OF LYMPH NODES EXAMINED
4718,medgemma,0.698,SPECIMEN LATERALITY
4719,medgemma,0.697,SPECIMEN LATERALITY
4720,medgemma,0.778,VISCERAL PLEURA INVASION
4721,medgemma,0.904,HISTOLOGIC GRADE
4722,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4723,medgemma,0.674,MARGIN STATUS FOR INVASIVE CARCINOMA
4724,medgemma,0.696,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4725,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4726,medgemma,0.822,PROCEDURE
4727,medgemma,0.716,TNM DESCRIPTORS
4728,medgemma,0.736,TUMOR FOCALITY
4729,medgemma,0.761,ADDITIONAL FINDINGS
4730,medgemma,0.698,NODAL SITE(S) EXAMINED
4731,medgemma,0.716,REGIONAL LYMPH NODE STATUS
4732,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4733,medgemma,0.698,SPECIMEN LATERALITY
4734,medgemma,0.699,NODAL SITE(S) EXAMINED
4735,medgemma,0.892,HISTOLOGIC GRADE
4736,medgemma,0.804,ADDITIONAL FINDINGS
4737,medgemma,0.685,SPREAD THROUGH AIR SPACES (STAS)
4738,medgemma,0.743,VISCERAL PLEURA INVASION
4739,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4740,medgemma,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4741,medgemma,0.89,TUMOR SITE
4742,medgemma,0.716,REGIONAL LYMPH NODE STATUS
4743,medgemma,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4744,medgemma,0.815,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4745,medgemma,0.793,PROCEDURE
4746,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4747,medgemma,0.821,LYMPHOVASCULAR INVASION
4748,medgemma,0.811,TUMOR FOCALITY
4749,medgemma,0.708,NUMBER OF LYMPH NODES EXAMINED
4750,medgemma,0.699,NODAL SITE(S) EXAMINED
4751,medgemma,0.89,TUMOR SITE
4752,medgemma,0.713,NUMBER OF LYMPH NODES EXAMINED
4753,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4754,medgemma,0.778,VISCERAL PLEURA INVASION
4755,medgemma,0.815,HISTOLOGIC GRADE
4756,medgemma,0.697,SPECIMEN LATERALITY
4757,medgemma,0.739,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4758,medgemma,0.727,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4759,medgemma,0.827,PROCEDURE
4760,medgemma,0.701,SPREAD THROUGH AIR SPACES (STAS)
4761,medgemma,0.815,REGIONAL LYMPH NODE STATUS
4762,medgemma,0.902,ADDITIONAL FINDINGS
4763,medgemma,0.718,TUMOR FOCALITY
4764,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4765,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4766,medgemma,0.825,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4767,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4768,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4769,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4770,medgemma,0.892,HISTOLOGIC GRADE
4771,medgemma,0.692,TUMOR FOCALITY
4772,medgemma,0.701,NODAL SITE(S) EXAMINED
4773,medgemma,0.697,SPECIMEN LATERALITY
4774,medgemma,0.826,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4775,medgemma,0.706,NUMBER OF LYMPH NODES EXAMINED
4776,medgemma,0.815,REGIONAL LYMPH NODE STATUS
4777,medgemma,0.778,VISCERAL PLEURA INVASION
4778,medgemma,0.826,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4779,medgemma,0.865,TUMOR SITE
4780,medgemma,0.827,PROCEDURE
4781,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4782,medgemma,0.748,NODAL SITE(S) EXAMINED
4783,medgemma,0.798,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4784,medgemma,0.698,SPECIMEN LATERALITY
4785,medgemma,0.815,REGIONAL LYMPH NODE STATUS
4786,medgemma,0.811,TUMOR FOCALITY
4787,medgemma,0.865,TUMOR SITE
4788,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4789,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4790,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4791,medgemma,0.698,VISCERAL PLEURA INVASION
4792,medgemma,0.72,NUMBER OF LYMPH NODES EXAMINED
4793,medgemma,0.847,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4794,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4795,medgemma,0.827,PROCEDURE
4796,medgemma,0.707,ADDITIONAL FINDINGS
4797,medgemma,0.727,NODAL SITE(S) EXAMINED
4798,medgemma,0.823,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4799,medgemma,0.711,PROCEDURE
4800,medgemma,0.89,TUMOR SITE
4801,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4802,medgemma,0.706,HISTOLOGIC GRADE
4803,medgemma,0.816,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4804,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4805,medgemma,0.815,REGIONAL LYMPH NODE STATUS
4806,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4807,medgemma,0.697,SPECIMEN LATERALITY
4808,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4809,medgemma,0.778,VISCERAL PLEURA INVASION
4810,medgemma,0.692,TUMOR FOCALITY
4811,medgemma,0.716,REGIONAL LYMPH NODE STATUS
4812,medgemma,0.697,SPECIMEN LATERALITY
4813,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4814,medgemma,0.778,VISCERAL PLEURA INVASION
4815,medgemma,0.739,NODAL SITE(S) EXAMINED
4816,medgemma,0.802,PROCEDURE
4817,medgemma,0.734,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4818,medgemma,0.885,TUMOR SITE
4819,medgemma,0.695,NUMBER OF LYMPH NODES EXAMINED
4820,medgemma,0.774,MARGIN STATUS FOR INVASIVE CARCINOMA
4821,medgemma,0.67,SPREAD THROUGH AIR SPACES (STAS)
4822,medgemma,0.892,HISTOLOGIC GRADE
4823,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4824,medgemma,0.828,TUMOR FOCALITY
4825,medgemma,0.78,VISCERAL PLEURA INVASION
4826,medgemma,0.698,SPECIMEN LATERALITY
4827,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4828,medgemma,0.865,TUMOR SITE
4829,medgemma,0.689,SPREAD THROUGH AIR SPACES (STAS)
4830,medgemma,0.757,PROCEDURE
4831,medgemma,0.698,LYMPHOVASCULAR INVASION
4832,medgemma,0.735,NODAL SITE(S) WITH TUMOR
4833,medgemma,0.78,REGIONAL LYMPH NODE STATUS
4834,medgemma,0.699,NUMBER OF LYMPH NODES WITH TUMOR
4835,medgemma,0.697,NODAL SITE(S) EXAMINED
4836,medgemma,0.778,HISTOLOGIC GRADE
4837,medgemma,0.838,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4838,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4839,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4840,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4841,medgemma,0.811,TUMOR FOCALITY
4842,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
4843,medgemma,0.78,VISCERAL PLEURA INVASION
4844,medgemma,0.698,SPECIMEN LATERALITY
4845,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4846,medgemma,0.78,REGIONAL LYMPH NODE STATUS
4847,medgemma,0.879,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4848,medgemma,0.715,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4849,medgemma,0.811,TUMOR FOCALITY
4850,medgemma,0.745,LYMPHOVASCULAR INVASION
4851,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4852,medgemma,0.865,TUMOR SITE
4853,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4854,medgemma,0.639,NODAL SITE(S) WITH TUMOR
4855,medgemma,0.706,NUMBER OF LYMPH NODES WITH TUMOR
4856,medgemma,0.679,NODAL SITE(S) EXAMINED
4857,medgemma,0.8,NUMBER OF LYMPH NODES EXAMINED
4858,medgemma,0.774,ADDITIONAL FINDINGS
4859,medgemma,0.803,PROCEDURE
4860,medgemma,0.778,HISTOLOGIC GRADE
4861,medgemma,0.697,SPECIMEN LATERALITY
4862,medgemma,0.811,TUMOR FOCALITY
4863,medgemma,0.815,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4864,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4865,medgemma,0.879,MARGIN STATUS FOR INVASIVE CARCINOMA
4866,medgemma,0.815,REGIONAL LYMPH NODE STATUS
4867,medgemma,0.67,SPREAD THROUGH AIR SPACES (STAS)
4868,medgemma,0.847,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4869,medgemma,0.892,HISTOLOGIC GRADE
4870,medgemma,0.865,TUMOR SITE
4871,medgemma,0.723,NODAL SITE(S) EXAMINED
4872,medgemma,0.793,PROCEDURE
4873,medgemma,0.71,ADDITIONAL FINDINGS
4874,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4875,medgemma,0.683,NODAL SITE(S) EXAMINED
4876,medgemma,0.778,VISCERAL PLEURA INVASION
4877,medgemma,0.755,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4878,medgemma,0.692,LYMPHOVASCULAR INVASION
4879,medgemma,0.735,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4880,medgemma,0.657,NODAL SITE(S) EXAMINED
4881,medgemma,0.706,SPREAD THROUGH AIR SPACES (STAS)
4882,medgemma,0.938,ADDITIONAL FINDINGS
4883,medgemma,0.697,SPECIMEN LATERALITY
4884,medgemma,0.748,MARGIN STATUS FOR INVASIVE CARCINOMA
4885,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4886,medgemma,0.89,TUMOR SITE
4887,medgemma,0.815,REGIONAL LYMPH NODE STATUS
4888,medgemma,0.811,TUMOR FOCALITY
4889,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4890,medgemma,0.78,VISCERAL PLEURA INVASION
4891,medgemma,0.904,HISTOLOGIC GRADE
4892,medgemma,0.788,PROCEDURE
4893,medgemma,0.815,REGIONAL LYMPH NODE STATUS
4894,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4895,medgemma,0.697,SPECIMEN LATERALITY
4896,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4897,medgemma,0.815,HISTOLOGIC GRADE
4898,medgemma,0.766,NODAL SITE(S) EXAMINED
4899,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4900,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4901,medgemma,0.811,TUMOR FOCALITY
4902,medgemma,0.865,TUMOR SITE
4903,medgemma,0.827,PROCEDURE
4904,medgemma,0.835,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4905,medgemma,0.778,VISCERAL PLEURA INVASION
4906,medgemma,0.805,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4907,medgemma,0.698,NUMBER OF LYMPH NODES EXAMINED
4908,medgemma,0.713,ADDITIONAL FINDINGS
4909,medgemma,0.718,SPREAD THROUGH AIR SPACES (STAS)
4910,medgemma,0.832,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4911,medgemma,0.778,VISCERAL PLEURA INVASION
4912,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4913,medgemma,0.742,ADDITIONAL FINDINGS
4914,medgemma,0.716,REGIONAL LYMPH NODE STATUS
4915,medgemma,0.904,HISTOLOGIC GRADE
4916,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4917,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
4918,medgemma,0.689,TUMOR SITE
4919,medgemma,0.717,PROCEDURE
4920,medgemma,0.757,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4921,medgemma,0.697,SPECIMEN LATERALITY
4922,medgemma,0.729,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4923,medgemma,0.677,LYMPH NODE(S) FROM PRIOR PROCEDURES
4924,medgemma,0.741,NODAL SITE(S) EXAMINED
4925,medgemma,0.811,TUMOR FOCALITY
4926,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4927,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
4928,medgemma,0.778,VISCERAL PLEURA INVASION
4929,medgemma,0.717,ADDITIONAL FINDINGS
4930,medgemma,0.698,SPECIMEN LATERALITY
4931,medgemma,0.817,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4932,medgemma,0.815,HISTOLOGIC GRADE
4933,medgemma,0.815,REGIONAL LYMPH NODE STATUS
4934,medgemma,0.712,NODAL SITE(S) EXAMINED
4935,medgemma,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4936,medgemma,0.713,NUMBER OF LYMPH NODES EXAMINED
4937,medgemma,0.827,PROCEDURE
4938,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4939,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4940,medgemma,0.692,TUMOR FOCALITY
4941,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4942,medgemma,0.89,TUMOR SITE
4943,medgemma,0.865,TUMOR SITE
4944,medgemma,0.716,REGIONAL LYMPH NODE STATUS
4945,medgemma,0.692,TUMOR FOCALITY
4946,medgemma,0.741,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4947,medgemma,0.698,SPECIMEN LATERALITY
4948,medgemma,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4949,medgemma,0.683,LYMPH NODE(S) FROM PRIOR PROCEDURES
4950,medgemma,0.788,PROCEDURE
4951,medgemma,0.7,SPREAD THROUGH AIR SPACES (STAS)
4952,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4953,medgemma,0.774,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4954,medgemma,0.892,HISTOLOGIC GRADE
4955,medgemma,0.729,NODAL SITE(S) EXAMINED
4956,medgemma,0.778,VISCERAL PLEURA INVASION
4957,medgemma,0.774,ADDITIONAL FINDINGS
4958,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4959,medgemma,0.841,MARGIN STATUS FOR INVASIVE CARCINOMA
4960,medgemma,0.714,NODAL SITE(S) EXAMINED
4961,medgemma,0.722,ADDITIONAL FINDINGS
4962,medgemma,0.697,SPECIMEN LATERALITY
4963,medgemma,0.778,VISCERAL PLEURA INVASION
4964,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4965,medgemma,0.716,REGIONAL LYMPH NODE STATUS
4966,medgemma,0.699,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4967,medgemma,0.796,PROCEDURE
4968,medgemma,0.818,HISTOLOGIC GRADE
4969,medgemma,0.798,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4970,medgemma,0.7,SPREAD THROUGH AIR SPACES (STAS)
4971,medgemma,0.811,TUMOR FOCALITY
4972,medgemma,0.792,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4973,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4974,medgemma,0.89,TUMOR SITE
4975,medgemma,0.753,PROCEDURE
4976,medgemma,0.778,VISCERAL PLEURA INVASION
4977,medgemma,0.89,TUMOR SITE
4978,medgemma,0.694,NODAL SITE(S) EXAMINED
4979,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4980,medgemma,0.818,HISTOLOGIC GRADE
4981,medgemma,0.78,SPREAD THROUGH AIR SPACES (STAS)
4982,medgemma,0.804,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4983,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
4984,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4985,medgemma,0.815,REGIONAL LYMPH NODE STATUS
4986,medgemma,0.811,TUMOR FOCALITY
4987,medgemma,0.737,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4988,medgemma,0.713,NUMBER OF LYMPH NODES EXAMINED
4989,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4990,medgemma,0.698,SPECIMEN LATERALITY
4991,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
4992,medgemma,0.697,SPECIMEN LATERALITY
4993,medgemma,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4994,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
4995,medgemma,0.815,REGIONAL LYMPH NODE STATUS
4996,medgemma,0.89,TUMOR SITE
4997,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
4998,medgemma,0.796,PROCEDURE
4999,medgemma,0.778,VISCERAL PLEURA INVASION
5000,medgemma,0.811,TUMOR FOCALITY
5001,medgemma,0.837,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5002,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5003,medgemma,0.779,NUMBER OF LYMPH NODES EXAMINED
5004,medgemma,0.733,NODAL SITE(S) EXAMINED
5005,medgemma,0.818,HISTOLOGIC GRADE
5006,medgemma,0.688,ADDITIONAL FINDINGS
5007,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
5008,medgemma,0.778,HISTOLOGIC GRADE
5009,medgemma,0.698,LYMPHOVASCULAR INVASION
5010,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5011,medgemma,0.78,REGIONAL LYMPH NODE STATUS
5012,medgemma,0.713,NUMBER OF LYMPH NODES WITH TUMOR
5013,medgemma,0.71,NODAL SITE(S) EXAMINED
5014,medgemma,0.811,TUMOR FOCALITY
5015,medgemma,0.707,NUMBER OF LYMPH NODES WITH TUMOR
5016,medgemma,0.697,SPECIMEN LATERALITY
5017,medgemma,0.777,NODAL SITE(S) WITH TUMOR
5018,medgemma,0.89,TUMOR SITE
5019,medgemma,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5020,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5021,medgemma,0.762,NODAL SITE(S) WITH TUMOR
5022,medgemma,0.698,VISCERAL PLEURA INVASION
5023,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5024,medgemma,0.781,PROCEDURE
5025,medgemma,0.698,NUMBER OF LYMPH NODES EXAMINED
5026,medgemma,0.847,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5027,medgemma,0.743,MARGIN STATUS FOR NON-INVASIVE TUMOR
5028,medgemma,0.835,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5029,medgemma,0.775,NUMBER OF LYMPH NODES EXAMINED
5030,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5031,medgemma,0.735,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5032,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5033,medgemma,0.778,VISCERAL PLEURA INVASION
5034,medgemma,0.824,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5035,medgemma,0.93,ADDITIONAL FINDINGS
5036,medgemma,0.692,TUMOR FOCALITY
5037,medgemma,0.783,PROCEDURE
5038,medgemma,0.719,NODAL SITE(S) EXAMINED
5039,medgemma,0.815,REGIONAL LYMPH NODE STATUS
5040,medgemma,0.865,TUMOR SITE
5041,medgemma,0.818,HISTOLOGIC GRADE
5042,medgemma,0.697,SPECIMEN LATERALITY
5043,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5044,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5045,medgemma,0.776,PROCEDURE
5046,medgemma,0.825,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5047,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5048,medgemma,0.815,REGIONAL LYMPH NODE STATUS
5049,medgemma,0.865,TUMOR SITE
5050,medgemma,0.706,ADDITIONAL FINDINGS
5051,medgemma,0.718,SPREAD THROUGH AIR SPACES (STAS)
5052,medgemma,0.811,TUMOR FOCALITY
5053,medgemma,0.778,VISCERAL PLEURA INVASION
5054,medgemma,0.892,HISTOLOGIC GRADE
5055,medgemma,0.716,NODAL SITE(S) EXAMINED
5056,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5057,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5058,medgemma,0.798,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5059,medgemma,0.697,SPECIMEN LATERALITY
5060,medgemma,0.697,SPECIMEN LATERALITY
5061,medgemma,0.769,NODAL SITE(S) EXAMINED
5062,medgemma,0.778,VISCERAL PLEURA INVASION
5063,medgemma,0.72,NUMBER OF LYMPH NODES EXAMINED
5064,medgemma,0.774,PROCEDURE
5065,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5066,medgemma,0.838,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5067,medgemma,0.811,TUMOR FOCALITY
5068,medgemma,0.91,TUMOR SITE
5069,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5070,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5071,medgemma,0.706,HISTOLOGIC GRADE
5072,medgemma,0.815,REGIONAL LYMPH NODE STATUS
5073,medgemma,0.727,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5074,medgemma,0.757,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5075,medgemma,0.718,ADDITIONAL FINDINGS
5076,medgemma,0.815,REGIONAL LYMPH NODE STATUS
5077,medgemma,0.7,NODAL SITE(S) EXAMINED
5078,medgemma,0.818,HISTOLOGIC GRADE
5079,medgemma,0.811,TUMOR FOCALITY
5080,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5081,medgemma,0.865,TUMOR SITE
5082,medgemma,0.743,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5083,medgemma,0.708,ADDITIONAL FINDINGS
5084,medgemma,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5085,medgemma,0.76,PROCEDURE
5086,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5087,medgemma,0.676,SPREAD THROUGH AIR SPACES (STAS)
5088,medgemma,0.778,VISCERAL PLEURA INVASION
5089,medgemma,0.698,SPECIMEN LATERALITY
5090,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5091,medgemma,0.821,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5092,medgemma,0.78,REGIONAL LYMPH NODE STATUS
5093,medgemma,0.811,TUMOR FOCALITY
5094,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5095,medgemma,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5096,medgemma,0.734,ADDITIONAL FINDINGS
5097,medgemma,0.663,NODAL SITE(S) WITH TUMOR
5098,medgemma,0.67,SPREAD THROUGH AIR SPACES (STAS)
5099,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5100,medgemma,0.698,SPECIMEN LATERALITY
5101,medgemma,0.778,VISCERAL PLEURA INVASION
5102,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5103,medgemma,0.698,LYMPHOVASCULAR INVASION
5104,medgemma,0.677,NODAL SITE(S) EXAMINED
5105,medgemma,0.713,NUMBER OF LYMPH NODES WITH TUMOR
5106,medgemma,0.89,TUMOR SITE
5107,medgemma,0.755,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5108,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5109,medgemma,0.778,HISTOLOGIC GRADE
5110,medgemma,0.766,NUMBER OF LYMPH NODES EXAMINED
5111,medgemma,0.752,PROCEDURE
5112,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5113,medgemma,0.838,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5114,medgemma,0.778,VISCERAL PLEURA INVASION
5115,medgemma,0.693,NUMBER OF LYMPH NODES EXAMINED
5116,medgemma,0.773,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5117,medgemma,0.692,TUMOR FOCALITY
5118,medgemma,0.801,PROCEDURE
5119,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
5120,medgemma,0.706,HISTOLOGIC GRADE
5121,medgemma,0.671,NODAL SITE(S) EXAMINED
5122,medgemma,0.775,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5123,medgemma,0.829,REGIONAL LYMPH NODE STATUS
5124,medgemma,0.888,MARGIN STATUS FOR INVASIVE CARCINOMA
5125,medgemma,0.698,SPECIMEN LATERALITY
5126,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5127,medgemma,0.89,TUMOR SITE
5128,medgemma,0.73,NODAL SITE(S) EXAMINED
5129,medgemma,0.817,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5130,medgemma,0.815,REGIONAL LYMPH NODE STATUS
5131,medgemma,0.819,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5132,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5133,medgemma,0.89,TUMOR SITE
5134,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5135,medgemma,0.811,TUMOR FOCALITY
5136,medgemma,0.796,PROCEDURE
5137,medgemma,0.701,NUMBER OF LYMPH NODES EXAMINED
5138,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5139,medgemma,0.697,SPECIMEN LATERALITY
5140,medgemma,0.815,HISTOLOGIC GRADE
5141,medgemma,0.778,VISCERAL PLEURA INVASION
5142,medgemma,0.682,LYMPH NODE(S) FROM PRIOR PROCEDURES
5143,medgemma,0.792,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5144,medgemma,0.815,REGIONAL LYMPH NODE STATUS
5145,medgemma,0.736,NODAL SITE(S) EXAMINED
5146,medgemma,0.811,TUMOR FOCALITY
5147,medgemma,0.8,PROCEDURE
5148,medgemma,0.699,NUMBER OF LYMPH NODES EXAMINED
5149,medgemma,0.734,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5150,medgemma,0.697,SPECIMEN LATERALITY
5151,medgemma,0.701,TUMOR SITE
5152,medgemma,0.815,HISTOLOGIC GRADE
5153,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5154,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5155,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5156,medgemma,0.778,VISCERAL PLEURA INVASION
5157,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5158,medgemma,0.818,HISTOLOGIC GRADE
5159,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5160,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5161,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5162,medgemma,0.714,NUMBER OF LYMPH NODES EXAMINED
5163,medgemma,0.829,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5164,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5165,medgemma,0.705,NODAL SITE(S) EXAMINED
5166,medgemma,0.697,SPECIMEN LATERALITY
5167,medgemma,0.815,REGIONAL LYMPH NODE STATUS
5168,medgemma,0.865,TUMOR SITE
5169,medgemma,0.827,PROCEDURE
5170,medgemma,0.811,TUMOR FOCALITY
5171,medgemma,0.825,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5172,medgemma,0.778,VISCERAL PLEURA INVASION
5173,medgemma,0.673,VISCERAL PLEURA INVASION
5174,medgemma,0.787,TUMOR SITE
5175,medgemma,0.872,MARGIN STATUS FOR INVASIVE CARCINOMA
5176,medgemma,0.716,LYMPH NODE(S) FROM PRIOR PROCEDURES
5177,medgemma,0.771,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5178,medgemma,0.827,PROCEDURE
5179,medgemma,0.78,REGIONAL LYMPH NODE STATUS
5180,medgemma,0.784,NODAL SITE(S) WITH TUMOR
5181,medgemma,0.75,HISTOLOGIC GRADE
5182,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5183,medgemma,0.697,SPECIMEN LATERALITY
5184,medgemma,0.706,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5185,medgemma,0.654,TNM DESCRIPTORS
5186,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5187,medgemma,0.721,NODAL SITE(S) EXAMINED
5188,medgemma,0.709,NUMBER OF LYMPH NODES EXAMINED
5189,medgemma,0.72,NUMBER OF LYMPH NODES WITH TUMOR
5190,medgemma,0.708,TUMOR FOCALITY
5191,medgemma,0.761,NUMBER OF LYMPH NODES EXAMINED
5192,medgemma,0.76,NODAL SITE(S) EXAMINED
5193,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5194,medgemma,0.898,TUMOR FOCALITY
5195,medgemma,0.716,REGIONAL LYMPH NODE STATUS
5196,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5197,medgemma,0.831,PROCEDURE
5198,medgemma,0.791,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5199,medgemma,0.734,HISTOLOGIC GRADE
5200,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5201,medgemma,0.778,VISCERAL PLEURA INVASION
5202,medgemma,0.89,TUMOR SITE
5203,medgemma,0.697,SPECIMEN LATERALITY
5204,medgemma,0.798,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5205,medgemma,0.717,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5206,medgemma,0.865,TUMOR SITE
5207,medgemma,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5208,medgemma,0.738,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5209,medgemma,0.683,LYMPH NODE(S) FROM PRIOR PROCEDURES
5210,medgemma,0.818,HISTOLOGIC GRADE
5211,medgemma,0.699,NUMBER OF LYMPH NODES EXAMINED
5212,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5213,medgemma,0.78,REGIONAL LYMPH NODE STATUS
5214,medgemma,0.737,NODAL SITE(S) WITH TUMOR
5215,medgemma,0.698,SPECIMEN LATERALITY
5216,medgemma,0.705,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5217,medgemma,0.713,NUMBER OF LYMPH NODES WITH TUMOR
5218,medgemma,0.745,LYMPHOVASCULAR INVASION
5219,medgemma,0.788,PROCEDURE
5220,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5221,medgemma,0.811,TUMOR FOCALITY
5222,medgemma,0.778,VISCERAL PLEURA INVASION
5223,medgemma,0.636,NODAL SITE(S) EXAMINED
5224,medgemma,0.774,ADDITIONAL FINDINGS
5225,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5226,medgemma,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5227,medgemma,0.811,TUMOR FOCALITY
5228,medgemma,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5229,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5230,medgemma,0.89,TUMOR SITE
5231,medgemma,0.778,VISCERAL PLEURA INVASION
5232,medgemma,0.815,REGIONAL LYMPH NODE STATUS
5233,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
5234,medgemma,0.803,PROCEDURE
5235,medgemma,0.693,NUMBER OF LYMPH NODES EXAMINED
5236,medgemma,0.825,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5237,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5238,medgemma,0.711,NODAL SITE(S) EXAMINED
5239,medgemma,0.697,SPECIMEN LATERALITY
5240,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5241,medgemma,0.686,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5242,medgemma,0.805,PROCEDURE
5243,medgemma,0.811,TUMOR FOCALITY
5244,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5245,medgemma,0.711,NODAL SITE(S) EXAMINED
5246,medgemma,0.744,NUMBER OF LYMPH NODES EXAMINED
5247,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
5248,medgemma,0.788,HISTOLOGIC GRADE
5249,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5250,medgemma,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5251,medgemma,0.698,SPECIMEN LATERALITY
5252,medgemma,0.815,REGIONAL LYMPH NODE STATUS
5253,medgemma,0.89,TUMOR SITE
5254,medgemma,0.778,VISCERAL PLEURA INVASION
5255,medgemma,0.832,ADDITIONAL FINDINGS
5256,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5257,medgemma,0.698,SPECIMEN LATERALITY
5258,medgemma,0.713,NUMBER OF LYMPH NODES EXAMINED
5259,medgemma,0.902,ADDITIONAL FINDINGS
5260,medgemma,0.819,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5261,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5262,medgemma,0.865,TUMOR SITE
5263,medgemma,0.827,PROCEDURE
5264,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5265,medgemma,0.698,NODAL SITE(S) EXAMINED
5266,medgemma,0.811,TUMOR FOCALITY
5267,medgemma,0.78,VISCERAL PLEURA INVASION
5268,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5269,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
5270,medgemma,0.836,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5271,medgemma,0.716,REGIONAL LYMPH NODE STATUS
5272,medgemma,0.818,HISTOLOGIC GRADE
5273,medgemma,0.736,PROCEDURE
5274,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5275,medgemma,0.697,SPECIMEN LATERALITY
5276,medgemma,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5277,medgemma,0.758,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5278,medgemma,0.89,TUMOR SITE
5279,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5280,medgemma,0.681,LYMPHOVASCULAR INVASION
5281,medgemma,0.741,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5282,medgemma,0.811,TUMOR FOCALITY
5283,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5284,medgemma,0.738,NODAL SITE(S) EXAMINED
5285,medgemma,0.75,HISTOLOGIC GRADE
5286,medgemma,0.716,REGIONAL LYMPH NODE STATUS
5287,medgemma,0.663,ADDITIONAL FINDINGS
5288,medgemma,0.78,VISCERAL PLEURA INVASION
5289,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
5290,medgemma,0.75,HISTOLOGIC GRADE
5291,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5292,medgemma,0.855,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5293,medgemma,0.765,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5294,medgemma,0.713,NODAL SITE(S) EXAMINED
5295,medgemma,0.717,NUMBER OF LYMPH NODES EXAMINED
5296,medgemma,0.815,REGIONAL LYMPH NODE STATUS
5297,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5298,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5299,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5300,medgemma,0.793,PROCEDURE
5301,medgemma,0.865,TUMOR SITE
5302,medgemma,0.697,SPECIMEN LATERALITY
5303,medgemma,0.78,VISCERAL PLEURA INVASION
5304,medgemma,0.811,TUMOR FOCALITY
5305,medgemma,0.797,HISTOLOGIC GRADE
5306,medgemma,0.744,NUMBER OF LYMPH NODES EXAMINED
5307,medgemma,0.699,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5308,medgemma,0.747,NODAL SITE(S) WITH TUMOR
5309,medgemma,0.805,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5310,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5311,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5312,medgemma,0.78,REGIONAL LYMPH NODE STATUS
5313,medgemma,0.749,PROCEDURE
5314,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5315,medgemma,0.811,TUMOR FOCALITY
5316,medgemma,0.865,TUMOR SITE
5317,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5318,medgemma,0.698,SPECIMEN LATERALITY
5319,medgemma,0.679,NODAL SITE(S) EXAMINED
5320,medgemma,0.72,NUMBER OF LYMPH NODES WITH TUMOR
5321,medgemma,0.698,VISCERAL PLEURA INVASION
5322,medgemma,0.692,TUMOR FOCALITY
5323,medgemma,0.815,REGIONAL LYMPH NODE STATUS
5324,medgemma,0.697,SPECIMEN LATERALITY
5325,medgemma,0.788,PROCEDURE
5326,medgemma,0.699,NUMBER OF LYMPH NODES EXAMINED
5327,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5328,medgemma,0.904,HISTOLOGIC GRADE
5329,medgemma,0.738,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5330,medgemma,0.778,VISCERAL PLEURA INVASION
5331,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5332,medgemma,0.768,NODAL SITE(S) EXAMINED
5333,medgemma,0.89,TUMOR SITE
5334,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5335,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5336,medgemma,0.714,NODAL SITE(S) EXAMINED
5337,medgemma,0.89,TUMOR SITE
5338,medgemma,0.802,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5339,medgemma,0.72,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5340,medgemma,0.697,SPECIMEN LATERALITY
5341,medgemma,0.708,TUMOR FOCALITY
5342,medgemma,0.7,SPREAD THROUGH AIR SPACES (STAS)
5343,medgemma,0.679,HISTOLOGIC GRADE
5344,medgemma,0.798,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5345,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5346,medgemma,0.888,MARGIN STATUS FOR NON-INVASIVE TUMOR
5347,medgemma,0.779,PROCEDURE
5348,medgemma,0.778,VISCERAL PLEURA INVASION
5349,medgemma,0.716,REGIONAL LYMPH NODE STATUS
5350,medgemma,0.838,ADDITIONAL FINDINGS
5351,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5352,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5353,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5354,medgemma,0.692,TUMOR FOCALITY
5355,medgemma,0.89,TUMOR SITE
5356,medgemma,0.709,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5357,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5358,medgemma,0.774,ADDITIONAL FINDINGS
5359,medgemma,0.778,VISCERAL PLEURA INVASION
5360,medgemma,0.697,SPECIMEN LATERALITY
5361,medgemma,0.726,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5362,medgemma,0.827,PROCEDURE
5363,medgemma,0.735,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5364,medgemma,0.7,SPREAD THROUGH AIR SPACES (STAS)
5365,medgemma,0.89,TUMOR SITE
5366,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5367,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5368,medgemma,0.798,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5369,medgemma,0.904,HISTOLOGIC GRADE
5370,medgemma,0.716,REGIONAL LYMPH NODE STATUS
5371,medgemma,0.788,PROCEDURE
5372,medgemma,0.756,NODAL SITE(S) EXAMINED
5373,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5374,medgemma,0.811,TUMOR FOCALITY
5375,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5376,medgemma,0.715,VISCERAL PLEURA INVASION
5377,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
5378,medgemma,0.697,SPECIMEN LATERALITY
5379,medgemma,0.83,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5380,medgemma,0.904,HISTOLOGIC GRADE
5381,medgemma,0.782,ADDITIONAL FINDINGS
5382,medgemma,0.815,REGIONAL LYMPH NODE STATUS
5383,medgemma,0.88,LYMPH NODE(S) FROM PRIOR PROCEDURES
5384,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5385,medgemma,0.692,TUMOR FOCALITY
5386,medgemma,0.708,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5387,medgemma,0.745,NUMBER OF LYMPH NODES EXAMINED
5388,medgemma,0.723,NODAL SITE(S) EXAMINED
5389,medgemma,0.778,VISCERAL PLEURA INVASION
5390,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
5391,medgemma,0.743,PROCEDURE
5392,medgemma,0.698,SPECIMEN LATERALITY
5393,medgemma,0.865,TUMOR SITE
5394,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5395,medgemma,0.696,TNM DESCRIPTORS
5396,medgemma,0.763,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5397,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5398,medgemma,0.815,REGIONAL LYMPH NODE STATUS
5399,medgemma,0.778,VISCERAL PLEURA INVASION
5400,medgemma,0.697,SPECIMEN LATERALITY
5401,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5402,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5403,medgemma,0.892,HISTOLOGIC GRADE
5404,medgemma,0.745,LYMPHOVASCULAR INVASION
5405,medgemma,0.767,NODAL SITE(S) EXAMINED
5406,medgemma,0.716,ADDITIONAL FINDINGS
5407,medgemma,0.865,TUMOR SITE
5408,medgemma,0.805,PROCEDURE
5409,medgemma,0.718,SPREAD THROUGH AIR SPACES (STAS)
5410,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5411,medgemma,0.811,TUMOR FOCALITY
5412,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5413,medgemma,0.717,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5414,medgemma,0.825,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5415,medgemma,0.87,MARGIN STATUS FOR NON-INVASIVE TUMOR
5416,medgemma,0.843,PROCEDURE
5417,medgemma,0.712,TUMOR FOCALITY
5418,medgemma,0.713,NUMBER OF LYMPH NODES WITH TUMOR
5419,medgemma,0.726,TNM DESCRIPTORS
5420,medgemma,0.737,NODAL SITE(S) WITH TUMOR
5421,medgemma,0.698,LYMPHOVASCULAR INVASION
5422,medgemma,0.705,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5423,medgemma,0.89,TUMOR SITE
5424,medgemma,0.697,SPECIMEN LATERALITY
5425,medgemma,0.8,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5426,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5427,medgemma,0.778,VISCERAL PLEURA INVASION
5428,medgemma,0.753,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5429,medgemma,0.892,HISTOLOGIC GRADE
5430,medgemma,0.774,ADDITIONAL FINDINGS
5431,medgemma,0.712,NODAL SITE(S) EXAMINED
5432,medgemma,0.78,REGIONAL LYMPH NODE STATUS
5433,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5434,medgemma,0.738,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5435,medgemma,0.697,SPECIMEN LATERALITY
5436,medgemma,0.692,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5437,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5438,medgemma,0.892,PROCEDURE
5439,medgemma,0.692,TUMOR FOCALITY
5440,medgemma,0.778,VISCERAL PLEURA INVASION
5441,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5442,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5443,medgemma,0.8,NUMBER OF LYMPH NODES EXAMINED
5444,medgemma,0.815,REGIONAL LYMPH NODE STATUS
5445,medgemma,0.803,NODAL SITE(S) EXAMINED
5446,medgemma,0.7,SPREAD THROUGH AIR SPACES (STAS)
5447,medgemma,0.865,TUMOR SITE
5448,medgemma,0.729,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5449,medgemma,0.706,HISTOLOGIC GRADE
5450,medgemma,0.892,HISTOLOGIC GRADE
5451,medgemma,0.734,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5452,medgemma,0.7,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5453,medgemma,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5454,medgemma,0.815,REGIONAL LYMPH NODE STATUS
5455,medgemma,0.718,VISCERAL PLEURA INVASION
5456,medgemma,0.693,NUMBER OF LYMPH NODES EXAMINED
5457,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5458,medgemma,0.811,TUMOR FOCALITY
5459,medgemma,0.779,NODAL SITE(S) EXAMINED
5460,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5461,medgemma,0.867,PROCEDURE
5462,medgemma,0.89,TUMOR SITE
5463,medgemma,0.697,SPECIMEN LATERALITY
5464,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5465,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5466,medgemma,0.771,PROCEDURE
5467,medgemma,0.749,NODAL SITE(S) WITH TUMOR
5468,medgemma,0.811,TUMOR FOCALITY
5469,medgemma,0.715,NODAL SITE(S) EXAMINED
5470,medgemma,0.78,REGIONAL LYMPH NODE STATUS
5471,medgemma,0.764,TUMOR SITE
5472,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5473,medgemma,0.697,SPECIMEN LATERALITY
5474,medgemma,0.838,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5475,medgemma,0.778,VISCERAL PLEURA INVASION
5476,medgemma,0.707,NUMBER OF LYMPH NODES WITH TUMOR
5477,medgemma,0.818,HISTOLOGIC GRADE
5478,medgemma,0.774,MARGIN STATUS FOR INVASIVE CARCINOMA
5479,medgemma,0.692,TNM DESCRIPTORS
5480,medgemma,0.811,TUMOR FOCALITY
5481,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5482,medgemma,0.72,NODAL SITE(S) WITH TUMOR
5483,medgemma,0.741,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5484,medgemma,0.766,LYMPHOVASCULAR INVASION
5485,medgemma,0.684,NODAL SITE(S) EXAMINED
5486,medgemma,0.705,NUMBER OF LYMPH NODES EXAMINED
5487,medgemma,0.89,TUMOR SITE
5488,medgemma,0.78,REGIONAL LYMPH NODE STATUS
5489,medgemma,0.654,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5490,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5491,medgemma,0.892,HISTOLOGIC GRADE
5492,medgemma,0.778,VISCERAL PLEURA INVASION
5493,medgemma,0.784,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5494,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5495,medgemma,0.801,PROCEDURE
5496,medgemma,0.736,TNM DESCRIPTORS
5497,medgemma,0.726,NUMBER OF LYMPH NODES WITH TUMOR
5498,medgemma,0.827,PROCEDURE
5499,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5500,medgemma,0.697,SPECIMEN LATERALITY
5501,medgemma,0.811,TUMOR FOCALITY
5502,medgemma,0.815,REGIONAL LYMPH NODE STATUS
5503,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5504,medgemma,0.865,TUMOR SITE
5505,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5506,medgemma,0.819,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5507,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5508,medgemma,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5509,medgemma,0.797,HISTOLOGIC GRADE
5510,medgemma,0.699,NODAL SITE(S) EXAMINED
5511,medgemma,0.778,VISCERAL PLEURA INVASION
5512,medgemma,0.716,REGIONAL LYMPH NODE STATUS
5513,medgemma,0.655,TNM DESCRIPTORS
5514,medgemma,0.705,TUMOR FOCALITY
5515,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5516,medgemma,0.7,SPREAD THROUGH AIR SPACES (STAS)
5517,medgemma,0.865,TUMOR SITE
5518,medgemma,0.699,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5519,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5520,medgemma,0.679,NODAL SITE(S) EXAMINED
5521,medgemma,0.701,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5522,medgemma,0.778,VISCERAL PLEURA INVASION
5523,medgemma,0.696,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5524,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5525,medgemma,0.698,SPECIMEN LATERALITY
5526,medgemma,0.831,PROCEDURE
5527,medgemma,0.78,REGIONAL LYMPH NODE STATUS
5528,medgemma,0.697,SPECIMEN LATERALITY
5529,medgemma,0.749,PROCEDURE
5530,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5531,medgemma,0.744,NODAL SITE(S) WITH TUMOR
5532,medgemma,0.748,NODAL SITE(S) EXAMINED
5533,medgemma,0.774,MARGIN STATUS FOR INVASIVE CARCINOMA
5534,medgemma,0.753,TUMOR SITE
5535,medgemma,0.743,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5536,medgemma,0.811,TUMOR FOCALITY
5537,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5538,medgemma,0.778,VISCERAL PLEURA INVASION
5539,medgemma,0.89,TUMOR SITE
5540,medgemma,0.707,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5541,medgemma,0.818,HISTOLOGIC GRADE
5542,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5543,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5544,medgemma,0.815,REGIONAL LYMPH NODE STATUS
5545,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5546,medgemma,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5547,medgemma,0.764,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5548,medgemma,0.697,SPECIMEN LATERALITY
5549,medgemma,0.718,NODAL SITE(S) EXAMINED
5550,medgemma,0.778,VISCERAL PLEURA INVASION
5551,medgemma,0.831,PROCEDURE
5552,medgemma,0.75,TUMOR FOCALITY
5553,medgemma,0.768,TNM DESCRIPTORS
5554,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5555,medgemma,0.729,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5556,medgemma,0.892,HISTOLOGIC GRADE
5557,medgemma,0.811,TUMOR FOCALITY
5558,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5559,medgemma,0.72,PROCEDURE
5560,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5561,medgemma,0.697,SPECIMEN LATERALITY
5562,medgemma,0.819,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5563,medgemma,0.778,VISCERAL PLEURA INVASION
5564,medgemma,0.713,NUMBER OF LYMPH NODES EXAMINED
5565,medgemma,0.773,NODAL SITE(S) EXAMINED
5566,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5567,medgemma,0.815,REGIONAL LYMPH NODE STATUS
5568,medgemma,0.865,TUMOR SITE
5569,medgemma,0.815,HISTOLOGIC GRADE
5570,medgemma,0.827,PROCEDURE
5571,medgemma,0.692,TUMOR FOCALITY
5572,medgemma,0.695,NODAL SITE(S) EXAMINED
5573,medgemma,0.778,VISCERAL PLEURA INVASION
5574,medgemma,0.89,TUMOR SITE
5575,medgemma,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5576,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5577,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5578,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5579,medgemma,0.706,NUMBER OF LYMPH NODES EXAMINED
5580,medgemma,0.755,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5581,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5582,medgemma,0.815,REGIONAL LYMPH NODE STATUS
5583,medgemma,0.698,SPECIMEN LATERALITY
5584,medgemma,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5585,medgemma,0.697,SPECIMEN LATERALITY
5586,medgemma,0.815,REGIONAL LYMPH NODE STATUS
5587,medgemma,0.778,VISCERAL PLEURA INVASION
5588,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5589,medgemma,0.728,LYMPH NODE(S) FROM PRIOR PROCEDURES
5590,medgemma,0.811,TUMOR FOCALITY
5591,medgemma,0.865,TUMOR SITE
5592,medgemma,0.709,NUMBER OF LYMPH NODES EXAMINED
5593,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5594,medgemma,0.827,PROCEDURE
5595,medgemma,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5596,medgemma,0.731,NODAL SITE(S) EXAMINED
5597,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5598,medgemma,0.771,PROCEDURE
5599,medgemma,0.697,SPECIMEN LATERALITY
5600,medgemma,0.89,TUMOR SITE
5601,medgemma,0.752,MARGIN STATUS FOR INVASIVE CARCINOMA
5602,medgemma,0.815,REGIONAL LYMPH NODE STATUS
5603,medgemma,0.811,TUMOR FOCALITY
5604,medgemma,0.656,NUMBER OF LYMPH NODES EXAMINED
5605,medgemma,0.892,HISTOLOGIC GRADE
5606,medgemma,0.701,SPREAD THROUGH AIR SPACES (STAS)
5607,medgemma,0.741,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5608,medgemma,0.759,NODAL SITE(S) EXAMINED
5609,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5610,medgemma,0.778,VISCERAL PLEURA INVASION
5611,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5612,medgemma,0.785,NUMBER OF LYMPH NODES EXAMINED
5613,medgemma,0.697,SPECIMEN LATERALITY
5614,medgemma,0.806,PROCEDURE
5615,medgemma,0.707,TNM DESCRIPTORS
5616,medgemma,0.729,NODAL SITE(S) EXAMINED
5617,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5618,medgemma,0.717,MARGIN STATUS FOR INVASIVE CARCINOMA
5619,medgemma,0.892,HISTOLOGIC GRADE
5620,medgemma,0.716,REGIONAL LYMPH NODE STATUS
5621,medgemma,0.78,VISCERAL PLEURA INVASION
5622,medgemma,0.707,MARGIN STATUS FOR NON-INVASIVE TUMOR
5623,medgemma,0.739,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5624,medgemma,0.811,TUMOR FOCALITY
5625,medgemma,0.89,TUMOR SITE
5626,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5627,medgemma,0.778,VISCERAL PLEURA INVASION
5628,medgemma,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5629,medgemma,0.715,NODAL SITE(S) EXAMINED
5630,medgemma,0.865,TUMOR SITE
5631,medgemma,0.827,PROCEDURE
5632,medgemma,0.815,REGIONAL LYMPH NODE STATUS
5633,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5634,medgemma,0.703,NUMBER OF LYMPH NODES EXAMINED
5635,medgemma,0.892,HISTOLOGIC GRADE
5636,medgemma,0.698,SPECIMEN LATERALITY
5637,medgemma,0.811,TUMOR FOCALITY
5638,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5639,medgemma,0.826,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5640,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5641,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5642,medgemma,0.89,TUMOR SITE
5643,medgemma,0.815,HISTOLOGIC GRADE
5644,medgemma,0.815,REGIONAL LYMPH NODE STATUS
5645,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5646,medgemma,0.766,PROCEDURE
5647,medgemma,0.716,NODAL SITE(S) EXAMINED
5648,medgemma,0.697,SPECIMEN LATERALITY
5649,medgemma,0.738,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5650,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5651,medgemma,0.811,TUMOR FOCALITY
5652,medgemma,0.778,VISCERAL PLEURA INVASION
5653,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5654,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
5655,medgemma,0.731,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5656,medgemma,0.805,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5657,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5658,medgemma,0.815,HISTOLOGIC GRADE
5659,medgemma,0.716,REGIONAL LYMPH NODE STATUS
5660,medgemma,0.778,VISCERAL PLEURA INVASION
5661,medgemma,0.811,TUMOR FOCALITY
5662,medgemma,0.717,NUMBER OF LYMPH NODES EXAMINED
5663,medgemma,0.765,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5664,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5665,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5666,medgemma,0.697,SPECIMEN LATERALITY
5667,medgemma,0.786,PROCEDURE
5668,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5669,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
5670,medgemma,0.91,TUMOR SITE
5671,medgemma,0.716,NODAL SITE(S) EXAMINED
5672,medgemma,0.818,HISTOLOGIC GRADE
5673,medgemma,0.89,TUMOR SITE
5674,medgemma,0.778,VISCERAL PLEURA INVASION
5675,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5676,medgemma,0.698,SPECIMEN LATERALITY
5677,medgemma,0.678,NODAL SITE(S) EXAMINED
5678,medgemma,0.823,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5679,medgemma,0.716,REGIONAL LYMPH NODE STATUS
5680,medgemma,0.797,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5681,medgemma,0.829,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5682,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5683,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5684,medgemma,0.776,PROCEDURE
5685,medgemma,0.752,ADDITIONAL FINDINGS
5686,medgemma,0.698,SPREAD THROUGH AIR SPACES (STAS)
5687,medgemma,0.811,TUMOR FOCALITY
5688,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5689,medgemma,0.778,VISCERAL PLEURA INVASION
5690,medgemma,0.745,LYMPHOVASCULAR INVASION
5691,medgemma,0.89,TUMOR SITE
5692,medgemma,0.74,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5693,medgemma,0.7,NUMBER OF LYMPH NODES EXAMINED
5694,medgemma,0.698,SPECIMEN LATERALITY
5695,medgemma,0.689,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5696,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5697,medgemma,0.701,HISTOLOGIC GRADE
5698,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5699,medgemma,0.858,NODAL SITE(S) EXAMINED
5700,medgemma,0.811,TUMOR FOCALITY
5701,medgemma,0.776,HISTOLOGIC GRADE
5702,medgemma,0.827,PROCEDURE
5703,medgemma,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5704,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5705,medgemma,0.815,REGIONAL LYMPH NODE STATUS
5706,medgemma,0.735,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5707,medgemma,0.733,HISTOLOGIC GRADE
5708,medgemma,0.778,VISCERAL PLEURA INVASION
5709,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5710,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5711,medgemma,0.682,NODAL SITE(S) WITH TUMOR
5712,medgemma,0.783,PROCEDURE
5713,medgemma,0.718,NODAL SITE(S) EXAMINED
5714,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5715,medgemma,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5716,medgemma,0.692,LYMPHOVASCULAR INVASION
5717,medgemma,0.698,SPECIMEN LATERALITY
5718,medgemma,0.89,TUMOR SITE
5719,medgemma,0.703,NUMBER OF LYMPH NODES WITH TUMOR
5720,medgemma,0.78,REGIONAL LYMPH NODE STATUS
5721,medgemma,0.782,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5722,medgemma,0.811,TUMOR FOCALITY
5723,medgemma,0.892,HISTOLOGIC GRADE
5724,medgemma,0.721,NODAL SITE(S) EXAMINED
5725,medgemma,0.716,LYMPHOVASCULAR INVASION
5726,medgemma,0.865,TUMOR SITE
5727,medgemma,0.815,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5728,medgemma,0.697,SPECIMEN LATERALITY
5729,medgemma,0.883,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5730,medgemma,0.719,PROCEDURE
5731,medgemma,0.811,TUMOR FOCALITY
5732,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5733,medgemma,0.699,NUMBER OF LYMPH NODES EXAMINED
5734,medgemma,0.778,VISCERAL PLEURA INVASION
5735,medgemma,0.817,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5736,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
5737,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5738,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5739,medgemma,0.764,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5740,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5741,medgemma,0.72,NODAL SITE(S) EXAMINED
5742,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
5743,medgemma,0.89,TUMOR SITE
5744,medgemma,0.778,VISCERAL PLEURA INVASION
5745,medgemma,0.811,TUMOR FOCALITY
5746,medgemma,0.904,HISTOLOGIC GRADE
5747,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5748,medgemma,0.735,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5749,medgemma,0.815,REGIONAL LYMPH NODE STATUS
5750,medgemma,0.698,SPECIMEN LATERALITY
5751,medgemma,0.713,NUMBER OF LYMPH NODES EXAMINED
5752,medgemma,0.831,ADDITIONAL FINDINGS
5753,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5754,medgemma,0.827,PROCEDURE
5755,medgemma,0.716,REGIONAL LYMPH NODE STATUS
5756,medgemma,0.755,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5757,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5758,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5759,medgemma,0.697,SPECIMEN LATERALITY
5760,medgemma,0.743,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5761,medgemma,0.892,HISTOLOGIC GRADE
5762,medgemma,0.893,TUMOR SITE
5763,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5764,medgemma,0.711,PROCEDURE
5765,medgemma,0.778,VISCERAL PLEURA INVASION
5766,medgemma,0.731,NODAL SITE(S) EXAMINED
5767,medgemma,0.811,TUMOR FOCALITY
5768,medgemma,0.695,NUMBER OF LYMPH NODES EXAMINED
5769,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5770,medgemma,0.902,ADDITIONAL FINDINGS
5771,medgemma,0.865,TUMOR SITE
5772,medgemma,0.811,TUMOR FOCALITY
5773,medgemma,0.778,VISCERAL PLEURA INVASION
5774,medgemma,0.723,NODAL SITE(S) EXAMINED
5775,medgemma,0.695,TNM DESCRIPTORS
5776,medgemma,0.7,NUMBER OF LYMPH NODES EXAMINED
5777,medgemma,0.816,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5778,medgemma,0.815,REGIONAL LYMPH NODE STATUS
5779,medgemma,0.741,PROCEDURE
5780,medgemma,0.768,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5781,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5782,medgemma,0.697,SPECIMEN LATERALITY
5783,medgemma,0.892,HISTOLOGIC GRADE
5784,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5785,medgemma,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5786,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5787,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5788,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5789,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5790,medgemma,0.865,TUMOR SITE
5791,medgemma,0.715,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5792,medgemma,0.738,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5793,medgemma,0.815,REGIONAL LYMPH NODE STATUS
5794,medgemma,0.818,PROCEDURE
5795,medgemma,0.811,TUMOR FOCALITY
5796,medgemma,0.702,NODAL SITE(S) EXAMINED
5797,medgemma,0.818,HISTOLOGIC GRADE
5798,medgemma,0.741,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5799,medgemma,0.718,VISCERAL PLEURA INVASION
5800,medgemma,0.753,NUMBER OF LYMPH NODES EXAMINED
5801,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
5802,medgemma,0.698,SPECIMEN LATERALITY
5803,medgemma,0.696,NODAL SITE(S) EXAMINED
5804,medgemma,0.818,HISTOLOGIC GRADE
5805,medgemma,0.711,ADDITIONAL FINDINGS
5806,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5807,medgemma,0.793,PROCEDURE
5808,medgemma,0.837,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5809,medgemma,0.89,TUMOR SITE
5810,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5811,medgemma,0.815,REGIONAL LYMPH NODE STATUS
5812,medgemma,0.811,TUMOR FOCALITY
5813,medgemma,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5814,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5815,medgemma,0.702,NUMBER OF LYMPH NODES EXAMINED
5816,medgemma,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5817,medgemma,0.778,VISCERAL PLEURA INVASION
5818,medgemma,0.698,SPECIMEN LATERALITY
5819,medgemma,0.716,REGIONAL LYMPH NODE STATUS
5820,medgemma,0.811,TUMOR FOCALITY
5821,medgemma,0.778,VISCERAL PLEURA INVASION
5822,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5823,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5824,medgemma,0.893,TUMOR SITE
5825,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5826,medgemma,0.826,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5827,medgemma,0.697,SPECIMEN LATERALITY
5828,medgemma,0.765,PROCEDURE
5829,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5830,medgemma,0.695,NUMBER OF LYMPH NODES EXAMINED
5831,medgemma,0.904,HISTOLOGIC GRADE
5832,medgemma,0.704,NODAL SITE(S) EXAMINED
5833,medgemma,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5834,medgemma,0.811,TUMOR FOCALITY
5835,medgemma,0.7,NUMBER OF LYMPH NODES EXAMINED
5836,medgemma,0.78,VISCERAL PLEURA INVASION
5837,medgemma,0.823,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5838,medgemma,0.686,NODAL SITE(S) EXAMINED
5839,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5840,medgemma,0.815,REGIONAL LYMPH NODE STATUS
5841,medgemma,0.698,SPECIMEN LATERALITY
5842,medgemma,0.865,TUMOR SITE
5843,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5844,medgemma,0.827,PROCEDURE
5845,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5846,medgemma,0.904,HISTOLOGIC GRADE
5847,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5848,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5849,medgemma,0.89,TUMOR SITE
5850,medgemma,0.835,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5851,medgemma,0.827,PROCEDURE
5852,medgemma,0.717,ADDITIONAL FINDINGS
5853,medgemma,0.698,SPECIMEN LATERALITY
5854,medgemma,0.904,HISTOLOGIC GRADE
5855,medgemma,0.829,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5856,medgemma,0.652,NODAL SITE(S) EXAMINED
5857,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5858,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5859,medgemma,0.778,VISCERAL PLEURA INVASION
5860,medgemma,0.675,SPREAD THROUGH AIR SPACES (STAS)
5861,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5862,medgemma,0.706,NUMBER OF LYMPH NODES EXAMINED
5863,medgemma,0.815,REGIONAL LYMPH NODE STATUS
5864,medgemma,0.811,TUMOR FOCALITY
5865,medgemma,0.811,TUMOR FOCALITY
5866,medgemma,0.655,NODAL SITE(S) EXAMINED
5867,medgemma,0.778,VISCERAL PLEURA INVASION
5868,medgemma,0.827,PROCEDURE
5869,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
5870,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5871,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5872,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5873,medgemma,0.698,SPECIMEN LATERALITY
5874,medgemma,0.904,HISTOLOGIC GRADE
5875,medgemma,0.815,REGIONAL LYMPH NODE STATUS
5876,medgemma,0.712,ADDITIONAL FINDINGS
5877,medgemma,0.847,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5878,medgemma,0.89,TUMOR SITE
5879,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5880,medgemma,0.736,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5881,medgemma,0.828,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5882,medgemma,0.892,HISTOLOGIC GRADE
5883,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5884,medgemma,0.869,MARGIN STATUS FOR INVASIVE CARCINOMA
5885,medgemma,0.89,TUMOR SITE
5886,medgemma,0.705,LYMPHOVASCULAR INVASION
5887,medgemma,0.798,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5888,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5889,medgemma,0.827,PROCEDURE
5890,medgemma,0.811,TUMOR FOCALITY
5891,medgemma,0.815,REGIONAL LYMPH NODE STATUS
5892,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5893,medgemma,0.688,NODAL SITE(S) EXAMINED
5894,medgemma,0.698,SPECIMEN LATERALITY
5895,medgemma,0.713,NUMBER OF LYMPH NODES EXAMINED
5896,medgemma,0.717,SPREAD THROUGH AIR SPACES (STAS)
5897,medgemma,0.778,VISCERAL PLEURA INVASION
5898,medgemma,0.815,REGIONAL LYMPH NODE STATUS
5899,medgemma,0.89,TUMOR SITE
5900,medgemma,0.778,VISCERAL PLEURA INVASION
5901,medgemma,0.712,TUMOR FOCALITY
5902,medgemma,0.697,HISTOLOGIC GRADE
5903,medgemma,0.648,TNM DESCRIPTORS
5904,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5905,medgemma,0.717,ADDITIONAL FINDINGS
5906,medgemma,0.745,MARGIN STATUS FOR NON-INVASIVE TUMOR
5907,medgemma,0.697,SPECIMEN LATERALITY
5908,medgemma,0.837,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5909,medgemma,0.694,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5910,medgemma,0.7,SPREAD THROUGH AIR SPACES (STAS)
5911,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5912,medgemma,0.796,PROCEDURE
5913,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5914,medgemma,0.701,NUMBER OF LYMPH NODES EXAMINED
5915,medgemma,0.715,NODAL SITE(S) EXAMINED
5916,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5917,medgemma,0.915,TUMOR FOCALITY
5918,medgemma,0.74,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5919,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5920,medgemma,0.778,VISCERAL PLEURA INVASION
5921,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5922,medgemma,0.89,TUMOR SITE
5923,medgemma,0.697,SPECIMEN LATERALITY
5924,medgemma,0.813,PROCEDURE
5925,medgemma,0.716,REGIONAL LYMPH NODE STATUS
5926,medgemma,0.732,NODAL SITE(S) EXAMINED
5927,medgemma,0.821,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5928,medgemma,0.701,SPREAD THROUGH AIR SPACES (STAS)
5929,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5930,medgemma,0.778,VISCERAL PLEURA INVASION
5931,medgemma,0.811,TUMOR FOCALITY
5932,medgemma,0.815,REGIONAL LYMPH NODE STATUS
5933,medgemma,0.745,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5934,medgemma,0.713,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5935,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5936,medgemma,0.797,PROCEDURE
5937,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5938,medgemma,0.698,SPECIMEN LATERALITY
5939,medgemma,0.698,NUMBER OF LYMPH NODES EXAMINED
5940,medgemma,0.89,TUMOR SITE
5941,medgemma,0.669,NODAL SITE(S) EXAMINED
5942,medgemma,0.75,HISTOLOGIC GRADE
5943,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
5944,medgemma,0.697,SPECIMEN LATERALITY
5945,medgemma,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5946,medgemma,0.693,NODAL SITE(S) EXAMINED
5947,medgemma,0.818,HISTOLOGIC GRADE
5948,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5949,medgemma,0.817,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5950,medgemma,0.89,TUMOR SITE
5951,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5952,medgemma,0.912,ADDITIONAL FINDINGS
5953,medgemma,0.778,VISCERAL PLEURA INVASION
5954,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5955,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5956,medgemma,0.702,NUMBER OF LYMPH NODES EXAMINED
5957,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
5958,medgemma,0.811,TUMOR FOCALITY
5959,medgemma,0.763,PROCEDURE
5960,medgemma,0.815,REGIONAL LYMPH NODE STATUS
5961,medgemma,0.74,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5962,medgemma,0.7,SPREAD THROUGH AIR SPACES (STAS)
5963,medgemma,0.698,SPECIMEN LATERALITY
5964,medgemma,0.703,NUMBER OF LYMPH NODES EXAMINED
5965,medgemma,0.778,VISCERAL PLEURA INVASION
5966,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5967,medgemma,0.691,NODAL SITE(S) EXAMINED
5968,medgemma,0.793,PROCEDURE
5969,medgemma,0.892,HISTOLOGIC GRADE
5970,medgemma,0.689,ADDITIONAL FINDINGS
5971,medgemma,0.811,TUMOR FOCALITY
5972,medgemma,0.89,TUMOR SITE
5973,medgemma,0.815,REGIONAL LYMPH NODE STATUS
5974,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5975,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5976,medgemma,0.835,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5977,medgemma,0.698,SPECIMEN LATERALITY
5978,medgemma,0.811,TUMOR FOCALITY
5979,medgemma,0.815,REGIONAL LYMPH NODE STATUS
5980,medgemma,0.837,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5981,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5982,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
5983,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
5984,medgemma,0.865,TUMOR SITE
5985,medgemma,0.738,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5986,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5987,medgemma,0.778,VISCERAL PLEURA INVASION
5988,medgemma,0.778,HISTOLOGIC GRADE
5989,medgemma,0.701,NUMBER OF LYMPH NODES EXAMINED
5990,medgemma,0.803,PROCEDURE
5991,medgemma,0.687,NODAL SITE(S) EXAMINED
5992,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
5993,medgemma,0.904,HISTOLOGIC GRADE
5994,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
5995,medgemma,0.811,TUMOR FOCALITY
5996,medgemma,0.696,ADDITIONAL FINDINGS
5997,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
5998,medgemma,0.717,PROCEDURE
5999,medgemma,0.74,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6000,medgemma,0.742,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6001,medgemma,0.815,REGIONAL LYMPH NODE STATUS
6002,medgemma,0.697,SPECIMEN LATERALITY
6003,medgemma,0.778,VISCERAL PLEURA INVASION
6004,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
6005,medgemma,0.704,NODAL SITE(S) EXAMINED
6006,medgemma,0.675,TUMOR SITE
6007,medgemma,0.782,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6008,medgemma,0.815,REGIONAL LYMPH NODE STATUS
6009,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
6010,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
6011,medgemma,0.89,TUMOR SITE
6012,medgemma,0.829,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6013,medgemma,0.684,NODAL SITE(S) EXAMINED
6014,medgemma,0.778,VISCERAL PLEURA INVASION
6015,medgemma,0.904,HISTOLOGIC GRADE
6016,medgemma,0.83,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6017,medgemma,0.801,PROCEDURE
6018,medgemma,0.698,SPECIMEN LATERALITY
6019,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
6020,medgemma,0.771,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6021,medgemma,0.811,TUMOR FOCALITY
6022,medgemma,0.697,SPECIMEN LATERALITY
6023,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
6024,medgemma,0.741,LYMPHOVASCULAR INVASION
6025,medgemma,0.817,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6026,medgemma,0.865,TUMOR SITE
6027,medgemma,0.713,NODAL SITE(S) EXAMINED
6028,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
6029,medgemma,0.892,HISTOLOGIC GRADE
6030,medgemma,0.698,SPREAD THROUGH AIR SPACES (STAS)
6031,medgemma,0.811,TUMOR FOCALITY
6032,medgemma,0.831,PROCEDURE
6033,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
6034,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6035,medgemma,0.71,VISCERAL PLEURA INVASION
6036,medgemma,0.815,REGIONAL LYMPH NODE STATUS
6037,medgemma,0.734,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6038,medgemma,0.718,VISCERAL PLEURA INVASION
6039,medgemma,0.82,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6040,medgemma,0.892,HISTOLOGIC GRADE
6041,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
6042,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
6043,medgemma,0.865,TUMOR SITE
6044,medgemma,0.697,SPECIMEN LATERALITY
6045,medgemma,0.676,SPREAD THROUGH AIR SPACES (STAS)
6046,medgemma,0.777,NUMBER OF LYMPH NODES EXAMINED
6047,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
6048,medgemma,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6049,medgemma,0.716,REGIONAL LYMPH NODE STATUS
6050,medgemma,0.811,TUMOR FOCALITY
6051,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6052,medgemma,0.714,NODAL SITE(S) EXAMINED
6053,medgemma,0.741,PROCEDURE
6054,medgemma,0.7,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6055,medgemma,0.716,REGIONAL LYMPH NODE STATUS
6056,medgemma,0.811,TUMOR FOCALITY
6057,medgemma,0.698,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6058,medgemma,0.892,HISTOLOGIC GRADE
6059,medgemma,0.761,NUMBER OF LYMPH NODES EXAMINED
6060,medgemma,0.825,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6061,medgemma,0.884,PROCEDURE
6062,medgemma,0.885,MARGIN STATUS FOR INVASIVE CARCINOMA
6063,medgemma,0.698,SPECIMEN LATERALITY
6064,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
6065,medgemma,0.89,TUMOR SITE
6066,medgemma,0.688,NODAL SITE(S) EXAMINED
6067,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
6068,medgemma,0.778,VISCERAL PLEURA INVASION
6069,medgemma,0.865,TUMOR SITE
6070,medgemma,0.827,PROCEDURE
6071,medgemma,0.821,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6072,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
6073,medgemma,0.815,REGIONAL LYMPH NODE STATUS
6074,medgemma,0.718,VISCERAL PLEURA INVASION
6075,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
6076,medgemma,0.805,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6077,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
6078,medgemma,0.74,NODAL SITE(S) EXAMINED
6079,medgemma,0.697,SPECIMEN LATERALITY
6080,medgemma,0.832,NUMBER OF LYMPH NODES EXAMINED
6081,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6082,medgemma,0.7,SPREAD THROUGH AIR SPACES (STAS)
6083,medgemma,0.811,TUMOR FOCALITY
6084,medgemma,0.725,LYMPHOVASCULAR INVASION
6085,medgemma,0.707,NODAL SITE(S) EXAMINED
6086,medgemma,0.89,TUMOR SITE
6087,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
6088,medgemma,0.757,PROCEDURE
6089,medgemma,0.78,REGIONAL LYMPH NODE STATUS
6090,medgemma,0.811,TUMOR FOCALITY
6091,medgemma,0.778,VISCERAL PLEURA INVASION
6092,medgemma,0.725,NODAL SITE(S) WITH TUMOR
6093,medgemma,0.702,NUMBER OF LYMPH NODES EXAMINED
6094,medgemma,0.713,NUMBER OF LYMPH NODES WITH TUMOR
6095,medgemma,0.835,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6096,medgemma,0.771,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6097,medgemma,0.697,SPECIMEN LATERALITY
6098,medgemma,0.745,LYMPHOVASCULAR INVASION
6099,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
6100,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
6101,medgemma,0.854,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6102,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
6103,medgemma,0.692,TUMOR FOCALITY
6104,medgemma,0.659,REGIONAL LYMPH NODE STATUS
6105,medgemma,0.697,SPECIMEN LATERALITY
6106,medgemma,0.673,NODAL SITE(S) EXAMINED
6107,medgemma,0.827,PROCEDURE
6108,medgemma,0.865,TUMOR SITE
6109,medgemma,0.75,HISTOLOGIC GRADE
6110,medgemma,0.713,NUMBER OF LYMPH NODES EXAMINED
6111,medgemma,0.714,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6112,medgemma,0.738,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6113,medgemma,0.78,VISCERAL PLEURA INVASION
6114,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
6115,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6116,medgemma,0.716,LYMPH NODE(S) FROM PRIOR PROCEDURES
6117,medgemma,0.815,REGIONAL LYMPH NODE STATUS
6118,medgemma,0.698,SPECIMEN LATERALITY
6119,medgemma,0.902,ADDITIONAL FINDINGS
6120,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
6121,medgemma,0.693,MARGIN STATUS FOR INVASIVE CARCINOMA
6122,medgemma,0.685,TUMOR FOCALITY
6123,medgemma,0.699,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6124,medgemma,0.778,VISCERAL PLEURA INVASION
6125,medgemma,0.696,TNM DESCRIPTORS
6126,medgemma,0.684,NODAL SITE(S) EXAMINED
6127,medgemma,0.706,HISTOLOGIC GRADE
6128,medgemma,0.803,PROCEDURE
6129,medgemma,0.784,TUMOR SITE
6130,medgemma,0.815,REGIONAL LYMPH NODE STATUS
6131,medgemma,0.798,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6132,medgemma,0.808,PROCEDURE
6133,medgemma,0.694,NUMBER OF LYMPH NODES EXAMINED
6134,medgemma,0.89,TUMOR SITE
6135,medgemma,0.698,SPECIMEN LATERALITY
6136,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
6137,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
6138,medgemma,0.838,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6139,medgemma,0.811,TUMOR FOCALITY
6140,medgemma,0.892,HISTOLOGIC GRADE
6141,medgemma,0.906,MARGIN STATUS FOR INVASIVE CARCINOMA
6142,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6143,medgemma,0.778,VISCERAL PLEURA INVASION
6144,medgemma,0.743,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6145,medgemma,0.627,NODAL SITE(S) EXAMINED
6146,medgemma,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6147,medgemma,0.892,HISTOLOGIC GRADE
6148,medgemma,0.717,MARGIN STATUS FOR NON-INVASIVE TUMOR
6149,medgemma,0.815,REGIONAL LYMPH NODE STATUS
6150,medgemma,0.7,SPREAD THROUGH AIR SPACES (STAS)
6151,medgemma,0.716,ADDITIONAL FINDINGS
6152,medgemma,0.692,TUMOR FOCALITY
6153,medgemma,0.778,VISCERAL PLEURA INVASION
6154,medgemma,0.691,PROCEDURE
6155,medgemma,0.704,NUMBER OF LYMPH NODES EXAMINED
6156,medgemma,0.698,MARGIN STATUS FOR INVASIVE CARCINOMA
6157,medgemma,0.683,LYMPH NODE(S) FROM PRIOR PROCEDURES
6158,medgemma,0.89,TUMOR SITE
6159,medgemma,0.709,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6160,medgemma,0.697,SPECIMEN LATERALITY
6161,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
6162,medgemma,0.831,PROCEDURE
6163,medgemma,0.892,HISTOLOGIC GRADE
6164,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
6165,medgemma,0.728,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6166,medgemma,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6167,medgemma,0.865,TUMOR SITE
6168,medgemma,0.793,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6169,medgemma,0.778,VISCERAL PLEURA INVASION
6170,medgemma,0.815,REGIONAL LYMPH NODE STATUS
6171,medgemma,0.811,TUMOR FOCALITY
6172,medgemma,0.73,NODAL SITE(S) EXAMINED
6173,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
6174,medgemma,0.697,SPECIMEN LATERALITY
6175,medgemma,0.711,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6176,medgemma,0.697,SPECIMEN LATERALITY
6177,medgemma,0.87,MARGIN STATUS FOR NON-INVASIVE TUMOR
6178,medgemma,0.743,REGIONAL LYMPH NODE STATUS
6179,medgemma,0.724,VISCERAL PLEURA INVASION
6180,medgemma,0.727,NODAL SITE(S) WITH TUMOR
6181,medgemma,0.752,NUMBER OF LYMPH NODES EXAMINED
6182,medgemma,0.698,LYMPHOVASCULAR INVASION
6183,medgemma,0.896,MARGIN STATUS FOR INVASIVE CARCINOMA
6184,medgemma,0.705,NUMBER OF LYMPH NODES WITH TUMOR
6185,medgemma,0.746,TUMOR SITE
6186,medgemma,0.808,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6187,medgemma,0.828,PROCEDURE
6188,medgemma,0.687,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6189,medgemma,0.716,NODAL SITE(S) EXAMINED
6190,medgemma,0.712,TUMOR FOCALITY
6191,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
6192,medgemma,0.731,LYMPHOVASCULAR INVASION
6193,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
6194,medgemma,0.693,NUMBER OF LYMPH NODES EXAMINED
6195,medgemma,0.731,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6196,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
6197,medgemma,0.739,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6198,medgemma,0.654,TNM DESCRIPTORS
6199,medgemma,0.78,REGIONAL LYMPH NODE STATUS
6200,medgemma,0.89,TUMOR SITE
6201,medgemma,0.782,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6202,medgemma,0.699,ADDITIONAL FINDINGS
6203,medgemma,0.798,PROCEDURE
6204,medgemma,0.697,SPECIMEN LATERALITY
6205,medgemma,0.811,TUMOR FOCALITY
6206,medgemma,0.693,NODAL SITE(S) EXAMINED
6207,medgemma,0.78,VISCERAL PLEURA INVASION
6208,medgemma,0.892,HISTOLOGIC GRADE
6209,medgemma,0.72,NUMBER OF LYMPH NODES WITH TUMOR
6210,medgemma,0.778,VISCERAL PLEURA INVASION
6211,medgemma,0.829,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6212,medgemma,0.705,NUMBER OF LYMPH NODES WITH TUMOR
6213,medgemma,0.817,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6214,medgemma,0.884,TUMOR SITE
6215,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
6216,medgemma,0.697,SPECIMEN LATERALITY
6217,medgemma,0.746,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6218,medgemma,0.748,PROCEDURE
6219,medgemma,0.811,TUMOR FOCALITY
6220,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
6221,medgemma,0.78,REGIONAL LYMPH NODE STATUS
6222,medgemma,0.904,HISTOLOGIC GRADE
6223,medgemma,0.738,NODAL SITE(S) WITH TUMOR
6224,medgemma,0.754,LYMPHOVASCULAR INVASION
6225,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
6226,medgemma,0.721,NODAL SITE(S) EXAMINED
6227,medgemma,0.698,SPECIMEN LATERALITY
6228,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
6229,medgemma,0.798,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6230,medgemma,0.743,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6231,medgemma,0.89,TUMOR SITE
6232,medgemma,0.883,MARGIN STATUS FOR INVASIVE CARCINOMA
6233,medgemma,0.757,PROCEDURE
6234,medgemma,0.778,VISCERAL PLEURA INVASION
6235,medgemma,0.691,NODAL SITE(S) EXAMINED
6236,medgemma,0.862,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6237,medgemma,0.716,REGIONAL LYMPH NODE STATUS
6238,medgemma,0.697,SPECIMEN LATERALITY
6239,medgemma,0.796,PROCEDURE
6240,medgemma,0.706,LYMPH NODE(S) FROM PRIOR PROCEDURES
6241,medgemma,0.692,TUMOR FOCALITY
6242,medgemma,0.778,SPREAD THROUGH AIR SPACES (STAS)
6243,medgemma,0.778,VISCERAL PLEURA INVASION
6244,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
6245,medgemma,0.718,NODAL SITE(S) EXAMINED
6246,medgemma,0.815,REGIONAL LYMPH NODE STATUS
6247,medgemma,0.94,MARGIN STATUS FOR NON-INVASIVE TUMOR
6248,medgemma,0.788,PROCEDURE
6249,medgemma,0.692,TUMOR FOCALITY
6250,medgemma,0.698,SPECIMEN LATERALITY
6251,medgemma,0.69,NODAL SITE(S) EXAMINED
6252,medgemma,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
6253,medgemma,0.778,VISCERAL PLEURA INVASION
6254,medgemma,0.738,ADDITIONAL FINDINGS
6255,medgemma,0.89,TUMOR SITE
6256,medgemma,0.815,REGIONAL LYMPH NODE STATUS
6257,medgemma,0.689,NUMBER OF LYMPH NODES EXAMINED
6258,medgemma,0.7,SPREAD THROUGH AIR SPACES (STAS)
6259,medgemma,0.705,HISTOLOGIC GRADE
6260,medgemma,0.831,PROCEDURE
6261,medgemma,0.7,VISCERAL PLEURA INVASION
6262,medgemma,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
6263,medgemma,0.716,REGIONAL LYMPH NODE STATUS
6264,medgemma,0.69,TUMOR SITE
6265,medgemma,0.77,LYMPH NODE(S) FROM PRIOR PROCEDURES
6266,medgemma,0.715,NODAL SITE(S) EXAMINED
6267,medgemma,0.701,SPREAD THROUGH AIR SPACES (STAS)
6268,medgemma,0.716,ADDITIONAL FINDINGS
6269,medgemma,0.747,NUMBER OF LYMPH NODES EXAMINED
6270,medgemma,0.698,SPECIMEN LATERALITY
6271,medgemma,0.678,TUMOR FOCALITY
0,gpt4,0.677,HISTOLOGIC GRADE
1,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
2,gpt4,0.719,TUMOR SITE
3,gpt4,0.673,LYMPHOVASCULAR INVASION
4,gpt4,0.645,TUMOR FOCALITY
5,gpt4,0.697,SPECIMEN LATERALITY
6,gpt4,0.718,MARGIN STATUS FOR INVASIVE CARCINOMA
7,gpt4,0.667,PROCEDURE
8,gpt4,0.737,MARGIN STATUS FOR NON-INVASIVE TUMOR
9,gpt4,0.925,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
10,gpt4,0.663,SPREAD THROUGH AIR SPACES (STAS)
11,gpt4,0.645,VISCERAL PLEURA INVASION
12,gpt4,0.717,ADDITIONAL FINDINGS
13,gpt4,0.652,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
14,gpt4,0.805,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
15,gpt4,0.667,HISTOLOGIC GRADE
16,gpt4,0.693,MARGIN STATUS FOR INVASIVE CARCINOMA
17,gpt4,0.755,NUMBER OF LYMPH NODES WITH TUMOR
18,gpt4,0.681,TUMOR FOCALITY
19,gpt4,0.735,PROCEDURE
20,gpt4,0.842,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
21,gpt4,0.739,NUMBER OF LYMPH NODES EXAMINED
22,gpt4,0.691,LYMPH NODE(S) FROM PRIOR PROCEDURES
23,gpt4,0.647,NODAL SITE(S) EXAMINED
24,gpt4,0.698,LYMPHOVASCULAR INVASION
25,gpt4,0.689,REGIONAL LYMPH NODE STATUS
26,gpt4,0.665,VISCERAL PLEURA INVASION
27,gpt4,0.666,MARGIN STATUS FOR NON-INVASIVE TUMOR
28,gpt4,0.663,SPREAD THROUGH AIR SPACES (STAS)
29,gpt4,0.809,SPECIMEN LATERALITY
30,gpt4,0.707,ADDITIONAL FINDINGS
31,gpt4,0.635,NODAL SITE(S) WITH TUMOR
32,gpt4,0.69,TUMOR SITE
33,gpt4,0.635,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
34,gpt4,0.678,MARGIN STATUS FOR INVASIVE CARCINOMA
35,gpt4,0.686,SPREAD THROUGH AIR SPACES (STAS)
36,gpt4,0.77,SPECIMEN LATERALITY
37,gpt4,0.671,TUMOR FOCALITY
38,gpt4,0.752,NUMBER OF LYMPH NODES EXAMINED
39,gpt4,0.67,MARGIN STATUS FOR NON-INVASIVE TUMOR
40,gpt4,0.631,NODAL SITE(S) EXAMINED
41,gpt4,0.75,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
42,gpt4,0.659,LYMPH NODE(S) FROM PRIOR PROCEDURES
43,gpt4,0.646,NODAL SITE(S) WITH TUMOR
44,gpt4,0.639,PROCEDURE
45,gpt4,0.709,NUMBER OF LYMPH NODES WITH TUMOR
46,gpt4,0.69,REGIONAL LYMPH NODE STATUS
47,gpt4,0.662,VISCERAL PLEURA INVASION
48,gpt4,0.706,TUMOR SITE
49,gpt4,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
50,gpt4,0.691,PROCEDURE
51,gpt4,0.722,REGIONAL LYMPH NODE STATUS
52,gpt4,0.686,TUMOR FOCALITY
53,gpt4,0.773,SPECIMEN LATERALITY
54,gpt4,0.678,HISTOLOGIC GRADE
55,gpt4,0.841,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
56,gpt4,0.632,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
57,gpt4,0.738,MARGIN STATUS FOR NON-INVASIVE TUMOR
58,gpt4,0.661,NODAL SITE(S) EXAMINED
59,gpt4,0.817,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
60,gpt4,0.723,TUMOR SITE
61,gpt4,0.683,LYMPHOVASCULAR INVASION
62,gpt4,0.708,VISCERAL PLEURA INVASION
63,gpt4,0.68,SPREAD THROUGH AIR SPACES (STAS)
64,gpt4,0.696,MARGIN STATUS FOR INVASIVE CARCINOMA
65,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
66,gpt4,0.733,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
67,gpt4,0.709,ADDITIONAL FINDINGS
68,gpt4,0.699,LYMPH NODE(S) FROM PRIOR PROCEDURES
69,gpt4,0.672,VISCERAL PLEURA INVASION
70,gpt4,0.644,MARGIN STATUS FOR NON-INVASIVE TUMOR
71,gpt4,0.737,REGIONAL LYMPH NODE STATUS
72,gpt4,0.639,NODAL SITE(S) EXAMINED
73,gpt4,0.718,TUMOR SITE
74,gpt4,0.708,NUMBER OF LYMPH NODES EXAMINED
75,gpt4,0.802,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
76,gpt4,0.654,PROCEDURE
77,gpt4,0.691,SPREAD THROUGH AIR SPACES (STAS)
78,gpt4,0.718,MARGIN STATUS FOR INVASIVE CARCINOMA
79,gpt4,0.655,TUMOR FOCALITY
80,gpt4,0.673,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
81,gpt4,0.719,HISTOLOGIC GRADE
82,gpt4,0.773,SPECIMEN LATERALITY
83,gpt4,0.688,SPREAD THROUGH AIR SPACES (STAS)
84,gpt4,0.649,NODAL SITE(S) EXAMINED
85,gpt4,0.705,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
86,gpt4,0.677,HISTOLOGIC GRADE
87,gpt4,0.699,MARGIN STATUS FOR INVASIVE CARCINOMA
88,gpt4,0.715,MARGIN STATUS FOR NON-INVASIVE TUMOR
89,gpt4,0.68,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
90,gpt4,0.702,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
91,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
92,gpt4,0.718,TUMOR SITE
93,gpt4,0.685,VISCERAL PLEURA INVASION
94,gpt4,0.765,REGIONAL LYMPH NODE STATUS
95,gpt4,0.736,SPECIMEN LATERALITY
96,gpt4,0.669,PROCEDURE
97,gpt4,0.694,TUMOR FOCALITY
98,gpt4,0.68,NODAL SITE(S) EXAMINED
99,gpt4,0.717,TUMOR SITE
100,gpt4,0.698,SPECIMEN LATERALITY
101,gpt4,0.71,MARGIN STATUS FOR INVASIVE CARCINOMA
102,gpt4,0.686,VISCERAL PLEURA INVASION
103,gpt4,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
104,gpt4,0.684,ADDITIONAL FINDINGS
105,gpt4,0.667,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
106,gpt4,0.655,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
107,gpt4,0.643,PROCEDURE
108,gpt4,0.776,LYMPH NODE(S) FROM PRIOR PROCEDURES
109,gpt4,0.665,TUMOR FOCALITY
110,gpt4,0.696,REGIONAL LYMPH NODE STATUS
111,gpt4,0.694,HISTOLOGIC GRADE
112,gpt4,0.814,NUMBER OF LYMPH NODES EXAMINED
113,gpt4,0.659,TNM DESCRIPTORS
114,gpt4,0.661,SPREAD THROUGH AIR SPACES (STAS)
115,gpt4,0.743,MARGIN STATUS FOR NON-INVASIVE TUMOR
116,gpt4,0.693,MARGIN STATUS FOR NON-INVASIVE TUMOR
117,gpt4,0.652,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
118,gpt4,0.63,NODAL SITE(S) EXAMINED
119,gpt4,0.81,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
120,gpt4,0.637,VISCERAL PLEURA INVASION
121,gpt4,0.699,MARGIN STATUS FOR INVASIVE CARCINOMA
122,gpt4,0.669,TUMOR FOCALITY
123,gpt4,0.72,TUMOR SITE
124,gpt4,0.706,HISTOLOGIC GRADE
125,gpt4,0.711,SPECIMEN LATERALITY
126,gpt4,0.665,PROCEDURE
127,gpt4,0.664,SPREAD THROUGH AIR SPACES (STAS)
128,gpt4,0.656,TNM DESCRIPTORS
129,gpt4,0.725,REGIONAL LYMPH NODE STATUS
130,gpt4,0.681,ADDITIONAL FINDINGS
131,gpt4,0.823,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
132,gpt4,0.776,LYMPH NODE(S) FROM PRIOR PROCEDURES
133,gpt4,0.693,HISTOLOGIC GRADE
134,gpt4,0.635,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
135,gpt4,0.765,MARGIN STATUS FOR NON-INVASIVE TUMOR
136,gpt4,0.682,LYMPH NODE(S) FROM PRIOR PROCEDURES
137,gpt4,0.647,TUMOR FOCALITY
138,gpt4,0.655,PROCEDURE
139,gpt4,0.677,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
140,gpt4,0.738,ADDITIONAL FINDINGS
141,gpt4,0.697,SPECIMEN LATERALITY
142,gpt4,0.702,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
143,gpt4,0.785,MARGIN STATUS FOR INVASIVE CARCINOMA
144,gpt4,0.725,REGIONAL LYMPH NODE STATUS
145,gpt4,0.643,NODAL SITE(S) EXAMINED
146,gpt4,0.718,TUMOR SITE
147,gpt4,0.733,VISCERAL PLEURA INVASION
148,gpt4,0.651,HISTOLOGIC GRADE
149,gpt4,0.773,SPECIMEN LATERALITY
150,gpt4,0.72,NODAL SITE(S) EXAMINED
151,gpt4,0.634,MARGIN STATUS FOR NON-INVASIVE TUMOR
152,gpt4,0.668,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
153,gpt4,0.729,TUMOR SITE
154,gpt4,0.683,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
155,gpt4,0.669,TUMOR FOCALITY
156,gpt4,0.692,ADDITIONAL FINDINGS
157,gpt4,0.719,REGIONAL LYMPH NODE STATUS
158,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
159,gpt4,0.701,MARGIN STATUS FOR INVASIVE CARCINOMA
160,gpt4,0.896,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
161,gpt4,0.8,NUMBER OF LYMPH NODES EXAMINED
162,gpt4,0.727,VISCERAL PLEURA INVASION
163,gpt4,0.647,PROCEDURE
164,gpt4,0.697,TUMOR SITE
165,gpt4,0.652,LYMPHOVASCULAR INVASION
166,gpt4,0.698,SPECIMEN LATERALITY
167,gpt4,0.807,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
168,gpt4,0.699,LYMPH NODE(S) FROM PRIOR PROCEDURES
169,gpt4,0.701,REGIONAL LYMPH NODE STATUS
170,gpt4,0.846,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
171,gpt4,0.672,TNM DESCRIPTORS
172,gpt4,0.703,NUMBER OF LYMPH NODES WITH TUMOR
173,gpt4,0.663,ADDITIONAL FINDINGS
174,gpt4,0.685,HISTOLOGIC GRADE
175,gpt4,0.676,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
176,gpt4,0.7,VISCERAL PLEURA INVASION
177,gpt4,0.638,NODAL SITE(S) WITH TUMOR
178,gpt4,0.645,NODAL SITE(S) EXAMINED
179,gpt4,0.674,SPREAD THROUGH AIR SPACES (STAS)
180,gpt4,0.707,MARGIN STATUS FOR INVASIVE CARCINOMA
181,gpt4,0.676,MARGIN STATUS FOR NON-INVASIVE TUMOR
182,gpt4,0.657,PROCEDURE
183,gpt4,0.674,TUMOR FOCALITY
184,gpt4,0.651,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
185,gpt4,0.652,PROCEDURE
186,gpt4,0.664,TNM DESCRIPTORS
187,gpt4,0.706,VISCERAL PLEURA INVASION
188,gpt4,0.631,SPECIMEN LATERALITY
189,gpt4,0.697,MARGIN STATUS FOR NON-INVASIVE TUMOR
190,gpt4,0.707,MARGIN STATUS FOR INVASIVE CARCINOMA
191,gpt4,0.763,TUMOR SITE
192,gpt4,0.713,LYMPH NODE(S) FROM PRIOR PROCEDURES
193,gpt4,0.69,HISTOLOGIC GRADE
194,gpt4,0.662,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
195,gpt4,0.701,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
196,gpt4,0.848,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
197,gpt4,0.686,HISTOLOGIC GRADE
198,gpt4,0.736,SPECIMEN LATERALITY
199,gpt4,0.737,MARGIN STATUS FOR NON-INVASIVE TUMOR
200,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
201,gpt4,0.716,TUMOR SITE
202,gpt4,0.642,NODAL SITE(S) EXAMINED
203,gpt4,0.659,TUMOR FOCALITY
204,gpt4,0.725,REGIONAL LYMPH NODE STATUS
205,gpt4,0.713,NUMBER OF LYMPH NODES EXAMINED
206,gpt4,0.674,MARGIN STATUS FOR INVASIVE CARCINOMA
207,gpt4,0.667,PROCEDURE
208,gpt4,0.673,ADDITIONAL FINDINGS
209,gpt4,0.634,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
210,gpt4,0.709,VISCERAL PLEURA INVASION
211,gpt4,0.747,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
212,gpt4,0.686,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
213,gpt4,0.681,SPREAD THROUGH AIR SPACES (STAS)
214,gpt4,0.65,TUMOR FOCALITY
215,gpt4,0.814,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
216,gpt4,0.663,NUMBER OF LYMPH NODES EXAMINED
217,gpt4,0.655,NODAL SITE(S) EXAMINED
218,gpt4,0.683,HISTOLOGIC GRADE
219,gpt4,0.715,SPECIMEN LATERALITY
220,gpt4,0.819,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
221,gpt4,0.661,VISCERAL PLEURA INVASION
222,gpt4,0.848,MARGIN STATUS FOR NON-INVASIVE TUMOR
223,gpt4,0.655,PROCEDURE
224,gpt4,0.711,MARGIN STATUS FOR INVASIVE CARCINOMA
225,gpt4,0.732,REGIONAL LYMPH NODE STATUS
226,gpt4,0.713,TUMOR SITE
227,gpt4,0.631,PROCEDURE
228,gpt4,0.787,NUMBER OF LYMPH NODES EXAMINED
229,gpt4,0.683,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
230,gpt4,0.704,VISCERAL PLEURA INVASION
231,gpt4,0.698,MARGIN STATUS FOR INVASIVE CARCINOMA
232,gpt4,0.728,TUMOR SITE
233,gpt4,0.724,MARGIN STATUS FOR NON-INVASIVE TUMOR
234,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
235,gpt4,0.667,TUMOR FOCALITY
236,gpt4,0.723,HISTOLOGIC GRADE
237,gpt4,0.661,SPREAD THROUGH AIR SPACES (STAS)
238,gpt4,0.633,NODAL SITE(S) EXAMINED
239,gpt4,0.704,SPECIMEN LATERALITY
240,gpt4,0.715,ADDITIONAL FINDINGS
241,gpt4,0.647,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
242,gpt4,0.73,REGIONAL LYMPH NODE STATUS
243,gpt4,0.695,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
244,gpt4,0.661,LYMPH NODE(S) FROM PRIOR PROCEDURES
245,gpt4,0.672,TUMOR FOCALITY
246,gpt4,0.788,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
247,gpt4,0.68,VISCERAL PLEURA INVASION
248,gpt4,0.646,NODAL SITE(S) EXAMINED
249,gpt4,0.725,REGIONAL LYMPH NODE STATUS
250,gpt4,0.707,TUMOR SITE
251,gpt4,0.624,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
252,gpt4,0.684,MARGIN STATUS FOR INVASIVE CARCINOMA
253,gpt4,0.851,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
254,gpt4,0.705,HISTOLOGIC GRADE
255,gpt4,0.684,SPREAD THROUGH AIR SPACES (STAS)
256,gpt4,0.773,SPECIMEN LATERALITY
257,gpt4,0.665,PROCEDURE
258,gpt4,0.819,MARGIN STATUS FOR NON-INVASIVE TUMOR
259,gpt4,0.821,NUMBER OF LYMPH NODES EXAMINED
260,gpt4,0.687,LYMPH NODE(S) FROM PRIOR PROCEDURES
261,gpt4,0.653,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
262,gpt4,0.634,TUMOR FOCALITY
263,gpt4,0.713,MARGIN STATUS FOR NON-INVASIVE TUMOR
264,gpt4,0.77,SPECIMEN LATERALITY
265,gpt4,0.671,VISCERAL PLEURA INVASION
266,gpt4,0.861,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
267,gpt4,0.678,SPREAD THROUGH AIR SPACES (STAS)
268,gpt4,0.67,SPREAD THROUGH AIR SPACES (STAS)
269,gpt4,0.672,PROCEDURE
270,gpt4,0.667,LYMPHOVASCULAR INVASION
271,gpt4,0.7,TUMOR SITE
272,gpt4,0.716,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
273,gpt4,0.713,MARGIN STATUS FOR INVASIVE CARCINOMA
274,gpt4,0.82,NUMBER OF LYMPH NODES WITH TUMOR
275,gpt4,0.673,HISTOLOGIC GRADE
276,gpt4,0.667,REGIONAL LYMPH NODE STATUS
277,gpt4,0.638,VISCERAL PLEURA INVASION
278,gpt4,0.652,NODAL SITE(S) EXAMINED
279,gpt4,0.68,REGIONAL LYMPH NODE STATUS
280,gpt4,0.65,NODAL SITE(S) WITH TUMOR
281,gpt4,0.808,MARGIN STATUS FOR NON-INVASIVE TUMOR
282,gpt4,0.726,REGIONAL LYMPH NODE STATUS
283,gpt4,0.827,NUMBER OF LYMPH NODES EXAMINED
284,gpt4,0.722,MARGIN STATUS FOR INVASIVE CARCINOMA
285,gpt4,0.817,NUMBER OF LYMPH NODES EXAMINED
286,gpt4,0.681,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
287,gpt4,0.651,PROCEDURE
288,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
289,gpt4,0.638,LYMPHOVASCULAR INVASION
290,gpt4,0.64,NODAL SITE(S) EXAMINED
291,gpt4,0.669,SPREAD THROUGH AIR SPACES (STAS)
292,gpt4,0.679,TUMOR SITE
293,gpt4,0.669,VISCERAL PLEURA INVASION
294,gpt4,0.666,PROCEDURE
295,gpt4,0.64,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
296,gpt4,0.822,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
297,gpt4,0.704,SPECIMEN LATERALITY
298,gpt4,0.656,TUMOR FOCALITY
299,gpt4,0.706,MARGIN STATUS FOR INVASIVE CARCINOMA
300,gpt4,0.645,VISCERAL PLEURA INVASION
301,gpt4,0.635,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
302,gpt4,0.675,PROCEDURE
303,gpt4,0.773,SPECIMEN LATERALITY
304,gpt4,0.677,ADDITIONAL FINDINGS
305,gpt4,0.753,REGIONAL LYMPH NODE STATUS
306,gpt4,0.67,TUMOR FOCALITY
307,gpt4,0.689,HISTOLOGIC GRADE
308,gpt4,0.717,NODAL SITE(S) EXAMINED
309,gpt4,0.861,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
310,gpt4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
311,gpt4,0.904,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
312,gpt4,0.711,TUMOR SITE
313,gpt4,0.643,TUMOR FOCALITY
314,gpt4,0.738,REGIONAL LYMPH NODE STATUS
315,gpt4,0.762,MARGIN STATUS FOR NON-INVASIVE TUMOR
316,gpt4,0.667,LYMPH NODE(S) FROM PRIOR PROCEDURES
317,gpt4,0.674,NODAL SITE(S) EXAMINED
318,gpt4,0.696,TUMOR SITE
319,gpt4,0.838,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
320,gpt4,0.687,PROCEDURE
321,gpt4,0.773,SPECIMEN LATERALITY
322,gpt4,0.711,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
323,gpt4,0.697,MARGIN STATUS FOR INVASIVE CARCINOMA
324,gpt4,0.661,HISTOLOGIC GRADE
325,gpt4,0.672,VISCERAL PLEURA INVASION
326,gpt4,0.684,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
327,gpt4,0.663,HISTOLOGIC GRADE
328,gpt4,0.642,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
329,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
330,gpt4,0.675,PROCEDURE
331,gpt4,0.661,TUMOR FOCALITY
332,gpt4,0.697,SPECIMEN LATERALITY
333,gpt4,0.715,REGIONAL LYMPH NODE STATUS
334,gpt4,0.699,MARGIN STATUS FOR INVASIVE CARCINOMA
335,gpt4,0.739,VISCERAL PLEURA INVASION
336,gpt4,0.679,NODAL SITE(S) EXAMINED
337,gpt4,0.808,MARGIN STATUS FOR NON-INVASIVE TUMOR
338,gpt4,0.829,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
339,gpt4,0.765,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
340,gpt4,0.728,TUMOR SITE
341,gpt4,0.646,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
342,gpt4,0.773,SPECIMEN LATERALITY
343,gpt4,0.716,TUMOR SITE
344,gpt4,0.705,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
345,gpt4,0.683,VISCERAL PLEURA INVASION
346,gpt4,0.837,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
347,gpt4,0.677,ADDITIONAL FINDINGS
348,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
349,gpt4,0.746,REGIONAL LYMPH NODE STATUS
350,gpt4,0.657,TUMOR FOCALITY
351,gpt4,0.918,MARGIN STATUS FOR NON-INVASIVE TUMOR
352,gpt4,0.663,PROCEDURE
353,gpt4,0.674,MARGIN STATUS FOR INVASIVE CARCINOMA
354,gpt4,0.64,NODAL SITE(S) EXAMINED
355,gpt4,0.663,HISTOLOGIC GRADE
356,gpt4,0.644,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
357,gpt4,0.673,TUMOR FOCALITY
358,gpt4,0.817,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
359,gpt4,0.77,SPECIMEN LATERALITY
360,gpt4,0.705,MARGIN STATUS FOR NON-INVASIVE TUMOR
361,gpt4,0.731,REGIONAL LYMPH NODE STATUS
362,gpt4,0.672,LYMPH NODE(S) FROM PRIOR PROCEDURES
363,gpt4,0.681,SPREAD THROUGH AIR SPACES (STAS)
364,gpt4,0.825,NUMBER OF LYMPH NODES EXAMINED
365,gpt4,0.7,PROCEDURE
366,gpt4,0.749,NODAL SITE(S) EXAMINED
367,gpt4,0.707,TUMOR SITE
368,gpt4,0.717,VISCERAL PLEURA INVASION
369,gpt4,0.708,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
370,gpt4,0.682,MARGIN STATUS FOR INVASIVE CARCINOMA
371,gpt4,0.671,PROCEDURE
372,gpt4,0.736,REGIONAL LYMPH NODE STATUS
373,gpt4,0.77,SPECIMEN LATERALITY
374,gpt4,0.683,LYMPH NODE(S) FROM PRIOR PROCEDURES
375,gpt4,0.897,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
376,gpt4,0.763,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
377,gpt4,0.788,NUMBER OF LYMPH NODES EXAMINED
378,gpt4,0.646,TUMOR FOCALITY
379,gpt4,0.675,MARGIN STATUS FOR INVASIVE CARCINOMA
380,gpt4,0.703,MARGIN STATUS FOR NON-INVASIVE TUMOR
381,gpt4,0.648,VISCERAL PLEURA INVASION
382,gpt4,0.68,HISTOLOGIC GRADE
383,gpt4,0.652,TUMOR SITE
384,gpt4,0.66,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
385,gpt4,0.692,MARGIN STATUS FOR INVASIVE CARCINOMA
386,gpt4,0.773,SPECIMEN LATERALITY
387,gpt4,0.71,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
388,gpt4,0.713,VISCERAL PLEURA INVASION
389,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
390,gpt4,0.733,REGIONAL LYMPH NODE STATUS
391,gpt4,0.666,ADDITIONAL FINDINGS
392,gpt4,0.686,MARGIN STATUS FOR NON-INVASIVE TUMOR
393,gpt4,0.739,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
394,gpt4,0.714,TUMOR SITE
395,gpt4,0.654,NODAL SITE(S) EXAMINED
396,gpt4,0.663,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
397,gpt4,0.649,TNM DESCRIPTORS
398,gpt4,0.642,TUMOR FOCALITY
399,gpt4,0.686,HISTOLOGIC GRADE
400,gpt4,0.68,PROCEDURE
401,gpt4,0.647,VISCERAL PLEURA INVASION
402,gpt4,0.81,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
403,gpt4,0.724,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
404,gpt4,0.673,NUMBER OF LYMPH NODES EXAMINED
405,gpt4,0.66,TUMOR FOCALITY
406,gpt4,0.672,LYMPH NODE(S) FROM PRIOR PROCEDURES
407,gpt4,0.747,HISTOLOGIC GRADE
408,gpt4,0.74,REGIONAL LYMPH NODE STATUS
409,gpt4,0.72,SPECIMEN LATERALITY
410,gpt4,0.708,TUMOR SITE
411,gpt4,0.702,NODAL SITE(S) EXAMINED
412,gpt4,0.664,PROCEDURE
413,gpt4,0.654,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
414,gpt4,0.7,MARGIN STATUS FOR INVASIVE CARCINOMA
415,gpt4,0.737,MARGIN STATUS FOR NON-INVASIVE TUMOR
416,gpt4,0.639,NODAL SITE(S) EXAMINED
417,gpt4,0.772,MARGIN STATUS FOR NON-INVASIVE TUMOR
418,gpt4,0.71,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
419,gpt4,0.809,SPECIMEN LATERALITY
420,gpt4,0.636,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
421,gpt4,0.655,PROCEDURE
422,gpt4,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
423,gpt4,0.659,TUMOR FOCALITY
424,gpt4,0.73,REGIONAL LYMPH NODE STATUS
425,gpt4,0.681,MARGIN STATUS FOR INVASIVE CARCINOMA
426,gpt4,0.904,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
427,gpt4,0.713,VISCERAL PLEURA INVASION
428,gpt4,0.744,TUMOR SITE
429,gpt4,0.765,NUMBER OF LYMPH NODES EXAMINED
430,gpt4,0.667,HISTOLOGIC GRADE
431,gpt4,0.652,LYMPHOVASCULAR INVASION
432,gpt4,0.655,NODAL SITE(S) WITH TUMOR
433,gpt4,0.661,LYMPH NODE(S) FROM PRIOR PROCEDURES
434,gpt4,0.691,NUMBER OF LYMPH NODES WITH TUMOR
435,gpt4,0.686,HISTOLOGIC GRADE
436,gpt4,0.689,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
437,gpt4,0.698,ADDITIONAL FINDINGS
438,gpt4,0.687,REGIONAL LYMPH NODE STATUS
439,gpt4,0.684,VISCERAL PLEURA INVASION
440,gpt4,0.644,MARGIN STATUS FOR NON-INVASIVE TUMOR
441,gpt4,0.695,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
442,gpt4,0.684,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
443,gpt4,0.675,TUMOR SITE
444,gpt4,0.67,MARGIN STATUS FOR INVASIVE CARCINOMA
445,gpt4,0.773,SPECIMEN LATERALITY
446,gpt4,0.655,TUMOR FOCALITY
447,gpt4,0.684,NODAL SITE(S) EXAMINED
448,gpt4,0.697,PROCEDURE
449,gpt4,0.646,VISCERAL PLEURA INVASION
450,gpt4,0.682,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
451,gpt4,0.702,ADDITIONAL FINDINGS
452,gpt4,0.652,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
453,gpt4,0.648,TUMOR FOCALITY
454,gpt4,0.825,MARGIN STATUS FOR INVASIVE CARCINOMA
455,gpt4,0.851,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
456,gpt4,0.645,NODAL SITE(S) EXAMINED
457,gpt4,0.665,PROCEDURE
458,gpt4,0.709,TUMOR SITE
459,gpt4,0.732,LYMPH NODE(S) FROM PRIOR PROCEDURES
460,gpt4,0.841,MARGIN STATUS FOR NON-INVASIVE TUMOR
461,gpt4,0.697,SPECIMEN LATERALITY
462,gpt4,0.747,HISTOLOGIC GRADE
463,gpt4,0.811,NUMBER OF LYMPH NODES EXAMINED
464,gpt4,0.625,HISTOLOGIC GRADE
465,gpt4,0.698,SPECIMEN LATERALITY
466,gpt4,0.681,MARGIN STATUS FOR INVASIVE CARCINOMA
467,gpt4,0.652,PROCEDURE
468,gpt4,0.7,MARGIN STATUS FOR NON-INVASIVE TUMOR
469,gpt4,0.711,VISCERAL PLEURA INVASION
470,gpt4,0.662,LYMPH NODE(S) FROM PRIOR PROCEDURES
471,gpt4,0.673,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
472,gpt4,0.659,NODAL SITE(S) EXAMINED
473,gpt4,0.675,NODAL SITE(S) WITH TUMOR
474,gpt4,0.687,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
475,gpt4,0.697,REGIONAL LYMPH NODE STATUS
476,gpt4,0.671,TUMOR FOCALITY
477,gpt4,0.65,LYMPHOVASCULAR INVASION
478,gpt4,0.713,NUMBER OF LYMPH NODES WITH TUMOR
479,gpt4,0.738,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
480,gpt4,0.724,TUMOR SITE
481,gpt4,0.665,TNM DESCRIPTORS
482,gpt4,0.74,MARGIN STATUS FOR NON-INVASIVE TUMOR
483,gpt4,0.677,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
484,gpt4,0.706,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
485,gpt4,0.648,PROCEDURE
486,gpt4,0.903,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
487,gpt4,0.722,LYMPH NODE(S) FROM PRIOR PROCEDURES
488,gpt4,0.661,SPECIMEN LATERALITY
489,gpt4,0.637,HISTOLOGIC GRADE
490,gpt4,0.72,TUMOR SITE
491,gpt4,0.692,ADDITIONAL FINDINGS
492,gpt4,0.679,SPREAD THROUGH AIR SPACES (STAS)
493,gpt4,0.681,VISCERAL PLEURA INVASION
494,gpt4,0.66,TUMOR FOCALITY
495,gpt4,0.692,MARGIN STATUS FOR INVASIVE CARCINOMA
496,gpt4,0.684,MARGIN STATUS FOR NON-INVASIVE TUMOR
497,gpt4,0.688,REGIONAL LYMPH NODE STATUS
498,gpt4,0.693,PROCEDURE
499,gpt4,0.653,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
500,gpt4,0.658,LYMPH NODE(S) FROM PRIOR PROCEDURES
501,gpt4,0.676,LYMPHOVASCULAR INVASION
502,gpt4,0.737,MARGIN STATUS FOR INVASIVE CARCINOMA
503,gpt4,0.654,ADDITIONAL FINDINGS
504,gpt4,0.679,HISTOLOGIC GRADE
505,gpt4,0.66,TUMOR FOCALITY
506,gpt4,0.798,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
507,gpt4,0.72,NUMBER OF LYMPH NODES WITH TUMOR
508,gpt4,0.66,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
509,gpt4,0.657,NODAL SITE(S) EXAMINED
510,gpt4,0.665,NODAL SITE(S) WITH TUMOR
511,gpt4,0.697,SPECIMEN LATERALITY
512,gpt4,0.693,VISCERAL PLEURA INVASION
513,gpt4,0.791,TUMOR SITE
514,gpt4,0.642,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
515,gpt4,0.685,VISCERAL PLEURA INVASION
516,gpt4,0.654,PROCEDURE
517,gpt4,0.704,SPECIMEN LATERALITY
518,gpt4,0.745,REGIONAL LYMPH NODE STATUS
519,gpt4,0.715,TUMOR SITE
520,gpt4,0.655,TUMOR FOCALITY
521,gpt4,0.667,ADDITIONAL FINDINGS
522,gpt4,0.81,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
523,gpt4,0.679,SPREAD THROUGH AIR SPACES (STAS)
524,gpt4,0.798,NUMBER OF LYMPH NODES EXAMINED
525,gpt4,0.722,MARGIN STATUS FOR NON-INVASIVE TUMOR
526,gpt4,0.639,NODAL SITE(S) EXAMINED
527,gpt4,0.69,HISTOLOGIC GRADE
528,gpt4,0.711,MARGIN STATUS FOR INVASIVE CARCINOMA
529,gpt4,0.693,LYMPH NODE(S) FROM PRIOR PROCEDURES
530,gpt4,0.79,NUMBER OF LYMPH NODES EXAMINED
531,gpt4,0.757,REGIONAL LYMPH NODE STATUS
532,gpt4,0.657,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
533,gpt4,0.706,HISTOLOGIC GRADE
534,gpt4,0.688,TUMOR FOCALITY
535,gpt4,0.698,SPECIMEN LATERALITY
536,gpt4,0.689,MARGIN STATUS FOR NON-INVASIVE TUMOR
537,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
538,gpt4,0.679,VISCERAL PLEURA INVASION
539,gpt4,0.661,TUMOR SITE
540,gpt4,0.655,SPREAD THROUGH AIR SPACES (STAS)
541,gpt4,0.67,PROCEDURE
542,gpt4,0.691,MARGIN STATUS FOR INVASIVE CARCINOMA
543,gpt4,0.924,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
544,gpt4,0.789,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
545,gpt4,0.692,NODAL SITE(S) EXAMINED
546,gpt4,0.669,TUMOR FOCALITY
547,gpt4,0.706,TUMOR SITE
548,gpt4,0.627,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
549,gpt4,0.643,NODAL SITE(S) EXAMINED
550,gpt4,0.693,MARGIN STATUS FOR INVASIVE CARCINOMA
551,gpt4,0.772,MARGIN STATUS FOR NON-INVASIVE TUMOR
552,gpt4,0.809,SPECIMEN LATERALITY
553,gpt4,0.731,REGIONAL LYMPH NODE STATUS
554,gpt4,0.817,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
555,gpt4,0.638,VISCERAL PLEURA INVASION
556,gpt4,0.712,LYMPH NODE(S) FROM PRIOR PROCEDURES
557,gpt4,0.691,SPREAD THROUGH AIR SPACES (STAS)
558,gpt4,0.658,PROCEDURE
559,gpt4,0.802,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
560,gpt4,0.671,ADDITIONAL FINDINGS
561,gpt4,0.672,TUMOR FOCALITY
562,gpt4,0.698,SPECIMEN LATERALITY
563,gpt4,0.675,SPREAD THROUGH AIR SPACES (STAS)
564,gpt4,0.705,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
565,gpt4,0.739,MARGIN STATUS FOR INVASIVE CARCINOMA
566,gpt4,0.771,REGIONAL LYMPH NODE STATUS
567,gpt4,0.659,TUMOR SITE
568,gpt4,0.639,NODAL SITE(S) EXAMINED
569,gpt4,0.681,VISCERAL PLEURA INVASION
570,gpt4,0.688,NUMBER OF LYMPH NODES EXAMINED
571,gpt4,0.687,MARGIN STATUS FOR NON-INVASIVE TUMOR
572,gpt4,0.647,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
573,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
574,gpt4,0.698,HISTOLOGIC GRADE
575,gpt4,0.67,PROCEDURE
576,gpt4,0.856,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
577,gpt4,0.776,LYMPH NODE(S) FROM PRIOR PROCEDURES
578,gpt4,0.657,NODAL SITE(S) EXAMINED
579,gpt4,0.7,HISTOLOGIC GRADE
580,gpt4,0.617,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
581,gpt4,0.682,MARGIN STATUS FOR INVASIVE CARCINOMA
582,gpt4,0.674,MARGIN STATUS FOR NON-INVASIVE TUMOR
583,gpt4,0.73,REGIONAL LYMPH NODE STATUS
584,gpt4,0.85,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
585,gpt4,0.665,VISCERAL PLEURA INVASION
586,gpt4,0.663,PROCEDURE
587,gpt4,0.668,TUMOR FOCALITY
588,gpt4,0.704,SPECIMEN LATERALITY
589,gpt4,0.712,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
590,gpt4,0.737,TUMOR SITE
591,gpt4,0.646,TUMOR FOCALITY
592,gpt4,0.734,HISTOLOGIC GRADE
593,gpt4,0.651,NODAL SITE(S) EXAMINED
594,gpt4,0.637,SPECIMEN LATERALITY
595,gpt4,0.807,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
596,gpt4,0.634,VISCERAL PLEURA INVASION
597,gpt4,0.645,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
598,gpt4,0.728,REGIONAL LYMPH NODE STATUS
599,gpt4,0.713,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
600,gpt4,0.717,TUMOR SITE
601,gpt4,0.635,PROCEDURE
602,gpt4,0.776,LYMPH NODE(S) FROM PRIOR PROCEDURES
603,gpt4,0.716,MARGIN STATUS FOR INVASIVE CARCINOMA
604,gpt4,0.738,MARGIN STATUS FOR NON-INVASIVE TUMOR
605,gpt4,0.678,LYMPH NODE(S) FROM PRIOR PROCEDURES
606,gpt4,0.679,PROCEDURE
607,gpt4,0.74,MARGIN STATUS FOR INVASIVE CARCINOMA
608,gpt4,0.627,NODAL SITE(S) WITH TUMOR
609,gpt4,0.661,VISCERAL PLEURA INVASION
610,gpt4,0.623,TUMOR FOCALITY
611,gpt4,0.82,NUMBER OF LYMPH NODES WITH TUMOR
612,gpt4,0.697,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
613,gpt4,0.809,SPECIMEN LATERALITY
614,gpt4,0.677,ADDITIONAL FINDINGS
615,gpt4,0.66,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
616,gpt4,0.647,HISTOLOGIC GRADE
617,gpt4,0.737,NODAL SITE(S) EXAMINED
618,gpt4,0.683,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
619,gpt4,0.674,SPREAD THROUGH AIR SPACES (STAS)
620,gpt4,0.684,MARGIN STATUS FOR NON-INVASIVE TUMOR
621,gpt4,0.667,TNM DESCRIPTORS
622,gpt4,0.713,TUMOR SITE
623,gpt4,0.695,REGIONAL LYMPH NODE STATUS
624,gpt4,0.652,NODAL SITE(S) EXAMINED
625,gpt4,0.789,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
626,gpt4,0.72,MARGIN STATUS FOR INVASIVE CARCINOMA
627,gpt4,0.721,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
628,gpt4,0.745,HISTOLOGIC GRADE
629,gpt4,0.77,SPECIMEN LATERALITY
630,gpt4,0.723,REGIONAL LYMPH NODE STATUS
631,gpt4,0.667,PROCEDURE
632,gpt4,0.638,MARGIN STATUS FOR NON-INVASIVE TUMOR
633,gpt4,0.668,TUMOR FOCALITY
634,gpt4,0.652,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
635,gpt4,0.686,LYMPH NODE(S) FROM PRIOR PROCEDURES
636,gpt4,0.683,SPREAD THROUGH AIR SPACES (STAS)
637,gpt4,0.748,TUMOR SITE
638,gpt4,0.734,VISCERAL PLEURA INVASION
639,gpt4,0.68,HISTOLOGIC GRADE
640,gpt4,0.673,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
641,gpt4,0.648,VISCERAL PLEURA INVASION
642,gpt4,0.753,MARGIN STATUS FOR INVASIVE CARCINOMA
643,gpt4,0.673,PROCEDURE
644,gpt4,0.768,LYMPH NODE(S) FROM PRIOR PROCEDURES
645,gpt4,0.701,REGIONAL LYMPH NODE STATUS
646,gpt4,0.719,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
647,gpt4,0.642,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
648,gpt4,0.638,NODAL SITE(S) WITH TUMOR
649,gpt4,0.72,TUMOR SITE
650,gpt4,0.678,LYMPHOVASCULAR INVASION
651,gpt4,0.649,MARGIN STATUS FOR NON-INVASIVE TUMOR
652,gpt4,0.692,NODAL SITE(S) EXAMINED
653,gpt4,0.773,SPECIMEN LATERALITY
654,gpt4,0.648,TUMOR FOCALITY
655,gpt4,0.65,HISTOLOGIC GRADE
656,gpt4,0.666,LYMPHOVASCULAR INVASION
657,gpt4,0.724,REGIONAL LYMPH NODE STATUS
658,gpt4,0.641,VISCERAL PLEURA INVASION
659,gpt4,0.689,SPREAD THROUGH AIR SPACES (STAS)
660,gpt4,0.705,MARGIN STATUS FOR INVASIVE CARCINOMA
661,gpt4,0.666,NODAL SITE(S) EXAMINED
662,gpt4,0.708,TUMOR SITE
663,gpt4,0.673,PROCEDURE
664,gpt4,0.809,SPECIMEN LATERALITY
665,gpt4,0.654,NODAL SITE(S) WITH TUMOR
666,gpt4,0.713,NUMBER OF LYMPH NODES WITH TUMOR
667,gpt4,0.799,NUMBER OF LYMPH NODES EXAMINED
668,gpt4,0.661,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
669,gpt4,0.647,TUMOR FOCALITY
670,gpt4,0.647,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
671,gpt4,0.662,TNM DESCRIPTORS
672,gpt4,0.718,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
673,gpt4,0.668,MARGIN STATUS FOR NON-INVASIVE TUMOR
674,gpt4,0.693,VISCERAL PLEURA INVASION
675,gpt4,0.697,SPECIMEN LATERALITY
676,gpt4,0.748,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
677,gpt4,0.731,MARGIN STATUS FOR INVASIVE CARCINOMA
678,gpt4,0.684,LYMPHOVASCULAR INVASION
679,gpt4,0.655,NODAL SITE(S) WITH TUMOR
680,gpt4,0.738,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
681,gpt4,0.688,HISTOLOGIC GRADE
682,gpt4,0.623,MARGIN STATUS FOR NON-INVASIVE TUMOR
683,gpt4,0.675,SPREAD THROUGH AIR SPACES (STAS)
684,gpt4,0.7,NUMBER OF LYMPH NODES WITH TUMOR
685,gpt4,0.683,REGIONAL LYMPH NODE STATUS
686,gpt4,0.692,PROCEDURE
687,gpt4,0.676,NODAL SITE(S) EXAMINED
688,gpt4,0.656,TUMOR FOCALITY
689,gpt4,0.664,LYMPH NODE(S) FROM PRIOR PROCEDURES
690,gpt4,0.661,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
691,gpt4,0.731,TUMOR SITE
692,gpt4,0.72,NUMBER OF LYMPH NODES EXAMINED
693,gpt4,0.798,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
694,gpt4,0.641,PROCEDURE
695,gpt4,0.678,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
696,gpt4,0.635,HISTOLOGIC GRADE
697,gpt4,0.734,REGIONAL LYMPH NODE STATUS
698,gpt4,0.693,MARGIN STATUS FOR NON-INVASIVE TUMOR
699,gpt4,0.728,MARGIN STATUS FOR INVASIVE CARCINOMA
700,gpt4,0.698,SPECIMEN LATERALITY
701,gpt4,0.636,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
702,gpt4,0.716,LYMPH NODE(S) FROM PRIOR PROCEDURES
703,gpt4,0.681,SPREAD THROUGH AIR SPACES (STAS)
704,gpt4,0.66,TUMOR FOCALITY
705,gpt4,0.655,NODAL SITE(S) EXAMINED
706,gpt4,0.724,TUMOR SITE
707,gpt4,0.666,VISCERAL PLEURA INVASION
708,gpt4,0.664,VISCERAL PLEURA INVASION
709,gpt4,0.661,PROCEDURE
710,gpt4,0.688,MARGIN STATUS FOR INVASIVE CARCINOMA
711,gpt4,0.67,TUMOR FOCALITY
712,gpt4,0.72,REGIONAL LYMPH NODE STATUS
713,gpt4,0.848,MARGIN STATUS FOR NON-INVASIVE TUMOR
714,gpt4,0.905,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
715,gpt4,0.776,LYMPH NODE(S) FROM PRIOR PROCEDURES
716,gpt4,0.698,SPECIMEN LATERALITY
717,gpt4,0.649,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
718,gpt4,0.901,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
719,gpt4,0.668,NODAL SITE(S) EXAMINED
720,gpt4,0.733,TUMOR SITE
721,gpt4,0.697,HISTOLOGIC GRADE
722,gpt4,0.682,SPREAD THROUGH AIR SPACES (STAS)
723,gpt4,0.796,MARGIN STATUS FOR NON-INVASIVE TUMOR
724,gpt4,0.679,PROCEDURE
725,gpt4,0.718,MARGIN STATUS FOR INVASIVE CARCINOMA
726,gpt4,0.801,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
727,gpt4,0.677,LYMPH NODE(S) FROM PRIOR PROCEDURES
728,gpt4,0.678,TUMOR SITE
729,gpt4,0.718,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
730,gpt4,0.654,NODAL SITE(S) EXAMINED
731,gpt4,0.8,NUMBER OF LYMPH NODES EXAMINED
732,gpt4,0.688,HISTOLOGIC GRADE
733,gpt4,0.746,REGIONAL LYMPH NODE STATUS
734,gpt4,0.669,TUMOR FOCALITY
735,gpt4,0.669,VISCERAL PLEURA INVASION
736,gpt4,0.698,SPECIMEN LATERALITY
737,gpt4,0.647,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
738,gpt4,0.68,PROCEDURE
739,gpt4,0.701,TUMOR SITE
740,gpt4,0.641,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
741,gpt4,0.669,ADDITIONAL FINDINGS
742,gpt4,0.689,HISTOLOGIC GRADE
743,gpt4,0.804,MARGIN STATUS FOR NON-INVASIVE TUMOR
744,gpt4,0.737,REGIONAL LYMPH NODE STATUS
745,gpt4,0.798,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
746,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
747,gpt4,0.691,SPREAD THROUGH AIR SPACES (STAS)
748,gpt4,0.662,VISCERAL PLEURA INVASION
749,gpt4,0.656,NODAL SITE(S) EXAMINED
750,gpt4,0.697,SPECIMEN LATERALITY
751,gpt4,0.662,NUMBER OF LYMPH NODES EXAMINED
752,gpt4,0.846,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
753,gpt4,0.641,TUMOR FOCALITY
754,gpt4,0.727,MARGIN STATUS FOR INVASIVE CARCINOMA
755,gpt4,0.69,HISTOLOGIC GRADE
756,gpt4,0.813,MARGIN STATUS FOR INVASIVE CARCINOMA
757,gpt4,0.72,NUMBER OF LYMPH NODES EXAMINED
758,gpt4,0.735,REGIONAL LYMPH NODE STATUS
759,gpt4,0.645,PROCEDURE
760,gpt4,0.67,TUMOR FOCALITY
761,gpt4,0.645,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
762,gpt4,0.648,NODAL SITE(S) EXAMINED
763,gpt4,0.679,SPREAD THROUGH AIR SPACES (STAS)
764,gpt4,0.77,SPECIMEN LATERALITY
765,gpt4,0.69,ADDITIONAL FINDINGS
766,gpt4,0.801,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
767,gpt4,0.742,MARGIN STATUS FOR NON-INVASIVE TUMOR
768,gpt4,0.681,VISCERAL PLEURA INVASION
769,gpt4,0.746,LYMPH NODE(S) FROM PRIOR PROCEDURES
770,gpt4,0.706,TUMOR SITE
771,gpt4,0.79,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
772,gpt4,0.744,LYMPH NODE(S) FROM PRIOR PROCEDURES
773,gpt4,0.696,VISCERAL PLEURA INVASION
774,gpt4,0.836,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
775,gpt4,0.761,NUMBER OF LYMPH NODES WITH TUMOR
776,gpt4,0.663,TUMOR FOCALITY
777,gpt4,0.686,NUMBER OF LYMPH NODES WITH TUMOR
778,gpt4,0.64,NODAL SITE(S) EXAMINED
779,gpt4,0.706,TUMOR SITE
780,gpt4,0.636,NODAL SITE(S) WITH TUMOR
781,gpt4,0.707,HISTOLOGIC GRADE
782,gpt4,0.72,PROCEDURE
783,gpt4,0.773,SPECIMEN LATERALITY
784,gpt4,0.706,REGIONAL LYMPH NODE STATUS
785,gpt4,0.686,SPREAD THROUGH AIR SPACES (STAS)
786,gpt4,0.635,NODAL SITE(S) EXAMINED
787,gpt4,0.897,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
788,gpt4,0.692,MARGIN STATUS FOR NON-INVASIVE TUMOR
789,gpt4,0.681,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
790,gpt4,0.718,MARGIN STATUS FOR INVASIVE CARCINOMA
791,gpt4,0.684,NUMBER OF LYMPH NODES EXAMINED
792,gpt4,0.645,HISTOLOGIC GRADE
793,gpt4,0.698,MARGIN STATUS FOR INVASIVE CARCINOMA
794,gpt4,0.711,TUMOR SITE
795,gpt4,0.799,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
796,gpt4,0.776,LYMPH NODE(S) FROM PRIOR PROCEDURES
797,gpt4,0.722,MARGIN STATUS FOR NON-INVASIVE TUMOR
798,gpt4,0.656,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
799,gpt4,0.66,TUMOR FOCALITY
800,gpt4,0.659,NUMBER OF LYMPH NODES EXAMINED
801,gpt4,0.673,REGIONAL LYMPH NODE STATUS
802,gpt4,0.645,NODAL SITE(S) EXAMINED
803,gpt4,0.7,NUMBER OF LYMPH NODES WITH TUMOR
804,gpt4,0.661,VISCERAL PLEURA INVASION
805,gpt4,0.623,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
806,gpt4,0.773,SPECIMEN LATERALITY
807,gpt4,0.671,PROCEDURE
808,gpt4,0.671,LYMPHOVASCULAR INVASION
809,gpt4,0.706,TUMOR SITE
810,gpt4,0.708,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
811,gpt4,0.647,LYMPHOVASCULAR INVASION
812,gpt4,0.644,NODAL SITE(S) EXAMINED
813,gpt4,0.653,LYMPH NODE(S) FROM PRIOR PROCEDURES
814,gpt4,0.672,SPREAD THROUGH AIR SPACES (STAS)
815,gpt4,0.659,HISTOLOGIC GRADE
816,gpt4,0.772,MARGIN STATUS FOR NON-INVASIVE TUMOR
817,gpt4,0.661,PROCEDURE
818,gpt4,0.697,SPECIMEN LATERALITY
819,gpt4,0.699,NUMBER OF LYMPH NODES EXAMINED
820,gpt4,0.74,REGIONAL LYMPH NODE STATUS
821,gpt4,0.663,VISCERAL PLEURA INVASION
822,gpt4,0.681,TUMOR FOCALITY
823,gpt4,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
824,gpt4,0.904,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
825,gpt4,0.679,LYMPH NODE(S) FROM PRIOR PROCEDURES
826,gpt4,0.693,REGIONAL LYMPH NODE STATUS
827,gpt4,0.809,SPECIMEN LATERALITY
828,gpt4,0.729,MARGIN STATUS FOR NON-INVASIVE TUMOR
829,gpt4,0.691,VISCERAL PLEURA INVASION
830,gpt4,0.651,TUMOR FOCALITY
831,gpt4,0.709,NUMBER OF LYMPH NODES WITH TUMOR
832,gpt4,0.805,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
833,gpt4,0.633,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
834,gpt4,0.757,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
835,gpt4,0.705,NUMBER OF LYMPH NODES EXAMINED
836,gpt4,0.628,PROCEDURE
837,gpt4,0.642,NODAL SITE(S) EXAMINED
838,gpt4,0.72,TUMOR SITE
839,gpt4,0.701,MARGIN STATUS FOR INVASIVE CARCINOMA
840,gpt4,0.643,NODAL SITE(S) WITH TUMOR
841,gpt4,0.635,NODAL SITE(S) EXAMINED
842,gpt4,0.848,MARGIN STATUS FOR NON-INVASIVE TUMOR
843,gpt4,0.661,ADDITIONAL FINDINGS
844,gpt4,0.729,REGIONAL LYMPH NODE STATUS
845,gpt4,0.776,LYMPH NODE(S) FROM PRIOR PROCEDURES
846,gpt4,0.64,TUMOR SITE
847,gpt4,0.673,HISTOLOGIC GRADE
848,gpt4,0.675,VISCERAL PLEURA INVASION
849,gpt4,0.68,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
850,gpt4,0.644,TUMOR FOCALITY
851,gpt4,0.675,PROCEDURE
852,gpt4,0.717,MARGIN STATUS FOR INVASIVE CARCINOMA
853,gpt4,0.682,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
854,gpt4,0.641,NUMBER OF LYMPH NODES EXAMINED
855,gpt4,0.698,SPECIMEN LATERALITY
856,gpt4,0.7,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
857,gpt4,0.668,SPREAD THROUGH AIR SPACES (STAS)
858,gpt4,0.675,SPREAD THROUGH AIR SPACES (STAS)
859,gpt4,0.657,HISTOLOGIC GRADE
860,gpt4,0.657,LYMPHOVASCULAR INVASION
861,gpt4,0.653,NODAL SITE(S) WITH TUMOR
862,gpt4,0.731,VISCERAL PLEURA INVASION
863,gpt4,0.679,LYMPH NODE(S) FROM PRIOR PROCEDURES
864,gpt4,0.711,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
865,gpt4,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
866,gpt4,0.763,PROCEDURE
867,gpt4,0.636,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
868,gpt4,0.698,SPECIMEN LATERALITY
869,gpt4,0.721,MARGIN STATUS FOR INVASIVE CARCINOMA
870,gpt4,0.715,NUMBER OF LYMPH NODES EXAMINED
871,gpt4,0.647,NODAL SITE(S) EXAMINED
872,gpt4,0.709,REGIONAL LYMPH NODE STATUS
873,gpt4,0.672,MARGIN STATUS FOR NON-INVASIVE TUMOR
874,gpt4,0.803,NUMBER OF LYMPH NODES WITH TUMOR
875,gpt4,0.644,TUMOR FOCALITY
876,gpt4,0.715,MARGIN STATUS FOR INVASIVE CARCINOMA
877,gpt4,0.698,VISCERAL PLEURA INVASION
878,gpt4,0.638,NODAL SITE(S) EXAMINED
879,gpt4,0.809,SPECIMEN LATERALITY
880,gpt4,0.664,PROCEDURE
881,gpt4,0.841,MARGIN STATUS FOR NON-INVASIVE TUMOR
882,gpt4,0.84,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
883,gpt4,0.697,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
884,gpt4,0.671,HISTOLOGIC GRADE
885,gpt4,0.759,REGIONAL LYMPH NODE STATUS
886,gpt4,0.685,SPREAD THROUGH AIR SPACES (STAS)
887,gpt4,0.805,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
888,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
889,gpt4,0.718,TUMOR SITE
890,gpt4,0.669,TUMOR FOCALITY
891,gpt4,0.734,NUMBER OF LYMPH NODES EXAMINED
892,gpt4,0.682,MARGIN STATUS FOR INVASIVE CARCINOMA
893,gpt4,0.708,PROCEDURE
894,gpt4,0.655,TUMOR FOCALITY
895,gpt4,0.695,SPECIMEN LATERALITY
896,gpt4,0.743,MARGIN STATUS FOR NON-INVASIVE TUMOR
897,gpt4,0.758,NUMBER OF LYMPH NODES WITH TUMOR
898,gpt4,0.679,VISCERAL PLEURA INVASION
899,gpt4,0.644,LYMPHOVASCULAR INVASION
900,gpt4,0.662,NODAL SITE(S) EXAMINED
901,gpt4,0.658,HISTOLOGIC GRADE
902,gpt4,0.629,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
903,gpt4,0.674,SPREAD THROUGH AIR SPACES (STAS)
904,gpt4,0.656,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
905,gpt4,0.657,MARGIN STATUS FOR INVASIVE CARCINOMA
906,gpt4,0.845,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
907,gpt4,0.658,NODAL SITE(S) WITH TUMOR
908,gpt4,0.704,REGIONAL LYMPH NODE STATUS
909,gpt4,0.701,TUMOR SITE
910,gpt4,0.765,LYMPH NODE(S) FROM PRIOR PROCEDURES
911,gpt4,0.681,SPREAD THROUGH AIR SPACES (STAS)
912,gpt4,0.658,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
913,gpt4,0.685,HISTOLOGIC GRADE
914,gpt4,0.722,REGIONAL LYMPH NODE STATUS
915,gpt4,0.817,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
916,gpt4,0.702,PROCEDURE
917,gpt4,0.66,NUMBER OF LYMPH NODES EXAMINED
918,gpt4,0.658,MARGIN STATUS FOR NON-INVASIVE TUMOR
919,gpt4,0.696,SPECIMEN LATERALITY
920,gpt4,0.655,TUMOR FOCALITY
921,gpt4,0.727,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
922,gpt4,0.652,NODAL SITE(S) EXAMINED
923,gpt4,0.68,MARGIN STATUS FOR INVASIVE CARCINOMA
924,gpt4,0.676,VISCERAL PLEURA INVASION
925,gpt4,0.726,TUMOR SITE
926,gpt4,0.666,MARGIN STATUS FOR NON-INVASIVE TUMOR
927,gpt4,0.657,NODAL SITE(S) WITH TUMOR
928,gpt4,0.817,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
929,gpt4,0.719,TUMOR SITE
930,gpt4,0.635,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
931,gpt4,0.769,LYMPH NODE(S) FROM PRIOR PROCEDURES
932,gpt4,0.675,SPREAD THROUGH AIR SPACES (STAS)
933,gpt4,0.671,HISTOLOGIC GRADE
934,gpt4,0.705,REGIONAL LYMPH NODE STATUS
935,gpt4,0.652,VISCERAL PLEURA INVASION
936,gpt4,0.681,LYMPHOVASCULAR INVASION
937,gpt4,0.704,NUMBER OF LYMPH NODES EXAMINED
938,gpt4,0.699,SPECIMEN LATERALITY
939,gpt4,0.624,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
940,gpt4,0.663,NODAL SITE(S) EXAMINED
941,gpt4,0.651,PROCEDURE
942,gpt4,0.68,MARGIN STATUS FOR INVASIVE CARCINOMA
943,gpt4,0.699,NUMBER OF LYMPH NODES WITH TUMOR
944,gpt4,0.658,TUMOR FOCALITY
945,gpt4,0.82,NUMBER OF LYMPH NODES WITH TUMOR
946,gpt4,0.722,TUMOR SITE
947,gpt4,0.638,NODAL SITE(S) EXAMINED
948,gpt4,0.707,MARGIN STATUS FOR INVASIVE CARCINOMA
949,gpt4,0.645,MARGIN STATUS FOR NON-INVASIVE TUMOR
950,gpt4,0.67,VISCERAL PLEURA INVASION
951,gpt4,0.688,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
952,gpt4,0.676,HISTOLOGIC GRADE
953,gpt4,0.666,NUMBER OF LYMPH NODES EXAMINED
954,gpt4,0.7,REGIONAL LYMPH NODE STATUS
955,gpt4,0.68,SPREAD THROUGH AIR SPACES (STAS)
956,gpt4,0.795,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
957,gpt4,0.708,PROCEDURE
958,gpt4,0.634,NODAL SITE(S) WITH TUMOR
959,gpt4,0.8,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
960,gpt4,0.696,LYMPH NODE(S) FROM PRIOR PROCEDURES
961,gpt4,0.773,SPECIMEN LATERALITY
962,gpt4,0.665,TUMOR FOCALITY
963,gpt4,0.702,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
964,gpt4,0.776,LYMPH NODE(S) FROM PRIOR PROCEDURES
965,gpt4,0.711,NUMBER OF LYMPH NODES WITH TUMOR
966,gpt4,0.696,PROCEDURE
967,gpt4,0.695,HISTOLOGIC GRADE
968,gpt4,0.686,REGIONAL LYMPH NODE STATUS
969,gpt4,0.813,NUMBER OF LYMPH NODES EXAMINED
970,gpt4,0.671,MARGIN STATUS FOR NON-INVASIVE TUMOR
971,gpt4,0.64,NODAL SITE(S) EXAMINED
972,gpt4,0.707,VISCERAL PLEURA INVASION
973,gpt4,0.752,MARGIN STATUS FOR INVASIVE CARCINOMA
974,gpt4,0.642,NODAL SITE(S) WITH TUMOR
975,gpt4,0.808,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
976,gpt4,0.68,TUMOR FOCALITY
977,gpt4,0.655,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
978,gpt4,0.665,TUMOR SITE
979,gpt4,0.809,SPECIMEN LATERALITY
980,gpt4,0.689,SPREAD THROUGH AIR SPACES (STAS)
981,gpt4,0.73,SPREAD THROUGH AIR SPACES (STAS)
982,gpt4,0.686,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
983,gpt4,0.809,SPECIMEN LATERALITY
984,gpt4,0.91,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
985,gpt4,0.76,MARGIN STATUS FOR NON-INVASIVE TUMOR
986,gpt4,0.725,NUMBER OF LYMPH NODES EXAMINED
987,gpt4,0.679,VISCERAL PLEURA INVASION
988,gpt4,0.688,LYMPH NODE(S) FROM PRIOR PROCEDURES
989,gpt4,0.72,TUMOR SITE
990,gpt4,0.731,REGIONAL LYMPH NODE STATUS
991,gpt4,0.698,HISTOLOGIC GRADE
992,gpt4,0.663,TUMOR FOCALITY
993,gpt4,0.66,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
994,gpt4,0.692,NODAL SITE(S) EXAMINED
995,gpt4,0.672,MARGIN STATUS FOR INVASIVE CARCINOMA
996,gpt4,0.677,PROCEDURE
997,gpt4,0.648,TUMOR FOCALITY
998,gpt4,0.776,LYMPH NODE(S) FROM PRIOR PROCEDURES
999,gpt4,0.678,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1000,gpt4,0.791,TUMOR SITE
1001,gpt4,0.672,NODAL SITE(S) EXAMINED
1002,gpt4,0.709,PROCEDURE
1003,gpt4,0.841,MARGIN STATUS FOR NON-INVASIVE TUMOR
1004,gpt4,0.684,HISTOLOGIC GRADE
1005,gpt4,0.707,MARGIN STATUS FOR INVASIVE CARCINOMA
1006,gpt4,0.716,SPECIMEN LATERALITY
1007,gpt4,0.722,REGIONAL LYMPH NODE STATUS
1008,gpt4,0.697,SPREAD THROUGH AIR SPACES (STAS)
1009,gpt4,0.667,VISCERAL PLEURA INVASION
1010,gpt4,0.666,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1011,gpt4,0.904,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1012,gpt4,0.686,LYMPHOVASCULAR INVASION
1013,gpt4,0.749,MARGIN STATUS FOR INVASIVE CARCINOMA
1014,gpt4,0.728,PROCEDURE
1015,gpt4,0.809,SPECIMEN LATERALITY
1016,gpt4,0.672,HISTOLOGIC GRADE
1017,gpt4,0.742,MARGIN STATUS FOR NON-INVASIVE TUMOR
1018,gpt4,0.714,LYMPH NODE(S) FROM PRIOR PROCEDURES
1019,gpt4,0.696,NUMBER OF LYMPH NODES EXAMINED
1020,gpt4,0.713,TUMOR SITE
1021,gpt4,0.685,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1022,gpt4,0.664,VISCERAL PLEURA INVASION
1023,gpt4,0.718,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1024,gpt4,0.707,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1025,gpt4,0.702,REGIONAL LYMPH NODE STATUS
1026,gpt4,0.727,ADDITIONAL FINDINGS
1027,gpt4,0.642,NODAL SITE(S) EXAMINED
1028,gpt4,0.671,TUMOR FOCALITY
1029,gpt4,0.908,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1030,gpt4,0.737,HISTOLOGIC GRADE
1031,gpt4,0.82,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1032,gpt4,0.718,TUMOR SITE
1033,gpt4,0.674,VISCERAL PLEURA INVASION
1034,gpt4,0.707,MARGIN STATUS FOR NON-INVASIVE TUMOR
1035,gpt4,0.745,REGIONAL LYMPH NODE STATUS
1036,gpt4,0.82,NUMBER OF LYMPH NODES EXAMINED
1037,gpt4,0.67,MARGIN STATUS FOR INVASIVE CARCINOMA
1038,gpt4,0.677,SPREAD THROUGH AIR SPACES (STAS)
1039,gpt4,0.663,TUMOR FOCALITY
1040,gpt4,0.733,NODAL SITE(S) EXAMINED
1041,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
1042,gpt4,0.697,SPECIMEN LATERALITY
1043,gpt4,0.641,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1044,gpt4,0.661,PROCEDURE
1045,gpt4,0.762,ADDITIONAL FINDINGS
1046,gpt4,0.706,ADDITIONAL FINDINGS
1047,gpt4,0.653,PROCEDURE
1048,gpt4,0.687,VISCERAL PLEURA INVASION
1049,gpt4,0.708,MARGIN STATUS FOR INVASIVE CARCINOMA
1050,gpt4,0.673,HISTOLOGIC GRADE
1051,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
1052,gpt4,0.73,REGIONAL LYMPH NODE STATUS
1053,gpt4,0.898,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1054,gpt4,0.697,SPECIMEN LATERALITY
1055,gpt4,0.682,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1056,gpt4,0.902,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1057,gpt4,0.673,TUMOR SITE
1058,gpt4,0.867,MARGIN STATUS FOR NON-INVASIVE TUMOR
1059,gpt4,0.658,SPREAD THROUGH AIR SPACES (STAS)
1060,gpt4,0.656,NODAL SITE(S) EXAMINED
1061,gpt4,0.665,TUMOR FOCALITY
1062,gpt4,0.669,PROCEDURE
1063,gpt4,0.716,TUMOR SITE
1064,gpt4,0.71,NODAL SITE(S) EXAMINED
1065,gpt4,0.672,SPREAD THROUGH AIR SPACES (STAS)
1066,gpt4,0.738,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1067,gpt4,0.698,SPECIMEN LATERALITY
1068,gpt4,0.681,VISCERAL PLEURA INVASION
1069,gpt4,0.841,MARGIN STATUS FOR NON-INVASIVE TUMOR
1070,gpt4,0.683,TNM DESCRIPTORS
1071,gpt4,0.664,TUMOR FOCALITY
1072,gpt4,0.672,ADDITIONAL FINDINGS
1073,gpt4,0.721,MARGIN STATUS FOR INVASIVE CARCINOMA
1074,gpt4,0.656,HISTOLOGIC GRADE
1075,gpt4,0.673,LYMPH NODE(S) FROM PRIOR PROCEDURES
1076,gpt4,0.629,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1077,gpt4,0.676,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1078,gpt4,0.738,REGIONAL LYMPH NODE STATUS
1079,gpt4,0.662,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1080,gpt4,0.658,VISCERAL PLEURA INVASION
1081,gpt4,0.776,LYMPH NODE(S) FROM PRIOR PROCEDURES
1082,gpt4,0.665,ADDITIONAL FINDINGS
1083,gpt4,0.675,PROCEDURE
1084,gpt4,0.809,SPECIMEN LATERALITY
1085,gpt4,0.68,MARGIN STATUS FOR INVASIVE CARCINOMA
1086,gpt4,0.725,MARGIN STATUS FOR NON-INVASIVE TUMOR
1087,gpt4,0.893,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1088,gpt4,0.645,TUMOR FOCALITY
1089,gpt4,0.664,TUMOR SITE
1090,gpt4,0.715,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1091,gpt4,0.674,HISTOLOGIC GRADE
1092,gpt4,0.658,LYMPHOVASCULAR INVASION
1093,gpt4,0.675,TUMOR FOCALITY
1094,gpt4,0.651,VISCERAL PLEURA INVASION
1095,gpt4,0.689,NODAL SITE(S) WITH TUMOR
1096,gpt4,0.685,SPREAD THROUGH AIR SPACES (STAS)
1097,gpt4,0.706,SPECIMEN LATERALITY
1098,gpt4,0.627,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1099,gpt4,0.791,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1100,gpt4,0.709,NUMBER OF LYMPH NODES WITH TUMOR
1101,gpt4,0.698,MARGIN STATUS FOR INVASIVE CARCINOMA
1102,gpt4,0.69,REGIONAL LYMPH NODE STATUS
1103,gpt4,0.734,MARGIN STATUS FOR NON-INVASIVE TUMOR
1104,gpt4,0.711,TUMOR SITE
1105,gpt4,0.647,PROCEDURE
1106,gpt4,0.676,NODAL SITE(S) EXAMINED
1107,gpt4,0.778,LYMPH NODE(S) FROM PRIOR PROCEDURES
1108,gpt4,0.817,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1109,gpt4,0.723,REGIONAL LYMPH NODE STATUS
1110,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
1111,gpt4,0.7,VISCERAL PLEURA INVASION
1112,gpt4,0.63,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1113,gpt4,0.772,MARGIN STATUS FOR NON-INVASIVE TUMOR
1114,gpt4,0.714,MARGIN STATUS FOR INVASIVE CARCINOMA
1115,gpt4,0.704,TUMOR SITE
1116,gpt4,0.79,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1117,gpt4,0.809,SPECIMEN LATERALITY
1118,gpt4,0.907,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1119,gpt4,0.683,HISTOLOGIC GRADE
1120,gpt4,0.637,NODAL SITE(S) EXAMINED
1121,gpt4,0.721,PROCEDURE
1122,gpt4,0.66,TUMOR FOCALITY
1123,gpt4,0.68,SPREAD THROUGH AIR SPACES (STAS)
1124,gpt4,0.723,REGIONAL LYMPH NODE STATUS
1125,gpt4,0.678,LYMPH NODE(S) FROM PRIOR PROCEDURES
1126,gpt4,0.667,NODAL SITE(S) EXAMINED
1127,gpt4,0.76,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1128,gpt4,0.727,ADDITIONAL FINDINGS
1129,gpt4,0.701,MARGIN STATUS FOR INVASIVE CARCINOMA
1130,gpt4,0.68,SPECIMEN LATERALITY
1131,gpt4,0.719,TUMOR SITE
1132,gpt4,0.635,MARGIN STATUS FOR NON-INVASIVE TUMOR
1133,gpt4,0.664,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1134,gpt4,0.787,NUMBER OF LYMPH NODES EXAMINED
1135,gpt4,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1136,gpt4,0.706,VISCERAL PLEURA INVASION
1137,gpt4,0.658,HISTOLOGIC GRADE
1138,gpt4,0.654,PROCEDURE
1139,gpt4,0.665,SPECIMEN LATERALITY
1140,gpt4,0.659,TUMOR FOCALITY
1141,gpt4,0.729,HISTOLOGIC GRADE
1142,gpt4,0.666,PROCEDURE
1143,gpt4,0.688,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1144,gpt4,0.717,TUMOR SITE
1145,gpt4,0.674,MARGIN STATUS FOR INVASIVE CARCINOMA
1146,gpt4,0.658,NODAL SITE(S) EXAMINED
1147,gpt4,0.642,TUMOR FOCALITY
1148,gpt4,0.668,SPECIMEN LATERALITY
1149,gpt4,0.725,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1150,gpt4,0.715,ADDITIONAL FINDINGS
1151,gpt4,0.653,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1152,gpt4,0.778,MARGIN STATUS FOR NON-INVASIVE TUMOR
1153,gpt4,0.724,REGIONAL LYMPH NODE STATUS
1154,gpt4,0.67,LYMPH NODE(S) FROM PRIOR PROCEDURES
1155,gpt4,0.648,VISCERAL PLEURA INVASION
1156,gpt4,0.738,REGIONAL LYMPH NODE STATUS
1157,gpt4,0.666,HISTOLOGIC GRADE
1158,gpt4,0.67,NODAL SITE(S) EXAMINED
1159,gpt4,0.665,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1160,gpt4,0.67,PROCEDURE
1161,gpt4,0.82,NUMBER OF LYMPH NODES EXAMINED
1162,gpt4,0.747,ADDITIONAL FINDINGS
1163,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
1164,gpt4,0.747,TUMOR SITE
1165,gpt4,0.698,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1166,gpt4,0.671,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1167,gpt4,0.67,VISCERAL PLEURA INVASION
1168,gpt4,0.701,MARGIN STATUS FOR INVASIVE CARCINOMA
1169,gpt4,0.681,SPREAD THROUGH AIR SPACES (STAS)
1170,gpt4,0.659,TUMOR FOCALITY
1171,gpt4,0.743,MARGIN STATUS FOR NON-INVASIVE TUMOR
1172,gpt4,0.773,SPECIMEN LATERALITY
1173,gpt4,0.693,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1174,gpt4,0.696,LYMPH NODE(S) FROM PRIOR PROCEDURES
1175,gpt4,0.715,NUMBER OF LYMPH NODES WITH TUMOR
1176,gpt4,0.728,HISTOLOGIC GRADE
1177,gpt4,0.642,NODAL SITE(S) WITH TUMOR
1178,gpt4,0.746,MARGIN STATUS FOR INVASIVE CARCINOMA
1179,gpt4,0.73,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1180,gpt4,0.697,SPECIMEN LATERALITY
1181,gpt4,0.68,MARGIN STATUS FOR NON-INVASIVE TUMOR
1182,gpt4,0.684,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1183,gpt4,0.69,TUMOR SITE
1184,gpt4,0.638,SPREAD THROUGH AIR SPACES (STAS)
1185,gpt4,0.636,NODAL SITE(S) EXAMINED
1186,gpt4,0.706,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1187,gpt4,0.676,TUMOR FOCALITY
1188,gpt4,0.688,PROCEDURE
1189,gpt4,0.679,LYMPHOVASCULAR INVASION
1190,gpt4,0.72,REGIONAL LYMPH NODE STATUS
1191,gpt4,0.707,NUMBER OF LYMPH NODES EXAMINED
1192,gpt4,0.636,NODAL SITE(S) EXAMINED
1193,gpt4,0.717,TUMOR SITE
1194,gpt4,0.701,NUMBER OF LYMPH NODES EXAMINED
1195,gpt4,0.832,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1196,gpt4,0.705,HISTOLOGIC GRADE
1197,gpt4,0.649,LYMPHOVASCULAR INVASION
1198,gpt4,0.684,SPREAD THROUGH AIR SPACES (STAS)
1199,gpt4,0.662,VISCERAL PLEURA INVASION
1200,gpt4,0.681,ADDITIONAL FINDINGS
1201,gpt4,0.705,MARGIN STATUS FOR INVASIVE CARCINOMA
1202,gpt4,0.71,SPECIMEN LATERALITY
1203,gpt4,0.643,TUMOR FOCALITY
1204,gpt4,0.79,MARGIN STATUS FOR NON-INVASIVE TUMOR
1205,gpt4,0.735,REGIONAL LYMPH NODE STATUS
1206,gpt4,0.701,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1207,gpt4,0.677,PROCEDURE
1208,gpt4,0.675,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1209,gpt4,0.843,MARGIN STATUS FOR NON-INVASIVE TUMOR
1210,gpt4,0.718,HISTOLOGIC GRADE
1211,gpt4,0.654,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1212,gpt4,0.905,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1213,gpt4,0.697,SPECIMEN LATERALITY
1214,gpt4,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1215,gpt4,0.711,MARGIN STATUS FOR INVASIVE CARCINOMA
1216,gpt4,0.791,TUMOR SITE
1217,gpt4,0.681,VISCERAL PLEURA INVASION
1218,gpt4,0.71,NUMBER OF LYMPH NODES EXAMINED
1219,gpt4,0.651,ADDITIONAL FINDINGS
1220,gpt4,0.698,PROCEDURE
1221,gpt4,0.669,TUMOR FOCALITY
1222,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
1223,gpt4,0.69,SPREAD THROUGH AIR SPACES (STAS)
1224,gpt4,0.668,NODAL SITE(S) EXAMINED
1225,gpt4,0.744,REGIONAL LYMPH NODE STATUS
1226,gpt4,0.685,ADDITIONAL FINDINGS
1227,gpt4,0.693,HISTOLOGIC GRADE
1228,gpt4,0.667,SPREAD THROUGH AIR SPACES (STAS)
1229,gpt4,0.676,MARGIN STATUS FOR INVASIVE CARCINOMA
1230,gpt4,0.655,NODAL SITE(S) EXAMINED
1231,gpt4,0.813,NUMBER OF LYMPH NODES EXAMINED
1232,gpt4,0.689,VISCERAL PLEURA INVASION
1233,gpt4,0.702,TUMOR SITE
1234,gpt4,0.725,MARGIN STATUS FOR NON-INVASIVE TUMOR
1235,gpt4,0.656,TUMOR FOCALITY
1236,gpt4,0.732,REGIONAL LYMPH NODE STATUS
1237,gpt4,0.809,SPECIMEN LATERALITY
1238,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
1239,gpt4,0.817,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1240,gpt4,0.631,PROCEDURE
1241,gpt4,0.669,ADDITIONAL FINDINGS
1242,gpt4,0.712,NUMBER OF LYMPH NODES EXAMINED
1243,gpt4,0.725,REGIONAL LYMPH NODE STATUS
1244,gpt4,0.736,SPECIMEN LATERALITY
1245,gpt4,0.732,MARGIN STATUS FOR NON-INVASIVE TUMOR
1246,gpt4,0.645,PROCEDURE
1247,gpt4,0.84,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1248,gpt4,0.667,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1249,gpt4,0.686,VISCERAL PLEURA INVASION
1250,gpt4,0.69,HISTOLOGIC GRADE
1251,gpt4,0.669,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1252,gpt4,0.714,MARGIN STATUS FOR INVASIVE CARCINOMA
1253,gpt4,0.666,SPREAD THROUGH AIR SPACES (STAS)
1254,gpt4,0.718,TUMOR SITE
1255,gpt4,0.654,NODAL SITE(S) EXAMINED
1256,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
1257,gpt4,0.667,TUMOR FOCALITY
1258,gpt4,0.68,MARGIN STATUS FOR NON-INVASIVE TUMOR
1259,gpt4,0.686,MARGIN STATUS FOR INVASIVE CARCINOMA
1260,gpt4,0.817,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1261,gpt4,0.698,HISTOLOGIC GRADE
1262,gpt4,0.689,ADDITIONAL FINDINGS
1263,gpt4,0.667,SPREAD THROUGH AIR SPACES (STAS)
1264,gpt4,0.676,NODAL SITE(S) EXAMINED
1265,gpt4,0.729,REGIONAL LYMPH NODE STATUS
1266,gpt4,0.687,PROCEDURE
1267,gpt4,0.689,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1268,gpt4,0.697,SPECIMEN LATERALITY
1269,gpt4,0.706,TUMOR SITE
1270,gpt4,0.678,VISCERAL PLEURA INVASION
1271,gpt4,0.658,LYMPH NODE(S) FROM PRIOR PROCEDURES
1272,gpt4,0.659,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1273,gpt4,0.651,TUMOR FOCALITY
1274,gpt4,0.681,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1275,gpt4,0.675,TNM DESCRIPTORS
1276,gpt4,0.843,MARGIN STATUS FOR NON-INVASIVE TUMOR
1277,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
1278,gpt4,0.647,NODAL SITE(S) EXAMINED
1279,gpt4,0.638,TUMOR FOCALITY
1280,gpt4,0.677,PROCEDURE
1281,gpt4,0.748,TUMOR SITE
1282,gpt4,0.672,MARGIN STATUS FOR INVASIVE CARCINOMA
1283,gpt4,0.739,REGIONAL LYMPH NODE STATUS
1284,gpt4,0.698,HISTOLOGIC GRADE
1285,gpt4,0.684,VISCERAL PLEURA INVASION
1286,gpt4,0.713,NUMBER OF LYMPH NODES EXAMINED
1287,gpt4,0.773,SPECIMEN LATERALITY
1288,gpt4,0.683,SPREAD THROUGH AIR SPACES (STAS)
1289,gpt4,0.663,NODAL SITE(S) EXAMINED
1290,gpt4,0.67,VISCERAL PLEURA INVASION
1291,gpt4,0.681,HISTOLOGIC GRADE
1292,gpt4,0.805,NUMBER OF LYMPH NODES EXAMINED
1293,gpt4,0.693,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1294,gpt4,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
1295,gpt4,0.683,REGIONAL LYMPH NODE STATUS
1296,gpt4,0.821,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1297,gpt4,0.68,SPREAD THROUGH AIR SPACES (STAS)
1298,gpt4,0.663,MARGIN STATUS FOR INVASIVE CARCINOMA
1299,gpt4,0.713,NUMBER OF LYMPH NODES WITH TUMOR
1300,gpt4,0.689,LYMPH NODE(S) FROM PRIOR PROCEDURES
1301,gpt4,0.652,TUMOR FOCALITY
1302,gpt4,0.659,PROCEDURE
1303,gpt4,0.773,SPECIMEN LATERALITY
1304,gpt4,0.688,TUMOR SITE
1305,gpt4,0.634,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1306,gpt4,0.766,NODAL SITE(S) EXAMINED
1307,gpt4,0.718,TUMOR SITE
1308,gpt4,0.671,ADDITIONAL FINDINGS
1309,gpt4,0.671,TUMOR FOCALITY
1310,gpt4,0.699,PROCEDURE
1311,gpt4,0.644,SPREAD THROUGH AIR SPACES (STAS)
1312,gpt4,0.677,VISCERAL PLEURA INVASION
1313,gpt4,0.668,MARGIN STATUS FOR NON-INVASIVE TUMOR
1314,gpt4,0.714,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1315,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
1316,gpt4,0.76,HISTOLOGIC GRADE
1317,gpt4,0.705,MARGIN STATUS FOR INVASIVE CARCINOMA
1318,gpt4,0.749,REGIONAL LYMPH NODE STATUS
1319,gpt4,0.713,NUMBER OF LYMPH NODES EXAMINED
1320,gpt4,0.809,SPECIMEN LATERALITY
1321,gpt4,0.665,VISCERAL PLEURA INVASION
1322,gpt4,0.718,TUMOR SITE
1323,gpt4,0.7,MARGIN STATUS FOR INVASIVE CARCINOMA
1324,gpt4,0.677,SPREAD THROUGH AIR SPACES (STAS)
1325,gpt4,0.656,PROCEDURE
1326,gpt4,0.697,SPECIMEN LATERALITY
1327,gpt4,0.893,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1328,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
1329,gpt4,0.652,HISTOLOGIC GRADE
1330,gpt4,0.669,TUMOR FOCALITY
1331,gpt4,0.647,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1332,gpt4,0.639,NODAL SITE(S) EXAMINED
1333,gpt4,0.645,MARGIN STATUS FOR NON-INVASIVE TUMOR
1334,gpt4,0.752,REGIONAL LYMPH NODE STATUS
1335,gpt4,0.825,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1336,gpt4,0.656,ADDITIONAL FINDINGS
1337,gpt4,0.7,NODAL SITE(S) EXAMINED
1338,gpt4,0.782,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1339,gpt4,0.75,REGIONAL LYMPH NODE STATUS
1340,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
1341,gpt4,0.666,VISCERAL PLEURA INVASION
1342,gpt4,0.82,NUMBER OF LYMPH NODES EXAMINED
1343,gpt4,0.667,PROCEDURE
1344,gpt4,0.893,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1345,gpt4,0.722,TUMOR SITE
1346,gpt4,0.773,SPECIMEN LATERALITY
1347,gpt4,0.677,MARGIN STATUS FOR NON-INVASIVE TUMOR
1348,gpt4,0.69,HISTOLOGIC GRADE
1349,gpt4,0.636,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1350,gpt4,0.668,TUMOR FOCALITY
1351,gpt4,0.667,MARGIN STATUS FOR INVASIVE CARCINOMA
1352,gpt4,0.693,TNM DESCRIPTORS
1353,gpt4,0.731,REGIONAL LYMPH NODE STATUS
1354,gpt4,0.686,LYMPH NODE(S) FROM PRIOR PROCEDURES
1355,gpt4,0.67,MARGIN STATUS FOR INVASIVE CARCINOMA
1356,gpt4,0.648,MARGIN STATUS FOR NON-INVASIVE TUMOR
1357,gpt4,0.657,NODAL SITE(S) EXAMINED
1358,gpt4,0.69,PROCEDURE
1359,gpt4,0.702,NUMBER OF LYMPH NODES EXAMINED
1360,gpt4,0.73,TUMOR FOCALITY
1361,gpt4,0.652,VISCERAL PLEURA INVASION
1362,gpt4,0.701,SPECIMEN LATERALITY
1363,gpt4,0.693,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1364,gpt4,0.642,TUMOR SITE
1365,gpt4,0.676,HISTOLOGIC GRADE
1366,gpt4,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1367,gpt4,0.669,MARGIN STATUS FOR NON-INVASIVE TUMOR
1368,gpt4,0.636,NODAL SITE(S) EXAMINED
1369,gpt4,0.657,TUMOR FOCALITY
1370,gpt4,0.678,NUMBER OF LYMPH NODES EXAMINED
1371,gpt4,0.716,TUMOR SITE
1372,gpt4,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1373,gpt4,0.656,VISCERAL PLEURA INVASION
1374,gpt4,0.657,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1375,gpt4,0.685,MARGIN STATUS FOR INVASIVE CARCINOMA
1376,gpt4,0.65,PROCEDURE
1377,gpt4,0.721,REGIONAL LYMPH NODE STATUS
1378,gpt4,0.704,SPECIMEN LATERALITY
1379,gpt4,0.773,SPECIMEN LATERALITY
1380,gpt4,0.705,TUMOR SITE
1381,gpt4,0.664,TNM DESCRIPTORS
1382,gpt4,0.695,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1383,gpt4,0.656,PROCEDURE
1384,gpt4,0.674,LYMPHOVASCULAR INVASION
1385,gpt4,0.776,LYMPH NODE(S) FROM PRIOR PROCEDURES
1386,gpt4,0.689,TUMOR FOCALITY
1387,gpt4,0.673,VISCERAL PLEURA INVASION
1388,gpt4,0.748,MARGIN STATUS FOR INVASIVE CARCINOMA
1389,gpt4,0.617,MARGIN STATUS FOR NON-INVASIVE TUMOR
1390,gpt4,0.673,HISTOLOGIC GRADE
1391,gpt4,0.725,MARGIN STATUS FOR NON-INVASIVE TUMOR
1392,gpt4,0.698,REGIONAL LYMPH NODE STATUS
1393,gpt4,0.662,SPREAD THROUGH AIR SPACES (STAS)
1394,gpt4,0.683,NODAL SITE(S) EXAMINED
1395,gpt4,0.693,NUMBER OF LYMPH NODES WITH TUMOR
1396,gpt4,0.684,LYMPH NODE(S) FROM PRIOR PROCEDURES
1397,gpt4,0.656,PROCEDURE
1398,gpt4,0.776,NUMBER OF LYMPH NODES EXAMINED
1399,gpt4,0.859,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1400,gpt4,0.661,TUMOR FOCALITY
1401,gpt4,0.661,ADDITIONAL FINDINGS
1402,gpt4,0.671,MARGIN STATUS FOR INVASIVE CARCINOMA
1403,gpt4,0.625,NODAL SITE(S) WITH TUMOR
1404,gpt4,0.722,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1405,gpt4,0.673,VISCERAL PLEURA INVASION
1406,gpt4,0.77,SPECIMEN LATERALITY
1407,gpt4,0.893,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1408,gpt4,0.717,TUMOR SITE
1409,gpt4,0.662,PROCEDURE
1410,gpt4,0.811,MARGIN STATUS FOR NON-INVASIVE TUMOR
1411,gpt4,0.747,TUMOR SITE
1412,gpt4,0.683,SPREAD THROUGH AIR SPACES (STAS)
1413,gpt4,0.811,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1414,gpt4,0.695,MARGIN STATUS FOR INVASIVE CARCINOMA
1415,gpt4,0.655,NUMBER OF LYMPH NODES EXAMINED
1416,gpt4,0.661,ADDITIONAL FINDINGS
1417,gpt4,0.893,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1418,gpt4,0.687,HISTOLOGIC GRADE
1419,gpt4,0.638,NODAL SITE(S) EXAMINED
1420,gpt4,0.752,REGIONAL LYMPH NODE STATUS
1421,gpt4,0.665,LYMPH NODE(S) FROM PRIOR PROCEDURES
1422,gpt4,0.668,SPECIMEN LATERALITY
1423,gpt4,0.673,VISCERAL PLEURA INVASION
1424,gpt4,0.722,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1425,gpt4,0.652,TUMOR FOCALITY
1426,gpt4,0.727,MARGIN STATUS FOR INVASIVE CARCINOMA
1427,gpt4,0.783,MARGIN STATUS FOR NON-INVASIVE TUMOR
1428,gpt4,0.672,NODAL SITE(S) EXAMINED
1429,gpt4,0.687,SPREAD THROUGH AIR SPACES (STAS)
1430,gpt4,0.703,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1431,gpt4,0.711,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1432,gpt4,0.66,TNM DESCRIPTORS
1433,gpt4,0.688,ADDITIONAL FINDINGS
1434,gpt4,0.724,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1435,gpt4,0.707,PROCEDURE
1436,gpt4,0.739,REGIONAL LYMPH NODE STATUS
1437,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
1438,gpt4,0.681,HISTOLOGIC GRADE
1439,gpt4,0.773,SPECIMEN LATERALITY
1440,gpt4,0.722,TUMOR SITE
1441,gpt4,0.68,VISCERAL PLEURA INVASION
1442,gpt4,0.745,TUMOR FOCALITY
1443,gpt4,0.69,REGIONAL LYMPH NODE STATUS
1444,gpt4,0.905,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1445,gpt4,0.663,VISCERAL PLEURA INVASION
1446,gpt4,0.68,ADDITIONAL FINDINGS
1447,gpt4,0.698,SPECIMEN LATERALITY
1448,gpt4,0.647,LYMPHOVASCULAR INVASION
1449,gpt4,0.729,MARGIN STATUS FOR INVASIVE CARCINOMA
1450,gpt4,0.681,LYMPH NODE(S) FROM PRIOR PROCEDURES
1451,gpt4,0.661,NODAL SITE(S) WITH TUMOR
1452,gpt4,0.68,PROCEDURE
1453,gpt4,0.726,TUMOR SITE
1454,gpt4,0.614,NODAL SITE(S) EXAMINED
1455,gpt4,0.644,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1456,gpt4,0.727,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1457,gpt4,0.7,SPREAD THROUGH AIR SPACES (STAS)
1458,gpt4,0.841,MARGIN STATUS FOR NON-INVASIVE TUMOR
1459,gpt4,0.782,NUMBER OF LYMPH NODES EXAMINED
1460,gpt4,0.713,NUMBER OF LYMPH NODES WITH TUMOR
1461,gpt4,0.652,TUMOR FOCALITY
1462,gpt4,0.702,TUMOR SITE
1463,gpt4,0.675,NODAL SITE(S) EXAMINED
1464,gpt4,0.771,MARGIN STATUS FOR NON-INVASIVE TUMOR
1465,gpt4,0.755,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1466,gpt4,0.643,HISTOLOGIC GRADE
1467,gpt4,0.676,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1468,gpt4,0.734,REGIONAL LYMPH NODE STATUS
1469,gpt4,0.718,SPECIMEN LATERALITY
1470,gpt4,0.691,TUMOR FOCALITY
1471,gpt4,0.65,VISCERAL PLEURA INVASION
1472,gpt4,0.72,MARGIN STATUS FOR INVASIVE CARCINOMA
1473,gpt4,0.739,LYMPH NODE(S) FROM PRIOR PROCEDURES
1474,gpt4,0.645,ADDITIONAL FINDINGS
1475,gpt4,0.636,PROCEDURE
1476,gpt4,0.832,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1477,gpt4,0.648,LYMPHOVASCULAR INVASION
1478,gpt4,0.701,SPREAD THROUGH AIR SPACES (STAS)
1479,gpt4,0.714,REGIONAL LYMPH NODE STATUS
1480,gpt4,0.647,TUMOR FOCALITY
1481,gpt4,0.685,ADDITIONAL FINDINGS
1482,gpt4,0.649,VISCERAL PLEURA INVASION
1483,gpt4,0.903,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1484,gpt4,0.663,PROCEDURE
1485,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
1486,gpt4,0.707,SPECIMEN LATERALITY
1487,gpt4,0.792,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1488,gpt4,0.709,TUMOR SITE
1489,gpt4,0.657,NODAL SITE(S) EXAMINED
1490,gpt4,0.781,MARGIN STATUS FOR NON-INVASIVE TUMOR
1491,gpt4,0.638,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1492,gpt4,0.788,NUMBER OF LYMPH NODES EXAMINED
1493,gpt4,0.705,MARGIN STATUS FOR INVASIVE CARCINOMA
1494,gpt4,0.675,LYMPHOVASCULAR INVASION
1495,gpt4,0.703,MARGIN STATUS FOR INVASIVE CARCINOMA
1496,gpt4,0.82,NUMBER OF LYMPH NODES WITH TUMOR
1497,gpt4,0.683,REGIONAL LYMPH NODE STATUS
1498,gpt4,0.689,HISTOLOGIC GRADE
1499,gpt4,0.663,NODAL SITE(S) WITH TUMOR
1500,gpt4,0.706,ADDITIONAL FINDINGS
1501,gpt4,0.657,NODAL SITE(S) EXAMINED
1502,gpt4,0.651,VISCERAL PLEURA INVASION
1503,gpt4,0.69,SPECIMEN LATERALITY
1504,gpt4,0.69,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1505,gpt4,0.687,SPREAD THROUGH AIR SPACES (STAS)
1506,gpt4,0.686,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1507,gpt4,0.701,PROCEDURE
1508,gpt4,0.722,TUMOR SITE
1509,gpt4,0.641,TUMOR FOCALITY
1510,gpt4,0.731,MARGIN STATUS FOR NON-INVASIVE TUMOR
1511,gpt4,0.692,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1512,gpt4,0.659,TNM DESCRIPTORS
1513,gpt4,0.694,LYMPH NODE(S) FROM PRIOR PROCEDURES
1514,gpt4,0.655,HISTOLOGIC GRADE
1515,gpt4,0.669,NODAL SITE(S) EXAMINED
1516,gpt4,0.67,TUMOR FOCALITY
1517,gpt4,0.67,LYMPHOVASCULAR INVASION
1518,gpt4,0.701,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1519,gpt4,0.734,VISCERAL PLEURA INVASION
1520,gpt4,0.663,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1521,gpt4,0.683,PROCEDURE
1522,gpt4,0.684,MARGIN STATUS FOR INVASIVE CARCINOMA
1523,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
1524,gpt4,0.697,SPECIMEN LATERALITY
1525,gpt4,0.669,SPREAD THROUGH AIR SPACES (STAS)
1526,gpt4,0.718,TUMOR SITE
1527,gpt4,0.705,MARGIN STATUS FOR NON-INVASIVE TUMOR
1528,gpt4,0.739,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1529,gpt4,0.723,REGIONAL LYMPH NODE STATUS
1530,gpt4,0.773,SPECIMEN LATERALITY
1531,gpt4,0.682,LYMPH NODE(S) FROM PRIOR PROCEDURES
1532,gpt4,0.712,MARGIN STATUS FOR INVASIVE CARCINOMA
1533,gpt4,0.752,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1534,gpt4,0.721,MARGIN STATUS FOR NON-INVASIVE TUMOR
1535,gpt4,0.757,ADDITIONAL FINDINGS
1536,gpt4,0.655,NODAL SITE(S) EXAMINED
1537,gpt4,0.675,TUMOR FOCALITY
1538,gpt4,0.647,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1539,gpt4,0.75,REGIONAL LYMPH NODE STATUS
1540,gpt4,0.649,VISCERAL PLEURA INVASION
1541,gpt4,0.692,HISTOLOGIC GRADE
1542,gpt4,0.66,PROCEDURE
1543,gpt4,0.704,SPREAD THROUGH AIR SPACES (STAS)
1544,gpt4,0.824,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1545,gpt4,0.725,TUMOR SITE
1546,gpt4,0.729,SPREAD THROUGH AIR SPACES (STAS)
1547,gpt4,0.664,TUMOR FOCALITY
1548,gpt4,0.643,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1549,gpt4,0.666,TNM DESCRIPTORS
1550,gpt4,0.718,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1551,gpt4,0.699,TUMOR SITE
1552,gpt4,0.702,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1553,gpt4,0.686,ADDITIONAL FINDINGS
1554,gpt4,0.8,MARGIN STATUS FOR INVASIVE CARCINOMA
1555,gpt4,0.694,NUMBER OF LYMPH NODES EXAMINED
1556,gpt4,0.688,VISCERAL PLEURA INVASION
1557,gpt4,0.711,LYMPH NODE(S) FROM PRIOR PROCEDURES
1558,gpt4,0.739,REGIONAL LYMPH NODE STATUS
1559,gpt4,0.743,HISTOLOGIC GRADE
1560,gpt4,0.672,NODAL SITE(S) EXAMINED
1561,gpt4,0.796,MARGIN STATUS FOR NON-INVASIVE TUMOR
1562,gpt4,0.697,SPECIMEN LATERALITY
1563,gpt4,0.636,PROCEDURE
1564,gpt4,0.794,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1565,gpt4,0.703,NODAL SITE(S) EXAMINED
1566,gpt4,0.722,REGIONAL LYMPH NODE STATUS
1567,gpt4,0.809,SPECIMEN LATERALITY
1568,gpt4,0.679,SPREAD THROUGH AIR SPACES (STAS)
1569,gpt4,0.654,TUMOR FOCALITY
1570,gpt4,0.666,HISTOLOGIC GRADE
1571,gpt4,0.646,PROCEDURE
1572,gpt4,0.649,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1573,gpt4,0.696,MARGIN STATUS FOR INVASIVE CARCINOMA
1574,gpt4,0.737,ADDITIONAL FINDINGS
1575,gpt4,0.725,TUMOR SITE
1576,gpt4,0.671,MARGIN STATUS FOR NON-INVASIVE TUMOR
1577,gpt4,0.667,VISCERAL PLEURA INVASION
1578,gpt4,0.856,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1579,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
1580,gpt4,0.705,NUMBER OF LYMPH NODES EXAMINED
1581,gpt4,0.809,SPECIMEN LATERALITY
1582,gpt4,0.735,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1583,gpt4,0.839,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1584,gpt4,0.686,MARGIN STATUS FOR INVASIVE CARCINOMA
1585,gpt4,0.72,TUMOR SITE
1586,gpt4,0.664,NODAL SITE(S) EXAMINED
1587,gpt4,0.69,VISCERAL PLEURA INVASION
1588,gpt4,0.731,REGIONAL LYMPH NODE STATUS
1589,gpt4,0.841,MARGIN STATUS FOR NON-INVASIVE TUMOR
1590,gpt4,0.687,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1591,gpt4,0.664,SPREAD THROUGH AIR SPACES (STAS)
1592,gpt4,0.655,TUMOR FOCALITY
1593,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
1594,gpt4,0.655,HISTOLOGIC GRADE
1595,gpt4,0.661,PROCEDURE
1596,gpt4,0.722,REGIONAL LYMPH NODE STATUS
1597,gpt4,0.847,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1598,gpt4,0.66,VISCERAL PLEURA INVASION
1599,gpt4,0.673,LYMPHOVASCULAR INVASION
1600,gpt4,0.693,MARGIN STATUS FOR INVASIVE CARCINOMA
1601,gpt4,0.643,PROCEDURE
1602,gpt4,0.783,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1603,gpt4,0.649,HISTOLOGIC GRADE
1604,gpt4,0.697,LYMPH NODE(S) FROM PRIOR PROCEDURES
1605,gpt4,0.662,TNM DESCRIPTORS
1606,gpt4,0.809,SPECIMEN LATERALITY
1607,gpt4,0.64,NODAL SITE(S) EXAMINED
1608,gpt4,0.675,TUMOR FOCALITY
1609,gpt4,0.649,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1610,gpt4,0.721,TUMOR SITE
1611,gpt4,0.699,MARGIN STATUS FOR NON-INVASIVE TUMOR
1612,gpt4,0.711,ADDITIONAL FINDINGS
1613,gpt4,0.684,LYMPHOVASCULAR INVASION
1614,gpt4,0.679,PROCEDURE
1615,gpt4,0.715,TUMOR SITE
1616,gpt4,0.707,MARGIN STATUS FOR NON-INVASIVE TUMOR
1617,gpt4,0.644,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1618,gpt4,0.702,TNM DESCRIPTORS
1619,gpt4,0.701,MARGIN STATUS FOR INVASIVE CARCINOMA
1620,gpt4,0.675,LYMPH NODE(S) FROM PRIOR PROCEDURES
1621,gpt4,0.667,NODAL SITE(S) WITH TUMOR
1622,gpt4,0.683,SPECIMEN LATERALITY
1623,gpt4,0.672,VISCERAL PLEURA INVASION
1624,gpt4,0.646,NODAL SITE(S) EXAMINED
1625,gpt4,0.659,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1626,gpt4,0.708,HISTOLOGIC GRADE
1627,gpt4,0.69,REGIONAL LYMPH NODE STATUS
1628,gpt4,0.709,NUMBER OF LYMPH NODES WITH TUMOR
1629,gpt4,0.726,NUMBER OF LYMPH NODES EXAMINED
1630,gpt4,0.776,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1631,gpt4,0.66,TUMOR FOCALITY
1632,gpt4,0.708,TUMOR SITE
1633,gpt4,0.651,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1634,gpt4,0.66,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1635,gpt4,0.788,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1636,gpt4,0.642,NODAL SITE(S) EXAMINED
1637,gpt4,0.663,VISCERAL PLEURA INVASION
1638,gpt4,0.696,MARGIN STATUS FOR INVASIVE CARCINOMA
1639,gpt4,0.718,ADDITIONAL FINDINGS
1640,gpt4,0.647,PROCEDURE
1641,gpt4,0.773,SPECIMEN LATERALITY
1642,gpt4,0.648,MARGIN STATUS FOR NON-INVASIVE TUMOR
1643,gpt4,0.727,LYMPH NODE(S) FROM PRIOR PROCEDURES
1644,gpt4,0.737,REGIONAL LYMPH NODE STATUS
1645,gpt4,0.627,TUMOR FOCALITY
1646,gpt4,0.63,NUMBER OF LYMPH NODES EXAMINED
1647,gpt4,0.694,SPREAD THROUGH AIR SPACES (STAS)
1648,gpt4,0.699,HISTOLOGIC GRADE
1649,gpt4,0.744,REGIONAL LYMPH NODE STATUS
1650,gpt4,0.893,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1651,gpt4,0.724,TUMOR SITE
1652,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
1653,gpt4,0.659,VISCERAL PLEURA INVASION
1654,gpt4,0.707,MARGIN STATUS FOR INVASIVE CARCINOMA
1655,gpt4,0.806,NUMBER OF LYMPH NODES EXAMINED
1656,gpt4,0.641,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1657,gpt4,0.678,PROCEDURE
1658,gpt4,0.698,SPECIMEN LATERALITY
1659,gpt4,0.894,MARGIN STATUS FOR NON-INVASIVE TUMOR
1660,gpt4,0.789,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1661,gpt4,0.644,TUMOR FOCALITY
1662,gpt4,0.82,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1663,gpt4,0.678,PROCEDURE
1664,gpt4,0.695,MARGIN STATUS FOR NON-INVASIVE TUMOR
1665,gpt4,0.71,REGIONAL LYMPH NODE STATUS
1666,gpt4,0.714,TUMOR SITE
1667,gpt4,0.636,NODAL SITE(S) WITH TUMOR
1668,gpt4,0.806,NUMBER OF LYMPH NODES WITH TUMOR
1669,gpt4,0.68,HISTOLOGIC GRADE
1670,gpt4,0.84,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1671,gpt4,0.659,VISCERAL PLEURA INVASION
1672,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
1673,gpt4,0.661,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1674,gpt4,0.677,LYMPHOVASCULAR INVASION
1675,gpt4,0.662,NODAL SITE(S) EXAMINED
1676,gpt4,0.651,ADDITIONAL FINDINGS
1677,gpt4,0.697,SPECIMEN LATERALITY
1678,gpt4,0.711,NUMBER OF LYMPH NODES EXAMINED
1679,gpt4,0.666,TUMOR FOCALITY
1680,gpt4,0.699,MARGIN STATUS FOR INVASIVE CARCINOMA
1681,gpt4,0.699,MARGIN STATUS FOR INVASIVE CARCINOMA
1682,gpt4,0.654,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1683,gpt4,0.773,SPECIMEN LATERALITY
1684,gpt4,0.665,NODAL SITE(S) EXAMINED
1685,gpt4,0.732,MARGIN STATUS FOR NON-INVASIVE TUMOR
1686,gpt4,0.717,TUMOR SITE
1687,gpt4,0.668,ADDITIONAL FINDINGS
1688,gpt4,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1689,gpt4,0.811,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1690,gpt4,0.681,LYMPH NODE(S) FROM PRIOR PROCEDURES
1691,gpt4,0.733,REGIONAL LYMPH NODE STATUS
1692,gpt4,0.664,HISTOLOGIC GRADE
1693,gpt4,0.648,TUMOR FOCALITY
1694,gpt4,0.66,SPREAD THROUGH AIR SPACES (STAS)
1695,gpt4,0.69,PROCEDURE
1696,gpt4,0.665,VISCERAL PLEURA INVASION
1697,gpt4,0.702,NUMBER OF LYMPH NODES EXAMINED
1698,gpt4,0.743,REGIONAL LYMPH NODE STATUS
1699,gpt4,0.687,HISTOLOGIC GRADE
1700,gpt4,0.749,NODAL SITE(S) EXAMINED
1701,gpt4,0.688,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1702,gpt4,0.765,MARGIN STATUS FOR INVASIVE CARCINOMA
1703,gpt4,0.697,TUMOR FOCALITY
1704,gpt4,0.696,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1705,gpt4,0.727,TUMOR SITE
1706,gpt4,0.658,VISCERAL PLEURA INVASION
1707,gpt4,0.646,PROCEDURE
1708,gpt4,0.681,LYMPHOVASCULAR INVASION
1709,gpt4,0.697,SPECIMEN LATERALITY
1710,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
1711,gpt4,0.712,MARGIN STATUS FOR NON-INVASIVE TUMOR
1712,gpt4,0.685,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1713,gpt4,0.808,MARGIN STATUS FOR INVASIVE CARCINOMA
1714,gpt4,0.793,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1715,gpt4,0.647,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1716,gpt4,0.696,TUMOR FOCALITY
1717,gpt4,0.687,NODAL SITE(S) EXAMINED
1718,gpt4,0.704,TUMOR SITE
1719,gpt4,0.669,HISTOLOGIC GRADE
1720,gpt4,0.696,ADDITIONAL FINDINGS
1721,gpt4,0.673,PROCEDURE
1722,gpt4,0.725,REGIONAL LYMPH NODE STATUS
1723,gpt4,0.684,SPREAD THROUGH AIR SPACES (STAS)
1724,gpt4,0.704,SPECIMEN LATERALITY
1725,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
1726,gpt4,0.715,VISCERAL PLEURA INVASION
1727,gpt4,0.834,MARGIN STATUS FOR NON-INVASIVE TUMOR
1728,gpt4,0.654,NODAL SITE(S) EXAMINED
1729,gpt4,0.757,MARGIN STATUS FOR INVASIVE CARCINOMA
1730,gpt4,0.84,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1731,gpt4,0.677,PROCEDURE
1732,gpt4,0.691,VISCERAL PLEURA INVASION
1733,gpt4,0.689,HISTOLOGIC GRADE
1734,gpt4,0.693,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1735,gpt4,0.654,TUMOR FOCALITY
1736,gpt4,0.693,SPECIMEN LATERALITY
1737,gpt4,0.684,SPREAD THROUGH AIR SPACES (STAS)
1738,gpt4,0.715,REGIONAL LYMPH NODE STATUS
1739,gpt4,0.676,TUMOR SITE
1740,gpt4,0.834,MARGIN STATUS FOR NON-INVASIVE TUMOR
1741,gpt4,0.656,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1742,gpt4,0.689,HISTOLOGIC GRADE
1743,gpt4,0.639,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1744,gpt4,0.828,NUMBER OF LYMPH NODES EXAMINED
1745,gpt4,0.736,SPECIMEN LATERALITY
1746,gpt4,0.698,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1747,gpt4,0.661,PROCEDURE
1748,gpt4,0.847,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1749,gpt4,0.751,MARGIN STATUS FOR INVASIVE CARCINOMA
1750,gpt4,0.74,TUMOR SITE
1751,gpt4,0.635,NODAL SITE(S) EXAMINED
1752,gpt4,0.677,LYMPH NODE(S) FROM PRIOR PROCEDURES
1753,gpt4,0.667,TUMOR FOCALITY
1754,gpt4,0.773,MARGIN STATUS FOR NON-INVASIVE TUMOR
1755,gpt4,0.685,VISCERAL PLEURA INVASION
1756,gpt4,0.726,REGIONAL LYMPH NODE STATUS
1757,gpt4,0.731,SPREAD THROUGH AIR SPACES (STAS)
1758,gpt4,0.695,VISCERAL PLEURA INVASION
1759,gpt4,0.736,SPECIMEN LATERALITY
1760,gpt4,0.658,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1761,gpt4,0.723,NUMBER OF LYMPH NODES EXAMINED
1762,gpt4,0.658,TUMOR SITE
1763,gpt4,0.733,REGIONAL LYMPH NODE STATUS
1764,gpt4,0.678,PROCEDURE
1765,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
1766,gpt4,0.772,MARGIN STATUS FOR NON-INVASIVE TUMOR
1767,gpt4,0.905,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1768,gpt4,0.646,TUMOR FOCALITY
1769,gpt4,0.697,MARGIN STATUS FOR INVASIVE CARCINOMA
1770,gpt4,0.677,HISTOLOGIC GRADE
1771,gpt4,0.718,NODAL SITE(S) EXAMINED
1772,gpt4,0.821,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1773,gpt4,0.926,LYMPH NODE(S) FROM PRIOR PROCEDURES
1774,gpt4,0.637,LYMPHOVASCULAR INVASION
1775,gpt4,0.642,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1776,gpt4,0.655,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1777,gpt4,0.789,REGIONAL LYMPH NODE STATUS
1778,gpt4,0.668,HISTOLOGIC GRADE
1779,gpt4,0.657,NODAL SITE(S) EXAMINED
1780,gpt4,0.679,VISCERAL PLEURA INVASION
1781,gpt4,0.702,MARGIN STATUS FOR INVASIVE CARCINOMA
1782,gpt4,0.666,SPECIMEN LATERALITY
1783,gpt4,0.735,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1784,gpt4,0.64,TUMOR FOCALITY
1785,gpt4,0.692,MARGIN STATUS FOR NON-INVASIVE TUMOR
1786,gpt4,0.674,PROCEDURE
1787,gpt4,0.686,SPREAD THROUGH AIR SPACES (STAS)
1788,gpt4,0.723,TUMOR SITE
1789,gpt4,0.677,TUMOR FOCALITY
1790,gpt4,0.705,TUMOR SITE
1791,gpt4,0.773,SPECIMEN LATERALITY
1792,gpt4,0.801,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1793,gpt4,0.7,MARGIN STATUS FOR INVASIVE CARCINOMA
1794,gpt4,0.747,REGIONAL LYMPH NODE STATUS
1795,gpt4,0.683,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1796,gpt4,0.676,PROCEDURE
1797,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
1798,gpt4,0.68,SPREAD THROUGH AIR SPACES (STAS)
1799,gpt4,0.727,MARGIN STATUS FOR NON-INVASIVE TUMOR
1800,gpt4,0.744,VISCERAL PLEURA INVASION
1801,gpt4,0.658,NODAL SITE(S) EXAMINED
1802,gpt4,0.7,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1803,gpt4,0.712,HISTOLOGIC GRADE
1804,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
1805,gpt4,0.668,VISCERAL PLEURA INVASION
1806,gpt4,0.67,TUMOR FOCALITY
1807,gpt4,0.705,HISTOLOGIC GRADE
1808,gpt4,0.754,MARGIN STATUS FOR NON-INVASIVE TUMOR
1809,gpt4,0.678,PROCEDURE
1810,gpt4,0.809,SPECIMEN LATERALITY
1811,gpt4,0.662,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1812,gpt4,0.697,MARGIN STATUS FOR INVASIVE CARCINOMA
1813,gpt4,0.74,NUMBER OF LYMPH NODES EXAMINED
1814,gpt4,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1815,gpt4,0.793,TUMOR SITE
1816,gpt4,0.736,REGIONAL LYMPH NODE STATUS
1817,gpt4,0.905,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1818,gpt4,0.644,NODAL SITE(S) EXAMINED
1819,gpt4,0.766,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1820,gpt4,0.77,SPECIMEN LATERALITY
1821,gpt4,0.776,LYMPH NODE(S) FROM PRIOR PROCEDURES
1822,gpt4,0.719,REGIONAL LYMPH NODE STATUS
1823,gpt4,0.685,MARGIN STATUS FOR INVASIVE CARCINOMA
1824,gpt4,0.724,NUMBER OF LYMPH NODES EXAMINED
1825,gpt4,0.65,VISCERAL PLEURA INVASION
1826,gpt4,0.671,NODAL SITE(S) EXAMINED
1827,gpt4,0.72,TUMOR SITE
1828,gpt4,0.654,TUMOR FOCALITY
1829,gpt4,0.713,PROCEDURE
1830,gpt4,0.648,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1831,gpt4,0.708,MARGIN STATUS FOR NON-INVASIVE TUMOR
1832,gpt4,0.669,HISTOLOGIC GRADE
1833,gpt4,0.799,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1834,gpt4,0.7,NUMBER OF LYMPH NODES EXAMINED
1835,gpt4,0.69,SPREAD THROUGH AIR SPACES (STAS)
1836,gpt4,0.649,VISCERAL PLEURA INVASION
1837,gpt4,0.689,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1838,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
1839,gpt4,0.697,MARGIN STATUS FOR NON-INVASIVE TUMOR
1840,gpt4,0.688,MARGIN STATUS FOR INVASIVE CARCINOMA
1841,gpt4,0.729,PROCEDURE
1842,gpt4,0.73,REGIONAL LYMPH NODE STATUS
1843,gpt4,0.644,HISTOLOGIC GRADE
1844,gpt4,0.681,ADDITIONAL FINDINGS
1845,gpt4,0.697,SPECIMEN LATERALITY
1846,gpt4,0.689,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1847,gpt4,0.711,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1848,gpt4,0.662,TUMOR FOCALITY
1849,gpt4,0.664,NODAL SITE(S) EXAMINED
1850,gpt4,0.791,TUMOR SITE
1851,gpt4,0.69,LYMPHOVASCULAR INVASION
1852,gpt4,0.663,TUMOR FOCALITY
1853,gpt4,0.682,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1854,gpt4,0.689,NODAL SITE(S) EXAMINED
1855,gpt4,0.734,ADDITIONAL FINDINGS
1856,gpt4,0.657,PROCEDURE
1857,gpt4,0.722,TUMOR SITE
1858,gpt4,0.772,MARGIN STATUS FOR NON-INVASIVE TUMOR
1859,gpt4,0.729,REGIONAL LYMPH NODE STATUS
1860,gpt4,0.628,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1861,gpt4,0.824,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1862,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
1863,gpt4,0.697,SPECIMEN LATERALITY
1864,gpt4,0.7,VISCERAL PLEURA INVASION
1865,gpt4,0.729,NUMBER OF LYMPH NODES EXAMINED
1866,gpt4,0.794,MARGIN STATUS FOR INVASIVE CARCINOMA
1867,gpt4,0.739,REGIONAL LYMPH NODE STATUS
1868,gpt4,0.766,LYMPH NODE(S) FROM PRIOR PROCEDURES
1869,gpt4,0.689,PROCEDURE
1870,gpt4,0.672,TUMOR FOCALITY
1871,gpt4,0.689,ADDITIONAL FINDINGS
1872,gpt4,0.678,HISTOLOGIC GRADE
1873,gpt4,0.811,MARGIN STATUS FOR NON-INVASIVE TUMOR
1874,gpt4,0.705,SPECIMEN LATERALITY
1875,gpt4,0.678,VISCERAL PLEURA INVASION
1876,gpt4,0.716,TUMOR SITE
1877,gpt4,0.64,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1878,gpt4,0.709,MARGIN STATUS FOR INVASIVE CARCINOMA
1879,gpt4,0.91,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1880,gpt4,0.704,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1881,gpt4,0.707,NODAL SITE(S) EXAMINED
1882,gpt4,0.77,SPECIMEN LATERALITY
1883,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
1884,gpt4,0.698,HISTOLOGIC GRADE
1885,gpt4,0.648,MARGIN STATUS FOR NON-INVASIVE TUMOR
1886,gpt4,0.689,MARGIN STATUS FOR INVASIVE CARCINOMA
1887,gpt4,0.643,NODAL SITE(S) EXAMINED
1888,gpt4,0.82,NUMBER OF LYMPH NODES WITH TUMOR
1889,gpt4,0.65,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1890,gpt4,0.637,NODAL SITE(S) WITH TUMOR
1891,gpt4,0.721,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1892,gpt4,0.717,REGIONAL LYMPH NODE STATUS
1893,gpt4,0.671,SPREAD THROUGH AIR SPACES (STAS)
1894,gpt4,0.673,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1895,gpt4,0.791,NUMBER OF LYMPH NODES EXAMINED
1896,gpt4,0.677,TUMOR FOCALITY
1897,gpt4,0.66,TUMOR SITE
1898,gpt4,0.683,VISCERAL PLEURA INVASION
1899,gpt4,0.674,PROCEDURE
1900,gpt4,0.681,MARGIN STATUS FOR INVASIVE CARCINOMA
1901,gpt4,0.724,REGIONAL LYMPH NODE STATUS
1902,gpt4,0.698,SPECIMEN LATERALITY
1903,gpt4,0.699,MARGIN STATUS FOR NON-INVASIVE TUMOR
1904,gpt4,0.674,PROCEDURE
1905,gpt4,0.688,TUMOR SITE
1906,gpt4,0.655,TUMOR FOCALITY
1907,gpt4,0.705,NUMBER OF LYMPH NODES EXAMINED
1908,gpt4,0.625,NODAL SITE(S) EXAMINED
1909,gpt4,0.848,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1910,gpt4,0.698,VISCERAL PLEURA INVASION
1911,gpt4,0.667,LYMPH NODE(S) FROM PRIOR PROCEDURES
1912,gpt4,0.672,HISTOLOGIC GRADE
1913,gpt4,0.773,SPECIMEN LATERALITY
1914,gpt4,0.664,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1915,gpt4,0.764,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1916,gpt4,0.727,REGIONAL LYMPH NODE STATUS
1917,gpt4,0.653,NODAL SITE(S) EXAMINED
1918,gpt4,0.658,VISCERAL PLEURA INVASION
1919,gpt4,0.706,TUMOR SITE
1920,gpt4,0.772,MARGIN STATUS FOR NON-INVASIVE TUMOR
1921,gpt4,0.829,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1922,gpt4,0.663,SPREAD THROUGH AIR SPACES (STAS)
1923,gpt4,0.68,PROCEDURE
1924,gpt4,0.673,MARGIN STATUS FOR INVASIVE CARCINOMA
1925,gpt4,0.653,LYMPH NODE(S) FROM PRIOR PROCEDURES
1926,gpt4,0.648,TUMOR FOCALITY
1927,gpt4,0.695,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1928,gpt4,0.695,HISTOLOGIC GRADE
1929,gpt4,0.705,REGIONAL LYMPH NODE STATUS
1930,gpt4,0.809,SPECIMEN LATERALITY
1931,gpt4,0.667,PROCEDURE
1932,gpt4,0.671,SPREAD THROUGH AIR SPACES (STAS)
1933,gpt4,0.635,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1934,gpt4,0.678,TUMOR FOCALITY
1935,gpt4,0.814,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1936,gpt4,0.642,NODAL SITE(S) EXAMINED
1937,gpt4,0.705,ADDITIONAL FINDINGS
1938,gpt4,0.772,MARGIN STATUS FOR NON-INVASIVE TUMOR
1939,gpt4,0.677,VISCERAL PLEURA INVASION
1940,gpt4,0.713,MARGIN STATUS FOR INVASIVE CARCINOMA
1941,gpt4,0.716,TUMOR SITE
1942,gpt4,0.776,LYMPH NODE(S) FROM PRIOR PROCEDURES
1943,gpt4,0.675,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1944,gpt4,0.722,TUMOR SITE
1945,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
1946,gpt4,0.736,SPECIMEN LATERALITY
1947,gpt4,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1948,gpt4,0.65,SPREAD THROUGH AIR SPACES (STAS)
1949,gpt4,0.685,HISTOLOGIC GRADE
1950,gpt4,0.633,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1951,gpt4,0.727,MARGIN STATUS FOR INVASIVE CARCINOMA
1952,gpt4,0.652,VISCERAL PLEURA INVASION
1953,gpt4,0.72,NUMBER OF LYMPH NODES EXAMINED
1954,gpt4,0.645,TUMOR FOCALITY
1955,gpt4,0.848,MARGIN STATUS FOR NON-INVASIVE TUMOR
1956,gpt4,0.7,NODAL SITE(S) EXAMINED
1957,gpt4,0.728,REGIONAL LYMPH NODE STATUS
1958,gpt4,0.655,PROCEDURE
1959,gpt4,0.641,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1960,gpt4,0.841,MARGIN STATUS FOR NON-INVASIVE TUMOR
1961,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
1962,gpt4,0.668,HISTOLOGIC GRADE
1963,gpt4,0.907,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1964,gpt4,0.798,NUMBER OF LYMPH NODES EXAMINED
1965,gpt4,0.736,SPECIMEN LATERALITY
1966,gpt4,0.671,SPREAD THROUGH AIR SPACES (STAS)
1967,gpt4,0.72,TUMOR SITE
1968,gpt4,0.72,MARGIN STATUS FOR INVASIVE CARCINOMA
1969,gpt4,0.724,REGIONAL LYMPH NODE STATUS
1970,gpt4,0.677,TUMOR FOCALITY
1971,gpt4,0.807,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1972,gpt4,0.684,PROCEDURE
1973,gpt4,0.667,NODAL SITE(S) EXAMINED
1974,gpt4,0.637,VISCERAL PLEURA INVASION
1975,gpt4,0.723,TUMOR SITE
1976,gpt4,0.676,MARGIN STATUS FOR INVASIVE CARCINOMA
1977,gpt4,0.697,SPECIMEN LATERALITY
1978,gpt4,0.69,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
1979,gpt4,0.724,PROCEDURE
1980,gpt4,0.684,NODAL SITE(S) EXAMINED
1981,gpt4,0.664,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
1982,gpt4,0.643,MARGIN STATUS FOR NON-INVASIVE TUMOR
1983,gpt4,0.656,TUMOR FOCALITY
1984,gpt4,0.831,NUMBER OF LYMPH NODES EXAMINED
1985,gpt4,0.723,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
1986,gpt4,0.644,VISCERAL PLEURA INVASION
1987,gpt4,0.67,LYMPH NODE(S) FROM PRIOR PROCEDURES
1988,gpt4,0.67,LYMPHOVASCULAR INVASION
1989,gpt4,0.82,NUMBER OF LYMPH NODES WITH TUMOR
1990,gpt4,0.706,REGIONAL LYMPH NODE STATUS
1991,gpt4,0.628,NODAL SITE(S) WITH TUMOR
1992,gpt4,0.654,TUMOR FOCALITY
1993,gpt4,0.68,VISCERAL PLEURA INVASION
1994,gpt4,0.654,NODAL SITE(S) EXAMINED
1995,gpt4,0.682,LYMPH NODE(S) FROM PRIOR PROCEDURES
1996,gpt4,0.727,MARGIN STATUS FOR INVASIVE CARCINOMA
1997,gpt4,0.656,HISTOLOGIC GRADE
1998,gpt4,0.703,PROCEDURE
1999,gpt4,0.697,SPECIMEN LATERALITY
2000,gpt4,0.718,TUMOR SITE
2001,gpt4,0.723,REGIONAL LYMPH NODE STATUS
2002,gpt4,0.805,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2003,gpt4,0.643,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2004,gpt4,0.678,ADDITIONAL FINDINGS
2005,gpt4,0.666,SPREAD THROUGH AIR SPACES (STAS)
2006,gpt4,0.697,NUMBER OF LYMPH NODES EXAMINED
2007,gpt4,0.82,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2008,gpt4,0.685,MARGIN STATUS FOR NON-INVASIVE TUMOR
2009,gpt4,0.66,TUMOR SITE
2010,gpt4,0.65,TUMOR FOCALITY
2011,gpt4,0.652,TNM DESCRIPTORS
2012,gpt4,0.654,MARGIN STATUS FOR NON-INVASIVE TUMOR
2013,gpt4,0.677,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2014,gpt4,0.66,HISTOLOGIC GRADE
2015,gpt4,0.809,SPECIMEN LATERALITY
2016,gpt4,0.653,NUMBER OF LYMPH NODES EXAMINED
2017,gpt4,0.687,LYMPH NODE(S) FROM PRIOR PROCEDURES
2018,gpt4,0.742,VISCERAL PLEURA INVASION
2019,gpt4,0.72,REGIONAL LYMPH NODE STATUS
2020,gpt4,0.696,ADDITIONAL FINDINGS
2021,gpt4,0.652,NODAL SITE(S) EXAMINED
2022,gpt4,0.694,MARGIN STATUS FOR INVASIVE CARCINOMA
2023,gpt4,0.655,SPREAD THROUGH AIR SPACES (STAS)
2024,gpt4,0.671,PROCEDURE
2025,gpt4,0.691,PROCEDURE
2026,gpt4,0.655,TUMOR FOCALITY
2027,gpt4,0.656,NODAL SITE(S) EXAMINED
2028,gpt4,0.641,ADDITIONAL FINDINGS
2029,gpt4,0.683,VISCERAL PLEURA INVASION
2030,gpt4,0.673,SPECIMEN LATERALITY
2031,gpt4,0.676,LYMPH NODE(S) FROM PRIOR PROCEDURES
2032,gpt4,0.666,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2033,gpt4,0.676,TUMOR SITE
2034,gpt4,0.918,MARGIN STATUS FOR NON-INVASIVE TUMOR
2035,gpt4,0.658,SPREAD THROUGH AIR SPACES (STAS)
2036,gpt4,0.76,MARGIN STATUS FOR INVASIVE CARCINOMA
2037,gpt4,0.723,REGIONAL LYMPH NODE STATUS
2038,gpt4,0.901,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2039,gpt4,0.806,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2040,gpt4,0.708,HISTOLOGIC GRADE
2041,gpt4,0.706,TUMOR SITE
2042,gpt4,0.693,VISCERAL PLEURA INVASION
2043,gpt4,0.683,ADDITIONAL FINDINGS
2044,gpt4,0.693,MARGIN STATUS FOR INVASIVE CARCINOMA
2045,gpt4,0.724,HISTOLOGIC GRADE
2046,gpt4,0.65,NODAL SITE(S) EXAMINED
2047,gpt4,0.698,SPECIMEN LATERALITY
2048,gpt4,0.742,LYMPH NODE(S) FROM PRIOR PROCEDURES
2049,gpt4,0.689,SPREAD THROUGH AIR SPACES (STAS)
2050,gpt4,0.651,NUMBER OF LYMPH NODES EXAMINED
2051,gpt4,0.904,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2052,gpt4,0.705,REGIONAL LYMPH NODE STATUS
2053,gpt4,0.662,PROCEDURE
2054,gpt4,0.772,MARGIN STATUS FOR NON-INVASIVE TUMOR
2055,gpt4,0.653,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2056,gpt4,0.837,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2057,gpt4,0.635,TUMOR FOCALITY
2058,gpt4,0.764,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2059,gpt4,0.674,LYMPH NODE(S) FROM PRIOR PROCEDURES
2060,gpt4,0.635,TUMOR FOCALITY
2061,gpt4,0.704,TUMOR SITE
2062,gpt4,0.718,SPECIMEN LATERALITY
2063,gpt4,0.645,LYMPHOVASCULAR INVASION
2064,gpt4,0.697,MARGIN STATUS FOR INVASIVE CARCINOMA
2065,gpt4,0.703,NUMBER OF LYMPH NODES EXAMINED
2066,gpt4,0.717,HISTOLOGIC GRADE
2067,gpt4,0.641,NODAL SITE(S) EXAMINED
2068,gpt4,0.655,VISCERAL PLEURA INVASION
2069,gpt4,0.669,PROCEDURE
2070,gpt4,0.643,MARGIN STATUS FOR NON-INVASIVE TUMOR
2071,gpt4,0.69,SPREAD THROUGH AIR SPACES (STAS)
2072,gpt4,0.659,TNM DESCRIPTORS
2073,gpt4,0.813,MARGIN STATUS FOR NON-INVASIVE TUMOR
2074,gpt4,0.683,NODAL SITE(S) EXAMINED
2075,gpt4,0.72,NUMBER OF LYMPH NODES WITH TUMOR
2076,gpt4,0.677,VISCERAL PLEURA INVASION
2077,gpt4,0.852,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2078,gpt4,0.736,TUMOR SITE
2079,gpt4,0.67,HISTOLOGIC GRADE
2080,gpt4,0.709,LYMPH NODE(S) FROM PRIOR PROCEDURES
2081,gpt4,0.699,REGIONAL LYMPH NODE STATUS
2082,gpt4,0.719,MARGIN STATUS FOR INVASIVE CARCINOMA
2083,gpt4,0.682,SPREAD THROUGH AIR SPACES (STAS)
2084,gpt4,0.641,TUMOR FOCALITY
2085,gpt4,0.664,TNM DESCRIPTORS
2086,gpt4,0.773,SPECIMEN LATERALITY
2087,gpt4,0.683,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2088,gpt4,0.648,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2089,gpt4,0.629,NODAL SITE(S) WITH TUMOR
2090,gpt4,0.655,PROCEDURE
2091,gpt4,0.715,TUMOR SITE
2092,gpt4,0.664,TUMOR FOCALITY
2093,gpt4,0.709,MARGIN STATUS FOR INVASIVE CARCINOMA
2094,gpt4,0.676,VISCERAL PLEURA INVASION
2095,gpt4,0.674,SPREAD THROUGH AIR SPACES (STAS)
2096,gpt4,0.705,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2097,gpt4,0.784,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2098,gpt4,0.622,NODAL SITE(S) EXAMINED
2099,gpt4,0.675,PROCEDURE
2100,gpt4,0.734,REGIONAL LYMPH NODE STATUS
2101,gpt4,0.698,SPECIMEN LATERALITY
2102,gpt4,0.668,HISTOLOGIC GRADE
2103,gpt4,0.841,MARGIN STATUS FOR NON-INVASIVE TUMOR
2104,gpt4,0.752,LYMPH NODE(S) FROM PRIOR PROCEDURES
2105,gpt4,0.657,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2106,gpt4,0.652,NODAL SITE(S) EXAMINED
2107,gpt4,0.664,VISCERAL PLEURA INVASION
2108,gpt4,0.795,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2109,gpt4,0.67,MARGIN STATUS FOR NON-INVASIVE TUMOR
2110,gpt4,0.668,PROCEDURE
2111,gpt4,0.793,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2112,gpt4,0.629,TUMOR FOCALITY
2113,gpt4,0.618,LYMPHOVASCULAR INVASION
2114,gpt4,0.74,SPECIMEN LATERALITY
2115,gpt4,0.789,MARGIN STATUS FOR INVASIVE CARCINOMA
2116,gpt4,0.734,NUMBER OF LYMPH NODES EXAMINED
2117,gpt4,0.728,TUMOR SITE
2118,gpt4,0.677,HISTOLOGIC GRADE
2119,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
2120,gpt4,0.708,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2121,gpt4,0.718,REGIONAL LYMPH NODE STATUS
2122,gpt4,0.67,ADDITIONAL FINDINGS
2123,gpt4,0.658,TUMOR FOCALITY
2124,gpt4,0.681,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2125,gpt4,0.672,MARGIN STATUS FOR NON-INVASIVE TUMOR
2126,gpt4,0.684,NODAL SITE(S) EXAMINED
2127,gpt4,0.656,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2128,gpt4,0.711,MARGIN STATUS FOR INVASIVE CARCINOMA
2129,gpt4,0.772,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2130,gpt4,0.667,SPREAD THROUGH AIR SPACES (STAS)
2131,gpt4,0.69,PROCEDURE
2132,gpt4,0.65,VISCERAL PLEURA INVASION
2133,gpt4,0.809,SPECIMEN LATERALITY
2134,gpt4,0.71,NUMBER OF LYMPH NODES EXAMINED
2135,gpt4,0.706,HISTOLOGIC GRADE
2136,gpt4,0.718,REGIONAL LYMPH NODE STATUS
2137,gpt4,0.707,TUMOR SITE
2138,gpt4,0.742,VISCERAL PLEURA INVASION
2139,gpt4,0.684,PROCEDURE
2140,gpt4,0.719,HISTOLOGIC GRADE
2141,gpt4,0.683,LYMPH NODE(S) FROM PRIOR PROCEDURES
2142,gpt4,0.829,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2143,gpt4,0.743,TUMOR SITE
2144,gpt4,0.714,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2145,gpt4,0.62,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2146,gpt4,0.688,SPECIMEN LATERALITY
2147,gpt4,0.74,REGIONAL LYMPH NODE STATUS
2148,gpt4,0.664,TUMOR FOCALITY
2149,gpt4,0.648,NODAL SITE(S) EXAMINED
2150,gpt4,0.745,MARGIN STATUS FOR NON-INVASIVE TUMOR
2151,gpt4,0.692,ADDITIONAL FINDINGS
2152,gpt4,0.741,NUMBER OF LYMPH NODES EXAMINED
2153,gpt4,0.751,MARGIN STATUS FOR INVASIVE CARCINOMA
2154,gpt4,0.654,TUMOR FOCALITY
2155,gpt4,0.679,PROCEDURE
2156,gpt4,0.72,TUMOR SITE
2157,gpt4,0.67,HISTOLOGIC GRADE
2158,gpt4,0.704,MARGIN STATUS FOR INVASIVE CARCINOMA
2159,gpt4,0.67,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2160,gpt4,0.775,MARGIN STATUS FOR NON-INVASIVE TUMOR
2161,gpt4,0.648,NODAL SITE(S) EXAMINED
2162,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
2163,gpt4,0.807,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2164,gpt4,0.712,REGIONAL LYMPH NODE STATUS
2165,gpt4,0.773,SPECIMEN LATERALITY
2166,gpt4,0.743,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2167,gpt4,0.711,VISCERAL PLEURA INVASION
2168,gpt4,0.703,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2169,gpt4,0.652,MARGIN STATUS FOR NON-INVASIVE TUMOR
2170,gpt4,0.7,VISCERAL PLEURA INVASION
2171,gpt4,0.644,PROCEDURE
2172,gpt4,0.636,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2173,gpt4,0.775,NUMBER OF LYMPH NODES EXAMINED
2174,gpt4,0.635,TUMOR FOCALITY
2175,gpt4,0.72,TUMOR SITE
2176,gpt4,0.709,ADDITIONAL FINDINGS
2177,gpt4,0.686,MARGIN STATUS FOR INVASIVE CARCINOMA
2178,gpt4,0.691,SPECIMEN LATERALITY
2179,gpt4,0.744,REGIONAL LYMPH NODE STATUS
2180,gpt4,0.679,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2181,gpt4,0.646,NODAL SITE(S) EXAMINED
2182,gpt4,0.671,HISTOLOGIC GRADE
2183,gpt4,0.654,LYMPH NODE(S) FROM PRIOR PROCEDURES
2184,gpt4,0.704,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2185,gpt4,0.648,LYMPHOVASCULAR INVASION
2186,gpt4,0.77,SPECIMEN LATERALITY
2187,gpt4,0.661,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2188,gpt4,0.651,ADDITIONAL FINDINGS
2189,gpt4,0.669,PROCEDURE
2190,gpt4,0.641,LYMPH NODE(S) FROM PRIOR PROCEDURES
2191,gpt4,0.676,NODAL SITE(S) EXAMINED
2192,gpt4,0.691,TNM DESCRIPTORS
2193,gpt4,0.66,VISCERAL PLEURA INVASION
2194,gpt4,0.715,MARGIN STATUS FOR INVASIVE CARCINOMA
2195,gpt4,0.662,NODAL SITE(S) WITH TUMOR
2196,gpt4,0.67,MARGIN STATUS FOR NON-INVASIVE TUMOR
2197,gpt4,0.662,TUMOR FOCALITY
2198,gpt4,0.792,TUMOR SITE
2199,gpt4,0.698,REGIONAL LYMPH NODE STATUS
2200,gpt4,0.69,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2201,gpt4,0.674,ADDITIONAL FINDINGS
2202,gpt4,0.623,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2203,gpt4,0.65,NODAL SITE(S) EXAMINED
2204,gpt4,0.734,VISCERAL PLEURA INVASION
2205,gpt4,0.658,PROCEDURE
2206,gpt4,0.735,REGIONAL LYMPH NODE STATUS
2207,gpt4,0.659,TNM DESCRIPTORS
2208,gpt4,0.721,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2209,gpt4,0.678,HISTOLOGIC GRADE
2210,gpt4,0.698,MARGIN STATUS FOR NON-INVASIVE TUMOR
2211,gpt4,0.661,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2212,gpt4,0.668,TUMOR FOCALITY
2213,gpt4,0.678,SPECIMEN LATERALITY
2214,gpt4,0.703,MARGIN STATUS FOR INVASIVE CARCINOMA
2215,gpt4,0.725,TUMOR SITE
2216,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
2217,gpt4,0.722,TUMOR SITE
2218,gpt4,0.723,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2219,gpt4,0.663,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2220,gpt4,0.68,LYMPH NODE(S) FROM PRIOR PROCEDURES
2221,gpt4,0.71,PROCEDURE
2222,gpt4,0.739,REGIONAL LYMPH NODE STATUS
2223,gpt4,0.851,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2224,gpt4,0.685,MARGIN STATUS FOR INVASIVE CARCINOMA
2225,gpt4,0.679,HISTOLOGIC GRADE
2226,gpt4,0.707,VISCERAL PLEURA INVASION
2227,gpt4,0.668,TUMOR FOCALITY
2228,gpt4,0.667,NODAL SITE(S) EXAMINED
2229,gpt4,0.848,MARGIN STATUS FOR NON-INVASIVE TUMOR
2230,gpt4,0.82,NUMBER OF LYMPH NODES EXAMINED
2231,gpt4,0.697,SPECIMEN LATERALITY
2232,gpt4,0.748,REGIONAL LYMPH NODE STATUS
2233,gpt4,0.638,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2234,gpt4,0.68,HISTOLOGIC GRADE
2235,gpt4,0.777,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2236,gpt4,0.78,MARGIN STATUS FOR NON-INVASIVE TUMOR
2237,gpt4,0.684,LYMPH NODE(S) FROM PRIOR PROCEDURES
2238,gpt4,0.642,TUMOR FOCALITY
2239,gpt4,0.74,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2240,gpt4,0.627,PROCEDURE
2241,gpt4,0.813,NUMBER OF LYMPH NODES EXAMINED
2242,gpt4,0.715,SPECIMEN LATERALITY
2243,gpt4,0.713,TUMOR SITE
2244,gpt4,0.674,NODAL SITE(S) EXAMINED
2245,gpt4,0.882,MARGIN STATUS FOR INVASIVE CARCINOMA
2246,gpt4,0.717,VISCERAL PLEURA INVASION
2247,gpt4,0.646,LYMPHOVASCULAR INVASION
2248,gpt4,0.659,PROCEDURE
2249,gpt4,0.697,NUMBER OF LYMPH NODES WITH TUMOR
2250,gpt4,0.675,LYMPH NODE(S) FROM PRIOR PROCEDURES
2251,gpt4,0.693,TUMOR SITE
2252,gpt4,0.648,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2253,gpt4,0.649,HISTOLOGIC GRADE
2254,gpt4,0.693,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2255,gpt4,0.697,MARGIN STATUS FOR INVASIVE CARCINOMA
2256,gpt4,0.69,REGIONAL LYMPH NODE STATUS
2257,gpt4,0.646,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2258,gpt4,0.659,NODAL SITE(S) EXAMINED
2259,gpt4,0.705,SPECIMEN LATERALITY
2260,gpt4,0.634,TUMOR FOCALITY
2261,gpt4,0.703,ADDITIONAL FINDINGS
2262,gpt4,0.674,SPREAD THROUGH AIR SPACES (STAS)
2263,gpt4,0.698,MARGIN STATUS FOR NON-INVASIVE TUMOR
2264,gpt4,0.701,NUMBER OF LYMPH NODES EXAMINED
2265,gpt4,0.669,VISCERAL PLEURA INVASION
2266,gpt4,0.67,TNM DESCRIPTORS
2267,gpt4,0.706,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2268,gpt4,0.685,TUMOR SITE
2269,gpt4,0.673,MARGIN STATUS FOR INVASIVE CARCINOMA
2270,gpt4,0.735,LYMPH NODE(S) FROM PRIOR PROCEDURES
2271,gpt4,0.652,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2272,gpt4,0.665,ADDITIONAL FINDINGS
2273,gpt4,0.636,NODAL SITE(S) EXAMINED
2274,gpt4,0.642,PROCEDURE
2275,gpt4,0.703,HISTOLOGIC GRADE
2276,gpt4,0.658,SPREAD THROUGH AIR SPACES (STAS)
2277,gpt4,0.68,TUMOR SITE
2278,gpt4,0.662,TUMOR FOCALITY
2279,gpt4,0.751,MARGIN STATUS FOR NON-INVASIVE TUMOR
2280,gpt4,0.91,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2281,gpt4,0.623,SPECIMEN LATERALITY
2282,gpt4,0.642,VISCERAL PLEURA INVASION
2283,gpt4,0.723,REGIONAL LYMPH NODE STATUS
2284,gpt4,0.746,MARGIN STATUS FOR INVASIVE CARCINOMA
2285,gpt4,0.718,SPECIMEN LATERALITY
2286,gpt4,0.834,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2287,gpt4,0.685,VISCERAL PLEURA INVASION
2288,gpt4,0.656,HISTOLOGIC GRADE
2289,gpt4,0.75,TUMOR SITE
2290,gpt4,0.65,NODAL SITE(S) EXAMINED
2291,gpt4,0.641,MARGIN STATUS FOR NON-INVASIVE TUMOR
2292,gpt4,0.73,SPREAD THROUGH AIR SPACES (STAS)
2293,gpt4,0.708,REGIONAL LYMPH NODE STATUS
2294,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
2295,gpt4,0.636,PROCEDURE
2296,gpt4,0.655,TUMOR FOCALITY
2297,gpt4,0.638,NODAL SITE(S) WITH TUMOR
2298,gpt4,0.841,MARGIN STATUS FOR NON-INVASIVE TUMOR
2299,gpt4,0.829,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2300,gpt4,0.663,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2301,gpt4,0.669,LYMPHOVASCULAR INVASION
2302,gpt4,0.671,SPECIMEN LATERALITY
2303,gpt4,0.691,TUMOR SITE
2304,gpt4,0.767,LYMPH NODE(S) FROM PRIOR PROCEDURES
2305,gpt4,0.704,VISCERAL PLEURA INVASION
2306,gpt4,0.66,TUMOR FOCALITY
2307,gpt4,0.662,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2308,gpt4,0.786,NUMBER OF LYMPH NODES EXAMINED
2309,gpt4,0.695,REGIONAL LYMPH NODE STATUS
2310,gpt4,0.703,HISTOLOGIC GRADE
2311,gpt4,0.636,NODAL SITE(S) EXAMINED
2312,gpt4,0.724,MARGIN STATUS FOR INVASIVE CARCINOMA
2313,gpt4,0.684,NUMBER OF LYMPH NODES WITH TUMOR
2314,gpt4,0.713,PROCEDURE
2315,gpt4,0.652,VISCERAL PLEURA INVASION
2316,gpt4,0.767,REGIONAL LYMPH NODE STATUS
2317,gpt4,0.685,MARGIN STATUS FOR INVASIVE CARCINOMA
2318,gpt4,0.664,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2319,gpt4,0.661,NODAL SITE(S) EXAMINED
2320,gpt4,0.695,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2321,gpt4,0.622,TUMOR SITE
2322,gpt4,0.71,PROCEDURE
2323,gpt4,0.776,LYMPH NODE(S) FROM PRIOR PROCEDURES
2324,gpt4,0.712,MARGIN STATUS FOR NON-INVASIVE TUMOR
2325,gpt4,0.664,ADDITIONAL FINDINGS
2326,gpt4,0.639,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2327,gpt4,0.7,SPREAD THROUGH AIR SPACES (STAS)
2328,gpt4,0.722,HISTOLOGIC GRADE
2329,gpt4,0.697,SPECIMEN LATERALITY
2330,gpt4,0.796,NUMBER OF LYMPH NODES EXAMINED
2331,gpt4,0.713,TUMOR FOCALITY
2332,gpt4,0.662,NODAL SITE(S) EXAMINED
2333,gpt4,0.658,TNM DESCRIPTORS
2334,gpt4,0.699,MARGIN STATUS FOR INVASIVE CARCINOMA
2335,gpt4,0.668,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2336,gpt4,0.684,TUMOR SITE
2337,gpt4,0.776,LYMPH NODE(S) FROM PRIOR PROCEDURES
2338,gpt4,0.791,NUMBER OF LYMPH NODES EXAMINED
2339,gpt4,0.672,PROCEDURE
2340,gpt4,0.77,SPECIMEN LATERALITY
2341,gpt4,0.699,HISTOLOGIC GRADE
2342,gpt4,0.737,REGIONAL LYMPH NODE STATUS
2343,gpt4,0.67,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2344,gpt4,0.747,ADDITIONAL FINDINGS
2345,gpt4,0.732,VISCERAL PLEURA INVASION
2346,gpt4,0.655,TUMOR FOCALITY
2347,gpt4,0.704,MARGIN STATUS FOR NON-INVASIVE TUMOR
2348,gpt4,0.702,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2349,gpt4,0.668,SPREAD THROUGH AIR SPACES (STAS)
2350,gpt4,0.634,NODAL SITE(S) WITH TUMOR
2351,gpt4,0.698,REGIONAL LYMPH NODE STATUS
2352,gpt4,0.743,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2353,gpt4,0.745,MARGIN STATUS FOR NON-INVASIVE TUMOR
2354,gpt4,0.719,TUMOR SITE
2355,gpt4,0.665,PROCEDURE
2356,gpt4,0.697,SPECIMEN LATERALITY
2357,gpt4,0.732,VISCERAL PLEURA INVASION
2358,gpt4,0.695,NUMBER OF LYMPH NODES EXAMINED
2359,gpt4,0.793,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2360,gpt4,0.64,LYMPHOVASCULAR INVASION
2361,gpt4,0.66,LYMPH NODE(S) FROM PRIOR PROCEDURES
2362,gpt4,0.697,MARGIN STATUS FOR INVASIVE CARCINOMA
2363,gpt4,0.659,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2364,gpt4,0.681,NODAL SITE(S) EXAMINED
2365,gpt4,0.678,TUMOR FOCALITY
2366,gpt4,0.67,LYMPH NODE(S) FROM PRIOR PROCEDURES
2367,gpt4,0.647,HISTOLOGIC GRADE
2368,gpt4,0.673,PROCEDURE
2369,gpt4,0.655,VISCERAL PLEURA INVASION
2370,gpt4,0.773,SPECIMEN LATERALITY
2371,gpt4,0.681,MARGIN STATUS FOR INVASIVE CARCINOMA
2372,gpt4,0.671,TUMOR SITE
2373,gpt4,0.688,MARGIN STATUS FOR NON-INVASIVE TUMOR
2374,gpt4,0.679,NODAL SITE(S) EXAMINED
2375,gpt4,0.846,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2376,gpt4,0.654,TUMOR FOCALITY
2377,gpt4,0.741,REGIONAL LYMPH NODE STATUS
2378,gpt4,0.698,LYMPHOVASCULAR INVASION
2379,gpt4,0.713,NUMBER OF LYMPH NODES EXAMINED
2380,gpt4,0.669,ADDITIONAL FINDINGS
2381,gpt4,0.657,HISTOLOGIC GRADE
2382,gpt4,0.708,REGIONAL LYMPH NODE STATUS
2383,gpt4,0.721,TUMOR SITE
2384,gpt4,0.699,MARGIN STATUS FOR INVASIVE CARCINOMA
2385,gpt4,0.761,NUMBER OF LYMPH NODES EXAMINED
2386,gpt4,0.642,NODAL SITE(S) EXAMINED
2387,gpt4,0.645,TUMOR FOCALITY
2388,gpt4,0.648,LYMPH NODE(S) FROM PRIOR PROCEDURES
2389,gpt4,0.673,VISCERAL PLEURA INVASION
2390,gpt4,0.644,PROCEDURE
2391,gpt4,0.848,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2392,gpt4,0.712,SPECIMEN LATERALITY
2393,gpt4,0.688,MARGIN STATUS FOR NON-INVASIVE TUMOR
2394,gpt4,0.709,HISTOLOGIC GRADE
2395,gpt4,0.692,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2396,gpt4,0.662,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2397,gpt4,0.772,MARGIN STATUS FOR NON-INVASIVE TUMOR
2398,gpt4,0.776,LYMPH NODE(S) FROM PRIOR PROCEDURES
2399,gpt4,0.696,TUMOR SITE
2400,gpt4,0.645,VISCERAL PLEURA INVASION
2401,gpt4,0.731,NUMBER OF LYMPH NODES EXAMINED
2402,gpt4,0.699,MARGIN STATUS FOR INVASIVE CARCINOMA
2403,gpt4,0.671,TUMOR FOCALITY
2404,gpt4,0.805,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2405,gpt4,0.698,SPECIMEN LATERALITY
2406,gpt4,0.639,NODAL SITE(S) EXAMINED
2407,gpt4,0.653,PROCEDURE
2408,gpt4,0.761,REGIONAL LYMPH NODE STATUS
2409,gpt4,0.716,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2410,gpt4,0.713,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2411,gpt4,0.702,HISTOLOGIC GRADE
2412,gpt4,0.729,REGIONAL LYMPH NODE STATUS
2413,gpt4,0.786,MARGIN STATUS FOR NON-INVASIVE TUMOR
2414,gpt4,0.664,TUMOR FOCALITY
2415,gpt4,0.697,SPECIMEN LATERALITY
2416,gpt4,0.669,ADDITIONAL FINDINGS
2417,gpt4,0.738,MARGIN STATUS FOR INVASIVE CARCINOMA
2418,gpt4,0.651,NODAL SITE(S) EXAMINED
2419,gpt4,0.672,VISCERAL PLEURA INVASION
2420,gpt4,0.647,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2421,gpt4,0.695,NUMBER OF LYMPH NODES EXAMINED
2422,gpt4,0.676,PROCEDURE
2423,gpt4,0.776,LYMPH NODE(S) FROM PRIOR PROCEDURES
2424,gpt4,0.715,TUMOR SITE
2425,gpt4,0.7,SPECIMEN LATERALITY
2426,gpt4,0.668,TUMOR FOCALITY
2427,gpt4,0.692,REGIONAL LYMPH NODE STATUS
2428,gpt4,0.657,VISCERAL PLEURA INVASION
2429,gpt4,0.705,NUMBER OF LYMPH NODES WITH TUMOR
2430,gpt4,0.667,PROCEDURE
2431,gpt4,0.671,NODAL SITE(S) WITH TUMOR
2432,gpt4,0.687,TNM DESCRIPTORS
2433,gpt4,0.745,MARGIN STATUS FOR INVASIVE CARCINOMA
2434,gpt4,0.699,MARGIN STATUS FOR NON-INVASIVE TUMOR
2435,gpt4,0.69,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2436,gpt4,0.708,TUMOR SITE
2437,gpt4,0.639,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2438,gpt4,0.627,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2439,gpt4,0.654,NODAL SITE(S) EXAMINED
2440,gpt4,0.733,MARGIN STATUS FOR NON-INVASIVE TUMOR
2441,gpt4,0.69,PROCEDURE
2442,gpt4,0.714,SPECIMEN LATERALITY
2443,gpt4,0.73,MARGIN STATUS FOR INVASIVE CARCINOMA
2444,gpt4,0.738,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2445,gpt4,0.664,TUMOR FOCALITY
2446,gpt4,0.691,HISTOLOGIC GRADE
2447,gpt4,0.738,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2448,gpt4,0.69,VISCERAL PLEURA INVASION
2449,gpt4,0.718,TUMOR SITE
2450,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
2451,gpt4,0.685,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2452,gpt4,0.703,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2453,gpt4,0.631,NODAL SITE(S) EXAMINED
2454,gpt4,0.704,MARGIN STATUS FOR NON-INVASIVE TUMOR
2455,gpt4,0.809,SPECIMEN LATERALITY
2456,gpt4,0.692,MARGIN STATUS FOR INVASIVE CARCINOMA
2457,gpt4,0.724,ADDITIONAL FINDINGS
2458,gpt4,0.636,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2459,gpt4,0.646,PROCEDURE
2460,gpt4,0.856,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2461,gpt4,0.69,HISTOLOGIC GRADE
2462,gpt4,0.741,REGIONAL LYMPH NODE STATUS
2463,gpt4,0.633,TUMOR FOCALITY
2464,gpt4,0.673,VISCERAL PLEURA INVASION
2465,gpt4,0.659,LYMPH NODE(S) FROM PRIOR PROCEDURES
2466,gpt4,0.727,TUMOR SITE
2467,gpt4,0.792,NUMBER OF LYMPH NODES EXAMINED
2468,gpt4,0.906,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2469,gpt4,0.704,MARGIN STATUS FOR INVASIVE CARCINOMA
2470,gpt4,0.742,SPREAD THROUGH AIR SPACES (STAS)
2471,gpt4,0.773,SPECIMEN LATERALITY
2472,gpt4,0.693,ADDITIONAL FINDINGS
2473,gpt4,0.722,TUMOR SITE
2474,gpt4,0.648,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2475,gpt4,0.652,HISTOLOGIC GRADE
2476,gpt4,0.673,TUMOR FOCALITY
2477,gpt4,0.683,PROCEDURE
2478,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
2479,gpt4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
2480,gpt4,0.728,VISCERAL PLEURA INVASION
2481,gpt4,0.811,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2482,gpt4,0.752,TUMOR SITE
2483,gpt4,0.645,NODAL SITE(S) WITH TUMOR
2484,gpt4,0.713,MARGIN STATUS FOR INVASIVE CARCINOMA
2485,gpt4,0.697,MARGIN STATUS FOR NON-INVASIVE TUMOR
2486,gpt4,0.668,TUMOR FOCALITY
2487,gpt4,0.68,HISTOLOGIC GRADE
2488,gpt4,0.636,VISCERAL PLEURA INVASION
2489,gpt4,0.709,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2490,gpt4,0.674,PROCEDURE
2491,gpt4,0.661,LYMPH NODE(S) FROM PRIOR PROCEDURES
2492,gpt4,0.694,REGIONAL LYMPH NODE STATUS
2493,gpt4,0.667,SPREAD THROUGH AIR SPACES (STAS)
2494,gpt4,0.669,NODAL SITE(S) EXAMINED
2495,gpt4,0.697,SPECIMEN LATERALITY
2496,gpt4,0.817,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2497,gpt4,0.793,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2498,gpt4,0.649,NODAL SITE(S) EXAMINED
2499,gpt4,0.658,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2500,gpt4,0.696,LYMPH NODE(S) FROM PRIOR PROCEDURES
2501,gpt4,0.68,VISCERAL PLEURA INVASION
2502,gpt4,0.725,REGIONAL LYMPH NODE STATUS
2503,gpt4,0.647,TUMOR FOCALITY
2504,gpt4,0.71,TUMOR SITE
2505,gpt4,0.679,HISTOLOGIC GRADE
2506,gpt4,0.811,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2507,gpt4,0.804,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2508,gpt4,0.652,SPREAD THROUGH AIR SPACES (STAS)
2509,gpt4,0.686,ADDITIONAL FINDINGS
2510,gpt4,0.811,MARGIN STATUS FOR NON-INVASIVE TUMOR
2511,gpt4,0.675,PROCEDURE
2512,gpt4,0.707,MARGIN STATUS FOR INVASIVE CARCINOMA
2513,gpt4,0.773,SPECIMEN LATERALITY
2514,gpt4,0.649,TUMOR FOCALITY
2515,gpt4,0.734,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2516,gpt4,0.656,HISTOLOGIC GRADE
2517,gpt4,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2518,gpt4,0.718,NODAL SITE(S) EXAMINED
2519,gpt4,0.684,SPECIMEN LATERALITY
2520,gpt4,0.658,SPREAD THROUGH AIR SPACES (STAS)
2521,gpt4,0.703,TUMOR SITE
2522,gpt4,0.73,REGIONAL LYMPH NODE STATUS
2523,gpt4,0.664,LYMPH NODE(S) FROM PRIOR PROCEDURES
2524,gpt4,0.655,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2525,gpt4,0.713,MARGIN STATUS FOR INVASIVE CARCINOMA
2526,gpt4,0.687,PROCEDURE
2527,gpt4,0.658,VISCERAL PLEURA INVASION
2528,gpt4,0.832,MARGIN STATUS FOR NON-INVASIVE TUMOR
2529,gpt4,0.712,NUMBER OF LYMPH NODES EXAMINED
2530,gpt4,0.716,ADDITIONAL FINDINGS
2531,gpt4,0.687,HISTOLOGIC GRADE
2532,gpt4,0.696,NODAL SITE(S) EXAMINED
2533,gpt4,0.919,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2534,gpt4,0.696,VISCERAL PLEURA INVASION
2535,gpt4,0.708,SPREAD THROUGH AIR SPACES (STAS)
2536,gpt4,0.663,PROCEDURE
2537,gpt4,0.726,REGIONAL LYMPH NODE STATUS
2538,gpt4,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2539,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
2540,gpt4,0.769,MARGIN STATUS FOR NON-INVASIVE TUMOR
2541,gpt4,0.738,TUMOR FOCALITY
2542,gpt4,0.896,MARGIN STATUS FOR INVASIVE CARCINOMA
2543,gpt4,0.718,TUMOR SITE
2544,gpt4,0.82,NUMBER OF LYMPH NODES EXAMINED
2545,gpt4,0.809,SPECIMEN LATERALITY
2546,gpt4,0.663,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2547,gpt4,0.663,NODAL SITE(S) EXAMINED
2548,gpt4,0.791,REGIONAL LYMPH NODE STATUS
2549,gpt4,0.656,HISTOLOGIC GRADE
2550,gpt4,0.637,TUMOR FOCALITY
2551,gpt4,0.713,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2552,gpt4,0.701,SPECIMEN LATERALITY
2553,gpt4,0.686,PROCEDURE
2554,gpt4,0.687,SPREAD THROUGH AIR SPACES (STAS)
2555,gpt4,0.734,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2556,gpt4,0.676,MARGIN STATUS FOR INVASIVE CARCINOMA
2557,gpt4,0.698,MARGIN STATUS FOR NON-INVASIVE TUMOR
2558,gpt4,0.66,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2559,gpt4,0.725,TUMOR SITE
2560,gpt4,0.889,LYMPH NODE(S) FROM PRIOR PROCEDURES
2561,gpt4,0.675,VISCERAL PLEURA INVASION
2562,gpt4,0.728,MARGIN STATUS FOR NON-INVASIVE TUMOR
2563,gpt4,0.816,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2564,gpt4,0.656,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2565,gpt4,0.809,SPECIMEN LATERALITY
2566,gpt4,0.848,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2567,gpt4,0.722,TUMOR SITE
2568,gpt4,0.683,SPREAD THROUGH AIR SPACES (STAS)
2569,gpt4,0.684,PROCEDURE
2570,gpt4,0.75,TUMOR FOCALITY
2571,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
2572,gpt4,0.722,MARGIN STATUS FOR INVASIVE CARCINOMA
2573,gpt4,0.729,VISCERAL PLEURA INVASION
2574,gpt4,0.679,HISTOLOGIC GRADE
2575,gpt4,0.808,MARGIN STATUS FOR NON-INVASIVE TUMOR
2576,gpt4,0.789,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2577,gpt4,0.673,PROCEDURE
2578,gpt4,0.683,NUMBER OF LYMPH NODES EXAMINED
2579,gpt4,0.718,SPECIMEN LATERALITY
2580,gpt4,0.726,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2581,gpt4,0.725,MARGIN STATUS FOR INVASIVE CARCINOMA
2582,gpt4,0.66,VISCERAL PLEURA INVASION
2583,gpt4,0.748,REGIONAL LYMPH NODE STATUS
2584,gpt4,0.637,TUMOR FOCALITY
2585,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
2586,gpt4,0.714,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2587,gpt4,0.793,TUMOR SITE
2588,gpt4,0.624,NODAL SITE(S) EXAMINED
2589,gpt4,0.689,SPREAD THROUGH AIR SPACES (STAS)
2590,gpt4,0.657,NODAL SITE(S) EXAMINED
2591,gpt4,0.655,HISTOLOGIC GRADE
2592,gpt4,0.676,TUMOR FOCALITY
2593,gpt4,0.758,MARGIN STATUS FOR NON-INVASIVE TUMOR
2594,gpt4,0.659,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2595,gpt4,0.684,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2596,gpt4,0.694,VISCERAL PLEURA INVASION
2597,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
2598,gpt4,0.668,PROCEDURE
2599,gpt4,0.773,SPECIMEN LATERALITY
2600,gpt4,0.724,REGIONAL LYMPH NODE STATUS
2601,gpt4,0.716,MARGIN STATUS FOR INVASIVE CARCINOMA
2602,gpt4,0.718,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2603,gpt4,0.698,NUMBER OF LYMPH NODES EXAMINED
2604,gpt4,0.707,TUMOR SITE
2605,gpt4,0.773,SPECIMEN LATERALITY
2606,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
2607,gpt4,0.714,TUMOR SITE
2608,gpt4,0.716,MARGIN STATUS FOR INVASIVE CARCINOMA
2609,gpt4,0.831,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2610,gpt4,0.717,PROCEDURE
2611,gpt4,0.676,TUMOR FOCALITY
2612,gpt4,0.629,NODAL SITE(S) EXAMINED
2613,gpt4,0.708,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2614,gpt4,0.683,HISTOLOGIC GRADE
2615,gpt4,0.707,REGIONAL LYMPH NODE STATUS
2616,gpt4,0.797,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2617,gpt4,0.699,MARGIN STATUS FOR NON-INVASIVE TUMOR
2618,gpt4,0.681,VISCERAL PLEURA INVASION
2619,gpt4,0.672,MARGIN STATUS FOR NON-INVASIVE TUMOR
2620,gpt4,0.696,MARGIN STATUS FOR INVASIVE CARCINOMA
2621,gpt4,0.817,NUMBER OF LYMPH NODES WITH TUMOR
2622,gpt4,0.672,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2623,gpt4,0.627,PROCEDURE
2624,gpt4,0.725,TUMOR SITE
2625,gpt4,0.643,TUMOR FOCALITY
2626,gpt4,0.647,TNM DESCRIPTORS
2627,gpt4,0.704,SPECIMEN LATERALITY
2628,gpt4,0.638,LYMPHOVASCULAR INVASION
2629,gpt4,0.662,NODAL SITE(S) EXAMINED
2630,gpt4,0.683,HISTOLOGIC GRADE
2631,gpt4,0.657,NODAL SITE(S) WITH TUMOR
2632,gpt4,0.846,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2633,gpt4,0.711,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2634,gpt4,0.691,LYMPH NODE(S) FROM PRIOR PROCEDURES
2635,gpt4,0.669,VISCERAL PLEURA INVASION
2636,gpt4,0.695,REGIONAL LYMPH NODE STATUS
2637,gpt4,0.702,NODAL SITE(S) EXAMINED
2638,gpt4,0.671,PROCEDURE
2639,gpt4,0.684,VISCERAL PLEURA INVASION
2640,gpt4,0.671,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2641,gpt4,0.809,SPECIMEN LATERALITY
2642,gpt4,0.652,ADDITIONAL FINDINGS
2643,gpt4,0.81,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2644,gpt4,0.647,SPREAD THROUGH AIR SPACES (STAS)
2645,gpt4,0.663,NUMBER OF LYMPH NODES EXAMINED
2646,gpt4,0.719,TUMOR SITE
2647,gpt4,0.645,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2648,gpt4,0.737,MARGIN STATUS FOR NON-INVASIVE TUMOR
2649,gpt4,0.644,TUMOR FOCALITY
2650,gpt4,0.708,MARGIN STATUS FOR INVASIVE CARCINOMA
2651,gpt4,0.748,REGIONAL LYMPH NODE STATUS
2652,gpt4,0.669,HISTOLOGIC GRADE
2653,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
2654,gpt4,0.657,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2655,gpt4,0.699,MARGIN STATUS FOR INVASIVE CARCINOMA
2656,gpt4,0.682,SPREAD THROUGH AIR SPACES (STAS)
2657,gpt4,0.708,NODAL SITE(S) EXAMINED
2658,gpt4,0.796,MARGIN STATUS FOR NON-INVASIVE TUMOR
2659,gpt4,0.685,PROCEDURE
2660,gpt4,0.663,HISTOLOGIC GRADE
2661,gpt4,0.663,TUMOR FOCALITY
2662,gpt4,0.75,REGIONAL LYMPH NODE STATUS
2663,gpt4,0.762,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2664,gpt4,0.638,VISCERAL PLEURA INVASION
2665,gpt4,0.698,NUMBER OF LYMPH NODES EXAMINED
2666,gpt4,0.798,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2667,gpt4,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2668,gpt4,0.714,TUMOR SITE
2669,gpt4,0.678,SPECIMEN LATERALITY
2670,gpt4,0.664,LYMPH NODE(S) FROM PRIOR PROCEDURES
2671,gpt4,0.653,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2672,gpt4,0.662,ADDITIONAL FINDINGS
2673,gpt4,0.741,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2674,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
2675,gpt4,0.699,MARGIN STATUS FOR NON-INVASIVE TUMOR
2676,gpt4,0.742,SPREAD THROUGH AIR SPACES (STAS)
2677,gpt4,0.707,TUMOR SITE
2678,gpt4,0.637,NODAL SITE(S) EXAMINED
2679,gpt4,0.699,HISTOLOGIC GRADE
2680,gpt4,0.661,LYMPHOVASCULAR INVASION
2681,gpt4,0.809,SPECIMEN LATERALITY
2682,gpt4,0.765,NUMBER OF LYMPH NODES EXAMINED
2683,gpt4,0.732,VISCERAL PLEURA INVASION
2684,gpt4,0.673,PROCEDURE
2685,gpt4,0.765,REGIONAL LYMPH NODE STATUS
2686,gpt4,0.717,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2687,gpt4,0.69,MARGIN STATUS FOR INVASIVE CARCINOMA
2688,gpt4,0.665,TUMOR FOCALITY
2689,gpt4,0.682,VISCERAL PLEURA INVASION
2690,gpt4,0.82,NUMBER OF LYMPH NODES WITH TUMOR
2691,gpt4,0.674,HISTOLOGIC GRADE
2692,gpt4,0.661,LYMPH NODE(S) FROM PRIOR PROCEDURES
2693,gpt4,0.742,SPREAD THROUGH AIR SPACES (STAS)
2694,gpt4,0.848,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2695,gpt4,0.679,TUMOR FOCALITY
2696,gpt4,0.761,TUMOR SITE
2697,gpt4,0.642,MARGIN STATUS FOR INVASIVE CARCINOMA
2698,gpt4,0.761,NUMBER OF LYMPH NODES EXAMINED
2699,gpt4,0.773,SPECIMEN LATERALITY
2700,gpt4,0.698,REGIONAL LYMPH NODE STATUS
2701,gpt4,0.674,NODAL SITE(S) EXAMINED
2702,gpt4,0.714,PROCEDURE
2703,gpt4,0.709,MARGIN STATUS FOR NON-INVASIVE TUMOR
2704,gpt4,0.69,SPREAD THROUGH AIR SPACES (STAS)
2705,gpt4,0.802,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2706,gpt4,0.665,NODAL SITE(S) EXAMINED
2707,gpt4,0.712,MARGIN STATUS FOR INVASIVE CARCINOMA
2708,gpt4,0.671,VISCERAL PLEURA INVASION
2709,gpt4,0.676,ADDITIONAL FINDINGS
2710,gpt4,0.677,PROCEDURE
2711,gpt4,0.64,LYMPHOVASCULAR INVASION
2712,gpt4,0.678,REGIONAL LYMPH NODE STATUS
2713,gpt4,0.749,LYMPH NODE(S) FROM PRIOR PROCEDURES
2714,gpt4,0.82,NUMBER OF LYMPH NODES WITH TUMOR
2715,gpt4,0.697,SPECIMEN LATERALITY
2716,gpt4,0.639,TUMOR SITE
2717,gpt4,0.718,NUMBER OF LYMPH NODES EXAMINED
2718,gpt4,0.667,NODAL SITE(S) WITH TUMOR
2719,gpt4,0.641,TUMOR FOCALITY
2720,gpt4,0.733,MARGIN STATUS FOR NON-INVASIVE TUMOR
2721,gpt4,0.723,TUMOR SITE
2722,gpt4,0.639,LYMPHOVASCULAR INVASION
2723,gpt4,0.699,MARGIN STATUS FOR INVASIVE CARCINOMA
2724,gpt4,0.679,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2725,gpt4,0.702,NODAL SITE(S) EXAMINED
2726,gpt4,0.701,SPECIMEN LATERALITY
2727,gpt4,0.711,MARGIN STATUS FOR NON-INVASIVE TUMOR
2728,gpt4,0.642,VISCERAL PLEURA INVASION
2729,gpt4,0.681,ADDITIONAL FINDINGS
2730,gpt4,0.748,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2731,gpt4,0.67,PROCEDURE
2732,gpt4,0.674,TUMOR FOCALITY
2733,gpt4,0.673,HISTOLOGIC GRADE
2734,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
2735,gpt4,0.673,SPREAD THROUGH AIR SPACES (STAS)
2736,gpt4,0.69,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2737,gpt4,0.742,REGIONAL LYMPH NODE STATUS
2738,gpt4,0.697,MARGIN STATUS FOR INVASIVE CARCINOMA
2739,gpt4,0.663,LYMPHOVASCULAR INVASION
2740,gpt4,0.672,SPREAD THROUGH AIR SPACES (STAS)
2741,gpt4,0.66,TUMOR FOCALITY
2742,gpt4,0.688,PROCEDURE
2743,gpt4,0.644,NODAL SITE(S) WITH TUMOR
2744,gpt4,0.663,VISCERAL PLEURA INVASION
2745,gpt4,0.72,NUMBER OF LYMPH NODES WITH TUMOR
2746,gpt4,0.703,REGIONAL LYMPH NODE STATUS
2747,gpt4,0.698,NUMBER OF LYMPH NODES EXAMINED
2748,gpt4,0.666,MARGIN STATUS FOR NON-INVASIVE TUMOR
2749,gpt4,0.706,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2750,gpt4,0.697,SPECIMEN LATERALITY
2751,gpt4,0.681,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2752,gpt4,0.675,HISTOLOGIC GRADE
2753,gpt4,0.641,NODAL SITE(S) EXAMINED
2754,gpt4,0.904,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2755,gpt4,0.709,TUMOR SITE
2756,gpt4,0.669,LYMPH NODE(S) FROM PRIOR PROCEDURES
2757,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
2758,gpt4,0.725,REGIONAL LYMPH NODE STATUS
2759,gpt4,0.667,TUMOR FOCALITY
2760,gpt4,0.671,LYMPHOVASCULAR INVASION
2761,gpt4,0.821,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2762,gpt4,0.709,MARGIN STATUS FOR INVASIVE CARCINOMA
2763,gpt4,0.848,MARGIN STATUS FOR NON-INVASIVE TUMOR
2764,gpt4,0.729,TUMOR SITE
2765,gpt4,0.637,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2766,gpt4,0.664,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2767,gpt4,0.717,VISCERAL PLEURA INVASION
2768,gpt4,0.654,PROCEDURE
2769,gpt4,0.647,NODAL SITE(S) EXAMINED
2770,gpt4,0.697,SPECIMEN LATERALITY
2771,gpt4,0.675,HISTOLOGIC GRADE
2772,gpt4,0.685,REGIONAL LYMPH NODE STATUS
2773,gpt4,0.764,MARGIN STATUS FOR INVASIVE CARCINOMA
2774,gpt4,0.728,TUMOR SITE
2775,gpt4,0.806,NUMBER OF LYMPH NODES EXAMINED
2776,gpt4,0.636,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2777,gpt4,0.651,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2778,gpt4,0.646,PROCEDURE
2779,gpt4,0.667,VISCERAL PLEURA INVASION
2780,gpt4,0.663,TUMOR FOCALITY
2781,gpt4,0.673,SPREAD THROUGH AIR SPACES (STAS)
2782,gpt4,0.841,MARGIN STATUS FOR NON-INVASIVE TUMOR
2783,gpt4,0.664,NODAL SITE(S) EXAMINED
2784,gpt4,0.82,NUMBER OF LYMPH NODES WITH TUMOR
2785,gpt4,0.773,SPECIMEN LATERALITY
2786,gpt4,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2787,gpt4,0.778,LYMPH NODE(S) FROM PRIOR PROCEDURES
2788,gpt4,0.634,NODAL SITE(S) WITH TUMOR
2789,gpt4,0.627,NODAL SITE(S) EXAMINED
2790,gpt4,0.728,VISCERAL PLEURA INVASION
2791,gpt4,0.698,SPECIMEN LATERALITY
2792,gpt4,0.757,MARGIN STATUS FOR NON-INVASIVE TUMOR
2793,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
2794,gpt4,0.654,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2795,gpt4,0.785,TUMOR SITE
2796,gpt4,0.664,TUMOR FOCALITY
2797,gpt4,0.752,ADDITIONAL FINDINGS
2798,gpt4,0.756,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2799,gpt4,0.733,MARGIN STATUS FOR INVASIVE CARCINOMA
2800,gpt4,0.749,REGIONAL LYMPH NODE STATUS
2801,gpt4,0.756,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2802,gpt4,0.661,HISTOLOGIC GRADE
2803,gpt4,0.656,PROCEDURE
2804,gpt4,0.8,NUMBER OF LYMPH NODES EXAMINED
2805,gpt4,0.734,REGIONAL LYMPH NODE STATUS
2806,gpt4,0.71,TUMOR SITE
2807,gpt4,0.678,HISTOLOGIC GRADE
2808,gpt4,0.662,PROCEDURE
2809,gpt4,0.685,LYMPH NODE(S) FROM PRIOR PROCEDURES
2810,gpt4,0.772,MARGIN STATUS FOR NON-INVASIVE TUMOR
2811,gpt4,0.893,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2812,gpt4,0.667,ADDITIONAL FINDINGS
2813,gpt4,0.712,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2814,gpt4,0.698,SPECIMEN LATERALITY
2815,gpt4,0.659,SPREAD THROUGH AIR SPACES (STAS)
2816,gpt4,0.669,VISCERAL PLEURA INVASION
2817,gpt4,0.702,MARGIN STATUS FOR INVASIVE CARCINOMA
2818,gpt4,0.657,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2819,gpt4,0.649,TUMOR FOCALITY
2820,gpt4,0.656,NODAL SITE(S) EXAMINED
2821,gpt4,0.686,MARGIN STATUS FOR INVASIVE CARCINOMA
2822,gpt4,0.732,TUMOR SITE
2823,gpt4,0.671,HISTOLOGIC GRADE
2824,gpt4,0.631,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2825,gpt4,0.732,VISCERAL PLEURA INVASION
2826,gpt4,0.669,TUMOR FOCALITY
2827,gpt4,0.74,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2828,gpt4,0.776,NUMBER OF LYMPH NODES EXAMINED
2829,gpt4,0.809,SPECIMEN LATERALITY
2830,gpt4,0.65,PROCEDURE
2831,gpt4,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2832,gpt4,0.674,ADDITIONAL FINDINGS
2833,gpt4,0.64,NODAL SITE(S) EXAMINED
2834,gpt4,0.735,REGIONAL LYMPH NODE STATUS
2835,gpt4,0.684,MARGIN STATUS FOR NON-INVASIVE TUMOR
2836,gpt4,0.655,LYMPHOVASCULAR INVASION
2837,gpt4,0.668,VISCERAL PLEURA INVASION
2838,gpt4,0.666,PROCEDURE
2839,gpt4,0.656,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2840,gpt4,0.655,TUMOR FOCALITY
2841,gpt4,0.704,SPECIMEN LATERALITY
2842,gpt4,0.696,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2843,gpt4,0.722,REGIONAL LYMPH NODE STATUS
2844,gpt4,0.718,TUMOR SITE
2845,gpt4,0.772,MARGIN STATUS FOR NON-INVASIVE TUMOR
2846,gpt4,0.693,NUMBER OF LYMPH NODES EXAMINED
2847,gpt4,0.726,MARGIN STATUS FOR INVASIVE CARCINOMA
2848,gpt4,0.661,NODAL SITE(S) EXAMINED
2849,gpt4,0.702,HISTOLOGIC GRADE
2850,gpt4,0.665,LYMPH NODE(S) FROM PRIOR PROCEDURES
2851,gpt4,0.797,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2852,gpt4,0.698,ADDITIONAL FINDINGS
2853,gpt4,0.773,SPECIMEN LATERALITY
2854,gpt4,0.738,MARGIN STATUS FOR INVASIVE CARCINOMA
2855,gpt4,0.841,MARGIN STATUS FOR NON-INVASIVE TUMOR
2856,gpt4,0.644,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2857,gpt4,0.723,REGIONAL LYMPH NODE STATUS
2858,gpt4,0.684,VISCERAL PLEURA INVASION
2859,gpt4,0.663,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2860,gpt4,0.733,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2861,gpt4,0.678,LYMPHOVASCULAR INVASION
2862,gpt4,0.706,PROCEDURE
2863,gpt4,0.651,NODAL SITE(S) EXAMINED
2864,gpt4,0.785,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2865,gpt4,0.665,HISTOLOGIC GRADE
2866,gpt4,0.667,TUMOR FOCALITY
2867,gpt4,0.713,TUMOR SITE
2868,gpt4,0.71,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2869,gpt4,0.699,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2870,gpt4,0.677,TUMOR SITE
2871,gpt4,0.757,REGIONAL LYMPH NODE STATUS
2872,gpt4,0.678,SPREAD THROUGH AIR SPACES (STAS)
2873,gpt4,0.731,VISCERAL PLEURA INVASION
2874,gpt4,0.652,HISTOLOGIC GRADE
2875,gpt4,0.713,MARGIN STATUS FOR INVASIVE CARCINOMA
2876,gpt4,0.701,MARGIN STATUS FOR NON-INVASIVE TUMOR
2877,gpt4,0.695,SPECIMEN LATERALITY
2878,gpt4,0.68,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2879,gpt4,0.674,TUMOR FOCALITY
2880,gpt4,0.656,NODAL SITE(S) EXAMINED
2881,gpt4,0.702,ADDITIONAL FINDINGS
2882,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
2883,gpt4,0.665,PROCEDURE
2884,gpt4,0.691,REGIONAL LYMPH NODE STATUS
2885,gpt4,0.653,LYMPHOVASCULAR INVASION
2886,gpt4,0.677,TUMOR FOCALITY
2887,gpt4,0.668,LYMPH NODE(S) FROM PRIOR PROCEDURES
2888,gpt4,0.666,NODAL SITE(S) EXAMINED
2889,gpt4,0.726,TUMOR SITE
2890,gpt4,0.658,NODAL SITE(S) WITH TUMOR
2891,gpt4,0.648,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2892,gpt4,0.687,MARGIN STATUS FOR INVASIVE CARCINOMA
2893,gpt4,0.646,VISCERAL PLEURA INVASION
2894,gpt4,0.675,HISTOLOGIC GRADE
2895,gpt4,0.829,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2896,gpt4,0.715,SPECIMEN LATERALITY
2897,gpt4,0.764,NUMBER OF LYMPH NODES EXAMINED
2898,gpt4,0.72,NUMBER OF LYMPH NODES WITH TUMOR
2899,gpt4,0.689,MARGIN STATUS FOR NON-INVASIVE TUMOR
2900,gpt4,0.677,PROCEDURE
2901,gpt4,0.837,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2902,gpt4,0.893,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2903,gpt4,0.716,TUMOR SITE
2904,gpt4,0.697,SPECIMEN LATERALITY
2905,gpt4,0.669,HISTOLOGIC GRADE
2906,gpt4,0.918,MARGIN STATUS FOR NON-INVASIVE TUMOR
2907,gpt4,0.669,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2908,gpt4,0.661,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2909,gpt4,0.641,PROCEDURE
2910,gpt4,0.719,VISCERAL PLEURA INVASION
2911,gpt4,0.671,ADDITIONAL FINDINGS
2912,gpt4,0.646,TUMOR FOCALITY
2913,gpt4,0.732,REGIONAL LYMPH NODE STATUS
2914,gpt4,0.691,LYMPH NODE(S) FROM PRIOR PROCEDURES
2915,gpt4,0.707,MARGIN STATUS FOR INVASIVE CARCINOMA
2916,gpt4,0.656,NODAL SITE(S) EXAMINED
2917,gpt4,0.698,SPECIMEN LATERALITY
2918,gpt4,0.693,PROCEDURE
2919,gpt4,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2920,gpt4,0.669,TUMOR FOCALITY
2921,gpt4,0.671,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2922,gpt4,0.668,LYMPH NODE(S) FROM PRIOR PROCEDURES
2923,gpt4,0.649,MARGIN STATUS FOR NON-INVASIVE TUMOR
2924,gpt4,0.74,NUMBER OF LYMPH NODES EXAMINED
2925,gpt4,0.679,VISCERAL PLEURA INVASION
2926,gpt4,0.728,REGIONAL LYMPH NODE STATUS
2927,gpt4,0.643,TUMOR SITE
2928,gpt4,0.659,NODAL SITE(S) EXAMINED
2929,gpt4,0.703,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2930,gpt4,0.699,MARGIN STATUS FOR INVASIVE CARCINOMA
2931,gpt4,0.753,REGIONAL LYMPH NODE STATUS
2932,gpt4,0.679,MARGIN STATUS FOR INVASIVE CARCINOMA
2933,gpt4,0.723,TUMOR SITE
2934,gpt4,0.648,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2935,gpt4,0.773,SPECIMEN LATERALITY
2936,gpt4,0.789,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2937,gpt4,0.768,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2938,gpt4,0.65,PROCEDURE
2939,gpt4,0.918,MARGIN STATUS FOR NON-INVASIVE TUMOR
2940,gpt4,0.652,NODAL SITE(S) EXAMINED
2941,gpt4,0.66,TUMOR FOCALITY
2942,gpt4,0.665,VISCERAL PLEURA INVASION
2943,gpt4,0.672,SPREAD THROUGH AIR SPACES (STAS)
2944,gpt4,0.662,HISTOLOGIC GRADE
2945,gpt4,0.776,LYMPH NODE(S) FROM PRIOR PROCEDURES
2946,gpt4,0.658,HISTOLOGIC GRADE
2947,gpt4,0.684,MARGIN STATUS FOR NON-INVASIVE TUMOR
2948,gpt4,0.674,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2949,gpt4,0.654,VISCERAL PLEURA INVASION
2950,gpt4,0.653,TNM DESCRIPTORS
2951,gpt4,0.65,NODAL SITE(S) EXAMINED
2952,gpt4,0.662,SPREAD THROUGH AIR SPACES (STAS)
2953,gpt4,0.653,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2954,gpt4,0.809,SPECIMEN LATERALITY
2955,gpt4,0.725,TUMOR SITE
2956,gpt4,0.655,LYMPH NODE(S) FROM PRIOR PROCEDURES
2957,gpt4,0.759,MARGIN STATUS FOR INVASIVE CARCINOMA
2958,gpt4,0.722,NUMBER OF LYMPH NODES EXAMINED
2959,gpt4,0.722,REGIONAL LYMPH NODE STATUS
2960,gpt4,0.712,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2961,gpt4,0.658,TUMOR FOCALITY
2962,gpt4,0.704,SPECIMEN LATERALITY
2963,gpt4,0.661,SPREAD THROUGH AIR SPACES (STAS)
2964,gpt4,0.721,REGIONAL LYMPH NODE STATUS
2965,gpt4,0.743,TUMOR SITE
2966,gpt4,0.672,MARGIN STATUS FOR NON-INVASIVE TUMOR
2967,gpt4,0.719,MARGIN STATUS FOR INVASIVE CARCINOMA
2968,gpt4,0.654,TUMOR FOCALITY
2969,gpt4,0.673,VISCERAL PLEURA INVASION
2970,gpt4,0.801,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2971,gpt4,0.662,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2972,gpt4,0.652,NODAL SITE(S) EXAMINED
2973,gpt4,0.776,LYMPH NODE(S) FROM PRIOR PROCEDURES
2974,gpt4,0.645,PROCEDURE
2975,gpt4,0.671,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2976,gpt4,0.655,TUMOR FOCALITY
2977,gpt4,0.783,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
2978,gpt4,0.682,NODAL SITE(S) EXAMINED
2979,gpt4,0.68,SPREAD THROUGH AIR SPACES (STAS)
2980,gpt4,0.724,ADDITIONAL FINDINGS
2981,gpt4,0.714,SPECIMEN LATERALITY
2982,gpt4,0.743,NUMBER OF LYMPH NODES EXAMINED
2983,gpt4,0.725,PROCEDURE
2984,gpt4,0.758,MARGIN STATUS FOR INVASIVE CARCINOMA
2985,gpt4,0.77,MARGIN STATUS FOR NON-INVASIVE TUMOR
2986,gpt4,0.701,REGIONAL LYMPH NODE STATUS
2987,gpt4,0.679,HISTOLOGIC GRADE
2988,gpt4,0.742,VISCERAL PLEURA INVASION
2989,gpt4,0.649,NODAL SITE(S) WITH TUMOR
2990,gpt4,0.719,TUMOR SITE
2991,gpt4,0.826,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
2992,gpt4,0.67,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
2993,gpt4,0.658,LYMPHOVASCULAR INVASION
2994,gpt4,0.695,LYMPH NODE(S) FROM PRIOR PROCEDURES
2995,gpt4,0.662,NODAL SITE(S) EXAMINED
2996,gpt4,0.66,ADDITIONAL FINDINGS
2997,gpt4,0.728,TUMOR SITE
2998,gpt4,0.82,NUMBER OF LYMPH NODES WITH TUMOR
2999,gpt4,0.677,LYMPH NODE(S) FROM PRIOR PROCEDURES
3000,gpt4,0.672,SPREAD THROUGH AIR SPACES (STAS)
3001,gpt4,0.673,NODAL SITE(S) WITH TUMOR
3002,gpt4,0.689,REGIONAL LYMPH NODE STATUS
3003,gpt4,0.705,SPECIMEN LATERALITY
3004,gpt4,0.661,VISCERAL PLEURA INVASION
3005,gpt4,0.65,HISTOLOGIC GRADE
3006,gpt4,0.688,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3007,gpt4,0.708,MARGIN STATUS FOR NON-INVASIVE TUMOR
3008,gpt4,0.82,NUMBER OF LYMPH NODES EXAMINED
3009,gpt4,0.675,PROCEDURE
3010,gpt4,0.676,TUMOR FOCALITY
3011,gpt4,0.661,LYMPHOVASCULAR INVASION
3012,gpt4,0.714,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3013,gpt4,0.72,NUMBER OF LYMPH NODES EXAMINED
3014,gpt4,0.664,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3015,gpt4,0.717,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3016,gpt4,0.712,SPECIMEN LATERALITY
3017,gpt4,0.648,VISCERAL PLEURA INVASION
3018,gpt4,0.63,TUMOR SITE
3019,gpt4,0.675,HISTOLOGIC GRADE
3020,gpt4,0.645,PROCEDURE
3021,gpt4,0.721,LYMPH NODE(S) FROM PRIOR PROCEDURES
3022,gpt4,0.683,MARGIN STATUS FOR INVASIVE CARCINOMA
3023,gpt4,0.651,TUMOR FOCALITY
3024,gpt4,0.717,REGIONAL LYMPH NODE STATUS
3025,gpt4,0.649,LYMPHOVASCULAR INVASION
3026,gpt4,0.672,SPREAD THROUGH AIR SPACES (STAS)
3027,gpt4,0.693,MARGIN STATUS FOR NON-INVASIVE TUMOR
3028,gpt4,0.667,NODAL SITE(S) EXAMINED
3029,gpt4,0.678,NODAL SITE(S) EXAMINED
3030,gpt4,0.785,TUMOR SITE
3031,gpt4,0.733,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3032,gpt4,0.684,MARGIN STATUS FOR INVASIVE CARCINOMA
3033,gpt4,0.717,REGIONAL LYMPH NODE STATUS
3034,gpt4,0.656,SPREAD THROUGH AIR SPACES (STAS)
3035,gpt4,0.727,MARGIN STATUS FOR NON-INVASIVE TUMOR
3036,gpt4,0.648,PROCEDURE
3037,gpt4,0.664,SPECIMEN LATERALITY
3038,gpt4,0.665,LYMPH NODE(S) FROM PRIOR PROCEDURES
3039,gpt4,0.688,ADDITIONAL FINDINGS
3040,gpt4,0.637,HISTOLOGIC GRADE
3041,gpt4,0.802,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3042,gpt4,0.688,TUMOR FOCALITY
3043,gpt4,0.646,VISCERAL PLEURA INVASION
3044,gpt4,0.648,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3045,gpt4,0.688,HISTOLOGIC GRADE
3046,gpt4,0.686,SPREAD THROUGH AIR SPACES (STAS)
3047,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
3048,gpt4,0.649,PROCEDURE
3049,gpt4,0.722,TUMOR SITE
3050,gpt4,0.83,NUMBER OF LYMPH NODES EXAMINED
3051,gpt4,0.638,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3052,gpt4,0.686,VISCERAL PLEURA INVASION
3053,gpt4,0.755,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3054,gpt4,0.679,TUMOR FOCALITY
3055,gpt4,0.738,REGIONAL LYMPH NODE STATUS
3056,gpt4,0.759,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3057,gpt4,0.618,MARGIN STATUS FOR NON-INVASIVE TUMOR
3058,gpt4,0.773,SPECIMEN LATERALITY
3059,gpt4,0.703,MARGIN STATUS FOR INVASIVE CARCINOMA
3060,gpt4,0.662,NODAL SITE(S) EXAMINED
3061,gpt4,0.636,LYMPH NODE(S) FROM PRIOR PROCEDURES
3062,gpt4,0.662,HISTOLOGIC GRADE
3063,gpt4,0.659,LYMPHOVASCULAR INVASION
3064,gpt4,0.699,TUMOR SITE
3065,gpt4,0.658,NODAL SITE(S) EXAMINED
3066,gpt4,0.771,MARGIN STATUS FOR NON-INVASIVE TUMOR
3067,gpt4,0.706,SPECIMEN LATERALITY
3068,gpt4,0.666,VISCERAL PLEURA INVASION
3069,gpt4,0.737,REGIONAL LYMPH NODE STATUS
3070,gpt4,0.772,MARGIN STATUS FOR INVASIVE CARCINOMA
3071,gpt4,0.657,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3072,gpt4,0.682,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3073,gpt4,0.649,PROCEDURE
3074,gpt4,0.713,TUMOR FOCALITY
3075,gpt4,0.712,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3076,gpt4,0.699,MARGIN STATUS FOR INVASIVE CARCINOMA
3077,gpt4,0.717,TUMOR SITE
3078,gpt4,0.706,PROCEDURE
3079,gpt4,0.672,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3080,gpt4,0.678,NODAL SITE(S) EXAMINED
3081,gpt4,0.732,REGIONAL LYMPH NODE STATUS
3082,gpt4,0.712,HISTOLOGIC GRADE
3083,gpt4,0.695,NUMBER OF LYMPH NODES EXAMINED
3084,gpt4,0.658,TUMOR FOCALITY
3085,gpt4,0.899,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3086,gpt4,0.705,MARGIN STATUS FOR NON-INVASIVE TUMOR
3087,gpt4,0.697,SPECIMEN LATERALITY
3088,gpt4,0.696,VISCERAL PLEURA INVASION
3089,gpt4,0.683,SPREAD THROUGH AIR SPACES (STAS)
3090,gpt4,0.703,MARGIN STATUS FOR INVASIVE CARCINOMA
3091,gpt4,0.694,REGIONAL LYMPH NODE STATUS
3092,gpt4,0.712,TUMOR SITE
3093,gpt4,0.658,HISTOLOGIC GRADE
3094,gpt4,0.7,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3095,gpt4,0.663,TUMOR FOCALITY
3096,gpt4,0.809,SPECIMEN LATERALITY
3097,gpt4,0.642,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3098,gpt4,0.627,PROCEDURE
3099,gpt4,0.718,NUMBER OF LYMPH NODES EXAMINED
3100,gpt4,0.656,LYMPH NODE(S) FROM PRIOR PROCEDURES
3101,gpt4,0.7,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3102,gpt4,0.725,NUMBER OF LYMPH NODES WITH TUMOR
3103,gpt4,0.646,NODAL SITE(S) EXAMINED
3104,gpt4,0.729,VISCERAL PLEURA INVASION
3105,gpt4,0.632,NODAL SITE(S) WITH TUMOR
3106,gpt4,0.674,MARGIN STATUS FOR NON-INVASIVE TUMOR
3107,gpt4,0.648,ADDITIONAL FINDINGS
3108,gpt4,0.705,MARGIN STATUS FOR INVASIVE CARCINOMA
3109,gpt4,0.653,SPREAD THROUGH AIR SPACES (STAS)
3110,gpt4,0.727,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3111,gpt4,0.896,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3112,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
3113,gpt4,0.72,TUMOR SITE
3114,gpt4,0.666,HISTOLOGIC GRADE
3115,gpt4,0.66,NODAL SITE(S) WITH TUMOR
3116,gpt4,0.637,TUMOR FOCALITY
3117,gpt4,0.672,NODAL SITE(S) EXAMINED
3118,gpt4,0.645,MARGIN STATUS FOR NON-INVASIVE TUMOR
3119,gpt4,0.683,REGIONAL LYMPH NODE STATUS
3120,gpt4,0.654,VISCERAL PLEURA INVASION
3121,gpt4,0.641,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3122,gpt4,0.652,PROCEDURE
3123,gpt4,0.72,NUMBER OF LYMPH NODES WITH TUMOR
3124,gpt4,0.736,SPECIMEN LATERALITY
3125,gpt4,0.765,PROCEDURE
3126,gpt4,0.689,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3127,gpt4,0.738,MARGIN STATUS FOR NON-INVASIVE TUMOR
3128,gpt4,0.656,SPECIMEN LATERALITY
3129,gpt4,0.817,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3130,gpt4,0.684,NODAL SITE(S) EXAMINED
3131,gpt4,0.664,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3132,gpt4,0.693,MARGIN STATUS FOR INVASIVE CARCINOMA
3133,gpt4,0.664,TUMOR FOCALITY
3134,gpt4,0.727,TUMOR SITE
3135,gpt4,0.668,HISTOLOGIC GRADE
3136,gpt4,0.67,NUMBER OF LYMPH NODES EXAMINED
3137,gpt4,0.742,REGIONAL LYMPH NODE STATUS
3138,gpt4,0.707,VISCERAL PLEURA INVASION
3139,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
3140,gpt4,0.776,LYMPH NODE(S) FROM PRIOR PROCEDURES
3141,gpt4,0.682,REGIONAL LYMPH NODE STATUS
3142,gpt4,0.655,NODAL SITE(S) EXAMINED
3143,gpt4,0.656,PROCEDURE
3144,gpt4,0.703,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3145,gpt4,0.642,VISCERAL PLEURA INVASION
3146,gpt4,0.685,NUMBER OF LYMPH NODES WITH TUMOR
3147,gpt4,0.719,HISTOLOGIC GRADE
3148,gpt4,0.742,MARGIN STATUS FOR NON-INVASIVE TUMOR
3149,gpt4,0.729,TUMOR SITE
3150,gpt4,0.692,SPECIMEN LATERALITY
3151,gpt4,0.661,NODAL SITE(S) WITH TUMOR
3152,gpt4,0.702,MARGIN STATUS FOR INVASIVE CARCINOMA
3153,gpt4,0.82,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3154,gpt4,0.817,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3155,gpt4,0.673,SPREAD THROUGH AIR SPACES (STAS)
3156,gpt4,0.667,TUMOR FOCALITY
3157,gpt4,0.665,PROCEDURE
3158,gpt4,0.811,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3159,gpt4,0.651,TUMOR FOCALITY
3160,gpt4,0.731,MARGIN STATUS FOR NON-INVASIVE TUMOR
3161,gpt4,0.807,NUMBER OF LYMPH NODES EXAMINED
3162,gpt4,0.694,SPREAD THROUGH AIR SPACES (STAS)
3163,gpt4,0.707,TUMOR SITE
3164,gpt4,0.69,REGIONAL LYMPH NODE STATUS
3165,gpt4,0.658,NODAL SITE(S) WITH TUMOR
3166,gpt4,0.776,LYMPH NODE(S) FROM PRIOR PROCEDURES
3167,gpt4,0.632,LYMPHOVASCULAR INVASION
3168,gpt4,0.72,NUMBER OF LYMPH NODES WITH TUMOR
3169,gpt4,0.678,HISTOLOGIC GRADE
3170,gpt4,0.645,MARGIN STATUS FOR INVASIVE CARCINOMA
3171,gpt4,0.681,VISCERAL PLEURA INVASION
3172,gpt4,0.644,NODAL SITE(S) EXAMINED
3173,gpt4,0.809,SPECIMEN LATERALITY
3174,gpt4,0.729,MARGIN STATUS FOR INVASIVE CARCINOMA
3175,gpt4,0.66,TUMOR FOCALITY
3176,gpt4,0.681,PROCEDURE
3177,gpt4,0.774,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3178,gpt4,0.635,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3179,gpt4,0.651,VISCERAL PLEURA INVASION
3180,gpt4,0.649,NODAL SITE(S) EXAMINED
3181,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
3182,gpt4,0.687,SPREAD THROUGH AIR SPACES (STAS)
3183,gpt4,0.841,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3184,gpt4,0.721,REGIONAL LYMPH NODE STATUS
3185,gpt4,0.706,TUMOR SITE
3186,gpt4,0.705,SPECIMEN LATERALITY
3187,gpt4,0.676,HISTOLOGIC GRADE
3188,gpt4,0.807,NUMBER OF LYMPH NODES EXAMINED
3189,gpt4,0.726,MARGIN STATUS FOR NON-INVASIVE TUMOR
3190,gpt4,0.903,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3191,gpt4,0.687,SPREAD THROUGH AIR SPACES (STAS)
3192,gpt4,0.81,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3193,gpt4,0.717,MARGIN STATUS FOR INVASIVE CARCINOMA
3194,gpt4,0.681,PROCEDURE
3195,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
3196,gpt4,0.649,TUMOR FOCALITY
3197,gpt4,0.65,NODAL SITE(S) EXAMINED
3198,gpt4,0.703,HISTOLOGIC GRADE
3199,gpt4,0.707,MARGIN STATUS FOR NON-INVASIVE TUMOR
3200,gpt4,0.82,NUMBER OF LYMPH NODES EXAMINED
3201,gpt4,0.735,REGIONAL LYMPH NODE STATUS
3202,gpt4,0.722,TUMOR SITE
3203,gpt4,0.681,VISCERAL PLEURA INVASION
3204,gpt4,0.646,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3205,gpt4,0.809,SPECIMEN LATERALITY
3206,gpt4,0.855,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3207,gpt4,0.693,MARGIN STATUS FOR NON-INVASIVE TUMOR
3208,gpt4,0.776,LYMPH NODE(S) FROM PRIOR PROCEDURES
3209,gpt4,0.732,VISCERAL PLEURA INVASION
3210,gpt4,0.724,REGIONAL LYMPH NODE STATUS
3211,gpt4,0.655,NODAL SITE(S) EXAMINED
3212,gpt4,0.673,MARGIN STATUS FOR INVASIVE CARCINOMA
3213,gpt4,0.662,HISTOLOGIC GRADE
3214,gpt4,0.649,TUMOR FOCALITY
3215,gpt4,0.703,ADDITIONAL FINDINGS
3216,gpt4,0.671,PROCEDURE
3217,gpt4,0.643,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3218,gpt4,0.704,SPECIMEN LATERALITY
3219,gpt4,0.777,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3220,gpt4,0.686,NUMBER OF LYMPH NODES EXAMINED
3221,gpt4,0.727,TUMOR SITE
3222,gpt4,0.718,MARGIN STATUS FOR INVASIVE CARCINOMA
3223,gpt4,0.678,TNM DESCRIPTORS
3224,gpt4,0.73,HISTOLOGIC GRADE
3225,gpt4,0.726,MARGIN STATUS FOR NON-INVASIVE TUMOR
3226,gpt4,0.717,ADDITIONAL FINDINGS
3227,gpt4,0.646,TUMOR FOCALITY
3228,gpt4,0.716,LYMPH NODE(S) FROM PRIOR PROCEDURES
3229,gpt4,0.66,SPREAD THROUGH AIR SPACES (STAS)
3230,gpt4,0.762,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3231,gpt4,0.709,TUMOR SITE
3232,gpt4,0.716,REGIONAL LYMPH NODE STATUS
3233,gpt4,0.657,PROCEDURE
3234,gpt4,0.792,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3235,gpt4,0.809,SPECIMEN LATERALITY
3236,gpt4,0.642,NODAL SITE(S) EXAMINED
3237,gpt4,0.626,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3238,gpt4,0.634,NUMBER OF LYMPH NODES EXAMINED
3239,gpt4,0.681,VISCERAL PLEURA INVASION
3240,gpt4,0.776,LYMPH NODE(S) FROM PRIOR PROCEDURES
3241,gpt4,0.772,MARGIN STATUS FOR NON-INVASIVE TUMOR
3242,gpt4,0.723,REGIONAL LYMPH NODE STATUS
3243,gpt4,0.759,NUMBER OF LYMPH NODES EXAMINED
3244,gpt4,0.704,SPECIMEN LATERALITY
3245,gpt4,0.643,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3246,gpt4,0.835,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3247,gpt4,0.689,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3248,gpt4,0.673,ADDITIONAL FINDINGS
3249,gpt4,0.659,NODAL SITE(S) EXAMINED
3250,gpt4,0.658,PROCEDURE
3251,gpt4,0.781,MARGIN STATUS FOR INVASIVE CARCINOMA
3252,gpt4,0.647,SPREAD THROUGH AIR SPACES (STAS)
3253,gpt4,0.661,TUMOR FOCALITY
3254,gpt4,0.706,TUMOR SITE
3255,gpt4,0.687,VISCERAL PLEURA INVASION
3256,gpt4,0.723,HISTOLOGIC GRADE
3257,gpt4,0.674,SPREAD THROUGH AIR SPACES (STAS)
3258,gpt4,0.683,ADDITIONAL FINDINGS
3259,gpt4,0.657,TUMOR FOCALITY
3260,gpt4,0.746,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3261,gpt4,0.675,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3262,gpt4,0.729,NUMBER OF LYMPH NODES EXAMINED
3263,gpt4,0.747,MARGIN STATUS FOR NON-INVASIVE TUMOR
3264,gpt4,0.645,NODAL SITE(S) EXAMINED
3265,gpt4,0.74,SPECIMEN LATERALITY
3266,gpt4,0.731,MARGIN STATUS FOR INVASIVE CARCINOMA
3267,gpt4,0.722,TUMOR SITE
3268,gpt4,0.668,TNM DESCRIPTORS
3269,gpt4,0.673,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3270,gpt4,0.663,VISCERAL PLEURA INVASION
3271,gpt4,0.689,REGIONAL LYMPH NODE STATUS
3272,gpt4,0.636,PROCEDURE
3273,gpt4,0.697,NUMBER OF LYMPH NODES EXAMINED
3274,gpt4,0.691,REGIONAL LYMPH NODE STATUS
3275,gpt4,0.668,ADDITIONAL FINDINGS
3276,gpt4,0.66,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3277,gpt4,0.82,NUMBER OF LYMPH NODES WITH TUMOR
3278,gpt4,0.808,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3279,gpt4,0.646,PROCEDURE
3280,gpt4,0.643,NODAL SITE(S) EXAMINED
3281,gpt4,0.691,TUMOR FOCALITY
3282,gpt4,0.707,MARGIN STATUS FOR INVASIVE CARCINOMA
3283,gpt4,0.691,LYMPH NODE(S) FROM PRIOR PROCEDURES
3284,gpt4,0.657,VISCERAL PLEURA INVASION
3285,gpt4,0.722,TUMOR SITE
3286,gpt4,0.68,NODAL SITE(S) WITH TUMOR
3287,gpt4,0.687,MARGIN STATUS FOR NON-INVASIVE TUMOR
3288,gpt4,0.697,SPECIMEN LATERALITY
3289,gpt4,0.658,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3290,gpt4,0.705,ADDITIONAL FINDINGS
3291,gpt4,0.776,LYMPH NODE(S) FROM PRIOR PROCEDURES
3292,gpt4,0.721,TUMOR SITE
3293,gpt4,0.631,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3294,gpt4,0.678,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3295,gpt4,0.7,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3296,gpt4,0.73,REGIONAL LYMPH NODE STATUS
3297,gpt4,0.649,PROCEDURE
3298,gpt4,0.731,MARGIN STATUS FOR INVASIVE CARCINOMA
3299,gpt4,0.635,NODAL SITE(S) EXAMINED
3300,gpt4,0.641,TUMOR FOCALITY
3301,gpt4,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
3302,gpt4,0.691,VISCERAL PLEURA INVASION
3303,gpt4,0.693,TNM DESCRIPTORS
3304,gpt4,0.691,SPECIMEN LATERALITY
3305,gpt4,0.799,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3306,gpt4,0.809,SPECIMEN LATERALITY
3307,gpt4,0.646,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3308,gpt4,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3309,gpt4,0.654,PROCEDURE
3310,gpt4,0.668,TUMOR FOCALITY
3311,gpt4,0.776,LYMPH NODE(S) FROM PRIOR PROCEDURES
3312,gpt4,0.628,NODAL SITE(S) EXAMINED
3313,gpt4,0.768,MARGIN STATUS FOR INVASIVE CARCINOMA
3314,gpt4,0.841,MARGIN STATUS FOR NON-INVASIVE TUMOR
3315,gpt4,0.713,TUMOR SITE
3316,gpt4,0.739,VISCERAL PLEURA INVASION
3317,gpt4,0.729,REGIONAL LYMPH NODE STATUS
3318,gpt4,0.648,PROCEDURE
3319,gpt4,0.679,LYMPH NODE(S) FROM PRIOR PROCEDURES
3320,gpt4,0.642,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3321,gpt4,0.637,NODAL SITE(S) EXAMINED
3322,gpt4,0.794,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3323,gpt4,0.759,REGIONAL LYMPH NODE STATUS
3324,gpt4,0.697,SPECIMEN LATERALITY
3325,gpt4,0.691,SPREAD THROUGH AIR SPACES (STAS)
3326,gpt4,0.642,ADDITIONAL FINDINGS
3327,gpt4,0.791,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3328,gpt4,0.734,VISCERAL PLEURA INVASION
3329,gpt4,0.708,MARGIN STATUS FOR INVASIVE CARCINOMA
3330,gpt4,0.676,NUMBER OF LYMPH NODES EXAMINED
3331,gpt4,0.705,TUMOR SITE
3332,gpt4,0.649,TUMOR FOCALITY
3333,gpt4,0.743,MARGIN STATUS FOR NON-INVASIVE TUMOR
3334,gpt4,0.638,TUMOR FOCALITY
3335,gpt4,0.776,LYMPH NODE(S) FROM PRIOR PROCEDURES
3336,gpt4,0.823,NUMBER OF LYMPH NODES EXAMINED
3337,gpt4,0.684,HISTOLOGIC GRADE
3338,gpt4,0.671,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3339,gpt4,0.742,SPREAD THROUGH AIR SPACES (STAS)
3340,gpt4,0.668,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3341,gpt4,0.644,PROCEDURE
3342,gpt4,0.711,MARGIN STATUS FOR INVASIVE CARCINOMA
3343,gpt4,0.784,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3344,gpt4,0.809,SPECIMEN LATERALITY
3345,gpt4,0.748,REGIONAL LYMPH NODE STATUS
3346,gpt4,0.784,MARGIN STATUS FOR NON-INVASIVE TUMOR
3347,gpt4,0.673,TUMOR SITE
3348,gpt4,0.673,VISCERAL PLEURA INVASION
3349,gpt4,0.66,TNM DESCRIPTORS
3350,gpt4,0.682,NODAL SITE(S) EXAMINED
3351,gpt4,0.628,LYMPHOVASCULAR INVASION
3352,gpt4,0.612,NODAL SITE(S) WITH TUMOR
3353,gpt4,0.8,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3354,gpt4,0.689,SPREAD THROUGH AIR SPACES (STAS)
3355,gpt4,0.685,REGIONAL LYMPH NODE STATUS
3356,gpt4,0.82,NUMBER OF LYMPH NODES WITH TUMOR
3357,gpt4,0.782,TUMOR SITE
3358,gpt4,0.67,MARGIN STATUS FOR NON-INVASIVE TUMOR
3359,gpt4,0.648,MARGIN STATUS FOR INVASIVE CARCINOMA
3360,gpt4,0.711,HISTOLOGIC GRADE
3361,gpt4,0.694,PROCEDURE
3362,gpt4,0.67,VISCERAL PLEURA INVASION
3363,gpt4,0.776,LYMPH NODE(S) FROM PRIOR PROCEDURES
3364,gpt4,0.699,NODAL SITE(S) EXAMINED
3365,gpt4,0.681,SPECIMEN LATERALITY
3366,gpt4,0.638,TUMOR FOCALITY
3367,gpt4,0.642,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3368,gpt4,0.741,MARGIN STATUS FOR NON-INVASIVE TUMOR
3369,gpt4,0.697,MARGIN STATUS FOR INVASIVE CARCINOMA
3370,gpt4,0.645,TUMOR FOCALITY
3371,gpt4,0.716,ADDITIONAL FINDINGS
3372,gpt4,0.652,NODAL SITE(S) EXAMINED
3373,gpt4,0.825,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3374,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
3375,gpt4,0.73,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3376,gpt4,0.671,HISTOLOGIC GRADE
3377,gpt4,0.695,PROCEDURE
3378,gpt4,0.683,SPECIMEN LATERALITY
3379,gpt4,0.813,NUMBER OF LYMPH NODES EXAMINED
3380,gpt4,0.694,VISCERAL PLEURA INVASION
3381,gpt4,0.713,TUMOR SITE
3382,gpt4,0.732,REGIONAL LYMPH NODE STATUS
3383,gpt4,0.698,SPREAD THROUGH AIR SPACES (STAS)
3384,gpt4,0.825,NUMBER OF LYMPH NODES EXAMINED
3385,gpt4,0.666,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3386,gpt4,0.648,NODAL SITE(S) EXAMINED
3387,gpt4,0.874,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3388,gpt4,0.715,MARGIN STATUS FOR INVASIVE CARCINOMA
3389,gpt4,0.671,NODAL SITE(S) WITH TUMOR
3390,gpt4,0.843,MARGIN STATUS FOR NON-INVASIVE TUMOR
3391,gpt4,0.659,LYMPH NODE(S) FROM PRIOR PROCEDURES
3392,gpt4,0.703,VISCERAL PLEURA INVASION
3393,gpt4,0.793,TUMOR SITE
3394,gpt4,0.672,HISTOLOGIC GRADE
3395,gpt4,0.675,SPREAD THROUGH AIR SPACES (STAS)
3396,gpt4,0.713,NUMBER OF LYMPH NODES WITH TUMOR
3397,gpt4,0.694,REGIONAL LYMPH NODE STATUS
3398,gpt4,0.809,SPECIMEN LATERALITY
3399,gpt4,0.763,PROCEDURE
3400,gpt4,0.667,TUMOR FOCALITY
3401,gpt4,0.817,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3402,gpt4,0.661,PROCEDURE
3403,gpt4,0.744,SPREAD THROUGH AIR SPACES (STAS)
3404,gpt4,0.653,TUMOR FOCALITY
3405,gpt4,0.65,MARGIN STATUS FOR NON-INVASIVE TUMOR
3406,gpt4,0.695,LYMPH NODE(S) FROM PRIOR PROCEDURES
3407,gpt4,0.738,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3408,gpt4,0.633,NODAL SITE(S) WITH TUMOR
3409,gpt4,0.695,REGIONAL LYMPH NODE STATUS
3410,gpt4,0.729,VISCERAL PLEURA INVASION
3411,gpt4,0.649,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3412,gpt4,0.673,NODAL SITE(S) EXAMINED
3413,gpt4,0.67,TNM DESCRIPTORS
3414,gpt4,0.693,HISTOLOGIC GRADE
3415,gpt4,0.773,SPECIMEN LATERALITY
3416,gpt4,0.811,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3417,gpt4,0.705,TUMOR SITE
3418,gpt4,0.691,MARGIN STATUS FOR INVASIVE CARCINOMA
3419,gpt4,0.81,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3420,gpt4,0.649,NODAL SITE(S) EXAMINED
3421,gpt4,0.676,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3422,gpt4,0.644,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3423,gpt4,0.739,VISCERAL PLEURA INVASION
3424,gpt4,0.687,SPREAD THROUGH AIR SPACES (STAS)
3425,gpt4,0.736,REGIONAL LYMPH NODE STATUS
3426,gpt4,0.695,TUMOR SITE
3427,gpt4,0.736,SPECIMEN LATERALITY
3428,gpt4,0.806,MARGIN STATUS FOR NON-INVASIVE TUMOR
3429,gpt4,0.668,PROCEDURE
3430,gpt4,0.82,NUMBER OF LYMPH NODES EXAMINED
3431,gpt4,0.687,MARGIN STATUS FOR INVASIVE CARCINOMA
3432,gpt4,0.68,TUMOR FOCALITY
3433,gpt4,0.663,HISTOLOGIC GRADE
3434,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
3435,gpt4,0.704,TUMOR SITE
3436,gpt4,0.694,MARGIN STATUS FOR NON-INVASIVE TUMOR
3437,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
3438,gpt4,0.637,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3439,gpt4,0.698,SPECIMEN LATERALITY
3440,gpt4,0.714,MARGIN STATUS FOR INVASIVE CARCINOMA
3441,gpt4,0.661,TUMOR SITE
3442,gpt4,0.668,HISTOLOGIC GRADE
3443,gpt4,0.706,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3444,gpt4,0.63,NODAL SITE(S) EXAMINED
3445,gpt4,0.678,SPREAD THROUGH AIR SPACES (STAS)
3446,gpt4,0.795,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3447,gpt4,0.654,TUMOR FOCALITY
3448,gpt4,0.682,PROCEDURE
3449,gpt4,0.717,VISCERAL PLEURA INVASION
3450,gpt4,0.725,REGIONAL LYMPH NODE STATUS
3451,gpt4,0.725,TUMOR SITE
3452,gpt4,0.68,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3453,gpt4,0.764,MARGIN STATUS FOR INVASIVE CARCINOMA
3454,gpt4,0.661,PROCEDURE
3455,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
3456,gpt4,0.685,SPREAD THROUGH AIR SPACES (STAS)
3457,gpt4,0.678,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3458,gpt4,0.841,MARGIN STATUS FOR NON-INVASIVE TUMOR
3459,gpt4,0.744,REGIONAL LYMPH NODE STATUS
3460,gpt4,0.773,SPECIMEN LATERALITY
3461,gpt4,0.635,NODAL SITE(S) EXAMINED
3462,gpt4,0.661,VISCERAL PLEURA INVASION
3463,gpt4,0.671,HISTOLOGIC GRADE
3464,gpt4,0.674,TUMOR FOCALITY
3465,gpt4,0.848,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3466,gpt4,0.841,MARGIN STATUS FOR NON-INVASIVE TUMOR
3467,gpt4,0.657,NODAL SITE(S) EXAMINED
3468,gpt4,0.797,NUMBER OF LYMPH NODES EXAMINED
3469,gpt4,0.742,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3470,gpt4,0.694,TUMOR SITE
3471,gpt4,0.805,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3472,gpt4,0.665,TUMOR FOCALITY
3473,gpt4,0.699,LYMPH NODE(S) FROM PRIOR PROCEDURES
3474,gpt4,0.749,MARGIN STATUS FOR INVASIVE CARCINOMA
3475,gpt4,0.724,REGIONAL LYMPH NODE STATUS
3476,gpt4,0.707,PROCEDURE
3477,gpt4,0.673,SPREAD THROUGH AIR SPACES (STAS)
3478,gpt4,0.665,VISCERAL PLEURA INVASION
3479,gpt4,0.809,SPECIMEN LATERALITY
3480,gpt4,0.637,ADDITIONAL FINDINGS
3481,gpt4,0.668,HISTOLOGIC GRADE
3482,gpt4,0.724,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3483,gpt4,0.693,PROCEDURE
3484,gpt4,0.645,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3485,gpt4,0.751,MARGIN STATUS FOR INVASIVE CARCINOMA
3486,gpt4,0.62,NODAL SITE(S) EXAMINED
3487,gpt4,0.732,LYMPH NODE(S) FROM PRIOR PROCEDURES
3488,gpt4,0.723,TUMOR SITE
3489,gpt4,0.676,TUMOR FOCALITY
3490,gpt4,0.669,VISCERAL PLEURA INVASION
3491,gpt4,0.703,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3492,gpt4,0.745,REGIONAL LYMPH NODE STATUS
3493,gpt4,0.789,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3494,gpt4,0.651,HISTOLOGIC GRADE
3495,gpt4,0.698,SPECIMEN LATERALITY
3496,gpt4,0.841,MARGIN STATUS FOR NON-INVASIVE TUMOR
3497,gpt4,0.696,NUMBER OF LYMPH NODES EXAMINED
3498,gpt4,0.658,VISCERAL PLEURA INVASION
3499,gpt4,0.751,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3500,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
3501,gpt4,0.749,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3502,gpt4,0.641,TUMOR FOCALITY
3503,gpt4,0.787,MARGIN STATUS FOR INVASIVE CARCINOMA
3504,gpt4,0.656,PROCEDURE
3505,gpt4,0.841,MARGIN STATUS FOR NON-INVASIVE TUMOR
3506,gpt4,0.682,ADDITIONAL FINDINGS
3507,gpt4,0.669,SPREAD THROUGH AIR SPACES (STAS)
3508,gpt4,0.653,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3509,gpt4,0.711,REGIONAL LYMPH NODE STATUS
3510,gpt4,0.791,TUMOR SITE
3511,gpt4,0.695,SPECIMEN LATERALITY
3512,gpt4,0.658,HISTOLOGIC GRADE
3513,gpt4,0.665,NODAL SITE(S) EXAMINED
3514,gpt4,0.678,VISCERAL PLEURA INVASION
3515,gpt4,0.732,REGIONAL LYMPH NODE STATUS
3516,gpt4,0.681,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3517,gpt4,0.69,SPECIMEN LATERALITY
3518,gpt4,0.841,MARGIN STATUS FOR NON-INVASIVE TUMOR
3519,gpt4,0.674,LYMPH NODE(S) FROM PRIOR PROCEDURES
3520,gpt4,0.682,MARGIN STATUS FOR INVASIVE CARCINOMA
3521,gpt4,0.712,SPREAD THROUGH AIR SPACES (STAS)
3522,gpt4,0.677,PROCEDURE
3523,gpt4,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3524,gpt4,0.724,TUMOR SITE
3525,gpt4,0.648,NODAL SITE(S) EXAMINED
3526,gpt4,0.655,TUMOR FOCALITY
3527,gpt4,0.647,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3528,gpt4,0.701,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3529,gpt4,0.717,MARGIN STATUS FOR INVASIVE CARCINOMA
3530,gpt4,0.651,TUMOR FOCALITY
3531,gpt4,0.661,VISCERAL PLEURA INVASION
3532,gpt4,0.709,ADDITIONAL FINDINGS
3533,gpt4,0.656,SPECIMEN LATERALITY
3534,gpt4,0.674,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3535,gpt4,0.723,REGIONAL LYMPH NODE STATUS
3536,gpt4,0.665,HISTOLOGIC GRADE
3537,gpt4,0.709,LYMPH NODE(S) FROM PRIOR PROCEDURES
3538,gpt4,0.711,TUMOR SITE
3539,gpt4,0.723,MARGIN STATUS FOR NON-INVASIVE TUMOR
3540,gpt4,0.628,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3541,gpt4,0.805,NUMBER OF LYMPH NODES EXAMINED
3542,gpt4,0.686,SPREAD THROUGH AIR SPACES (STAS)
3543,gpt4,0.671,NODAL SITE(S) EXAMINED
3544,gpt4,0.678,PROCEDURE
3545,gpt4,0.905,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3546,gpt4,0.701,MARGIN STATUS FOR INVASIVE CARCINOMA
3547,gpt4,0.903,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3548,gpt4,0.704,SPECIMEN LATERALITY
3549,gpt4,0.666,VISCERAL PLEURA INVASION
3550,gpt4,0.68,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3551,gpt4,0.789,MARGIN STATUS FOR NON-INVASIVE TUMOR
3552,gpt4,0.662,SPREAD THROUGH AIR SPACES (STAS)
3553,gpt4,0.637,NODAL SITE(S) EXAMINED
3554,gpt4,0.663,TUMOR SITE
3555,gpt4,0.662,PROCEDURE
3556,gpt4,0.666,TUMOR FOCALITY
3557,gpt4,0.752,REGIONAL LYMPH NODE STATUS
3558,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
3559,gpt4,0.714,HISTOLOGIC GRADE
3560,gpt4,0.662,LYMPH NODE(S) FROM PRIOR PROCEDURES
3561,gpt4,0.765,NUMBER OF LYMPH NODES EXAMINED
3562,gpt4,0.671,SPREAD THROUGH AIR SPACES (STAS)
3563,gpt4,0.657,TUMOR FOCALITY
3564,gpt4,0.695,SPECIMEN LATERALITY
3565,gpt4,0.72,NUMBER OF LYMPH NODES WITH TUMOR
3566,gpt4,0.7,MARGIN STATUS FOR NON-INVASIVE TUMOR
3567,gpt4,0.643,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3568,gpt4,0.724,MARGIN STATUS FOR INVASIVE CARCINOMA
3569,gpt4,0.648,NODAL SITE(S) EXAMINED
3570,gpt4,0.72,TUMOR SITE
3571,gpt4,0.663,PROCEDURE
3572,gpt4,0.66,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3573,gpt4,0.752,NODAL SITE(S) WITH TUMOR
3574,gpt4,0.695,REGIONAL LYMPH NODE STATUS
3575,gpt4,0.913,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3576,gpt4,0.671,VISCERAL PLEURA INVASION
3577,gpt4,0.7,ADDITIONAL FINDINGS
3578,gpt4,0.692,MARGIN STATUS FOR INVASIVE CARCINOMA
3579,gpt4,0.798,NUMBER OF LYMPH NODES EXAMINED
3580,gpt4,0.653,LYMPH NODE(S) FROM PRIOR PROCEDURES
3581,gpt4,0.688,SPREAD THROUGH AIR SPACES (STAS)
3582,gpt4,0.733,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3583,gpt4,0.657,NODAL SITE(S) EXAMINED
3584,gpt4,0.702,SPECIMEN LATERALITY
3585,gpt4,0.68,PROCEDURE
3586,gpt4,0.654,TNM DESCRIPTORS
3587,gpt4,0.691,TUMOR SITE
3588,gpt4,0.685,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3589,gpt4,0.731,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3590,gpt4,0.798,MARGIN STATUS FOR NON-INVASIVE TUMOR
3591,gpt4,0.651,TUMOR FOCALITY
3592,gpt4,0.717,HISTOLOGIC GRADE
3593,gpt4,0.646,VISCERAL PLEURA INVASION
3594,gpt4,0.704,REGIONAL LYMPH NODE STATUS
3595,gpt4,0.703,NUMBER OF LYMPH NODES EXAMINED
3596,gpt4,0.817,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3597,gpt4,0.808,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3598,gpt4,0.718,MARGIN STATUS FOR INVASIVE CARCINOMA
3599,gpt4,0.684,PROCEDURE
3600,gpt4,0.742,REGIONAL LYMPH NODE STATUS
3601,gpt4,0.703,TUMOR SITE
3602,gpt4,0.659,VISCERAL PLEURA INVASION
3603,gpt4,0.726,MARGIN STATUS FOR NON-INVASIVE TUMOR
3604,gpt4,0.663,HISTOLOGIC GRADE
3605,gpt4,0.665,TUMOR FOCALITY
3606,gpt4,0.659,LYMPH NODE(S) FROM PRIOR PROCEDURES
3607,gpt4,0.668,NODAL SITE(S) EXAMINED
3608,gpt4,0.675,SPECIMEN LATERALITY
3609,gpt4,0.668,SPREAD THROUGH AIR SPACES (STAS)
3610,gpt4,0.695,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3611,gpt4,0.709,TUMOR SITE
3612,gpt4,0.847,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3613,gpt4,0.677,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3614,gpt4,0.687,NUMBER OF LYMPH NODES EXAMINED
3615,gpt4,0.707,SPECIMEN LATERALITY
3616,gpt4,0.688,SPREAD THROUGH AIR SPACES (STAS)
3617,gpt4,0.653,TUMOR FOCALITY
3618,gpt4,0.713,MARGIN STATUS FOR INVASIVE CARCINOMA
3619,gpt4,0.799,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3620,gpt4,0.701,LYMPH NODE(S) FROM PRIOR PROCEDURES
3621,gpt4,0.661,PROCEDURE
3622,gpt4,0.638,NODAL SITE(S) EXAMINED
3623,gpt4,0.718,MARGIN STATUS FOR NON-INVASIVE TUMOR
3624,gpt4,0.733,REGIONAL LYMPH NODE STATUS
3625,gpt4,0.669,VISCERAL PLEURA INVASION
3626,gpt4,0.686,HISTOLOGIC GRADE
3627,gpt4,0.794,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3628,gpt4,0.643,SPREAD THROUGH AIR SPACES (STAS)
3629,gpt4,0.665,TNM DESCRIPTORS
3630,gpt4,0.714,REGIONAL LYMPH NODE STATUS
3631,gpt4,0.635,VISCERAL PLEURA INVASION
3632,gpt4,0.685,HISTOLOGIC GRADE
3633,gpt4,0.731,NODAL SITE(S) EXAMINED
3634,gpt4,0.722,TUMOR SITE
3635,gpt4,0.723,NUMBER OF LYMPH NODES EXAMINED
3636,gpt4,0.664,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3637,gpt4,0.625,TUMOR FOCALITY
3638,gpt4,0.841,MARGIN STATUS FOR NON-INVASIVE TUMOR
3639,gpt4,0.679,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3640,gpt4,0.776,LYMPH NODE(S) FROM PRIOR PROCEDURES
3641,gpt4,0.773,SPECIMEN LATERALITY
3642,gpt4,0.708,MARGIN STATUS FOR INVASIVE CARCINOMA
3643,gpt4,0.669,PROCEDURE
3644,gpt4,0.722,REGIONAL LYMPH NODE STATUS
3645,gpt4,0.729,TUMOR SITE
3646,gpt4,0.811,MARGIN STATUS FOR NON-INVASIVE TUMOR
3647,gpt4,0.681,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3648,gpt4,0.71,TUMOR FOCALITY
3649,gpt4,0.631,ADDITIONAL FINDINGS
3650,gpt4,0.688,NODAL SITE(S) EXAMINED
3651,gpt4,0.707,MARGIN STATUS FOR INVASIVE CARCINOMA
3652,gpt4,0.776,LYMPH NODE(S) FROM PRIOR PROCEDURES
3653,gpt4,0.7,SPECIMEN LATERALITY
3654,gpt4,0.758,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3655,gpt4,0.628,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3656,gpt4,0.738,VISCERAL PLEURA INVASION
3657,gpt4,0.661,SPREAD THROUGH AIR SPACES (STAS)
3658,gpt4,0.683,PROCEDURE
3659,gpt4,0.728,VISCERAL PLEURA INVASION
3660,gpt4,0.663,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3661,gpt4,0.666,PROCEDURE
3662,gpt4,0.72,NUMBER OF LYMPH NODES WITH TUMOR
3663,gpt4,0.656,ADDITIONAL FINDINGS
3664,gpt4,0.671,TUMOR FOCALITY
3665,gpt4,0.846,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3666,gpt4,0.723,TUMOR SITE
3667,gpt4,0.725,MARGIN STATUS FOR NON-INVASIVE TUMOR
3668,gpt4,0.691,REGIONAL LYMPH NODE STATUS
3669,gpt4,0.628,NODAL SITE(S) EXAMINED
3670,gpt4,0.636,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3671,gpt4,0.631,NODAL SITE(S) WITH TUMOR
3672,gpt4,0.704,LYMPHOVASCULAR INVASION
3673,gpt4,0.679,LYMPH NODE(S) FROM PRIOR PROCEDURES
3674,gpt4,0.697,SPECIMEN LATERALITY
3675,gpt4,0.716,NUMBER OF LYMPH NODES EXAMINED
3676,gpt4,0.685,HISTOLOGIC GRADE
3677,gpt4,0.692,MARGIN STATUS FOR INVASIVE CARCINOMA
3678,gpt4,0.68,SPREAD THROUGH AIR SPACES (STAS)
3679,gpt4,0.633,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3680,gpt4,0.705,REGIONAL LYMPH NODE STATUS
3681,gpt4,0.645,PROCEDURE
3682,gpt4,0.773,SPECIMEN LATERALITY
3683,gpt4,0.718,MARGIN STATUS FOR NON-INVASIVE TUMOR
3684,gpt4,0.667,VISCERAL PLEURA INVASION
3685,gpt4,0.695,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3686,gpt4,0.663,NODAL SITE(S) EXAMINED
3687,gpt4,0.666,LYMPHOVASCULAR INVASION
3688,gpt4,0.684,MARGIN STATUS FOR INVASIVE CARCINOMA
3689,gpt4,0.658,TUMOR FOCALITY
3690,gpt4,0.657,NODAL SITE(S) WITH TUMOR
3691,gpt4,0.645,LYMPH NODE(S) FROM PRIOR PROCEDURES
3692,gpt4,0.714,TUMOR SITE
3693,gpt4,0.712,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3694,gpt4,0.682,SPREAD THROUGH AIR SPACES (STAS)
3695,gpt4,0.684,HISTOLOGIC GRADE
3696,gpt4,0.666,ADDITIONAL FINDINGS
3697,gpt4,0.692,MARGIN STATUS FOR INVASIVE CARCINOMA
3698,gpt4,0.664,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3699,gpt4,0.709,REGIONAL LYMPH NODE STATUS
3700,gpt4,0.723,TUMOR SITE
3701,gpt4,0.678,MARGIN STATUS FOR NON-INVASIVE TUMOR
3702,gpt4,0.659,HISTOLOGIC GRADE
3703,gpt4,0.676,SPECIMEN LATERALITY
3704,gpt4,0.649,LYMPHOVASCULAR INVASION
3705,gpt4,0.67,SPREAD THROUGH AIR SPACES (STAS)
3706,gpt4,0.693,TUMOR FOCALITY
3707,gpt4,0.67,NODAL SITE(S) EXAMINED
3708,gpt4,0.642,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3709,gpt4,0.666,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3710,gpt4,0.677,PROCEDURE
3711,gpt4,0.69,TNM DESCRIPTORS
3712,gpt4,0.661,VISCERAL PLEURA INVASION
3713,gpt4,0.782,NUMBER OF LYMPH NODES EXAMINED
3714,gpt4,0.7,MARGIN STATUS FOR NON-INVASIVE TUMOR
3715,gpt4,0.651,ADDITIONAL FINDINGS
3716,gpt4,0.703,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3717,gpt4,0.644,VISCERAL PLEURA INVASION
3718,gpt4,0.84,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3719,gpt4,0.698,SPECIMEN LATERALITY
3720,gpt4,0.72,TUMOR SITE
3721,gpt4,0.717,MARGIN STATUS FOR INVASIVE CARCINOMA
3722,gpt4,0.728,REGIONAL LYMPH NODE STATUS
3723,gpt4,0.637,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3724,gpt4,0.661,HISTOLOGIC GRADE
3725,gpt4,0.639,NODAL SITE(S) EXAMINED
3726,gpt4,0.656,TUMOR FOCALITY
3727,gpt4,0.668,PROCEDURE
3728,gpt4,0.68,SPREAD THROUGH AIR SPACES (STAS)
3729,gpt4,0.632,PROCEDURE
3730,gpt4,0.713,TUMOR SITE
3731,gpt4,0.687,MARGIN STATUS FOR NON-INVASIVE TUMOR
3732,gpt4,0.664,VISCERAL PLEURA INVASION
3733,gpt4,0.635,LYMPH NODE(S) FROM PRIOR PROCEDURES
3734,gpt4,0.649,NODAL SITE(S) EXAMINED
3735,gpt4,0.73,REGIONAL LYMPH NODE STATUS
3736,gpt4,0.893,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3737,gpt4,0.644,TUMOR FOCALITY
3738,gpt4,0.657,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3739,gpt4,0.673,HISTOLOGIC GRADE
3740,gpt4,0.674,SPREAD THROUGH AIR SPACES (STAS)
3741,gpt4,0.704,MARGIN STATUS FOR INVASIVE CARCINOMA
3742,gpt4,0.697,SPECIMEN LATERALITY
3743,gpt4,0.657,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3744,gpt4,0.641,ADDITIONAL FINDINGS
3745,gpt4,0.686,SPREAD THROUGH AIR SPACES (STAS)
3746,gpt4,0.663,NODAL SITE(S) EXAMINED
3747,gpt4,0.692,MARGIN STATUS FOR NON-INVASIVE TUMOR
3748,gpt4,0.811,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3749,gpt4,0.761,NUMBER OF LYMPH NODES EXAMINED
3750,gpt4,0.675,HISTOLOGIC GRADE
3751,gpt4,0.706,TUMOR SITE
3752,gpt4,0.689,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3753,gpt4,0.773,SPECIMEN LATERALITY
3754,gpt4,0.673,LYMPH NODE(S) FROM PRIOR PROCEDURES
3755,gpt4,0.756,MARGIN STATUS FOR INVASIVE CARCINOMA
3756,gpt4,0.671,PROCEDURE
3757,gpt4,0.734,VISCERAL PLEURA INVASION
3758,gpt4,0.664,TUMOR FOCALITY
3759,gpt4,0.722,REGIONAL LYMPH NODE STATUS
3760,gpt4,0.635,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3761,gpt4,0.633,LYMPH NODE(S) FROM PRIOR PROCEDURES
3762,gpt4,0.669,SPREAD THROUGH AIR SPACES (STAS)
3763,gpt4,0.677,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3764,gpt4,0.747,MARGIN STATUS FOR INVASIVE CARCINOMA
3765,gpt4,0.68,ADDITIONAL FINDINGS
3766,gpt4,0.828,NUMBER OF LYMPH NODES EXAMINED
3767,gpt4,0.668,VISCERAL PLEURA INVASION
3768,gpt4,0.65,TUMOR FOCALITY
3769,gpt4,0.861,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3770,gpt4,0.671,REGIONAL LYMPH NODE STATUS
3771,gpt4,0.678,MARGIN STATUS FOR NON-INVASIVE TUMOR
3772,gpt4,0.813,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3773,gpt4,0.626,NODAL SITE(S) EXAMINED
3774,gpt4,0.623,NODAL SITE(S) WITH TUMOR
3775,gpt4,0.809,SPECIMEN LATERALITY
3776,gpt4,0.82,NUMBER OF LYMPH NODES WITH TUMOR
3777,gpt4,0.792,TUMOR SITE
3778,gpt4,0.708,PROCEDURE
3779,gpt4,0.653,LYMPHOVASCULAR INVASION
3780,gpt4,0.661,HISTOLOGIC GRADE
3781,gpt4,0.658,SPREAD THROUGH AIR SPACES (STAS)
3782,gpt4,0.848,MARGIN STATUS FOR NON-INVASIVE TUMOR
3783,gpt4,0.78,NUMBER OF LYMPH NODES EXAMINED
3784,gpt4,0.656,NODAL SITE(S) EXAMINED
3785,gpt4,0.696,MARGIN STATUS FOR INVASIVE CARCINOMA
3786,gpt4,0.704,ADDITIONAL FINDINGS
3787,gpt4,0.651,VISCERAL PLEURA INVASION
3788,gpt4,0.678,LYMPH NODE(S) FROM PRIOR PROCEDURES
3789,gpt4,0.692,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3790,gpt4,0.678,PROCEDURE
3791,gpt4,0.734,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3792,gpt4,0.743,REGIONAL LYMPH NODE STATUS
3793,gpt4,0.706,SPECIMEN LATERALITY
3794,gpt4,0.705,TUMOR SITE
3795,gpt4,0.686,HISTOLOGIC GRADE
3796,gpt4,0.649,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3797,gpt4,0.705,TNM DESCRIPTORS
3798,gpt4,0.643,TUMOR FOCALITY
3799,gpt4,0.685,HISTOLOGIC GRADE
3800,gpt4,0.847,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3801,gpt4,0.697,SPECIMEN LATERALITY
3802,gpt4,0.838,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3803,gpt4,0.703,SPREAD THROUGH AIR SPACES (STAS)
3804,gpt4,0.748,REGIONAL LYMPH NODE STATUS
3805,gpt4,0.681,VISCERAL PLEURA INVASION
3806,gpt4,0.696,NODAL SITE(S) EXAMINED
3807,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
3808,gpt4,0.69,PROCEDURE
3809,gpt4,0.623,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3810,gpt4,0.712,TUMOR SITE
3811,gpt4,0.656,TUMOR FOCALITY
3812,gpt4,0.655,ADDITIONAL FINDINGS
3813,gpt4,0.694,MARGIN STATUS FOR INVASIVE CARCINOMA
3814,gpt4,0.82,NUMBER OF LYMPH NODES EXAMINED
3815,gpt4,0.716,MARGIN STATUS FOR NON-INVASIVE TUMOR
3816,gpt4,0.619,NODAL SITE(S) EXAMINED
3817,gpt4,0.645,PROCEDURE
3818,gpt4,0.722,TUMOR SITE
3819,gpt4,0.683,MARGIN STATUS FOR NON-INVASIVE TUMOR
3820,gpt4,0.678,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3821,gpt4,0.704,HISTOLOGIC GRADE
3822,gpt4,0.648,NODAL SITE(S) WITH TUMOR
3823,gpt4,0.671,VISCERAL PLEURA INVASION
3824,gpt4,0.747,MARGIN STATUS FOR INVASIVE CARCINOMA
3825,gpt4,0.637,LYMPH NODE(S) FROM PRIOR PROCEDURES
3826,gpt4,0.709,REGIONAL LYMPH NODE STATUS
3827,gpt4,0.697,TUMOR FOCALITY
3828,gpt4,0.712,NUMBER OF LYMPH NODES EXAMINED
3829,gpt4,0.679,SPECIMEN LATERALITY
3830,gpt4,0.706,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3831,gpt4,0.67,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3832,gpt4,0.729,NUMBER OF LYMPH NODES WITH TUMOR
3833,gpt4,0.645,MARGIN STATUS FOR NON-INVASIVE TUMOR
3834,gpt4,0.68,TUMOR FOCALITY
3835,gpt4,0.744,TUMOR SITE
3836,gpt4,0.676,MARGIN STATUS FOR INVASIVE CARCINOMA
3837,gpt4,0.776,LYMPH NODE(S) FROM PRIOR PROCEDURES
3838,gpt4,0.734,VISCERAL PLEURA INVASION
3839,gpt4,0.777,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3840,gpt4,0.648,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3841,gpt4,0.672,HISTOLOGIC GRADE
3842,gpt4,0.68,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3843,gpt4,0.629,NODAL SITE(S) EXAMINED
3844,gpt4,0.716,NUMBER OF LYMPH NODES WITH TUMOR
3845,gpt4,0.643,PROCEDURE
3846,gpt4,0.688,REGIONAL LYMPH NODE STATUS
3847,gpt4,0.656,NODAL SITE(S) WITH TUMOR
3848,gpt4,0.703,SPECIMEN LATERALITY
3849,gpt4,0.712,ADDITIONAL FINDINGS
3850,gpt4,0.745,MARGIN STATUS FOR INVASIVE CARCINOMA
3851,gpt4,0.714,TUMOR SITE
3852,gpt4,0.679,VISCERAL PLEURA INVASION
3853,gpt4,0.719,REGIONAL LYMPH NODE STATUS
3854,gpt4,0.693,HISTOLOGIC GRADE
3855,gpt4,0.723,NODAL SITE(S) EXAMINED
3856,gpt4,0.805,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3857,gpt4,0.649,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3858,gpt4,0.663,PROCEDURE
3859,gpt4,0.697,SPECIMEN LATERALITY
3860,gpt4,0.68,LYMPH NODE(S) FROM PRIOR PROCEDURES
3861,gpt4,0.798,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3862,gpt4,0.757,MARGIN STATUS FOR NON-INVASIVE TUMOR
3863,gpt4,0.659,TUMOR FOCALITY
3864,gpt4,0.684,SPREAD THROUGH AIR SPACES (STAS)
3865,gpt4,0.749,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3866,gpt4,0.679,MARGIN STATUS FOR INVASIVE CARCINOMA
3867,gpt4,0.655,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3868,gpt4,0.655,PROCEDURE
3869,gpt4,0.659,VISCERAL PLEURA INVASION
3870,gpt4,0.687,LYMPH NODE(S) FROM PRIOR PROCEDURES
3871,gpt4,0.71,TUMOR SITE
3872,gpt4,0.701,MARGIN STATUS FOR NON-INVASIVE TUMOR
3873,gpt4,0.733,REGIONAL LYMPH NODE STATUS
3874,gpt4,0.771,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3875,gpt4,0.708,SPREAD THROUGH AIR SPACES (STAS)
3876,gpt4,0.689,ADDITIONAL FINDINGS
3877,gpt4,0.67,TUMOR FOCALITY
3878,gpt4,0.773,SPECIMEN LATERALITY
3879,gpt4,0.66,HISTOLOGIC GRADE
3880,gpt4,0.649,NODAL SITE(S) EXAMINED
3881,gpt4,0.663,ADDITIONAL FINDINGS
3882,gpt4,0.676,NODAL SITE(S) EXAMINED
3883,gpt4,0.753,MARGIN STATUS FOR NON-INVASIVE TUMOR
3884,gpt4,0.649,PROCEDURE
3885,gpt4,0.813,NUMBER OF LYMPH NODES EXAMINED
3886,gpt4,0.696,MARGIN STATUS FOR INVASIVE CARCINOMA
3887,gpt4,0.708,REGIONAL LYMPH NODE STATUS
3888,gpt4,0.695,LYMPH NODE(S) FROM PRIOR PROCEDURES
3889,gpt4,0.696,SPECIMEN LATERALITY
3890,gpt4,0.633,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3891,gpt4,0.653,HISTOLOGIC GRADE
3892,gpt4,0.809,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3893,gpt4,0.649,TUMOR FOCALITY
3894,gpt4,0.664,VISCERAL PLEURA INVASION
3895,gpt4,0.692,SPREAD THROUGH AIR SPACES (STAS)
3896,gpt4,0.705,TUMOR SITE
3897,gpt4,0.77,SPECIMEN LATERALITY
3898,gpt4,0.703,NUMBER OF LYMPH NODES WITH TUMOR
3899,gpt4,0.632,TNM DESCRIPTORS
3900,gpt4,0.679,MARGIN STATUS FOR NON-INVASIVE TUMOR
3901,gpt4,0.694,REGIONAL LYMPH NODE STATUS
3902,gpt4,0.676,NODAL SITE(S) EXAMINED
3903,gpt4,0.664,HISTOLOGIC GRADE
3904,gpt4,0.723,TUMOR SITE
3905,gpt4,0.654,LYMPHOVASCULAR INVASION
3906,gpt4,0.685,VISCERAL PLEURA INVASION
3907,gpt4,0.68,SPREAD THROUGH AIR SPACES (STAS)
3908,gpt4,0.711,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3909,gpt4,0.622,NODAL SITE(S) WITH TUMOR
3910,gpt4,0.687,MARGIN STATUS FOR INVASIVE CARCINOMA
3911,gpt4,0.659,PROCEDURE
3912,gpt4,0.651,TUMOR FOCALITY
3913,gpt4,0.65,LYMPH NODE(S) FROM PRIOR PROCEDURES
3914,gpt4,0.691,MARGIN STATUS FOR INVASIVE CARCINOMA
3915,gpt4,0.705,MARGIN STATUS FOR NON-INVASIVE TUMOR
3916,gpt4,0.738,REGIONAL LYMPH NODE STATUS
3917,gpt4,0.651,PROCEDURE
3918,gpt4,0.667,TUMOR SITE
3919,gpt4,0.691,LYMPH NODE(S) FROM PRIOR PROCEDURES
3920,gpt4,0.68,NODAL SITE(S) EXAMINED
3921,gpt4,0.644,TUMOR FOCALITY
3922,gpt4,0.688,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3923,gpt4,0.773,SPECIMEN LATERALITY
3924,gpt4,0.679,ADDITIONAL FINDINGS
3925,gpt4,0.627,VISCERAL PLEURA INVASION
3926,gpt4,0.688,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3927,gpt4,0.643,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3928,gpt4,0.681,TNM DESCRIPTORS
3929,gpt4,0.663,HISTOLOGIC GRADE
3930,gpt4,0.672,SPREAD THROUGH AIR SPACES (STAS)
3931,gpt4,0.66,VISCERAL PLEURA INVASION
3932,gpt4,0.723,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3933,gpt4,0.671,MARGIN STATUS FOR INVASIVE CARCINOMA
3934,gpt4,0.656,PROCEDURE
3935,gpt4,0.684,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3936,gpt4,0.644,NODAL SITE(S) EXAMINED
3937,gpt4,0.659,SPECIMEN LATERALITY
3938,gpt4,0.787,MARGIN STATUS FOR NON-INVASIVE TUMOR
3939,gpt4,0.696,HISTOLOGIC GRADE
3940,gpt4,0.7,TUMOR SITE
3941,gpt4,0.647,LYMPHOVASCULAR INVASION
3942,gpt4,0.652,LYMPH NODE(S) FROM PRIOR PROCEDURES
3943,gpt4,0.645,ADDITIONAL FINDINGS
3944,gpt4,0.646,TUMOR FOCALITY
3945,gpt4,0.665,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3946,gpt4,0.682,HISTOLOGIC GRADE
3947,gpt4,0.66,TUMOR FOCALITY
3948,gpt4,0.668,TNM DESCRIPTORS
3949,gpt4,0.705,TUMOR SITE
3950,gpt4,0.658,NODAL SITE(S) EXAMINED
3951,gpt4,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3952,gpt4,0.66,VISCERAL PLEURA INVASION
3953,gpt4,0.742,MARGIN STATUS FOR NON-INVASIVE TUMOR
3954,gpt4,0.648,NODAL SITE(S) WITH TUMOR
3955,gpt4,0.686,MARGIN STATUS FOR INVASIVE CARCINOMA
3956,gpt4,0.802,NUMBER OF LYMPH NODES EXAMINED
3957,gpt4,0.696,REGIONAL LYMPH NODE STATUS
3958,gpt4,0.812,NUMBER OF LYMPH NODES WITH TUMOR
3959,gpt4,0.649,PROCEDURE
3960,gpt4,0.809,SPECIMEN LATERALITY
3961,gpt4,0.669,LYMPHOVASCULAR INVASION
3962,gpt4,0.664,LYMPH NODE(S) FROM PRIOR PROCEDURES
3963,gpt4,0.677,NODAL SITE(S) EXAMINED
3964,gpt4,0.65,ADDITIONAL FINDINGS
3965,gpt4,0.68,TUMOR FOCALITY
3966,gpt4,0.733,REGIONAL LYMPH NODE STATUS
3967,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
3968,gpt4,0.808,MARGIN STATUS FOR INVASIVE CARCINOMA
3969,gpt4,0.704,SPECIMEN LATERALITY
3970,gpt4,0.643,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3971,gpt4,0.656,PROCEDURE
3972,gpt4,0.761,NUMBER OF LYMPH NODES EXAMINED
3973,gpt4,0.662,HISTOLOGIC GRADE
3974,gpt4,0.679,SPREAD THROUGH AIR SPACES (STAS)
3975,gpt4,0.837,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3976,gpt4,0.702,TUMOR SITE
3977,gpt4,0.643,MARGIN STATUS FOR NON-INVASIVE TUMOR
3978,gpt4,0.663,VISCERAL PLEURA INVASION
3979,gpt4,0.65,PROCEDURE
3980,gpt4,0.674,SPREAD THROUGH AIR SPACES (STAS)
3981,gpt4,0.675,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3982,gpt4,0.73,NUMBER OF LYMPH NODES EXAMINED
3983,gpt4,0.7,SPECIMEN LATERALITY
3984,gpt4,0.643,VISCERAL PLEURA INVASION
3985,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
3986,gpt4,0.647,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
3987,gpt4,0.841,MARGIN STATUS FOR NON-INVASIVE TUMOR
3988,gpt4,0.693,TUMOR FOCALITY
3989,gpt4,0.806,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3990,gpt4,0.644,NODAL SITE(S) EXAMINED
3991,gpt4,0.689,MARGIN STATUS FOR INVASIVE CARCINOMA
3992,gpt4,0.683,HISTOLOGIC GRADE
3993,gpt4,0.731,TUMOR SITE
3994,gpt4,0.734,REGIONAL LYMPH NODE STATUS
3995,gpt4,0.635,ADDITIONAL FINDINGS
3996,gpt4,0.806,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
3997,gpt4,0.907,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
3998,gpt4,0.706,TUMOR SITE
3999,gpt4,0.669,ADDITIONAL FINDINGS
4000,gpt4,0.729,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4001,gpt4,0.628,NODAL SITE(S) EXAMINED
4002,gpt4,0.668,HISTOLOGIC GRADE
4003,gpt4,0.749,MARGIN STATUS FOR NON-INVASIVE TUMOR
4004,gpt4,0.683,SPREAD THROUGH AIR SPACES (STAS)
4005,gpt4,0.708,MARGIN STATUS FOR INVASIVE CARCINOMA
4006,gpt4,0.822,NUMBER OF LYMPH NODES EXAMINED
4007,gpt4,0.773,SPECIMEN LATERALITY
4008,gpt4,0.67,VISCERAL PLEURA INVASION
4009,gpt4,0.729,REGIONAL LYMPH NODE STATUS
4010,gpt4,0.675,TUMOR FOCALITY
4011,gpt4,0.629,PROCEDURE
4012,gpt4,0.675,LYMPH NODE(S) FROM PRIOR PROCEDURES
4013,gpt4,0.646,PROCEDURE
4014,gpt4,0.712,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4015,gpt4,0.68,HISTOLOGIC GRADE
4016,gpt4,0.658,TUMOR FOCALITY
4017,gpt4,0.686,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4018,gpt4,0.704,SPECIMEN LATERALITY
4019,gpt4,0.708,TUMOR SITE
4020,gpt4,0.68,SPREAD THROUGH AIR SPACES (STAS)
4021,gpt4,0.641,NODAL SITE(S) EXAMINED
4022,gpt4,0.743,REGIONAL LYMPH NODE STATUS
4023,gpt4,0.734,VISCERAL PLEURA INVASION
4024,gpt4,0.701,MARGIN STATUS FOR NON-INVASIVE TUMOR
4025,gpt4,0.836,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4026,gpt4,0.707,MARGIN STATUS FOR INVASIVE CARCINOMA
4027,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
4028,gpt4,0.734,VISCERAL PLEURA INVASION
4029,gpt4,0.811,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4030,gpt4,0.669,TUMOR FOCALITY
4031,gpt4,0.808,MARGIN STATUS FOR NON-INVASIVE TUMOR
4032,gpt4,0.773,SPECIMEN LATERALITY
4033,gpt4,0.694,ADDITIONAL FINDINGS
4034,gpt4,0.722,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4035,gpt4,0.674,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4036,gpt4,0.72,TUMOR SITE
4037,gpt4,0.637,HISTOLOGIC GRADE
4038,gpt4,0.706,MARGIN STATUS FOR INVASIVE CARCINOMA
4039,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
4040,gpt4,0.675,PROCEDURE
4041,gpt4,0.726,REGIONAL LYMPH NODE STATUS
4042,gpt4,0.702,ADDITIONAL FINDINGS
4043,gpt4,0.702,SPECIMEN LATERALITY
4044,gpt4,0.678,TNM DESCRIPTORS
4045,gpt4,0.744,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4046,gpt4,0.664,PROCEDURE
4047,gpt4,0.683,VISCERAL PLEURA INVASION
4048,gpt4,0.658,NODAL SITE(S) EXAMINED
4049,gpt4,0.669,HISTOLOGIC GRADE
4050,gpt4,0.667,TUMOR SITE
4051,gpt4,0.705,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4052,gpt4,0.659,LYMPHOVASCULAR INVASION
4053,gpt4,0.701,MARGIN STATUS FOR NON-INVASIVE TUMOR
4054,gpt4,0.776,LYMPH NODE(S) FROM PRIOR PROCEDURES
4055,gpt4,0.686,MARGIN STATUS FOR INVASIVE CARCINOMA
4056,gpt4,0.64,TUMOR FOCALITY
4057,gpt4,0.685,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4058,gpt4,0.694,HISTOLOGIC GRADE
4059,gpt4,0.612,VISCERAL PLEURA INVASION
4060,gpt4,0.643,TUMOR FOCALITY
4061,gpt4,0.709,TUMOR SITE
4062,gpt4,0.684,PROCEDURE
4063,gpt4,0.741,REGIONAL LYMPH NODE STATUS
4064,gpt4,0.645,SPECIMEN LATERALITY
4065,gpt4,0.652,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4066,gpt4,0.728,MARGIN STATUS FOR NON-INVASIVE TUMOR
4067,gpt4,0.681,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4068,gpt4,0.663,NODAL SITE(S) EXAMINED
4069,gpt4,0.653,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4070,gpt4,0.802,NUMBER OF LYMPH NODES EXAMINED
4071,gpt4,0.692,MARGIN STATUS FOR INVASIVE CARCINOMA
4072,gpt4,0.649,TNM DESCRIPTORS
4073,gpt4,0.918,LYMPH NODE(S) FROM PRIOR PROCEDURES
4074,gpt4,0.645,TUMOR FOCALITY
4075,gpt4,0.704,SPECIMEN LATERALITY
4076,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
4077,gpt4,0.743,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4078,gpt4,0.689,MARGIN STATUS FOR INVASIVE CARCINOMA
4079,gpt4,0.612,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4080,gpt4,0.702,HISTOLOGIC GRADE
4081,gpt4,0.722,REGIONAL LYMPH NODE STATUS
4082,gpt4,0.656,NODAL SITE(S) EXAMINED
4083,gpt4,0.655,TUMOR SITE
4084,gpt4,0.792,MARGIN STATUS FOR NON-INVASIVE TUMOR
4085,gpt4,0.683,VISCERAL PLEURA INVASION
4086,gpt4,0.683,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4087,gpt4,0.645,PROCEDURE
4088,gpt4,0.669,SPREAD THROUGH AIR SPACES (STAS)
4089,gpt4,0.841,MARGIN STATUS FOR NON-INVASIVE TUMOR
4090,gpt4,0.639,NODAL SITE(S) EXAMINED
4091,gpt4,0.715,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4092,gpt4,0.663,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4093,gpt4,0.719,TUMOR SITE
4094,gpt4,0.672,VISCERAL PLEURA INVASION
4095,gpt4,0.809,SPECIMEN LATERALITY
4096,gpt4,0.797,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4097,gpt4,0.685,NUMBER OF LYMPH NODES EXAMINED
4098,gpt4,0.734,REGIONAL LYMPH NODE STATUS
4099,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
4100,gpt4,0.647,TUMOR FOCALITY
4101,gpt4,0.673,PROCEDURE
4102,gpt4,0.695,MARGIN STATUS FOR INVASIVE CARCINOMA
4103,gpt4,0.637,LYMPH NODE(S) FROM PRIOR PROCEDURES
4104,gpt4,0.719,MARGIN STATUS FOR INVASIVE CARCINOMA
4105,gpt4,0.684,TUMOR FOCALITY
4106,gpt4,0.709,VISCERAL PLEURA INVASION
4107,gpt4,0.861,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4108,gpt4,0.676,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4109,gpt4,0.675,TNM DESCRIPTORS
4110,gpt4,0.64,MARGIN STATUS FOR NON-INVASIVE TUMOR
4111,gpt4,0.72,SPECIMEN LATERALITY
4112,gpt4,0.724,TUMOR SITE
4113,gpt4,0.773,NODAL SITE(S) EXAMINED
4114,gpt4,0.82,NUMBER OF LYMPH NODES WITH TUMOR
4115,gpt4,0.688,PROCEDURE
4116,gpt4,0.699,REGIONAL LYMPH NODE STATUS
4117,gpt4,0.714,NUMBER OF LYMPH NODES EXAMINED
4118,gpt4,0.742,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4119,gpt4,0.655,NODAL SITE(S) WITH TUMOR
4120,gpt4,0.83,MARGIN STATUS FOR INVASIVE CARCINOMA
4121,gpt4,0.773,SPECIMEN LATERALITY
4122,gpt4,0.809,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4123,gpt4,0.717,TUMOR SITE
4124,gpt4,0.635,NODAL SITE(S) EXAMINED
4125,gpt4,0.748,MARGIN STATUS FOR NON-INVASIVE TUMOR
4126,gpt4,0.667,TUMOR FOCALITY
4127,gpt4,0.686,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4128,gpt4,0.721,LYMPH NODE(S) FROM PRIOR PROCEDURES
4129,gpt4,0.664,PROCEDURE
4130,gpt4,0.689,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4131,gpt4,0.74,REGIONAL LYMPH NODE STATUS
4132,gpt4,0.667,TUMOR FOCALITY
4133,gpt4,0.699,MARGIN STATUS FOR NON-INVASIVE TUMOR
4134,gpt4,0.843,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4135,gpt4,0.638,NODAL SITE(S) EXAMINED
4136,gpt4,0.744,NUMBER OF LYMPH NODES EXAMINED
4137,gpt4,0.656,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4138,gpt4,0.797,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4139,gpt4,0.684,VISCERAL PLEURA INVASION
4140,gpt4,0.699,TUMOR SITE
4141,gpt4,0.687,LYMPH NODE(S) FROM PRIOR PROCEDURES
4142,gpt4,0.768,REGIONAL LYMPH NODE STATUS
4143,gpt4,0.703,MARGIN STATUS FOR INVASIVE CARCINOMA
4144,gpt4,0.667,HISTOLOGIC GRADE
4145,gpt4,0.809,SPECIMEN LATERALITY
4146,gpt4,0.649,PROCEDURE
4147,gpt4,0.654,HISTOLOGIC GRADE
4148,gpt4,0.801,REGIONAL LYMPH NODE STATUS
4149,gpt4,0.738,PROCEDURE
4150,gpt4,0.735,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4151,gpt4,0.718,NODAL SITE(S) EXAMINED
4152,gpt4,0.658,TUMOR FOCALITY
4153,gpt4,0.892,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4154,gpt4,0.72,TUMOR SITE
4155,gpt4,0.71,MARGIN STATUS FOR NON-INVASIVE TUMOR
4156,gpt4,0.739,VISCERAL PLEURA INVASION
4157,gpt4,0.711,SPECIMEN LATERALITY
4158,gpt4,0.825,NUMBER OF LYMPH NODES EXAMINED
4159,gpt4,0.662,LYMPH NODE(S) FROM PRIOR PROCEDURES
4160,gpt4,0.67,SPREAD THROUGH AIR SPACES (STAS)
4161,gpt4,0.664,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4162,gpt4,0.698,MARGIN STATUS FOR INVASIVE CARCINOMA
4163,gpt4,0.754,MARGIN STATUS FOR INVASIVE CARCINOMA
4164,gpt4,0.645,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4165,gpt4,0.695,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4166,gpt4,0.685,VISCERAL PLEURA INVASION
4167,gpt4,0.664,TUMOR FOCALITY
4168,gpt4,0.722,TUMOR SITE
4169,gpt4,0.697,SPECIMEN LATERALITY
4170,gpt4,0.739,REGIONAL LYMPH NODE STATUS
4171,gpt4,0.661,NODAL SITE(S) EXAMINED
4172,gpt4,0.663,LYMPH NODE(S) FROM PRIOR PROCEDURES
4173,gpt4,0.663,LYMPHOVASCULAR INVASION
4174,gpt4,0.841,MARGIN STATUS FOR NON-INVASIVE TUMOR
4175,gpt4,0.72,PROCEDURE
4176,gpt4,0.691,LYMPH NODE(S) FROM PRIOR PROCEDURES
4177,gpt4,0.697,SPECIMEN LATERALITY
4178,gpt4,0.744,SPREAD THROUGH AIR SPACES (STAS)
4179,gpt4,0.67,ADDITIONAL FINDINGS
4180,gpt4,0.914,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4181,gpt4,0.701,VISCERAL PLEURA INVASION
4182,gpt4,0.669,NODAL SITE(S) EXAMINED
4183,gpt4,0.698,TUMOR SITE
4184,gpt4,0.716,MARGIN STATUS FOR INVASIVE CARCINOMA
4185,gpt4,0.722,NUMBER OF LYMPH NODES EXAMINED
4186,gpt4,0.653,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4187,gpt4,0.668,PROCEDURE
4188,gpt4,0.729,REGIONAL LYMPH NODE STATUS
4189,gpt4,0.668,TUMOR FOCALITY
4190,gpt4,0.665,MARGIN STATUS FOR NON-INVASIVE TUMOR
4191,gpt4,0.7,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4192,gpt4,0.728,TUMOR SITE
4193,gpt4,0.726,REGIONAL LYMPH NODE STATUS
4194,gpt4,0.731,MARGIN STATUS FOR INVASIVE CARCINOMA
4195,gpt4,0.642,NODAL SITE(S) EXAMINED
4196,gpt4,0.651,TNM DESCRIPTORS
4197,gpt4,0.675,VISCERAL PLEURA INVASION
4198,gpt4,0.692,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4199,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
4200,gpt4,0.715,SPECIMEN LATERALITY
4201,gpt4,0.642,ADDITIONAL FINDINGS
4202,gpt4,0.634,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4203,gpt4,0.659,PROCEDURE
4204,gpt4,0.69,SPREAD THROUGH AIR SPACES (STAS)
4205,gpt4,0.732,MARGIN STATUS FOR NON-INVASIVE TUMOR
4206,gpt4,0.657,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4207,gpt4,0.631,TUMOR FOCALITY
4208,gpt4,0.682,HISTOLOGIC GRADE
4209,gpt4,0.791,MARGIN STATUS FOR INVASIVE CARCINOMA
4210,gpt4,0.811,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4211,gpt4,0.646,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4212,gpt4,0.659,TUMOR FOCALITY
4213,gpt4,0.809,SPECIMEN LATERALITY
4214,gpt4,0.731,VISCERAL PLEURA INVASION
4215,gpt4,0.679,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4216,gpt4,0.684,LYMPH NODE(S) FROM PRIOR PROCEDURES
4217,gpt4,0.631,NODAL SITE(S) EXAMINED
4218,gpt4,0.744,SPREAD THROUGH AIR SPACES (STAS)
4219,gpt4,0.69,HISTOLOGIC GRADE
4220,gpt4,0.711,REGIONAL LYMPH NODE STATUS
4221,gpt4,0.71,TUMOR SITE
4222,gpt4,0.636,NODAL SITE(S) EXAMINED
4223,gpt4,0.7,PROCEDURE
4224,gpt4,0.743,MARGIN STATUS FOR NON-INVASIVE TUMOR
4225,gpt4,0.695,PROCEDURE
4226,gpt4,0.665,VISCERAL PLEURA INVASION
4227,gpt4,0.731,REGIONAL LYMPH NODE STATUS
4228,gpt4,0.896,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4229,gpt4,0.651,TUMOR FOCALITY
4230,gpt4,0.694,TUMOR SITE
4231,gpt4,0.743,MARGIN STATUS FOR NON-INVASIVE TUMOR
4232,gpt4,0.684,MARGIN STATUS FOR INVASIVE CARCINOMA
4233,gpt4,0.677,NODAL SITE(S) EXAMINED
4234,gpt4,0.668,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4235,gpt4,0.674,SPREAD THROUGH AIR SPACES (STAS)
4236,gpt4,0.664,LYMPH NODE(S) FROM PRIOR PROCEDURES
4237,gpt4,0.686,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4238,gpt4,0.773,SPECIMEN LATERALITY
4239,gpt4,0.659,HISTOLOGIC GRADE
4240,gpt4,0.697,MARGIN STATUS FOR INVASIVE CARCINOMA
4241,gpt4,0.679,REGIONAL LYMPH NODE STATUS
4242,gpt4,0.773,SPECIMEN LATERALITY
4243,gpt4,0.732,VISCERAL PLEURA INVASION
4244,gpt4,0.679,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4245,gpt4,0.643,NODAL SITE(S) WITH TUMOR
4246,gpt4,0.633,TUMOR FOCALITY
4247,gpt4,0.896,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4248,gpt4,0.761,NUMBER OF LYMPH NODES WITH TUMOR
4249,gpt4,0.652,PROCEDURE
4250,gpt4,0.653,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4251,gpt4,0.651,TNM DESCRIPTORS
4252,gpt4,0.69,SPREAD THROUGH AIR SPACES (STAS)
4253,gpt4,0.776,LYMPH NODE(S) FROM PRIOR PROCEDURES
4254,gpt4,0.704,ADDITIONAL FINDINGS
4255,gpt4,0.681,MARGIN STATUS FOR NON-INVASIVE TUMOR
4256,gpt4,0.661,TUMOR SITE
4257,gpt4,0.663,NODAL SITE(S) EXAMINED
4258,gpt4,0.71,NODAL SITE(S) EXAMINED
4259,gpt4,0.66,HISTOLOGIC GRADE
4260,gpt4,0.637,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4261,gpt4,0.699,MARGIN STATUS FOR NON-INVASIVE TUMOR
4262,gpt4,0.687,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4263,gpt4,0.698,SPECIMEN LATERALITY
4264,gpt4,0.776,LYMPH NODE(S) FROM PRIOR PROCEDURES
4265,gpt4,0.692,VISCERAL PLEURA INVASION
4266,gpt4,0.738,REGIONAL LYMPH NODE STATUS
4267,gpt4,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4268,gpt4,0.735,MARGIN STATUS FOR INVASIVE CARCINOMA
4269,gpt4,0.675,PROCEDURE
4270,gpt4,0.668,SPREAD THROUGH AIR SPACES (STAS)
4271,gpt4,0.639,TUMOR FOCALITY
4272,gpt4,0.775,NUMBER OF LYMPH NODES EXAMINED
4273,gpt4,0.707,MARGIN STATUS FOR NON-INVASIVE TUMOR
4274,gpt4,0.692,SPECIMEN LATERALITY
4275,gpt4,0.678,HISTOLOGIC GRADE
4276,gpt4,0.678,SPREAD THROUGH AIR SPACES (STAS)
4277,gpt4,0.708,LYMPH NODE(S) FROM PRIOR PROCEDURES
4278,gpt4,0.806,NUMBER OF LYMPH NODES EXAMINED
4279,gpt4,0.691,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4280,gpt4,0.618,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4281,gpt4,0.731,REGIONAL LYMPH NODE STATUS
4282,gpt4,0.837,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4283,gpt4,0.674,PROCEDURE
4284,gpt4,0.646,NODAL SITE(S) EXAMINED
4285,gpt4,0.651,TUMOR FOCALITY
4286,gpt4,0.703,TUMOR SITE
4287,gpt4,0.704,MARGIN STATUS FOR INVASIVE CARCINOMA
4288,gpt4,0.656,VISCERAL PLEURA INVASION
4289,gpt4,0.815,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4290,gpt4,0.665,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4291,gpt4,0.728,REGIONAL LYMPH NODE STATUS
4292,gpt4,0.724,TUMOR SITE
4293,gpt4,0.708,MARGIN STATUS FOR NON-INVASIVE TUMOR
4294,gpt4,0.685,ADDITIONAL FINDINGS
4295,gpt4,0.691,MARGIN STATUS FOR INVASIVE CARCINOMA
4296,gpt4,0.672,NUMBER OF LYMPH NODES EXAMINED
4297,gpt4,0.897,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4298,gpt4,0.773,SPECIMEN LATERALITY
4299,gpt4,0.664,SPREAD THROUGH AIR SPACES (STAS)
4300,gpt4,0.663,TUMOR FOCALITY
4301,gpt4,0.662,HISTOLOGIC GRADE
4302,gpt4,0.666,LYMPH NODE(S) FROM PRIOR PROCEDURES
4303,gpt4,0.659,PROCEDURE
4304,gpt4,0.693,NODAL SITE(S) EXAMINED
4305,gpt4,0.701,VISCERAL PLEURA INVASION
4306,gpt4,0.672,NODAL SITE(S) WITH TUMOR
4307,gpt4,0.68,TUMOR FOCALITY
4308,gpt4,0.692,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4309,gpt4,0.678,NODAL SITE(S) EXAMINED
4310,gpt4,0.658,VISCERAL PLEURA INVASION
4311,gpt4,0.732,TUMOR SITE
4312,gpt4,0.667,LYMPH NODE(S) FROM PRIOR PROCEDURES
4313,gpt4,0.622,LYMPHOVASCULAR INVASION
4314,gpt4,0.703,REGIONAL LYMPH NODE STATUS
4315,gpt4,0.685,PROCEDURE
4316,gpt4,0.658,HISTOLOGIC GRADE
4317,gpt4,0.794,MARGIN STATUS FOR INVASIVE CARCINOMA
4318,gpt4,0.72,NUMBER OF LYMPH NODES WITH TUMOR
4319,gpt4,0.665,SPREAD THROUGH AIR SPACES (STAS)
4320,gpt4,0.668,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4321,gpt4,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4322,gpt4,0.713,NUMBER OF LYMPH NODES EXAMINED
4323,gpt4,0.715,MARGIN STATUS FOR NON-INVASIVE TUMOR
4324,gpt4,0.773,SPECIMEN LATERALITY
4325,gpt4,0.642,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4326,gpt4,0.68,SPECIMEN LATERALITY
4327,gpt4,0.679,SPREAD THROUGH AIR SPACES (STAS)
4328,gpt4,0.68,PROCEDURE
4329,gpt4,0.721,TUMOR SITE
4330,gpt4,0.719,MARGIN STATUS FOR NON-INVASIVE TUMOR
4331,gpt4,0.675,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4332,gpt4,0.696,TUMOR FOCALITY
4333,gpt4,0.776,LYMPH NODE(S) FROM PRIOR PROCEDURES
4334,gpt4,0.708,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4335,gpt4,0.679,HISTOLOGIC GRADE
4336,gpt4,0.686,MARGIN STATUS FOR INVASIVE CARCINOMA
4337,gpt4,0.666,VISCERAL PLEURA INVASION
4338,gpt4,0.735,REGIONAL LYMPH NODE STATUS
4339,gpt4,0.659,HISTOLOGIC GRADE
4340,gpt4,0.762,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4341,gpt4,0.647,PROCEDURE
4342,gpt4,0.809,SPECIMEN LATERALITY
4343,gpt4,0.721,MARGIN STATUS FOR INVASIVE CARCINOMA
4344,gpt4,0.645,NODAL SITE(S) EXAMINED
4345,gpt4,0.718,TUMOR SITE
4346,gpt4,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4347,gpt4,0.694,NUMBER OF LYMPH NODES EXAMINED
4348,gpt4,0.647,VISCERAL PLEURA INVASION
4349,gpt4,0.678,MARGIN STATUS FOR NON-INVASIVE TUMOR
4350,gpt4,0.672,SPREAD THROUGH AIR SPACES (STAS)
4351,gpt4,0.667,TUMOR FOCALITY
4352,gpt4,0.68,ADDITIONAL FINDINGS
4353,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
4354,gpt4,0.664,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4355,gpt4,0.672,SPREAD THROUGH AIR SPACES (STAS)
4356,gpt4,0.697,HISTOLOGIC GRADE
4357,gpt4,0.702,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4358,gpt4,0.704,MARGIN STATUS FOR INVASIVE CARCINOMA
4359,gpt4,0.7,VISCERAL PLEURA INVASION
4360,gpt4,0.698,ADDITIONAL FINDINGS
4361,gpt4,0.659,NODAL SITE(S) EXAMINED
4362,gpt4,0.68,TUMOR SITE
4363,gpt4,0.649,LYMPHOVASCULAR INVASION
4364,gpt4,0.659,TUMOR FOCALITY
4365,gpt4,0.811,NUMBER OF LYMPH NODES EXAMINED
4366,gpt4,0.627,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4367,gpt4,0.688,PROCEDURE
4368,gpt4,0.713,SPECIMEN LATERALITY
4369,gpt4,0.687,MARGIN STATUS FOR NON-INVASIVE TUMOR
4370,gpt4,0.835,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4371,gpt4,0.776,LYMPH NODE(S) FROM PRIOR PROCEDURES
4372,gpt4,0.65,TNM DESCRIPTORS
4373,gpt4,0.664,HISTOLOGIC GRADE
4374,gpt4,0.718,SPECIMEN LATERALITY
4375,gpt4,0.655,TUMOR FOCALITY
4376,gpt4,0.722,TUMOR SITE
4377,gpt4,0.698,REGIONAL LYMPH NODE STATUS
4378,gpt4,0.66,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4379,gpt4,0.696,MARGIN STATUS FOR NON-INVASIVE TUMOR
4380,gpt4,0.659,PROCEDURE
4381,gpt4,0.697,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4382,gpt4,0.665,LYMPHOVASCULAR INVASION
4383,gpt4,0.66,TNM DESCRIPTORS
4384,gpt4,0.665,NODAL SITE(S) EXAMINED
4385,gpt4,0.66,SPREAD THROUGH AIR SPACES (STAS)
4386,gpt4,0.676,MARGIN STATUS FOR INVASIVE CARCINOMA
4387,gpt4,0.684,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4388,gpt4,0.676,LYMPH NODE(S) FROM PRIOR PROCEDURES
4389,gpt4,0.64,NODAL SITE(S) WITH TUMOR
4390,gpt4,0.647,VISCERAL PLEURA INVASION
4391,gpt4,0.672,NODAL SITE(S) WITH TUMOR
4392,gpt4,0.655,NODAL SITE(S) EXAMINED
4393,gpt4,0.72,NUMBER OF LYMPH NODES WITH TUMOR
4394,gpt4,0.773,SPECIMEN LATERALITY
4395,gpt4,0.793,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4396,gpt4,0.668,TUMOR FOCALITY
4397,gpt4,0.711,REGIONAL LYMPH NODE STATUS
4398,gpt4,0.738,NUMBER OF LYMPH NODES EXAMINED
4399,gpt4,0.697,MARGIN STATUS FOR INVASIVE CARCINOMA
4400,gpt4,0.683,ADDITIONAL FINDINGS
4401,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
4402,gpt4,0.707,TUMOR SITE
4403,gpt4,0.648,PROCEDURE
4404,gpt4,0.713,SPREAD THROUGH AIR SPACES (STAS)
4405,gpt4,0.686,MARGIN STATUS FOR NON-INVASIVE TUMOR
4406,gpt4,0.804,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4407,gpt4,0.656,HISTOLOGIC GRADE
4408,gpt4,0.628,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4409,gpt4,0.658,VISCERAL PLEURA INVASION
4410,gpt4,0.739,REGIONAL LYMPH NODE STATUS
4411,gpt4,0.673,NODAL SITE(S) EXAMINED
4412,gpt4,0.673,HISTOLOGIC GRADE
4413,gpt4,0.632,LYMPH NODE(S) FROM PRIOR PROCEDURES
4414,gpt4,0.676,PROCEDURE
4415,gpt4,0.666,SPREAD THROUGH AIR SPACES (STAS)
4416,gpt4,0.639,MARGIN STATUS FOR INVASIVE CARCINOMA
4417,gpt4,0.649,ADDITIONAL FINDINGS
4418,gpt4,0.654,TUMOR FOCALITY
4419,gpt4,0.655,MARGIN STATUS FOR NON-INVASIVE TUMOR
4420,gpt4,0.773,SPECIMEN LATERALITY
4421,gpt4,0.665,TNM DESCRIPTORS
4422,gpt4,0.693,VISCERAL PLEURA INVASION
4423,gpt4,0.692,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4424,gpt4,0.723,TUMOR SITE
4425,gpt4,0.702,MARGIN STATUS FOR NON-INVASIVE TUMOR
4426,gpt4,0.645,TUMOR FOCALITY
4427,gpt4,0.668,PROCEDURE
4428,gpt4,0.672,LYMPH NODE(S) FROM PRIOR PROCEDURES
4429,gpt4,0.726,TUMOR SITE
4430,gpt4,0.691,NUMBER OF LYMPH NODES WITH TUMOR
4431,gpt4,0.686,REGIONAL LYMPH NODE STATUS
4432,gpt4,0.658,LYMPHOVASCULAR INVASION
4433,gpt4,0.657,SPECIMEN LATERALITY
4434,gpt4,0.643,NODAL SITE(S) WITH TUMOR
4435,gpt4,0.633,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4436,gpt4,0.745,HISTOLOGIC GRADE
4437,gpt4,0.655,VISCERAL PLEURA INVASION
4438,gpt4,0.663,NODAL SITE(S) EXAMINED
4439,gpt4,0.667,SPREAD THROUGH AIR SPACES (STAS)
4440,gpt4,0.715,NUMBER OF LYMPH NODES EXAMINED
4441,gpt4,0.71,MARGIN STATUS FOR INVASIVE CARCINOMA
4442,gpt4,0.834,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4443,gpt4,0.671,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4444,gpt4,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4445,gpt4,0.651,TUMOR FOCALITY
4446,gpt4,0.648,ADDITIONAL FINDINGS
4447,gpt4,0.655,PROCEDURE
4448,gpt4,0.743,MARGIN STATUS FOR INVASIVE CARCINOMA
4449,gpt4,0.755,LYMPH NODE(S) FROM PRIOR PROCEDURES
4450,gpt4,0.652,HISTOLOGIC GRADE
4451,gpt4,0.81,MARGIN STATUS FOR NON-INVASIVE TUMOR
4452,gpt4,0.74,REGIONAL LYMPH NODE STATUS
4453,gpt4,0.835,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4454,gpt4,0.697,SPECIMEN LATERALITY
4455,gpt4,0.662,SPREAD THROUGH AIR SPACES (STAS)
4456,gpt4,0.718,TUMOR SITE
4457,gpt4,0.665,NODAL SITE(S) EXAMINED
4458,gpt4,0.639,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4459,gpt4,0.709,VISCERAL PLEURA INVASION
4460,gpt4,0.679,NUMBER OF LYMPH NODES EXAMINED
4461,gpt4,0.668,NODAL SITE(S) EXAMINED
4462,gpt4,0.691,SPREAD THROUGH AIR SPACES (STAS)
4463,gpt4,0.716,REGIONAL LYMPH NODE STATUS
4464,gpt4,0.635,TUMOR FOCALITY
4465,gpt4,0.639,VISCERAL PLEURA INVASION
4466,gpt4,0.657,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4467,gpt4,0.667,PROCEDURE
4468,gpt4,0.659,TUMOR SITE
4469,gpt4,0.881,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4470,gpt4,0.706,HISTOLOGIC GRADE
4471,gpt4,0.659,LYMPHOVASCULAR INVASION
4472,gpt4,0.696,MARGIN STATUS FOR NON-INVASIVE TUMOR
4473,gpt4,0.666,MARGIN STATUS FOR INVASIVE CARCINOMA
4474,gpt4,0.657,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4475,gpt4,0.634,SPECIMEN LATERALITY
4476,gpt4,0.735,MARGIN STATUS FOR INVASIVE CARCINOMA
4477,gpt4,0.641,LYMPHOVASCULAR INVASION
4478,gpt4,0.701,NUMBER OF LYMPH NODES EXAMINED
4479,gpt4,0.804,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4480,gpt4,0.624,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4481,gpt4,0.649,VISCERAL PLEURA INVASION
4482,gpt4,0.642,PROCEDURE
4483,gpt4,0.808,MARGIN STATUS FOR NON-INVASIVE TUMOR
4484,gpt4,0.756,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4485,gpt4,0.688,SPECIMEN LATERALITY
4486,gpt4,0.656,HISTOLOGIC GRADE
4487,gpt4,0.659,TUMOR FOCALITY
4488,gpt4,0.628,NODAL SITE(S) EXAMINED
4489,gpt4,0.707,TUMOR SITE
4490,gpt4,0.747,REGIONAL LYMPH NODE STATUS
4491,gpt4,0.788,MARGIN STATUS FOR NON-INVASIVE TUMOR
4492,gpt4,0.691,ADDITIONAL FINDINGS
4493,gpt4,0.825,NUMBER OF LYMPH NODES EXAMINED
4494,gpt4,0.91,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4495,gpt4,0.773,SPECIMEN LATERALITY
4496,gpt4,0.674,TUMOR FOCALITY
4497,gpt4,0.646,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4498,gpt4,0.738,REGIONAL LYMPH NODE STATUS
4499,gpt4,0.755,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4500,gpt4,0.664,PROCEDURE
4501,gpt4,0.649,LYMPHOVASCULAR INVASION
4502,gpt4,0.705,NODAL SITE(S) EXAMINED
4503,gpt4,0.643,VISCERAL PLEURA INVASION
4504,gpt4,0.719,TUMOR SITE
4505,gpt4,0.71,MARGIN STATUS FOR INVASIVE CARCINOMA
4506,gpt4,0.681,SPREAD THROUGH AIR SPACES (STAS)
4507,gpt4,0.644,VISCERAL PLEURA INVASION
4508,gpt4,0.615,NODAL SITE(S) EXAMINED
4509,gpt4,0.735,MARGIN STATUS FOR NON-INVASIVE TUMOR
4510,gpt4,0.722,MARGIN STATUS FOR INVASIVE CARCINOMA
4511,gpt4,0.644,NODAL SITE(S) WITH TUMOR
4512,gpt4,0.67,SPREAD THROUGH AIR SPACES (STAS)
4513,gpt4,0.667,LYMPH NODE(S) FROM PRIOR PROCEDURES
4514,gpt4,0.825,NUMBER OF LYMPH NODES EXAMINED
4515,gpt4,0.817,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4516,gpt4,0.674,LYMPHOVASCULAR INVASION
4517,gpt4,0.72,NUMBER OF LYMPH NODES WITH TUMOR
4518,gpt4,0.64,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4519,gpt4,0.674,HISTOLOGIC GRADE
4520,gpt4,0.706,REGIONAL LYMPH NODE STATUS
4521,gpt4,0.809,SPECIMEN LATERALITY
4522,gpt4,0.661,TUMOR FOCALITY
4523,gpt4,0.833,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4524,gpt4,0.705,TUMOR SITE
4525,gpt4,0.63,PROCEDURE
4526,gpt4,0.731,SPREAD THROUGH AIR SPACES (STAS)
4527,gpt4,0.691,MARGIN STATUS FOR INVASIVE CARCINOMA
4528,gpt4,0.651,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4529,gpt4,0.841,MARGIN STATUS FOR NON-INVASIVE TUMOR
4530,gpt4,0.713,REGIONAL LYMPH NODE STATUS
4531,gpt4,0.697,SPECIMEN LATERALITY
4532,gpt4,0.675,HISTOLOGIC GRADE
4533,gpt4,0.658,TUMOR FOCALITY
4534,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
4535,gpt4,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4536,gpt4,0.665,PROCEDURE
4537,gpt4,0.72,NUMBER OF LYMPH NODES EXAMINED
4538,gpt4,0.674,NODAL SITE(S) EXAMINED
4539,gpt4,0.678,VISCERAL PLEURA INVASION
4540,gpt4,0.908,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4541,gpt4,0.714,TUMOR SITE
4542,gpt4,0.699,MARGIN STATUS FOR NON-INVASIVE TUMOR
4543,gpt4,0.649,NODAL SITE(S) EXAMINED
4544,gpt4,0.704,MARGIN STATUS FOR INVASIVE CARCINOMA
4545,gpt4,0.679,SPECIMEN LATERALITY
4546,gpt4,0.65,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4547,gpt4,0.664,TUMOR FOCALITY
4548,gpt4,0.649,VISCERAL PLEURA INVASION
4549,gpt4,0.651,LYMPH NODE(S) FROM PRIOR PROCEDURES
4550,gpt4,0.718,TUMOR SITE
4551,gpt4,0.71,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4552,gpt4,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4553,gpt4,0.721,REGIONAL LYMPH NODE STATUS
4554,gpt4,0.651,ADDITIONAL FINDINGS
4555,gpt4,0.679,PROCEDURE
4556,gpt4,0.673,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4557,gpt4,0.653,LYMPH NODE(S) FROM PRIOR PROCEDURES
4558,gpt4,0.662,TUMOR FOCALITY
4559,gpt4,0.728,VISCERAL PLEURA INVASION
4560,gpt4,0.74,REGIONAL LYMPH NODE STATUS
4561,gpt4,0.77,MARGIN STATUS FOR NON-INVASIVE TUMOR
4562,gpt4,0.694,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4563,gpt4,0.82,NUMBER OF LYMPH NODES EXAMINED
4564,gpt4,0.722,MARGIN STATUS FOR INVASIVE CARCINOMA
4565,gpt4,0.672,PROCEDURE
4566,gpt4,0.669,HISTOLOGIC GRADE
4567,gpt4,0.663,NODAL SITE(S) EXAMINED
4568,gpt4,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4569,gpt4,0.697,SPECIMEN LATERALITY
4570,gpt4,0.711,TUMOR SITE
4571,gpt4,0.677,VISCERAL PLEURA INVASION
4572,gpt4,0.727,LYMPH NODE(S) FROM PRIOR PROCEDURES
4573,gpt4,0.62,LYMPHOVASCULAR INVASION
4574,gpt4,0.673,ADDITIONAL FINDINGS
4575,gpt4,0.696,TUMOR SITE
4576,gpt4,0.808,MARGIN STATUS FOR NON-INVASIVE TUMOR
4577,gpt4,0.666,TUMOR FOCALITY
4578,gpt4,0.738,NUMBER OF LYMPH NODES EXAMINED
4579,gpt4,0.652,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4580,gpt4,0.773,SPECIMEN LATERALITY
4581,gpt4,0.631,NODAL SITE(S) EXAMINED
4582,gpt4,0.765,REGIONAL LYMPH NODE STATUS
4583,gpt4,0.841,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4584,gpt4,0.669,SPREAD THROUGH AIR SPACES (STAS)
4585,gpt4,0.813,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4586,gpt4,0.674,PROCEDURE
4587,gpt4,0.652,HISTOLOGIC GRADE
4588,gpt4,0.742,MARGIN STATUS FOR INVASIVE CARCINOMA
4589,gpt4,0.656,VISCERAL PLEURA INVASION
4590,gpt4,0.654,MARGIN STATUS FOR NON-INVASIVE TUMOR
4591,gpt4,0.658,TUMOR FOCALITY
4592,gpt4,0.797,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4593,gpt4,0.701,ADDITIONAL FINDINGS
4594,gpt4,0.702,MARGIN STATUS FOR INVASIVE CARCINOMA
4595,gpt4,0.66,PROCEDURE
4596,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
4597,gpt4,0.729,SPECIMEN LATERALITY
4598,gpt4,0.638,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4599,gpt4,0.719,TUMOR SITE
4600,gpt4,0.721,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4601,gpt4,0.656,HISTOLOGIC GRADE
4602,gpt4,0.641,NODAL SITE(S) EXAMINED
4603,gpt4,0.737,REGIONAL LYMPH NODE STATUS
4604,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
4605,gpt4,0.697,SPECIMEN LATERALITY
4606,gpt4,0.682,PROCEDURE
4607,gpt4,0.7,MARGIN STATUS FOR INVASIVE CARCINOMA
4608,gpt4,0.742,SPREAD THROUGH AIR SPACES (STAS)
4609,gpt4,0.672,HISTOLOGIC GRADE
4610,gpt4,0.609,NUMBER OF LYMPH NODES EXAMINED
4611,gpt4,0.665,MARGIN STATUS FOR NON-INVASIVE TUMOR
4612,gpt4,0.725,REGIONAL LYMPH NODE STATUS
4613,gpt4,0.719,TUMOR SITE
4614,gpt4,0.659,TUMOR FOCALITY
4615,gpt4,0.728,VISCERAL PLEURA INVASION
4616,gpt4,0.807,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4617,gpt4,0.904,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4618,gpt4,0.648,NODAL SITE(S) EXAMINED
4619,gpt4,0.66,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4620,gpt4,0.848,MARGIN STATUS FOR NON-INVASIVE TUMOR
4621,gpt4,0.789,REGIONAL LYMPH NODE STATUS
4622,gpt4,0.726,MARGIN STATUS FOR INVASIVE CARCINOMA
4623,gpt4,0.798,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4624,gpt4,0.636,PROCEDURE
4625,gpt4,0.773,SPECIMEN LATERALITY
4626,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
4627,gpt4,0.647,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4628,gpt4,0.68,HISTOLOGIC GRADE
4629,gpt4,0.661,VISCERAL PLEURA INVASION
4630,gpt4,0.73,TUMOR SITE
4631,gpt4,0.713,NUMBER OF LYMPH NODES EXAMINED
4632,gpt4,0.675,TUMOR FOCALITY
4633,gpt4,0.629,NODAL SITE(S) EXAMINED
4634,gpt4,0.678,SPREAD THROUGH AIR SPACES (STAS)
4635,gpt4,0.682,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4636,gpt4,0.653,PROCEDURE
4637,gpt4,0.658,SPREAD THROUGH AIR SPACES (STAS)
4638,gpt4,0.704,MARGIN STATUS FOR INVASIVE CARCINOMA
4639,gpt4,0.809,SPECIMEN LATERALITY
4640,gpt4,0.707,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4641,gpt4,0.647,NODAL SITE(S) EXAMINED
4642,gpt4,0.738,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4643,gpt4,0.733,REGIONAL LYMPH NODE STATUS
4644,gpt4,0.729,MARGIN STATUS FOR NON-INVASIVE TUMOR
4645,gpt4,0.646,TUMOR FOCALITY
4646,gpt4,0.68,ADDITIONAL FINDINGS
4647,gpt4,0.686,HISTOLOGIC GRADE
4648,gpt4,0.623,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4649,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
4650,gpt4,0.709,VISCERAL PLEURA INVASION
4651,gpt4,0.665,NUMBER OF LYMPH NODES EXAMINED
4652,gpt4,0.706,TUMOR SITE
4653,gpt4,0.672,PROCEDURE
4654,gpt4,0.703,NUMBER OF LYMPH NODES EXAMINED
4655,gpt4,0.78,TUMOR SITE
4656,gpt4,0.641,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4657,gpt4,0.752,REGIONAL LYMPH NODE STATUS
4658,gpt4,0.701,MARGIN STATUS FOR INVASIVE CARCINOMA
4659,gpt4,0.773,SPECIMEN LATERALITY
4660,gpt4,0.683,HISTOLOGIC GRADE
4661,gpt4,0.639,MARGIN STATUS FOR NON-INVASIVE TUMOR
4662,gpt4,0.717,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4663,gpt4,0.652,TUMOR FOCALITY
4664,gpt4,0.648,VISCERAL PLEURA INVASION
4665,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
4666,gpt4,0.674,SPREAD THROUGH AIR SPACES (STAS)
4667,gpt4,0.856,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4668,gpt4,0.646,NODAL SITE(S) EXAMINED
4669,gpt4,0.625,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4670,gpt4,0.718,ADDITIONAL FINDINGS
4671,gpt4,0.651,HISTOLOGIC GRADE
4672,gpt4,0.691,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4673,gpt4,0.687,MARGIN STATUS FOR NON-INVASIVE TUMOR
4674,gpt4,0.685,SPREAD THROUGH AIR SPACES (STAS)
4675,gpt4,0.669,VISCERAL PLEURA INVASION
4676,gpt4,0.65,PROCEDURE
4677,gpt4,0.798,NUMBER OF LYMPH NODES EXAMINED
4678,gpt4,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4679,gpt4,0.639,NODAL SITE(S) EXAMINED
4680,gpt4,0.766,MARGIN STATUS FOR INVASIVE CARCINOMA
4681,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
4682,gpt4,0.722,TUMOR SITE
4683,gpt4,0.656,TUMOR FOCALITY
4684,gpt4,0.739,REGIONAL LYMPH NODE STATUS
4685,gpt4,0.718,SPECIMEN LATERALITY
4686,gpt4,0.742,REGIONAL LYMPH NODE STATUS
4687,gpt4,0.773,SPECIMEN LATERALITY
4688,gpt4,0.718,NODAL SITE(S) EXAMINED
4689,gpt4,0.66,HISTOLOGIC GRADE
4690,gpt4,0.679,SPREAD THROUGH AIR SPACES (STAS)
4691,gpt4,0.704,TUMOR SITE
4692,gpt4,0.745,MARGIN STATUS FOR NON-INVASIVE TUMOR
4693,gpt4,0.72,NUMBER OF LYMPH NODES EXAMINED
4694,gpt4,0.663,TUMOR FOCALITY
4695,gpt4,0.656,VISCERAL PLEURA INVASION
4696,gpt4,0.669,PROCEDURE
4697,gpt4,0.797,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4698,gpt4,0.717,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4699,gpt4,0.811,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4700,gpt4,0.688,MARGIN STATUS FOR INVASIVE CARCINOMA
4701,gpt4,0.776,LYMPH NODE(S) FROM PRIOR PROCEDURES
4702,gpt4,0.652,TUMOR FOCALITY
4703,gpt4,0.693,SPREAD THROUGH AIR SPACES (STAS)
4704,gpt4,0.659,PROCEDURE
4705,gpt4,0.696,HISTOLOGIC GRADE
4706,gpt4,0.747,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4707,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
4708,gpt4,0.658,ADDITIONAL FINDINGS
4709,gpt4,0.739,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4710,gpt4,0.696,MARGIN STATUS FOR NON-INVASIVE TUMOR
4711,gpt4,0.656,NODAL SITE(S) EXAMINED
4712,gpt4,0.72,TUMOR SITE
4713,gpt4,0.67,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4714,gpt4,0.68,VISCERAL PLEURA INVASION
4715,gpt4,0.727,MARGIN STATUS FOR INVASIVE CARCINOMA
4716,gpt4,0.701,REGIONAL LYMPH NODE STATUS
4717,gpt4,0.705,NUMBER OF LYMPH NODES EXAMINED
4718,gpt4,0.698,SPECIMEN LATERALITY
4719,gpt4,0.701,SPECIMEN LATERALITY
4720,gpt4,0.679,VISCERAL PLEURA INVASION
4721,gpt4,0.709,HISTOLOGIC GRADE
4722,gpt4,0.649,MARGIN STATUS FOR NON-INVASIVE TUMOR
4723,gpt4,0.625,MARGIN STATUS FOR INVASIVE CARCINOMA
4724,gpt4,0.655,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4725,gpt4,0.679,LYMPH NODE(S) FROM PRIOR PROCEDURES
4726,gpt4,0.684,PROCEDURE
4727,gpt4,0.696,TNM DESCRIPTORS
4728,gpt4,0.649,TUMOR FOCALITY
4729,gpt4,0.746,ADDITIONAL FINDINGS
4730,gpt4,0.66,NODAL SITE(S) EXAMINED
4731,gpt4,0.75,REGIONAL LYMPH NODE STATUS
4732,gpt4,0.705,MARGIN STATUS FOR INVASIVE CARCINOMA
4733,gpt4,0.707,SPECIMEN LATERALITY
4734,gpt4,0.641,NODAL SITE(S) EXAMINED
4735,gpt4,0.678,HISTOLOGIC GRADE
4736,gpt4,0.674,ADDITIONAL FINDINGS
4737,gpt4,0.678,SPREAD THROUGH AIR SPACES (STAS)
4738,gpt4,0.647,VISCERAL PLEURA INVASION
4739,gpt4,0.712,MARGIN STATUS FOR NON-INVASIVE TUMOR
4740,gpt4,0.757,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4741,gpt4,0.704,TUMOR SITE
4742,gpt4,0.714,REGIONAL LYMPH NODE STATUS
4743,gpt4,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4744,gpt4,0.645,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4745,gpt4,0.67,PROCEDURE
4746,gpt4,0.776,LYMPH NODE(S) FROM PRIOR PROCEDURES
4747,gpt4,0.661,LYMPHOVASCULAR INVASION
4748,gpt4,0.642,TUMOR FOCALITY
4749,gpt4,0.817,NUMBER OF LYMPH NODES EXAMINED
4750,gpt4,0.66,NODAL SITE(S) EXAMINED
4751,gpt4,0.716,TUMOR SITE
4752,gpt4,0.688,NUMBER OF LYMPH NODES EXAMINED
4753,gpt4,0.684,MARGIN STATUS FOR NON-INVASIVE TUMOR
4754,gpt4,0.731,VISCERAL PLEURA INVASION
4755,gpt4,0.658,HISTOLOGIC GRADE
4756,gpt4,0.773,SPECIMEN LATERALITY
4757,gpt4,0.841,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4758,gpt4,0.634,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4759,gpt4,0.685,PROCEDURE
4760,gpt4,0.672,SPREAD THROUGH AIR SPACES (STAS)
4761,gpt4,0.729,REGIONAL LYMPH NODE STATUS
4762,gpt4,0.675,ADDITIONAL FINDINGS
4763,gpt4,0.664,TUMOR FOCALITY
4764,gpt4,0.693,MARGIN STATUS FOR INVASIVE CARCINOMA
4765,gpt4,0.776,LYMPH NODE(S) FROM PRIOR PROCEDURES
4766,gpt4,0.825,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4767,gpt4,0.666,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4768,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
4769,gpt4,0.693,MARGIN STATUS FOR INVASIVE CARCINOMA
4770,gpt4,0.714,HISTOLOGIC GRADE
4771,gpt4,0.656,TUMOR FOCALITY
4772,gpt4,0.61,NODAL SITE(S) EXAMINED
4773,gpt4,0.773,SPECIMEN LATERALITY
4774,gpt4,0.809,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4775,gpt4,0.82,NUMBER OF LYMPH NODES EXAMINED
4776,gpt4,0.739,REGIONAL LYMPH NODE STATUS
4777,gpt4,0.678,VISCERAL PLEURA INVASION
4778,gpt4,0.79,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4779,gpt4,0.713,TUMOR SITE
4780,gpt4,0.665,PROCEDURE
4781,gpt4,0.841,MARGIN STATUS FOR NON-INVASIVE TUMOR
4782,gpt4,0.681,NODAL SITE(S) EXAMINED
4783,gpt4,0.789,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4784,gpt4,0.809,SPECIMEN LATERALITY
4785,gpt4,0.724,REGIONAL LYMPH NODE STATUS
4786,gpt4,0.666,TUMOR FOCALITY
4787,gpt4,0.737,TUMOR SITE
4788,gpt4,0.688,MARGIN STATUS FOR INVASIVE CARCINOMA
4789,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
4790,gpt4,0.66,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4791,gpt4,0.644,VISCERAL PLEURA INVASION
4792,gpt4,0.72,NUMBER OF LYMPH NODES EXAMINED
4793,gpt4,0.813,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4794,gpt4,0.738,MARGIN STATUS FOR NON-INVASIVE TUMOR
4795,gpt4,0.663,PROCEDURE
4796,gpt4,0.768,ADDITIONAL FINDINGS
4797,gpt4,0.634,NODAL SITE(S) EXAMINED
4798,gpt4,0.794,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4799,gpt4,0.721,PROCEDURE
4800,gpt4,0.782,TUMOR SITE
4801,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
4802,gpt4,0.645,HISTOLOGIC GRADE
4803,gpt4,0.81,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4804,gpt4,0.696,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4805,gpt4,0.733,REGIONAL LYMPH NODE STATUS
4806,gpt4,0.772,MARGIN STATUS FOR NON-INVASIVE TUMOR
4807,gpt4,0.773,SPECIMEN LATERALITY
4808,gpt4,0.778,MARGIN STATUS FOR INVASIVE CARCINOMA
4809,gpt4,0.734,VISCERAL PLEURA INVASION
4810,gpt4,0.669,TUMOR FOCALITY
4811,gpt4,0.728,REGIONAL LYMPH NODE STATUS
4812,gpt4,0.702,SPECIMEN LATERALITY
4813,gpt4,0.635,MARGIN STATUS FOR NON-INVASIVE TUMOR
4814,gpt4,0.676,VISCERAL PLEURA INVASION
4815,gpt4,0.638,NODAL SITE(S) EXAMINED
4816,gpt4,0.674,PROCEDURE
4817,gpt4,0.863,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4818,gpt4,0.701,TUMOR SITE
4819,gpt4,0.784,NUMBER OF LYMPH NODES EXAMINED
4820,gpt4,0.721,MARGIN STATUS FOR INVASIVE CARCINOMA
4821,gpt4,0.66,SPREAD THROUGH AIR SPACES (STAS)
4822,gpt4,0.671,HISTOLOGIC GRADE
4823,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
4824,gpt4,0.701,TUMOR FOCALITY
4825,gpt4,0.661,VISCERAL PLEURA INVASION
4826,gpt4,0.809,SPECIMEN LATERALITY
4827,gpt4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
4828,gpt4,0.709,TUMOR SITE
4829,gpt4,0.66,SPREAD THROUGH AIR SPACES (STAS)
4830,gpt4,0.644,PROCEDURE
4831,gpt4,0.66,LYMPHOVASCULAR INVASION
4832,gpt4,0.609,NODAL SITE(S) WITH TUMOR
4833,gpt4,0.704,REGIONAL LYMPH NODE STATUS
4834,gpt4,0.79,NUMBER OF LYMPH NODES WITH TUMOR
4835,gpt4,0.652,NODAL SITE(S) EXAMINED
4836,gpt4,0.684,HISTOLOGIC GRADE
4837,gpt4,0.76,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4838,gpt4,0.779,LYMPH NODE(S) FROM PRIOR PROCEDURES
4839,gpt4,0.708,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4840,gpt4,0.707,MARGIN STATUS FOR INVASIVE CARCINOMA
4841,gpt4,0.644,TUMOR FOCALITY
4842,gpt4,0.677,SPREAD THROUGH AIR SPACES (STAS)
4843,gpt4,0.667,VISCERAL PLEURA INVASION
4844,gpt4,0.77,SPECIMEN LATERALITY
4845,gpt4,0.634,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4846,gpt4,0.69,REGIONAL LYMPH NODE STATUS
4847,gpt4,0.721,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4848,gpt4,0.746,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4849,gpt4,0.646,TUMOR FOCALITY
4850,gpt4,0.684,LYMPHOVASCULAR INVASION
4851,gpt4,0.691,LYMPH NODE(S) FROM PRIOR PROCEDURES
4852,gpt4,0.727,TUMOR SITE
4853,gpt4,0.735,MARGIN STATUS FOR NON-INVASIVE TUMOR
4854,gpt4,0.628,NODAL SITE(S) WITH TUMOR
4855,gpt4,0.83,NUMBER OF LYMPH NODES WITH TUMOR
4856,gpt4,0.665,NODAL SITE(S) EXAMINED
4857,gpt4,0.755,NUMBER OF LYMPH NODES EXAMINED
4858,gpt4,0.639,ADDITIONAL FINDINGS
4859,gpt4,0.649,PROCEDURE
4860,gpt4,0.676,HISTOLOGIC GRADE
4861,gpt4,0.663,SPECIMEN LATERALITY
4862,gpt4,0.658,TUMOR FOCALITY
4863,gpt4,0.711,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4864,gpt4,0.694,LYMPH NODE(S) FROM PRIOR PROCEDURES
4865,gpt4,0.686,MARGIN STATUS FOR INVASIVE CARCINOMA
4866,gpt4,0.727,REGIONAL LYMPH NODE STATUS
4867,gpt4,0.65,SPREAD THROUGH AIR SPACES (STAS)
4868,gpt4,0.676,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4869,gpt4,0.705,HISTOLOGIC GRADE
4870,gpt4,0.729,TUMOR SITE
4871,gpt4,0.647,NODAL SITE(S) EXAMINED
4872,gpt4,0.653,PROCEDURE
4873,gpt4,0.659,ADDITIONAL FINDINGS
4874,gpt4,0.841,MARGIN STATUS FOR NON-INVASIVE TUMOR
4875,gpt4,0.648,NODAL SITE(S) EXAMINED
4876,gpt4,0.658,VISCERAL PLEURA INVASION
4877,gpt4,0.79,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4878,gpt4,0.645,LYMPHOVASCULAR INVASION
4879,gpt4,0.707,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4880,gpt4,0.671,NODAL SITE(S) EXAMINED
4881,gpt4,0.675,SPREAD THROUGH AIR SPACES (STAS)
4882,gpt4,0.694,ADDITIONAL FINDINGS
4883,gpt4,0.697,SPECIMEN LATERALITY
4884,gpt4,0.686,MARGIN STATUS FOR INVASIVE CARCINOMA
4885,gpt4,0.641,LYMPH NODE(S) FROM PRIOR PROCEDURES
4886,gpt4,0.791,TUMOR SITE
4887,gpt4,0.719,REGIONAL LYMPH NODE STATUS
4888,gpt4,0.646,TUMOR FOCALITY
4889,gpt4,0.653,MARGIN STATUS FOR NON-INVASIVE TUMOR
4890,gpt4,0.669,VISCERAL PLEURA INVASION
4891,gpt4,0.67,HISTOLOGIC GRADE
4892,gpt4,0.694,PROCEDURE
4893,gpt4,0.734,REGIONAL LYMPH NODE STATUS
4894,gpt4,0.735,MARGIN STATUS FOR NON-INVASIVE TUMOR
4895,gpt4,0.773,SPECIMEN LATERALITY
4896,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
4897,gpt4,0.684,HISTOLOGIC GRADE
4898,gpt4,0.66,NODAL SITE(S) EXAMINED
4899,gpt4,0.654,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4900,gpt4,0.697,MARGIN STATUS FOR INVASIVE CARCINOMA
4901,gpt4,0.636,TUMOR FOCALITY
4902,gpt4,0.702,TUMOR SITE
4903,gpt4,0.67,PROCEDURE
4904,gpt4,0.672,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4905,gpt4,0.727,VISCERAL PLEURA INVASION
4906,gpt4,0.905,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4907,gpt4,0.761,NUMBER OF LYMPH NODES EXAMINED
4908,gpt4,0.732,ADDITIONAL FINDINGS
4909,gpt4,0.658,SPREAD THROUGH AIR SPACES (STAS)
4910,gpt4,0.809,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4911,gpt4,0.663,VISCERAL PLEURA INVASION
4912,gpt4,0.711,MARGIN STATUS FOR INVASIVE CARCINOMA
4913,gpt4,0.677,ADDITIONAL FINDINGS
4914,gpt4,0.729,REGIONAL LYMPH NODE STATUS
4915,gpt4,0.679,HISTOLOGIC GRADE
4916,gpt4,0.649,MARGIN STATUS FOR NON-INVASIVE TUMOR
4917,gpt4,0.708,SPREAD THROUGH AIR SPACES (STAS)
4918,gpt4,0.677,TUMOR SITE
4919,gpt4,0.651,PROCEDURE
4920,gpt4,0.646,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4921,gpt4,0.773,SPECIMEN LATERALITY
4922,gpt4,0.714,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4923,gpt4,0.676,LYMPH NODE(S) FROM PRIOR PROCEDURES
4924,gpt4,0.664,NODAL SITE(S) EXAMINED
4925,gpt4,0.651,TUMOR FOCALITY
4926,gpt4,0.657,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4927,gpt4,0.69,SPREAD THROUGH AIR SPACES (STAS)
4928,gpt4,0.734,VISCERAL PLEURA INVASION
4929,gpt4,0.688,ADDITIONAL FINDINGS
4930,gpt4,0.718,SPECIMEN LATERALITY
4931,gpt4,0.91,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4932,gpt4,0.667,HISTOLOGIC GRADE
4933,gpt4,0.731,REGIONAL LYMPH NODE STATUS
4934,gpt4,0.646,NODAL SITE(S) EXAMINED
4935,gpt4,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4936,gpt4,0.674,NUMBER OF LYMPH NODES EXAMINED
4937,gpt4,0.687,PROCEDURE
4938,gpt4,0.783,MARGIN STATUS FOR NON-INVASIVE TUMOR
4939,gpt4,0.673,MARGIN STATUS FOR INVASIVE CARCINOMA
4940,gpt4,0.662,TUMOR FOCALITY
4941,gpt4,0.776,LYMPH NODE(S) FROM PRIOR PROCEDURES
4942,gpt4,0.707,TUMOR SITE
4943,gpt4,0.717,TUMOR SITE
4944,gpt4,0.721,REGIONAL LYMPH NODE STATUS
4945,gpt4,0.646,TUMOR FOCALITY
4946,gpt4,0.681,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4947,gpt4,0.77,SPECIMEN LATERALITY
4948,gpt4,0.65,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4949,gpt4,0.654,LYMPH NODE(S) FROM PRIOR PROCEDURES
4950,gpt4,0.667,PROCEDURE
4951,gpt4,0.69,SPREAD THROUGH AIR SPACES (STAS)
4952,gpt4,0.651,MARGIN STATUS FOR NON-INVASIVE TUMOR
4953,gpt4,0.774,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4954,gpt4,0.693,HISTOLOGIC GRADE
4955,gpt4,0.637,NODAL SITE(S) EXAMINED
4956,gpt4,0.695,VISCERAL PLEURA INVASION
4957,gpt4,0.619,ADDITIONAL FINDINGS
4958,gpt4,0.692,MARGIN STATUS FOR INVASIVE CARCINOMA
4959,gpt4,0.688,MARGIN STATUS FOR INVASIVE CARCINOMA
4960,gpt4,0.658,NODAL SITE(S) EXAMINED
4961,gpt4,0.647,ADDITIONAL FINDINGS
4962,gpt4,0.773,SPECIMEN LATERALITY
4963,gpt4,0.734,VISCERAL PLEURA INVASION
4964,gpt4,0.774,MARGIN STATUS FOR NON-INVASIVE TUMOR
4965,gpt4,0.71,REGIONAL LYMPH NODE STATUS
4966,gpt4,0.658,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4967,gpt4,0.639,PROCEDURE
4968,gpt4,0.673,HISTOLOGIC GRADE
4969,gpt4,0.657,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4970,gpt4,0.674,SPREAD THROUGH AIR SPACES (STAS)
4971,gpt4,0.628,TUMOR FOCALITY
4972,gpt4,0.827,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4973,gpt4,0.626,LYMPH NODE(S) FROM PRIOR PROCEDURES
4974,gpt4,0.719,TUMOR SITE
4975,gpt4,0.667,PROCEDURE
4976,gpt4,0.653,VISCERAL PLEURA INVASION
4977,gpt4,0.726,TUMOR SITE
4978,gpt4,0.631,NODAL SITE(S) EXAMINED
4979,gpt4,0.771,MARGIN STATUS FOR NON-INVASIVE TUMOR
4980,gpt4,0.663,HISTOLOGIC GRADE
4981,gpt4,0.653,SPREAD THROUGH AIR SPACES (STAS)
4982,gpt4,0.785,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
4983,gpt4,0.776,LYMPH NODE(S) FROM PRIOR PROCEDURES
4984,gpt4,0.691,MARGIN STATUS FOR INVASIVE CARCINOMA
4985,gpt4,0.727,REGIONAL LYMPH NODE STATUS
4986,gpt4,0.662,TUMOR FOCALITY
4987,gpt4,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4988,gpt4,0.699,NUMBER OF LYMPH NODES EXAMINED
4989,gpt4,0.643,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
4990,gpt4,0.809,SPECIMEN LATERALITY
4991,gpt4,0.918,MARGIN STATUS FOR NON-INVASIVE TUMOR
4992,gpt4,0.736,SPECIMEN LATERALITY
4993,gpt4,0.811,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
4994,gpt4,0.747,LYMPH NODE(S) FROM PRIOR PROCEDURES
4995,gpt4,0.72,REGIONAL LYMPH NODE STATUS
4996,gpt4,0.721,TUMOR SITE
4997,gpt4,0.732,MARGIN STATUS FOR INVASIVE CARCINOMA
4998,gpt4,0.632,PROCEDURE
4999,gpt4,0.664,VISCERAL PLEURA INVASION
5000,gpt4,0.668,TUMOR FOCALITY
5001,gpt4,0.837,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5002,gpt4,0.656,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5003,gpt4,0.78,NUMBER OF LYMPH NODES EXAMINED
5004,gpt4,0.662,NODAL SITE(S) EXAMINED
5005,gpt4,0.68,HISTOLOGIC GRADE
5006,gpt4,0.717,ADDITIONAL FINDINGS
5007,gpt4,0.68,SPREAD THROUGH AIR SPACES (STAS)
5008,gpt4,0.662,HISTOLOGIC GRADE
5009,gpt4,0.653,LYMPHOVASCULAR INVASION
5010,gpt4,0.652,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5011,gpt4,0.715,REGIONAL LYMPH NODE STATUS
5012,gpt4,0.82,NUMBER OF LYMPH NODES WITH TUMOR
5013,gpt4,0.677,NODAL SITE(S) EXAMINED
5014,gpt4,0.657,TUMOR FOCALITY
5015,gpt4,0.707,NUMBER OF LYMPH NODES WITH TUMOR
5016,gpt4,0.697,SPECIMEN LATERALITY
5017,gpt4,0.642,NODAL SITE(S) WITH TUMOR
5018,gpt4,0.718,TUMOR SITE
5019,gpt4,0.789,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5020,gpt4,0.683,LYMPH NODE(S) FROM PRIOR PROCEDURES
5021,gpt4,0.666,NODAL SITE(S) WITH TUMOR
5022,gpt4,0.656,VISCERAL PLEURA INVASION
5023,gpt4,0.689,MARGIN STATUS FOR INVASIVE CARCINOMA
5024,gpt4,0.707,PROCEDURE
5025,gpt4,0.797,NUMBER OF LYMPH NODES EXAMINED
5026,gpt4,0.901,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5027,gpt4,0.679,MARGIN STATUS FOR NON-INVASIVE TUMOR
5028,gpt4,0.835,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5029,gpt4,0.807,NUMBER OF LYMPH NODES EXAMINED
5030,gpt4,0.664,LYMPH NODE(S) FROM PRIOR PROCEDURES
5031,gpt4,0.676,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5032,gpt4,0.699,MARGIN STATUS FOR INVASIVE CARCINOMA
5033,gpt4,0.735,VISCERAL PLEURA INVASION
5034,gpt4,0.697,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5035,gpt4,0.716,ADDITIONAL FINDINGS
5036,gpt4,0.662,TUMOR FOCALITY
5037,gpt4,0.657,PROCEDURE
5038,gpt4,0.675,NODAL SITE(S) EXAMINED
5039,gpt4,0.729,REGIONAL LYMPH NODE STATUS
5040,gpt4,0.704,TUMOR SITE
5041,gpt4,0.64,HISTOLOGIC GRADE
5042,gpt4,0.704,SPECIMEN LATERALITY
5043,gpt4,0.733,MARGIN STATUS FOR NON-INVASIVE TUMOR
5044,gpt4,0.686,MARGIN STATUS FOR INVASIVE CARCINOMA
5045,gpt4,0.663,PROCEDURE
5046,gpt4,0.811,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5047,gpt4,0.761,MARGIN STATUS FOR NON-INVASIVE TUMOR
5048,gpt4,0.757,REGIONAL LYMPH NODE STATUS
5049,gpt4,0.697,TUMOR SITE
5050,gpt4,0.784,ADDITIONAL FINDINGS
5051,gpt4,0.665,SPREAD THROUGH AIR SPACES (STAS)
5052,gpt4,0.678,TUMOR FOCALITY
5053,gpt4,0.698,VISCERAL PLEURA INVASION
5054,gpt4,0.67,HISTOLOGIC GRADE
5055,gpt4,0.643,NODAL SITE(S) EXAMINED
5056,gpt4,0.649,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5057,gpt4,0.671,LYMPH NODE(S) FROM PRIOR PROCEDURES
5058,gpt4,0.908,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5059,gpt4,0.697,SPECIMEN LATERALITY
5060,gpt4,0.664,SPECIMEN LATERALITY
5061,gpt4,0.65,NODAL SITE(S) EXAMINED
5062,gpt4,0.677,VISCERAL PLEURA INVASION
5063,gpt4,0.747,NUMBER OF LYMPH NODES EXAMINED
5064,gpt4,0.672,PROCEDURE
5065,gpt4,0.733,MARGIN STATUS FOR NON-INVASIVE TUMOR
5066,gpt4,0.843,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5067,gpt4,0.654,TUMOR FOCALITY
5068,gpt4,0.739,TUMOR SITE
5069,gpt4,0.697,MARGIN STATUS FOR INVASIVE CARCINOMA
5070,gpt4,0.687,LYMPH NODE(S) FROM PRIOR PROCEDURES
5071,gpt4,0.633,HISTOLOGIC GRADE
5072,gpt4,0.724,REGIONAL LYMPH NODE STATUS
5073,gpt4,0.727,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5074,gpt4,0.654,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5075,gpt4,0.672,ADDITIONAL FINDINGS
5076,gpt4,0.749,REGIONAL LYMPH NODE STATUS
5077,gpt4,0.678,NODAL SITE(S) EXAMINED
5078,gpt4,0.651,HISTOLOGIC GRADE
5079,gpt4,0.66,TUMOR FOCALITY
5080,gpt4,0.701,MARGIN STATUS FOR INVASIVE CARCINOMA
5081,gpt4,0.714,TUMOR SITE
5082,gpt4,0.64,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5083,gpt4,0.71,ADDITIONAL FINDINGS
5084,gpt4,0.633,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5085,gpt4,0.659,PROCEDURE
5086,gpt4,0.631,LYMPH NODE(S) FROM PRIOR PROCEDURES
5087,gpt4,0.666,SPREAD THROUGH AIR SPACES (STAS)
5088,gpt4,0.698,VISCERAL PLEURA INVASION
5089,gpt4,0.688,SPECIMEN LATERALITY
5090,gpt4,0.843,MARGIN STATUS FOR NON-INVASIVE TUMOR
5091,gpt4,0.845,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5092,gpt4,0.709,REGIONAL LYMPH NODE STATUS
5093,gpt4,0.651,TUMOR FOCALITY
5094,gpt4,0.703,MARGIN STATUS FOR INVASIVE CARCINOMA
5095,gpt4,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5096,gpt4,0.662,ADDITIONAL FINDINGS
5097,gpt4,0.656,NODAL SITE(S) WITH TUMOR
5098,gpt4,0.655,SPREAD THROUGH AIR SPACES (STAS)
5099,gpt4,0.694,MARGIN STATUS FOR NON-INVASIVE TUMOR
5100,gpt4,0.679,SPECIMEN LATERALITY
5101,gpt4,0.669,VISCERAL PLEURA INVASION
5102,gpt4,0.674,LYMPH NODE(S) FROM PRIOR PROCEDURES
5103,gpt4,0.659,LYMPHOVASCULAR INVASION
5104,gpt4,0.631,NODAL SITE(S) EXAMINED
5105,gpt4,0.82,NUMBER OF LYMPH NODES WITH TUMOR
5106,gpt4,0.748,TUMOR SITE
5107,gpt4,0.755,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5108,gpt4,0.634,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5109,gpt4,0.661,HISTOLOGIC GRADE
5110,gpt4,0.766,NUMBER OF LYMPH NODES EXAMINED
5111,gpt4,0.676,PROCEDURE
5112,gpt4,0.776,LYMPH NODE(S) FROM PRIOR PROCEDURES
5113,gpt4,0.817,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5114,gpt4,0.65,VISCERAL PLEURA INVASION
5115,gpt4,0.8,NUMBER OF LYMPH NODES EXAMINED
5116,gpt4,0.716,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5117,gpt4,0.675,TUMOR FOCALITY
5118,gpt4,0.721,PROCEDURE
5119,gpt4,0.735,SPREAD THROUGH AIR SPACES (STAS)
5120,gpt4,0.66,HISTOLOGIC GRADE
5121,gpt4,0.635,NODAL SITE(S) EXAMINED
5122,gpt4,0.7,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5123,gpt4,0.731,REGIONAL LYMPH NODE STATUS
5124,gpt4,0.906,MARGIN STATUS FOR INVASIVE CARCINOMA
5125,gpt4,0.698,SPECIMEN LATERALITY
5126,gpt4,0.683,MARGIN STATUS FOR NON-INVASIVE TUMOR
5127,gpt4,0.741,TUMOR SITE
5128,gpt4,0.658,NODAL SITE(S) EXAMINED
5129,gpt4,0.691,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5130,gpt4,0.719,REGIONAL LYMPH NODE STATUS
5131,gpt4,0.861,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5132,gpt4,0.829,MARGIN STATUS FOR INVASIVE CARCINOMA
5133,gpt4,0.785,TUMOR SITE
5134,gpt4,0.784,MARGIN STATUS FOR NON-INVASIVE TUMOR
5135,gpt4,0.655,TUMOR FOCALITY
5136,gpt4,0.658,PROCEDURE
5137,gpt4,0.672,NUMBER OF LYMPH NODES EXAMINED
5138,gpt4,0.68,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5139,gpt4,0.704,SPECIMEN LATERALITY
5140,gpt4,0.661,HISTOLOGIC GRADE
5141,gpt4,0.647,VISCERAL PLEURA INVASION
5142,gpt4,0.641,LYMPH NODE(S) FROM PRIOR PROCEDURES
5143,gpt4,0.848,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5144,gpt4,0.732,REGIONAL LYMPH NODE STATUS
5145,gpt4,0.662,NODAL SITE(S) EXAMINED
5146,gpt4,0.654,TUMOR FOCALITY
5147,gpt4,0.652,PROCEDURE
5148,gpt4,0.733,NUMBER OF LYMPH NODES EXAMINED
5149,gpt4,0.706,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5150,gpt4,0.663,SPECIMEN LATERALITY
5151,gpt4,0.667,TUMOR SITE
5152,gpt4,0.665,HISTOLOGIC GRADE
5153,gpt4,0.706,MARGIN STATUS FOR NON-INVASIVE TUMOR
5154,gpt4,0.656,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5155,gpt4,0.709,MARGIN STATUS FOR INVASIVE CARCINOMA
5156,gpt4,0.657,VISCERAL PLEURA INVASION
5157,gpt4,0.675,LYMPH NODE(S) FROM PRIOR PROCEDURES
5158,gpt4,0.645,HISTOLOGIC GRADE
5159,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
5160,gpt4,0.848,MARGIN STATUS FOR NON-INVASIVE TUMOR
5161,gpt4,0.664,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5162,gpt4,0.682,NUMBER OF LYMPH NODES EXAMINED
5163,gpt4,0.907,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5164,gpt4,0.726,MARGIN STATUS FOR INVASIVE CARCINOMA
5165,gpt4,0.709,NODAL SITE(S) EXAMINED
5166,gpt4,0.697,SPECIMEN LATERALITY
5167,gpt4,0.734,REGIONAL LYMPH NODE STATUS
5168,gpt4,0.704,TUMOR SITE
5169,gpt4,0.668,PROCEDURE
5170,gpt4,0.721,TUMOR FOCALITY
5171,gpt4,0.846,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5172,gpt4,0.656,VISCERAL PLEURA INVASION
5173,gpt4,0.623,VISCERAL PLEURA INVASION
5174,gpt4,0.701,TUMOR SITE
5175,gpt4,0.691,MARGIN STATUS FOR INVASIVE CARCINOMA
5176,gpt4,0.661,LYMPH NODE(S) FROM PRIOR PROCEDURES
5177,gpt4,0.704,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5178,gpt4,0.67,PROCEDURE
5179,gpt4,0.692,REGIONAL LYMPH NODE STATUS
5180,gpt4,0.633,NODAL SITE(S) WITH TUMOR
5181,gpt4,0.671,HISTOLOGIC GRADE
5182,gpt4,0.639,MARGIN STATUS FOR NON-INVASIVE TUMOR
5183,gpt4,0.659,SPECIMEN LATERALITY
5184,gpt4,0.723,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5185,gpt4,0.627,TNM DESCRIPTORS
5186,gpt4,0.669,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5187,gpt4,0.649,NODAL SITE(S) EXAMINED
5188,gpt4,0.737,NUMBER OF LYMPH NODES EXAMINED
5189,gpt4,0.82,NUMBER OF LYMPH NODES WITH TUMOR
5190,gpt4,0.65,TUMOR FOCALITY
5191,gpt4,0.828,NUMBER OF LYMPH NODES EXAMINED
5192,gpt4,0.669,NODAL SITE(S) EXAMINED
5193,gpt4,0.694,LYMPH NODE(S) FROM PRIOR PROCEDURES
5194,gpt4,0.676,TUMOR FOCALITY
5195,gpt4,0.721,REGIONAL LYMPH NODE STATUS
5196,gpt4,0.699,MARGIN STATUS FOR NON-INVASIVE TUMOR
5197,gpt4,0.638,PROCEDURE
5198,gpt4,0.78,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5199,gpt4,0.654,HISTOLOGIC GRADE
5200,gpt4,0.79,MARGIN STATUS FOR INVASIVE CARCINOMA
5201,gpt4,0.656,VISCERAL PLEURA INVASION
5202,gpt4,0.718,TUMOR SITE
5203,gpt4,0.773,SPECIMEN LATERALITY
5204,gpt4,0.628,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5205,gpt4,0.785,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5206,gpt4,0.714,TUMOR SITE
5207,gpt4,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5208,gpt4,0.707,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5209,gpt4,0.664,LYMPH NODE(S) FROM PRIOR PROCEDURES
5210,gpt4,0.668,HISTOLOGIC GRADE
5211,gpt4,0.735,NUMBER OF LYMPH NODES EXAMINED
5212,gpt4,0.693,MARGIN STATUS FOR NON-INVASIVE TUMOR
5213,gpt4,0.691,REGIONAL LYMPH NODE STATUS
5214,gpt4,0.646,NODAL SITE(S) WITH TUMOR
5215,gpt4,0.698,SPECIMEN LATERALITY
5216,gpt4,0.665,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5217,gpt4,0.713,NUMBER OF LYMPH NODES WITH TUMOR
5218,gpt4,0.669,LYMPHOVASCULAR INVASION
5219,gpt4,0.788,PROCEDURE
5220,gpt4,0.725,MARGIN STATUS FOR INVASIVE CARCINOMA
5221,gpt4,0.681,TUMOR FOCALITY
5222,gpt4,0.662,VISCERAL PLEURA INVASION
5223,gpt4,0.67,NODAL SITE(S) EXAMINED
5224,gpt4,0.66,ADDITIONAL FINDINGS
5225,gpt4,0.772,MARGIN STATUS FOR NON-INVASIVE TUMOR
5226,gpt4,0.669,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5227,gpt4,0.637,TUMOR FOCALITY
5228,gpt4,0.797,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5229,gpt4,0.678,LYMPH NODE(S) FROM PRIOR PROCEDURES
5230,gpt4,0.717,TUMOR SITE
5231,gpt4,0.691,VISCERAL PLEURA INVASION
5232,gpt4,0.75,REGIONAL LYMPH NODE STATUS
5233,gpt4,0.744,SPREAD THROUGH AIR SPACES (STAS)
5234,gpt4,0.669,PROCEDURE
5235,gpt4,0.719,NUMBER OF LYMPH NODES EXAMINED
5236,gpt4,0.716,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5237,gpt4,0.69,MARGIN STATUS FOR INVASIVE CARCINOMA
5238,gpt4,0.736,NODAL SITE(S) EXAMINED
5239,gpt4,0.705,SPECIMEN LATERALITY
5240,gpt4,0.742,MARGIN STATUS FOR NON-INVASIVE TUMOR
5241,gpt4,0.669,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5242,gpt4,0.712,PROCEDURE
5243,gpt4,0.645,TUMOR FOCALITY
5244,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
5245,gpt4,0.666,NODAL SITE(S) EXAMINED
5246,gpt4,0.642,NUMBER OF LYMPH NODES EXAMINED
5247,gpt4,0.689,SPREAD THROUGH AIR SPACES (STAS)
5248,gpt4,0.688,HISTOLOGIC GRADE
5249,gpt4,0.767,MARGIN STATUS FOR INVASIVE CARCINOMA
5250,gpt4,0.671,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5251,gpt4,0.809,SPECIMEN LATERALITY
5252,gpt4,0.721,REGIONAL LYMPH NODE STATUS
5253,gpt4,0.747,TUMOR SITE
5254,gpt4,0.7,VISCERAL PLEURA INVASION
5255,gpt4,0.68,ADDITIONAL FINDINGS
5256,gpt4,0.645,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5257,gpt4,0.698,SPECIMEN LATERALITY
5258,gpt4,0.82,NUMBER OF LYMPH NODES EXAMINED
5259,gpt4,0.657,ADDITIONAL FINDINGS
5260,gpt4,0.804,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5261,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
5262,gpt4,0.708,TUMOR SITE
5263,gpt4,0.667,PROCEDURE
5264,gpt4,0.843,MARGIN STATUS FOR NON-INVASIVE TUMOR
5265,gpt4,0.642,NODAL SITE(S) EXAMINED
5266,gpt4,0.656,TUMOR FOCALITY
5267,gpt4,0.674,VISCERAL PLEURA INVASION
5268,gpt4,0.703,MARGIN STATUS FOR INVASIVE CARCINOMA
5269,gpt4,0.697,SPREAD THROUGH AIR SPACES (STAS)
5270,gpt4,0.838,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5271,gpt4,0.743,REGIONAL LYMPH NODE STATUS
5272,gpt4,0.688,HISTOLOGIC GRADE
5273,gpt4,0.695,PROCEDURE
5274,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
5275,gpt4,0.773,SPECIMEN LATERALITY
5276,gpt4,0.636,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5277,gpt4,0.667,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5278,gpt4,0.717,TUMOR SITE
5279,gpt4,0.704,MARGIN STATUS FOR INVASIVE CARCINOMA
5280,gpt4,0.708,LYMPHOVASCULAR INVASION
5281,gpt4,0.824,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5282,gpt4,0.657,TUMOR FOCALITY
5283,gpt4,0.799,MARGIN STATUS FOR NON-INVASIVE TUMOR
5284,gpt4,0.63,NODAL SITE(S) EXAMINED
5285,gpt4,0.663,HISTOLOGIC GRADE
5286,gpt4,0.746,REGIONAL LYMPH NODE STATUS
5287,gpt4,0.687,ADDITIONAL FINDINGS
5288,gpt4,0.649,VISCERAL PLEURA INVASION
5289,gpt4,0.687,SPREAD THROUGH AIR SPACES (STAS)
5290,gpt4,0.668,HISTOLOGIC GRADE
5291,gpt4,0.733,MARGIN STATUS FOR INVASIVE CARCINOMA
5292,gpt4,0.855,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5293,gpt4,0.778,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5294,gpt4,0.669,NODAL SITE(S) EXAMINED
5295,gpt4,0.702,NUMBER OF LYMPH NODES EXAMINED
5296,gpt4,0.738,REGIONAL LYMPH NODE STATUS
5297,gpt4,0.739,MARGIN STATUS FOR NON-INVASIVE TUMOR
5298,gpt4,0.656,LYMPH NODE(S) FROM PRIOR PROCEDURES
5299,gpt4,0.656,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5300,gpt4,0.667,PROCEDURE
5301,gpt4,0.708,TUMOR SITE
5302,gpt4,0.697,SPECIMEN LATERALITY
5303,gpt4,0.67,VISCERAL PLEURA INVASION
5304,gpt4,0.675,TUMOR FOCALITY
5305,gpt4,0.68,HISTOLOGIC GRADE
5306,gpt4,0.795,NUMBER OF LYMPH NODES EXAMINED
5307,gpt4,0.66,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5308,gpt4,0.64,NODAL SITE(S) WITH TUMOR
5309,gpt4,0.799,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5310,gpt4,0.669,LYMPH NODE(S) FROM PRIOR PROCEDURES
5311,gpt4,0.763,MARGIN STATUS FOR INVASIVE CARCINOMA
5312,gpt4,0.687,REGIONAL LYMPH NODE STATUS
5313,gpt4,0.715,PROCEDURE
5314,gpt4,0.735,MARGIN STATUS FOR NON-INVASIVE TUMOR
5315,gpt4,0.701,TUMOR FOCALITY
5316,gpt4,0.709,TUMOR SITE
5317,gpt4,0.642,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5318,gpt4,0.683,SPECIMEN LATERALITY
5319,gpt4,0.639,NODAL SITE(S) EXAMINED
5320,gpt4,0.72,NUMBER OF LYMPH NODES WITH TUMOR
5321,gpt4,0.687,VISCERAL PLEURA INVASION
5322,gpt4,0.657,TUMOR FOCALITY
5323,gpt4,0.76,REGIONAL LYMPH NODE STATUS
5324,gpt4,0.673,SPECIMEN LATERALITY
5325,gpt4,0.726,PROCEDURE
5326,gpt4,0.701,NUMBER OF LYMPH NODES EXAMINED
5327,gpt4,0.902,LYMPH NODE(S) FROM PRIOR PROCEDURES
5328,gpt4,0.672,HISTOLOGIC GRADE
5329,gpt4,0.891,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5330,gpt4,0.677,VISCERAL PLEURA INVASION
5331,gpt4,0.666,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5332,gpt4,0.676,NODAL SITE(S) EXAMINED
5333,gpt4,0.791,TUMOR SITE
5334,gpt4,0.693,MARGIN STATUS FOR INVASIVE CARCINOMA
5335,gpt4,0.701,MARGIN STATUS FOR NON-INVASIVE TUMOR
5336,gpt4,0.654,NODAL SITE(S) EXAMINED
5337,gpt4,0.718,TUMOR SITE
5338,gpt4,0.705,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5339,gpt4,0.694,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5340,gpt4,0.697,SPECIMEN LATERALITY
5341,gpt4,0.639,TUMOR FOCALITY
5342,gpt4,0.684,SPREAD THROUGH AIR SPACES (STAS)
5343,gpt4,0.705,HISTOLOGIC GRADE
5344,gpt4,0.679,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5345,gpt4,0.655,LYMPH NODE(S) FROM PRIOR PROCEDURES
5346,gpt4,0.704,MARGIN STATUS FOR NON-INVASIVE TUMOR
5347,gpt4,0.683,PROCEDURE
5348,gpt4,0.664,VISCERAL PLEURA INVASION
5349,gpt4,0.741,REGIONAL LYMPH NODE STATUS
5350,gpt4,0.679,ADDITIONAL FINDINGS
5351,gpt4,0.679,MARGIN STATUS FOR INVASIVE CARCINOMA
5352,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
5353,gpt4,0.666,MARGIN STATUS FOR NON-INVASIVE TUMOR
5354,gpt4,0.667,TUMOR FOCALITY
5355,gpt4,0.718,TUMOR SITE
5356,gpt4,0.656,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5357,gpt4,0.712,MARGIN STATUS FOR INVASIVE CARCINOMA
5358,gpt4,0.637,ADDITIONAL FINDINGS
5359,gpt4,0.671,VISCERAL PLEURA INVASION
5360,gpt4,0.687,SPECIMEN LATERALITY
5361,gpt4,0.898,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5362,gpt4,0.827,PROCEDURE
5363,gpt4,0.7,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5364,gpt4,0.676,SPREAD THROUGH AIR SPACES (STAS)
5365,gpt4,0.722,TUMOR SITE
5366,gpt4,0.776,LYMPH NODE(S) FROM PRIOR PROCEDURES
5367,gpt4,0.675,MARGIN STATUS FOR NON-INVASIVE TUMOR
5368,gpt4,0.789,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5369,gpt4,0.666,HISTOLOGIC GRADE
5370,gpt4,0.73,REGIONAL LYMPH NODE STATUS
5371,gpt4,0.648,PROCEDURE
5372,gpt4,0.642,NODAL SITE(S) EXAMINED
5373,gpt4,0.645,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5374,gpt4,0.685,TUMOR FOCALITY
5375,gpt4,0.689,MARGIN STATUS FOR INVASIVE CARCINOMA
5376,gpt4,0.669,VISCERAL PLEURA INVASION
5377,gpt4,0.672,SPREAD THROUGH AIR SPACES (STAS)
5378,gpt4,0.695,SPECIMEN LATERALITY
5379,gpt4,0.896,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5380,gpt4,0.672,HISTOLOGIC GRADE
5381,gpt4,0.72,ADDITIONAL FINDINGS
5382,gpt4,0.735,REGIONAL LYMPH NODE STATUS
5383,gpt4,0.679,LYMPH NODE(S) FROM PRIOR PROCEDURES
5384,gpt4,0.696,MARGIN STATUS FOR INVASIVE CARCINOMA
5385,gpt4,0.656,TUMOR FOCALITY
5386,gpt4,0.709,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5387,gpt4,0.765,NUMBER OF LYMPH NODES EXAMINED
5388,gpt4,0.65,NODAL SITE(S) EXAMINED
5389,gpt4,0.678,VISCERAL PLEURA INVASION
5390,gpt4,0.679,SPREAD THROUGH AIR SPACES (STAS)
5391,gpt4,0.661,PROCEDURE
5392,gpt4,0.698,SPECIMEN LATERALITY
5393,gpt4,0.709,TUMOR SITE
5394,gpt4,0.698,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5395,gpt4,0.68,TNM DESCRIPTORS
5396,gpt4,0.763,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5397,gpt4,0.645,MARGIN STATUS FOR NON-INVASIVE TUMOR
5398,gpt4,0.725,REGIONAL LYMPH NODE STATUS
5399,gpt4,0.696,VISCERAL PLEURA INVASION
5400,gpt4,0.66,SPECIMEN LATERALITY
5401,gpt4,0.699,MARGIN STATUS FOR NON-INVASIVE TUMOR
5402,gpt4,0.776,LYMPH NODE(S) FROM PRIOR PROCEDURES
5403,gpt4,0.673,HISTOLOGIC GRADE
5404,gpt4,0.648,LYMPHOVASCULAR INVASION
5405,gpt4,0.67,NODAL SITE(S) EXAMINED
5406,gpt4,0.657,ADDITIONAL FINDINGS
5407,gpt4,0.722,TUMOR SITE
5408,gpt4,0.664,PROCEDURE
5409,gpt4,0.671,SPREAD THROUGH AIR SPACES (STAS)
5410,gpt4,0.693,MARGIN STATUS FOR INVASIVE CARCINOMA
5411,gpt4,0.631,TUMOR FOCALITY
5412,gpt4,0.651,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5413,gpt4,0.717,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5414,gpt4,0.899,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5415,gpt4,0.798,MARGIN STATUS FOR NON-INVASIVE TUMOR
5416,gpt4,0.67,PROCEDURE
5417,gpt4,0.635,TUMOR FOCALITY
5418,gpt4,0.82,NUMBER OF LYMPH NODES WITH TUMOR
5419,gpt4,0.662,TNM DESCRIPTORS
5420,gpt4,0.635,NODAL SITE(S) WITH TUMOR
5421,gpt4,0.649,LYMPHOVASCULAR INVASION
5422,gpt4,0.667,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5423,gpt4,0.705,TUMOR SITE
5424,gpt4,0.773,SPECIMEN LATERALITY
5425,gpt4,0.804,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5426,gpt4,0.759,LYMPH NODE(S) FROM PRIOR PROCEDURES
5427,gpt4,0.679,VISCERAL PLEURA INVASION
5428,gpt4,0.649,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5429,gpt4,0.693,HISTOLOGIC GRADE
5430,gpt4,0.628,ADDITIONAL FINDINGS
5431,gpt4,0.662,NODAL SITE(S) EXAMINED
5432,gpt4,0.691,REGIONAL LYMPH NODE STATUS
5433,gpt4,0.686,MARGIN STATUS FOR INVASIVE CARCINOMA
5434,gpt4,0.798,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5435,gpt4,0.773,SPECIMEN LATERALITY
5436,gpt4,0.689,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5437,gpt4,0.732,MARGIN STATUS FOR INVASIVE CARCINOMA
5438,gpt4,0.699,PROCEDURE
5439,gpt4,0.655,TUMOR FOCALITY
5440,gpt4,0.673,VISCERAL PLEURA INVASION
5441,gpt4,0.733,MARGIN STATUS FOR NON-INVASIVE TUMOR
5442,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
5443,gpt4,0.8,NUMBER OF LYMPH NODES EXAMINED
5444,gpt4,0.729,REGIONAL LYMPH NODE STATUS
5445,gpt4,0.663,NODAL SITE(S) EXAMINED
5446,gpt4,0.699,SPREAD THROUGH AIR SPACES (STAS)
5447,gpt4,0.723,TUMOR SITE
5448,gpt4,0.671,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5449,gpt4,0.67,HISTOLOGIC GRADE
5450,gpt4,0.669,HISTOLOGIC GRADE
5451,gpt4,0.703,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5452,gpt4,0.626,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5453,gpt4,0.811,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5454,gpt4,0.723,REGIONAL LYMPH NODE STATUS
5455,gpt4,0.654,VISCERAL PLEURA INVASION
5456,gpt4,0.743,NUMBER OF LYMPH NODES EXAMINED
5457,gpt4,0.728,LYMPH NODE(S) FROM PRIOR PROCEDURES
5458,gpt4,0.675,TUMOR FOCALITY
5459,gpt4,0.651,NODAL SITE(S) EXAMINED
5460,gpt4,0.714,MARGIN STATUS FOR NON-INVASIVE TUMOR
5461,gpt4,0.726,PROCEDURE
5462,gpt4,0.725,TUMOR SITE
5463,gpt4,0.714,SPECIMEN LATERALITY
5464,gpt4,0.73,MARGIN STATUS FOR INVASIVE CARCINOMA
5465,gpt4,0.683,LYMPH NODE(S) FROM PRIOR PROCEDURES
5466,gpt4,0.637,PROCEDURE
5467,gpt4,0.658,NODAL SITE(S) WITH TUMOR
5468,gpt4,0.649,TUMOR FOCALITY
5469,gpt4,0.653,NODAL SITE(S) EXAMINED
5470,gpt4,0.699,REGIONAL LYMPH NODE STATUS
5471,gpt4,0.701,TUMOR SITE
5472,gpt4,0.685,MARGIN STATUS FOR NON-INVASIVE TUMOR
5473,gpt4,0.697,SPECIMEN LATERALITY
5474,gpt4,0.838,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5475,gpt4,0.668,VISCERAL PLEURA INVASION
5476,gpt4,0.82,NUMBER OF LYMPH NODES WITH TUMOR
5477,gpt4,0.637,HISTOLOGIC GRADE
5478,gpt4,0.679,MARGIN STATUS FOR INVASIVE CARCINOMA
5479,gpt4,0.657,TNM DESCRIPTORS
5480,gpt4,0.669,TUMOR FOCALITY
5481,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
5482,gpt4,0.658,NODAL SITE(S) WITH TUMOR
5483,gpt4,0.81,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5484,gpt4,0.667,LYMPHOVASCULAR INVASION
5485,gpt4,0.64,NODAL SITE(S) EXAMINED
5486,gpt4,0.736,NUMBER OF LYMPH NODES EXAMINED
5487,gpt4,0.722,TUMOR SITE
5488,gpt4,0.708,REGIONAL LYMPH NODE STATUS
5489,gpt4,0.651,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5490,gpt4,0.663,MARGIN STATUS FOR INVASIVE CARCINOMA
5491,gpt4,0.672,HISTOLOGIC GRADE
5492,gpt4,0.662,VISCERAL PLEURA INVASION
5493,gpt4,0.712,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5494,gpt4,0.717,MARGIN STATUS FOR NON-INVASIVE TUMOR
5495,gpt4,0.66,PROCEDURE
5496,gpt4,0.672,TNM DESCRIPTORS
5497,gpt4,0.713,NUMBER OF LYMPH NODES WITH TUMOR
5498,gpt4,0.66,PROCEDURE
5499,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
5500,gpt4,0.697,SPECIMEN LATERALITY
5501,gpt4,0.671,TUMOR FOCALITY
5502,gpt4,0.74,REGIONAL LYMPH NODE STATUS
5503,gpt4,0.789,MARGIN STATUS FOR INVASIVE CARCINOMA
5504,gpt4,0.715,TUMOR SITE
5505,gpt4,0.918,MARGIN STATUS FOR NON-INVASIVE TUMOR
5506,gpt4,0.813,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5507,gpt4,0.712,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5508,gpt4,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5509,gpt4,0.707,HISTOLOGIC GRADE
5510,gpt4,0.637,NODAL SITE(S) EXAMINED
5511,gpt4,0.735,VISCERAL PLEURA INVASION
5512,gpt4,0.724,REGIONAL LYMPH NODE STATUS
5513,gpt4,0.664,TNM DESCRIPTORS
5514,gpt4,0.614,TUMOR FOCALITY
5515,gpt4,0.678,MARGIN STATUS FOR NON-INVASIVE TUMOR
5516,gpt4,0.658,SPREAD THROUGH AIR SPACES (STAS)
5517,gpt4,0.712,TUMOR SITE
5518,gpt4,0.712,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5519,gpt4,0.716,MARGIN STATUS FOR INVASIVE CARCINOMA
5520,gpt4,0.664,NODAL SITE(S) EXAMINED
5521,gpt4,0.639,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5522,gpt4,0.679,VISCERAL PLEURA INVASION
5523,gpt4,0.68,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5524,gpt4,0.659,LYMPH NODE(S) FROM PRIOR PROCEDURES
5525,gpt4,0.665,SPECIMEN LATERALITY
5526,gpt4,0.645,PROCEDURE
5527,gpt4,0.708,REGIONAL LYMPH NODE STATUS
5528,gpt4,0.671,SPECIMEN LATERALITY
5529,gpt4,0.692,PROCEDURE
5530,gpt4,0.652,LYMPH NODE(S) FROM PRIOR PROCEDURES
5531,gpt4,0.653,NODAL SITE(S) WITH TUMOR
5532,gpt4,0.649,NODAL SITE(S) EXAMINED
5533,gpt4,0.706,MARGIN STATUS FOR INVASIVE CARCINOMA
5534,gpt4,0.737,TUMOR SITE
5535,gpt4,0.731,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5536,gpt4,0.649,TUMOR FOCALITY
5537,gpt4,0.65,MARGIN STATUS FOR NON-INVASIVE TUMOR
5538,gpt4,0.642,VISCERAL PLEURA INVASION
5539,gpt4,0.718,TUMOR SITE
5540,gpt4,0.74,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5541,gpt4,0.684,HISTOLOGIC GRADE
5542,gpt4,0.793,LYMPH NODE(S) FROM PRIOR PROCEDURES
5543,gpt4,0.701,MARGIN STATUS FOR INVASIVE CARCINOMA
5544,gpt4,0.73,REGIONAL LYMPH NODE STATUS
5545,gpt4,0.771,MARGIN STATUS FOR NON-INVASIVE TUMOR
5546,gpt4,0.625,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5547,gpt4,0.675,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5548,gpt4,0.773,SPECIMEN LATERALITY
5549,gpt4,0.664,NODAL SITE(S) EXAMINED
5550,gpt4,0.659,VISCERAL PLEURA INVASION
5551,gpt4,0.638,PROCEDURE
5552,gpt4,0.687,TUMOR FOCALITY
5553,gpt4,0.665,TNM DESCRIPTORS
5554,gpt4,0.656,MARGIN STATUS FOR NON-INVASIVE TUMOR
5555,gpt4,0.67,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5556,gpt4,0.657,HISTOLOGIC GRADE
5557,gpt4,0.671,TUMOR FOCALITY
5558,gpt4,0.707,MARGIN STATUS FOR INVASIVE CARCINOMA
5559,gpt4,0.644,PROCEDURE
5560,gpt4,0.77,LYMPH NODE(S) FROM PRIOR PROCEDURES
5561,gpt4,0.684,SPECIMEN LATERALITY
5562,gpt4,0.804,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5563,gpt4,0.667,VISCERAL PLEURA INVASION
5564,gpt4,0.682,NUMBER OF LYMPH NODES EXAMINED
5565,gpt4,0.643,NODAL SITE(S) EXAMINED
5566,gpt4,0.671,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5567,gpt4,0.713,REGIONAL LYMPH NODE STATUS
5568,gpt4,0.718,TUMOR SITE
5569,gpt4,0.699,HISTOLOGIC GRADE
5570,gpt4,0.659,PROCEDURE
5571,gpt4,0.682,TUMOR FOCALITY
5572,gpt4,0.605,NODAL SITE(S) EXAMINED
5573,gpt4,0.669,VISCERAL PLEURA INVASION
5574,gpt4,0.721,TUMOR SITE
5575,gpt4,0.798,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5576,gpt4,0.655,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5577,gpt4,0.701,MARGIN STATUS FOR NON-INVASIVE TUMOR
5578,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
5579,gpt4,0.82,NUMBER OF LYMPH NODES EXAMINED
5580,gpt4,0.746,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5581,gpt4,0.692,MARGIN STATUS FOR INVASIVE CARCINOMA
5582,gpt4,0.73,REGIONAL LYMPH NODE STATUS
5583,gpt4,0.714,SPECIMEN LATERALITY
5584,gpt4,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5585,gpt4,0.697,SPECIMEN LATERALITY
5586,gpt4,0.755,REGIONAL LYMPH NODE STATUS
5587,gpt4,0.652,VISCERAL PLEURA INVASION
5588,gpt4,0.661,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5589,gpt4,0.644,LYMPH NODE(S) FROM PRIOR PROCEDURES
5590,gpt4,0.67,TUMOR FOCALITY
5591,gpt4,0.705,TUMOR SITE
5592,gpt4,0.683,NUMBER OF LYMPH NODES EXAMINED
5593,gpt4,0.695,MARGIN STATUS FOR INVASIVE CARCINOMA
5594,gpt4,0.674,PROCEDURE
5595,gpt4,0.757,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5596,gpt4,0.65,NODAL SITE(S) EXAMINED
5597,gpt4,0.661,MARGIN STATUS FOR NON-INVASIVE TUMOR
5598,gpt4,0.668,PROCEDURE
5599,gpt4,0.697,SPECIMEN LATERALITY
5600,gpt4,0.711,TUMOR SITE
5601,gpt4,0.706,MARGIN STATUS FOR INVASIVE CARCINOMA
5602,gpt4,0.736,REGIONAL LYMPH NODE STATUS
5603,gpt4,0.67,TUMOR FOCALITY
5604,gpt4,0.656,NUMBER OF LYMPH NODES EXAMINED
5605,gpt4,0.711,HISTOLOGIC GRADE
5606,gpt4,0.684,SPREAD THROUGH AIR SPACES (STAS)
5607,gpt4,0.82,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5608,gpt4,0.637,NODAL SITE(S) EXAMINED
5609,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
5610,gpt4,0.674,VISCERAL PLEURA INVASION
5611,gpt4,0.672,MARGIN STATUS FOR NON-INVASIVE TUMOR
5612,gpt4,0.7,NUMBER OF LYMPH NODES EXAMINED
5613,gpt4,0.773,SPECIMEN LATERALITY
5614,gpt4,0.68,PROCEDURE
5615,gpt4,0.672,TNM DESCRIPTORS
5616,gpt4,0.741,NODAL SITE(S) EXAMINED
5617,gpt4,0.776,LYMPH NODE(S) FROM PRIOR PROCEDURES
5618,gpt4,0.651,MARGIN STATUS FOR INVASIVE CARCINOMA
5619,gpt4,0.67,HISTOLOGIC GRADE
5620,gpt4,0.732,REGIONAL LYMPH NODE STATUS
5621,gpt4,0.629,VISCERAL PLEURA INVASION
5622,gpt4,0.673,MARGIN STATUS FOR NON-INVASIVE TUMOR
5623,gpt4,0.899,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5624,gpt4,0.631,TUMOR FOCALITY
5625,gpt4,0.72,TUMOR SITE
5626,gpt4,0.668,LYMPH NODE(S) FROM PRIOR PROCEDURES
5627,gpt4,0.646,VISCERAL PLEURA INVASION
5628,gpt4,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5629,gpt4,0.683,NODAL SITE(S) EXAMINED
5630,gpt4,0.704,TUMOR SITE
5631,gpt4,0.718,PROCEDURE
5632,gpt4,0.735,REGIONAL LYMPH NODE STATUS
5633,gpt4,0.706,MARGIN STATUS FOR INVASIVE CARCINOMA
5634,gpt4,0.685,NUMBER OF LYMPH NODES EXAMINED
5635,gpt4,0.677,HISTOLOGIC GRADE
5636,gpt4,0.809,SPECIMEN LATERALITY
5637,gpt4,0.652,TUMOR FOCALITY
5638,gpt4,0.699,MARGIN STATUS FOR NON-INVASIVE TUMOR
5639,gpt4,0.906,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5640,gpt4,0.697,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5641,gpt4,0.76,MARGIN STATUS FOR NON-INVASIVE TUMOR
5642,gpt4,0.66,TUMOR SITE
5643,gpt4,0.663,HISTOLOGIC GRADE
5644,gpt4,0.746,REGIONAL LYMPH NODE STATUS
5645,gpt4,0.707,LYMPH NODE(S) FROM PRIOR PROCEDURES
5646,gpt4,0.703,PROCEDURE
5647,gpt4,0.655,NODAL SITE(S) EXAMINED
5648,gpt4,0.72,SPECIMEN LATERALITY
5649,gpt4,0.893,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5650,gpt4,0.661,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5651,gpt4,0.662,TUMOR FOCALITY
5652,gpt4,0.688,VISCERAL PLEURA INVASION
5653,gpt4,0.708,MARGIN STATUS FOR INVASIVE CARCINOMA
5654,gpt4,0.683,SPREAD THROUGH AIR SPACES (STAS)
5655,gpt4,0.701,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5656,gpt4,0.705,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5657,gpt4,0.906,MARGIN STATUS FOR INVASIVE CARCINOMA
5658,gpt4,0.659,HISTOLOGIC GRADE
5659,gpt4,0.737,REGIONAL LYMPH NODE STATUS
5660,gpt4,0.689,VISCERAL PLEURA INVASION
5661,gpt4,0.671,TUMOR FOCALITY
5662,gpt4,0.805,NUMBER OF LYMPH NODES EXAMINED
5663,gpt4,0.779,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5664,gpt4,0.657,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5665,gpt4,0.72,LYMPH NODE(S) FROM PRIOR PROCEDURES
5666,gpt4,0.687,SPECIMEN LATERALITY
5667,gpt4,0.668,PROCEDURE
5668,gpt4,0.918,MARGIN STATUS FOR NON-INVASIVE TUMOR
5669,gpt4,0.688,SPREAD THROUGH AIR SPACES (STAS)
5670,gpt4,0.713,TUMOR SITE
5671,gpt4,0.667,NODAL SITE(S) EXAMINED
5672,gpt4,0.704,HISTOLOGIC GRADE
5673,gpt4,0.718,TUMOR SITE
5674,gpt4,0.677,VISCERAL PLEURA INVASION
5675,gpt4,0.756,MARGIN STATUS FOR INVASIVE CARCINOMA
5676,gpt4,0.67,SPECIMEN LATERALITY
5677,gpt4,0.65,NODAL SITE(S) EXAMINED
5678,gpt4,0.65,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5679,gpt4,0.712,REGIONAL LYMPH NODE STATUS
5680,gpt4,0.685,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5681,gpt4,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5682,gpt4,0.682,LYMPH NODE(S) FROM PRIOR PROCEDURES
5683,gpt4,0.742,MARGIN STATUS FOR NON-INVASIVE TUMOR
5684,gpt4,0.666,PROCEDURE
5685,gpt4,0.728,ADDITIONAL FINDINGS
5686,gpt4,0.676,SPREAD THROUGH AIR SPACES (STAS)
5687,gpt4,0.651,TUMOR FOCALITY
5688,gpt4,0.902,LYMPH NODE(S) FROM PRIOR PROCEDURES
5689,gpt4,0.731,VISCERAL PLEURA INVASION
5690,gpt4,0.65,LYMPHOVASCULAR INVASION
5691,gpt4,0.667,TUMOR SITE
5692,gpt4,0.718,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5693,gpt4,0.7,NUMBER OF LYMPH NODES EXAMINED
5694,gpt4,0.809,SPECIMEN LATERALITY
5695,gpt4,0.679,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5696,gpt4,0.806,MARGIN STATUS FOR NON-INVASIVE TUMOR
5697,gpt4,0.638,HISTOLOGIC GRADE
5698,gpt4,0.766,MARGIN STATUS FOR INVASIVE CARCINOMA
5699,gpt4,0.611,NODAL SITE(S) EXAMINED
5700,gpt4,0.666,TUMOR FOCALITY
5701,gpt4,0.736,HISTOLOGIC GRADE
5702,gpt4,0.827,PROCEDURE
5703,gpt4,0.893,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5704,gpt4,0.743,MARGIN STATUS FOR NON-INVASIVE TUMOR
5705,gpt4,0.725,REGIONAL LYMPH NODE STATUS
5706,gpt4,0.654,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5707,gpt4,0.657,HISTOLOGIC GRADE
5708,gpt4,0.682,VISCERAL PLEURA INVASION
5709,gpt4,0.68,MARGIN STATUS FOR NON-INVASIVE TUMOR
5710,gpt4,0.699,MARGIN STATUS FOR INVASIVE CARCINOMA
5711,gpt4,0.622,NODAL SITE(S) WITH TUMOR
5712,gpt4,0.671,PROCEDURE
5713,gpt4,0.683,NODAL SITE(S) EXAMINED
5714,gpt4,0.664,LYMPH NODE(S) FROM PRIOR PROCEDURES
5715,gpt4,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5716,gpt4,0.646,LYMPHOVASCULAR INVASION
5717,gpt4,0.682,SPECIMEN LATERALITY
5718,gpt4,0.735,TUMOR SITE
5719,gpt4,0.709,NUMBER OF LYMPH NODES WITH TUMOR
5720,gpt4,0.679,REGIONAL LYMPH NODE STATUS
5721,gpt4,0.647,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5722,gpt4,0.674,TUMOR FOCALITY
5723,gpt4,0.689,HISTOLOGIC GRADE
5724,gpt4,0.651,NODAL SITE(S) EXAMINED
5725,gpt4,0.658,LYMPHOVASCULAR INVASION
5726,gpt4,0.71,TUMOR SITE
5727,gpt4,0.648,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5728,gpt4,0.704,SPECIMEN LATERALITY
5729,gpt4,0.883,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5730,gpt4,0.672,PROCEDURE
5731,gpt4,0.638,TUMOR FOCALITY
5732,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
5733,gpt4,0.803,NUMBER OF LYMPH NODES EXAMINED
5734,gpt4,0.645,VISCERAL PLEURA INVASION
5735,gpt4,0.847,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5736,gpt4,0.675,SPREAD THROUGH AIR SPACES (STAS)
5737,gpt4,0.751,MARGIN STATUS FOR NON-INVASIVE TUMOR
5738,gpt4,0.736,MARGIN STATUS FOR NON-INVASIVE TUMOR
5739,gpt4,0.788,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5740,gpt4,0.732,LYMPH NODE(S) FROM PRIOR PROCEDURES
5741,gpt4,0.635,NODAL SITE(S) EXAMINED
5742,gpt4,0.676,SPREAD THROUGH AIR SPACES (STAS)
5743,gpt4,0.729,TUMOR SITE
5744,gpt4,0.739,VISCERAL PLEURA INVASION
5745,gpt4,0.654,TUMOR FOCALITY
5746,gpt4,0.718,HISTOLOGIC GRADE
5747,gpt4,0.676,MARGIN STATUS FOR INVASIVE CARCINOMA
5748,gpt4,0.735,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5749,gpt4,0.734,REGIONAL LYMPH NODE STATUS
5750,gpt4,0.712,SPECIMEN LATERALITY
5751,gpt4,0.805,NUMBER OF LYMPH NODES EXAMINED
5752,gpt4,0.704,ADDITIONAL FINDINGS
5753,gpt4,0.66,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5754,gpt4,0.649,PROCEDURE
5755,gpt4,0.736,REGIONAL LYMPH NODE STATUS
5756,gpt4,0.746,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5757,gpt4,0.715,MARGIN STATUS FOR INVASIVE CARCINOMA
5758,gpt4,0.701,MARGIN STATUS FOR NON-INVASIVE TUMOR
5759,gpt4,0.693,SPECIMEN LATERALITY
5760,gpt4,0.847,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5761,gpt4,0.66,HISTOLOGIC GRADE
5762,gpt4,0.719,TUMOR SITE
5763,gpt4,0.652,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5764,gpt4,0.679,PROCEDURE
5765,gpt4,0.644,VISCERAL PLEURA INVASION
5766,gpt4,0.66,NODAL SITE(S) EXAMINED
5767,gpt4,0.663,TUMOR FOCALITY
5768,gpt4,0.801,NUMBER OF LYMPH NODES EXAMINED
5769,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
5770,gpt4,0.662,ADDITIONAL FINDINGS
5771,gpt4,0.722,TUMOR SITE
5772,gpt4,0.668,TUMOR FOCALITY
5773,gpt4,0.686,VISCERAL PLEURA INVASION
5774,gpt4,0.714,NODAL SITE(S) EXAMINED
5775,gpt4,0.655,TNM DESCRIPTORS
5776,gpt4,0.82,NUMBER OF LYMPH NODES EXAMINED
5777,gpt4,0.662,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5778,gpt4,0.73,REGIONAL LYMPH NODE STATUS
5779,gpt4,0.661,PROCEDURE
5780,gpt4,0.702,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5781,gpt4,0.776,LYMPH NODE(S) FROM PRIOR PROCEDURES
5782,gpt4,0.704,SPECIMEN LATERALITY
5783,gpt4,0.721,HISTOLOGIC GRADE
5784,gpt4,0.711,MARGIN STATUS FOR INVASIVE CARCINOMA
5785,gpt4,0.792,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5786,gpt4,0.656,MARGIN STATUS FOR NON-INVASIVE TUMOR
5787,gpt4,0.673,LYMPH NODE(S) FROM PRIOR PROCEDURES
5788,gpt4,0.687,MARGIN STATUS FOR NON-INVASIVE TUMOR
5789,gpt4,0.682,MARGIN STATUS FOR INVASIVE CARCINOMA
5790,gpt4,0.713,TUMOR SITE
5791,gpt4,0.668,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5792,gpt4,0.837,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5793,gpt4,0.729,REGIONAL LYMPH NODE STATUS
5794,gpt4,0.695,PROCEDURE
5795,gpt4,0.668,TUMOR FOCALITY
5796,gpt4,0.664,NODAL SITE(S) EXAMINED
5797,gpt4,0.662,HISTOLOGIC GRADE
5798,gpt4,0.647,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5799,gpt4,0.683,VISCERAL PLEURA INVASION
5800,gpt4,0.691,NUMBER OF LYMPH NODES EXAMINED
5801,gpt4,0.694,SPREAD THROUGH AIR SPACES (STAS)
5802,gpt4,0.678,SPECIMEN LATERALITY
5803,gpt4,0.658,NODAL SITE(S) EXAMINED
5804,gpt4,0.656,HISTOLOGIC GRADE
5805,gpt4,0.666,ADDITIONAL FINDINGS
5806,gpt4,0.77,MARGIN STATUS FOR NON-INVASIVE TUMOR
5807,gpt4,0.65,PROCEDURE
5808,gpt4,0.687,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5809,gpt4,0.686,TUMOR SITE
5810,gpt4,0.693,MARGIN STATUS FOR INVASIVE CARCINOMA
5811,gpt4,0.726,REGIONAL LYMPH NODE STATUS
5812,gpt4,0.671,TUMOR FOCALITY
5813,gpt4,0.629,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5814,gpt4,0.708,LYMPH NODE(S) FROM PRIOR PROCEDURES
5815,gpt4,0.702,NUMBER OF LYMPH NODES EXAMINED
5816,gpt4,0.914,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5817,gpt4,0.667,VISCERAL PLEURA INVASION
5818,gpt4,0.77,SPECIMEN LATERALITY
5819,gpt4,0.734,REGIONAL LYMPH NODE STATUS
5820,gpt4,0.676,TUMOR FOCALITY
5821,gpt4,0.678,VISCERAL PLEURA INVASION
5822,gpt4,0.649,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5823,gpt4,0.776,MARGIN STATUS FOR INVASIVE CARCINOMA
5824,gpt4,0.721,TUMOR SITE
5825,gpt4,0.776,LYMPH NODE(S) FROM PRIOR PROCEDURES
5826,gpt4,0.809,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5827,gpt4,0.72,SPECIMEN LATERALITY
5828,gpt4,0.644,PROCEDURE
5829,gpt4,0.756,MARGIN STATUS FOR NON-INVASIVE TUMOR
5830,gpt4,0.798,NUMBER OF LYMPH NODES EXAMINED
5831,gpt4,0.664,HISTOLOGIC GRADE
5832,gpt4,0.628,NODAL SITE(S) EXAMINED
5833,gpt4,0.811,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5834,gpt4,0.638,TUMOR FOCALITY
5835,gpt4,0.692,NUMBER OF LYMPH NODES EXAMINED
5836,gpt4,0.671,VISCERAL PLEURA INVASION
5837,gpt4,0.759,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5838,gpt4,0.644,NODAL SITE(S) EXAMINED
5839,gpt4,0.751,MARGIN STATUS FOR INVASIVE CARCINOMA
5840,gpt4,0.739,REGIONAL LYMPH NODE STATUS
5841,gpt4,0.713,SPECIMEN LATERALITY
5842,gpt4,0.715,TUMOR SITE
5843,gpt4,0.691,MARGIN STATUS FOR NON-INVASIVE TUMOR
5844,gpt4,0.666,PROCEDURE
5845,gpt4,0.668,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5846,gpt4,0.675,HISTOLOGIC GRADE
5847,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
5848,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
5849,gpt4,0.793,TUMOR SITE
5850,gpt4,0.741,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5851,gpt4,0.664,PROCEDURE
5852,gpt4,0.671,ADDITIONAL FINDINGS
5853,gpt4,0.809,SPECIMEN LATERALITY
5854,gpt4,0.686,HISTOLOGIC GRADE
5855,gpt4,0.887,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5856,gpt4,0.62,NODAL SITE(S) EXAMINED
5857,gpt4,0.656,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5858,gpt4,0.719,MARGIN STATUS FOR NON-INVASIVE TUMOR
5859,gpt4,0.735,VISCERAL PLEURA INVASION
5860,gpt4,0.649,SPREAD THROUGH AIR SPACES (STAS)
5861,gpt4,0.714,MARGIN STATUS FOR INVASIVE CARCINOMA
5862,gpt4,0.723,NUMBER OF LYMPH NODES EXAMINED
5863,gpt4,0.73,REGIONAL LYMPH NODE STATUS
5864,gpt4,0.65,TUMOR FOCALITY
5865,gpt4,0.666,TUMOR FOCALITY
5866,gpt4,0.637,NODAL SITE(S) EXAMINED
5867,gpt4,0.734,VISCERAL PLEURA INVASION
5868,gpt4,0.693,PROCEDURE
5869,gpt4,0.667,SPREAD THROUGH AIR SPACES (STAS)
5870,gpt4,0.918,MARGIN STATUS FOR NON-INVASIVE TUMOR
5871,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
5872,gpt4,0.677,MARGIN STATUS FOR INVASIVE CARCINOMA
5873,gpt4,0.809,SPECIMEN LATERALITY
5874,gpt4,0.721,HISTOLOGIC GRADE
5875,gpt4,0.727,REGIONAL LYMPH NODE STATUS
5876,gpt4,0.666,ADDITIONAL FINDINGS
5877,gpt4,0.901,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5878,gpt4,0.722,TUMOR SITE
5879,gpt4,0.65,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5880,gpt4,0.847,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5881,gpt4,0.797,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5882,gpt4,0.713,HISTOLOGIC GRADE
5883,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
5884,gpt4,0.711,MARGIN STATUS FOR INVASIVE CARCINOMA
5885,gpt4,0.715,TUMOR SITE
5886,gpt4,0.661,LYMPHOVASCULAR INVASION
5887,gpt4,0.789,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5888,gpt4,0.918,MARGIN STATUS FOR NON-INVASIVE TUMOR
5889,gpt4,0.664,PROCEDURE
5890,gpt4,0.663,TUMOR FOCALITY
5891,gpt4,0.738,REGIONAL LYMPH NODE STATUS
5892,gpt4,0.711,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5893,gpt4,0.6,NODAL SITE(S) EXAMINED
5894,gpt4,0.712,SPECIMEN LATERALITY
5895,gpt4,0.693,NUMBER OF LYMPH NODES EXAMINED
5896,gpt4,0.67,SPREAD THROUGH AIR SPACES (STAS)
5897,gpt4,0.703,VISCERAL PLEURA INVASION
5898,gpt4,0.728,REGIONAL LYMPH NODE STATUS
5899,gpt4,0.708,TUMOR SITE
5900,gpt4,0.671,VISCERAL PLEURA INVASION
5901,gpt4,0.658,TUMOR FOCALITY
5902,gpt4,0.686,HISTOLOGIC GRADE
5903,gpt4,0.676,TNM DESCRIPTORS
5904,gpt4,0.653,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5905,gpt4,0.635,ADDITIONAL FINDINGS
5906,gpt4,0.69,MARGIN STATUS FOR NON-INVASIVE TUMOR
5907,gpt4,0.773,SPECIMEN LATERALITY
5908,gpt4,0.811,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5909,gpt4,0.697,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5910,gpt4,0.695,SPREAD THROUGH AIR SPACES (STAS)
5911,gpt4,0.682,LYMPH NODE(S) FROM PRIOR PROCEDURES
5912,gpt4,0.659,PROCEDURE
5913,gpt4,0.733,MARGIN STATUS FOR INVASIVE CARCINOMA
5914,gpt4,0.815,NUMBER OF LYMPH NODES EXAMINED
5915,gpt4,0.667,NODAL SITE(S) EXAMINED
5916,gpt4,0.668,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5917,gpt4,0.686,TUMOR FOCALITY
5918,gpt4,0.691,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5919,gpt4,0.676,MARGIN STATUS FOR NON-INVASIVE TUMOR
5920,gpt4,0.656,VISCERAL PLEURA INVASION
5921,gpt4,0.669,LYMPH NODE(S) FROM PRIOR PROCEDURES
5922,gpt4,0.719,TUMOR SITE
5923,gpt4,0.7,SPECIMEN LATERALITY
5924,gpt4,0.646,PROCEDURE
5925,gpt4,0.726,REGIONAL LYMPH NODE STATUS
5926,gpt4,0.719,NODAL SITE(S) EXAMINED
5927,gpt4,0.802,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5928,gpt4,0.68,SPREAD THROUGH AIR SPACES (STAS)
5929,gpt4,0.772,MARGIN STATUS FOR NON-INVASIVE TUMOR
5930,gpt4,0.688,VISCERAL PLEURA INVASION
5931,gpt4,0.674,TUMOR FOCALITY
5932,gpt4,0.725,REGIONAL LYMPH NODE STATUS
5933,gpt4,0.694,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5934,gpt4,0.649,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5935,gpt4,0.708,MARGIN STATUS FOR INVASIVE CARCINOMA
5936,gpt4,0.667,PROCEDURE
5937,gpt4,0.776,LYMPH NODE(S) FROM PRIOR PROCEDURES
5938,gpt4,0.77,SPECIMEN LATERALITY
5939,gpt4,0.667,NUMBER OF LYMPH NODES EXAMINED
5940,gpt4,0.693,TUMOR SITE
5941,gpt4,0.649,NODAL SITE(S) EXAMINED
5942,gpt4,0.673,HISTOLOGIC GRADE
5943,gpt4,0.688,SPREAD THROUGH AIR SPACES (STAS)
5944,gpt4,0.697,SPECIMEN LATERALITY
5945,gpt4,0.797,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5946,gpt4,0.654,NODAL SITE(S) EXAMINED
5947,gpt4,0.667,HISTOLOGIC GRADE
5948,gpt4,0.661,LYMPH NODE(S) FROM PRIOR PROCEDURES
5949,gpt4,0.69,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5950,gpt4,0.719,TUMOR SITE
5951,gpt4,0.697,MARGIN STATUS FOR INVASIVE CARCINOMA
5952,gpt4,0.708,ADDITIONAL FINDINGS
5953,gpt4,0.687,VISCERAL PLEURA INVASION
5954,gpt4,0.654,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5955,gpt4,0.734,MARGIN STATUS FOR NON-INVASIVE TUMOR
5956,gpt4,0.732,NUMBER OF LYMPH NODES EXAMINED
5957,gpt4,0.694,SPREAD THROUGH AIR SPACES (STAS)
5958,gpt4,0.666,TUMOR FOCALITY
5959,gpt4,0.659,PROCEDURE
5960,gpt4,0.725,REGIONAL LYMPH NODE STATUS
5961,gpt4,0.708,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5962,gpt4,0.674,SPREAD THROUGH AIR SPACES (STAS)
5963,gpt4,0.809,SPECIMEN LATERALITY
5964,gpt4,0.747,NUMBER OF LYMPH NODES EXAMINED
5965,gpt4,0.672,VISCERAL PLEURA INVASION
5966,gpt4,0.689,MARGIN STATUS FOR NON-INVASIVE TUMOR
5967,gpt4,0.643,NODAL SITE(S) EXAMINED
5968,gpt4,0.656,PROCEDURE
5969,gpt4,0.665,HISTOLOGIC GRADE
5970,gpt4,0.642,ADDITIONAL FINDINGS
5971,gpt4,0.64,TUMOR FOCALITY
5972,gpt4,0.676,TUMOR SITE
5973,gpt4,0.708,REGIONAL LYMPH NODE STATUS
5974,gpt4,0.706,MARGIN STATUS FOR INVASIVE CARCINOMA
5975,gpt4,0.664,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5976,gpt4,0.838,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5977,gpt4,0.809,SPECIMEN LATERALITY
5978,gpt4,0.653,TUMOR FOCALITY
5979,gpt4,0.726,REGIONAL LYMPH NODE STATUS
5980,gpt4,0.811,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
5981,gpt4,0.841,MARGIN STATUS FOR NON-INVASIVE TUMOR
5982,gpt4,0.686,SPREAD THROUGH AIR SPACES (STAS)
5983,gpt4,0.713,MARGIN STATUS FOR INVASIVE CARCINOMA
5984,gpt4,0.72,TUMOR SITE
5985,gpt4,0.804,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
5986,gpt4,0.662,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
5987,gpt4,0.673,VISCERAL PLEURA INVASION
5988,gpt4,0.707,HISTOLOGIC GRADE
5989,gpt4,0.701,NUMBER OF LYMPH NODES EXAMINED
5990,gpt4,0.666,PROCEDURE
5991,gpt4,0.65,NODAL SITE(S) EXAMINED
5992,gpt4,0.776,LYMPH NODE(S) FROM PRIOR PROCEDURES
5993,gpt4,0.73,HISTOLOGIC GRADE
5994,gpt4,0.848,MARGIN STATUS FOR NON-INVASIVE TUMOR
5995,gpt4,0.665,TUMOR FOCALITY
5996,gpt4,0.742,ADDITIONAL FINDINGS
5997,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
5998,gpt4,0.71,PROCEDURE
5999,gpt4,0.704,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6000,gpt4,0.726,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6001,gpt4,0.718,REGIONAL LYMPH NODE STATUS
6002,gpt4,0.773,SPECIMEN LATERALITY
6003,gpt4,0.688,VISCERAL PLEURA INVASION
6004,gpt4,0.771,MARGIN STATUS FOR INVASIVE CARCINOMA
6005,gpt4,0.651,NODAL SITE(S) EXAMINED
6006,gpt4,0.662,TUMOR SITE
6007,gpt4,0.671,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6008,gpt4,0.7,REGIONAL LYMPH NODE STATUS
6009,gpt4,0.744,MARGIN STATUS FOR NON-INVASIVE TUMOR
6010,gpt4,0.695,MARGIN STATUS FOR INVASIVE CARCINOMA
6011,gpt4,0.75,TUMOR SITE
6012,gpt4,0.671,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6013,gpt4,0.644,NODAL SITE(S) EXAMINED
6014,gpt4,0.662,VISCERAL PLEURA INVASION
6015,gpt4,0.67,HISTOLOGIC GRADE
6016,gpt4,0.805,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6017,gpt4,0.68,PROCEDURE
6018,gpt4,0.809,SPECIMEN LATERALITY
6019,gpt4,0.698,LYMPH NODE(S) FROM PRIOR PROCEDURES
6020,gpt4,0.644,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6021,gpt4,0.666,TUMOR FOCALITY
6022,gpt4,0.704,SPECIMEN LATERALITY
6023,gpt4,0.691,MARGIN STATUS FOR INVASIVE CARCINOMA
6024,gpt4,0.67,LYMPHOVASCULAR INVASION
6025,gpt4,0.817,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6026,gpt4,0.722,TUMOR SITE
6027,gpt4,0.669,NODAL SITE(S) EXAMINED
6028,gpt4,0.709,MARGIN STATUS FOR NON-INVASIVE TUMOR
6029,gpt4,0.664,HISTOLOGIC GRADE
6030,gpt4,0.656,SPREAD THROUGH AIR SPACES (STAS)
6031,gpt4,0.663,TUMOR FOCALITY
6032,gpt4,0.646,PROCEDURE
6033,gpt4,0.671,LYMPH NODE(S) FROM PRIOR PROCEDURES
6034,gpt4,0.68,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6035,gpt4,0.709,VISCERAL PLEURA INVASION
6036,gpt4,0.741,REGIONAL LYMPH NODE STATUS
6037,gpt4,0.818,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6038,gpt4,0.644,VISCERAL PLEURA INVASION
6039,gpt4,0.672,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6040,gpt4,0.658,HISTOLOGIC GRADE
6041,gpt4,0.681,MARGIN STATUS FOR INVASIVE CARCINOMA
6042,gpt4,0.776,LYMPH NODE(S) FROM PRIOR PROCEDURES
6043,gpt4,0.719,TUMOR SITE
6044,gpt4,0.72,SPECIMEN LATERALITY
6045,gpt4,0.662,SPREAD THROUGH AIR SPACES (STAS)
6046,gpt4,0.715,NUMBER OF LYMPH NODES EXAMINED
6047,gpt4,0.755,MARGIN STATUS FOR NON-INVASIVE TUMOR
6048,gpt4,0.833,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6049,gpt4,0.702,REGIONAL LYMPH NODE STATUS
6050,gpt4,0.662,TUMOR FOCALITY
6051,gpt4,0.669,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6052,gpt4,0.684,NODAL SITE(S) EXAMINED
6053,gpt4,0.654,PROCEDURE
6054,gpt4,0.775,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6055,gpt4,0.728,REGIONAL LYMPH NODE STATUS
6056,gpt4,0.658,TUMOR FOCALITY
6057,gpt4,0.709,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6058,gpt4,0.665,HISTOLOGIC GRADE
6059,gpt4,0.785,NUMBER OF LYMPH NODES EXAMINED
6060,gpt4,0.681,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6061,gpt4,0.669,PROCEDURE
6062,gpt4,0.72,MARGIN STATUS FOR INVASIVE CARCINOMA
6063,gpt4,0.77,SPECIMEN LATERALITY
6064,gpt4,0.64,MARGIN STATUS FOR NON-INVASIVE TUMOR
6065,gpt4,0.651,TUMOR SITE
6066,gpt4,0.636,NODAL SITE(S) EXAMINED
6067,gpt4,0.701,LYMPH NODE(S) FROM PRIOR PROCEDURES
6068,gpt4,0.675,VISCERAL PLEURA INVASION
6069,gpt4,0.715,TUMOR SITE
6070,gpt4,0.691,PROCEDURE
6071,gpt4,0.805,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6072,gpt4,0.783,LYMPH NODE(S) FROM PRIOR PROCEDURES
6073,gpt4,0.738,REGIONAL LYMPH NODE STATUS
6074,gpt4,0.73,VISCERAL PLEURA INVASION
6075,gpt4,0.724,MARGIN STATUS FOR INVASIVE CARCINOMA
6076,gpt4,0.805,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6077,gpt4,0.732,MARGIN STATUS FOR NON-INVASIVE TUMOR
6078,gpt4,0.652,NODAL SITE(S) EXAMINED
6079,gpt4,0.697,SPECIMEN LATERALITY
6080,gpt4,0.775,NUMBER OF LYMPH NODES EXAMINED
6081,gpt4,0.65,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6082,gpt4,0.695,SPREAD THROUGH AIR SPACES (STAS)
6083,gpt4,0.675,TUMOR FOCALITY
6084,gpt4,0.651,LYMPHOVASCULAR INVASION
6085,gpt4,0.67,NODAL SITE(S) EXAMINED
6086,gpt4,0.706,TUMOR SITE
6087,gpt4,0.715,MARGIN STATUS FOR NON-INVASIVE TUMOR
6088,gpt4,0.634,PROCEDURE
6089,gpt4,0.73,REGIONAL LYMPH NODE STATUS
6090,gpt4,0.667,TUMOR FOCALITY
6091,gpt4,0.668,VISCERAL PLEURA INVASION
6092,gpt4,0.676,NODAL SITE(S) WITH TUMOR
6093,gpt4,0.802,NUMBER OF LYMPH NODES EXAMINED
6094,gpt4,0.713,NUMBER OF LYMPH NODES WITH TUMOR
6095,gpt4,0.856,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6096,gpt4,0.802,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6097,gpt4,0.695,SPECIMEN LATERALITY
6098,gpt4,0.688,LYMPHOVASCULAR INVASION
6099,gpt4,0.776,LYMPH NODE(S) FROM PRIOR PROCEDURES
6100,gpt4,0.682,MARGIN STATUS FOR INVASIVE CARCINOMA
6101,gpt4,0.657,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6102,gpt4,0.751,MARGIN STATUS FOR NON-INVASIVE TUMOR
6103,gpt4,0.649,TUMOR FOCALITY
6104,gpt4,0.741,REGIONAL LYMPH NODE STATUS
6105,gpt4,0.661,SPECIMEN LATERALITY
6106,gpt4,0.619,NODAL SITE(S) EXAMINED
6107,gpt4,0.692,PROCEDURE
6108,gpt4,0.718,TUMOR SITE
6109,gpt4,0.714,HISTOLOGIC GRADE
6110,gpt4,0.82,NUMBER OF LYMPH NODES EXAMINED
6111,gpt4,0.695,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6112,gpt4,0.738,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6113,gpt4,0.676,VISCERAL PLEURA INVASION
6114,gpt4,0.735,MARGIN STATUS FOR INVASIVE CARCINOMA
6115,gpt4,0.667,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6116,gpt4,0.68,LYMPH NODE(S) FROM PRIOR PROCEDURES
6117,gpt4,0.747,REGIONAL LYMPH NODE STATUS
6118,gpt4,0.718,SPECIMEN LATERALITY
6119,gpt4,0.685,ADDITIONAL FINDINGS
6120,gpt4,0.687,MARGIN STATUS FOR NON-INVASIVE TUMOR
6121,gpt4,0.656,MARGIN STATUS FOR INVASIVE CARCINOMA
6122,gpt4,0.632,TUMOR FOCALITY
6123,gpt4,0.71,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6124,gpt4,0.653,VISCERAL PLEURA INVASION
6125,gpt4,0.714,TNM DESCRIPTORS
6126,gpt4,0.648,NODAL SITE(S) EXAMINED
6127,gpt4,0.666,HISTOLOGIC GRADE
6128,gpt4,0.646,PROCEDURE
6129,gpt4,0.739,TUMOR SITE
6130,gpt4,0.72,REGIONAL LYMPH NODE STATUS
6131,gpt4,0.772,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6132,gpt4,0.667,PROCEDURE
6133,gpt4,0.717,NUMBER OF LYMPH NODES EXAMINED
6134,gpt4,0.664,TUMOR SITE
6135,gpt4,0.809,SPECIMEN LATERALITY
6136,gpt4,0.776,LYMPH NODE(S) FROM PRIOR PROCEDURES
6137,gpt4,0.787,MARGIN STATUS FOR NON-INVASIVE TUMOR
6138,gpt4,0.714,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6139,gpt4,0.678,TUMOR FOCALITY
6140,gpt4,0.68,HISTOLOGIC GRADE
6141,gpt4,0.68,MARGIN STATUS FOR INVASIVE CARCINOMA
6142,gpt4,0.643,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6143,gpt4,0.682,VISCERAL PLEURA INVASION
6144,gpt4,0.743,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6145,gpt4,0.659,NODAL SITE(S) EXAMINED
6146,gpt4,0.905,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6147,gpt4,0.714,HISTOLOGIC GRADE
6148,gpt4,0.758,MARGIN STATUS FOR NON-INVASIVE TUMOR
6149,gpt4,0.798,REGIONAL LYMPH NODE STATUS
6150,gpt4,0.694,SPREAD THROUGH AIR SPACES (STAS)
6151,gpt4,0.632,ADDITIONAL FINDINGS
6152,gpt4,0.647,TUMOR FOCALITY
6153,gpt4,0.674,VISCERAL PLEURA INVASION
6154,gpt4,0.677,PROCEDURE
6155,gpt4,0.813,NUMBER OF LYMPH NODES EXAMINED
6156,gpt4,0.725,MARGIN STATUS FOR INVASIVE CARCINOMA
6157,gpt4,0.945,LYMPH NODE(S) FROM PRIOR PROCEDURES
6158,gpt4,0.709,TUMOR SITE
6159,gpt4,0.684,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6160,gpt4,0.71,SPECIMEN LATERALITY
6161,gpt4,0.697,MARGIN STATUS FOR INVASIVE CARCINOMA
6162,gpt4,0.705,PROCEDURE
6163,gpt4,0.66,HISTOLOGIC GRADE
6164,gpt4,0.806,MARGIN STATUS FOR NON-INVASIVE TUMOR
6165,gpt4,0.636,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6166,gpt4,0.813,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6167,gpt4,0.706,TUMOR SITE
6168,gpt4,0.813,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6169,gpt4,0.731,VISCERAL PLEURA INVASION
6170,gpt4,0.732,REGIONAL LYMPH NODE STATUS
6171,gpt4,0.664,TUMOR FOCALITY
6172,gpt4,0.66,NODAL SITE(S) EXAMINED
6173,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
6174,gpt4,0.697,SPECIMEN LATERALITY
6175,gpt4,0.691,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6176,gpt4,0.773,SPECIMEN LATERALITY
6177,gpt4,0.693,MARGIN STATUS FOR NON-INVASIVE TUMOR
6178,gpt4,0.707,REGIONAL LYMPH NODE STATUS
6179,gpt4,0.635,VISCERAL PLEURA INVASION
6180,gpt4,0.645,NODAL SITE(S) WITH TUMOR
6181,gpt4,0.772,NUMBER OF LYMPH NODES EXAMINED
6182,gpt4,0.64,LYMPHOVASCULAR INVASION
6183,gpt4,0.699,MARGIN STATUS FOR INVASIVE CARCINOMA
6184,gpt4,0.798,NUMBER OF LYMPH NODES WITH TUMOR
6185,gpt4,0.682,TUMOR SITE
6186,gpt4,0.642,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6187,gpt4,0.674,PROCEDURE
6188,gpt4,0.65,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6189,gpt4,0.647,NODAL SITE(S) EXAMINED
6190,gpt4,0.635,TUMOR FOCALITY
6191,gpt4,0.701,MARGIN STATUS FOR NON-INVASIVE TUMOR
6192,gpt4,0.66,LYMPHOVASCULAR INVASION
6193,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
6194,gpt4,0.716,NUMBER OF LYMPH NODES EXAMINED
6195,gpt4,0.704,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6196,gpt4,0.702,MARGIN STATUS FOR INVASIVE CARCINOMA
6197,gpt4,0.781,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6198,gpt4,0.661,TNM DESCRIPTORS
6199,gpt4,0.698,REGIONAL LYMPH NODE STATUS
6200,gpt4,0.672,TUMOR SITE
6201,gpt4,0.668,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6202,gpt4,0.699,ADDITIONAL FINDINGS
6203,gpt4,0.678,PROCEDURE
6204,gpt4,0.716,SPECIMEN LATERALITY
6205,gpt4,0.642,TUMOR FOCALITY
6206,gpt4,0.659,NODAL SITE(S) EXAMINED
6207,gpt4,0.662,VISCERAL PLEURA INVASION
6208,gpt4,0.687,HISTOLOGIC GRADE
6209,gpt4,0.83,NUMBER OF LYMPH NODES WITH TUMOR
6210,gpt4,0.739,VISCERAL PLEURA INVASION
6211,gpt4,0.719,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6212,gpt4,0.82,NUMBER OF LYMPH NODES WITH TUMOR
6213,gpt4,0.795,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6214,gpt4,0.731,TUMOR SITE
6215,gpt4,0.675,MARGIN STATUS FOR NON-INVASIVE TUMOR
6216,gpt4,0.704,SPECIMEN LATERALITY
6217,gpt4,0.647,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6218,gpt4,0.657,PROCEDURE
6219,gpt4,0.648,TUMOR FOCALITY
6220,gpt4,0.677,LYMPH NODE(S) FROM PRIOR PROCEDURES
6221,gpt4,0.693,REGIONAL LYMPH NODE STATUS
6222,gpt4,0.681,HISTOLOGIC GRADE
6223,gpt4,0.644,NODAL SITE(S) WITH TUMOR
6224,gpt4,0.671,LYMPHOVASCULAR INVASION
6225,gpt4,0.682,MARGIN STATUS FOR INVASIVE CARCINOMA
6226,gpt4,0.651,NODAL SITE(S) EXAMINED
6227,gpt4,0.809,SPECIMEN LATERALITY
6228,gpt4,0.721,MARGIN STATUS FOR NON-INVASIVE TUMOR
6229,gpt4,0.683,DISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN
6230,gpt4,0.736,TOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR)
6231,gpt4,0.793,TUMOR SITE
6232,gpt4,0.688,MARGIN STATUS FOR INVASIVE CARCINOMA
6233,gpt4,0.646,PROCEDURE
6234,gpt4,0.671,VISCERAL PLEURA INVASION
6235,gpt4,0.653,NODAL SITE(S) EXAMINED
6236,gpt4,0.663,CLOSEST MARGIN(S) TO INVASIVE CARCINOMA
6237,gpt4,0.724,REGIONAL LYMPH NODE STATUS
6238,gpt4,0.697,SPECIMEN LATERALITY
6239,gpt4,0.71,PROCEDURE
6240,gpt4,0.776,LYMPH NODE(S) FROM PRIOR PROCEDURES
6241,gpt4,0.643,TUMOR FOCALITY
6242,gpt4,0.659,SPREAD THROUGH AIR SPACES (STAS)
6243,gpt4,0.681,VISCERAL PLEURA INVASION
6244,gpt4,0.841,MARGIN STATUS FOR NON-INVASIVE TUMOR
6245,gpt4,0.655,NODAL SITE(S) EXAMINED
6246,gpt4,0.73,REGIONAL LYMPH NODE STATUS
6247,gpt4,0.789,MARGIN STATUS FOR NON-INVASIVE TUMOR
6248,gpt4,0.692,PROCEDURE
6249,gpt4,0.646,TUMOR FOCALITY
6250,gpt4,0.77,SPECIMEN LATERALITY
6251,gpt4,0.687,NODAL SITE(S) EXAMINED
6252,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
6253,gpt4,0.672,VISCERAL PLEURA INVASION
6254,gpt4,0.67,ADDITIONAL FINDINGS
6255,gpt4,0.716,TUMOR SITE
6256,gpt4,0.709,REGIONAL LYMPH NODE STATUS
6257,gpt4,0.702,NUMBER OF LYMPH NODES EXAMINED
6258,gpt4,0.69,SPREAD THROUGH AIR SPACES (STAS)
6259,gpt4,0.653,HISTOLOGIC GRADE
6260,gpt4,0.674,PROCEDURE
6261,gpt4,0.668,VISCERAL PLEURA INVASION
6262,gpt4,0.627,MARGIN STATUS FOR NON-INVASIVE TUMOR
6263,gpt4,0.723,REGIONAL LYMPH NODE STATUS
6264,gpt4,0.672,TUMOR SITE
6265,gpt4,0.921,LYMPH NODE(S) FROM PRIOR PROCEDURES
6266,gpt4,0.677,NODAL SITE(S) EXAMINED
6267,gpt4,0.665,SPREAD THROUGH AIR SPACES (STAS)
6268,gpt4,0.647,ADDITIONAL FINDINGS
6269,gpt4,0.739,NUMBER OF LYMPH NODES EXAMINED
6270,gpt4,0.654,SPECIMEN LATERALITY
6271,gpt4,0.721,TUMOR FOCALITY
